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Danger Signaling Through The Inflammasome: A Master Switch Between Tolerance 
and Sensitization to Irritant Chemicals
O Gaide1, H Watanabe1, S Gehrke1, S Roques1, A Caillon1, J Tschopp2, LE French3
1Geneva University Hospital, Switzerland 2UNIL, Epalinges, Switzerland 3University 
Hospital Zürich, Switzerland
We have recently shown that contact hypersensitivity (CHS) due to irritant chemicals, 
such as di-nitro-fluoro-benzene (DNFB), is dependent on the inflammasome. This 
protein complex regulates the activation of caspase-1 and, subsequently, of the pro-
inflammatory cytokines IL-1b and IL-18. Di-nitro-thiocyano-benzene (DNTB), which 
is structurally related to DNFB, not only fails to induce CHS but induces tolerance, 
as DNFB fails to sensitize mice that were pre-treated with DNTB. Interestingly, DNFB 
sensitized mice are allergic to DNTB, suggesting that both molecules provide similar 
antigens, but differ in their effect on the adaptive immune system. We hypothesized that 
danger signals mediated by the inflammasome are implicated in tolerance vs sensitiza-
tion mechanisms, and studied the effect of DNTB, DNFB and inflammasome signaling 
in vitro and in vivo. We found that DNTB, unlike DNFB, di-nitro-chloro-benzene, tri-
nitro-chloro-benzene and urushiol, fail to activate the inflammasome in primary kerati-
nocytes. In vivo, DNTB becomes a sensitizer if concomitant inflammasome signaling is 
provided, using SDS or IL-1b. Conversely, blocking inflammasome signaling (using the 
caspase-1 inhibitor zYVAD or ASC deficient mice) turns DNFB into a tolerizer, through 
an IL-12 -dependent mechanism. These findings strongly suggest that the inflammasome 
acts as a master switch between tolerance and sensitization to irritant chemicals. They 
illustrate the sequential role of innate immunity and adaptive immunity in CHS, and 
hint at new strategies to modulate T cell responses in the skin.
002 [Oral 025]
Mast Cell-Derived Endothelin-1 Contributes To Allergic Inflammation
M Metz1, B Schäfer2, M Tsai2, SJ Galli2, M Maurer1 1Charité Berlin, Berlin, Germany 
2Stanford University, Stanford, USA
Allergic activation of mast cells (MCs) is induced by cross-linking IgE bound to MC FcεRI. 
However, the factors that may influence IgE/antigen-mediated MC activation are not fully un-
derstood. We investigated the contribution of endothelin-1 (ET-1) to allergic inflammation by 
pharmacologically targeting the ET receptors ETA and ETB in systemic (PSA) or cutaneous (PCA) 
anaphylaxis in mice and measuring various aspects of the responses. The robust drop in body 
temperature after PSA was significantly reduced by the ETA antagonist BQ-123 (-5.8°C in ve-
hicle vs. -4.6°C in BQ-123 pre-treated mice, p<0.0005), but not by BQ-788, an ETB antago-
nist. Similar results were obtained in PCA: ear swelling at 60 min was significantly reduced by 
BQ-123 (by 30.5%, p<0.05). Fluid extravasation in the ears also was assessed by measuring 
amounts of previously injected Evans blue. BQ-123 pre-treated mice exhibited significant re-
ductions in PCA-associated Evans blue extravasation (by 39.3%, p<0.05). Since both PCA and 
PSA are models of MC-dependent inflammation, we investigated whether inhibition of ETA 
reduced IgE/antigen-mediated MC degranulation. Analysis of MCs in the peritoneal lavage fluid 
after induction of PSA revealed a significantly reduced percentage of extensively degranulated 
MCs in BQ-123 pre-treated mice. Elevated levels of ET-1 were not detected in the peritoneal 
fluid of any of the groups, arguing against a substantial release of ET-1 during IgE-dependent 
anaphylaxis. It has been reported that MCs can produce ET-1. We detected the secretion of 
small amounts of ET-1 from bone marrow-derived cultured mast cells (BMCMCs; generated in 
medium containing IL-3, IL-4 and SCF) after IgE/antigen-induced degranulation in vitro, sug-
gesting that ET-1 released from MCs upon IgE/antigen-mediated activation, as well as ET-1 from 
other sources, may directly or indirectly enhance MC degranulation. Our results suggest that 
ETA may function, at least under some circumstances, as a co-activating MC receptor in IgE- and 
MC-dependent allergic responses.
003 [Oral 026]
Reduced systemic anaphylaxis and impaired mast cell degranulation in mice defi-
cient in the K+ channel SK4
F Woelbing, E Shumilina, R Lam, M Sobiesiak, IM Zemtsova, H Mahmud, M Sausbier, 
P Ruth, F Lang, T Biedermann Eberhard Karls University, Tübingen, Germany
Cross linking of IgE molecules bound to mast cell surface-FcεRI initiates signal transduc-
tion resulting in a fast increase of cytosolic free Ca2+ followed by mast cell degranulation. 
The purpose of our work was to examine the role of the Ca2+-activated K+ channel SK4 
for FcεRI dependent mast cell activation and degranulation. To this end, mice were pas-
sively sensitised with Dinitrophenol (DNP)-specific IgE over night and challenged with 
different doses of DNP to determine the threshold dose of DNP eliciting systemic ana-
phylaxis. Anaphylaxis read out was the decrease of core body temperature as detected 
by measuring rectal temperature every 5-7 min. After passive sensitisation, sk4 knockout 
mice (sk4-/-) and their sk4 wild-type littermates (sk4+/+) were challenged with 120µg 
DNP and core body temperature was monitored for 112 minutes. A fast decline in body 
temperature was detected in all mice, but only sk4+/+ mice developed full-blown ana-
phylaxis after 30 min with a maximum temperature drop of 3,1±0,56°C. Anaphylaxis 
was significantly reduced in sk4-/- mice showing a maximal temperature drop of only 
1,6±0,47°C. To analyze whether reduced anaphylaxis depended on the absence of SK4 
in mast cells, bone marrow derived mast cells (BMMC) of sk4-/- and sk4+/+ mice were 
generated showing unequivocal phenotypes after 4 weeks of culture with IL-3 and SCF 
(CD117+, CD34+, FceRI+). In vitro degranulation of mast cells as detected by release of 
ß-hexosaminidase was significantly reduced in BMMC from sk4-/- mice (>50%). In order 
to identify the role of the K+ channel SK4 in more detail, patch clamping was performed 
demonstrating that allergen specific activation resulted in cell membrane hyperpolarisa-
tion in sk4+/+ but not in sk4-/- BMMC. We conclude that SK4 is required for degranula-
tion of mast cells and systemic anaphylaxis.
004 [Oral 027]
A New Mouse Model for Mastocytosis
A Roers, A Gerbaulet, J Scholten, T Krieg, K Hartmann University of Cologne, 
Germany
Mastocytosis is characterized by infiltration of abnormal numbers of mast cells into 
skin and internal organs. The clinical spectrum is broad ranging from mild increases 
in cutaneous mast cell numbers to severe forms of mast cell leukaemia. The disease 
is associated with activating somatic point mutations of the receptor tyrosine kinase 
Kit, however, the relevance of these mutations for the different forms of the disease is 
unclear. We generated a transgenic mouse model based on a 200 kb BAC containing 
the entire kit gene. Two modifications were introduced: 1) the activating point muta-
tion D814V and 2) a floxed ‘stop’ cassette, allowing Cre/LoxP-mediated control of 
transgene expression. The construct was pronucleus-injected and founder animals 
transmitted the transgene in the germline. KitD814Vflox transgenic mice were bred to 
the hCMV (deleter)-Cre-line for ubiquitous deletion of the stop element, which should 
result in expression of the mutated kit under the control of the kit promotor elements 
contained in the transgene. KitD814Vflox deleter-Cre double transgenic mice were 
born in numbers significantly lower than expected indicating a high frequency of em-
bryonic lethality. The few animals born alive displayed a diverse spectrum of pheno-
types. While some mice showed cutaneous mastocytosis of variable intensity, others 
developed various additional neoplasms including malignant mast cell tumors. We are 
presently investigating the cause of embryonic death in the majority of KitD814Vflox 
deleter-Cre double transgenic embryos, the effect of KitD814V expression in mature 
mast cells of KitD814Vflox Mcpt5-Cre double transgenic mice and the induction of 
KitD814V expression in adult KitD814Vflox Mx-Cre double transgenic mice.
005 [Oral 028]
TGF-beta/Smad3 -signaling regulates inflammatory responses in a murine model of 
contact hypersensitivity
A Lauerma, M Anthoni, N Fyhrquist-Vanni, H Wolff, H Alenius Finnish Institute of 
Occupational Health, Helsinki, Finland
TGF-β is an important modulator of immune functions and cellular responses, such 
as differentiation, proliferation, migration and apoptosis. The Smad proteins, which 
are intracellular TGF-β signal transducers, mediate most actions of TGF-β. This study 
examines the role of the Smad3-mediated pathway of TGF-β signaling in a murine 
model of contact hypersensitivity (CHS). Neutrophil infiltration was more intensive 
in the skin of Smad3 deficient mice when compared to their wild type siblings. The 
deviating cell infiltration was accompanied by significantly increased levels of mRNA 
for pro-inflammatory cytokines IL-6, IL-1-alpha and TNF-alpha as well as Th2 type cy-
tokine IL-4 and chemokines CCL24, CCL3 and CXCL5. Topical exposure to oxazolo-
ne induced significantly increased expression of TGF-β and Foxp3 mRNA. However, 
Th1 cytokine IFN-gamma, as well as Th1 type chemokines CXCL9 and CXCL10 were 
unaffected by the lack of Smad3, and the ear swelling responses to topically applied 
oxazolone were similar in Smad3 knockout mice compared to wild type mice. The 
lack of intact TGF-β signaling via Smad3 elevates pro-inflammatory processes in CHS, 
accelerated expression of chemokines and Th2 cytokines, and increased infiltration 
of neutrophils. Understanding the response mechanisms of TGF-β -signaling on CHS 
may offer treatment and prevention strategies to this often disabling disease.
006 [Oral 029]
TLR7-Agonists induce the expression of SOCSs genes in human Plasmacytoid Den-
dritic Cells 
N Novak, WM Peng, L Maintz, C Bussmann, JP Allam, CF Yu University of Bonn, 
Bonn, Germany
Toll-like receptor (TLR)-7 is an intracellular receptor expressed by Plasmacytoid 
dendritic cells to recognize viral RNA. Following TLR signalling, professional type I 
interferon producing cells (PDC) are transferred into mature PDC-derived dendritic 
cells. Recently, it has been shown that TLR signalling is controlled by proteins of the 
suppressors of cytokine signalling (SOCS) family, which have been demonstrated to 
reveal strong negative regulatory functions on cytokine signalling. We hypothesized 
that SOCSs could be involved in TRL7 signalling to regulate the duration and intensity 
of TRL7 mediated signal transduction events in PDC. Firstly, we found a profound shift 
from PDC into PDC-dervied DC after TLR7 agonist stimulation of PDC isolated from 
human peripheral blood. Costimulatory molecules such as CD80 and CD86, CD40, 
as well as major histocompatiblitiy class (MHC) I and II molecules were up-regulated, 
while the expression of the blood dendritic cell antigen (BDCA)-2 was downregulated 
on TLR7-stimulated PDC. Furthermore, enhanced SOCS1 and SOCS3 mRNA levels, 
but not SOCS5 mRNA levels could be induced in human PDC after TLR7 activation. 
In addition, using neutralizing antibodies against cytokines produced by PDC in re-
sponse to TLR7-ligation, such as IFNalpha-beta, IL-10 and TNF-alpha, we could show 
that induction of SOCSs genes was rather related to a direct TLR7-mediated induction 
of the SOCS signalling cascade than an indirect endogenous effect of cytokines re-
leased by PDC. From our data we conclude that TLR7 agonist- mediated SOCS1 and 
SOCS3 gene induction in PDC might play a role for the therapeutic effect of TLR7-
agonists such as imiquimod in the treatment of skin diseases which involve PDC.
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UV-induced regulatory T cells inhibit antigen-presenting cells via by-stander suppression
A Schwarz, A Maeda, T Schwarz University of Schleswig-Holstein, Kiel, Germany
UV-induced regulatory T cells (UV-Treg) inhibit sensitization in an antigen (Ag)-
specific fashion. As demonstrated recently, the migratory behavior of UV-Treg can be 
reprogrammed by tissue-specific antigen-presenting cells (APC) in an Ag-specific manner. 
Here we studied whether in turn UV-induced Treg can influence APC and whether this 
is Ag-specific. Therefore, bone marrow-derived dendritic cells (DC) coupled with DNBS, 
the water soluble analogue of the hapten dinitrofluorobencene (DNFB), were co-cultured 
with DNFB-specific CD4+CD25+ Treg obtained from UV-tolerized mice. 16 h later T cells 
were depleted and APC were subcutaneously (s.c.) injected into naïve mice. 5 days later 
ears were challenged with DNFB and ear thickness measured 24 h later. While DNBS-
coupled DC induced contact hypersensitivity (CHS), s.c. injection of DNBS-coupled BM-
DC which had been co-cultured with Treg failed to induce CHS to DNFB. To determine 
whether this loss of Ag-presenting capacity of DC induced by UV-Treg is Ag-specific, 
UV-Treg were co-cultured with DC coupled with DNBS. After depletion of T cells, DC 
were pulsed with TNBS, the analogue of trinitrochlorobencene (TNCB), and injected 
s.c. into naïve mice. This did not result in sensitization against TNCB, indicating that 
DNFB-specific UV-Treg can inhibit APC to present other antigens than DNFB. In contrast, 
injection of TNBS-coupled DC which were co-incubated with DNFB-specific Treg in the 
absence of DNBS induced CHS to TNCB in naïve mice. These findings indicate that UV-
Treg, once activated Ag-specifically, inhibit the function of APC in general. Upon Ag-
specific activation, UV-Treg released high amounts of IL-10 which might be responsible 
for the inhibition of APC. This indicates that UV-Treg in turn can modulate APC. Once 
activated in an Ag-specific fashion, UV-Treg inhibit APC function in an Ag-independent 
manner via the release of IL-10, as it has been described for by-stander suppression. 
 
008 [Oral 031]
Beta endorphin produced by tumor cells plays a role in immune escape
B Duthey1, E Deak1, K Hardt1, S Hoehl1, D Schadendorf2, WH Boehncke1 1Clinic 
of the J.W. Goethe University, Frankfurt/Main, Germany 2University of Heidelberg, 
Heidelberg, Germany
Beta endorphin is an endogenous peptide which binds to the mu opioid receptor 
(MOR). It is released mainly by neurons and to a lesser extend by neutrophils to 
promote analgesic effects. Interestingly, beta endorphin has also been found to 
be secreted in several tumors such as melanoma, breast colon prostate and lung 
cancer.  By using a cohort of human biopsies of melanoma we showed that a 
correlation exists between beta endorphin secretion in tumor and malignancy. The 
purpose of this study was then to investigate if beta endorphin could play a role 
in cancer progression. We used mu opioid receptor knock out mice (MOR KO) as 
a model and injected subcutaneously B16 melanoma cells which secrete naturally 
beta endorphin. A significant decrease in tumor growth was observed in the MOR 
KO mice vs the WT counterparts (p <0,001). Analysis of tumors by FACs revealed 
higher amounts of CD4 +, CD8+, CD11c + and NK cells in tumors from MOR KO 
vs WT. Vessel formation within the tumor was also highly upregulated in MOR KO 
mice, as indicated by CD31 staining. In vitro analysis revealed that beta endorphin 
reduces the proliferation of human PBMCs and also downregulates the migration of 
leukocytes towards chemokines such as CXCL9, IP-10, Rantes and Fractalkine known 
to be implicated in the recruitment of immune cells within tumor.
These data bring evidence that secretion of beta endorphin by tumor cells plays a role 
in immune escape and offer new perspectives in cancer therapy. 
 
009 [Oral 032]
Antimicrobially active hornerin peptides as protective factors of healthy skin
ZH Wu, U Meyer-Hoffert, J Bartels, YH He, J Harder, J-M Schröder University of 
Schleswig-Holstein, Kiel, Germany
Human skin is constantly exposed to microorganisms, but normally stays healthy. 
During the last years it became clear that our skin serves not only as a physical barrier 
against infection but also as a chemical barrier by producing antimicrobial peptides 
and proteins (AMPs). With a biochemical/functional strategy, we previously identified 
RNase7 and psoriasin as principal AMPs in extracts of healthy persons’ stratum 
corneum (SC). Upon further analyses we purified a novel AMP, which we identified as a 
peptide fragment of hornerin. To verify this observation, we cloned hornerin, a member 
of the fused S100 gene family which encodes a 235-kDa protein consist of a S100 
domain, an EF-hand domain, a spacer sequence and two types of multiple tandem 
repeats, by RACE-PCR and short range RT-PCR. Human hornerin mRNA was detected 
to be constitutively expressed in foreskin-derived primary keratinocytes cultures, but 
surprisingly - in contrast to previous studies - also location-dependent in healthy skin. 
Immunohistochemistry and Western blot analyses using affinity-purified antibodies 
having been raised against recombinant 8-16 kDa hornerin peptides revealed hornerin 
is present exclusively in palmar and plantar stratum granulosum and SC. Because we 
detected antimicrobial activity in HPLC-fractions containing defined hornerin peptides, 
we generated several recombinant peptides representative for different parts of the 
molecule, including the tandem repeat unit A. Only the latter was found to exhibit 
antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa and Candida 
albicans. We further discovered that different tandem repeat motifs targeted different 
microbes. Our results suggest that hornerin has a protective function. In healthy skin 
it may represent a member of the second chemical barrier, which could be converted 
from a locally preformed inactive pro-AMPs into numerous active AMPs through 
proteolytical cleavage by either endogenous proteases or microbes adhering to SC. 
010 [Oral 033]
Phenotypic and Functional Characterization of Circulating CD4 T Lymphocytes 
Expressing the Glyscosylphosphatidylinositol-anchored CD160 Receptor
V Schiavon1, N Ortonne2, C Schmitt1, M Bagot2, A Bensussan1 1INSERM U841, Creteil, 
France 2Hôpital Henri Mondor, Creteil, France
CD160 is a GPI-anchored Ig-like receptor expressed by circulating CD56dim+ 
NK cells and TCRγδ  lymphocytes. Further, whereas most intestinal intraepithelial 
T lymphocytes express it, only a minor circulating TCRαβ CD8bright+ lymphocyte 
subset is CD160+. Although CD160+CD4+ TCRαβ lymphocytes have never 
been reported in human, recent in situ analyses performed on various chronic 
inflammatory skin lesions revealed for the first time their existence. Here, we describe 
that CD4+CD160+ T lymphocyte population can be isolated from the peripheral 
blood of normal individuals and corresponds to less than 0.3% of the whole CD4+ 
cells. These T lymphocytes co-express CD244 and perforin and are distinct from the 
CD4+KIR+, the CD4+CD25++ and the CD4+CD28- lymphocyte subsets. The T-cell 
receptor beta-variable repertoire analyses indicate that they display an oligoclonal 
TCRVβ repertoire. Functional analyses performed with freshly isolated CD4+CD160+ 
lymphocytes reveal that anti-CD3 monoclonal antibodies fail to induce proliferation 
although they trigger redirected cytotoxic activity. Further, these cells exhibit low 
responses to allogeneic lymphocytes in mixed lymphocyte cultures and do not inhibit 
autologous CD4+CD160- allogeneic induced-proliferation. Thus, these data indicate 
that CD160 membrane expression delineates within the circulating CD4+ lymphocytes 
a unique subset of cytotoxic effector T lymphocyte. As these lymphocytes have been 
initially identified in inflammatory skin biopsies and that we found that they are not 
increased in these patients blood, it indicates that their development and recruitment 
mainly occurs in inflammatory tissues and that they are poorly recirculating. 
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Correlation between Helicobacter Pylori and Chronic Urticaria
A Sadighha Ilam University Of Medical Science, Ilam, Iran
Treatment of silent infection is one of the methods for the control of chronic urticaria 
As the HP infections is one of the most common infections in humans we made this 
study to evaluate the frequency of HP infections in the chronic urticaria. This analytic 
study were made on 72 cases of chronic urticaria and 77 healthy person that evaluated 
regarding to HP infections by serological test (ELISA) for detection the specific Ab Ig G 
and Ig A against HP in immunologic laboratory of blood transfusion organization of 
IR Iran and health center laboratory of Tehran university. Demographic features were 
matched between two group and there were not any significant difference about age 
and gender between two groups.chronic urticaria defined as the weals that lasts more 
than 6 weeks. 52% of patients in case group and 46% in control group were positive 
for Ig A against HP that this difference was not statistically meaningful.(p=0.0001). 
It seems that HP could able to shift the T cell profil from Th1 to Th2.This means that 
eradication of HP do not necesserically improve the urticaria but HP infection plays 
an important role in chronic urticaria.
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The endogenous cannabinoid system alters the chemokine expression profile in the 
skin during allergic contact dermatitis 
E Gaffal, L Wang-Eckhardt, M Karsak, R Steuder, D Tormo, A Zimmer, T Tüting 
University of Bonn, Bonn, Germany
Evidence has accumulated that the endogenous cannabinoid (CB) system is involved 
in the regulation of inflammatory responses. Using CB-receptor deficient mice, we 
have shown that endogenous cannabinoids attenuate allergic contact dermatitis. 
To investigate how endogenous cannabinoids are able to control inflammatory 
responses in the skin we performed microarray experiments. Contact hypersensitivity 
(CHS) was induced in C57Bl/6 mice lacking both known CB-receptors (CB1/2-/-) 
mice as well as in wildtype control mice by application of 0,2% DNFB on the shaved 
abdomen. CHS was elicited by painting one ear with 0,3% DNFB. Microarrays were 
performed on inflamed and normal tissue. Gene expression changes were confirmed 
using RT-PCR as well as in situ hybridization. In microarray experiments immune 
related probe sets represented the largest group of strongly upregulated genes in 
contact allergic skin in both mouse strains. Importantly, CCL8/MCP-2 a member 
of the monocyte chemotactic protein (MCP) family was differentially expressed in 
CB-receptor deficient animals in comparison to wildtype mice. In situ hybridization 
for CCL8/MCP-2 revealed keratinocytes as the major source of this chemokine. Our 
results indicate that modulation of chemokine expression may be involved in the 
downregulation of cutaneous hypersensitivity responses by endogenous cannabinoids. 
 
2007 ESDR Abstracts v2.indd   2 8/13/07   11:31:30 PM
www.jidonline.org  S3
ABSTRACTS
013
Decreased Activity Of Neutrophil Glutathione Peroxidase In Chronic Plaque-Type 
Psoriasis
O Seifert, J Holmberg, B-M Linnarsson
County Hospital Ryhov, Jönköping, Sweden
There is growing evidence supporting the reactive oxygen species in the pathogenesis 
of psoriasis. Insufficient antioxidant activity has been determined in psoriasis. This 
study was performed to evaluate and compare glutathione peroxidase activity in 
neutrophils in patients with psoriasis and controls. 25 psoriatic patients and 23 
healthy controls were involved in this study. Glutathione peroxidase activity was 
investigated by ELISA. The Psoriasis Area and Severity Index was determined for 
each patient. Our data revealed a significantly decreased activity of glutathione 
peroxidase in neutrophils in patients with psoriasis. A significant negative 
correlation to the Psoriasis Area and Severity Index was found. These results support 
the hypothesis of an imbalance in the oxidant-antioxidant system in psoriasis. 
Increased levels of hydrogen peroxide as a result of low glutathione peroxidase 
activity might be responsible for induction of inflammatory processes in psoriasis. 
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Absence of amplification of CD4+CD25high regulatory T cells during in vitro 
expansion of Tumour Infiltrating Lymphocytes (TIL) in melanoma patients
AC Knol1, F Lemaître2, MC Pandolfino1, C Volteau1, G Quéreux1, S Saiagh1, A 
Khammari1, M Viguier3, B Dréno1 1Inserm, U601, Nantes, France 2Inserm, U668, 
Paris, France 3Service de dermatologie Hôpital St Louis, Paris, France
The exact role of CD4+CD25high regulatory T cells (Treg) in adoptive immunotherapy 
of melanoma is still to be determined and whether an expansion of Treg cells is 
associated with the expansion of therapeutic TIL remains unknown. In this context, the 
aim of our study was to determine whether functional Treg cells were detectable and 
amplified among TIL expansion obtained from ten metastatic melanoma LNs. In this 
study, we investigated the expression of Foxp3 in invaded LNs from stage III metastatic 
melanoma (AJCC) patients, and determined proportion and functionality of Treg cells 
among therapeutic Tumor Infiltrating Lymphocytes (TIL) obtained from these ten 
metastatic melanoma LNs at different steps of their in vitro expansion before injection 
to the patient. We found that metastatic melanoma LNs expressed very heterogeneous 
levels of Foxp3 and that CD4+CD25high Treg cells extracted from these LNs were 
detectable at each step of the in vitro culture of TIL but decreasing during the culture. In 
addition, functional assays demonstrated that CD4+CD25high T cells were capable of 
suppressing autologous CD4- or CD8+ and CD4+CD25- T cell proliferation. These cells 
were indeed Treg cells as they expressed Foxp3, and in almost all the cases, the presence 
of Treg type 1/Th3-like lymphocytes could also be demonstrated. In the present work, 
if we observe that functional CD4+CD25high Foxp3 expressing Treg cells were present 
both in the metastatic tissue from which TIL are obtained and in in vitro amplified TIL, we 
also show that conditions for producing autologous TIL infused to melanoma patients, 
do not support the numeric expansion of Treg cells, whose proportion remains weak. 
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In vivo activation of injected Tregs precedes the suppression of the elicitation phase 
of Contact hypersensitivity reactions independent from spleen and lymph nodes
S Ring, K Mahnke, AH Enk University Hospital Heidelberg, Heidelberg, Germany
We previously demonstrated that adoptively transferred naïve CD4+CD25+ T 
cells (Treg) suppress the elicitation phase of allergic contact dermatitis (CHS), 
by inhibiting the endothelium-interaction and extravasation of effector CD8+ T 
cells. Since activation of Treg is necessary to generate this suppressive activity, we 
determined the activation status of isolated Tregs in the course of injection. Directly 
after isolation, the naïve CD4+CD25+ T cells displayed a non-activated phenotype 
as assessed by low expression of CD69 and CD44, and high expression of CD62L. 
2h after injection and re-isolation of the dye-labelled Treg we detected significantly 
increased expression of the activation markers CD69, Foxp3 and CD44, whereas 
CD62L decreased in Treg in vivo after hapten application. This indicates that Treg 
become activated in vivo after injection and explains the comparable suppressive 
function of naïve and activated Treg in vivo. To further determine the importance 
of homing to lymphoid organs for Treg action, we splenektomised mice or injected 
CD62L- Treg. By this way we excluded the homing of Treg to spleen or lymph nodes, 
respectively. In these experiments the Treg were still able to suppress the elicitation 
phase of CHS, indicating that peripheral lymphoid organs are not essential for the 
activation and consequently for the suppressive capacity of injected naïve Treg in 
vivo. These data show that naïve Treg upregulate characteristic activation markers in 
vivo after hapten application which results in the suppression of the elicitation phase 
of CHS, independently of peripheral lymphoid organs. Therefore we can speculate 
that cellular interaction(s) in the blood or at the site of inflammation and/or soluble 
factors are involved in mediating suppressive function(s) of Treg in a CHS model. 
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Differential immune response of a living skin equivalent model colonised by 
Staphylococcus epidermidis and Staphylococcus aureus
DB Holland, AHT Jeremy, RA Bojar, KT Holland University of Leeds, Leeds, UK
Staphylococcus epidermidis is a commensal on skin, whereas Staphylococcus aureus is 
a transient pathogen. The aim of this study was to determine whether the skin’s defence 
systems responded differently to these microorganisms. Differential gene expression 
of a tissue engineered human skin equivalent (SE) model was assessed by microarray 
technology, in response to colonisation by S. epidermidis or S. aureus. Living SEs 
were constructed with a dermal equivalent composed of fibrin containing fibroblasts, 
a continuous basement membrane, a stratified epidermis and a stratum corneum with 
barrier function. Human skin genome 60-mer oligonucleotide microarrays (Agilent) were 
used for comparative examination of cRNA from SEs colonised or not colonised (control) 
with microorganisms. Only a small number of transcripts were significantly (p<0.0001) 
increased (12) or decreased (35) with gene expression changes of >2 fold on SEs colonized 
with S. epidermidis compared with controls. Expression of six innate skin defence genes 
including psoriasin, beta defensin 4, beta defensin 3, lipocalin 2 and peptidoglycan 
recognition protein 2 was downregulated, with pentaxin upregulated. In contrast, large 
numbers of transcripts were significantly increased (480) or decreased (397) with gene 
expression changes of >2 fold on SEs colonized with S. aureus compared with controls. 
There was upregulation in gene expression of many skin defence factors including Toll-
like receptor 2, beta defensin 4, properdin, pentaxin, proinflammatory cytokines IL-
1beta, IL-1alpha, IL-8, IL-17, IL-23A, TNFalpha and chemokines CCL4, CCL5, CCL20 
and CCL27. Thus colonization of SEs by S. epidermidis downregulated the expression of 
genes of the innate immune system, while S. aureus stimulated the upregulation of many 
factors involved in the innate and adaptive immune responses. These differences may 
indicate why S. epidermidis is tolerated by skin and S. aureus is not. 
017
Clonal proliferating non-malignant T cells are representing a restricted TCR repertoire 
and persist in the peripheral blood in cutaneous CD30+ lymphoproliferations
D Humme, A Lukowsky, M Steinhoff, M Beyer, P Walden, W Sterry, C Assaf Charité 
Berlin, Berlin, Germany
The CD30-positive cutaneous lymphoproliferative disorders (CLPD) include lymphomatoid 
papulosis (LyP) and primary cutaneous anaplastic large cell lymphoma (cALCL). Despite 
the histology of malignant appearance LyP is associated with an excellent prognosis, 
with a characteristic tendency to undergo spontaneous regression. Patients typically 
experience a reoccurrence of their disease and even after several years of clinical 
remission identical clonal T cell population of the initial LyP-lesion can be detected in 
the newly erupting skin lesion. This fact raised the question of persistence of the clonal 
T cell population in the peripheral blood at the time of clinical occurrence and during 
periods of clinical remission. In order to answer this question we investigated genomic 
DNA of 125 lesional skin and peripheral blood samples from a total of 31 patients with 
CLPD, obtained at time points of active disease and clinical remission. Molecular genetic 
analysis have been performed using a standardized European TCR-γ protocol (Biomed II) 
in combination with the Genescan technique. In addition, for qualitative and quantitative 
assessment of the TCR repertoire of peripheral blood T cells we analysed mRNA using 
a sensitive betavariable complementarity-determining region 3 spectratyping. We could 
determine in 36/43 (84%) a clonal T cell population in lesional skin T-cell and, in 35/83 
(42%) in the peripheral blood lymphocytes. Comparison of each compartment in each 
patient demonstrated different T cell clones in lesional skin and corresponding blood 
samples, indicating that the clonal T cells in the blood are reactive and not representing 
the malignant T-cell population. Moreover, CDR3 spectratyping of the peripheral blood 
lymphocytes shows that the proliferating T cells represent a restricted T cell repertoire, 
indicating T cell stimulation by an unknown common antigen. 
018
Treatment of established RMA-Tag tumors via DC directed targeting of tumor 
antigens is further improved by depletion of regulatory T cells
V Storn1, K Mahnke1, S Schallenberg1, TS Johnson1, T Bedke1, N Garbi2, B Arnold2, 
GJ Hämmerling2, AH Enk1 1University Hospital Heidelberg, Heidelberg, Germany 
2German Cancer Research Center, Heidelberg, Germany
Tumor antigens, chemically coupled to the antiDEC205 antibody, can target dendritic 
cells in vivo and were successfully applied in murine preventive tumor vaccination 
studies. In this study our aim was to test whether antiDEC205-protein conjugates have 
the potential to reduce the tumor growth of already established tumors. For this end we 
coupled the tumor antigen Tag to antiDEC205 and treated RMA-Tag tumor-bearing mice 
with these conjugates. When the tumors had reached an average diameter of 5 mm the 
mice were injected with antiDEC205-Tag conjugate or Tag protein, plus adjuvants in 
5-day intervals. Although tumor growth was initially slowed down after injection of the 
antiDEC205-Tag conjugates as compared to Tag-treated mice, it resumed two to three 
weeks after the first vaccination. Analysis of the immune response initially revealed 
a strong induction of tumor specific CD8+ T-cells in antiDEC205-Tag treated mice. 
However, when tumor growth resumed increased numbers of CD4+CD25+FoxP3+ 
regulatory T cells (Tregs) in the tumor draining lymph node were noticeable. Thus, 
to assess the suppressive effects of Tregs during tumor therapy, anti-CD25 antibodies 
were used to deplete Tregs from tumor bearing animals during anti-tumor treatment. 
By concomitant injection of antiDEC205-Tag conjugates we could cure up to 40% of 
the tumor bearing mice and tumors were rejected. Furthermore, the survival of tumor 
bearing mice of the autochthonous tumor model RIP-Tag5 could be prolonged for up 
to ten weeks after treatment with antiDEC205-Tag conjugates compared to untreated, 
or Tag-treated mice respectively. In aggregate our data indicate that depletion of CD25+ 
Treg during cancer therapy bolsters the effectiveness of DC based anti-tumor therapies 
and that antiDEC205 targeted vaccination improves treatment of autochthonous tumors. 
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CD4+ T reg cells prevent the priming of weak hapten-specific T cells in vivo
M Vocanson, A Hennino, M Cluzel-Tailhardat, M Valeyrie, J Bénetière, D Kaiserlian, 
A Rozières, JF Nicolas INSERM, Lyon, France
Allergic contact dermatitis (ACD) is mediated by hapten-specific CD8+ T cells and 
down-regulated by CD4+ T cells. We have recently shown in an experimental model 
of ACD to weak haptens (fragrances) that priming of IFNγ-producing CD8+ T cells 
and development of skin inflammation could be obtained in mice deficient in CD4+ 
T cells, but not in normal mice, suggesting that CD4+ T regulatory cells (Treg) control 
the priming of weak hapten-specific T cells. Here, we show that IFNγ production 
by lymph node (LN) cells draining the site of skin sensitization of CD4+ T cell-
deficient mice is a marker of CD8+ T cell priming and therefore a marker of the skin 
sensitizing properties of weak haptens. Auricular draining LN cells were recovered 
5 days after skin painting with a series of 8 weak fragrance allergens and of 4 non 
sensitizers and/or irritants, then cultured for 20 hrs in the presence of submitogenic 
doses of phytohemagglutinine and finally tested for the production of IFNγ (ELISA 
assay). Results show that :i) production of INFγ by LN cells is induced by weak and 
moderate allergens in a dose dependant fashion in CD4+ T cell-deficient mice only; 
ii) chemicals without sensitizing properties and irritants are unable to stimulate IFNγ 
production by LN cells of both normal mice and CD4+ T cell-depleted mice. These 
results confirm that CD4+ T reg cells control the priming and expansion of hapten-
specific T cells and suggest that IFNγ production by LN cells of mice exposed to 
chemicals could represent a new marker of the sensitizing properties of chemicals. 
 
020
The chemokine receptor CCR3 participates in tissue remodeling during atopic skin 
inflammation
K Gaspar, G Kukova, B Homey Heinrich Heine University, Düsseldorf, Germany
Atopic dermatitis represents a chronic inflammatory skin disease with pronounced 
tissue remodeling. Although recent studies provided insight into the recruitment and 
activation pathways of leukocytes the underlying mechanisms of tissue remodeling 
in atopic inflammation remain elusive. Our objective was to identify chemokine-
mediated communication pathways regulating tissue remodeling during atopic 
skin inflammation. Systematic analysis of CCR3 expression and that of relevant 
chemokines in atopic vs. non-atopic skin inflammation and in healthy skin, and 
on cultured skin structural cells were characterized by quantitative real-time 
PCR. Immunofluorescent microscopy, flow cytometry analysis were performed 
on cultured fibroblasts. Cellular origin of chemokine receptor and ligands were 
determined by immunohistochemistry. Functional relevance were demonstrated by 
intracellular calcium mobilization, in vitro- repair, cell migration, and BrdU assays. 
Here we demonstrate that human primary fibroblasts express a distinct chemokine 
receptor profile including CCR3. The receptor is also expressed on fibroblasts in 
lesional skin of atopic dermatitis patients. CCR3 ligands, in particular CCL26, are 
significantly up-regulated in lesional atopic dermatitis compared to healthy skin. 
CCL26 enhances fibroblast migration and in vitro-wound repair through CCR3 
signaling. CCL26 has no effect on fibroblast proliferation in vitro. TH2-cytokines, 
such as IL-4 and IL-13, markedly up-regulate CCL26 in human primary fibroblasts. 
Taken together, human dermal fibroblasts express functionally active CCR3 on 
their cell surface. During atopic skin inflammation CCR3 ligands, such as CCL26, 
induce fibroblast migration and repair resulting in skin-related tissue remodeling. 
 
021
Hyposensitization Through Grafted Skin Is Mediated by interleukin-10-producing 
Langerhans Cells and Regulatory T Cells
R Yoshiki, K Kabashima, K Sugita, K Atarashi, T Shimauchi, Y Tokura UOEH, 
Kitakyushu City, Japan
Although skin grafting is one of the frequently used surgical techniques, the 
immunological state of the grafted skin remains unelucidated. An experimental model 
has shown that the development of murine contact hypersensitivity is depressed when 
mice are sensitized with a hapten via the full-thickness grafted skin. We explored the 
immunological mechanisms underlying this hyposensitization, focusing on the fate of 
Langerhans cells (LCs). The number of LCs in the 7 day-grafted skin was reduced up to 
one fourth of normal skin. When FITC was applied to the grafted skin, FITC-bearing 
LCs were capable of migrating to the draining lymph nodes, since the number of LCs 
in the lymph nodes was again one fourth of normal skin-sensitized control mice. LCs 
isolated from the grafted skin produced a high amount of IL-10 as assessed by real-
time PCR. Adoptive transfer of immune lymph node cells from the tolerated mice 
suppressed CHS response of recipients in an antigen-specific manner. CD4+CD25+ 
but not CD4+CD25- T cells purified from the lymph node cells were responsible 
for this suppression. These findings suggest that the hyposensitization of CHS via 
the grafted skin is not merely attributable to the reduction of LC number, but IL-10-
producing LCs may exert a downmodulatory effect by inducing regulatory T cells. 
 
022
Augumentation of Intracellular TLR2 Expression by Peptidoglycan, β-Glucan, and 
Histamine in Human Keratinocytes
M Kobayashi, K Kabashima, Y Tokura UOEH, Kitakyushu, Japan
The stimulatory agents and culture conditions that promote Toll-like receptor (TLR) 
expression and the detection means for TLRs remain unsolved in normal human 
epidermal keratinocytes. Considering that the epidermis is exposed externally to Gram-
positive bacteria and dermatophytes, and internally to skin inflammation-relevant 
histamine, modulation of TLR expression by peptidoglycan (PGN), β-glucan, and 
histamine is an issue to be elucidated. We investigated the effects of these substances on 
the surface and intracellular expression of TLR2 as determined by flow cytometry and 
confocal microscopy, and its mRNA expression as assessed by quantitative real-time PCR 
in normal human epidermal keratinocytes. The surface expression of TLR2 was barely 
detectable by flow cytometry, and its surface level was not increased by PGN, β-glucan 
or histamine. However, when the intracellular expression of TLR2 was monitored, we 
found an apparent elevation of its expression by all the stimuli. Suggesting the positive 
feedback via ligation and the promotion by histamine. A confocal microscopic analysis 
also revealed the enhanced expression of TLR2 in the cytoplasm. TLR2 expression on 
keratinocytes was functional, since ELISA analysis of the culture supernatants revealed 
that the TLR2 ligands, PGN and β-glucan, induced cytokine/chemokine production by 
keratinocytes. By using the intracellular expression, we observed a synergistic effect 
of PGN and histamine on the expression of TLR2. This synergism was also confirmed 
by real-time PCR analysis of not only TLR2, but also β-defensin 2 and dectin-1. 
Moreover, the TLR-related synergism between PGN and histamine or between 
β-glucan and histamine was functional in the production of TNF-α and IL-8. Our study 
demonstrated that TLR2 expression is detectable by flow cytometry in the cytoplasm of 
keratinocytes and upregulated by TLR ligands and histamine in a synergistic manner. 
023
Repeated epicutaneous application with contact sensitizing agent induces allergic 
skin inflammation in hairless mice
JH Ju, JK Lee, JH Kim, JR Kim, EY Chun, IY Kim, KH Sohn, SH Kim, KL Park NITR, 
KFDA, Seoul, South Korea
Skin sensitization is an important occupational and environmental health issue. Atopic 
dermatitis is a chronic inflammatory skin disease characterized by intensive pruritic 
subacute and chronic eczematous plaques. To further explore the pathogenesis and 
treatment of atopic dermatitis, a suitable animal model is necessary. The objective of this 
study were to investigate the possibility of atopic dermatitis like model induced by contact 
allergen, dinitrochlorobenzene (DNCB) and the potential biomarker of sensitization model 
induced in hairless mice. We treated the repeated application with DNCB intradermally 
on the skin of SKH-1 hairless mice. Epicutaneous DNCB sensitization induces dermatitis 
characterized by atopic dermatitis-like skin lesions including erythema followed edema, 
excoriation and scaling. The histological examinations of the affected skin showed 
epidermal hyperplasia with hyperkeratosis, severe infiltration of eosinophils and increase 
of mast cells. The total serum IgE level was markedly elevated and the level of IgG1 and 
IgG2a was increased in hapten-induced mice. Following DNCB sensitization, interleukin-
1β and interleukin-4, IFN-gamma mRNA expression were increased in DNCB-sensitized 
skin sites. Moreover, the results of immunohistochemical analysis, there were significant 
increase of CD8, IL-4, Calgranulin B in mice skin treated with DNCB. To identify 
differential gene expressions associated with the effects of contact allergen exposure, 
microarray experiments were conducted on mice skin. We have detected several genes 
with changed expression levels (up- or down-regulated), especially observed increase 
of the gene expression in the calgranulin A, calgranulin B, CCL6, CXCL2, CXCL5, 
granzyme A in DNCB-sensitized skin site. These results suggest that DNCB exposure 
could induce allergic skin inflammation and increase IgE level in hairless mice. 
024
Vitreoscilla Filiformis Modulates Human Dendritic Cell Phenotype and Cytokine 
Production
A Gueniche1, J Peguet-Navarro2, E Colomb2, C  Vincent2, L Breton1 1L’Oréal Recherche, 
Clichy, France 2Hôpital Ed Herriot, EA 37-32, Lyon, France
Vitreoscilla filiformis (Vf, ATCC15551) is a Gram negative bacterium found in spa 
waters. Vf biomass balances cutaneous immune homeostasis, especially when 
applied onto skin of atopic patients. Since cutaneous dendritic cells (DC) are involved 
in the inflammatory process, we investigated the effects of Vf biomass and LPS-free 
fraction on in vitro DC phenotype and cytokine production. DC were generated from 
monocytes (MoDC) cultured for 6 days with GM-CSF and IL-4. The cells were treated, 
or not, with either Vf preparations at different concentrations (5, 2.5 or 0.5%, v/v) or 
LPS from E. Coli (1, 10 microg/ml) as positive control. Two days later, phenotypic 
modifications were assessed by flow cytometry analysis. Cytokine production in cell 
supernatants was analysed using the cytokine bead array kit. At day 6, MoDC displayed 
an immature phenotype, as assessed by the absence or low expression of DC-Lamp, 
CD83 and CD86. In contrast, the expression of all these maturation markers was 
significantly increased by Vf biomass, LPS from E.Coli and, to a less extent, Vf LPS-free 
fraction. MoDC stimulated by LPS from E.Coli produced high levels of IL8 , TNFalpha, 
IL10 and IL-12 p70 and the IL10/IL12 ratio ranged from 1 to 6. Very interestingly, no IL-
12 p70 but high levels of IL-10 were detectable in the presence of Vf biomass and LPS 
free fraction, leading to a very high IL-10/IL-12 ratio. This particular immunoregulatory 
cytokine pattern might thus hamper effector T cell activation and inflammatory 
response. The results indicate a possible mode of action for this therapeutic bacterium 
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Differential CXCR4 expression induced by skin sensitizers or irritants in dendritic 
cell models
B Neves1, MT Cruz1, M Gonçalo2, A Figueiredo2, CB Duarte1, M-C Lopes1 1Center for 
Neuroscience & Cell Biology, Coimbra, Portugal 2Univ Hospital, Coimbra, Portugal
Most promising in vitro approaches to predict the skin sensitizing potential of chemicals are 
based on their capacity to induce functional and phenotypical modifications on dendritic 
cells (DC). In this context, we evaluated the effect of skin sensitizers, irritants and a non-
sensitizer on the expression of the chemokine receptor CXCR4 and the costimulatory 
protein CD40. As an in vitro experimental model, we used a fetal skin-derived dendritic 
cell line (FSDC), which has morphological, phenotypical and functional characteristics 
of skin DC. To validate the results, CXCR4 levels were also assessed in dendritic cells 
derived from human peripheral blood monocytes (MoDC). Protein levels were evaluated 
by western blot and immunocytochemistry, after 24h stimulation with the skin sensitizers 
2,4-dinitrofluorobenzene (DNFB), 1,4-phenylenediamine (PPD) and nickel sulfate (Ni), 
the non-sensitizer 2,4-dichloronitrobenzene (DCNB), and the irritants sodium dodecil 
sulfate (SDS) and benzalkonium chloride (BC). The non-sensitizer DCNB had no 
significant effect, but all skin sensitizers tested increased the levels of CXCR4 and CD40 
above control. CXCR4 expression increased 46.3±20.5%, 63.9±26.8% and 8.1±21.5%, 
respectively for DNFB, PPD and Ni, and CD40 increased 24.9±5.9%, 47.2±21.4% and 
5.4±12.9% for the same sensitizers. In contrast, skin irritants decreased the levels of both 
proteins, with a more pronounced effect on CXCR4, which was reduced 67.6±17.4% 
and 69,2±16.7% below control, respectively for SDS and BC. In agreement with the 
observations on FSDC, MoDC showed a similar response pattern to the skin sensitizer 
and irritant tested, PPD and SDS. These results indicate that skin sensitizers and irritants 
have opposite effects on the expression of CXCR4 and CD40 in DC, suggesting that 
these markers may be useful for in vitro assessment of sensitizing potential of chemicals. 
026
Identification of the Human CD160 Gene Promoter
C Schmitt1, F Bellier1, B Ghazi1, M Bagot2, A Bensussan1 1INSERM U841, Créteil, 
France 2Hôpital Henri Mondor, Créteil, France
CD160 is an activating cell surface receptor for HLA class I molecules. It is expressed 
on cytotoxic lymphocytes that correspond to the majority of natural killer cells and a 
subset of CD8+ T-lymphocytes. We recently reported that CD160 is also expressed by 
a subpopulation of CD4+ T-cells in the infiltrate inflammatory skin lesions of atopic 
dermatitis, contact dermatitis or psoriasis. CD160+ cells are also present in normal skin 
and a CD4+CD160+ lymphocyte population is also found in the circulation of healthy 
individual where it represented less that 0.3% of the whole CD4+ cells. CD4+CD160+ 
cells have a cytotoxic potential and CD160 expression can be induced in IL2- or IL15-
activated CD4+ blood lymphocytes. In an effort to better understand the role of CD160 
we studied the regulation of CD160 expression. Here we report the identification of 
the human CD160 gene promoter. The CD160 gene is encoded on chromosome 1, 
contains 6 exons with the translation initiation codon in exon 3. Bioinformatics analysis 
pointed to 3 potential promoter regions, 2 upstream of exon 1 and one in front of exon 
3. Identification of the transcription start site (TSS) and reporter gene of the putative 
promoter regions identified the region immediately upstream of exon 1. Sequential 
deletion analysis of this region lead to the identification of a 371 bp sequence, located 
between -314 and +57 relative to the TSS, as the core promoter sequence driving CD160 
gene transcription. Sequence alignment of the mouse and human CD160 genomic 
promoter region revealed a strong homology in the 371 bp sequence identified and 
pointed out to 2 conserved binding sites for AML and Cox transcription factor families 
implicated in other NK or cytotoxic function associated genes. Work is in progress to 
confirm the role of these transcription factors in the regulation of CD160 gene expression. 
 
027
C-myc regulation by interferon gamma-producing Th1 cells
T Wieder, H Braumüller, N Bauer, M Röcken
Eberhard-Karls University, Tübingen, Germany
Treatment of mice with antigen-specific Th1 cells leads to reduction of the tumor 
size of endogenously growing insulinoma (transgenic RIP1-Tag2 mice expressing 
the T antigen (Tag) of the simian virus 40 under control of the rat-insulin-promotor 
(RIP)), and significantly prolongs the life of treated animals as compared with 
sham-treated controls. This effect is not due to tumor-infiltrating cytotoxic T cells, 
and no significant apoptosis could be detected in vivo in the tumor tissue of treated 
mice. The present study was performed to elucidate the mechanisms underlying 
the therapeutic efficacy of the antigen-specific Th1 cells, by analyzing the effect of 
Tag-specific Th1 cells on c-myc regulation. After different times of restimulation, 
the polarization of Th1 cells was verified by enzyme-linked immunosorbent assays 
(ELISA) of interleukin-4 (IL-4) and interferon-γ (IFN-γ). The transcriptional activity 
of the antigen presenting cells and Th1 cells after restimulation was determined 
by reverse transcriptase polymerase chain reaction (RT-PCR) of the target genes 
IFN-γ and c-myc, and the phosphorylation status of the transcription factor c-myc 
was examined by Western blot. Additionally, IFN-γ-mediated regulation of c-myc 
was investigated in INS-1 insulinoma cells. Restimulation of Th1 cells indeed led 
to the expected cytokine profile, i. e. an increase of IFN-γ whereas IL-4 was only 
detected at background levels. RT-PCR analysis revealed a constant level of c-myc 
transcripts during 24 h of restimulation. However, first results showed a dramatic 
decline of c-myc phosphorylation after restimulation of Th1 cells. On the other hand, 
IFN-γ treatment of INS-1 cells led to a slightly enhanced phophorylation of c-myc. 
In conclusion, in vitro restimulation of Tag-specific Th1 cells by antigen presenting 
cells leads to release of IFN-γ into the supernatant and to differential regulation 
of c-myc signaling in antigen presenting cells and in insulinoma target cells. 
028
Functional analysis of the killer cell Ig-like receptors CD158a, CD158b, and CD158k 
on malignant CD4+ T cells from a Sezary patient
A Marie-Cardine1, M Bagot2, A Bensussan1 1INSERM U841 EQ02, Créteil, France 
2Hôpital Henri Mondor, Creteil, France
Sezary Syndrome (SS) is a CD4+CD45RO+ leukemic variant of cutaneous T cell 
lymphomas. In previous studies we found that malignant Sezary cells specifically 
expressed KIR3DL2/CD158k receptors and thus could be distinguished from normal 
lymphocytes. By performing multiple KIR expression analysis on circulating cells 
from SS patients, we found one patient (Ogu) whose malignant cells simultaneously 
expressed CD158a, CD158b and CD158k. Although patient Ogu CD4+ tumor 
cells, and their corresponding ex vivo derived-T cell clone, expressed both KIR2D-S 
and KIR2D-L molecules, CD158a or CD158b triggering resulted in an increased 
CD3-induced malignant cell proliferation. While no tyrosine phosphorylation and 
subsequent association with SHP-1 of both KIRs inhibitory isoform was detected upon 
cell activation, CD158a or CD158b engagement led to the recruitment of the DAP12-
independent c-Jun NH2-terminal protein kinase (Jnk) signaling pathway. This suggests 
that, when expressed and recruited, the activatory KIR receptors might participate to 
Sezary cell expansion. Conversely, we demonstrated that CD158k/KIR3DL2 exhibited 
an inhibitory function in patient Ogu T cell clone by recruiting the tyrosine phosphatase 
SHP-1. In addition, we found that CD158k triggering resulted in the down-modulation 
of the CD3-mediated cell proliferation and Jnk activation. Altogether, our data indicated 
that the MHC class I molecule binding receptors KIRs are functional in malignant 
Sezary cells, and suggested that their outgrowth might be under the control of a tightly 
regulated balance between these inhibitory and activatory cell membrane receptors. 
 
029
Distorted reactive oxygen species production by psoriatic neutrophils
A Kepska1, P Lewkowicz2, H Tchórzewski3, A Zalewska1 1Medical University of Lodz, 
Lodz, Poland 2Polish Mother’s Memorial Hospital, Lodz, Poland 3Department of 
Clinical Immunology, CZMP, Lodz, Poland
Neutrophils are regarded to be involved in psoriasis pathogeneis. The aim of the study 
was to evaluate reactive oxygen species (ROS) production by psoriatic neutrophils. 
Neutrophils were obtained from the peripheral blood of both psoriatic patients 
and healthy subjects by isolation on Gradisol G. For experiments, performed in 
duplicate, neutrophils density was 2x106 cells/ml. ROS production was assessed by 
chemiluminescence (CL) enhanced by luminol using MLX Microtiter Plate Luminometer 
(Dynex, USA). Neutrophils were either stimulated with N-formyl-methionyl-leucyl-
phenyloalanine (FMLP; concentration 2x106M) or phorbol myristate acetate (PMA, 
concentration - 200 ng/ml). Moreover, the cells were also primed with TNF-α (10 
ng/ml). The results are expressed as Relative Light Units (RLU), in detail RLUmax 
- the highest CL value during 45 minutes of assessment, and RLUtotal - the whole 
CL during 45 minutes. After priming, in controls significantly higher RLUtotal were 
observed in both psoriatic and normal neutrophils in comparison to not primed cells 
(p<0.05). Furthermore, priming led to significantly higher ROS production, expressed 
as RLUmax, by normal healthy neutrophils stimulated by FMLP in comparison to not 
primed cells (p<0.05). Normal neutrophils produced significantly higher ROS levels 
expressed by both RLUmax and RLUtotal in comparison to psoriatic neutrophils in all 
the studied conditions (control, FMLP or PMA stimulation) (p<0.05).
Psoriatic neutrophils seem to be ‘exhausted’by the local long-lasting inflammatory 
stimulation and thus priming with TNF-α in vitro is unable to stimulate them further 
to ROS production.
 
030
Defective interleukin-12 production by psoriatic neutrophils
I Haduch1, E Glowacka2, H Tchórzewski3, A Zalewska1 1Medical University of Lodz, 
Lodz, Poland 2Polish Mother’s Memorial Hospital, Lodz, Poland 3Department of 
Clinical Immunology, CZMP, Lodz, Poland
Neutrophils-fibroblasts interactions seem to play an active role in psoriatic lesion 
development. The aim of the study was to evaluate interleukin 12 (IL-12) levels in 
supernatants of psoriatic neutrophils and fibroblasts. Fibroblasts were obtained from 
psoriatic lesions, perilesional skin and healthy subjects skin by enzymatic dispersion. 
Cells from passages 3-4 were used for experiments. Neutrophils were obtained from 
the peripheral blood of both psoriatic patients and healthy subjects by isolation on 
Gradisol G. For co-culture experiments neutrophils density was 106 cells/ml and 
fibroblasts 105 cells/ml. Experiments were performed in Eagle medium supplemented 
with 20% fetal calf serum and stimulated with either IL-8 (0.1 mg/ml) or TNF-α (10 
ng/ml). IL-12 was evaluated by ELISA (Endogen, USA; sensitivity below 1 pg/ml). In 
all the examined supernatants of both normal and psoriatic fibroblasts, IL-12 levels 
were below the detection levels. There was no significant influence of the examined 
fibroblasts on IL-12 production by normal neutrophils (p>0.05). Upon TNF-α 
stimulation, psoriatic neutrophils produced significantly lower IL-12 levels than 
normal neutrophils (p<0.05). In normal fibroblasts/psoriatic neutrophils co-cultures, 
IL-12 production was significantly higher than in psoriatic neutrophils monocultures 
(p<0.05). The obtained results point out at the defect in IL-12 production in psoriatic 
neutrophils. This could in turn lead to inhibition of anti-inflammatory IL-10 production 
and thus could be further responsible for lack of inhibition in proinflammatory IL-12 
production.
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The effect of Cyclosporin A and etanercept in a rat model of chronic skin 
inflammation
LA Jopling1, K McNeil2, GF Watt1, A Lyon1, MI Christie1 1UCB, Cambridgeshire, UK 
2Avecia Biologics Ltd., Billingham, UK
Psoriasis is a chronic inflammatory skin disorder, characterised by epidermal thickening, 
leukocyte infiltration and angiogenesis. Few preclinical models possess all hallmarks of 
psoriasis or validation with clinically relevant therapies. Using a rodent model of chronic 
skin inflammation, responsive to topical tacrolimus, we set out to test suitability as a 
preclinical model of psoriasis using two clinically validated reagents, Cyclosporin A (CsA) 
and etanercept administered systemically. Female Sprague-Dawley rats were sensitised to 
the abdomen on day 0 with 2% oxazalone in acetone:olive oil (4:1), on day 7 the right ear 
was measured and challenged with 1.6% oxazalone or vehicle only. This was repeated 
every three days until day 22. In the CsA study, rats were dosed with water or CsA (10mg/kg 
or 30mg/kg p.o. u.i.d) day 0-day 10 and every other day thereafter. In the etanercept study, 
rats were dosed with water or etanercept (3mg/kg s.c. three times/week) from day -1-day 
20. Repeated application of oxazalone to the ears of sensitised rats induced significant ear 
swelling characterised by epidermal thickening and cellular infiltration. Treatment with 
CsA caused a significant inhibition of the ear swelling response (53%±5% and 75±1% at 
10mg/kg and 30mg/kg, respectively). Histological analysis demonstrated that only 30mg/
kg CsA significantly inhibited epidermal thickness, CD3+ and ED-1+ cellular infiltration. 
Proliferation of auricular lymph node cells was significantly decreased in the 30mg/kg but 
not the 10mg/kg CsA treatment group. By contrast, TNF-α was undetectable in inflamed 
ears and blockade of TNF-a by etanercept treatment was without effect. In conclusion, 
the effect of CsA in this chronic contact sensitisation model demonstrated a significant T 
cell component, consistent with the proposed mechanism of action of CsA in psoriasis. 
However, this model may not be appropriate for evaluating anti-TNF-α approaches. 
032
Casitas B cell lymphoma-b protein (cbl-b) controls the development of UV-induced 
skin cancer
K Loser1, S Loeser2, S Balkow1, JMP Penninger2, TA Luger1, S Beissert1 1Univ of 
Münster, Münster, Germany 2Inst of Molecular Biotechnology, Vienna, Austria
The development of cutaneous malignancies seems to be controlled by the immune system. 
In many cases skin cancer growth and the lack of antitumoral immunity can be ascribed to the 
fact that tumor cells induce tolerance in tumor-reactive T cells. Therefore, the identification of 
key factors that determine activation of tumor-reactive cytotoxic T cells might be promising to 
increase antitumor activity. The E3 ubiquitin ligase cbl-b has been previously identified as a 
negative regulator of antigen-specific T cell activation. To investigate whether cbl-b contributes 
to anticancer immunity during the spontaneous development of UV-induced skin cancer 
cbl-b-/- and wildtype (wt) mice were chronically UV-irradiated and tumor development was 
documented. Interestingly, cbl-b-/- mice developed significantly less UV-induced skin tumors. 
Whereas all skin tumors grew progressively in UV-irradiated wt mice, tumors were rejected 
in cbl-b-/- animals after an initial growth phase. Additionally, the number of tumor infiltrating 
CD8+ T cells was dramatically increased in UV-induced skin tumors of cbl-b-/- mice compared 
to wt controls. Furthermore, TUNEL-stainings revealed elevated levels of apoptotic cells in skin 
tumors of cbl-b-/- mice suggesting that cbl-b-/- CD8+ T cells infiltrate more rapidly into the 
tumor tissue and might be responsible for the spontaneous rejection of UV-induced skin tumors. 
To address whether CD8+ T cells are indeed involved in the surveillance of UV-induced skin 
cancer, CD8+ T cells were depleted from cbl-b-/- mice after chronic UV irradiation. Strikingly, 
10 days after the depletion of CD8+ T cells 50 % of chronically UV-irradiated and previously 
tumor-free cbl-b-/- mice started to develop progressively growing skin tumors indicating that 
antitumoral immunity in cbl-b-/- mice is mediated by CD8+ T cells. Together, these data 
demonstrate that cbl-b-/- mice exhibit a reduced develoment of UV-induced skin cancer and 
identify cbl-b as a key molecule that controls antitumor activity of cytotoxic CD8+ T cells. 
033
Targeting of tumor antigens to dendritic cells (DCs) using a novel DEC-205 single 
chain fragment variable
TS Johnson1, K Mahnke1, D. Nettelbeck2, V Storn1, AH Enk1 1University of Heidelberg, 
Heidelberg, Germany 2DKFZ, Heidelberg, Germany
DEC205 is a prototype receptor for antigen uptake, which is expressed specifically by 
DCs and increases antigen presentation by 500-fold over other presentation pathways 
such as pinocytosis. To utilize the antigen receptor to load DCs in vivo, we created 
novel single chain fragment variables (ScFv) specific for DEC205, using RT-PCR with 
degenerative primers on total RNA from a hybridoma cell line (HB290). The isolated 
variable heavy, and variable light regions were subcloned into an expression vector, 
fused to a His tag and c-myc tag, then expressed as a native protein in E. coli. The 
inclusion of the two tags allows for the isolation of the protein via a nickel-NTA 
column (His) and immunohistochemical detection (c-myc) via anti c-myc antibodies. 
In addition, we have created a ScFv anti-murine DEC205 fused to the melanoma 
tumor associated antigen gp100. In C57/Bl6 mice, initial immunohistochemical 
staining of CD11c+ lymph node cells showed positive staining of ScFv comparable 
to the mAb anti-DEC205. In further experiments, C57/Bl6 mice were vaccinated 
with the DEC205 ScFv in the footpad or left untreated. After 8 to 16 hours, lymph 
nodes were isolated and examined for DEC staining. Here, the ScFv vaccinated mice 
showed more c-myc positively stained cells in comparison to the untreated controls. 
The staining pattern is similar to immunohistochemical staining seen in mice injected 
with the mAb anti-DEC205. Thus, we can demonstrate that murine ScFv DEC205 can 
target to CD11c+ DCs in vivo. Further experiments using the ScFv DEC205-gp100 
will show whether this targeting can result in induction of GP100 specific CD8+ 
T cells and therefore, may be a useful tool for the induction of an anti-melanoma 
response. 
 
034
Maturation of dendritic cells (DCs) results in differential modulation of B7-H1 
expression in pDCs and mDCs
S Karakhanova, K Mahnke, AH Enk University of Heidelberg, Germany
Expression of regulatory molecules of the B7-H family by DCs plays an important 
role in the regulation of immune responses. However, their function(s) as well as 
regulation of their expression during DC maturation is not completely understood. 
To test how DC maturation affects expression of these molecules, we stimulated in 
vitro prepared monocyte derived DCs (MoDCs) as well as genuine DCs, isolated from 
peripheral blood of healthy donors. Stimulation of MoDCs with a cytokine cocktail 
resulted in increased expression of CD80, CD83, CD86 molecules as well as increased 
stimulatory capacity. In parallel we observed upregulation of B7H1. Similar results 
were observed using genuine DCs. This means that cytokine cocktail maturated 
genuine DCs showed enhanced stimulatory capacity and we observed upregulation of 
B7H1 expression. While MoDC represent a homogenous population of myeloid origin, 
genuine DCs consist of a mixed (mDC and pDCs) population with a different repertoire 
of TLR receptors. Total genuine DC populations were stimulated with various TLR 
ligands and assessed by FACS and functional assays to determine whether the surface 
expression of B7H1 molecules is affected. LPS as well as cytokines enhance expression 
of B7H1 preferentially in mDC, while Poly IC induced B7H1 expression in pDC. 
We furthermore show that cytokine stimulation activates the MAPK kinase pathway 
in MoDCs. Blocking of ERK/MAPK phosphorylation with a specific inhibitor reduced 
increased B7H1 expression. Our results indicate that the expression of B7H1, at least 
in part, is regulated by the MAPK kinase pathway. Additional functional assays are 
going to be performed to identify supplementary signalling events responsible for B7H1 
upregulation and to dissect the initial receptor/receptors responsible for activation. 
 
035
Baclofen as an Anti Inflammatory Agent in Dermatology
B Duthey, J Pfeffer, S Diehl, A Hubner, WH Boehncke
Clinic of the J.W. Goethe University, FRANKFURT/ MAIN, Germany
Baclofen is a selective agonist of the GABA B receptor which is one of the most 
important receptor in synaptic transmission. Baclofen was initially used in the clinic 
since the 1972 to treat symptoms of spasticity caused by heroin withdrawal but its 
use has been extended since then. Indeed, it is now sold in the market as a muscle 
relaxant. New properties of baclofen in the treatment of depression, anxiety and pain 
have also been described recently. The GABA B receptor is expressed not only by 
neurons but also in cells of the immune system such as lymphocytes, neutrophils, 
and platelets where its role has been little studied so far. Here we report that baclofen 
is able to impair significatively the signs of inflammation in a mice model called 
“ear swelling response”. This effect was observed in a dose dependant manner. 
Considerable decrease of leukocytes infiltration was observed within the ears of the 
mice treated with baclofen vs ctrl. We performed in vitro experiments to determine 
the mechanism and showed that Baclofen significatively reduces the secretion of 
inflammatory cytokines such as TNF-α together with the migration of PBMCs towards 
MCP-1, Rantes, SDF 1a, Fractalkine and IP-10, chemokines which are known to 
be overexpressed in several skin diseases. These new findings highlight new roles 
for baclofen in inflammation and could offer new perspectives for the treatment of 
psoriasis, atopic dermatitis, eczema and wound healing.
 
 
036
Role of the chemerin-ChemR23 axis in the recruitment of plasmacytoid dendritic 
cells in psoriatic skin
C Albanesi1, C Scarponi1, S Pallotta1, R Daniele2, D Bosisio2, P Fortugno1, S Madonna1, 
S Gonzalvo-Feo3, O De Pità1, G Girolomoni4, S Sozzani2 1IDI-IRCCS, Rome, Italy 
2University of Brescia, Brescia, Italy 3Istituto Clinico Humanitas, Rozzano, Italy 
4University of Verona, Verona, Italy
Human plasmacytoid dendritic cells (pDCs) constitute a cell subset characterized by 
plasma cell morphology and a unique surface phenotype (CD4+, CD45RA+, CD123+, 
BDCA-2+, BDCA-4+, CD62L+, CLA+, CD11c-). Upon viral stimulation, but also 
during certain noninfectious inflammatory conditions, pDCs differentiate into a mature 
DC phenotype associated with the production of massive amounts of IFN-a and the 
ability to induce T cell activation. Recently, pDCs have been suggested to have a key 
functional role in the pathogenesis of psoriasis. pDC recruitment is crucially governed 
by the chemotactic factor chemerin and its receptor counterpart ChemR23. The aim of 
this study was to evaluate whether the chemerin/ChemR23 axis could be involved in 
pDC positioning in skin affected by psoriasis. CD123+ and BDCA-2+ ChemR23+ pDCs 
were detected in psoriatic lesions during the early phase of the disease development, in 
coincidence with the massive presence of CD15+ neutrophils in the papillary dermis. 
Conversely, ChemR23+ pDC infiltration was strongly decreased or absent at later phases 
of the disease. Infiltration of ChemR23+ pDCs was associated with strong chemerin 
expression by dermal fibroblasts, mast cells and endothelial cells. Cultured fibroblasts 
isolated from skin of psoriatic lesions constitutively expressed chemerin mRNA, whereas 
chemerin expression was barely detectable in fibroblasts obtained from healthy or 
uninvolved psoriatic skin. Interestingly, supernatants of fibroblasts isolated from lesional, 
but not from uninvolved, psoriatic skin induced pDC transmigration in vitro, in a 
ChemR23-dependent fashion. As a whole, these data indicate that chemerin/ChemR23 
axis is involved in the recruitment of pDC in the early phase of psoriasis development. 
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Role of Toll-Like Receptors in Autoantibody Production and Disease in Murine Lupus
A Lartigue, A Francois, P Courville, C Arnoult, F Tron, D Gilbert, P Musette INSERM 
U519, Rouen, France
SLE is characterized by nephritis and vasculitis associated with the production of antibodies 
directed against nuclear antigens, in particular DNA which correlate with the disease activity. 
Both genetic and environmental factors participate to the outset of the disease and a role of 
microorganisms has been suggested. Toll-like receptors (TLR) recognize pathogen-associated 
molecular patterns (PAMPs) and for example, TLR9 and TLR4 respectively bind unmethylated 
CpG sequences of bacterial DNA and LPS, a major component of Gram-bacteria. Lpr/Lpr mice 
are widely used as an animal model for human systemic lupus (SLE). We sought to determine 
the role of TLRs in SLE by creating C57BL/6-lpr/lpr-TLR9-/- and C57BL/6-lpr/lpr-TLR4-/- mice 
and analyzing their phenotype. Concerning lupus-like autoimmunity, the TLR9-/- serological 
profile was very different compared with TLR9+/+ since anti-histone and anti-nucleosome 
antibodies remained negative until 6 months in TLR9 deficient mice while no difference was 
observed in the frequency of anti-dsDNA autoantibodies whose levels were strikingly higher 
in TLR9-/- mice. The assessment of the renal disease showed more glomerular IgG deposits 
exhibiting different autoantibody isotypes than TLR9+/+ mice. These results demonstrate that 
TLR9 receptors are absolutely required for the autoantibody response playing a role in both 
autoantibody specificity and switch. In contrast, TLR4 deficient mice develop less severe clinical 
disease with few immunological alterations. We found that anti-cardiolipin, anti-dsDNA, anti-
nucleosome and rheumatoid factor productions are decreased in TLR4-/- mice. Moreover, 
renal examination showed less lesions associated with decrease of glomerular IgG deposits 
in TLR4-/- mice compared to TLR4+/+. All these results showed that TLR4 deficient mice had 
an improved disease. This study provides clear evidence for the role of TLR9 and TLR4 in the 
development of the lupus disease. These results have important implications for TLR-directed 
therapy of autoimmune disease.
038
Mass spectrometric comparison of antimicrobial active psoriatic scale and healthy 
person’s stratum corneum extracts
J Bartels, J Harder, J-M Schröder University of Schleswig-Holstein, Kiel, Germany
Why is healthy skin not infected and psoriatic lesions remarkably free of microbial infections? This 
question led to the discovery of previously unknown antimicrobial peptides and proteins in skin. 
Because of the diversity of potential antimicrobial threats we wondered, whether there might 
be additional antimicrobial molecules contributing to a broad antimicrobial defense function 
of the skin. To address this question we analyzed and compared mass spectrometric profiles 
with antimicrobial activities of fractionated psoriatic scale and healthy person’s stratum corneum 
extracts. Many HPLC fractions of heparin-affinity purified scale and stratum corneum extracts 
revealed antimicrobial activity against various microorganisms. While scale extracts are a rich 
source of antimicrobials higher amounts of stratum corneum material were necessary to isolate 
and analyze antimicrobial activity. Major mass signals (revealed by ESI-QTOF mass spectrometric 
analysis) in antimicrobial active fractions of both extracts correspond to known heparin-binding 
antimicrobial peptides/proteins identified as psoriasin, hBD2, lysozym and RNase 7. The 
mass spectrometric signal for psoriasin was the most prominent signal in both extracts. Mass 
spectrometric signal intensities for hBD2, RNase 7 and lysozyme relative to the psoriasin mass 
signal appeared enhanced in psoriatic scale extracts when compared to stratum corneum extracts. 
Less intense mass signals in other HPLC fractions containing antimicrobial activity were found in 
both extracts and indicate the presence of not yet identified antimicrobials differentially expressed 
in healthy person’s heel stratum corneum and psoriatic lesions. Further, search for the cathelicidin 
hCAP-18/LL-37 and its truncated forms in both, extracts of chronic plaque psoriasis and healthy 
person’s stratum corneum, failed, suggesting that it is only present in minute amounts. Future 
mass spectrometric mapping and sequencing experiments following further purification and 
re-evaluation of antimicrobial activity may provide first clues on the identity of these molecules. 
039
Dimethylfumarate reduces leukocyte rolling in vivo through modulation of adhesion 
molecule expression
SR Rubant, RJ Ludwig, S Diehl, K Hardt, R Kaufmann, JM Pfeilschifter, 
WH Boehncke Clinic of the J.W. Goethe University, Frankfurt/Main, Germany
Esters of the fumaric acid have a long tradition in the treatment of psoriasis. It becomes 
evident, that compared to the mixture of FAEs used in clinic so far, dimethylfumarate 
(DMF) as monosubstance provides the therapeutic potency. However, molecular 
mechanisms of DMF action are not completely understood. Here we investigate 
effects of DMF on lymphocyte adhesion molecule expression in vitro and interactions 
with endothelial cells in vivo. Using flow cytometry on CD3+ T-cells we showed that 
DMF dose-dependently reduced superantigen-induced expression of CD25, HLA-DR 
and CLA by 27%, 22% and 48%, respectively. No change was observed for CD54, 
VLA-4 and PSGL-1. An enhancement of CD69 expression was noted (22%). Reduced 
CLA-expression resulted in decreased binding to E-selectin, P-selectin and VCAM-1. 
Intravital microscopy of PBMCs in ear vasculature of wild type and knock-out mice 
showed that rolling was mainly P-selectin dependent and could be reduced by 61% 
through DMF-incubation. We further investigated the effects of DMF on the regulation 
of important fucosyltransferases using RT-PCR, where DMF reduced the expression of 
FucT7 on mRNA level. Taken together, this is the first report focussing on DMF effects 
on adhesion molecule expression on human leukocytes and on their rolling behavior 
in vivo, indicating that DMF directly affects the initial step of leukocyte extravasation. 
 
040
TNF-alpha is required for tolerance to allergens
K Steinbrink1, U Frankenberg1, M Maurer2, R Alt1, M Metz2, J Knop1 1University of 
Mainz, Mainz, Germany 2Charité Berlin, Berlin, Germany
Mechanisms of peripheral tolerance to allergens are poorly understood. In this study, we 
use the model of low zone tolerance (LZT) to contact allergens, induced by epicutaneous 
application of subimmunogenic doses of haptens, resulting in the generation of regulatory 
CD8+ T cells (Tc2) that inhibit the development of Tc1-mediated contact hypersensitivity 
(CHS). Analysis of TNF-alpha and TNF-receptor deficient mice revealed that LZT is 
TNF-alpha-dependent as TNFalpha-/- and receptor-double-KO-mice failed to develop 
LZT. Interestingly, TNFR1-/- (p55-/-) mice showed normal LZT responses, whereas no 
induction of LZT was observed in TNFR2-/- (p75-/-) mice. Additionally, prevention of 
hapten-specific clonal expansion of lymph node cells and upregulation of Tc2 cytokines 
after tolerization did not occur in TNFalpha-/-, receptor-double-KO- and p75-/- mice. 
Adoptive transfer of T cells from tolerized TNFalpha-/-, TNFR2-/- or WT mice that were 
injected vice versa into WT, TNFalpha-/- or TNFR2-/- animals demonstrated that TNF-
alpha and TNFR2 signaling is not required for the induction and function of CD8+ 
suppressor T cells of LZT. However, TNF-alpha induced signaling via TNFR2 is essential 
for the effector phase of LZT. Reconstitution of TNFR2-/- mice with T cells of WT mice 
and adoptive transfer experiments showed that the expression of TNFR2 on CD8+ T cells 
of CHS is mandatory for LZT. Importantly, TNF-alpha induced apoptosis via TNFR2 in 
hapten-specific CD8+ effector T cells of CHS is essential for LZT and the inhibition of the 
T cell-dependent allergic inflammation. Thus, our data demonstrate a critical role of TNF-
alpha via TNFR2 (p75) signaling in the effector phase of LZT to contact allergens, in which 
it inhibits the generation of CHS-promoting Tc1 cells and consequently the development 
of CHS and depicts the novel finding that apoptosis mediated by p75 -mediated signaling 
is involved in tolerance reactions to allergens. 
041
Mechanisms underlying Helper T Cell Mediated Tumor Arrest
AI Ziegler1, R Heidenreich1, H Wolburg1, H Braumüller1, R. Mocikat2, M Röcken1 
1Eberhard-Karls University, Tübingen, Germany 2GSF-Institute of Molecular 
Immunology, Munich, Germany
Various data suggest that tumor-reactive helper T cells control tumor growth more efficiently 
than cytotoxic T cells. Yet, the underlying mechanisms remain enigmatic. Here, we investigated 
the effects of tumor-antigen reactive Th1 cells on syngeneic murine colon carcinoma cells 
(CT26) that stably expressed the human epithelial adhesion molecule EpCAM. We generated 
EpCAM-reactive Th1 cells and started adoptive Th1 cell therapy intraperitoneally 4 days 
after subcutaneous injection of tumor cells. To determine the therapeutic effects, tumors 
were harvested on day 10, 11, 13, and 18 after tumor cell injection. Tumor weight, gene 
expression profile, histology, and ultrastructure of tumors were analysed. The therapy led 
to a strong inhibition of tumor growth up to 84% on day 18. Quantitative real-time PCR 
revealed an upregulation of Th1 and genes associated with angiogenesis inhibitors in the Th1 
cell treated tumors, peaking on day 13. The most pronounced upregulation was found for 
IL23/p19 and IL12/p35; IFN-g, IL27/Ebi3, IL6, and ICAM-1 were also induced. Conventional 
histology showed only minor differences in tumor vascularisation, morphology, or necrosis. 
In sharp contrast, electron microscopy showed endothelial cell death, cytoplasma-
enriched endothelia and vessel obliteration, suggesting that tumor vessels of Th1-treated 
mice were non-functional. Moreover, enhanced diapedesis and a 10-20 fold increase of 
CD4 positive cells were detected in the tumor tissue as signs of inflammation. As we did 
not observe any direct effect of Th1 cells on the carcinomas neither in vitro nor in vivo, the 
data strongly suggest that tumor-antigen reactive Th1 cells inhibit tumor growth primarily by 
damaging the endothelia of tumor vessels. Further investigations have to characterize the 
target cells of the helper T cells and the source of the anti-angiogenic cytokines. The data 
underline a crucial role of tumor-antigen reactive Th1 cells in the control of tumor growth. 
042
In vitro induction of hapten-specific CD25+ Treg from circulating naive CD4+ T 
lymphocytes of allergic individuals
D Filipponi, F Nasorri, C Bedini, D Pennino, O De Pità, A Cavani IDI-IRCCS, Rome, 
Italy
We have previously demonstrated that nickel allergy is correlated with the impaired 
capacity of CD25+ Treg to inhibit nickel-specific, but not allogeneic, T cell responses. 
To disclose whether nickel-specific Treg function could be restored in allergic 
individuals, naïve CD4+ T cells were isolated form peripheral blood and cultured 
21 days with mature or immature monocyte-derived dendritic cells in the presence 
of the metal. The resulting T cell populations contained variable percentage (8-22%) 
of Foxp3+ CD25high T cells. Foxp3+ T cells belong to the CFSE low population, 
demonstrating that they actively proliferate in vitro, and strongly suppress nickel-
specific responses of CD4+ and CD8+ T cells from nickel-allergic donors. Regulatory 
activity of CD25high Treg emerged from cultures stimulated with immature dendritic 
cells were only slightly more prominent compared to CD25high T cells activated 
by mature dendritic cells. In contrast, addition of TGF-β, but not anti-TNF-α, to 
immature dendritic cells-T cells co-cultures strongly increase both the yield of 
Foxp3+ CD25high T cells and their suppressive activity. The data demonstrate 
that allergic individuals maintain the capacity to expand allergen-specific Treg 
cells, thus suggesting innovative immunotherapeutic approaches for skin allergies 
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Neuromedin U as a protective factor for IgE-mediated allergic inflammation
Y Mizukawa, T Shiohara Kyorin University, School of Medicine, Mitaka, Japan
Many attempts have been made to identify the molecules that provide a rapid host 
defense while conferring protection from allergic inflammation, without success. 
In view of the ability to bridge innate and acquired immunity by activating mast 
cells, neuromedin U (NMU), the neuropeptide stored in keratinocytes is the leading 
candidate. In this regard, we have recently established a mouse model that can be 
used as a tool to identify the molecules: a single hapten exposure at sites protected 
from scratching results in the development of TLR2-dependent innate-type immediate 
hypersensitivity (IH): in contrast, repeated hapten exposure at sites subjected to 
scratching leads to IgE-mediated allergic inflammation. Here we investigated whether 
NMU could mediate the TLR2- dependent innate immune responses and whether the 
absence or depletion of NMU could be responsible for the subsequent development 
of IgE-mediated allergic inflammation. We found that initial hapten exposure resulted 
in the rapid release of NMU from keratinocytes and induced TLR2-dependent IH 
via mast cell degranulation, which was downregulated by of IgE and scratching. 
This was confirmed in mast-cell knockin mice reconstituted with mast cells from 
TLR2-/- and NMU-/- mice. After repeated hapten exposure, NMU has been depleted 
from the epidermis coincident with the development of IgE-mediated allergic 
inflammation in BALB/c but not C57BL/6 (B6) mice. A targeted disruption of the 
NMU gene rendered these otherwise refractory B6 mice susceptible to IgE-mediated 
allergic inflammation. These results indicate that, as far as NMU is maintained in 
the epidermis, scratching and IgE act to limit TLR2-dependent innate immune 
responses: after depletion of NMU, however, scratching causes IgE to be seduced 
to the dark side of acquired immune responses, IgE-mediated allergic inflammation. 
 
044
Synthesis of complete hapten-modified antigens and the structural basis of T-cell 
specificity
SR Ahlfors, M Holmdahl, R Holmdahl, C Hansson University of Lund, Sweden
Allergic contact dermatitis is elicited by stimulation from endogenous hapten-modified 
peptides in a T-cell mediated way. No endogenous hapten-modified complete antigen has 
yet been chemically defined and the structural basis of the T-cell response is not known. 
In our study we synthesised a set of hapten-modified complete antigens to determine 
the T-cell specificity. We used a dinitrophenyl(DNP)-modified pentadekapeptide, an 
immune dominant sequence (256-270) from collagen II with affinity to MHC class 
II, as synthetic complete antigen for immunisation of mice. Clones of DNP-specific 
T-cell hybridomas were isolated. These T-cells were then stimulated by different DNP-
modified peptides and the immunologic response was determined. Our results show 
a high specificity and selectivity of the formed T-cells hybridomas in the recognition of 
the antigens. We found a complete loss of the immunologic response when the side 
chain in the lysine residue carrying the hapten was shortened one carbon in length. The 
use of the one carbon longer homolysine gave a similar response as the original DNP-
antigen used at immunisation as well as the closely related lysine analog the DNP-
Ala-4-piperidyl ring structure. The stereochemical requirements for antigen recognition 
were further shown by the weak response from the DNP-D-Lysine substituted antigen. 
Neither peptides without DNP-modification nor a peptide modified with a different 
hapten gave any T-cell response. Truncation of the DNP-peptide sequence to shorter 
DNP-peptides gave a complete loss of T-cell response. Our T-cell model proved to be 
very useful for studying the molecular mechanisms in allergic contact dermatitis and 
the results contribute to a better understanding of the chemical structures of antigens 
associated with allergic contact dermatitis
 
045
D1 but not D2 and D3 cyclin is overexpressed in psoriatic lesional skin
N Belso, B Kormos, M Széll, A Pivarcsi, A Kenderessy, A Dobozy, L Kemény, Z Bata-
Csörgo University of Szeged, Szeged, Hungary
Psoriasis is considered to be a multigenic inflammatory skin disease with characteristic 
hyperproliferation and abnormal differentiation of the epidermal keratinocytes. 
Although, dysregulated inflammation plays a pivotal role in disease development 
and maintenance, data indicate that epidermal abnormalities contribute to disease 
susceptibility. Because D type cyclins are major sensors of cell cycle driving 
enviromental signals we wanted to characterize the expression of D type cyclins in 
psoriasis. In the basal layers of the lesional psoriatic epidermis we found increased 
numbers of cyclin D1 expressing keratinocytes compared to both normal and non-
lesional epidermis, while the expression of cyclin D1 mRNA showed no difference 
among the samples. In chronic plaques of lesional psoriatic epidermis the expression 
of cyclin D2 and D3 mRNAs were significantly increased compared to non-lesional 
and normal epidermis with no difference in protein expressions. In our previous 
work we have shown that the G0-G1/S phase of the keratinocyte cell cycle was 
characterized by the appearance of D1-type cyclin, while during the rapid repeated 
turnover of highly proliferating cells the expression of cyclin D2 and D3 dominated. 
Knocking down the expression of cyclin D1 mRNA in HaCaT keratinocytes by RNA 
interference however resulted in no change of cell proliferation and cell morphology, 
indicating that D2 and D3 cyclins could substitute for D1 in driving keratinocyte 
cell cycle. The overexpression of cyclin D1 protein in the basal keratinocytes of 
the psoriatic lesional epidermis without increased expression of cyclin D1 mRNA 
in the tissue indicates a possible posttranscriptional dysregulation of cyclin D1 
in psoriatic keratinocytes, that could be partially responsible for keratinocyte 
hyperproliferation and abnormal differentiation of the basal keratinocytes in psoriasis. 
 
046
Impact of Tacrolimus on Cutaneous Neurogenic Inflammation (CNI)
U Péreira1, N Boulais1, L Lefeuvre2, G Dorange1, A Gougerot2, L Misery1 1EA 3879 
U.P.C.I., Brest, France 2Laboratoires dermatologiques d’Uriage, Courbevoie, France
The calcineurin inhibitor tacrolimus or FK 506 is an antifungal natural product 
macrolide and has been used as an immunosuppressant and in the treatment of 
atopic dermatitis. However, following the application many patients suffer from 
transient adverse sensations such as burning and itching at the beginning of topical 
therapy, whereas tacrolimus has a very interesting anti-pruritic effect later, suggesting 
a capsaicin-like mechanism. In order to understand the underlying mechanism 
of these effects, we examined whether or not tacrolimus is able to stimulate the 
substance P (SP) release in a in vitro model of cutaneous neurogenic inflammation 
(CNI). This model is based on an enzyme immunoassay (EIA) of SP in a porcine co-
culture (very close to human response) of dorsal root ganglion neurons (DRGN) and 
keratinocytes (K). After incubation with different concentrations of tacrolimus, we 
noted an increase of SP release that was not dose-dependent, on average of 30% for 
the different concentrations tested (contrary to capsaicin). Furthermore, the use of 
a medium without calcium or an antagonist of calcium channel like ruthenium red 
was able to inhibit this release On the other hand the pre-treatment (15 min) of the 
co-culture by tacrolimus was sufficient to inhibit the CNI reproduce by the adding of 
capsaicin (which normally induce an important SP release). These results suggest that 
application of tacrolimus may lead to neuropeptide release by a calcium influx and 
cause a neuropeptide depletion of nerve fibres which explains the initial inflammatory 
effects (pain, itching, burning) and in a second time, the soothing effect. 
 
 
047
Interleukin-31 - a new link between T cells and pruritus in atopic skin 
inflammation
G Kukova Heinrich Heine University, Düsseldorf, Germany
(a) To investigate the role of human IL-31, a novel T cell-derived cytokine, that 
induces severe pruritus and dermatitis in transgenic mice, and signals through a 
heterodimeric receptor composed of interleukin-31 receptor A and oncostatin M 
receptor, in ‘pruritic’ and ‘non-pruritic’ inflammatory skin diseases.
(b) The expression of IL-31 and its receptor heterodimer was analyzed by quantitative 
real-time PCR in skin samples of healthy individuals and patients with chronic 
inflammatory skin diseases. Moreover, IL-31 expression was analyzed in non-lesional 
skin of atopic dermatitis patients after allergen or superantigen exposure, as well as in 
stimulated leukocytes. The tissue distribution of the IL-31 receptor heterodimer was 
investigated by DNA microarray analysis. (c) IL-31 was significantly overexpressed 
in ‘pruritic’ atopic compared to ‘non-pruritic’ psoriatic skin inflammation. Highest 
IL-31 levels were detected in prurigo nodularis, one of the most pruritic forms of 
chronic skin inflammation. In vivo, staphylococcal superantigen rapidly induced IL-
31 expression in atopic individuals. In vitro, staphylococcal enterotoxin B but not 
viruses or Th1 and Th2 cytokines induced IL-31 in leukocytes. In atopic dermatitis 
patients, activated leukocytes expressed significantly higher IL-31 levels as compared 
to control subjects. IL-31 receptor A showed most abundant expression in dorsal root 
ganglia representing the site where the cell bodies of cutaneous sensory neurons 
reside. (d) Our findings provide a new link between staphylococcal colonization, 
subsequent T cell recruitment/activation and pruritus induction in atopic dermatitis 
patients. Taken together, IL-31 may represent a novel target for antipruritic drug 
development. 
 
048
Transcriptional regulation of lymphocyte JAM-C expression by nuclear factor of 
activated T-cells (NFAT)
RJ Ludwig1, S Immenschuh2, H Beschmann1, S Naidu2, R Kaufmann1, WH Boehncke1, 
S Santoso2 1Clinic of the J.W. Goethe University, Frankfurt Am Main, Germany 2Institut 
für Klinische Immunologie, Gießen, Germany
Junctional Adhesion Molecule-C (JAM-C) is a cell surface protein, which is highly expressed on 
platelets and endothelial cells and has been shown to mediate leukocyte extravasation in several 
model systems. To investigate the role of JAM-C in T-lymphocytes and its potential regulatory role 
in the adaptive immune system, we examined the expression of JAM-C in resting and activated 
human T-lymphocytes. Expression of JAM-C in quiescent T-lymphocytes was significantly lower in 
comparison to human platelets or cultured human umbilical vein endothelial cells. As determined 
by FACS analysis, treatment with the polymeric carbohydrate-binding protein phytohemagglutinin 
(PHA), which is a potent polyclonal activator of lymphocytes, markedly induced JAM-C expression 
in isolated human T cells: On average an over 2-fold increased JAM-C expression was evident in 
PHA-stimulated cells compared to unstimulated controls. PHA-dependent up-regulation of JAM-C 
expression in T-lymphocytes was also observed in Western blot analysis and occurred in a time- and 
dose-dependent manner. In addition, treatment of T-lymphocytes with antibodies, which specifically 
bind to the T cell receptor or T cell receptor associated proteins (CD3 and CD28), up-regulated JAM-C 
protein expression. An increase of JAM-C during PHA-mediated T cell activation was also observed 
on the mRNA level suggesting a transcriptional mechanism of JAM-C gene regulation. Finally, pre-
treatment of T-lymphocytes with the immunosuppressant cyclosporine A caused a dose-dependent 
inhibition of JAM-C induction by PHA to almost baseline levels (unstimulated: 19.5∼2.2%, PHA: 
37.8∼6.5%, PHA + CSA: 21.7∼8.8% JAM-C positive T-lymphocytes). This indicated a possible 
regulation of T-lymphocyte expression by NFAT. Preliminary experiments indicate towards a 
possible role of this pathway, as we found several NFAT-binding sites in the JAM-C promotor. 
In summary, the data suggest that JAM-C is up-regulated in activated human T-lymphocytes via 
a transcriptional mechanism and, therefore, may play an important role for the T cell response. 
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Depletion of CD4+ cells leads to increased inflammation in a transgenic mouse 
model over expressing VEGF in the skin
H Henning, I Teige, L Svensson, P Kvist, K Kemp LEO Pharma, Ballerup, Denmark
Transgenic mice over-expressing vascular endothelial growth factor (VEGF) in the 
epidermal basal layer have previously been reported to develop a psoriasis-like 
inflammatory condition in the skin. The inflammation is characterised by increased 
angiogenesis in the skin, epidermal hyperplasia and an influx of infiltrating T-cells in the 
dermis and epidermis. To investigate the role of CD4+ T cells in the model we induced 
a cutaneous inflammation in the ear skin by repeated topical treatments with a phorbol 
ester (TPA). The inflammation was chronic in nature, however it decreased with time. 
We isolated lymphocytes from the ear and found that the major part of the T cells 
were CD25+ and CD44hi thus showing an activated phenotype, which was in sharp 
contrast to the primarily naïve lymphocytes isolated from peripheral blood. The pro-
inflammatory cytokines KC and TNF-α levels were significantly higher in serum when 
compared to animals not treated with TPA. Furthermore, IL-1β and TNF-α levels were 
significantly higher in the TPA treated ears when compared to either ears from untreated 
VEGF transgenics or from TPA treated wildtype mice. To investigate the functional role 
of the CD4+ cells in this model we depleted CD4+ cells by antibody treatment. The 
treatment lead to a significant increase in inflammation when compared to animals 
treated with the relevant isotype control, both when ear thickness and epidermal 
thickness was compared. Furthermore, the levels of pro-inflammatory cytokines TNF-α, 
IL-1β, IL-6, KC, IL-12p40, IL-12p70 and IL-17 were significantly increased in the TPA 
treated ears from CD4+ depleted animals when compared to the TPA treated ears from 
isotype control treated animals. These results show that CD4+ T cells have a regulatory 
rather than a pro-inflammatory role in VEGF driven skin inflammation.
 
050
Psoriasin (S100A7) is a major antimicrobial component of the female genital tract
M Mildner1, A Abtin1, R Gmeiner1, C Sam1, R Gläser2, J-M Schröder2, V Mlitz1, M 
Stichenwirth1, J Pammer1, A Geusau1, E Tschachler1 1Medical University of Vienna, 
Vienna, Austria 2University Hospital Schleswig-Holstein, Kiel, Germany
Psoriasin has been shown to be the major Escherichia coli-killing antimicrobial 
peptide in the skin. Here we investigated the expression and regulation of 
psoriasin in mucous epithelia of the female genital tract. Multilayered vaginal 
epithelium but not single layered cervical epithelium strongly expressed psoriasin 
as determined by immunohistochemistry. When vaginal fluids obtained by lavage 
with 2 ml physiological NaCl-solutions from healthy donors were analyzed by 
Western blot and ELISA, we detected up to 2 µg/ml secreted psoriasin. Using an 
in vitro 3D-model of human vaginal epithelium obtained from MatTek Corporation 
(EpiVaginal™), we could show that exposure of this model to IL-1alpha, as well 
as to secreted components of E. coli, strongly induced psoriasin expression. 
Finally, we could show that vaginal fluids potently killed E. coli and Neisseria 
gonorrhoeae in an anti-microbial activity assay system. Taken together these data 
show the high potency of the vaginal fluid in anti-microbial defense. Furthermore 
the intra-vaginal high amount of psoriasin implicates an important role of this 
antimicrobial peptide in the innate immune response of the female genital tract. 
 
051
Dendritic cells mature in response to cell-to-cell contact with mature mast cells
A Dudeck, S Heydrich, M Maurer Charité Berlin, Berlin, Germany
Mast cells (MCs) have been recently suggested to link innate immune responses 
and long lasting adaptive immunity resulting from pathogen infection. However, the 
underlying mechanisms of this novel mast cell function remain to be elucidated in 
detail. Here, we asked whether MCs can induce the maturation of dendritic cells 
(DCs), which is required for the generation of effective adaptive immune responses. 
Most notably, we found that mature murine connective tissue type mast cells (CTMCs) 
can undergo cell-to-cell interactions with immature murine bone marrow derived 
DCs. The cellular contact of CTMCs to immature DCs induced the expression of the 
costimulatory signals CD80, CD86 and CD40 on the cell surface of DCs, suggesting 
the induction of DC maturation. Moreover, the interaction between CTMCs and 
immature DCs induced the expression of the chemokine receptor CCR7 by DCs, 
which is required for the initiation of DC migration to T cell areas of draining lymph 
nodes. Interestingly, the induction of DC maturation by contact to CTMCs depends 
on the mature status of MCs, as the expression of CD80, CD86, CD40, and CCR7 on 
DC surface was not enhanced by cellular contact to immature bone marrow derived 
cultured mast cells. Furthermore, the interaction between CTMCs and DCs resulted 
in the release of IFN-γ and IL-2, suggesting a potential influence on T cell activation 
and survival. In conclusion, our results show, for the first time, that a cellular 
contact between immature DCs and mature MCs can induce the maturation of DCs 
and facilitate DC migration. Thus, MCs may, at least in part, initiate and promote 
adaptive immune responses by modulating dendritic cell maturation and function. 
 
052
Effect of electromagnetic field on keratinocyte: Correlation of chemokines 
production and cell growth in HaCaT cells
P Amerio, M Reale, G Vianale, A D’intino, A Tulli, MR Muraro University of Chieti-
Pescara, Chieti, Italy
The effect of extremely low-frequency electromagnetic field (ELF-EMF) exposure on human 
health has been widely debated. Studies have reported that EMFs can exert biological 
effects and they have been used in clinical practice to promote regeneration processes.
The mechanism of action of ELF-EMF is still unknown some studies have demonstrated 
that magnetic fields can alter the rates of cellular transcription and modify gene induction, 
other studies have focused on induction of differentiation and other morphological and 
histological aspect in in vivo models treated with ELF-EMF. Moreover, histological studies 
in animal tissue repair models have shown that magnetic fields can reduce and improve 
the quality of inflammatory cells of the repair mechanism. In experimental models 
healing is shown to be associated with a shift toward macrophage and anti-inflammatory 
chemokine profiles that parallel the progression to later stages of wound closure. Healing 
is associated with a decreases of pro-inflammatory chemokines RANTES, MCP-1, MIP-1 
alpha and IL-8. Our aim was to elucidate the effect of EMF on keratinocyte proliferation 
and chemokines production in an in vitro model of electromagnetic field exposure. We 
assessed mRNA production by ReatTime PCR and protein production by elisa for some 
chemokines such as MCP-1, RANTES and MIP-1 moreover we assessed keratinocyte 
growth and NF-kB expression after EMF exposure. Our results suggest that effects on 
tissue inflammation by ELF-EMF may be mediated by the modulation of chemokines 
induced in keratinocytes. Moreover we demonstrated that this modulation as well as 
the inhibition of cell growth in this model of ELF-EMF - keratinocyte interaction may be 
mediated through NFKB downregulation. 
 
053
Psoriasin (S100A7) expression is strongly induced in mammary glands during lactation
M Schmid1, M Mildner1, A Abtin1, H Rossiter1, R Gläser2, J-M Schröder2, J Pammer1, 
V Mlitz1, E Tschachler1 1Medical University of Vienna, Vienna, Austria 2University 
Hospital Schleswig-Holstein, Kiel, Germany
The S100 protein psoriasin has been shown to be the major E.coli killing antimicrobial 
peptide in the skin. Therefore we investigated the expression and regulation of 
psoriasin in human breast milk and mammary gland cells in vivo and in vitro. By 
Western blot analysis we detected high concentrations of psoriasin in human 
breast milk. Quantification by ELSIA confirmed these data and revealed that human 
breast milk contained between 15 and 30 ng/ml psoriasin. Immunohistochemical 
staining of mammary glands showed little if any positive psoriasin staining in non-
lactating mammary glands. In contrast, psoriasin expression was strongly induced 
in lactating human mammary gland epithelium. In addition to these in vivo data, 
we could demonstrate that stimulation of primary human mammary epithelial 
cells with a cocktail consisting of prolactin, dexametasone and insulin, inducing 
a lactating phenotype of mammary gland epithelial cells in vitro, led to a strong 
induction of both psoriasin mRNA and protein expression. Our data suggest that 
the high psoriasin production and secretion by mammary glands could be an 
important factor for the prevention of E. coli infection of the breast during the 
lactation period. Furthermore the high psoriasin concentration in human breast 
milk might also represent an important protective factor for breastfed babies. 
 
054
IL-4 and IL-15 promote immature mast cell adhesion to endothelial cells and 
chemotaxis
A Zimmermann, M Grusser, M Maurer, A Dudeck Charité Berlin, Berlin, Germany
Mast cell numbers in peripheral tissues are stable under physiological conditions but 
markedly increased at sites of chronic inflammation or persistent immune responses. 
The mechanisms of mast cell (MC) hyperplasia are largely unknown. Possible 
explanations include the modified regulation of proliferation, survival, maturation, and 
migration of MCs. Here, we characterized the regulation of immature MC recruitment 
from the vasculature to peripheral tissue by assessing their endothelial adhesion 
and chemotaxis. In confirmation of our previous findings, immature MCs, i.e. bone 
marrow derived cultured MCs exhibited spontaneous adhesion to microvascular 
endothelial cells and underwent directed transendothelial migration. The adhesion of 
immature MCs to endothelial cells was markedly enhanced by previous stimulation 
with IL-4 or IL-15, both described to be released by mature connective tissue type 
MCs upon stimulation. In contrast, immature MC adhesion to endothelial cells was 
not significantly affected by the leukocyte chemoattractants RANTES, MIP-1α or 
MCP-1. Furthermore, the chemotaxis of immature MCs was induced by IL-4 and 
IL-15, but not by RANTES, MIP-1α, or MCP-1. However, the chemotaxis of mature 
peritoneal MCs was induced by a wide spectrum of chemokines and cytokines 
including IL-4 and IL-15 but also RANTES, MIP-1α, and MCP-1. Thus, our data show 
that immature MC adhesion to endothelium and chemotaxis is promoted by IL-4 
and IL-15, but not by leukocyte chemoattractants, suggesting a selective recruitment 
of immature MCs from the vasculature independent of leukocyte infiltration. 
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Effect of Ultraviolet B Irradiation and Viral Infection on Retinoic Acid-Inducible 
Gene-I Expression
K Kimura, Y Matsuzaki, H Kitamura, H Nakano, T Imaizumi, K Satoh, K Hanada, D 
Sawamura Hirosaki Univ Graduate School of Medicine, Hirosaki, Japan
Retinoic acid-inducible gene-I (RIG-I) is a RNA helicase to mediate antiviral defense. 
Our recent study has indicated that RIG-I expression is induced upon stimulation by 
IFN-γ and TNF-α in human epidermal keratinocytes (HaCaT cells). Furthermore, RIG-I is 
expressed in psoriatic keratinocytes of the spinous and basal layers, suggesting that RIG-I 
might function as a mediator of the cytokine network. UVB is a major external factor 
contributing to the epidermal damage as well as viral infection, and has been known to 
suppress the immunoresponse of the skin. We investigated the effects of viral infection 
and UVB irradiation on RIG-I expression in HaCaT cells.  Polyinosinic-polycytidylic acid 
(poly-(I:C)), synthetic double-stranded RNA, was used as a replication intermediate of 
RNA virus. The mRNA and protein expression of RIG-I was analyzed by RT-PCR and 
western blot, respectively. The expression of RIG-I mRNA was induced after 0.5 h of 
poly-(I:C) treatment and reached a maximum at 6 h, and gradually decreased. RIG-I 
protein was similarly increased to a peak level at 12 h. We examined the time course of 
RIG-I expression in response to co-stimulation with poly-(I:C) and UVB in HaCaT cells. 
The poly-(I:C)-induced expression of RIG-I mRNA and protein was suppressed during 
12 h after UVB irradiation (30 mJ/cm2), and gradually increased to a peak level at 24 h. 
Moreover, IFN-β, that was upregulated by activation of downstream signals of RIG-I, was 
induced by stimulation with poly-(I:C), and the expression was delayed by co-stimulation 
with poly-(I:C) and UVB. Our results implicate that poly-(I:C) is a potent agonist for the 
production of RIG-I and IFN-β in human epidermal keratinocytes, and that UVB irradiation 
might cause suppression of antiviral response by delaying time of the RIG-I induction. 
 
056
Absence of TLR4 leads to massive enhancement of TLR2-mediated immunoregulatory 
properties of non-pathogenic gram-negative bacteria
T Volz1, E Guenova1, A Gueniche2, S Kaesler1, L Breton2, M Röcken1, T Biedermann1
1Eberhard-Karls University, Tübingen, Germany 2L’Oréal Recherche, Clichy, France
Skin and gut epithelia are colonized by non-pathogenic bacteria in the absence of signs of 
inflammation. Non-pathogenic bacteria have even been utilized to treat or prevent inflammatory 
allergic or autoimmune responses, such as the non-pathogenic gram-negative bacteria Vitreoscilla 
filiformis, which has been successfully used to treat atopic dermatitis by cutaneous application. 
Investigations on the immunological effects of V. filiformis extracts should allow to understand 
the underlying therapeutic mechanisms and to demonstrate general principles of how non-
pathogenic bacteria help to stabilize the epithelial immune barrier. All V. filiformis preparations 
investigated led to dendritic cell (DC) maturation but varied greatly regarding the functional DC 
phenotype. V. filiformis lipopolysaccharide induced high levels of IL-12 in DC and consecutive 
co-cultures with T-cells led to IFN-γ producing Th1 cells. In contrast, complete bacterial extract 
of V. filiformis induced low IL-12 levels but large amounts of IL-10 in DC. Consequently, co-
cultures of these DC with T-cells evoked remarkably high levels of IL-10 together with some 
IFN-γ in CD4+ T-cells, a phenotype characteristic for inducible regulatory T-cells. Analysis of 
several knockout (ko) DC revealed that IL-10 production was almost abolished in TLR2ko DC 
suggesting an unknown but dominant tolerogenic TLR2 ligand. Low IL-12 levels were unchanged 
in TLR2ko DC but undetectable in TLR4ko DC while IL-10 levels remained high in TLR4ko DC. 
Blocking TLR4 signaling of V. filiformis during DC activation even significantly enhanced IL-10 
production in CD4+ T-cells after co-culture. Our data demonstrate how bacteria like V. filiformis 
can control inflammation by stimulating DC to induce IL-10 producing T-cells. We identified 
TLR2 signaling as the targeted pathway responsible for this immuno-dominant activity disclosing 
an underlying mechanism of a new option for AD and possibly of a general principle of non-
pathogenic bacteria stabilizing the immune barrier of surface organs such as the skin or the gut. 
057
Effect of Toll-like Receptor 2 ligand Lipoteichoic acid on development of Atopic 
Dermatitis
S Kaesler, U Hein, T Volz, K Chen, M Röcken, T Biedermann Eberhard-Karls University, 
Tübingen, Germany
Atopic Dermatitis (AD) is a chronic inflammatory skin disease induced by infiltrating 
Th cells. While Th2 cells dominate the acute flares of AD as seen in atopy patch tests, 
chronic AD lesions are indistinguishable from other forms of eczema and are dominated 
by Th1 cells. However, the mechanism underlying this change of inflammatory pattern 
in AD remained elusive. It is well known that more than 90% of our AD patients show 
colonization with Staphylococcus aureus, its role for this well documented change 
of inflammation pattern has not been investigated so far. To this end, we established 
a model for the initial phase of AD by adoptively transferring OVA-specific Th2 cells 
with or without OVA into the skin of naive mice. The increase of ear thickness after 
adoptive transfer correlated with antigen-specific inflammation. While injection 
of Th2 or OVA alone only lead to minor alterations the transfer of Th2 plus OVA 
provoked an inflammatory reaction and resulted in a strong ear swelling after 24h. One 
important pathogen associated molecular pattern (PAMP) of Staphylococcus aureus is 
the cell wall component and TLR2-Ligand Lipoteichoic acid (LTA). Interestingly, the 
presence of LTA during the AD-like inflammation resulted in prolonged and increased 
dermatitis compared to Th2 plus OVA alone, an inflammation pattern identical to 
OVA-specific dermatitis observed after transfer of Th1 cells. Investigations using TLR2-
deficient mice as recipients showed complete abrogation of this effect demonstrating 
that LTA binding of TLR2 is operative in this change of inflammation pattern. These 
data indicate that S. aureus derived LTA shifts transient cutaneous inflammation 
mediated by Th2 cells towards a chronic and persistent form of dermatitis implicating 
an important role of LTA in the process of AD development and chronification. 
 
058
IL-4 mediated conditioning of human dendritic cell precursors to become IL-12p70 
producing DC1 cells
E Guenova, T Volz, K Sauer, S Kaesler, M Röcken, T Biedermann Eberhard-Karls 
University, Tübingen, Germany
In chronic inflammation, activated dendritic cells (DC) migrate to draining lymph nodes 
and newly recruited DC-precursors differentiate into tissue resident DC. Interleukin (IL)-4 
dominates early cutaneous inflammation as in atopic dermatitis, however, its precise role in 
DC differentiation remains elusive. Therefore, the effect of IL-4 on differentiation of human 
DC-precursors was investigated using the monocyte-derived DC model. Concentrations of 
5-50ng/ml IL-4 unequivocally allowed generation of immature DC (CD11c++/CD14-/HLA-
DRlow/CD86low), but DC activation revealed distinct polarized functional phenotypes: In 
all cases, DC upregulated HLA-DR, CD86, and CD83 indicating unchanged DC maturation 
efficacy. In contrast, only high concentrations of IL-4 during DC-precursor development 
markedly altered DC cytokine production, resulting in a DC1-phenotype with enhanced 
IL-12p70 production. In DC generated under low dose IL-4 an IL-12/IL-10 ratio < 1 was 
observed, whereas in high dose IL-4 treated DC IL-12 was up- and IL-10 was downregulated 
resulting in an IL-12/IL-10 ratio > 1. Investigating underlying mechanisms we found that 
enhanced IL-12p70 levels depended on IL-10 reduction. Consequently, the same DC 
phenotype could be generated when blocking IL-10. Further functional experiments were 
carried out by priming human naïve autologous CD4+CD45RA+ T cells with DC developed 
under either high or low dose IL-4. IFN-γ but not IL-4 production was significantly increased 
in T cells after coculture with DC generated under high dose IL-4. Our data clearly show 
in which way an IL-4 dominated inflammatory milieu determines the differentiation of 
recently immigrated DC-precursors. Based on a regulatory balance between IL-12 and IL-
10, IL-4 orchestrates the development of IL-12p70 producing DC1 and, consequently, IFN-γ 
dominated Th1 immune responses as observed in chronic atopic dermatitis or asthma. 
059
Generation of T-cell memory critically depends on the cell volume regulator TauT
S Kaesler1, M Sobiesiak1, M Kneilling1, T Wieder1, B Heller-Stilb2, U Warskulat2, D 
Häussinger2, F Lang1, T Biedermann1 1Eberhard-Karls University, Tübingen, Germany 
2Heinrich Heine University, Düsseldorf, Germany
After activation only few lymphocytes survive to become memory cells, but the 
mechanisms that control the decision of apoptosis versus memory are poorly understood. 
We hypothesized that regulators of cell volume contribute to this process. Cellular 
accumulation of organic osmolytes like taurine is one important mechanism of cell 
volume regulation and the carrier accomplishing concentrative cellular uptake of taurine 
is the taurine transporter (TauT). To characterize the role of TauT for the generation of 
immune memory, we analyzed taut-/- in comparison to wildtype (wt) mice. Contact 
hypersensitivity responses (CHS) to TNCB were significantly reduced in taut-/- mice as 
determined by ear swelling and cellular skin infiltrate. Interestingly, while no difference 
was detected in lymph node cells of naïve mice, exclusively CD4+ and CD8+ T-cells were 
significantly reduced in skin draining lymph nodes after CHS induction in taut-/- mice. 
This indicates a role for TauT in rescuing T-cells from activation induced cell death (AICD). 
Indeed, after in vitro activation, T-cells from taut-/- mice expressed significantly higher 
levels of the apoptosis marker AnnexinV and survival of taut-/- T-cells was significantly 
decreased indicating enhanced AICD. To prove an in vivo role of TauT for T-cell survival, 
we adoptively transferred TNCB specific CFSE loaded T-cells from taut+/+ and taut-/- 
mice into naïve wt recipients that were challenged with TNCB consecutively. Strikingly, 
recovery of dividing CFSE+ CD4+ and even more pronounced of dividing CFSE+ CD8+ 
taut-/- T-cells was significantly reduced compared to wt indicating increased AICD of 
taut-/- T-cells in vivo. In summary, we could show that cell volume regulation by TauT 
is crucial during T-cell activation, modulates induction of T-cell apoptosis, and plays a 
role for T cell survival and the selective process of generation of T lymphocyte memory. 
060
Sustained Antigen Specific Induction of the Th1 Cytokine OPN is a Central 
Mechanism in the Chronification of Allergic Contact Dermatitis
AM Seier, AC Renkl, G Schulz, A Sindrilaru, JM Weiss Ulm University, Germany
Osteopontin (OPN) is a secreted phosphoglycoprotein with Th1 cytokine functions 
in cell mediated immunity. Speculating that OPN is of importance in stabilizing the 
Th1 dominated challengephase of allergic contact dermatitis towards chronification, 
we investigated the antigen specific regulation of OPN. In skin specimen of allergic 
contact dermatitis we found that CD45RO+ memory T-cells are a major source of 
OPN. Upon NiSO4 stimulation of T-cells from nickel allergic individuals these cells 
highly secreted OPN. Similarly OPN was induced on the mRNA and protein level 
by antigen specific CD4+ and CD8+ T-cells of TNCB sensitized mice. Interestingly 
CD8+ T-cells, the central effector cells of CHS, produced the highest OPN levels. To 
further characterize OPN regulation, T-cell clones from nickel allergic donors were 
established. Clones with an IFN-γ secreting Th1 phenotype secreted little OPN, while 
clones with predominant IL-4 secretion (Th2 phenotype) produced high amounts 
of OPN. OPN secretion by such Th2 skewed T-cells may therefore contribute to 
Th1 dominated switch towards chronification. We speculated that OPN fragments 
produced by thrombin cleavage in chronic inflammation may influence T-cells 
and found that nickel specific T-cell clones express receptors for both C-terminal 
(CD44s, CD44v6) and N-terminal (avß1, a9ß1 Integrin) OPN fragments. Stimulation 
of Nickel clones with different OPN variants indicated, that uncleaved OPN down 
modulates IFN-g secretion, while the C-terminal fragment has the tendency to 
induce IFN-g. To prove that specific OPN expression contributes to chronification 
of contact eczema in vivo, OPN wt and OPN -/- mice were compared in their 
chronic CHS response to TNCB. Indeed OPN -/- mice displayed reduced acute and 
chronic ear swelling responses. In conclusion antigen specific modulation of OPN 
seems to be a central factor in the promotion of chronified T-cell mediated disease. 
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Murine mast cells express Proteinase-activated receptors 1-4 and migrate towards 
their ligands
CA Suender1, M Grusser1, M Maurer1, A Dudeck1, M Steinhoff2 1Charité Berlin, Berlin, 
Germany 2IZKF Münster, Münster, Germany
Proteinase activated receptors (PARs) are activated via proteolytic cleavage by 
several serine proteases such as thrombin, trypsin, tryptase, and cathepsin G thereby 
contributing to inflammatory skin reactions. As trypsin, tryptase, and cathepsin G are 
released by mast cells upon stimulation, the aim of the study was to investigate the 
expression and function of PARs on mast cells. Interestingly, we found that all four 
PARs 1-4 are expressed on both immature murine bone marrow derived mast cells 
(BMMCs) and mature murine connective tissue type mast cells (CTMCs), as assessed 
by PCR analyses. We also examined the influence of the activation of mast cells via 
PARs on mast cell-dependent passive systemic anaphylaxis by determining the body 
temperature of mice injected i.p. with anti-DNP-IgE and DNP. Surprisingly, the PAR 
ligands thrombin, trypsin, and cathepsin G neither effected the decrease in body 
temperature observed in mast cell-mediated passive systemic anaphylaxis nor did they 
result in a body temperature decrease by themselves. In contrast, activation of CTMCs 
with the PAR ligand combination thrombin, trypsin, and cathepsin G in vitro resulted in 
enhanced chemokinesis. Additionally, mature mast cells not previously stimulated via 
PAR showed a directed chemotaxis towards the PAR ligands thrombin and cathepsin G. 
Taken together, our data suggest that mast cell chemokinesis and directed chemotaxis 
is modulated by PAR / PAR ligand-interactions, whereas IgE-dependent mast cell-
mediated anaphylaxis is not modulated by PARs. These findings may explain, at least 
in part, why mast cell numbers tend to be increased at sites of chronic inflammation. 
 
062
Human Langerhans cells express the functional Toll-like receptors at protein levels
Y Ogawa1, T Kawamura1, A Blauvelt2, S Shimada1 1University of Yamanashi, Yamanashi, 
Japan 2Oregon Health & Science University, Portland, USA
Langerhans cells (LC) play a critical role on the initiation of immune responses 
to cutaneous pathogens. Toll-like receptors (TLR) allow detection of pathogen-
associated molecular patterns (PAMPS) by dendritic cells (DC). Although recent 
studies documented the expression of TLR on human LC at mRNA levels, their 
expression at protein levels is unknown. In this context, the purpose of this study was 
to assess the expression of TLR in human LC and their function for LC maturation. 
Using flow cytometry, we investigated the expression of TLR1-4 and TLR6-9 in 
monocyte-derived LC (MDLC) generated in the presence of GM-CSF, IL-4 and 
TGF-β and monocyte-derived DC (MDDC) generated in the presence of GM-CSF 
and IL-4, respectively. Their ability to directly respond to TLR1-9 ligands was also 
investigated. MDLC express TLR1-3 and TLR6, whereas MDDC express TLR1-4 and 
TLR6. We could not detect TLR7-9 expression in MDLC and MDDC. In line with TLR 
expression, when MDLC and MDDC were stimulated with TLR1-9 ligands for 24hs, 
MDLC and MDDC significantly increased the expression levels of CD83 and CD86 
in response to TLR1-3 and TLR6 ligands, but not TLR7-9 ligands. In addition, MDLC 
and MDDC efficiently mature in response to peptidoglycan (PGN; TLR2 ligand) from 
Gram-positive bacteria. Interestingly, MDLC were unresponsive to TLR4 ligand, while 
MDDC mature in response to it. We found that LC express the functional TLR1, 2, 
3, and 6 and DC express the functional TLR1, 2, 3, 4, and 6 at protein levels. Our 
data suggest that human LC are equipped with TLR that induce maturation upon 
detection of PAMPS from dsRNA viruses, Gram-positive bacteria, but not Gram-
negative bacteria. 
 
063
Alpha-melanocyte stimulating hormone and related compounds suppress PHA 
induced lymphocyte proliferation in vitro
RK Sihota, EP Healy, C Pickard, PS Friedmann University of Southampton, 
Southampton, UK
Alpha-melanocyte stimulating hormone (αMSH) has immunosuppressive activity. For 
example, it has been demonstrated that αMSH can increase the production of interleukin-10, 
suppress the expression of the co-stimulatory molecules CD86 and CD40, and inhibit NF-kB 
activation in human monocytes. We have previously demonstrated that αMSH suppresses 
antigen induced lymphocyte proliferation in humans in vitro, and that this is independent 
of melanocortin 1 receptor gene variants. In this study we investigated whether analogues of 
αMSH are more potent than αMSH alone in suppressing phytohaemagglutinin (PHA) induced 
lymphocyte proliferation. The compounds investigated included NDP-αMSH (a super potent 
analogue of αMSH), MTII and SHU 9119 (cyclic analogues of αMSH) and KPV (c-terminal 
tripeptide of αMSH). PBMCs were isolated from 10 healthy volunteers and stimulated with PHA 
alone for 48 hours and with PHA plus αMSH or one of its analogues (at concentrations of 10-
13M, 10-11M, 10-9M and 10-7M) for a similar period. PHA induced lymphocyte proliferation 
was suppressed by αMSH (p=0.0038), NDP-αMSH (p=0.0026), MTII (p=0.0018), SHU 9119 
(p=<0.0001) and KPV (p=0.0018). There was an amount of variability between individuals in 
the degree of suppression by the different compounds, with each of the compounds exhibiting 
up to greater than 50% suppression in some subjects. However, the mean suppression ranged 
from 19% to 26% at 10-13M and 16% to 26% at 10-11M for all five compounds. In addition, 
forskolin (which, similar to αMSH, increases the intracellular production of cAMP) caused 
a mean suppression of PHA-induced lymphocyte proliferation by 20% (p=<0.0001). By 
contrast, no significant suppression was observed with leptin in this system (p=0.9971).We 
conclude that none of the analogues of αMSH which were investigated in this study are more 
potent than αMSH alone at suppressing PHA induced lymphocyte proliferation.
 
064
The Effect of 1α,25 Dihydroxyvitamin D3 and Dexamethasone on Dendritic Cells
G Nagy, N Dobrosi, E Páyer, E Rajnavölgyi, T. Bíró, A Szegedi University of Debrecen, 
Debrecen, Hungary
Dendritic cells have a crucial role in initiating and regulating the innate and adaptive 
immunity. It is well known that Dexamethasone and 1α,25-dihydroxyvitamin D3, the 
biologically active form of Vitamin D3 have an effect on the differentiation and maturation 
of dendritic cells and they influence the dendritic cell-dependent T cell activation. Our 
aim was to investigate the effect of the two substances on the expression of the cell surface 
markers and the costimulatory molecules of monocyte-derived dendritic cells. Monocytes, 
isolated by magnetic cell sorting were cultured for five days in the presence of GM-
CSF and IL-4. To investigate the effects of Dexamethasone and Vitamin D3 on immature 
dendritic cells we continued the culturing procedure with the mentioned cytokines, 
Dexamethasone and Vitamin D3 for another three days. To investigate the effect on mature 
dendritic cells we added LPS and the examined agents to the medium. We identified the 
cell surface markers by flow cytometry and western-blot analysis. Untreated cells served 
as control. On immature DCs both Vitamin D3 and Dexamethasone decreased the 
expression of CD1a, and increased the frequency of CD14, on mature DCs both of them 
reduced the CD83 expression. These data suggest that Vitamin D3 and Dexamethasone 
inhibit the differentiation and maturation of dendritic cells. CD274 (B7-H1) and CD273 
(B7-DC) are the ligands of PD1 receptor. Vitamin D3 and Dexamethasone had opposite 
effect on the expression of CD274 on immature DCs, although they did not influence 
the expression of CD274 on mature DCs. Immature DCs did not express CD273, but 
on mature DCs both Vitamin D3 and Dexamethasone decreased the CD273 ratio. We 
conclude that both Vitamin D3 and Dexamethasone inhibit dendritic cell maturation and 
differentiation but they could play different role in T cell activation. 
 
065
Study of mRNA expression of the CIITA transactivator in human keratinocytes
G Emri*, S Benko*, A Balogh, A Varga, E Remenyik, E Rajnavölgyi University of 
Debrecen, Debrecen, Hungary
The skin immune system represents a first line of defence against various environmental 
stimuli, wherein the epidermal keratinocytes play a primary role. These cells are able 
to express and release various cytokines, which may initiate inflammatory reactions 
in the skin as well as regulate cell proliferation. Chronic inflammatory dermatoses are 
characterized by an altered local cytokine milieu and may become self-maintaining 
due to the interplay of immune cells and keratinocytes. For instance, keratinocytes of 
the normal epidermis do not express major histocompatibility complex (MHC) class 
II molecules on their surface, but inflammatory signals, such as IFN-γ produced by 
infiltrating T cells may induce MHC class II expression. The MHC class II transactivator 
(CIITA) is a transcriptional cofactor that regulates MHCII gene expression in different cell 
types. Its expression can be driven by 4 different promoters (pI-IV) ensuring promoter- 
and cell type-specificity. In normal human keratinocytes CIITA transcription was shown 
to be regulated mainly by pIV and to a lesser extent by pIII in response to IFN-γ. Here, 
we studied CIITA mRNA expression in HaCaT and primary keratinocyte cell cultures 
by means of quantitative RT-PCR. We found increasing CIITA mRNA expression, driven 
by the pIV promoter in the absence of any exogenous stimulus, in correlation with 
increasing confluence of the cells in the HaCaT, but not in the primary keratinocyte cell 
cultures. Interestingly, enhanced promoter activity did not result in augmented expression 
of MHCII molecules on the cell surface. The presence of IFN-γ in these systems could 
be excluded by undetectable levels of the cytokine measured by ELISA. These results 
suggest that cell contact-dependent inhibition of proliferation and/or differentiation of 
HaCaT cells concomitant with increasing cellular confluence may induce transactivation 
of pIV without triggering MHC class II trafficking to the cell surface. *Contributed equally 
066
Upregulation of the 5-HT2A receptor in human allergic contact dermatitis: a kinetic 
study
HB El-Nour, R Al-Tawil, K Nordlind Karolinska Institute, Stockholm, Sweden
The aim of this study was to investigate the expression of the 5-HT2A receptor (R) 
in nickel-allergic patients (n= 10), using skin biopsies from epicutaneous patch test 
reactions to nickel sulphate, obtained at different time points (0, 6, 24, 48, and 72 
h) after application of the antigen. The skin biopsies were fixed in a mixture of 10% 
formalin with 0.2% picric acid, and rinsed in 0.1 M phosphate buffer containing 
10% sucrose for at least 24 h, before being cut into 14 µm thick sections and 
stained using immunohistochemistry and a streptavidin-biotin technique. 5-HT2AR 
expression was observed on dermal mononuclear cells that were seen to infiltrate 
the epidermis, in the biopsies obtained at the later time points (48 and 72 h), and 
also being visible in vesicles in the highly inflamed skin biopsies. The total (dermis 
plus epidermis) number of 5-HT2AR positive cells was increased to reach 3.5 cells/
section (median) (p<0.01) at 6 h compared to 1.9 cells/section) at 0h. At 24, 48 and 
72 h the total numbers of 5-HT2AR immunoreactive cells were 5.5 (p<0.05), 25.3 
(p<0.001) and 29.4 (p<0.001), respectively. Furthermore, the increased number of 
5-HT2AR positive cells was directly proportional with the progress of time. 5-HT2AR 
immunoreactivity was also observed on blood vessels and smooth muscles as well as 
the basal membrane. In addition, the upper quarter of the epidermis was reactive for 
5-HT2A receptor. Our findings suggest an implication of 5-HT2A receptor during the 
onset of allergic contact eczematous reaction and a possibility to target this receptor 
for the treatment of this reaction at an early time point. 
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The value of drug hypersensitivity testing in the clinic
HL Cooper, C Pickard, F Louafi, EP Healy, PS Friedmann University of Southampton, 
Southampton, UK
We present 3 interesting cases in which confirming the diagnosis of drug hypersensitivity 
prevented open heart surgery, future peri-operative complications and possible divorce 
proceedings. Case 1: A 62 year old man presented with a cardiac pacemaker eroding 
through the skin, intracardiac vegetations and S. Aureus infection. The patient was 
commenced on teicoplanin, but despite initial improvement the patient developed pyrexia 
and lymphadenopathy. Progressive endocarditis was suspected and open heart surgery 
contemplated, fortunately, an alternative diagnosis of teicoplanin hypersensitivity was also 
considered. Case 2: A 26 year old man developed an aggressive post-operative toxic erythema 
on 2 occasions. He was due to undergo further surgery but a potential hypersensitivity to 
an anaesthetic agent was suspected. Case 3: A 36 year old man presented with an episodic 
pruritic eczematous penile eruption. A detailed history revealed his rash coincided with his 
wife taking azathioprine. To investigate each case, we carried out patch-testing, lymphocyte 
transformation tests (LTT) and CFSE (CarboxyFluorescein Succinimidyl Ester) dilution assay to 
assess the proliferation of T-cell subsets. The cytokine profile of the responding T-cell subset 
was determined using flow cytometry. In case 1, the results of the patch-test to teicoplanin was 
negative (patient had no rash clinically), however the LTT demonstrated a positive response to 
the drug (stimulation index=14), and the results from the CFSE-assay showed the proliferative 
cells to be CD4+ displaying a T-helper 0 phenotype (high IFN-γ and IL-5). In case 2, results of 
the patch-test and LTT identified an allergy to amoxicillin, codeine and possibly ondansetron 
but no allergy to anaesthetic agents. In case 3, the patch-testing demonstrated an allergy to 
azathioprine, thus alleviating his wife’s concerns of infidelity. In conclusion, a combination 
of in vivo and in vitro investigations are helpful in diagnosing drug hypersensitivity in the 
clinical setting.
068
Lymph node lymphangiogenesis associated with chronic skin inflammation does not 
require the induction of an adaptive immune response
B Vigl1, C Halin1, NE Tobler1, LF Brown2, M Detmar1 1Inst of Pharmaceutical Sciences, 
ETHZ, Zurich, Switzerland 2Harvard Medical School, Boston, USA
Lymphangiogenesis has recently been shown to accompany various chronic inflammatory 
disorders. In this study, we have investigated the role of lymphangiogenesis in chronic skin 
inflammation. To this end, we induced and maintained delayed-type hypersensitivity (DTH) 
reactions in the ears of mice by repeated application of the contact sensitizer oxazolone, and 
then analyzed the resulting lymphangiogenesis in the inflamed tissue and draining lymph 
nodes (LNs). We found that long lasting inflammation induced a significant increase in the 
number of lymphatic endothelial cells, not only in the inflamed ears, but also in the ear-
draining auricular LNs. Inflammation-induced lymphangiogenesis in the ears and draining 
LNs was potently blocked by systemic administration of a VEGF-A neutralizing antibody. 
Interestingly, analysis of VEGF-A gene and protein expression revealed that VEGF-A was 
expressed at high levels in the epidermis of inflamed ears, but was only increased at the 
protein level, not at the mRNA level, in ear-draining LNs. Our data reveal that chronic 
inflammation actively induces lymphangiogenesis in LNs, which is remotely controlled by 
VEGF-A produced at the site of inflammation. In line with these findings inflammation-
induced lymphangiogenesis in LNs did not require the presence of VEGF-A secreting B cells 
in the draining LNs, as shown in B cell-deficient mice. Interestingly, repeated application 
of oxazolone onto the ears even led to an expansion of lymphatic structures in the ears 
and draining LNs of SCID/beige mice, which lack B and T cells and harbor dysfunctional 
NK cells. These findings indicate that oxazolone-induced ear and LN lymphangiogenesis 
occurs partially independent of the induction of an adaptive immune response. Overall, 
our data suggest, that also chronic inflammation elicited by an antigen-non-specific 
stimulus may induce lymphangiogenesis in the inflamed tissue and draining LNs. 
069
IFN-α and viral triggers promote functional maturation of human monocyte-derived 
dendritic cells: a pathogenic role for psoriasis?
A Farkas1, G Tonel2, FO Nestle3 1University of Szeged, Hungary 2University Hospital 
of Zurich, Switzerland 3Kings College School of Medicine, London, UK
Type I interferons (IFNs) play an important role in the pathogenesis of many 
autoimmune disorders including psoriasis. In the presence of IFN-α and granulocyte/
macrophage colony-stimulating factor monocytes differentiate into dendritic cells 
(DCs) referred to as IFN-DCs. IFN-DCs potentially mimic DC populations involved 
in psoriasis and express a wide range of Toll-like receptor (TLR) subtypes. Recently, 
it was shown that single-stranded RNA (ssRNA) triggers TLR7 and TLR8 therefore we 
studied ssRNA, as a surrogate for ssRNA viruses and their impact on IFN-DCs. We 
found that IFN-DCs express mRNA for TLR7 and TLR8 and that ssRNA stimulation 
significantly improves their costimulatory molecule expression, phenotype stability 
and enhances their capacity to stimulate naïve T cell proliferation. Unstimulated IFN-
DCs were not producing bioactive interleukin (IL)-12 and were producing low levels 
of other proinflammatory cytokines. In contrast, ssRNA stimulation led to a significant 
production of IL-12p70, IL-1β, IL-6 and tumor necrosis factor alpha. IFN-DCs contained 
mRNA for IL-12p35, IL-12p40, IL-23p19, IL-27p28 and IL-27EBI, which was further 
increased by incubation with ssRNA. As assessed by the detection of IFN-α- or IL-4-
producing cells, coincubation of unstimulated IFN-DCs with allogeneic naïve T cells 
led to mixed T-helper 1/T-helper 2 (Th1/Th2) responses, which was shifted towards a 
Th1 type response after ssRNA stimulation. Our study sheds light on a potential role 
for IFN-α and viral infections in triggering DC populations in psoriasis. These results 
provide additional data to better understand human autoimmune and antiviral responses 
and may also have implications for strategies developing cancer immunotherapy. 
 
070
Mitogenic activity of human neurofibroma cells is enhanced by mast cell-derived 
tumor necrosis factor-alpha
Y Nakamura, T Takahashi, H Sato, Y Fujisawa, Y Kawachi, F Otsuka University of 
Tsukuba, Tsukuba, Ibaraki, Japan
Neurofibromas multiply arise and continuously grow in neurofibromatosis 1 (NF1) 
patients. Although the size is various, some neurofibromas considerably grow despite 
of the benign tumor. This allowed us to explore the contributory factor, except for 
NF1 gene, to mitogenic activity of neurofibroma cells. We previously showed that 
tumor necrosis factor-alpha (TNF-α) accelerated the proliferation of NF1-derived 
neurofibroma cells in vitro. TNF-α mostly acts as an apoptotic agent but selectively 
serve as a mitogenic factor for some cell types. Normal Schwann cells are led to 
apoptosis by TNF-α. Our previous study however evidenced that TNF-α also activated 
AKT and MEK/ERK cascades but not intrinsic apoptotic signals in neurofibroma cells. 
The TNF-α effects were attenuated by anti-TNF-α neutralizing monoclonal antibody. 
Those results implied the similar mitogenic role of TNF-α in vivo. Therefore, the present 
study examined the in vivo origin of TNF-α in neurofibroma. Immunostaining of 
TNF-α positively stained for mast cells but not any other cells in neurofibroma tissues 
containing normal skin while that of TNF-α receptor 1 was positive in mast cells, 
neurofibroma cells and most normal cutaneous cells. Both culture supernatant of mast 
cells derived from neurofibroma and coculture of mast cells and neurofibroma cells 
resulted in the accelerated proliferation of neurofibroma cells. Those results suggest that 
mast cells may play an important role in neurofibroma growth via TNF-α stimulation. 
 
071
Chemotactic effect of Rosai-Dorfman disease-derived B lymphocytes on monocytes
T Kaneko1, T Takahashi2 1Fraternity Memorial Hospital, Tokyo, Japan 2University of 
Tsukuba, Tsukuba, Ibaraki, Japan
Rosai-Dorfman disease, also known as sinus histiocytosis with massive 
lymphadenopathy, is a rare non-neoplastic histiocytosis of unknown etiology. This 
uncommon disorder is clinically characterized by painless cervical lymphadenopathy 
and occasional extranodal masses. Despite of its propensity to form large nodules 
and disseminate to extranodal sites, the disease is generally considered a benign 
self-limited proliferation of histiocytes. Typical histological findings exhibit a dermal 
or subcutaneous dense infiltrate of histiocytes with varing population of lymphocytes 
and emperipolesis. The reason of the preferential infiltration of histiocytes has not 
been understood. We here show that B lymphocytes, which were isolated from 
cutaneous mass of Rosai-Dorfman disease and cultured with 1% FBS RPMI1640 
adding not any cytokine in vitro, expressed macrophage chemotactic protein and 
macrophage infiltrating factor. In addition, they had a significant chemotactic effect 
on monocytes, which was confirmed by migration assay using modified Boyden 
chamber. The findings suggest that B lymphocytes infiltrating into the lesion have 
a potential of a chemoattractant to monocytes. Although the biological behavior 
of the infiltrating lymphocytes in vivo is unclear, it is possible that the infiltrate 
of B lymphocytes might be not the resultant inflammatory response but, at least 
partially, contribute to the main histogenetic pathway in Rosai-Dorfman disease. 
 
072
Evidence for a counter-regulation of FcepsilonRI-mediated mechanisms by 
tetraspanins in human antigen presenting cells
N Novak, WM Peng, CF Yu, L Maintz, C Bussmann, JP Allam, J Jockers, J Hart 
University of Bonn, Germany
Engagement of the high affinity receptor for IgE (FcepsilonRI) on antigen presenting 
cells (APC) plays a central role in allergic diseases such as atopic dermatitis (AD) and 
results in a cascade of cell signaling events, the release of various soluble mediators 
as well as modified cell survival of FcepsilonRI-challenged APC. Tetraspanins 
represent a family of cell-surface proteins which form the so called ‘tetraspanin-web’. 
Tetraspanins associate with themselves and partner proteins, transmit external stimuli 
to intracellular signalling components and modulate the capacities of APC to migrate 
and take-up antigens. We found increased expression of the tetraspanins CD9, CD37 
and CD81 on epidermal dendritic cells (DC) of patients with atopic dermatitis (AD) 
compared to healthy controls and elevated expression of the tetraspanins CD9, CD63, 
CD81 and CD82 on in vitro generated inflammatory dendritic epidermal cell (IDEC)-
like DC. We could show that up-regulation of some of the tetraspanins was dependent 
on the redox-state and micromilieu of differentiating DC. Further on, FcepsilonRI-
engagement profoundly modulated the expression pattern of tetraspanins on APC 
in vitro, with significant down-regulation of CD8, CD37, CD53 and CD151 and 
concomitant up-regulation of CD151. Co-localization of tetraspans with FcepsilonRI 
on APC was evaluated by confocal microscopy and co-immunoprecipitation 
experiments. Activation of APC via tetraspanins alone or in combination with 
FcepsilonRI-engagement modified the survival of APC and their capacity to take up 
antigens in vitro. Together, these data provide evidence for a counter-regulation of 
FcepsilonRI-mediated mechanisms of APC by tetraspanins, which might impact on the 
immune functions of human FcepsilonRI-bearing APC in atopic disorders such as AD. 
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Intracellular ROS level modulate the outcome of inflammatory immune responses
C Weigert, K Ghoreschi, J Brück, M Röcken Eberhard-Karls Univ, Tübingen, Germany
Activation of Toll like receptor (TLR)4 by lipopolysaccharid or TLR9 by unmethylated CpG 
oligodeoxynucleotide induces a dendritic cell (DC) phenotype, producing large amounts 
of Interleukin (IL)-12 or IL-23 and thus promoting TH1 or TH17 responses. In contrast, DC, 
deficient in IL-12- or IL-23 induce IL-4-producing TH2 cells. Thus, innate stimuli acting on 
DC regulate immune responses to self or foreign antigens resulting in autoimmune diseases. 
Under physiological conditions, DC receive TLR-stimulation during infection. Since not 
every infection results in autoimmune disease, further factors may have a dominant influence 
in directing autoimmunity. Various data show that reactive oxygen species (ROS) strongly 
interfere with intracellular signaling. ROS are frequently generated during infections and seem 
to have an important role in tumor defense. We investigated the role of ROS in TLR induced 
immune activation. H2O2 as well as depletion of intracellular ROS scavenger almost diminish 
the production of IL-12 and IL-23 by DC in response to TLR4/TLR9 signaling. These effects 
were compensated by exposure to ROS scavengers such as glutathione or N-acetylcysteine. 
Next, we followed the influence of intracellular ROS levels in DC on their capacity to 
determine T cell differentiation. TLR4 or TLR9 stimulation induces IL-12 and IL-23 producing 
DC that induce interferon (IFN-γ-producing TH1 or IL-17-producing TH17 cells at low ROS 
concentrations only. High ROS concentrations prevent expression of pro-inflammatory 
cytokines in DC. Instead, these DC produce enhanced amounts of IL-10 and induce IL-4-
producing TH2 cells. In vivo, high ROS concentrations also prevent TLR-induced expression 
of pro-inflammatory cytokines and the development of TH1 responses and instead induce an 
IL-4 dominated TH2 immune response that protects from encephalomyelitis, a TH1/TH17-
mediated autoimmune disease.Thus, intracellular levels of ROS or ROS scavenger modulate 
TLR-signaling in DC that determines the differentiation of TH1, TH17 or TH2 responses in 
vitro and in vivo.
074
Interferon-γ, TRAIL and TWEAK induce apoptosis of keratinocytes in Toxic Epidermal 
Necrolysis
J-C Roujeau1, G Lapree2, S Le Gouvello2, R Incitti2, G Beaud2, P Musette3, M Bagot1, A 
Bensussan2, A Tsapis2 1Hôpital Henri Mondor, Créteil, France 2Inserm U841, Créteil, 
France 3Inserm U519, Rouen, France
We investigated the role of cytokines activating death receptors in the induction of 
toxic epidermal necrolysis (TEN) under the hypothesis that the massive apoptosis of 
keratinocytes cannot be totally explained by drug specific activated cytotoxic T cells. 
Blister fluids (BF) were collected in TEN patients. Cytokine concentrations were 
measured by ELISA in BF supernatants. RNA extracted from BF mononuclear cells was 
tested for the expression of genes on microarrays. Relevant results were checked on 
further samples by qRT-PCR. Induction of apoptosis on keratinocytes in culture (HaCaT 
cells and normal human keratinocytes NHK) was evaluated (annexin V, and propidium 
iodide) after incubation with BF supernatants and with recombinant cytokines. We 
previously found that IFN-γ was the cytokine with the highest concentration in BF. 
Additionally we found elevated levels of two other death mediators of the TNF family: 
TRAIL in 5/6 cases and TWEAK in all 6. BF mononuclear cells over-expressed mRNA 
for IFN-γ (x 4 to 9), TRAIL (x 5 to 8) and TWEAK (x 1.4 to 8). BF supernatants diluted 1/8 
induced apoptosis in 50% of HaCaT cells and NHK. Recombinant IFN-γ, TRAIL and 
TWEAK each induced apoptosis in HaCat and NHK, TRAIL having the most marked 
effect at concentration as low as 10 ng/ml. A synergistic effect was obtained upon 
simultaneous addition of these three ligands, resulting in the death of more than 90% 
of cells within 48 hours. Thus, the results suggest that in addition to the drug-specific 
cytotoxic T-cells mechanism, there is a non specific cytokine mediated phenomenon 
which destroy normal keratinocytes. IFN-γ, and 2 ligands of death receptors TWEAK 
and TRAIL all produced by mononuclear cells present in the lesions.
075
CD160 expression and release by cutaneous mast cells further support a role for 
these cells in skin inflammation
N Ortonne1, S Abecassis1, J Giustiniani1, M Bagot1, M Arock2, A Bensussan3 1Hôpital 
Henri Mondor, Créteil, France 2ENS de Cachan, France 3INSERM U841, Créteil, France
Mast cells play an essential role in allergic diseases and participate to innate immunity and to 
host defense against several infectious pathogens. BY55By55/CD160 is an immunoglobulin-
like glycosyl phosphatidyl inositol (GPI)-anchored receptor, expressed in vivo by cytotoxic 
lymphocytes including intestinal intraepithelial lymphocytes, circulating natural killer cells 
(NK) and minor subsets of circulating and skin-homed CD4+ T lymphocytes. In NK, membrane 
bound CD160 interacts with MHC class Ia/Ib molecules to trigger target cell lysis and cytokine 
production. Further, CD160 is cleaved and released by a GPI-PLD upon lymphocyte activation 
and the soluble secreted protein was found to exhibit immunoregulatory properties as it inhibits 
cell-mediated cytotoxicity. We investigated the expression of CD160 by the human mast cell 
line HMC-1, using specific RT-PCR, Western-blot and enzyme linked immunosorbent assay 
(ELISA). In addition, CD160 expression was analyzed in vivo using immunohistochemistry 
(with the CL1-R2 anti-CD160 monoclonal antibody) in nude mouse and human tissue samples, 
including normal skin and various inflammatory dermatoses. We found that BY55By55/CD160 
is expressed by human and murine mast cells in vivo and in vitro. In normal human and mouse 
tissue samples, CD160 protein was detected by immunohistochemistry in all resident mast cells. 
In these tissues, double immunostaining with anti-CD160 and anti-CD117/c-Kit antibodies 
showed co-localization of both markers. In various skin inflammatory diseases, the proportion of 
CD160+ mast cells was increased. In HMC-1 cells, CD160 expression was demonstrated at both 
transcript and protein levels. Interestingly, CD160 was also detected in the culture supernatant 
of HMC-1, indicating that mast cells release soluble CD160. Our results show that human mast 
cells produce and secrete soluble CD160, and that CD160+ mast cells are recruited at the site 
of cutaneous inflammation, where soluble CD160 may play a role in the regulation of the innate 
and specific immunities. 
076
Cinnamic aldehyde but not cinnamic alcohol identified as potent sensitizer in a 
dendritic cell-based in vitro model of contact allergy
H Ott1, M Andresen-Bergström2, HF Merk3, G Zwadlo-Klarwasser1, JM Baron3 
1University Hospital Aachen, Aachen, Germany 2Göteborg University, Göteborg, 
Sweden 3RWTH Aachen, Aachen, Germany
Previous in vivo and in vitro studies have described trans-cinnamic aldehyde (CAld) and 
trans-cinnamic alcohol (CAlc) as clinically relevant causes of allergic contact dermatitis. 
Furthermore, CAlc has been proposed to be a prohapten, activated into CAld by skin 
metabolism. However, the allergenic activity in vitro of CAlc and CAld has not been 
investigated. We therefore established a dendritic cell (DC) assay in order to compare the 
sensitizing potential of these two low molecular weight compounds in vitro. As contact 
sensitizers have previously been shown to upregulate IL-8 mRNA expression in human DCs, 
we first generated immature DCs from human peripheral blood monocytes by depletion of 
CD2, CD7, CD19, CD56, CD16, CD235a positive leukocytes and consecutive incubation 
with GM-CSF and IL-4. Secondly, at least 6 million cells were stimulated with the following 
test compounds for 30 hours respectively: the model sensitizer 2,4,6-trinitrobenzene 
sulfonic acid - TNBS (200 mg/ml), the model irritant sodium dodecyl sulfate - SDS (5 mg/
ml), dimethyl sulfoxide - DMSO (0.1%), CAld (0,1 mM) and CAlc (0.1 mM). After RNA 
isolation of the treated cells, reverse transcriptase-PCR analysis was performed using a 
primer/probe set specific for the detection of IL-8 mRNA expression. A sensitizing effect of 
CAld could be shown for all 6 donors as indicated by a median IL-8 upregulation of 34.3 
fold normalized relative to medium-treated controls. In contrast, the median enhancement 
of IL-8 mRNA expression was not significantly greater after incubation with CAlc (2.13) 
than after stimulation with the irritants SDS (2.22) and DMSO (1.2). In conclusion, using 
this in vitro assay, cinnamic aldehyde possesses a stronger allergenic activity than cinnamic 
alcohol which was found to be an irritant agent rather than a truly sensitizing compound.
077
Three Low Dose Intralymphatic Injections with Pollen Extract are a Safe, Rapid and 
Long Lasting Treatment of Hay Fever
TM Kündig1, G Senti1, P Johansen1, R Crameri2 1University of Zurich, Zürich, 
Switzerland 2SIAF, Davos, Switzerland
Allergen specific immunotherapy is the only causative treatment of IgE-mediated 
allergies. The disadvantages of immunotherapy, however, are the requirement of 
numerous allergen administrations over three to five years, and that the treatment itself 
causes frequent allergic reactions. We aimed at enhancing grass pollen immunotherapy 
in hay fever patients by injecting the allergen directly into subcutaneous lymph nodes. 
In a monocentric randomized trial safety and efficacy of intralymphatic immunotherapy 
with 3 low dose grass pollen extract injections over 2 months (cumulative allergen dose 
3’000 SQ-U) were compared to subcutaneous immunotherapy using 54 injections 
over 3 years (cumulative allergen dose 4’031’540 SQ-U). Intralymphatic allergen 
injections were practically painless and caused significantly less allergic adverse events 
than subcutaneous immunotherapy. Intralymphatic allergen administration induced 
tolerance to nasal provocation with pollen extract already within 4 months, which 
was significantly faster than subcutaneous administration. In the first year of treatment 
patients in the intralymphatic group used less rescue medication than patients in 
the subcutaneous group. The drop in grass pollen specific serum IgE was significant 
and comparable in both intralymphatic and subcutaneous patients. Intralymphatic 
immunotherapy induced long lasting allergen tolerance in nasal provocation testing 
and long lasting amelioration of hay fever symptoms during the pollen season that 
were as profound as standard subcutaneous immunotherapy. Intralymphatic allergen 
administration enhanced the safety of immunotherapy and reduced the treatment time 
from three years to eight weeks.
 
078
Toll-like receptor ligation on oral mucosal Langerhans Cells leads to tolerogeneic 
and TH1 immune responses
JP Allam1, B Niederhagen1, S Bergé2, M Wenghoefer1, T Bieber1, T Appel1, N Novak1 
1University of Bonn, Germany 2University of Nijmegen, Netherlands
Although a high number of bacteria colonize the oral mucosa, acute infections are 
rarely seen within this organ assuming that tolerogenic mechanisms predominate 
at this site. Toll-like receptors (TLR) play a pivotal role in recognition of bacterial 
antigens. The expression of TLR on oral mucosal APCs such as Langerhans cells (oLC) 
has not been investigated in detail so far. It has been shown recently that epidermal 
Langerhans cells (eLC) show an impaired expression of TLR2 and TLR4 and response 
to activation with TLR2 and TLR4 ligands. In contrast, we could show that significant 
amounts of mRNA for TLR2 and TLR4 were detectable in oLC enriched from the 
oral mucosa. Futher on, we observed expression of TLR2 and TLR4 protein on the 
cell surface of oLC. Together with significant surface expression of the LPS receptor 
CD14 on oLC, which is associated with TLR4, these findings suggest a susceptibility 
of oLC towards TLR4-agonists. In this context we could show that TLR4 ligation on 
oLC up-regulated the expression of the co-inhibitory molecules B7-1 and B7-H3, 
which are characteristic for regulatory DC subtypes capable to induce tolerance. 
Additionally, we could demonstrate that TLR4 ligation led to an increased release 
of the anti-inflammatory cytokine IL-10 by oLC which correlated with a decreased 
proliferation of cocultured T cells. Moreover, TLR4 ligation on oLC induced T cells 
with high IL-10 and TGF-β producing capacities and augmented the production of 
the Th1 cytokines IFN-γ and IL-2 by T-cells co-cultured with oLC after TLR4-ligation.
In view of these data, TLR4 activation of oLC might not only play an important role in 
pathogen recognition leading to efficient immunity in the oral mucosa but might also 
contribute to the tolerogenic state which predominates at this site. 
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Identification of native human dendritic cells that are highly responsive to TLR7- 
and TLR8-stimulation
A Hänsel, M Meurer, EP Rieber, K Schäkel TU Dresden, Germany
Slan-dendritic cells (6-sulfoLacNAc expressing dendritic cells) are a myeloid 
dendritic cell type found in large numbers in human blood and inflamed dermis 
such as in psoriasis vulgaris. Previously we described their very high capacity to 
produce TNF-α as well as IL-12 in response to microbial stimulation. However, their 
expression profile of the toll-like receptors is not known so far. We here demonstrate 
that slanDC express mRNA encoding for TLR2, 4, -5, -6, -7 and -8 as revealed by 
qualitative and quantitative RT-PCR (TLR7-8). In contrast, CD1c+ myeloid DC express 
TLR3, but failed to express significant levels of TLR -4, -6 and -8, and plasmacytoid 
DC (pDC) expressed preferentially TLR7 and -9. In our functional studies we 
focussed on the relevance of the TLR7- and 8-expression by slanDC, as agonist of 
these TLRs are of high therapeutic value for the treatment of certain skin neoplasms. 
When slanDC were stimulated with R848, a ligand of TLR7 and TLR8 we observed 
a by far higher IL-12p40 and IL-12p70 production among slanDC compared to 
CD1c+ DC and pDC. Specific ligation of TLR7 (3M-001) and TLR8 (3M-002) 
revealed that slanDC, but not other DC subsets, can respond to both ligands with 
a strong production of IL-12 as well as TNF-α. Taken together, slanDC expressing 
high levels of functional TLR7 and TLR8 may be important proinflammatory 
effector cells when treating cutaneous malignancies with TLR7/8-ligands. 
 
080
Skin primed T-cells induce dermatitis after adoptive transfer and epicutaneous ova 
peptide exposure
I Glocova, A Yazdi, M Röcken, K Ghoreschi Eberhard-Karls Univ, Tübingen, Germany
Antigen-specific CD4+ T Helper (TH) cells play a crucial role in the development of contact 
dermatitis in patients with contact allergy or atopic dermatitis. We established a mouse model 
for protein contact dermatitis to investigate migration and pathogenicity of antigen-specific 
TH cells. OVA T-cell receptor transgenic mice (DO11.10) were sensitized epicutaneously 
with OVA-peptide or saline. Mice treated with OVA-peptide developed strong eczema with 
inflammatory infiltration as well as acanthosis, spongiosis and hypergranulosis compared to 
saline treated mice, which showed no responses to epicutaneously treatment and normal skin 
histology. In addition, we analyzed the cytokine production of T lymphocytes isolated from skin 
draining lymph nodes (drLN), mesenteric lymph nodes and spleens of epicutaneously sensitized 
mice. Only T-cells from skin drLN produce high levels of IFN-gamma after sensitization with 
OVA. Minimal or no cytokine production was observed in other lymphoid organs and in saline 
treated mice. To investigate the pathogenicity of epicutaneously primed T lymphocytes, we 
transferred DO11.10 T-cells into naïve BALB/c mice and exposed these epicutaneously with 
OVA-peptide or saline. In parallel naïve DO11.10 T lymphocytes or DO11.10 T lymphocytes 
primed by oral antigen administration were transferred into naïve BALB/c mice. These mice 
were also treated epicutaneously with OVA-peptide or saline. Saline treatment led to a random 
distribution in all lymphoid organs of the recipient and normal skin histology. OVA-peptide 
application on the skin induced a selective migration into skin drLN in all mice independent of 
activation form of transferred T-cells. Importantly, an induction of protein-contact dermatitis with 
a strong inflammatory infiltration and acanthosis was only observed in BALB/c mice receiving 
epicutaneously primed T-cells. Thus, epicutaneous antigen-application instructs skin primed 
T lymphocytes to home into the skin associated lymphoid tissue (SALT) and to cause allergic 
contact hypersensitivity reaction.
081
In vivo modulation of autoimmunity through dimethylfumarate in a mouse model 
of encephalomyelitis
J Brück, C Weigert, K Ghoreschi, M Röcken Eberhard-Karls Univ, Tübingen, Germany
Experimental autoimmune encephalomyelitis (EAE) is a TH1/TH17 mediated 
inflammatory demyelinating disease of the central nervous system (CNS) that is 
induced by the generation of an immune response against myelin epitopes. EAE is 
used as a model for multiple sclerosis and CNS inflammation can be induced by 
active immunization with myelin peptide, complete Freund’s adjuvant (CFA) and 
pertussis toxin or by adoptive transfer of myelin-specific TH1/TH17 cells. Myelin-
specific IL-4-producing TH2 cells have been shown to induce EAE only in immune-
deficient mice. Thus, immunomodulating therapies may be feasible for the therapy 
of multiple sclerosis or other inflammatory autoimmune diseases. Dimethylfumarate 
(DMF) is effective for the treatment of psoriasis, a TH1-mediated autoimmune disease 
of skin. Since DMF has been shown to modulate immune responses towards a TH2 
phenotype, we investigated whether in vitro or in vivo treatment with DMF is able to 
induce protection against TH1/TH17-induced encephalomyelitis. In vitro stimulation 
of naïve CD4+ TH cells in the presence of DMF induced autoreactive TH cells with 
an anti-inflammatory TH2 phenotype. The role of DMF on the immune system 
was also investigated in vivo. Mice were treated with DMF or PBS. After feeding, 
mice were challenged with the myelin autoantigen in CFA and pertussis toxin and 
the intracellular cytokine expression in draining lymph nodes was analyzed by 
quantitative PCR (RT PCR) and intracellular cytokine staining. Analysis of draining 
lymph nodes from DMF fed mice after active EAE induction shows suppressed mRNA 
levels of proinflammatory cytokines such as IL-12p35, IL12p40 and IL-17 compared 
to control mice with high expression of these cytokines. These results show, that 
feeding with DMF before an active EAE induction with autoantigen in CFA and 
pertussis toxin modulates the immune response in vivo towards a TH2-like phenotype. 
082
Mast cell-specific Cre/loxP-mediated mutagenesis in vivo 
A Roers1, J Scholten1, A Gerbaulet1, T Krieg1, G Testa2, K Hartmann1 1Univ of Cologne, 
Germany 2European Institute of Oncology, Milan, Italy
Mast cells are important effector cells in type I allergy, but were recently also shown 
to play key roles in host defence against pathogens. Investigation of this important 
cell type, however, was severely hampered by the scarcity of mast cells in tissues. 
Herein, we use the Cre/loxP recombination system for conditional mast cell-specific 
mutagenesis in vivo. A bacterial artificial chromosome (BAC) containing the entire 
mouse mast cell protease 5 (Mcpt5) locus was shortened to exclude neighbouring 
genes using homologous recombination in E. coli. The first exon of the Mcpt5 gene 
was replaced by a Cre cassette. Transgenic mice harboring the modified BAC were 
obtained by pronucleus injection. In order to demonstrate mast cell-specific Cre-
mediated recombination, six Mcpt5-Cre founder lines were crossed to a Rosa26-
EYFP Cre-excision reporter line. For three of the transgenic lines, FACS analysis of 
cell suspensions from various tissues showed efficient Cre-mediated induction of the 
fluorescent reporter protein in mast cells, but not in other cell types. The new Cre-
transgenic mouse lines will be useful tools in the elucidation of mast cell biology.
 
 
083
Evidence for the Regulation of IgE-production by Perforin in Mice and in Patients 
with Atopic Dermatitis
A Ambach1, M Hoefeld-Fegeler1, C Besser1, A Weren1, B Bonnekoh1, B Schraven1, 
T Jakob2, H Gollnick1 1Otto-von-Guericke-University, Magdeburg, Germany 2Albert-
Ludwigs-University, Freiburg, Germany
In atopic patients, perforin (Perf)-reduction and -hyperreleasability were described, elevated 
serum levels of total IgE and exaggerated IgE-responses to allergens are well known.To 
elucidate, if Perf regulates IgE-levels in vivo, we investigated (i) C57BL/6-Prf1tm1Sdz/J Perf-
knockout (-/-) mice backcrossed by us onto a Balb/cJ background and (ii) 50 patients with 
exacerbated atopic dermatitis. From Pf -/-, Pf +/- and wt F8-mice, blood was obtained at 
week 7, 12 and 20. In addition, female Perf -/- and wt F8-mice were immunized i.p. with 
ovalbumin (OVA) at week 7, 9 and 15 +/- 1 using alumn as adjuvant. Total serum IgE- and 
OVA-specific IgE-levels were measured by ELISA at week 7, 9, 12, 15, 17. Patients were 
characterized with regard to total serum IgE-levels and their peripheral Perf-system. In a 
subgroup, IgE-production was measured in vitro of (i) PBMC, (ii) PBMC depleted of CD8+ 
T cells, (iii) CD8-depleted PBMC reconstituted with CD8+ T cells. Results were analyzed 
using the SPSS-software. Male mice showed significant lower basal IgE-levels as compared to 
females. There was no significant difference between Perf -/-, Perf +/- and wt-mice. After the 
second and third immunization, OVA-specific and total IgE-responses were significant higher 
in Perf -/- mice as compared to wt-animals. In patients, serum IgE-levels correlated negatively 
with the absolute number of peripheral CD8+ T cells; in addition, a correlation to Perf+ CD8+ 
cells was found. Depleting these cells in vitro resulted, as compared to controls, in significant 
higher IgE-levels which correlated with the portion of Perf+ CD8+ T cells removed. Taken 
together, Perf regulates IgE-responses to antigen exposure in mice, but not basal serum IgE-
levels. In patients, Perf+ CD8+ T cells seem to be involved in IgE-regulation as well.
 
084
Antihistamines are immunosuppressive and increase susceptibility to bacterial and 
viral infections
P Johansen, G Senti, A Bünter, C Bull, JM Martínez Gómez, B Wüthrich, TM Kündig
University of Zurich, ZURICH, Switzerland
Antihistamines (H1-receptor antagonists) are over the counter drugs widely used 
against allergies, pruritus, nausea, cough, and as sleeping aids. Apart from older 
antihistamines that may cause drowsiness and sedation, this class of drugs is 
considered very safe, illustrated by the fact that prescription antihistamine sales 
totaled more than US $ 4.3 billion in 2001 with more than a hundred million annual 
prescriptions. We tested the effect of antihistamine treatment on susceptibility to 
bacterial and viral infections in mice as well as on the effect of sensitisation and 
desensitisation with bee venom allergen. Mice treated with antihistamines showed 
critically suppressed innate and adaptive immunity and succumbed to bacterial 
and viral infections. Moreover, the efficacy of allergen-specific immunotherapy 
was impaired when simultaneously treating mice with antihistamine. Thus, 
the safety profile of antihistamines and their wide-spread and long term use 
should be revisited with respect to wanted and unwanted immunological effects. 
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085 [Oral 036]
Efficacy of low-calorie diet associated to suboptimal cyclosporine in the treatment 
of severe chronic plaque psoriasis of obese patients: open, controlled, randomized 
clinical trial
P Gisondi, F Adami, V Di Francesco, M Zamboni, G Girolomoni University of Verona, 
Verona, Italy
Chronic plaque psoriasis is associated to obesity in 12.9-34% of cases. Cyclosporine at a 
dose inferior to 3 mg/Kg/day is poorly effective in the treatment of severe psoriasis. Calorie 
restriction diet improves clinical findings and reduces markers of inflammation in obese 
patients with chronic inflammatory diseases including asthma or rheumatoid arthritis. The 
aim of the study was to investigate whether a significant weight loss (i.e. a BMI reduction of at 
least 10%) could improve the response rate to a suboptimal dose of cyclosporine in patients 
with severe psoriasis. We compared the efficacy of a low-calorie diet associated to suboptimal 
cyclosporine dose (2.5 mg/Kg/day) versus cyclosporine alone in the treatment of obese patients 
with severe chronic plaque psoriasis. A 24-week open, controlled, randomized clinical trial 
was performed. Sixty obese patients (BMI > 30) with a severe chronic plaque psoriasis (PASI > 
10) were randomized in two cohorts: 30 patients adhered to a low-calorie diet and received 
cyclosporine at a dose of 2.5 mg/Kg/day, whereas the other 30 patients received cyclosporine 
alone at a dose of 2.5 mg/Kg/day. At baseline the two cohorts of patients were comparable in 
terms of mean age, BMI, psoriasis severity and male/female ratio. A mean weight loss of 6.7 Kg 
was reached in patients who adhered to diet. At week 24, PASI 75 response rate was observed 
in 66.6% of patients treated with cyclosporine and low calorie diet, compared to 20.5% of 
patients treated with cyclosporine alone (p<0.001). Mean PASI reduction was 83.1% in the 
first cohort compared to 44.8% in the other (p<0.001). These findings show that significant 
weight loss reduction (at least 10%) in obese patients with severe psoriasis could improve 
the response to systemic therapy, and it is warranted in the global management of patients. 
 
086 [Oral 037]
Completion of a pharmacogenetic screen of the methotrexate metabolic pathway 
B Warren1, RL Smith1, E Campalani2, C Smith2, JN Barker3, J Worthington1, CEM 
Griffiths1 1The University of Manchester, Manchester, UK 2King’s College, London, UK 
3St Johns Institute of Dermatology, London, UK
Methotrexate, a first-line systemic therapy for moderate-to-severe psoriasis, is limited by 
unpredictable efficacy and toxicity. Pharmacogenetic studies of methotrexate in psoriasis 
patients have shown the potential of polymorphisms in the efflux carrier, ABCC1 and enzyme of 
the pyrimidine pathway, thymidylate synthase, to influence methotrexate treatment outcomes. 
However, significant sections of the methotrexate metabolic pathway are yet to be investigated. 
We hypothesised that in psoriasis patients single nucleotide polymorphisms (SNPs) in the 
key enzymes responsible for methotrexate activation and deactivation, FPGS and GGH, the 
methotrexate influx carrier, SLC19A1 and, an enzyme of the purine pathway, ATIC, are associated 
with clinical response to methotrexate. DNA was collected from 378 psoriasis patients who had 
been treated with methotrexate and defined as either ‘responder’or ‘non-responder’to therapy. 
Haplotype tagging SNPs (r2 >0.8) for GGH (n=17), FPGS (n=3), SCL19A1 (n=10) and ATIC 
(n=15), with a minor allele frequency of >5% were selected from the HAPMAP phase II data, 
giving 91%, 88%, 96% and 95% gene coverage respectively. Genotyping was undertaken using 
the Mass Array spectrometric method (Sequenom®). No SNPs in GGH or FPGS are associated 
with response to methotrexate in psoriasis patients. Two functional SNPs, rs1051266 (SLC19A1) 
and rs2372536 (ATIC) are significantly associated, p=0.03 and p 0.01 respectively, with the 
onset of toxicity of methotrexate. In the former the risk inferred by the carriage of 2 copies of 
allele 2 gives an OR of 1.8 (95%CI 1.0-3.4, p=0.02) for the onset of toxicity, while in the later the 
risk inferred by the carriage of 2 copies of allele 1 gives an OR = 1.7 (95%CI 1.1-2.7, p=0.01). 
These data indicate that SNPs in SCL19A1 and ATIC may prove helpful in identifying psoriasis 
patients suitable for therapy with methotrexate and completes the study of 9 key genes within 
the methotrexate metabolic pathway. 
087 [Oral 038]
CT327: a novel topical treatment of psoriasis and dermatitis
L Bertarione Rava Rossa1, S Traversa1, V Mainero1, D Barone1, C Oderda1, S Fumero1, 
C Pincelli2, A Marconi2 1Creabilis Therapeutics Spa, Colleretto Giacosa, Italy 
2University of Modena and Reggio Emiliana, Modena, Italy
Nerve growth factor (NGF) represents a crucial substance not only in the nervous 
system, but also at skin level: keratinocytes in the epidermal basal layer secrete NGF, 
that stimulates their proliferation. A potent inhibitor of NGF high-affinity receptor TrkA, 
the natural alkaloid K-252a, blocks keratinocyte proliferation in vitro and has been shown 
to improve psoriatic plaque in an in vivo model, thus suggesting a successful therapeutic 
approach for the treatment of cutaneous pathologies characterized by keratinocyte 
hyperproliferation such psoriasis and dermatitis. Creabilis therapeutics has developed 
a novel topical therapeutic agent by conferring drugability to K-252a, a molecule which 
could hardly become a drug as such, because of its intrinsic toxicity due to accumulation in 
cell membranes. The new agent, named CT327, is obtained by MiniPEGylation of K-252a 
and it is characterized in terms of in vitro antiproliferative activity, kinase selectivity, PK 
and toxicity profiles. This New Chemical Entity (neither a pro-drug, nor a drug delivery 
system) proves to meet all the targets originally envisaged: high solubility, high stability, 
antiproliferative activity on human keratinocytes, improved kinase selectivity, IC50 on TrkA 
in the nM range, dramatically reduced systemic absorption after dermal administration. 
After regulatory pre-clinical studies completion, CT327 shows an extremely favorable 
toxicity profile after single and repeated administration and proves to be non-irritant, non-
mutagenic and well tolerated in Safety Pharmacology assays. CT327 proves to be active 
in animal models: its topical administration actively inhibits the irritant contact dermatitis 
induced by SDS. Creabilis therapeutics received MHRA authorization to carry out Phase 
I clinical trial (which is planned mid 2007) for topical CT327. For its characteristics and 
biological activity, CT327 meets the target profile of a product suitable for topical treatment 
of psoriasis, dermatitis, and other pathologies related to keratinocyte hyperproliferation. 
088
Wet-wrap treatment using different dilutions of tacrolimus ointment and fluticasone 
propionate cream in APOC1 +/+ mice with atopic dermatitis
AP Oranje1, P Verzaal2, R Verbeek2, I Haspels2, E Prens1, L Nagelkerken2 1Erasmusmc, 
Rotterdam, Netherlands 2TNO, Leiden, Netherlands
Transgenic mice for human apolipoprotein C1 (APOC1) were developed to evaluate its role in 
lipoprotein metabolism. APOC1 (+/+) mice develop severe pruritic dermatitis with a moderate 
epidermal hyperplasia and hyper- and parakeratosis after 6-9 weeks. These mice provide a 
novel in-vivo model for atopic dermatitis (AD). Wet-wrap treatment [WWT] using dampened 
bandages to reduce inflamed dermatitis is an old remedy. Recently, it has received renewed 
interest with new technical improvements. However, currently large prospective studies 
evaluating the efficacy and the safety of WWT are lacking. Recent studies concluded the 
evidence-based efficacy of WWT to be of grade C recommendation. In order to evaluate 
the current indications for the so-called WWT for AD and to compare the different current 
recognised methods, we decided to evaluate this method in the AD model in APO C1 
mice. We studied different dilutions of Tacrolimus ointment and base ointment, as well as 
Fluticasone propionate (FP) 0.05% cream and emollient as topical treatments. For WWT 
tacrolimus ointment was titrated to 0.03% and FP cream to 0.017%. The dermatitis responded 
to all these applications (without and with wet- wraps), but the results showed no statistical 
significant difference between FP and emollient, and a slightly better effect of Tacrolimus 
ointment and its base. Tacrolimus ointment under wet-wraps was more effective than the 
other modalities (not significant, trend). Reduction in excoriations under wet- wraps was 
evident. Other parameters such as epidermal hyperplasia and AD severity scale (three items 
severity scale for mice) showed no convincing results in favour of the practiced WWT. Our 
conclusion is that wet-wraps enhance the effect of the topical agents that were used, but the 
most convincing effect was a reduction in excoriations.
 
089
Quo Vadis Aesthetic Dermatology?
D Kopera, R Horejsi, R Moeller Medical University Graz, Austria
Aesthetic medicine is booming, creating more sophisticated, non- or minimally 
invasive procedures for rejuvenating, styling and shaping facial and various other parts 
of the body. Most alternatives however lack evidence based medical background.
Our objective was to provide evidence based medical background of injection 
lipolysis and skin tightening utilizing bipolar radiofrequency, we carried out two 
controlled pilot studies. Injection lipolysis: 26 healthy female volunteers participated 
in a half-side controlled clinical trial focused on the reduction of saddlebag 
trochanteric bulges. Radiofrequency: 19 healthy female volunteers participated in a 
lipometer controlled clinical study to assess the postulated abilities of bipolar RF in 
skin tightening and fat shrinking. Results: Injection lipolysis: Clinical photography, 
lipometer and tape measurements assessing the SAT thickness and thigh circumference 
respectively at baseline and at week 20 did not show any significant change. 
Radiofrequency: Following most disappointing progress after 45 days of treatment, 7 
participants prematurely dropped out of the protocol. On the 12 remaining subjects 
no significant reduction of SAT thickness could be assessed (lipometer) at day 60. We 
concluded that innumerable devices and procedures are being developed to satisfy 
the demand of consumers longing for a ‘quick-fix’ to improve appearance. To give 
greater authenticity some of these procedures are indicated as medical treatments - 
often before their critical scientific evaluation. Evidence based medical science needs 
to be aware of this exploitation and more clinical studies should be undertaken in 
the field of aesthetic medicine. Perhaps we ought to abandon some methods that 
only satisfy the opportunism of the applicant to cosmeticians and/or ‘quacks’. Let us 
remain trustworthy, unbiased and reliable physicians respected by the community. 
 
090
Characterization of genes preferentially expressed by Sézary cells in peripheral 
blood
K Fujii1, E Laine2, O Eichhoff2, K Asagoe1, K Iwatsuki1, R Dummer2, M Urosevic2 
1Okayama University Graduate School, Okayama, Japan 2University Hospital of 
Zurich, Zurich, Switzerland
Sézary syndrome (SS) belongs to cutaneous T-cell lymphomas (CTCL) that are characterized 
by malignant proliferation of clonal CD4+ T-cells in the skin. SS is leukemic and aggressive 
variant of CTCL defined by erythroderma, lymphadenopathy and the presence of neoplastic 
T lymphocytes (‘Sézary cells’[SCs]), in the skin, lymph nodes and peripheral blood. Gene 
expression profiling has been employed on several occasions to expand the understanding 
of the pathogenesis of SS by using either peripheral blood mononuclear cells or CD4+ T 
cells. To gain more insight in the biology of SCs, we performed microarray analysis on CD4+ 
clonal T cells additionally sorted according to patient-specific TCR Vbeta expression (Vbeta+). 
The expression patterns of CD4 clonal (Vbeta+) T cells from 5 patients were compared to 
those of CD4+ non-clonal cells from the patients (Vbeta-). Using HG-U95Av2 Affymetrix 
arrays, we identified 115 probes as significantly differentially expressed (32 probes up-
regulated and 83 down-regulated in SCs), and found versican as the most up-regulated gene 
in clonal CD4+Vbeta+ T cells (71-fold overexpressed). To validate microarray results, versican 
expression was assessed by real-time qPCR and predominant expression (up to 114-fold) of 
versican in clonal cells was confirmed. Versican is a large chondroitin-sulphate proteoglycan 
and has at least 4 isoforms (V0-V3). Because each isoform has its own expression pattern 
and function (e.g. lymphocyte migration, control of apoptosis), the expression of these 
isoforms was assayed by qPCR using isoform-specific primers. Obtained expression pattern 
revealed preferential expression of V1 isoform in the clonal CD4+Vbeta+ population as 
compared to V2 and V3 expression. Western blotting was in line with PCR data showing 
increased V0/V1 protein expression 5/7 clonal CD4+Vbeta+ cell preparations. Currently, the 
experiments are ongoing investigating the effects of versican overexpression on T-cell function. 
2007 ESDR Abstracts v2.indd   15 8/13/07   11:31:33 PM
ABSTRACTS
S16  Journal of Investigative Dermatology (2007), Volume 127 
091
Sensitisation and Colonisation status of Malassezia in patients with atopic dermatitis
S Haug1, A Roll1, J Meyer1, M Mempel2, P Schmid-Grendelmeier1 1University Hospital 
Zürich, Switzerland 2Technical University, Munich, Germany
Malassezia represent a contributing factor in AE. Recently, the genus Malassezia 
was classified into eleven species based on their morphological, biochemical, and 
genetic characteristics. It is still unknown how, where and why patients suffering from 
AE become sensitized to allergens of this lopophilic yeast, it becomes evident that 
sensitization to Malassezia particularly M. Sympodialis occurs almost exclusively in 
AE patients. The success of antimycotic treatment in some patients with AD indicates 
that Malassezia is involved in the pathogenesis of AD. We collected skin scales from 
52 patients with atopic eczema. Specific IgE was measured against Malassezia using 
commercial kit (m70 and m 223). Presence of the various Malassezia species were 
analysed by culture, microscopically examination and a real-time PCR based method 
for testing qualities and quantities of patient skin scales so as to detect directly and 
confirm the identity of Malassezia species. In 33 of 52 patients Malassezia PCR was 
positive. The presence of Malassezia did not correlate with the level of specific IgE 
found against this yeast. Also we did not detect a correlation between severity of 
AD and levels of specific IgE. However response to systemic antifungals was more 
prone in patients with high levels of specific IgE against Malassezia. The presence 
of M. sympodialis, M. globosa and M. restricta was highly variable.We identified 
three different species of Malassezia colonizing the skin and leading to IgE-mediated 
sensitization in atopic eczema. Further analysis of quantitative fungal load will 
probably help to identify AE patients that benefit from antifungal therapy.
 
 
092
TNF-alpha-bearing macrophages- a target for TNF-alpha inhibitors in non-infectious 
granulomatous diseases?
C Bangert, S Kohlhofer, R Kunstfeld, N Selenko-Gebauer, F Karlhofer, G Stingl, T Kopp 
Medical University of Vienna, Vienna, Austria
TNF-alpha antagonists have revolutionized the treatment of non-infectious inflammatory skin 
diseases such as psoriasis, M. Behcet and pyoderma gangrenosum. One serious side effect of 
this form of treatment is the reactivation of infectious processes such as tuberculosis. In this case, 
the spread of mycobacteria is apparently due to a granuloma-disrupting effect of anti-TNF-alpha 
agents. We therefore reasoned that these agents could be promising tools in the treatment of 
widespread, non-infectious granulomatous processes such as disseminated granuloma anulare 
(GA), sarcoidosis and others. To test this hypothesis, we initiated i.v. treatment with the TNF-
alpha inhibitor Infliximab (5 mg/kg/day at weeks 0, 2, 6, 14, 22 etc.) in four female patients with 
disseminated GA. The clinical effects were quite dramatic. GA lesions began to regress already 
during the first two weeks of treatment and had completely disappeared after 4 administrations of 
infliximab. By immunohistology, untreated GA lesions displayed increased numbers of CD207+ 
epidermal Langerhans cells and, most notably, palisading granulomas consisting predominantly 
of CD11b+/CD14+ macrophages and CD3+ T cells. These latter cell types also exhibited 
pronounced anti-TNF-α reactivity. For reasons yet unknown, the expression density of MHC 
class II on LC and macrophages was greatly reduced compared to that of normal skin. After 
4 administrations of infliximab, LC and macrophages were greatly decreased and TNF-alpha 
expression had disappeared. T cells, by contrast, were still present, albeit at a slightly reduced 
frequency. We conclude that infliximab is an effective treatment for recalcitrant disseminated 
GA and that TNF-alpha-producing macrophages are the main target of its action. It is tempting 
to speculate that an infliximab-induced macrophage apoptosis might induce immunological 
events resulting in the downregulation of the inflammatory process. 
 
093
Certain Severity-Related Parameters in Atopic Dermatitis: Possible Candida Role 
and its Therapeutic Response
A Hassan, M El-naggar Mansoura Faculty of Medicine, Mansoura, Egypt
The aim was to evaluate certain severity-related markers of atopic dermatitis in relation 
to Severity Scoring (SCORAD) and to clarify the relationship between Candida albicans 
colonization and severity of atopic dermatitis with the effect of antifungal treatment on 
previous markers. A prospective study included 82 atopic dermatitis (AD) patients and 20 
healthy controls. Patients were grouped into two groups according to the severity of the 
disease. Full history & clinical examination were done to evaluate SCORAD index for each. 
Blood samples were taken for detection of total eosinophilic count, total IgE , Candida albicans 
specific IgE, intercellular adhesion molecule-1 (ICAM-1) and eosinophil cationic protein 
(ECP). Isolation and identification of Candida albicans was done, then an oral antifungal 
drug (Fluconazole) was given for 4 weeks with monitoring changes in these parameters. 
There was significant increase in ECP, ICAM-1, total eosinophilic count, total IgE levels in 
AD patients as compared with control especially the severe group (P<.001). Serum levels 
of ECP, ICAM-1 represented high significant positive correlation with SCORAD. Significant 
high incidence of C. albicans isolates were detected in both AD groups (Severe group 
40%, mild-moderate group 36.7%) with significant increase in C. albicans specific IgE that 
could be correlated with SCORAD (P<.001). With Fluconazole, there was mild to moderate 
significant improvement of SCORAD, decrease of ECP & ICAM-1 with high sgnificant 
decrease in C. albicans specific IgE. In conclusion, Eosinophils are important effector cells 
in atopic dermatitis. The serum levels of ECP and ICAM-1 have been proven to be high 
significant predictors of disease severity. Isolation of Candida albicans and high level of its 
specific IgE especially in severe AD group that could be correlated with SCORAD confirms a 
possible role of antifungal treatment of atopic dermatitis with positive C. albicans isolation. 
 
094
Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in primary cutaneous B-cell 
lymphomas: an open-label pilot study
M Steinhoff, M Maza, S Gellrich, C Assaf, H Orawa, D Munz, W Sterry Charité Berlin, 
Germany
Radioimmunotherapy with Yttrium-90 ibritumomab tiuxetan (YIT), a radio-labelled 
anti-CD20 antibody, was shown to be highly effective in systemic B-cell lymphomas. We 
conducted an open-label pilot study to evaluate outcome and assess complications of 
YIT therapy in patients with primary cutaneous B-cell lymphomas (PCBCL), a rare and 
distinct group of non-Hodgkin lymphomas. Ten patients, all but one, with relapsed or 
refractory PCBCL were included and treated with rituximab (250mg/m2/body surface) 
on day 1 and 8 followed by a single dose of YIT (11-15 MBq/kg). The median follow 
up period was 19 months (range 9-29 months). Results: The overall response rate was 
100%. The complete response rate was 100% within 8 weeks after YIT application. 
The median time to progression was 12 months. Ongoing remission was achieved in 4 
patients. Transient and reversible myelosuppression in 80% of patients was the primary 
toxicity. We concluded that radioimmunotherapy with YIT is a highly effective and 
safe treatment option in PCBCL, which could serve as an alternative treatment option 
for patients with 1.) disseminated, relapsed or refractory follicle center lymphoma 
and marginal zone lymphoma, 2.) aggressive diffuse large B-cell lymphoma in 
which standard therapies often fail, and 3.) secondary systemic involvement. 
095
Clinical and biophysical evolution of Japanese adolescent skin
F Bonté1, K Kikuchi2, C Heusele1, D Pelle de Queral1, JB Grieu3 1LVMH Recherche, 
Saint Jean de Braye, France 2Tohoku University, Sendai, Japan 3Parfums Christian Dior 
Japon, Tokyo, Japan
The aim of the study was to characterize the facial skin of 60 Japanese young females (13-
22 years old divided in 3 groups) clinically and with non-invasive instrumental methods. 
Biophysical and clinical parameters were evaluated in same individuals after 2 years. 
Questionnaire regarding life-style and skin condition were also performed. Measurements 
of skin surface hygrometer, capacitance, TEWL, skin pH, surface lipid levels and skin 
colour were conducted. Sebum secretion was assessed by Sebutape and image analysis. 
Size of corneocytes was quantified by image analysis. Replicas were taken to assess ridge 
and furrow pattern, anisotropy and papules with photographic grading scores. Follicular 
plugs and desquamation were assessed with high-resolution photographies. Conductance 
and capacitance, parameters for hydration of the stratum corneum and sebum secretion, 
increased with age. Significant lower values of skin surface lipid level were observed in 
youngest. With age, luminosity increases and yellowness decreases. In 16-18 years old skin 
surface pH values tended to be higher and smaller size corneocytes were observed. In 13-14 
years old, there was a significant lower score of follicular plugs and papules. Questionnaires 
analyses reveals that subjects who had acne were 62%, 74% and 74% in 12-14, 16-18,19-
22 years old, respectively. Number of subjects who had oily skin increased with age. 
The same study performed two years later reveals in the youngest groups a tendency of 
TEWL increase, a decrease of corneocytes size, a sebum secretion increase, a luminosity 
increase and a redness decrease. Scores of anisotropy and follicular plugs also increased in 
2 years. In middle group, a significant increase in luminosity, a decrease in a* and b* values 
were observed. In conclusion, the main evolutions were observed during the first years of 
adolescence when important hormonal changes occur. 
096
Treatment of Superficial Skin Tumors with Phenol and/or Trichloroacetic Acid Peels
Y Yamamoto, C Kaminaka, N Yonei, K Uede, F Furukawa Wakayama Medical 
University, Wakayama, Japan
Recently, the number of aged patients with skin cancer has increased in Japan. 
The problem of treatment is that some aged patients refuse surgical intervention. 
For such patients,non-invasive therapies might be more useful,such as topical 
therapy,photodynamic therapy,cryosurgery and laser therapy.Based on the histological 
findings and the historical safety of phenol in medicine,these patients have been 
treated with peeling using phenol and/or trichloroacetic acid (TCA). Twenty-one cases 
have been treated with these peels for actinic keratosis, 14 cases for Bowen’s deaease, 
and 6 cases for the superficial type of basal cell carcinoma in our department over the 
past 6 years. There were 19 cases of actinic keratosis with complete response (CR), 
and the average treatments were 2.9 times. Eleven cases of Bowen’s disease and 5 
cases of the superficial type of basal cell carcinoma with CR were treated for more 
than 5 times. Clinical improvement and side effects were evaluated, and analyzed 
histopathological and immunohistochemical parameters for tumor thickness, 
malignancy and proliferation, using p53 and proliferating cell nuclear antigen(PCNA) 
expression. Superficial skin tumors such as actinic keratosis, Bowen’s deaease and the 
superficial type of basal cell carcinoma seemed to be good candidates for this therapy. 
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Laser Doppler flowmetry for assessing localized scleroderma (morphoea) in 
children
L Weibel1, KJ Howell2, MT Visentin3, A Rudiger4, CP Denton4, F Zulian3, P Woo5, 
JI Harper5 1University Hospital of Zurich, Zurich, Switzerland 2Royal Free Hospital, 
London, UK 3University of Padua, Padua, Italy 4University College London, London, 
UK 5Great Ormond Street Hospital, London, UK
Assessment of disease activity is a major challenge in the management of patients 
with localized scleroderma (LS). The aim of this study was to evaluate the role of laser 
Doppler flowmetry (LDF) in disease activity detection in comparison with infrared 
thermography. In 41 children with LS we assessed 111 lesions on two occasions 
by clinical examination, LDF and thermography. Measurements from unaffected 
contralateral areas served as intra-patient controls and differences in blood flow and 
temperature were calculated between corresponding sites. We investigated sensitivity 
and specificity of LDF and thermography to detect clinically active lesions. Seventy-
five (34%) active and 147 (66%) inactive lesions were clinically identified. The 
median relative increase in blood flow measured by LDF was +89 (-69 to +449) % 
for clinically active lesions and +11 (-46 to +302) % for inactive lesions (P < 0.001). 
Thermography showed a median difference in temperature of +0.5 (-0.1 to +4.1) °C 
and +0.3 (-1.9 to +2.7) °C for clinically active and inactive lesions, respectively (P = 
0.024). A cut-off level of 39% increase in blood flow had a sensitivity and specificity 
of 80% and 77%, respectively, to detect clinically active lesions. For thermography 
no useful cut-off level was identified. The correlation between blood flow and 
temperature was significant but small (r2 = 0.120, P < 0.001). We concluded that 
LDF is a helpful, non-invasive diagnostic modality to discriminate disease activity in 
LS and more accurate for this purpose than thermography.
 
098
Effect of pantothenate on skin cells in an in vitro model of wound healing
JM Baron, T Wiederholt, Y Marquardt, R Heise, S Joussen, M Neis, HF Merk RWTH 
Aachen, Germany
Pantothenate is widely used in clinical practice for improvement of wound heeling. Previous 
studies identified a positive effect of pantothenate on migration and proliferation. However 
these studies were mainly descriptive with no molecular data supporting a possible 
model of its action. In this study we first tested the concentration dependant viability of 
dermal fibroblasts and epidermal keratinocytes. All cells were primary cultures isolated 
from donors undergoing a surgical procedure. The cells were exposed to concentrations 
of pantothenate ranging from 10 µg/ml to 40 µg/ml and toxicity was was determined 
using a bioluminescent somatic cell assay kit (Sigma). At a concentration of 40 µg/ml 
a substantial decrease in viability was detected in both fibroblasts and keratinocytes. A 
concentration of 10 µg/ml was tolerated well by both cell types. To test the functional effect 
pantothenate primary cultures of fibroblasts and keratinocytes were cultured to almost 
complete confluency. Then cells were scratched away with sterile yellow pipet tip leaving 
a scratch not covered with cells with a width of approximately 150 µm. Cultivation of 
cells was continued for another 24 hours and cell growth at the edges of the scratch was 
measured, photodocumented and immunoflourescence staining with antibodies specific for 
cytokeratin 67 or KI67 was performed at the end of the experiment. A proliferative effect of 
pantothenate was shown for epidermal keratinocytes in 2 out of 3 donors and for dermal 
fibroblasts in all 3 donors. To study the molecular mechanisms resulting in the proliferative 
effect of pantothenate gene expression was compared in cultured cells cultivated with 
the substance to control cultures cultivated without the substance using the GeneChip® 
Human Exon 1.0 ST Array from Affymetrix. A substantial number of the total regulated genes 
showed a positive net effect on proliferation, thereby confirming the functional results. 
 
099
Effects of CNTO 1275 administration on primate/human antigen-recall and humoral 
immune response function
C Brodmerkel1, Y Zhu1, T Jiao1, G Treacy1, MA Mascelli1, AB Gottlieb2 1Centocor 
Research and Development, Inc., Malvern, USA 2Tufts University, Boston, USA
Agents that inhibit the IL-12/IL-23 pathway are beneficial in the treatment of psoriasis. 
A fully human IgG1 monoclonal antibody directed against IL-12/23 via the p40 subunit 
(CNTO 1275) has demonstrated significant efficacy in moderate-to-severe psoriasis patients. 
To determine the effect of IL-12/23 pathway inhibition on immunocompetency, the antigen-
recall response was evaluated in a preclinical multiple-dose monkey toxicology study 
and 3 single-dose Phase 1 studies in patients with psoriasis and patients with multiple 
sclerosis (MS). Cynomolgus monkeys (n=32) that received CNTO 1275 22.5 or 45mg/kg 
SC twice weekly for 26 weeks were assessed for antibody responsiveness to keyhole limpet 
hemocyanin (KLH) at Weeks 8, 13, 26, 30, and 38. Monkey exposure to CNTO 1275 was 
substantially higher than the exposure in phase 1 studies; antibody titers to KLH in animals 
that received CNTO 1275 were comparable to those that received placebo. In the Phase 1 
studies, patients received a single administration of CNTO 1275 (dose range, 0.09 to 4.5mg/
kg IV or SC; n=46) or placebo (n=8), and then were challenged with both pneumococcal and 
tetanus antigens. Thirty-four patients (73.9%) who received CNTO 1275 exhibited a normal 
antibody response (>=2-fold increase from baseline) to pneumococcal antigen, compared 
with 4 (50%) who received placebo. Similarly, 12 patients (60%) who received treatment 
with CNTO 1275 exhibited a normal antigen-recall response (>=4-fold increase from 
baseline) to tetanus toxoid exposure. In addition, CNTO 1275 had no impact on the number 
of circulating immune cell populations (T-cells, B-cells, natural killer cells). Results from 
these studies suggest that single dose administration of CNTO 1275 in patients with psoriasis 
or MS and multiple administrations in cynomologous monkeys may not impair normal 
innate and recall humoral immune system functions. However, further study is warranted to 
validate these findings and evaluate the effects of multiple administrations of CNTO 1275. 
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Low bone mineral density in patients with atopic dermatitis
IM Haeck, L Timmer-de Mik, EGWM Lentjes, HJJ Verhaar, DJ Hijnen, CAFM Bruijnzeel-
Koomen, MS De Bruin-Weller University Medical Center Utrecht, Netherlands
The aim of this study was to assess bone mineral density (BMD) using Dual-Energy 
X-ray Absorptiometry (DXA) in patients with moderate tot severe atopic dermatitis 
(AD) and to correlate this with the use of topical corticosteroids. 125 patients with AD 
(age 17-65, mean 34 years), 64 men and 61 women were recruited from the outpatient 
clinic (n=70) and clinical department (n=50) of the University Medical Center Utrecht. 
Patients were interviewed or filled out a questionnaire about corticosteroid use. Bone 
mineral density of the lumbar spine and both hips was evaluated using DXA and 
blood was drawn for the measurement of serum parameters of bone metabolism.
Osteoporosis was found in 6 of the 125 patients (4,8%) and osteopenia in 52 of the 
125 patients (41,6%) in minimally one of the three areas measured by DXA; 67 of the 
125 patients (53.6%) had normal bone mineral density in all three areas. Comparing 
the two groups, group A (normal BMD) and group B (decreased BMD, T-score ≤ -1) 
there was no significant difference in the amount of topical corticosteroids used in 
the 2-5 years prior to DXA. However, there was a difference in body mass index (BMI) 
and in exercise, group B had a lower BMI and exerted less exercise than group A. 
There was no difference between the two groups in other risk factors of osteoporosis 
and serum parameters of bone metabolism. We observed a high percentage of low 
BMD in patients with AD; this was not related to the use of topical corticosteroids. 
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Post-translational modifications of transthyretin are serum markers in patients with 
mycosis fungoides
N Escher1, M Kaatz1, C Melle1, C Hipler1, Z Mirjana1, D Driesch1, U Wollina2, F Von 
Eggeling1 1University of Jena, Germany 2University of Dresden, Germany
Cutaneous T-cell lymphomas (CTCL) are characterized by the recruitment of malignant 
T-cell clones, predominantly of the CD4+ T-helper subpopulation, into the skin. Mycosis 
fungoides (MF) is the most common type of CTCL and accounts for almost 50% of 
all primary cutaneous lymphomas. The ProteinChip technology SELDI-TOF (surface 
enhanced laser desorption/ionisation time of flight) was used to detect biomarkers 
in serum from MF patients (n = 25) and healthy controls (n = 26). Therefore diluted 
serums were applied to IMAC30 ProteinChip arrays and the resulting protein profiles 
were bioinformatically analysed. A protein set was identified which distinguishes MF 
patients from healthy controls with a sensitivity of 82.6 % and a specificity of 100 %. 
Four significant peaks were identified by 2-D gel electrophoresis, immunodepletion 
and SELDI-TOF MS as transthyretin (TTR) and three TTR modifications. A subsequent 
ELISA confirmed these findings. The ability, to detect and identify proteins as well as 
protein modifications using SELDI-TOF-MS might reveal a better insight in this kind of 
disease and may lead to a better understanding and earlier detection of MF patients. 
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A combination of Lactobacillus paracasei CNCM I-2116 and Bifidobacterium lactis 
CNCM I-3446 probiotic strains decreases skin reactivity
A Gueniche1, J Benyacoub2, L Breton1, I Bureau-Franz2, S Blum2, J Leclaire1 1L’Oréal 
Recherche, Clichy, France 2Nestlé Research Center, Lausanne, Switzerland
Over the last decades the prevalence of reactive skin symptoms has increased in 
industrialized countries. Sensitive skin is associated with smarty and itchy condition.
Probiotics are defined as live microorganisms that, when ingested in sufficient 
amount positively balance the host microbiota and have a beneficial impact on 
health. Beyond the effect on the intestinal microbiota, some probiotic strains show 
potent immune-modulatory properties. The aim of this study was to evaluate the 
effect of probiotics on reactive skin symptoms. For that purpose, a mixed preparation 
of Lactobacillus paracaseï CNCM I-2116 and Bifidobacterium lactis CNCM I-3446 
was tested in a randomized double-blind placebo-controlled trial. This probiotic mix 
is expected to have health promoting effects all along the gut (upper and lower gut 
intestinal tract). Moreover, with regards to potential antagonistic effect on allergy and 
inflammation both strains display very promising immune modulation properties in 
vitro as well as in vivo. Sixty female volunteers (18-35 years old) with reactive skin 
ingested daily either probiotic (1010 CFU of each probiotic strain) (n=33) or placebo 
(n=33) powders suspended in drinking water for 8 weeks. Skin reactivity was assessed 
by a stinging test performed at initiation, middle and end of the study. We have found 
a significant diminution of cutaneous neurosensitivity (p=0.02) in volunteers receiving 
probiotic mix compared to those taking control powder at the end of the treatment. 
These results provide the first clinical demonstration that specific probiotics strains 
can have beneficial effects on skin reactivity and afford new opportunity to device 
strategies to improve sensitive skin.
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Probiotic strain Lactobacillus paracasei CNCM I-2116 decreases skin reactivity
A Gueniche1, J Benyacoub2, I Bureau-Franz2, I Castiel1, S Blum2, J Leclaire1 1L’Oréal 
Recherche, Clichy, France 2Nestlé Research Center, Lausanne, Switzerland
Reactive skin is characterized by a marked sensitivity of the skin to physical or chemical stimuli 
and impaired skin barrier repair ability. Probiotics are defined as live microorganisms that when 
ingested in sufficient amount positively balance the host microbiota and beneficially improve 
health. Some probiotic strains display potent immune-modulatory properties including at the 
skin level. The aim of this study was to evaluate the effect of probiotics on skin reactivity. For 
that purpose, a preparation of Lactobacillus paracaseï CNCM I-2116 powder was tested in 
a randomized double-blind vehicle-controlled trial. 66 female volunteers with reactive skin 
received probiotics (n=33) vs. placebo (N=33) powders at a daily dose of 10 10 CFU for 
two months period. Skin sensitivity was assessed by stinging test and skin barrier function 
recovery was determined by the evaluation of the TEWL following disruption by repeated 
tape-stripping. These evaluations were performed at initiation (day1), d29, d43, at the end 
of the supplementation (day57) and during a follow-up period at days 64 and 78. The results 
showed that the volunteers who received L. paracasei CNCM I-2116 presented a significant 
decrease in skin sensitivity over the treatment period. Moreover the barrier function recovery, 
following tape-stripping disruption, was significantly faster for the volunteers having received 
L. paracasei CNCM I-2116 compared to the volunteers taking control powder.These effect 
was also observed during the follow up period. Cutaneous moisturizing factors such as urea 
and lactate remained unchanged throughout the study in the volunteers receiving probiotics 
whereas they were decreased in the placebo group. The results of the study demonstrate that 
oral supplementation with the probiotic L. paracasei CNCM I-2116 has a beneficial effect 
on reactive skin. This finding supports new strategies based on a nutritional approach for the 
treatment and/or prevention of the symptoms related to reactive skin.
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Vitreoscilla filiformis bacterial extract improves seborrheic dermatitis  
A Gueniche1, A Cathelineau2, P Bastien1, R Martin3, C Queille-Roussel2, L Breton1
1L’Oréal Recherche, Clichy, France 2CPCAD, Hôpital ARCHET 2, NICE, France 3c/o 
CRN, L’Oréal, Notre Dame d’Oe, France
Seborrheic dermatitis is a chronic cutaneous inflammatory condition. It may occur on the face 
as well as on the scalp. Lesions are erythematous and scaly and may be associated with intense 
pruritus and a burning sensation in the involved areas. Treatments of seborrheic dermatitis of 
the scalp have been based on the use of antifungal shampoos and topical antifungal or anti-
inflammatory agents. However, appropriate non pharmacological treatment strategies and the 
daily use of safe effective shampoos and lotions should be the first line approach to reduce 
scalp erythema, scaling and pruritus. These products may also be able to restore to some 
extent scalp homeostasis and thus improve symptoms. Thus, we tested the efficacy of LRP-
Biomass extract from a filamentous micro-organism (naturally found in oligotrophic lakes and 
also in sodium rich spa water) which had been cultured in a medium prepared with La Roche 
Posay spa (LRP) water (rich in selenium and strontium). For this purpose 66 patients with 
moderate scalp seborrheic dermatitis were included in a randomised, double-blind, vehicle-
controlled and parallel group comparison study. The total clinical score (sum of erythema 
and scaling sub-scores) showed a significant improvement (62.7% decrease) in the group 
treated with the test lotion (5% LRP-Biomass lotion) once daily for 4 weeks compared to 
vehicle treated group(p<0.0001). In parallel, the level of pruritus self-assessed by the subjects 
showed a significant decrease (73.4%) in the 5% LRP-Biomass lotion treated group at Day 28 
versus vehicle treated group(p=0.01). Moreover, a persistent effect of the 5% LRP-Biomass 
lotion was found. This study showed that LRP-Biomass lotion may be valuable when used 
between conventional drug treatments and may prevent relapses. More generally, the active 
extract used at lower concentration should prove beneficial when incorporated into cosmetic 
products, such as dandruff shampoos, designed to reduce scalp scaling.
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Framing and focussing biases: their roles in the subjective quantification of disease
S Murray,  JL Rees University of Edinburgh, UK
Subjective measures of symptoms are routinely used in Dermatology. Psychologists 
acknowledge that questionnaires used to elicit these data are open to focussing and 
framing biases. No information on the vulnerability of the tools used in Dermatology 
(especially Dermatology life Quality Index, DLQI) to focussing and framing biases 
is available: we investigated the effects. First, 80 consecutive phototherapy patients 
were randomly assigned to two groups (four sub-groups.) Group 1 answered standard 
DLQI: sub-group A answered DLQI before the Global Health Question (GHQ) whilst 
sub-group B answered GHQ then DLQI. Group 2 were assigned an amended DLQI 
(ADLQI): sub-group C answered ADLQI first, sub-group D answered GHQ then 
ADLQI. The ADLQI questions were focussed and framed in neutral sentences - the 
standard DLQI emphasises negative aspects of skin disease. The median DLQI score 
was 7, ADLQI median 9 (Mann-Whitney U, p=0.066.) The GHQ mean was similar 
for the all groups (p=0.99.) Order of questionnaire presentation did not affect score.
Secondly, 40 consecutive phototherapy patients were randomly assigned to two 
groups. Group 1 read and remembered ten negative words then completed GHQ, 
DLQI and VAS’s of disease extent, itch and insomnia. Group 2 read and remembered 
ten neutral words and then completed the same questions as Group 1. This experiment 
tested for focussing bias. The means of the two groups’ scores were similar: GHQ 
(p=0.99), DLQI (p=0.93) and VAS (extent: p=0.62, itch: p=0.83, insomnia: p=0.65.) 
Correlation between DLQI and VAS was stronger for Group 1 (negative words): extent, 
Spearman’s rho=0.64, p=0.004; itch, rho=0.63, p=0.005. Group 2’s results: extent 
rho=0.26, p=0.25, itch rho=0.27, p=0.25. The GHQ appears to be able to withstand 
framing and/or focussing biases, however adjustment in DLQI and VAS correlation 
after negative focussing does suggest vulnerability in DLQI. Further studies continue 
to explain and evaluate the clinical meaning of this effect.
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Digital signal processing of accelerometer output to yield itch data
S Murray1, SD Pye2, K McBride2, JL Rees1 1University of Edinburgh, UK 2Medical 
Physics Department, NHS LUHD, Edinburgh, UK
The pinnacle of quantifying human itch is the design of a specific, automated itch monitor. 
Recently, we have used newer accelerometers which allow Fast Fourier Transform (FFT) 
of data: the signal:noise ratio of this accelerometer data can be improved to allow more 
specific detection of itch-related movements. We present the stages of this refinement 
process. (1) Previously, parent-recorded sleep/rising times denoted hours for data analysis. 
An early evening ‘peak’ in accelerometer score was noticed: was this itch or not? Using 
infrared videos (n=6, 15 nights) comparison of observed sleep/rising times to parent-
recorded times was undertaken. Parent-recorded sleep times were ˜40mins earlier whilst 
rising times ˜30 mins later than observed. As subjects’ being awake artificially inflates 
accelerometer scores, this data guided us to analyse mid-night hours only. (2) Separating 
itch-related movement from other movement by using ‘frequency of action’ determined by 
FFT of accelerometer data: FFT acceleration score per epoch for 0.5-2.5Hz was compared 
to movement on video (n=6.) The score predicted the type of movement occurring: <50G-s: 
no movement; >450G-s: ‘out of bed;’ 50-450Gs itch-related movement. (3) Enrichment of 
data to further separate itchy subjects’ scores from controls’: based on data from 26 itchy 
subjects and 26 non-itchy controls, separation was first compared for different frequency 
bands (0.5-2.5Hz, 1-3Hz, 0.5-5Hz and 0.16-10Hz.) and second, separation for 0.5-2.5Hz, 
was further enriched for amplitude/acceleration and analysed. The best separation was for 
frequency enrichment (0.5-2.5Hz) followed by enrichment for amplitude 100-400Gs: itchy 
mean (SEM): 4890.4G-s (±517); control mean: (SEM) 2651.9Gs (±188.9); t-test p=0.005; 
Effect size = 82%. Conclusions: a) critical analysis of subject/parent-recorded data is 
necessary and b) appropriately enriched FFT accelerometer data appears to offer a more 
specific measure of itch-related movement.
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Effective treatment of atopic dermatitis by cutaneous application of non-pathogenic 
bacteria Vitreoscilla filiformis ointment 5%: Results from a randomized, double-
blind, vehicle-controlled study
A Gueniche1, B Knaudt2, E Piche2, T Volz2, M Röcken2, T Biedermann2, P Bastien1, 
L Breton1 1L’Oréal Recherche, Clichy, France 2Eberhard-Karls-Univ, Tübingen, Germany
Atopic dermatitis (AD), a chronic and relapsing inflammatory skin disease, is associated with elevated 
IgE levels and Th2 responses. It is currently believed that non-pathogenic bacteria modulate intestinal 
immune responses avoiding the development of allergic diseases. However, effects of oral probiotics 
on AD could not be reproduced in all studies and direct immuno-modulation of the skin associated 
immune response by non-pathogenic bacteria has not been investigated so far. We therefore performed 
a double blind placebo controlled clinical study on the effects of an ointment containing 5% extracts 
of the non-pathogenic bacteria Vitreoscilla filiformis on AD. Seventy-five AD patients (6-70 years of 
age) were randomized to receive either Vitreoscilla filiformis ointment 5% or vehicle ointment daily 
for 30 days. Efficacy evaluations, including the ‘Score of Atopic Dermatitis’(SCORAD), transepidermal 
water loss, assessement of microflora, and the patient assessment of itch and loss of sleep occurred 
at baseline, day 15, and day 29. Compared to placebo, Vitreoscilla filiformis significantly decreased 
SCORAD levels (p=0.0044) and pruritus (p=0.0171). In addition, active ointment significantly 
decreased loss of sleep from day 0 to day 29 (p= 0.0074). Qualitative and quantitative assessement 
of cutaneous microbial colonization demonstrated Vitreoscilla filiformis mediated suppression of 
S. aureus without reaching significance. A significant reduction of the transepidermal water loss 
could be detected in both the verum and the placebo group. Thus, the results of our study indicate 
that significant improvement of AD mediated by Vitreoscilla filiformis is not secondary to barrier 
stabilization. Despite an effect on microbial colonization, the efficacious treatment of AD as detected 
by SCORAD and pruritus indicates a direct immuno-modulatory potential of the extract of non-
pathogenic bacteria Vitreoscilla filiformis on the skin associated immune response. A novel clinical trial 
will begin, in order to directly address the question of the Vitreoscilla filiformis effect on skin microflora. 
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Borrelia burgdoferi is not associated with male genital lichen sclerosus in the UK
EV Edmonds1, N Francis2, D Ho-Yen3, C Bunker1 1Chelsea & Westminster Hospital, 
London, UK 2Charing Cross Hospital, London, UK 3Raigmore Hospital, Inverness, 
UK
Lichen sclerosus (LSc) is an acquired mucocutaneous disease of unknown aetiology. 
The most serious sequel is squamous cell carcinoma (SCC) but it can also cause 
significant sexual dysfunction. Conventional treatment comprises potent topical 
steroids or circumcision. The cutaneous manifestations of Lyme disease caused by 
the spirochaete Borrelia burgdoferi and LSc share clinical and histological similarities 
such that B. burgdoferi has previously been implicated in the pathogenesis of LSc and 
oral antibiotic treatment recommended. Our aims were to determine whether there 
is serological evidence for B.burgdoferi infection in the pathogenesis of LSc. Sera 
from male patients who attended the Male Genital Dermatoses Clinic at Chelsea & 
Westminster Hospital between 2005 and 2007 with biopsy proven male genital LSc 
and male age-matched controls were assayed by B. burgdoferi ELISA and IgG Western 
immunoblotting. 62 (30 disease, 32 controls) samples were analysed. All samples 
were ELISA negative. On Western blotting 1 control sample was positive (1/62). 3 
control samples and 5 disease samples were equivocal (8/62). The remainder of the 
samples was negative (53/62). We concluded that B burgdoferi infection is unlikely 
to be involved in the pathogenesis of MGLSc.
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Endostatin and aminoterminal propeptide of collagen III in plasma of psoriatic 
patients
A Zalewska, B Dziankowska-Bartkowiak, A Sysa-Jedrzejowska Medical University of 
Lodz, Lodz, Poland
Endostatin (En) and aminoterminal propeptide of collagen III (PIIINP) belong to collagen 
proteins. En exerts an anti-angiogenic properties whereas higher levels of PIIINP are observed in 
patients with liver disturbances.The aim of the study was to evaluate En and PIIINP plasma levels 
in hospitalized psoriasis vulgaris patients.The study group comprised 106 psoriasis vulgaris in-
patients (30 females, 76 males; mean age 44.9 years) treated using classical methods (anthralin 
plus UVB-NB, PUVA, methotrexate-MTX, cyclosporine A - CyA). Severity of the disease was 
evaluated by Psoriasis Area and Severity Index (PASI). The control group comprised 40 healthy 
subjects. En plasma levels were measured by ELISA (R&D Systems, USA; sensitivity- 1.953 ng/
ml) whereas PIIINP by radioimmunoassay (Orion Diagnostika, Finland - sensitivity 0.2 mg/l). 
Both parameters were evaluated before treatment and after three weeks of in-patient therapy. 
There was a significant decrease in PASI after treatment when comparing with baseline 
conditions (p<0.05). En plasma levels were significantly lower in psoriatic patients before 
treatment (mean±SD: 249±50.6 ng/ml) in comparison to the results obtained after 3 weeks of in-
patient treatment (305.6±62.1 ng/ml) (p<0.001). However, both before and after treatment, En 
plasma levels in psoriatic patients were significantly higher than in the control group (78.4± 29.6 
ng/ml) (P<0.001). Additionally, both before and 3 weeks after treatment, PIIINP plasma levels 
were significantly higher in comparison to the control group (5.2±0.7 mg/l and 4.4±1.2 mg/l, 
respectively) (p<0.001). Of note, before treatment a significant negative correlation between 
PIIINP and En plasma levels was observed (r=-0.2; p<0.05). The obtained results point out at 
some functional hepatic disturbances in patients with long-lasting psoriasis irrespective of MTX 
ingestion in the past. Negative correlation between En and PIIINP before treatment may result 
from some imbalance of both compounds metabolic pathways in the liver.
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Effect of classical treatment on interleukin-4 plasma levels in psoriatic patients
A Zalewska1, P Janowski2, J Wyczolkowska3
1Medical University of Lodz, Lodz, Poland 2Out-Patient Dermatological Department, 
Lodz, Poland 3Centre for Medical Biology, PAN, Lodz, Poland
Psoriasis is regarded as Th1-type disease, however there are reports on Th2 cytokines 
development involvement in this disease course. The aim of the study was to evaluate 
interleukin 4 (IL-4) and soluble receptor of interleukin 2 (sIL-2R) plasma levels in hospitalized 
psoriasis vulgaris patients. The study group comprised 106 active psoriasis vulgaris in-patients 
(30 females, 76 males; mean age 44.9 years) treated with classical methods (anthralin plus 
UVB-NB, PUVA, methotrexate-MTX, cyclosporine A-CyA). Severity of the disease was 
evaluated by Psoriasis Area and Severity Index (PASI). The control group comprised 40 healthy 
subjects. IL-4 and sIL-2R plasma levels were measured by ELISA (IL-4 sensitivity - 1.2 pg/ml; 
sIL-2R - below 1 pg/ml). Both parameters were evaluated before treatment and after three 
weeks of in-patient therapy. There was a significant decrease in both PASI and sIL-2R after 
treatment when comparing with baseline conditions (p<0.05 and p<0.001, respectively).
Before treatment, psoriatic patients presented higher mean±SD IL-4 levels (13.1±71.2 pg/ml) 
in comparison to the results obtained both after 3 weeks of in-patient treatment (8.5±54.4 pg/
ml) (p<0.001) and the control group (4.6±1.5 pg/ml) (p<0.05). Also before treatment a positive 
correlation between IL-4 plasma levels and PASI was noted (r=0.21; p<0.05). Moreover, 
before treatment a positive correlation between sIL-2R and IL-4 plasma levels was observed 
(r=0.25; p<0.001). Of note, variability of IL-4 plasma levels reached 500-600%, which means 
that individual variation in IL-4 production in psoriatic patients is extremely high.The obtained 
results point out at the efficacy of classical anti-psoriatic treatment in normalization of Th1/
Th2 ration in the course of this disease. Furthermore, sIL-2R plasma levels seem to be useful 
in evaluation of psoriatic lesion regression.
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Decreased quality of life and general health in psoriatic patients
T Hawro, J Miniszewska, A Sysa-Jedrzejowska, A Zalewska Medical University of 
Lodz, Lodz, Poland
Health related quality of life (HRQL) is more and more important in evaluating treatment 
results in numerous skin diseases. The aim of the study was to assess HRQL in psoriatic 
in-patients. The study comprised 100 in-patients presenting psoriasis vulgaris (30 females, 
70 males; mean age 39.4 years). PASI was used to assess disease severity. For comparison 
purposes the patients were divided into 2 groups: mild psoriasis (PASI<11.0; 46 patients) 
and severe psoriasis (PASI>11.0; 54 patients). SKINDEX-29 (by Chren) was used to 
evaluate HRQL: and General Health Questionnaire (GHQ, by Goldberg) was employed 
to assess general health of the patients. Psoriatic patients presented higher scores in 
somatic symptoms, anxiety/helplessness, functioning disturbances, depression and general 
health status (GHQ). This means that they regard their health as bad in all the examined 
dimensions. This group also demonstrated lower mean results in general QOL and all its 
dimensions (somatic symptoms - pain, itching, stinging; emotions - anxiety, embarrassment, 
shame; psychological functioning - bad relations with others) (SKINDEX-29). No significant 
differences were observed between males and females in their assessment of both general 
health and HRQL (p>0.05). Disease severity positively correlated with all HRQL dimensions 
i.e. the more severe the disease the worse the quality of life of the patients. Additionally, 
the longer the disease duration the more troublesome somatic symptoms were. Positive 
psoriatic family history was not a differentiating factor in both HRQL and general health 
assessment of the examined patients (p>0.05). Of note, PASI positively correlated with 
somatic symptoms, anxiety and general health (p<0.05). Furthermore, the older the patients 
the more troublesome the above symptoms were. The obtained results point out at an 
urgent need of providing psoriatic patients, especially the older ones, with an adequate 
psychological help in addition to appropriate pharmacological treatment.
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3D visualisation of skin lesions use in photogrammetry
JL Rees1, Y Bisset1, T Lukins1, C Urquhart2, H Ravindranath1, R Fisher1
1The University of Edinburgh, UK 2Dimensional Imaging Limited, Glasgow, UK
Dermatology is, in large part, an imaging speciality. Automated programmes based 
on analysis of two-dimensional images, such as those provided by dermoscopy, 
have achieved similar diagnostic accuracies to those of humans in some studies. 
One area in which the technology is inefficient compared to the human viewer, is 
that it has not been possible to easily represent the three-dimensional nature of skin 
lesions. This means that it has not been possible to assess lesion volume or surface 
texture efficiently, such that it could form the basis for diagnostic algorithms. In the 
present study, we report our progress using photogrammetry of skin lesions using 
technology developed by Dimensional Imaging. The advantage of this approach, 
over other alternatives such as laser scanning, is that capture is almost instantaneous 
with few artefacts due to subject movement; dense data calculation at each image 
pixel; one to one colour registration unaffected by structural lighting; and that it is 
non invasive and well tolerated. We have used two Canon EOS 350D cameras in a 
bespoke frame, under ring flash illumination. A Macbeth colour chart is included in 
every shot as a standard. An extremely detailed model of the lesion can be recovered 
from which the image colour and range data can be projected as a 3D model. The 
interpixel spacing is 0.040mm (and typical skin epidermal cell spacing is 0.100mm).
We have now examined over 700 lesions. The vividness of the reconstructed image 
is striking and they lend themselves both to teaching and further analysis. Preliminary 
analysis using simple picture extraction measures suggests that such approaches may 
be useful diagnostically. The 3D images will be demonstrated on a laptop.
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Augmentation of Sebaceous Lipogenesis by Extract of Grifola frondosa (Maitake 
Mushroom) In Vivo and In Vitro
T Sato1, N Akimoto1, M Nagao2, M Takahashi2, A Ito1 1Tokyo University, Tokyo, Japan 
2Heimat Co., Ltd., Tokyo, Japan
Sebaceous lipids (sebum) play an important role in maintaining physiological functions by 
forming a biological barrier in the skin. The decrease in sebum levels in the skin is thought 
to depress the barrier functions, and thereafter may be associated with the development of 
dry skin (xerosis) with a variety of complaints including a rough or scaly skin surface, and 
pruritus. Therefore, a novel aspect to control sebaceous lipogenesis might be beneficial for 
the prevention of dry skin and sequential itching. In the present study, we investigated the 
effects of an ethanol extract of Grifola frondosa (Maitake) fruiting body (Gripin®) on sebum 
production in hamsters and humans in vivo and in vitro. When hamster sebocytes were 
treated with Gripin®, the intracellular lipid droplet formation was augmented in a dose-
dependent manner (100-400 microg/ml). In addition, Gripin® preferentially augmented 
the synthesis of triacylglycerols (TG), a major sebum component, in hamster sebocytes. 
Furthermore, the topical treatment of 1-4% Gripin® in the skin of hamster auricles 
augmented sebum accumulation in sebaceous glands. However, another ethanol extract 
prepared from Agaricus blazei murrill showed less activity in sebaceous lipogenesis in 
hamsters in vivo and in vitro. Moreover, when 0.1-1% Gripin® and vehicle were topically 
treated three times a day for 14 days in posterior antebrachials of seven healthy volunteers, 
a thin-layer chromatographic analysis of the skin surface sebum showed that sebum 
components including TG, squalene, free-fatty acids, and cholesterol, as well as total sebum 
levels, increased in the Gripin® treated skin. These results provide novel evidence that 
Gripin® augments sebaceous lipogenesis in hamsters and humans in vivo and in vitro. Thus, 
Gripin® is likely to be a unique anti-dry skin agent with lipogenic actions for sebocytes. 
 
114
What is the basis for similarity and dissimilarity in viewing dermatological lesions?
JL Rees, K Robertson, A Kharrudin The University of Edinburgh, UK
Dermatological expertise is expensive to acquire and unevenly distributed. We are 
interested in developing (interactive) computer based image retrieval systems to 
improve the ability of non-experts to diagnose skin lesions. A fundamental issue is 
what is the basis of similarity both between lesions and between different observers 
viewing the same lesion? In other words, do different observers share a common 
frame of reference and, second, is it possible to represent the search space of all 
lesions meaningfully? Previous work suggests that verbal recall of explicit rules and 
justifications do not reflect the basis of expertise and, therefore, any such approaches 
need to be image based. We have studied 20 non-experts and 9 dermatological 
experts and have used a Likert scale for scoring similarity for 12 photographs of skin 
lesions (solitary lesions such as skin tumours). Repeat examination one week apart 
showed that reproducibility was high and Kendal’s ‘W’ for ordinal data was highly 
significant for both experts and non-experts (W=0.73 and W=0.71 respectively, 
P<0.0001). We interpret this as supporting the hypothesis that there is at least some 
degree of commonality between different observers. Dissimilarity matrices were used 
as an input into non-parametric multi-dimensional scaling (MDS) and the resulting 
output visualised. There was clear clustering of the 2D representation, for both 
experts and non-experts, but most noticeably for non-experts. The effects of colour, 
skin texture and shape appeared evident. These results provide some support for the 
idea that there is commonality in the search space, both within and between experts 
and non-experts. These results suggest that approaches based on interactive computer 
based image retrieval may be viable.
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Factors influencing the efficacy of the long-term treatment of psoriasis with 
infliximab
R Gniadecki, SM Aagard Bispebjerg Hospital, Copenhagen, Denmark
Infliximab is a chimaeric, monoclonal antibody against TNF-alpha exhibiting high 
efficacy in the treatment of moderate and severe plaque psoriasis. In this study we 
examined the clinical efficacy and side effect profile of infliximab in the consecutive 
36 psoriasis patients treated with this drug. Infliximab was efficacious in 77% of 
patients, as measured by PASI-75 reduction after the 3-month treatment period. 
However, we observed a significant and steady dropout of 74% of the initial 
responders over a 30-month treatment period (mean half-life 16 months). The 
main reasons for the dropout were side effects, primarily infusion reactions (n=7) 
and loss of efficacy (n=7). There was no correlation between the response to other 
systemic psoriasis therapy and the effect of infliximab. However, patients with the 
predominantly acral form of plaque psoriasis and those treated on demand were 
especially susceptible to drop-out (half-life of 5 months (on demand) and 7 months 
(acral) versus 24 months in the rest of the patients). Our retrospective study may 
help to optimize the clinical outcome of the treatment with infliximab in a clinical 
setting. Management of infusion reactions and strict adherence to the treatment 
schedule would increase the success rate of the maintenance therapy with infliximab. 
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A rexinoid that inhibits thymic stromal lymphopoietin (TSLP) expression and Th2 
inflammation in mouse and human skin. A topical targeted-therapy concept for 
atopic dermatitis?
C Tran, M Milingou, C Antille, D Grand, P Carraux, J-H Saurat Geneva University 
Hospital, Geneva, Switzerland
TSLP, a cytokine produced by dendritic and epithelial cells, polarizes Th2 responses and 
inflammation. TSLP is overexpressed in atopic patients epidermis, not in normal skin. Transgenic 
mice overexpressing epidermal TSLP develop a atopic-like phenotype. Epidermal TSLP 
production is controlled by RXR, RXR deletion in mouse epidermis induced TSLP overexpression 
and an atopic-like phenotype. We show here that TSLP expression is modulated by topical 
agonist and antagonist RXR ligands. Applications on mouse ears of 0.05% 9-cis-RA, the RXR 
natural ligand, induced a strong inflammation (x75-fold myeloperoxidase activity and x2.5-fold 
ears thickness) parallel to increasing TSLP gene (x8-fold/qRT-PCR) and proteins expression (from 
3 to 12 pg/µg) in skin and blood (from 8 to 2991 pg/ml), determined by ELISA. It also increased 
IL-4, and CCL8 but decreased TNF, INF-γ and CXCL10 genes in skin. These Th2-like responses 
were inhibited by application of a RXR antagonist (BAL10092 1%). MPO activity was decreased 
by 80%, thickness by 77%, TSLP mRNA by 68%, and proteins by 55 % in skin and only 17% 
in blood, indicating a local effect. BAL10092 also inhibited TSLP expression in cultured human 
keratinocytes.Since this rexinoid is the first compound identified to counteract TSLP expression 
in keratinocytes, we obtained ethical committee approval for limited application in humans. 
As a proof of concept study, we used the atopy patch test (APT). BAL10092 1%, applied for 3 
days on 14 atopic volunteers, decreased APT skin infiltration by 58% (ultrasounds), compared 
to pimecrolimus 1% (35%) and clobetasone 0.05% (39%). Our findings demonstrate for the first 
time that a rexinoid exerts a significant, Th2-targeted, topical anti-inflammatory activity in mouse 
and humans, at least by decreasing the expression of TSLP. Since the compound does not induce 
skin irritation, our observations open a new field for the topical therapy of atopic dermatitis. 
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Evaluation of meglumine antimoniate effect on liver, kidney and pancreas function 
tests in patients with cutaneous leishmaniasis
M Nassiri Kashani1, AF Firooz1, P Davari1, F Gorouhi1, SE Eskandari1, MH Ghoorchi2, 
A Khamesipour1, A Khatami1, A Javadi3, Y Dowlati1 1Medical Sciences/University of 
Tehran, Tehran, Iran 2Mashhad University of Medical Sciences, Mashhad, Iran 3Qazvin 
University of Medical Sciences, Qazvin, Iran
This study was performed to evaluate the safety of meglumine antimoniate on liver, 
kidney, and pancreas function. In an endemic area for anthroponotic cutaneous 
leishmaniasis caused by leishmania tropica, 80 patients with cutaneous leishmaniasis 
fulfilled the study criteria. Patients were treated with intramuscular injections of 
meglumine antimoniate (Glucantime) at a dose of 20 mg Sb+5/kg/day equivalent 
to 60 mg/kg/day of meglumine antimoniate for 15 days. Blood urea nitrogen, 
creatinine, sodium, potassium, total and direct bilirubin, aspartate aminotransferase, 
alanine aminotransferase, alkaline phosphatase, amylase, lipase, gamma glutamyl 
transpeptidase were taken to evaluate liver, kidney, and pancreas function before 
and after treatment. Mean serum levels of blood urea nitrogen, creatinine, sodium, 
total and direct bilirubin, aspartate aminotransferase, alanine aminotransferase, and 
alkaline phosphatase significantly increased after treatment, although most of them 
were within normal range. There were no significant differences in serum levels of 
potassium, amylase, lipase, and γ-glutamyl transpeptidase before and after treatment.
In conclusion it should be stated that one course of treatment with 60 mg/kg/day 
meglumine antimoniate for 15 days does not significantly alter the liver, kidney and 
pancreas function tests in patients with cutaneous leishmaniasis.
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Regulation of HaCaT Keratinocytes migration by calcineurin
R Tiberio, G. Pertusi, V Codemo, R. Ramonda, R Zaninetti, C Bozzo, LG Fresu, E 
Colombo, G Leigheb University of Piemonte Orientale, Novara, Italy
In this study, we investigated the role played by the Ca2+/CaM phosphatase calcineurin 
in the regulation of the keratinocyte cell line HaCaT. To our knowledge, after tissue 
injury, epithelial cell migration is rapidly initiated in order to re-estabilish tissue 
integrity. Induction of keratinocyte motility is regulated through EGF and GSK3. The 
latter is a kinase that counteracts the activation and consequent nuclear localization 
of nuclear factors for activated T-cells (NFATs) usually performed by calcineurin.
We analysed HaCaT migration by the Boyden’s Chamber assay after treatment with 
calcineurin inhibitors. Our data show that cell migration is significantly increased 
after incubation with FK506. The effect is time-dependent, as it is greater after 48 
hours of treatment compared to 24 hours. Therefore, the calcineurin/NFAT pathway 
appears to inhibit a transcription program promoting HaCaT mobility and the use of 
inhibitors unmasks the promigratory pathway. To conclude, our results suggest a new 
mechanism of action of calcineurin inhibitors that could be responsible of wound 
healing and that might contribute to the normalization of cutaneous inflammatory 
conditions such as atopic dermatitis. This would confirm that also keratinocytes 
and not only lymphocytes, as previously thought, could be a therapeutic target of 
calcineurin inhibitors such as tacrolimus and pimecrolimus.
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Computerised Image Analysis in the Assessment of Human Nail Growth Rate
A Sparavigna1, M Setaro1, F Mailland2 1Derming, Monza (Milan), Italy 2Polichem SA, 
Lugano, Switzerland
Human nail growth rate is known to be approximately 3mm per month (0.1 mm/
day) and may be subjected to variation due to constitutional, physiological (mainly 
due to hormonal status and nutrition), pharmacological factors as well as to systemic 
and/or local diseases. The possibility that systemic and/or topical treatments may 
interfere with nail growth rate does exist and, to the best of our knowledge, until 
now very little attention has been paid to document such a variation using objective, 
sensitive and reproducible methods. Based on clinical observations, a previously 
studied transungual technology based on hydroxypropylchytosan biopolymer 
had accelerated the nail growth rate in treated patients. Our work was aimed at 
evaluating, by a non-invasive objective method, the activity exerted by the new 
topic nail formulation used daily for four weeks, on nail growth speed. The study 
was conducted on 21 female healthy volunteers, whose informed consent had been 
obtained, age range 18 - 50 (mean = 43). To measure the growth rate, digital images of 
the nails were taken in baseline conditions (T0a) and 3 days after (T0b) using a digital 
camera (Olympus Camedia C5050), a standard illumination and a finger positioning 
system. Digital nail images were repeated at the end of the study period at T4a and 
at T4b (3 day after T4a) in the same experimental conditions. The reproducibility of 
the used method was quite acceptable (VC=0.04-0.08%). Obtained results at the 
end of treatment period showed a statistically significant increase (Student t test 
p<0.01 vs T0) of treated nail growth rate corresponding to 15% (from a baseline 
mean value of 0.071 mm/day to a final mean value of 0.082). No variation of nail 
growth rate was highlighted for the untreated nails (0.075 mm/day at T0 and T4). 
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The efficacy of maleated castor oil in delivering skin moisturization and restoring 
healthy skin in rinse-off cleansing formulations
J Moore, M Gorcea ISP, Wayne, USA
Skin cleansing routinely results in skin barrier damage often leading to painful dry skin and 
skin irritation. The presentation will describe in vitro biophysical studies and in vivo clinical 
studies evaluating maleated castor oil, a synthetically modified triglyceride molecule, 
specifically designed to form a substantive and occlusive lipid film on skin. Data will be 
presented from biophysical studies demonstrating that the maleated castor oil molecule is 
delivered to the skin from rinse-off applications. In addition, related spectroscopy studies 
will be described demonstrating improved glycerol delivery from rinse-off formulations 
containing maleated castor oil compared to control systems. This presentation will also 
include clinical data from a regression study comparing matching cleansing formulations, 
without and with maleated castor oil (0.55%). Panelists preconditioned for the study by 
washing their arms daily with soap for seven days. Panelists then were washed by a clinician 
on marked sites, using controlled doses of rinse-off cleanser formulations, once a day for 
five days. During this treatment period panelist continued their daily arm wash with soap. 
Photographs were taken after days 0, 5, and 3 days of regression (treatment ceased but 
soap washing continued). Skin hydration was measured on the marked treated sites on 
days 1 through5 and after 3 days regression. Hydration was determined by measuring 
skin conductance with a Skicon instrument. Four sites were measured: untreated, water 
washed, formulation with maleated castor oil, and formulation without maleated castor 
oil. The sites cleansed with the formulation containing maleated castor oil (0.55%) were 
significantly more hydrated at day five and after regression (p < 0.05), compared to all other 
sites none of which were difference from each other. These clinical results are consistent 
with the laboratory studies demonstrating that maleated castor oil can be effectively 
delivered from cleansing rinse-off formulations and provide significant skin hydration. 
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The clinical efficacy of a lipophilic tocopheryl phosphate complex in the prevention 
and repair of skin irritation in individuals with sensitive skin
J Moore, B Gomez, M Gorcea ISP, Wayne, USA
Recent studies have determined that tocopheryl phosphate is a naturally occurring 
form of tocopheryl which is found in human tissues, plants, and food. A combination 
of in vitro and human in vivo studies has further demonstrated that tocopheryl 
phosphate is an effective antioxidant molecule (although not a free radical scavenger) 
and also directly mediates skin irritation by acting on inflammation pathways. The 
current presentation describes a recent 28 person clinical study designed to assess 
the utility of topical tocopheryl phosphate in mitigating erythema, folliculitis, 
and skin roughness. The study, which was designed and conducted at Stephens 
and Associates, included 15 women and 13 men for whom shaving caused mild 
to moderate skin irritation. At their first clinic visit these individuals were expertly 
clinically graded and a digital cross-polarized photograph was taken about 30 
minutes after shaving. A topical lamellar lipid formulation containing ˜2% tocopheryl 
phosphate was given to each panelist for daily application after shaving. Clinical 
grades at weeks two and four were statistically compared to the initial grades for 
each panelist. Differences were considered significant when p < 0.05; all clinically 
graded parameters were significantly improved compared to baseline. Expert 
clinical scores were decreased by 85% for erythema, 92% for folliculitis, 80% 
for roughness, and 92% for nicks and cuts. This presentation will present the raw 
clinical data and scores from this study and discuss the efficacy of tocopheryl 
phosphate in preventing and repairing irritated skin, particularly in the context of 
on-going research into the biological pathways of tocopheryl phosphate activity 
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T Cells Repertoire, Phenotype and Functionality in Drug Hypersensitivity Syndrome
B Janela1, D Picard1, V Descamps2, M D’Incan3, S Rogez4, H Moins-Teisserenc5, J-C 
Roujeau6, P Joly1, P Musette1 1CHU Charles Nicolle, INSERM 519, Rouen, France 
2CHU Bichat, Paris, France 3CHU Clermont Ferrand, France 4CHU Limoges, France 
5CHU Saint-Louis, Paris, France 6CHU Henri Mondor, Créteil, France
The drug hypersensitivity syndrome (DHS) or DRESS is a severe hypersensitivity reaction associated 
with visceral manifestations. The immunological mechanisms involved are still poorly understood. 
We propose to characterize the repertoire, phenotype and the functionality of T cells in DHS. 
40 patients with DHS were included in our study. CD4+ and CD8+ T cells were separated from 
PBMC. A T lymphocyte repertoire analysis was performed with the immunoscope technique. 
Lymphocyte phenotype and cytokine secretion were analysed by FACS on blood samples 
collected at D0 to D360. Immunoscope analysis permitted to detect repertoire bias corresponding 
to expanded lymphocyte population within a particular Vβ family. Immunoscope analysis reveals 
repertoire bias in all patients, preferentially among the CD8+ subset. A viral reactivation analysis 
was performed in all patients and the anti-EBV cellular immunity of the CD8+ T cells was tested 
using the MHC tetramers technique.T cells presented an activated phenotype more remarkable 
within the CD8+ subset. Expression of these markers decreases between D0 and D90. CD4+ and 
CD8+ cells overexpress cutaneous homing markers at the early stages of the disease. The cytokine 
profiling of CD4+ T cells is Th1 orientated, and the proportion of CD4+ and CD8+ T cells secreting 
IFNγ and TNFα increases between D0 and D90. An analysis of 400 sequences of CDR3β of CD8+ 
T cells expanded in 11 patients permitted to detect sequence homology with CDR3 motifs from 
EBV specific T cells. Moreover, viral reactivation analysis permitted to detect a frequent EBV and 
HHV6 reactivation and MHC tetramer technique detect a high proportion of CD8+ specific to EBV 
immuno-dominant peptides at the onset of the desease. In DHS, high proportions of CD8+ T cells 
secrete TNFα, IFNγ and IL2 and recognize EBV epitope. All of this suggests that the major response 
in DHS is directed towards viral antigens.
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Expression of glucocorticoid receptor b in lymphocytes of patients with atopic 
dermatitis
P Hägg, T Hurskainen, R Palatsi, M Ilves, A Oikarinen University of Oulu, Finland
Alternative splicing of the glucocorticoid receptor (GR) pre-mRNA generates a second 
GR, termed glucocorticoid receptor β (GRβ), which does not bind glucocorticoids but 
antagonizes the activity of the classic GRβ. Thus increased expression of GRβ could 
account for glucocorticoid insensitivity. The purpose of this study was to investigate the 
GRβ mRNA and protein expression in lymphocytes of patients with atopic dermatitis 
(AD) before and after treatment with topical corticosteroids. Peripheral venous blood 
was collected from 11 healthy donors, 10 patients with mild AD and 14 patients 
with severe AD (IGA > 3, EASI 20.7-43.2). mRNA was isolated from peripheral 
blood mononuclear cells. Expression of GRβ and GRβ mRNA was determined by 
RT-PCR and quantitated by real time PCR. Protein expression of GR isoforms was 
confirmed by Western blot analysis. The expression of GRβ mRNA was detected in all 
patients and healthy volunteers. In contrast, GRβ mRNA was detected 4 of 11 healthy 
volunteers, 5 of 10 patients with mild AD and 12 of 14 patients with severe AD. Eight 
of the 14 patients with severe AD showed 6- to10-fold increase in the expression of 
GRβ mRNA during two week treatment with topical corticosteroid. In these patients 
clinical response to topical corticosteroid was poor (EASI decreased < 8 %). The 
results show that the expression of GRβ is increased during topical corticosteroid 
treatment in lymphocytes of patients with AD and that especially glucocorticoid-
insensitive AD is associated with increased expression of GRβ.
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Toll-like receptor agonists in adjuvant immunotherapy for cancer
A Farkas1, M Urosevic2, R Dummer2 1University of Szeged, Szeged, Hungary 
2University Hospital of Zurich, Zurich, Switzerland
Innate immunity receptors, referred to as pattern recognition receptors (PRRs), are a class 
of proteins capable of recognizing pathogen-associated molecular patterns. PRR signaling is 
transmitted through evolutionary conserved inflammation pathways such as nuclear factor-kB 
and interferon regulatory factor. The recently discovered toll-like receptors (TLRs) represent 
the best-characterized class of PRRs.TLRs have a key role in inflammation and in initiation 
of subsequent immune responses, including adaptive immunity, therefore TLR agonists are 
promising therapeutics for various tumors. TLR signaling induces interferons, chemokines and 
proinflammatory cytokines and mature dendritic cells (DCs) for enhanced efficiency in antigen 
presentation. The mediators then play a crucial role in the organization of acquired immunity 
and, together with matured DCs, activate cytotoxic T cells and natural killer cells. Several TLR 
agonists have long been used alone or in combination with various agents as immunoadjuvants 
in anti cancer immunotherapy including cutaneous precancerous and cancerous skin lesions 
such as superficial basal cell carcinoma, actinic keratosis and in situ melanoma. Clinical 
trials in metastatic melanoma have also been undertaken, with tumor regression in some 
patients. On the other hand TLRs are increasingly implicated in human disease pathogenesis 
and both clinical and experimental evidence suggests that the neoplastic process may subvert 
TLR signalling pathways to advance cancer progression. Recent discoveries in the TLR 
system help us to identify new therapeutic approaches but extrapolation of such TLR system 
manipulations to a clinical oncological setting demands care to prevent potential activation 
of TLR-mediated survival pathways. Thus the immune activation induced via TLRs is a double-
edged sword for the immune system, which needs to be carefully wielded in the setting of 
neoplastic disease. An update on the scientific rationale for targeting TLRs, and an update 
on the development status of drug candidates in cancer immunotherapy will be presented. 
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Mild Psoriasis Arthritis Affects the Health-related Quality of Life in Psoriasis Patients
AV Kuznetsov1, S Polunina2, L Kouznetsov1, P Weisenseel1, S Sohn3, T Ruzicka1, 
S Schewe1, JC Prinz1 1Ludwig-Maximilians Univ Munich, Germany 2I.M. Sechenov 
Moscow Medical Academy, Russian Federation 3Friedrich-Alexander Univ Nurnberg, 
Germany
Psoriasis arthritis (PsA) occurs in 10-30 % of psoriasis vulgaris (PsV) patients. We investigated the 
impact of untreated mild PsA on the health-related quality of life (HRQL) in patients with mild 
PsV (PsV+PsA). Life quality was assessed in 72 patients with mild plaque type PsV (PASI<12, 
BSA<10%) without any other moderate/ severe mental or physical illness; 30 of them (PsV+PsA) 
had additionally mild mono-/oligoarthritis (50%), or polyarthritis (50 %). Life quality was 
assessed by the generic (SF-36) and dermatologic specific (DLQI) instruments. The PsV+PsA 
(14 f, 16 m, mean age 50.9 years), and PsV group (17 f, 25 m, mean age 46.6 years) showed 
minimal differences (p<0.05) in mean PASI: 2.9+2.7 (PsV+PsA) vs. 3.9+2.5 (PsV), respectively. 
The overall mean DLQI of PsV+PsA and PsV was low and without significant differences: 
0.85+0.84 (PsV+PsA) vs. 1.0+0.65 (PsV), p>0.05, respectively. PsV+PsA patients vs. PsV had 
significantly lower (= worse) scores in their physical health as measured by the SF-36 summary 
score: 42.1+8.6 (PsV+PsA) vs. 48.3+5.5 (PsV), p = 0.001, but not in the mental health summary 
score: 44.4+11.0 (PsV+PsA) vs. 43.4+13.1 (PsV), p>0.05. PsV+PsA patients showed lower 
scores (p<0.05) in physical functioning (PF): 68.3+25.8 (PsV+PsA), vs. 87.7+15.1 (PsV); in role 
limitations due to physical problems (RP): 53.3+43.4 (PsV+PsA), vs. 83.9+30.2 (PsV); in general 
health (GH) perceptions: 47.4+17.8 (PsV+PsA) vs. 57.8+19.2 (PsV); and role limitations due to 
emotional problems (RE): 56.7+43.9 (PsV+PsA) vs. 78.6+38.1 (PsV). Only bodily pain (BP) was 
higher (better) in PsV+PsA than in PsV (61.2+13.2 vs. 57.6+8.8; p=0.012), probably due to the 
use of NSARDs for arthritis. Mild psoriasis arthritis aggravates the health-related quality of life in 
patients with mild psoriasis vulgaris not only in areas of physical activities (PF), physical health 
(RP), and the assessment of personal health (GH), but also in emotional health (RE).
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Trafficking of 8-MOP Treated Leukocytes After Photopheresis in Humans
U Just1, E Dimou1, R Knobler1, G Klosner1, E Ivancic1, H Greinix1, A Becherer2, F 
Trautinger3 1Medical University of Vienna, Vienna, Austria, 2Feldkirch, Austria 3Karl 
Landsteiner Institute for Dermatolology, St Pölten, Austria
Photopheresis is an established treatment for cutaneous T-cell lymphoma, systemic 
sclerosis, graft-vs-host-disease and other autoimmune diseases. During photopheresis 
a leukocyte fraction (buffy coat) of the peripheral blood is extracorporeally exposed to 
8-methoxypsoralen and UVA before reinfusion into the patient. The precise mechanisms 
of photophesesis are not yet known. The aim of the present study was to investigate the 
fate of the UVA irradiated cells after reinfusion. For this purpose a fraction of the UVA-
irradiated buffy coat was sampled prior to reinfusion, separated into lymphocytes (LC) 
and polymorphonuclear leukocytes (PMN), and labelled with Indium-111 before being 
reinjected into the patient. Scans were acquired at 10min, 3h, and 24h after injection. 
Regions of interest were drawn over liver, spleen, spine, right lung and heart. Pixel-
normalised ratios of organ to background were calculated, with correction for physical 
decay. Each patient was investigated separately for migration of labelled LC and PMN with 
an interval of 4 weeks. Five patients have been included in the study. Using trypan blue we 
found that viability of 8-MOP/UVA treated LC and PMN was only minimally affected by 
labelling and that our technique results in a sufficiently strong signal to follow the labelled 
cells for 24h.The most prominent difference between the migration patterns of LC and PMN 
observed in all patients is the retention of LC but not of PMN in the lungs immediately after 
injection within the first 3h after injection. LC on the other hand were rapidly cleared from 
blood pool, while PMN showed blood pool activity over the first 3h. These preliminary 
results show for the first time that specific radiolabelling of blood cells after photopheresis 
in humans is feasible with a high yield and low cell damage and that 8-MOP/UVA treated 
LC and PMN have different and specific migration patterns. 
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Clinical images and therapy of cutaneous side-effects induced by inhibitors of the 
epidermal growth factor receptor
PA Gerber, E Enderlein, B Homey Heinrich-Heine-University, Düsseldorf, Germany
Here we present the broad spectrum of cutaneous side-effects induced by inhibitors of the receptor 
of the epidermal growth factor (EGFR). Futhermore, we discuss novel clinical observations, that 
provide interesting new insights into the pathogenesis of this unique cutaneous toxicities. Finally, 
an algorithm for the management of EGFR-inhibitor (EGFRI) is given. Recently, EGFRI, like the 
tyrosine kinase inhibitors erlotinib and gefitinib, or the monoclonal antibody cetuximab, have 
been established successfully as [quotleft]targeted cancer drugs’ in the clinical practice. Most 
frequent and severe side-effects of this class of drugs are cutaneous toxicities occurring in more 
than 50 percent of the patients: Within the first weeks after initiation of EGFRI therapy patients 
develop inflammatory, papulopustular eruptions mainly located on the face and the upper 
trunk. Supsequent superinfection of this rash is observed frequently. Additionally, many patients 
develop paronychias, xerosis cutis, itch, as well as a progressive atrophy of the skin. Interestingly, 
cutaneous lesions appear to be induced or aggravated by physical stimuli like mechanical trauma 
or UV-irradiation. Next to the skin also hair follicles are a target of EGFRI. Patients develop a 
variety of hair alterations like non-scarring alopecia, trichorhexis or trichomegaly. EGFRI related 
cutaneous side-effects represent a severe threat for patient compliance and their management 
is challenging. Nevertheless,most side-effects are reversible when EGFRI therapy is stopped or 
doses are reduced. However, own clinical experiences have shown, that side-effects can be 
managed effectively by applying combinations of anti-inflammatory and anti-microbial agents 
according to a specific management algorithm. Taken together, our results present the broad 
variety of EGFRI-induced cutaneous side-effects. An effective treatment algorithm can help to 
manage these challenging toxicities and avoid a reduction of dosis or even cessation of EGFRI 
therapy in the most cases. 
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No Significant Mutation Found in Hemojuvelin Gene in Patients with Porphyria 
Cutanea Tarda from Southern France
A Duthanh, P Martinez, D Bessis, B Guillot, O Dereure University of Montpellier I, 
Montpellier, France
Hemojuvelin (HJV) gene, encoding an important actor of iron metabolism, was studied in 
search of relevant mutations in patients with Porphyria Cutanea Tarda (PCT), a condition 
where an iron overload is considered as a prominent feature and where mutations of HFE 
gene are present in up to one third of patients. To assess this question, 33 consecutive 
patients with PCT diagnosed upon usual biochemical investigations were included, all of 
them originating from Southern France. After informed consent was obtained, genomic DNA 
was extracted from PBMC and sequence analysis of the 4 exons and flanking sequences of 
the HJV gene was carried out using a technique adapted from the SCAIP (single condition 
of amplification with internal primer) method. PCR conditions were adjusted to avoid the 
use of an internal primer and to sequence in a standard 96 wells microplate in a single PCR 
condition. Iron status was evaluated according to iron and ferritin levels in peripheral blood.
An iron overload was present in 18 (54%) patients according to an elevated ferritin rate 
above 450µg/L in peripheral blood, a figure consistent with previous studies in patients from 
the same geographic area. No deleterious sequence change was observed. An heterozygous 
intronic polymorphism located in IVS 2, 6 bp upstream from exon 2 [c.98-6C>G] was 
present in only one patient. This polymorphism has previously been described with an allele 
frequency of 0.203 in a group of white people with iron overload. 99 unrelated control 
chromosomes with no background of iron overload were assessed in our laboratory as well 
and we found that this polymorphism had a allele frequency of 0.208 in this population. 
To conclude, hemojuvelin gene abnormalities are unlikely to play a significant role in PCT 
pathomechanisms in analysed patients whatever their iron status may be. 
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HLA-Cw6 and TNF-α polymorphisms may help predict response to biologic therapy 
in patients with chronic plaque psoriasis
W Gulliver, Z Tomi, S Pirzada NewLab Clinical Research, St. John’s, Newfoundland, 
Canada
Psoriasis is a common inherited inflammatory disorder that affects 1 to 2 percent of 
the population. With the introduction of biologics the treatment of psoriasis has been 
transformed. To date response to biologics has been based on clinical observation 
and no genetics markers have been found to predict response to treatment. Recently 
in rheumatoid arthritis response to etanercept may be predicted when patients are 
sub divided using single nucleotide polymorphisms, TNF-α 308, G/A genotype versus 
G/G genotype. It was found that the G/A genotype had a 20.1% response versus 
a 79.1% response in the G/G genotype.Using the Newfoundland and Labrador 
founder population we have genotyped 19 patients who have been treated with 
biologics. Seven treated with etanercept, 6 with Alefacept, 4 with Efalizumab and 
2 with Infliximab. HLA-Cw6 status as well as TNF-α 238 and 308 status has been 
determined. The frequency of HLA-Cw6 is 32%, TNF-α 238 G/G is 85% and G/A 
is 15%. The TNF-α 308 G/G is 68% and G/A is 32%.Preliminary results suggested 
that patients who are positive for HLA-Cw6 respond to biologics and those patients 
negative for HLA-Cw6 may fail biologics. In the Newfoundland and Labrador founder 
population analysis of TNF-α 238 and 308 SNPs will be analyzed and may also be 
useful in determining response to biologics as was seen in the rheumatoid arthritis 
patient population. This study demonstrates that the use of the Newfoundland and 
Labrador founder population and HLA-Cw6 status may be helpful in predicting 
response to certain biologics. 
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Antimycotic activity of subungual fluids as a proof of in vitro efficacious nail 
permeation by antimycotic nail lacquers
F Mailland1, D Monti2, L Saccomani2, E Mucci2, E Ghelardi2 1Polichem SA, Lugano, 
Switzerland 2University of Pisa, Pisa, Italy
The availability of antimycotic agents in effective concentrations at nail bed is a prerequisite 
for an efficacious treatment of onychomycosis. Recently, a novel water soluble nail lacquer 
(P-3051) containing hydroxypropyl-chitosan as film-forming agent was demonstrated to 
improve nail permeation of 8% ciclopirox (CPX) compared to the traditional water insoluble 
nail lacquers. We compared the in vitro bovine hoof membrane penetration of CPX from 
P-3051 with that of a commercial nail lacquer containing 5% amorolfine (MRF). For the 
permeation experiments (30 hours) Gummer-type vertical permeation cells were employed; 
250 mcL of test product represented the donor phase, the receiving solution consisted of 
isotonic pH 7.4 phosphate buffer. At suitable intervals, the receiving solution was collected 
and immediately replaced by an equal volume of fresh buffer. Additionally, we tested 
the antimycotic activity of permeated fluids against dermatophytes (T. mentagrophytes, T. 
rubrum, M. canis), molds (S. brevicaulis), and yeasts (C. parapsilosis) by broth microdilution. 
HPLC analysis of samples showed drug transungual fluxes of 7.37 ± 1.55 and 0.30 ± 0.04 
mcg/cm2.h for CPX and MRF, respectively. After application of P-3051, subungual fluids 
displayed antimycotic activity against all the tested strains. In particular, inhibition of fungal 
growth was evidenced with fluids collected from 2 to 30 hours after one application of the 
lacquer. Although MRF displayed antifungal activity against all fungi, a better efficacy of 
P-3051 was demonstrated. Indeed, the efficacy coefficients (EC) calculated as flux (mcg/
cm2.day)/MIC were significantly higher for P-3051 than that for amorolfine in all tested 
fungal strains. In conclusion, our method is suitable to investigate the nail release of different 
active drugs in effective concentrations, and hydroxypropyl-chitosan proves very promising 
as film forming agent for medicated nail lacquers.
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Modification of hymenoptera-venom extracts for investigating the relevance of CCDs
M Mertens, R Brehler University of Münster, Münster, Germany
About 20% of allergic patients have specific immunoglobulin (Ig)E-antibodies against the 
carbohydrate-part of allergens (cross-reactive carbohydrate determinant = CCD). These 
glycans are found on a wide variety of allergens like pollens, hymenoptera-venoms and 
foods. In most cases patients with specific-IgE against CCDs show no clinical symptoms 
and skin prick tests (SPT) are negative. In sera-tests these antibodies are referred as ‘false-
positive’results. However, for a small subset of allergens (e. g. a specific celery-allergen) 
it is shown that CCDs alone have the property to induce allergic reactions. An important 
step in analysing the significance of CCDs is the generation of modified allergens - on 
the one hand without glycan-epitopes, on the other hand without protein-epitopes. 
By using these modifications we can perform functional cell tests which can indicate a 
clinical relevance of specific IgE to CCDs. Here, we present the modification of wasp- 
and honeybee venom extracts. Glycan-epitopes of native honeybee- and wasp venom 
were destroyed by incubation with NaIO4. Protein-epitopes of wasp venom were 
degraded by proteinase K. Using a specific anti-glycan-antibody in western blot-analysis 
it could be demonstrated that the glycan-epitopes of the wasp venom were fully destroyed 
after two hours of incubation with NaIO4 - the honeybee venom glycan-epitopes were 
destroyed after one hour of incubation. The elimination of the protein-epitopes of wasp 
venom was verified by SDS-polyacrylamid-gelelectrophoresis (SDS-PAGE) with silver-
staining. An investigation if the newly generated allergens, in particular the wasp-venom 
without protein-epitopes, can activate basophils of well-defined patient-groups is in 
process. The stimulation is monitored by measuring the up-regulation of CD203c on the 
basophilic cell-surface by FACS-analysis. Our study will give further information about 
a possible clinical relevance of specific IgE against CCD-epitopes of single allergens. 
 
132
Azimed in treatment of urogenital chlamydiosis
TDY Dasyuk1, AV Bujanova2 1Danylo Halytsky Lviv Nat Med Univ, Lviv, Ukraine 
2Ivano-Frankivsk State Medical University, Ivano-Frankivsk, Ukraine
A special attention among sexually transmitted diseases should be paid to 
chlamydiosis. Every year near 92 millions of new cases are registered worldwide, and 
approximately 10 millions of cases in Europe. For effective treatment of chlamydiosis, 
antibiotic Azimed (azithromycin) is proposed. It possesses a quality of accumulation 
in tissues, durable period of half-elimination (35-50 hours). Proper tolerance of the 
drug by patients makes it an effective remedy for treatment of urogenital diseases 
(manufacturer of Azimed: joint-stock company “Kyivmedpreparat”, Ukraine). 
54 patients (24 male, 30 female), aged 16-50, with urogenital chlamydiosis were 
examined. Duration of the disease constituted from 2 months to 5 years. The patients 
were divided into 2 groups: the first one - 32 patients (15 male and 17 female) 
with uncomplicated form of the disease; the second group - 22 patients (9 male 
and 13 female) with complicated form of the disease. The patients were treated with 
Azimed in the dose of 1.0 gr. during the first day of treatment, and in the dose of 
0.5 gr. during four consecutive days. Throughout the entire course of treatment, the 
patients received antioxidants, vitamins and other drugs, taking into consideration the 
laboratory analyses and course of the disease. Recovery was controlled every week 
during the first two months, then on the third and the sixth month after treatment was 
completed. The effectiveness of the suggested treatment of the patients with urogenital 
chlamydiosis constitutes 96.3 % (in case of uncomplicated form - 96.9 %, in case of 
complicated form - 95.5 %). We concluded that: 1. Azimed may be recommended 
for treatment of urogenital chlamydiosis as well as mixed chlamydial-ureaplasmal 
and mycoplasmal infections. 2. The suggested treatment increases effectiveness of 
urogenital chlamydiosis treatment, decreases cases of relapse, and helps diminish 
treatment period of chlamydial urogenital pathology.
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Minipunch graft for chronic leg ulcers
G Gualdi1, A Giannetti1, P Monari2, PG Calzavara-Pinton2 1Univ of Modena and 
Reggio Emiliana, Modena, Italy 2University of Brescia, Brescia, Italy
Tissue repair is a complex and well-regulated process involving many different 
types of cells such as cheratinocytes, fibroblasts, endothelial cell, nervous fibers 
and immune-ematic cells. Studies in the last decades show how these different cells 
communicate and influence each other through adhesion molecules, cytokines and 
growth factors in order to lead to wound healing. In particular it is well demonstrated 
that every single component is activelly involved for wound repair and this activity 
must be finely regulated. Starting from this knowledge and based on the recent data 
regarding the ripigmentation technique used for the therapy of vitiligo we decided to 
treat long time leg ulcers through the minipunch graft technique. The method preview 
the creation of niches inside the ulcer, at the distance of 1 cm from the border, using 
a 5mm punch biopsy. A full thickness graft is taken from a donor site (arms), using a 
6mm punch biopsy. Our aim is not to cover all the defect, but to use the full-thickness 
minigraft as a deposit of active and functional cells able to lead the wound healing. 
Moreover, this technique does not require special equipment and assistance, and 
the hospitalization of the patient, so the cost is very low. Furthermore this method 
is well tolerated because it allows the mobilization of the patient in the same day. 
We therefore decided to propose our preliminary but interesting clinical data as a 
promosing therapeutic approach.
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Association of lichen aureus and mycosis fungoides - a clinicopathologic study
R Fink-Puches, P Wolf, H Kerl, L Cerroni Medical University of Graz, Graz, Austria
A possible association between lichen aureus (LA) and mycosis fungoides (MF) has 
been suggested previously, and patients with LA and subsequent “progression” to 
MF have been described. Histopathologically, LA is characterized by lichenoid 
lymphocytic infiltrates admixed with extravasated erythrocytes and siderophages in a 
fibrotic papillary dermis, a picture that can be extremely difficult to distinguish from 
that of MF. The purpose of our study was to evaluate the clinicopathologic features of 
LA and its relationship to MF. Twenty-one patients (M:F=12:9; median age 57; range: 
17-83) with clinical and histopathologic diagnosis of LA were included in this study. 
In most patients (16) lesions were located asymmetrically on one lower extremity. At 
last follow-up (median 64 months, range: 11-274), 10 patients were alive without any 
sign of skin disease (2 of them after complete surgical excision of the original lesion), 
9 were alive with unmodified skin lesions, and the last 2 died of unrelated entities 
with unmodified skin lesions. Treatment modalities (local steroids, UV therapy) did 
not influence the outcome. A clonal T-cell receptor gamma gene rearrangement was 
detected in 9 of 18 cases (50%). There was no relationship between presence or 
absence of monoclonality and status at follow-up. Interestingly, one patient revealed 
the same monoclonal T-cell rearrangement at first diagnosis and on a second biopsy 
taken after more than 15 years. Our study demonstrates that patients with classical 
lesions of LA do not show any sign of progression into MF. On the other hand, a 
monoclonal T-cell population is a feature of half of the cases, and about half of the 
pattients have unmodified lesions that do not regress upon treatment, thus suggesting 
the possibility of a persistent clonal dermatitis. In this context, patients should be 
kept under follow-up and any new lesion suspicious of MF should be biopsied. 
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Temporin A in the Treatment of Experimental Surgical Wound Infections Induced 
with a Methicillin-Resistant Strain of Staphylococcus Aureus in Mice
O Simonetti, G Goteri, O Cirioni, A Giacometti, F Orlando, R Ghiselli, A Offidani 
University of Ancona, Ancona, Italy
Staphylococcus aureus is able to adapt rapidly to the selective pressure of antibiotics resulting 
in the emergence of methicillin-resistant S. aureus. Our aim was to compare the efficacy of 
topical temporin A alone and/or combined with i.p. teicoplanin for the treatment of surgical 
wound infections induced with a methicillin-resistant strain of S. aureus. We studied: 
reepithelization, granulation tissue, collagen organization, VEGF expression in wound before 
and after treatment and VEGF in serum. A full thickness wound was established through the 
panniculus carnosus on the back of adult BALB/c male mice. A small gauze was placed 
over each wound and then inoculated with 5x107 colony-forming units of S. aureus. The 
study included a control group (without treatment) and five contaminated groups treated, 
with:  drug-free Allevyn; temporin A-soaked Allevyn; daily intraperitoneal teicoplanin (7 
mg/Kg); drug-free Allevyn and daily intraperitoneal teicoplanin; temporin A-soaked Allevyn 
and daily intraperitoneal teicoplanin. Data analysis showed that the highest inhibition of 
bacterial growth was obtained in the group that received temporin A and intraperitoneal 
teicoplanin. Moreover temporin A-soaked Allevyn, with and without i.p. teicoplanin, was 
associated with a wound remodeling similar to not infected mice, characterized by an 
increase of collagen deposition and reduced microvessel density. Immunohistochemical 
staining for VEGF and CD31 showed that the clinical improvement was associated to a 
significant increase in neovascularization and VEGF expression in tissue. On day (D(+7) a 
significant VEGF increase in serum was observed in mice who received temporin A (13±1.6 
ng/ml, P<0.01) and temporin A associated with i.p.teicoplanin (50±2.5 ng/ml, P<0.005). Our 
data confirm the lack of toxic effects of the temporin A against mammalian normal cells at 
concentrations required to kill bacteria. Moreover we observed that the addition of peptides 
to the foam accelerate the wound repair process by reducing significantly the bacterial load. 
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Comparative evaluation of MAPK-related protein expression between primary and 
recurrent Merkel cell carcinoma
K Kenjiro, Y Nakamura, T Takahashi, F Otsuka
University of Tsukuba, Tsukuba, Ibaraki, Japan
Mitogenic intrinsic signaling pathway is representative of mitogen-activated protein 
kinase (MAPK) cascade including MAPK kinase (MEK), extracellular signal-regulated 
protein kinase (ERK), p38 MAPK and Jun NH2-terminal protein kinase (JNK) activation 
pathways. The selective specificity of three MAP kinase pathways among cell types 
and progression states has largely been unclear. We here report the enhanced 
expression of phosphorylated p38 expression in recurrent lesions of Merkel cell 
carcinoma (MCC) compared with the primary lesions. Specimens were obtained 
from the primary and recurrent lesions in 6 cases of MCC and 15 cases of eccrine 
porocarcinoma. Expression of MAPK proteins were examined using the corresponding 
antibodies and avidin-biotin complex kit. Total MEK1/2, phosphorylated MEK1/2 
(p-MEK1/2), ERK1/2 and p-ERK1/2 were ubiquitously expressed in all tumors while 
p38, p-p38, JNK and p-JNK were restrictedly expressed dependent on cases and tumor 
types. Different expression of p-p38 between the primary lesion and the recurrent 
lesion in MCC was obviously observed. Generally, recurrent lesions more rapidly 
grow than the primary tumors. The active progression may be modulated by some 
environmental elements and contributory cytokines. Even though any enhancement 
of mitogenic activity may occur, the phenomenon should be associated with intrinsic 
mitogenic signaling pathway. Our findings suggest the possibility of more specific 
participation of p38 MAPK pathway in the rapid growth of the recurrent MCC lesion. 
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2-day-kinetics of prostanoid release in human skin after UVB-irradiation combining 
dermal microdialysis with sensitive gas chromatography-mass spectrometry
R Quist, I Wiswedel, I Döring, H Gollnick Otto-von-Guericke Univ, Magdeburg, 
Germany
Cutaneous microdialysis is a novel method to analyze the kinetic of inflammation markers 
of prostaglandin synthesis and oxidative stress in vivo. Release of prostanoids in human 
skin were observed for 48h after UVB-irradiation in vivo. For cutaneous microdialysis 20kD 
cutoff membranes (CMA70) were placed in the dermis (at 0,7-1,2mm) and perfused with 
NaCl 0,9%, initial flow rate of 5 µl/min for 2h followed by a continuous flow rate of 0,5µl/
min for 60h using mobile CMA 107 microdialysis pumps. After 14h up to 6 areas of 3 cm2 
on the volar forearm of 6 healthy volunteers were exposed to UVB irradiation (2-fold MED, 
450-550 mJ/cm2). Microdialysate samples were collected on cold packs from 12h before 
irradiation up to 48 after UVB irradiation in 4h intervals. In one volunteer, samples were 
collected in the presence or absence of the antioxidative butylhydroxytoluole (BHT, 0,01%). 
The lipid mediators F2-isoprostane (8-iso-PGF2α) and prostaglandins 9α,11α-PGF2α and 
PGE2 in microdialysate samples were measured by sensitive gas chromatography-mass 
spectrometry/negative ion chemical ionization. Cutaneous microdialysis of up to 62h was 
well tolerated and a 4h sample interval was practicable in all 6 volunteers. Prostanoid levels 
were increased up to the first 10h due to insertion of the membrane into skin. Increased 
levels of 9α,11α-PGF2α and 8-iso-PGF2α were observed in the first 4h directly after UVB-
irradiation, as well as after 12-16h and 24-32h demonstrating two main peaks in the kinetic 
release of inflammatory prostanoids. However levels of PGE2 were quite low, possibly due 
to oxidative degeneration during the 4h sample interval. No differences in prostanoid levels 
were observed regarding the presence or absence of BHT. We concluded that insertion of 
the membrane up to 10h as well as UVB irradiation induced high extracellular prostaglandin 
and isoprostane levels in vivo, particularly at 0-4h, 12-16h and 24-32h after UVB irradiation. 
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Effects of tacrolimus and omega fatty acids on prostanoid synthesis in patients with 
atopic dermatitis using cutaneous microdialysis
R Quist, I Wiswedel, I Döring, H Gollnick Otto-von-Guericke University, Magdeburg, 
Germany
Prostanoid synthesis are of interest in skin inflammation. Cutaneous microdialysis 
is a novel method to analyze the kinetic of inflammation markers in vivo. We 
addressed the issue if treatment with Picrolimus or Omega-fatty-acids of atopic skin 
in patients with atopic dermatitis have an effect on prostanoid synthesis. 6 patients 
with mild to moderate atopic dermatitis (SCORAD <50) at least at both arms were 
included. They used tacrolimus ointment 0,1% twice daily for 5 days at one arm 
and a lotion containing 12% omega-fatty-acid twice daily for 5 days at the other 
arm. At day 5, microdialysis was performed at one area of each treated atopic skin, 
as well as untreated atopic skin and normal skin at the arms of each patient. For 
cutaneous microdialysis, 20kD cutoff membranes of 2 cm with a flow rate of 0,5µl/
min were used and perfused with NaCl 0,9% by mobile CMA 107 microdialysis 
pumps. Microdialysate samples were collected at 30-min intervals up to 8h. The lipid 
mediators F(2)-isoprostane (8-iso-PGF(2alpha)) and prostaglandins 9alpha,11alpha-
PGF(2alpha) and PGE2 in these microdialysate samples were measured by sensitive 
gas chromatography-mass spectrometry/negative ion chemical ionization. Cutanous 
microdialysis was well tolerated by all 6 patients with atopic dermatitis without any 
side effects. Treatment of atopic skin with tacrolimus did reduce prostanoid levels 
in atopic skin more than with Omega-fatty-acids compared to untreated skin. We 
concluded that treatment of the skin with Omega-fatty-acids 12% lotion as well 
as tacrolimus 0,1% ointment did reduce prostanoid levels in patients with atopic 
dermatitis. However antiinflammatory effects of tacrolimus were much stronger than 
those effects of omega-fatty acids.
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Prostaglandin E1 decreases serum fractalkine in systemic sclerosis
J Sicinska1, E Szymanska1, E Gorska2, M Cicha1, A Kuklo-Kowalska1, V Hamze1, K 
Stepien1, M Wasik2, L Rudnicka1 1CSK MSWiA, Warsaw, Poland 2Medical University 
of Warsaw, Warsaw, Poland
The aim of the study was to evaluate serum level of fractalkine (FKN), a mediator of 
leukocyte transmigration and chemoattractant and expression of integrins CD11a and 
CD49d on peripheral blood lymphocytes in systemic sclerosis (SSc) and to investigate 
whether they are modulated by intravenous prostaglandin E1 (PGE1). 50 SSc patients 
and in 18 healthy controls were included in the study. Serum levels of fractalkine was 
evaluated by enzyme-linked immunosorbent assay. Expression of CD11a and CD49d 
on peripheral blood lymphocytes was assessed by flow cytometry. In 25 SSc patients 
studied parameters were evaluated also after 3 consecutive daily PGE1 infusions (20 
µg-40 µg-60 µg) and after 4 weeks. In SSc fractalkine basal level was significantly 
higher than in controls (9.04±1.79 ng/ml vs 1.17±0.1 ng/ml; p<0.0001) and decreased 
significantly after PGE1 (5.16±1.27 ng/ml, p<0.05). After four weeks fractalkine level 
was still significantly lower than baseline 7.70±2.19 ng/ml (p<0.05). Basal percentage of 
CD11a(+) nor CD49d(+) lymphocytes in SSc (82.38±1.60%, 70.74±1.68%, respectively) 
did not differ from controls (85.73±2.04%, 75.62±2.48%; respectively, p>0.05). PGE1 
treatment resulted in decrease of both CD11a(+) (67.72±3.34%, p<0.0001) and CD49d 
(+) lymphocytes (65.32±1.62%, p<0.0001). After 4 weeks the percentage of CD11a(+) 
and CD49d(+) lymphocytes remained significantly lower than at baseline (77.80±2.47% 
and 65.32±1.62%, respectively, both p<0.001). In conclusion, our results show that 
intravenous prostaglandin E1 treatment decreases serum fractalkine level and down-
regulates CD11a and CD49d expression on peripheral blood lymphocytes, what indicates 
that both, endothelial cells and lymphocytes are targeted in this therapy.
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Neural processing of disgust in patients with psoriasis
C Kleyn1, A Ross1, S McKie1, L Gregory1, D Montaldi1, C Isaac2, H Richards1, D 
Fortune1, CEM Griffiths1 1The University of Manchester, UK 2The University of 
Sheffield, UK
It is known that patients with psoriasis may experience aversive reactions from others, such 
as expressions of disgust, in response to their appearance. Functional magnetic resonance 
imaging (fMRI) has delineated a cerebral network of areas, including regions of the frontal, 
temporal and occipital cortex, responsible for processing of facial expressions of emotion. In 
addition, the insula and amygdala are key regions activated in processing disgust and fear 
respectively. We utilized fMRI to determine whether the insula response to facial expressions of 
disgust differed between patients with psoriasis and healthy volunteers. Thirteen right-handed 
males with moderate/severe chronic plaque psoriasis, treated with topical and/or systemic 
medication (mean PASI: 7.1±1; range: 1.1-14.1), and 13 age-matched male healthy volunteers 
viewed validated photographs depicting either disgusted, fearful or neutral facial expressions. 
Fear was included as an aversive control. Brain images representing blood oxygen-level 
dependent (BOLD) contrast were acquired during presentation of the facial expressions using 
a 3T Philips MR scanner. Images were analysed using random effects ANOVA in Statistical 
Parametric Mapping (SPM5) at a threshold of punc<0.01. In both groups, disgust and fear 
significantly activated the network for facial expressions of emotion. Furthermore, expressions 
of disgust resulted in a significant reduction of BOLD signal bilaterally in the insula of subjects 
with psoriasis as compared to controls. Although both patients and controls demonstrated 
increased BOLD signal bilaterally in the amygdala in response to fearful faces there was no 
significant difference between the groups. There is evidence for differentiation between insula 
responses to disgust in patients with psoriasis as compared to controls. Moreover, as shown 
by results for fear, the differential response appears specific to disgust and not aversive facial 
expressions in general. These data lend further support to the concept of the ‘brain-skin’ axis.
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Toxicological side effects, antibacterial, and antifungal potencies of silver 
sulfadiazine and a novel silver compound containing nanoscalic silver
O Brandt1, M Mildner1, A Egger2, M Groessl2, C Hartinger2, B Keppler2, C Strupp3, 
B Mueller3, G Stingl1 1Medical University of Vienna, Vienna, Austria 2Institute of 
Inorganic Chemistry, Vienna, Austria 3Spirig Pharma Ltd, Egerkingen, Switzerland
The rate of fungal infections in the general population has been increasing worldwide 
for several years. Even though there are several classes of antifungal substances 
available, resistances to these drugs rise constantly. Due to its well known broad 
spectrum antibacterial activities silver has been used successfully for decades and has 
become a standard treatment for burns and bacterial skin infections. Silver-containing 
creams, particularly silver sulfadiazine (AgSD), possess effective activities not only 
against bacteria but also against fungals, and resistances to these drugs are rarely 
reported. However, there is serious concern that silver ions applied to inflamed and/ 
or denuded skin might be absorbed in significant amounts, thus introducing the risk 
of silver deposition, potentially leading to internal organ injury. In view of these facts 
we compared the percutaneous absorption and the antimicrobial potency of AgSD 
with a new composition where nanoscalic silver is linked to an inorganic carrier 
material (NSAg) leading to a highly stable complex that is less likely to be absorbed 
via the skin. The backs of hairless mice (SKH-hr1) were treated on five consecutive 
days with AgSD 1%, NSAg 1%, and NSAg 0.1%, respectively. While both AgSD 
and NSAg showed strong antimicrobial activities against different bacterial strains, 
candida species, and dermatophytes, quantification of silver ions in inner organs, 
blood and faeces revealed significantly lower absorption rates in the NSAg-treated 
animals than in the AgSD group. These results suggest that NSAg-containing creams 
are well suited for the prevention and treatment of skin infections, even when applied 
to large surfaces.
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Clinical, histological end immuno-histochimical negativisation of Kaposi skin nodule 
HHV 8 related after electrochemiotherapy
G Gualdi, F Fantini, AM Cesinaro, A Giannetti Univ of Modena and Reggio Emiliana, 
Modena, Italy
Electrochemotherapy (ECT) is a recent therapeutic technique that relies on pulsed, high 
intensity electrical currents (electroporation) to reversibly increase cell membrane 
permeability, thus enhancing the penetration of cytotoxic drugs into tumor cells 
Although several chemotherapeutic agents have been proposed, bleomycin, either 
systemic or intralesionally delivered, has shown the greatest antitumor activity when 
used in conjunction with electroporation. Kaposi’s sarcoma nodules represents ideal 
target for electrochemyotherapy because of the large number of lesions on the skin; 
in recent years many studies showed only the clinical efficacy in the treatment of 
Kaposi’s sarcoma. We decided to present clinical, and also histological and immuno-
histochimical images of Kaposi’s nodules positive for HHV 8.  The lesions were 
positive for HHV8 before therapy,  but after intralesional injection of bleomicine 
and electroporation,  they result in a complete clinical regression and the at the 
same time histological substitution of cancer with fibrosis and immuno-histochimical 
negativisation to HHV 8. 
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In vitro evaluation method of slimming active ingredients by videomicroscopy and 
image analysis
E Noblesse, F Pellicier, E Perrier, R Kurfürst, S Schnebert LVMH Recherche, St Jean 
de Braye, France
Normal adipose tissue development and increases in adipose tissue mass associated 
with weight gain and obesity require the formation of mature adipocytes from 
preadipocytes or stromal progenitor cells. The factors and processes that mediate the 
conversion of preadipocytes to mature adipocytes have been elucidated, at least in 
part, in immortalized preadipocyte cell lines like 3T3-F442A. The goal of this study was 
to determine the effect of a lipolytic agent natural extract for his ability to reduce the 
adipocyte differentiation using a technique of videomicroscopy and image analysis. 
Preadipocytes which present a fibroblastic phenotype, proliferate until confluence in 
exponential phase. At confluence, the medium is supplemented by 10% Fetal calf serum 
and 5 µg/ml insulin. In 15 days, cells acquired an adipocyte phenotype with rounded 
lipid-filled vesicles which could be easily followed and quantified by optical microscopy. 
The present work investigates the effect of a lipolytic agent and an inhibitor of adipocyte 
maturation , the Plectrantus barbatus during 15 hours treatment. At day 0, cells were 
treated or not with the active ingredient and incubated on a videomicroscope (NIKON 
TE2000) in an incubation chamber allowing to maintain the cells in culture at 37°C and 
5% CO2. We acquired automatically images of each cells wells every 10 min in phase 
contrast in a multipoint mode. Images were then analysed by an image analysis software 
(QWIN, Leica) to determine the effect of the active ingredient on the cell surface and 
intracellular lipid quantity. We showed, by this method, that the Plectrantus barbatus is 
able to dedifferentiate the adipocyte in a preadipocyte phenotype with a decrease of cell 
surface (-56%) and a disappearance of lipid vesicles confirmed by a Oil Red O staining. 
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Is there any relationship between disease severity in acne patients and dermatology-
related/diseased-specific Quality of Life
P Hashemi1, F Gorouhi2, N Markazi Moghaddam2, F Gorouhi3, A Firooz2 1Razi 
Hospital, Tehran, Iran 2Tehran University of medical Sciences, Tehran, Iran 3The 
Reading Hospital and Medical Center, West Reading, USA
Quality of life always remains a concerning part in the management of any skin 
disease. It is more important when the disease affects the sun-exposed parts of skin. 
Psychological, social, and affective problems have been reported in acne vulgaris 
patients. In this historical cohort study, acne and control volunteers were studied 
to evaluate the effect of acne on the different aspects of quality of life, including 
two questionnaires: AQOLS (Acne Quality of Life Scale) and DLQI (Dermatology 
Life Quality Index). The objective was to investigate any relationship between 
disease severity in acne patients and dermatology/diseased related QOL. One 
hundred and fifty four acne patients (96 females [62.3%] and 58 males [37.7%]) 
with a mean age of 19.3 ± 2.1 were entered the study. On the other hand, 150 
healthy volunteers (including 95 females [63.3%] and 55 males [36.7%]) with 
a mean age of 18.5 ± 1.8 were assessed as controls. There was no significant 
relationship between acne severity and QOL scores (P>0.05). Disease-specific 
(P<0.0001) and dermatology-related (P<0.0001) QOL scores of the patients with 
acne were significantly higher than normal controls. Therefore, it seems that so 
many other factors like personal culture, affects, character and environmental 
manipulators but not the disease severity may play the major roles in this setting. 
So primarily, there should be some efforts to minimize other aforementioned 
factors more than acne severity to improve the quality of life of such patients 
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Primary Cutaneous T-Cell Lymphoma with CD8+ Phenotype - the Zürich Experience
A Cozzio, K Kerl, W Kempf, R Dummer University Hospital Zürich, Switzerland
Recently, the World Health Organization (WHO) and the European Organization 
for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Group 
proposed a new classification for primary cutaneous T (CTCL) and B (CBCL) cell 
lymphomas. The classification is based on a combination of clinical, histological, 
immunohistochemical, and genetic criteria and contains well defined entities as well 
as some provisional forms. Mycosis fungoides (MF) is the most prevalent form of 
primary cutaneous T-cell lymphoma and consists, in the far majority of the cases, of 
clonal CD4+ CD45RO+ memory T-cells; however, cases of CD8+ MF cells have been 
described with similar prognosis as their CD4+ counterparts. These CD8+ cases of 
MF are not enlisted in the current WHO-EORTC classification on CTCL. On the other 
side, primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma have been 
recognized by their fulminant course of disease leading to early death after diagnosis. 
This CD8+ T-cell lymphoma has been recognized as a provisional entity in the WHO-
EORTC classification. In this study we report on the aggressive and non-aggressive 
cases with CD8+ CTCL that we have encountered in our cutaneous lymphoma unit 
at the University of Zürich, and discuss the clinical, immunohistochemical and 
molecular features. Ultimately, it will be important to distinguish early on between 
the two forms of CD8+ CTCL in order to adapt the therapeutic regimen to the distinct 
prognosis of the two diseases. 
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Primary cutaneous B-cell lymphomas - Clinicopathologic, prognostic and therapeutic 
characterization of 54 cases
W Kempf, P Golling, R Dummer, LE French, A Cozzio University Hospital Zürich, 
Switzerland
Staging and therapy of primary cutaneous B-cell lymphomas (CBCL) are not yet 
standarized. Moreover, the new WHO-EORTC classification for cutaneous lymphomas 
(CL) and the new TNM staging system for CL other than MF and SS have redefined the 
classification and documentation of disease extent in CBCL. We conducted a study 
on clinical and prognostic features as well as therapeutic aspects in 54 well-defined 
primary cutaneous cases of marginal zone B-cell lymphoma (pcMZL), follicle center 
lymphoma (pcFCL) as well as diffuse large B-cell lymphoma. leg type (pcDLBL).The 
majority of CBCL belonged to pcMZL. A significant overlap in the predilection sites 
in the group of low-grade malignant CBCL was found. Disseminated tumor lesions 
(T3 stage) occurred only in pcMZL, whereas in the vast majority tumors were solitary 
(T1) or regionally clustered (T2). Surgical excision or radiotherapy are highly effective 
in pcMZL and pcFCL. Recurrences occurred in up to 32% of the patients and in the 
vast majority of patients in the same body area. Antibiotic treatment did not result 
in complete remission in any of the patients. None of the patients with pcMZL and 
pcFCL experienced extracutaneous spread of the disease or died due to lymphoma. 
In contrast, 43% of patients with pcDLBCL died due to lymphoma. 
We concluded that, in pcMZL and pcFCL, surgical excision or radiotherapy are highly 
effective in T1 or T2 stage, although recurrences are common. Antibiotic treatment 
has no significant beneficial effect. In regard to the high recurrence rate in pcMZL 
and pcFZL and the poor outcome in pcDLBL, new therapies for CBCL are needed. 
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In vivo Confocal Laser Scanning Microscopy of Equivocal Pigmented Skin Lesions
R Hofmann-Wellenhof, V Ahlgrimm-Siess, R Fink-Puches, E Richtig, IH Wolf, 
A Gerger, J Smolle, H Kerl Medical University of Graz, Graz, Austria
The in vivo confocal laser scanning microscopy (CLSM) offers the possibility to non-
invasively investigate skin lesions at nearly histological resolution. A recent study 
showed a high sensitivity (97.6%) and specificity (88.15%) for the discrimination 
of clinically definitely to diagnose benign and malignant melanocytic skin lesions. 
In this study we investigated the value of CLSM for the diagnosis of equivocal 
pigmented skin lesions. We included 50 pigmented skin lesions in which clinically 
and dermoscopically a melanoma could not be ruled out. 19 malignant tumors (15 
melanomas, 3 basal cell carcinomas, 1 metastasis of melanoma) and 31 benign lesions 
(25 melanocytic nevi, 6 non-melanocytic pigmented skin lesions) were documented 
with clinical, dermoscpic and CLSM images. In the first step of the study the CLSM-
images were diagnosed as benign or malignant without a clinical or dermoscopic 
image. In the second step the CLSM-images were evaluated together with the clinical 
and dermoscopic images. Judging the CLSM images alone 2 melanomas could not 
be identified (sensitivity 89.4%) and the specificity was 67.7%. Together with the 
clinical and dermoscopic images the sensitivity remained 89.4% but the specificity 
was increased significantly to 87%. The CLSM seems to be useful as an additional 
diagnostic tool in equivocal pigmented skin lesions. 
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How does cyclosporine therapy influence patients’ mental comfort and 
adaptability?
H Zelenkova, J Stracenská DOST Private Clinic, SVIDNÍK, Slovakia
It is a well known fact that patients suffering from psoriasis, especially from the 
types affecting extensive body areas or from the inverted type also suffer from 
mental discomfort and in some cases from serious mental distress. Such conditions 
distort, at the end of the day, interpersonal relations within the family, at work and 
in the environment of such patients. In such cases, dermatologists must acquire the 
confidence of the patients and become their psychologists, who are able to listen 
carefully and provide their patients with counselling. If the dermatologist feels 
he or she is not really able to take up this new role, they must invite a certified 
psychologist or a psychiatrist to participate in the treatment course. The results that 
can be obtained are really astonishing. A modern and well performed psoriasis 
therapy employing (adequately indicated) systemic agents the right way and a great 
possibility to improve the overall health and mental condition of the patients and help 
them participate fully in their family and professional life. Cases shall be presented 
of patients with extensive psoriasis, in which improvement of the local finding was 
observed after the commencement of therapy with cyclosporine, which, in turn, lead 
to significant improvement as regards the lifestyle and the quality of life. 
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A Novel ingredient for reactive skin
A Gueniche, P Bastien, I Castiel, L Breton L’Oréal Recherche, Clichy, France
Reactive skin is characterized by a marked sensitivity to physical or chemical stimuli 
and by an impaired of skin barrier repair ability. The aim of this study was to evaluate 
the effect of a novel bacterial extract in aqueous solution on skin reactivity. For this 
purpose, a topical cream containing the active extract was tested in a randomized 
double-blind placebo-controlled trial. 66 female volunteers with reactive skin where 
randomly given either the cream with the bacterial extract at 10% (n=33) or control 
cream (N=33). The volunteers applied twice a day the cream to the face, arms and 
legs for two months. Skin sensitivity was assessed by the stinging test (lactic acid) and 
skin barrier recovery was evaluated by measuring TEWL following barrier disruption 
induced by repeated tape-stripping at day1, d29 and d57. The results showed that the 
volunteers who applied the cream with bacterial extract had a significant decrease in 
skin sensitivity at the end of the treatment (p=0.0024) and the treatment led to increase 
skin resistance against aggression compared to control group. Noteworthy, the 
stripping number to obtain barrier function disruption was significantly increased for 
volunteers treated with the active ingredient compared to control group (p=0.0044). 
Clinical and self-assessment revealed a significant decrease in skin dryness (at day 
29, p=0.03). Since in vitro studies shown that isolate sensitive neurons release less 
CGRP under capsaicin stimulation in the presence of the bacterial extract on one 
hand and increased skin resistance is found in volunteers applying the test cream on 
the other hand, we speculate that this novel ingredient may decrease sensitive skin by 
reducing neurons reactivity and neurons accessibility. These findings suggest that new 
approaches based on a lysate from bacteria, could be developed for the treatment 
and/or prevention of symptoms related to reactive and dry skin.
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Component resolved diagnosis in carrot allergy
P Fritsche, B Ballmer-Weber, I Bätscher University Hospital of Zürich, Switzerland
Up to 25% of all food allergic patients in Central Europe suffer from carrot allergy. 
Skin prick test (SPT) with commercial carrot extracts shows low sensitivity and 
specificity. The major allergen of carrot Dau c 1 and the carrot profilin Dau c 4 have 
been identified to be the most relevant allergens in carrot allergy. Therefore, we have 
produced two isoforms of Dau c 1, Dau c 1.0201 and Dau c 1.0104, and of Dau c 
4 in recombinant form and have validated their diagnostic use for SPT. 80 patients 
were included into the study. 39 carrot allergic patients with confirmed carrot allergy 
by double-blind food challenge (DBPCFC) were included into group 1. To assess 
specificity of the new diagnostic procedure, we included 21 pollen allergic patients 
without food allergy into group 2 and 20 patients without any allergy as a negative 
control in group 3. In group 2 and 3 carrot allergy was excluded by a negative open 
food provocation with raw carrot. In all patients SPT with rDau c 1.0104, rDau c 
1.0201 and rDau c 4 and commercial carrot extract were performed. Under DBPCFC 
all patients of group 1 claimed about oral allergy syndrome. No severe symptoms 
were observed. The sensitivity of SPT for the commercial carrot extract was 88%, 
74% of the carrot allergic patients were sensitized to rDau c 1.0104, 54% to rDau c 
1.0201 and 51% to rDau c 4. By use of all three recombinant allergens we observed 
a sensitivity of 100%. We observed no positive SPT to the recombinant allergens in 
non-allergic subjects (specificity 100%). Patients with birch pollen sensitisation but 
no carrot allergy recognized cross-reactive epitopes in 48%. In conclusion: SPT with 
three different recombinant carrot allergens is highly sensitive for the diagnosis of 
carrot allergy.
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Meat allergy in Central Europe
P Fritsche, TB Theler, M Dutta, B Ballmer-Weber University Hospital of Zürich, 
Switzerland
There are only few reports on meat allergy in the literature. A Swiss study in 1996 
reported an incidence of meat allergy of 8.2% among patients with IgE-dependent 
food allergies. The present study investigates clinical characteristics of meat allergic 
patients and validates the currently used routine diagnostic tools. Within the framework 
of the EU-project REDALL patients with a positive case history of a meat allergy were 
included into the study. In patients with a positive history of an anaphylactic reaction 
meat allergy was regarded to be confirmed. All other patients underwent titrated 
double-blind placebo-controlled food challenge (DBPCFC) up to a cumulative dose 
of 50g of meat. IgE reactivity to pork (f26), beef (f27) and chicken (f83) was assessed in 
vitro by CAP-FEIA. Prick-to-prick tests were performed with native meats. 13 patients 
with a positive case history of meat allergy either to chicken (n=6), beef (n=5) or 
pork (n=2) have been identified from 2/2003 to 6/2005. In 6/13 patients meat allergy 
was confirmed either by the history of an anaphylactic reaction (n=3) or a positive 
DBPCFC (n=3). The reported symptoms ranged from oral allergy syndrome (OAS), 
flush, angioedema and gastrointestinal disorders to anaphylaxis with drop of blood 
pressure and unconciousness. In 7/10 patients DBPCFC was negative. 
In patients with confirmed meat allergy the sensitivity of the skin prick test was 67% 
and of the CAP 33%, respectively. Meat allergy seems to be an uncommon allergy 
in Switzerland. Meat induced symptoms range from OAS to severe anaphylactic 
reactions. The current routine diagnostic tools to detect meat allergy are dissatisfying. 
In vitro determination of specific IgE (CAP) shows low sensitivity (33%) whereas 
prick-to-prick test detects 66% of the meat allergic patients. 
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Chronic Urticaria: Cognitive flexibility influences the cause of urticaria
B Töndury, S Büchi, B Mühleisen, G Hofbauer, B Ballmer-Weber University Hospital 
of Zurich, Switzerland
A consultation for urticaria patients was established at the Dermatology Department 
of the University Hospital of Zurich. Correlation between patient’s history and type/
cause of urticaria, impact of a positive autologous serum skin test (ASST) and of 
psychological factors on the course of urticaria were investigated. 43 patients with 
a mean age of 38 years (range: 13-69 years) and chronic or acute intermittent 
urticaria were recruited from January till May 2007. Patients were interviewed on 
suspected trigger factors of their urticaria and their cognitive flexibility was assessed 
using a Pictorial Representation of Illness and Self Measure (PRISM). ASST and 
physical tests (for pressure, cold, etc.) were performed. Patient’s history correlated 
in four patients with the identified type of urticaria (9,3%). Food allergy was 
suspected to cause urticaria by 18 patients (41,9%), physical triggers by 23 patients 
(35,5%), but could be only confirmed in one and three patients respectively. The 
ASST was positive in nine cases (42,9%). 29 patients (85,3%) demonstrated in 
PRISM analysis to have a cognitive flexibility, i.e. to be able to see a variation in 
the intensity and frequency of their symptoms. Thirteen of those patients showed 
a favourable course, i.e. a reduction of days with urticaria symptoms of 25%. 
Five patients had no cognitive flexibility and none of those showed a favourable 
course. However, there was no correlation between the outcome of ASST and 
the course of the urticaria. In conclusion: patient’s history did not correlate with 
the clinical test results. More importantly however, there is an indication that 
cognitive flexibility could be a predictive marker for the course of chronic urticaria 
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Determination of diamine oxidase activity does not facilitate diagnosis of histamine 
intolerance
B Töndury, P Schmid-Grendelmeier, B Ballmer-Weber University Hospital of Zurich, 
Switzerland
About 1-2% of the general population are thought to suffer from histamine intolerance 
(HIT), which is defined as allergy like symptoms after ingestion of histamine rich 
food due to reduced diamine oxidase (DAO) activity. The aim of our study was to 
investigate if patient’s histories, that are suggestive for HIT, correlate with a reduced 
serum DAO activity. At the Department of Dermatology, University Hospital of Zurich, 
we have recruited 42 patients from May 2005 to May 2007 with suspected HIT. 
Patients were interviewed on clinical symptoms and the relation of symptoms to food 
ingestion. Sera were analysed for DAO activity using an ELISA test (Sciotec, Vienna, 
A). A reduced DAO activity was measured in 15 (35,71%) patients. Ten of those 
patients (67%) showed a history compatible with symptoms of HIT that occurred after 
intake of histamine rich food. In the remaining five patients gastrointestinal symptoms 
occurred without any correlation to the intake of histamine rich food. In the group 
of patients with normal DAO activity (n=27), 22 (81,5%) had a history of typical 
symptoms after histamine rich food whereas 5 (18,5%) did not show any correlation 
with the intake of histamine rich food. In conclusion: based on the patient’s history 
with allergy like symptoms occuring with intake of histamine rich food determination 
of DAO activity does not facilitate diagnosis of HIT.
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Consistent Response with Infliximab in Psoriasis Patients Independent of Previous 
Systemic Therapies
S Phillip1, D Thaci2, B Bräu3, W Sterry1 1Charité Berlin, Berlin, Germany 2Johann 
Wolfgang Goethe-University, Frankfurt, Germany 3Office Based Dermatologist, 
Giessen, Germany
We evaluated the safety and efficacy of infliximab in patients with moderate-to-
severe psoriasis that were previously treated with either two or more of currently 
available systemic therapies (Group I) versus patients treated with one or no previous 
systemic therapy (Group II). 593 adult patients suffering from psoriasis for ≥ 6 months 
with at least 10% of total Body Surface Area affected and with a PASI of ≥ 12 were 
assigned to group I or II and receive infliximab 5 mg/kg at weeks 0, 2, 6 and 14. 
Patients’ response was evaluated at Week 22. Patients in Group I had significantly 
more severe disease than in Group II (PASI 27.8 vs 24.4; BSA 34.4% vs 28.9% for 
Groups I and II respectively), longer duration of disease (Group I: 21.4 years; Group 
II: 19.4 years; p < 0.01), and had received a mean of 2.9 vs 0.6 previous systemic 
therapies. 72.4% of patients in Group I and 70.6% in Group II achieved a PASI 75 
(ITT-analysis). Approximately half of the patients in each group achieved a PASI 90 
(Group I: 52.8%; Group II: 48.8%) from baseline to week 22 leading to significant 
improvement in patients’ QoL. Serious adverse events occurred in 6.1% (18/293) and 
3.8% (11/289) of the patients in Groups I and II respectively; infections and infusion 
reactions were the most frequent ones. We concluded that Infliximab demonstrates 
consistent efficacy in patients with chronic plaque psoriasis independent of their 
previous treatment and/or disease state as demonstrated by 75% PASI improvement 
at Week 22 and is safe and well tolerated.
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A proof-of-concept study of oral DA-9102 in adult patients with mild to moderate 
atopic dermatitis
TH Lee, YK Kwon, TY Oh, CH Cho, MW Son, JK Rhee, SH Kim Dong-A Pharm. Co. 
Ltd., Youngin-Si, South Korea
Atopic dermatitis (AD) is a chronic inflammatory skin disease with increasing incidence 
in recent decades. There is a need for alternatives to topical treatment in patients with AD, 
because the disease is frequently not satisfactorily controlled topical therapy. DA-9102 is a 
botanical drug isolated from Actinidia arguta that significantly reduces dermatitis severity 
via modulation of Th1/Th2 pathways in murine models. We have assessed the safety and 
efficacy of oral DA-9102 (250, 500, 1000 or 2000 mg twice daily) in adult patients with 
mild to moderate atopic dermatitis in a randomized, multicenter, double-blind, placebo-
controlled, 4-weeks proof-of-concept (POC) clinical trial using objective outcome measures. 
Disease activity was assessed every 2 weeks during treatment. The primary efficacy variable 
was the reduction of the Eczema Area and Severity Index (EASI) score. Secondary efficacy 
variable were 4-week change in Investigator’s Global Assessment (IGA), Patient’s Global 
Assessment (PGA), patients’ assessment of itch and sleep, Dermatology Life Quality Index 
(DLQI) and serum IgE level. Adverse events and hematological parameters were monitored 
during the study. The therapeutic effect of DA-9102 treatment was observed with a 
statistically significant reduction from baseline of the EASI score at week 4 in the 1000mg 
twice daily dose group and the greatest change of 33.7% in the 250 mg dose group. There 
were significant improvements in quality of life, loss of sleep and pruritus in the 1000 
mg dose group. Few adverse events related to treatment were reported during the study. 
Dyspepsia was the most frequent event reported by 2 of 72 patients. These data suggested 
that oral DA-9102 might be effective and safe treatment for patients with mild to moderate 
AD. Further long-term and large-scale trials are required to ascertain its efficacy fully. 
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Clinical Trial of Gripin® Cream (Maitake Mushroom Extract Cream) for Xerosis 
Therapy
M Nagao1, S Matsuzaki2, A Ito3, T Sato3, M Takahashi1 1Heimat Co., Ltd., Tokyo, Japan 
2Yoshii Central Clinic, Gunma, Japan 3Tokyo Univ Pharm Life Sci, Tokyo, Japan
Xerosis is defined as dehydration of stratum corneum and characterized by scales, 
fissures, erosions, and callus in the skin, which thereby impair the skin barrier function. 
Xerosis is considered to be caused by aging and various environmental factors, and is 
also a common symptom that occurs in chronic skin disease such as atopic dermatitis. 
Since patients with xerosis exhibit symptoms including a scaly and rough skin surface 
and uncomfortable feelings of itching or pain, effective candidate(s) to structurally and 
functionally improve the impaired skin barrier may be of benefit to the patients. On 
the other hand, we found novel evidence that Grifola frondosa (Maitake mushroom) 
extract (Gripin®) facilitates the biosynthesis of sebum, which plays an important 
role in maintaining the skin barrier, in hamsters and humans in vivo and in vitro. 
In the present study, to clarify whether or not Gripin® may be effective for xerosis, 
we performed a clinical trial investigation of 0.2% Gripin® cream in the posterior 
antebrachial and crural of patients with moderate to severe xerosis. Sixty patients 
were initially enrolled in the trial. Twelve and thirty-five patients completed the entire 
1- and 5-week treatment (once a day), respectively. Evaluation of treatment benefit 
was based on measurement of skin desquamation. Both 1- and 5-week treatments 
resulted in significant improvement in the skin of the posterior antebrachial and 
crural. In addition, Gripin® cream was found to be effective in treating moderate 
to mild xerosis rather than severe conditions. Thus, these results suggest that 
Gripin® cream may be useful for remission and/or cure of xerosis by the possible 
mechanism that it augments the level of sebum to restore barrier function in the skin. 
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Results of a Phase II study of CNTO 1275 in the treatment of psoriasis
N Yeilding1, GG Krueger2, RR Langley3, C Leonardi4, C Guzzo1, Y Yuhua1, 
C Brodmerkel1, M Lebwohl5 1Centocor Research and Development, Inc., Malvern, 
USA 2University of Utah Health Science Center, Salt Lake City, USA 3Dalhousie 
University, Halifax, Canada 4St. Louis University School of Medicine, St. Louis, USA 
5Mount Sinai School of Medicine, New York, USA
We evaluated the safety and efficacy of anti-IL12p40, an antagonist to interleukins-12 and -23, 
two key cytokines in type 1 immune responses, in the treatment of plaque psoriasis. In this 52 
wk, double-blind, placebo-controlled trial, 320 patients were randomized to subcutaneously 
administered CNTO 1275 (1 injection of 45mg or 90mg; 4 weekly 45mg injections, or 90mg 
injections) or placebo. Patients in the CNTO 1275 groups received an additional dose at wk 16 
if they did not have an excellent or complete response (<75% clearing) by Physician’s Global 
Assessment (PGA). Patients in the placebo group received 90mg of CNTO 1275 at wk 20. At wk 
12, >=75% improvement in PASI was observed in 52%, 59%, 67%, and 81% of patients treated 
with 45mg, 90mg, four weekly 45mg injections, or four weekly 90mg injections of CNTO 1275, 
respectively, vs 2% of placebo-treated patients (p<0.001 for each comparison vs placebo). At 
least a 90% improvement in PASI was observed in 23%, 30%, 44%, and 52% of patients in the 
respective CNTO 1275 groups vs 2% of placebo-treated patients (p<0.001 for each comparison 
vs placebo). Improvements in clinical measures correlated with improvements in quality of life. 
CNTO 1275 was generally well tolerated. Through wk 20 (placebo-controlled portion) 79.0% of 
CNTO 1275-treated patients experienced >=1 AE vs 68.7% of placebo-treated patients (average 
duration of follow-up was 17.9 wks, 19.4 wks, 19.3 wks, 20 wks, and 20.1 wks for the placebo, 
45mg, 90mg, 180mg, and 360mg groups, respectively). Serious adverse events were uncommon 
in all groups. A low percentage of patients developed antibodies to CNTO 1275 (4.1%). This 
study demonstrates that subcutaneously administered anti-IL12p40 is efficacious in psoriasis 
and validates the role of the p40 family of cytokines in psoriasis pathogenesis.
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Concomitant treatment of chronic plaque psoriasis with initial pulsed dye laser and 
narrow-band UV-B therapy
A Hofer, D Kopera, FJ Legat, H Kerl, P Wolf Medical University of Graz, Austria
Chronic plaque psoriasis is often resistant to topical therapy and sometimes also shows 
a delayed response to light therapy. Recently, the pulsed dye laser (PDL) has been shown 
to exhibit anti-psoriatic properties by selectively damaging the microvascularization of 
psoriasis plaques. The purpose of this study was to investigate whether the efficacy of 
narrow band UV-B therapy in chronic psoriasis plaques can be enhanced by additional 
initial dye laser treatment. Eleven patients with recalcitrant plaque psoriasis on the 
elbows were included in the study. Three similar lesions were randomly selected to be 
treated either with narrow-band UV-B therapy three times a week, with PDL (585nm, 
0.5msec, 7J/cm2) once or twice at 3 week intervals or with a combination of these two 
treatment modalities. After 6 weeks the clinical response was evaluated using a plaques 
severity score (sum score of erythema, induration, and scaling). After 6 weeks the treated 
plaques showed a 40%, 57%, and 68% reduction of the plaque severity score after PDL 
therapy, narrow-band UV-B therapy, and the combination therapy, respectively. The 
combined PDL/UV-B therapy was more effective compared to the PDL monotherapy 
(p=0.001). However, there was no significant difference between the efficacy of the 
combined therapy and narrow-band UV-B monotherapy. Ten of 11 patients relapsed 
within 2 to 5 months. Concerning duration of remission, in 40% of the lesions there 
was no difference between UV-B therapy and the combined UV-B and laser therapy, 
in 50% it was longer in lesions treated with UV-B and laser, and in 10% it was longer 
in lesions treated with UVB monotherapy. We concluded that concomitant treatment 
with initial PDL and narrow-band UV-B did not enhance the clinical outcome after 6 
weeks of treatment compared to narrow-band UV-B monotherapy. However, a subset 
of patients may achieve a prolonged remission with the combined therapy.
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Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur 
mustard
SM Davoudi1, SB Sadr2 1Baqyatallah Univ of Medical Sciences, Tehran, Iran 2Tehran 
University of Medical Sciences, Tehran, Iran
This study was conducted to compare the safety and efficacy of doxepin and 
hydroxyzine in the treatment of chronic pruritus due to exposure to sulfur mustard.
In a randomized, double-blind safety and efficacy study, 50 patients with chronic 
pruritus were given either doxepin 10 mg/d or hydroxyzine 25 mg/d for 4 weeks. 
Pruritic score was calculated for each patient before treatment and after 1 month 
treatment. The initial pruritic scores of two groups were not significantly different 
(37.3±5.1 vs 37.2±4.9, P=.876). After treatment, the mean pruritic scores ± SD of 
the hydroxyzine and doxepin groups were 16.7±2.3 and 17.8±2.5, respectively. The 
severity of pruritus was decreased in 80% of patients in the hydroxyzine group and 
75% in the doxepin group (P=.786). Eighteen patients in the hydroxyzine group and 
14 patients in the doxepin group reported sedation (P=.145). Both hydroxyzine and 
doxepin are effective and have equivalent results in controlling the symptoms of 
patients with chronic pruritus due to exposure to sulfur mustard.
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Comparative evaluation of oral and local spironolactone efficacy in management 
of hirsutism
SM Davoudi1, SB Sadr2, H Jahandideh3 1Baqyatallah Univ of Medical Sciences, 
Tehran, Iran 2Tehran University of Medical Sciences, Tehran, Iran 3Shahid Beheshti 
Medical University, Tehran, Iran
The aim of this study is to evaluate the formulation of spironolactone cream and to 
compare the efficacy of oral and local spironolactone preparations in the management 
of hirsutism. 77 patients with hirsutism were randomized to use spironolactone 
cream (n=39) or spironolactone tablets (n=38). Before beginning the study, the 
hirsutism scores were measured in both groups and no significant difference was 
observed between them. All the patients used their medications for 7 months and 
were visited by a dermatologist monthly. After the course of treatment completed, 
the hirsutism scores were measured in all patients and compared with the baseline 
scores. In the tablet group, the hirsutism scores decreased significantly in 15.8% 
of patients (p<0.05). In 44.7% of patients, there was a non-significant decrease in 
the hirsutism scores and the scores in the reminding of patients didn’t change. In 
contrast, 55.8% of patients used spironolactone cream had significant decrease in 
their hirsutism scores and in the rest of the patients of this group, some decrease 
was observed in the scores but it was not significant. In cream-receiving patients, no 
one experienced any side effect while in the patients took oral spironolactone, drug 
adverse effects including headache, nausea and menstrual dysfunction were seen 
in 40% of cases. Using spironolactone cream instead of tablets was associated with 
significant decrease in hirsutism score and less side effects. As hirsutism needs a long 
term therapy, it seems that local therapy with spironolactone cream is much better in 
treating hirsute patients. 
 
161 [Oral 013]
Patients with severe psoriasis have an increased risk of mortality
SK Kurd, JM Gelfand, L James, AB Troxel, D Margolis, DB Shin, X Wang, BL Strom 
University of Pennsylvania, Philadelphia, USA
Psoriasis is associated with obesity, cardiac disease, diabetes, smoking and alcohol use. 
The purpose of this study was to determine if psoriasis is associated with excess mortality. 
We performed a population-based cohort study of adult patients who were followed by 
general practitioners in the General Practice Research Database (GPRD) in the UK from 
1987-2002. The GPRD has been previously shown to validly identify psoriasis and 
accurately capture information from specialists. Patients were classified as having psoriasis 
if they had a medical record of psoriasis. Psoriasis patients with no record of systemic 
therapy were classified as mild, whereas those who received a therapy consistent with 
severe psoriasis were classified as severe. Up to 5 patients with no history of psoriasis 
were selected randomly from the same practice and time period as patients with mild 
and severe psoriasis. We performed Cox models adjusted for age and sex to determine 
the hazard ratio (HR) of death associated with psoriasis. We matched 133,568 patients 
with mild psoriasis to 560,358 controls, and matched 3,911 patients with severe psoriasis 
to 15,075 controls. Severe psoriasis patients had an increased risk of mortality (HR 1.14, 
95% CI 1.004, 1.30), whereas no increased risk of mortality was observed in patients with 
mild psoriasis (HR 1.00, 95%CI 0.97, 1.02). Similar results were obtained when patients 
with psoriatic arthritis were excluded and results were robust to several sensitivity analyses. 
The increased risk of mortality in severe psoriasis may translate to a significant number 
of years of life lost given that patients with psoriasis have the disease for decades. The 
median age at death of female and male patients with severe psoriasis was 5.87 and 2.81 
years younger (P<0.001) respectively than patients without psoriasis who died. Future 
studies are necessary to determine which factors account for this increased risk of mortality. 
 
162 [Oral 034]
The Effect of PageRank Adjustment on Dermatology Journal Impact Factor
RP Dellavalle1, LM Schilling2, MA Rodriguez3, H Van de Sompel3, J Bollen3 1Denver 
VA Medical Center, Denver, USA 2U. Colorado Health Sciences Center, Aurora, USA 
3Los Alamos National Laboratory, Los Alamos, USA
Journal impact factor (IF) is increasingly used in performance measures for authors, 
editors, funding agencies, and academic departments. IF is the most common 
measure of dermatology journal status and is based on crude citation counts that 
do not account for the quality of the journals from which the citations originate. 
Dermatology journal impact factors from 2003 were adjusted by the same technology 
that improved Internet search engines with the advent of Google - a PageRank 
algorithm that gave greater weight to citations originating from more frequently 
cited journals. PageRank adjustment elevated the rankings of the journals Contact 
Dermatitis and Burns most (22nd to 7th and 21st to 10th respectively) and lowered 
the ranking of Journal of Cutaneous Medicine and Surgery most (19th to 27th). 
While the top ranking of the JID remained unchanged, the JAAD moved ahead of 
Archives of Dermatology (from third to second) with PageRank adjustment. Adjusting 
for citation origin changes dermatology journal IF rankings and may provide a 
more refined measure of journal status for publication performance evaluation. 
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Cumulative incidence of skin cancer in Simultaneous Pancreas Kidney transplant 
recipients and the role of immunosuppressive therapy
HC Wisgerhof, PJM Van der Boog, HJW De Fijter, R Willemze, JN Bouwes Bavinck 
Leiden University Medical Center, Leiden, Netherlands
Organ-transplant recipients have an increased risk of skin cancer. We substantiated this 
risk in Simultaneous Pancreas Kidney (SPK) transplant recipients and investigated the role 
of the immunosuppressive regimen on the skin cancer risk. All 208 patients who had 
received a SPK transplant between March 1986 and January 2006 at our University Medical 
Center were included and analyzed in a retrospective follow-up study. Dose and type of 
the immunosuppressive therapy, rejection and induction treatments were documented. 
Student’s T-test, chi-square test, Cox regression and Kaplan Meier survival analyses were 
performed for statistical analyses. During a mean follow-up period of 6.5 years (range 
0.1-20 years), 120 squamous-cell carcinomas (SCC) and basal-cell carcinomas (BCC) 
developed in 24 out of 208 patients. The risk to develop any skin cancer increased from 
20% after 10 years to almost 60% after 20 years. Immunosuppressive regimens consisted 
of prednisone (P), azathioprine (Aza) and Cyclosporine (CsA) between 1986 and 1995 and 
P, mycofenolatemofetil (MMF) and CsA between 1995 and 2001. Recipients who were 
transplanted between 1996 and 2001 had developed statistically significant more BCCs 
within 4 to 9 years after transplantation then recipients who were transplanted between 
1986 and 1995, suggesting that a regimen with MMF in stead of Aza is associated with 
an increased risk of BCC. We did not observe such a trend for developing SCCs. ATG as 
rejection or induction treatment was not associated with an increased risk of skin cancer. 
This study showed an increased incidence of skin cancer in SPK transplant recipients. 
Immunosuppressive therapy is an important risk factor for developing skin cancer and, 
considering the development of BCCs, type of immunosuppression was modulating this risk. 
 
164 [Oral 040]
Critical review of generic and dermatology specific health related quality of life 
instruments
T Nijsten, H Both, JJ Busschbach, ML Essink-Bot Erasmus University Medical Center, 
Rotterdam, Netherlands
The measurement of health related quality of life (HRQOL) is increasingly important 
in patients with skin diseases. Despite the availability of a variety of instruments 
and new psychometric techniques, there is no consensus about which HRQOL 
instruments are preferred in dermatology. The objective of this review is to review 
a selection of generic (health profiles and preference based measurements) and 
dermatology specific HRQOL instruments (SF-36, 12, and-6D, NHP, SIP, WHOQOL-
100 and-BREF, EQ-5D, DLQI, Skindex-29, -16 and-17, DQLS and DSQL). Criteria 
that are evaluated include conceptual and measurement model, reliability, validity, 
responsiveness, item functioning, meaning of scores, administrative burden, 
respondent burden, alternative forms and cultural and language adaptations 
(adapted from existing guidelines). Each criteria was graded simply from A (excellent 
track record), C (substantial inadequacy or not reported) and B somewhere in 
between based on consensus of three HRQOL experts. Although the selection 
of the appropriate instrument is a trade-off and psychometric methodology 
evolves, the SF-36, EQ-5D and Skindex-29 are the instruments of choice, for 
now. Promising new instruments are the SF-6D, WHOQOL and the Skindex-17. 
 
165 [Oral 041]
The association between skin prick tests for house dust mite and atopic dermatitis 
differs between boys and girls in Ghana
JN Bouwes Bavinck1, AA Hogewoning2, S Lavrijsen1, M Yazdanbakhsh1, Y Aryetey3, 
I Akosua Larbi3, AS Amoah3, D Boakye3 1Leiden University Medical Center, Leiden, 
Netherlands 2University of Ghana Medical School, Accra, Ghana 3Noguchi Memorial 
Inst for Med Research, Legon, Ghana
A case-control study in Accra consisted of 52 children with atopic dermatitis (AD) 
and 99 controls. Skin prick tests (SPT) for house dust mite (HDM) and cockroach 
(CO) and allergen-specific IgE tests (IgE) were performed. SPT for HDM and HDM 
IgE were positive in 27.0% and 35.3% of the boys and 10.5% and 20.4% of the 
girls. SPT for CO (15.8%) and CO IgE (32.4%) did not differ between boys and girls. 
Among boys a positive SPT for HDM was associated with AD [odds ratio 3.0 (0.94; 
9.3)]; among girls there was no association [0.65 (0.12;3.5)]. A positive HDM IgE was 
associated with AD in both boys [3.9 (1.1;13.3)] and to a lower degree in girls [1.9 
(0.50;7.4)]. CO IgE was associated with AD in boys [3.7 (1.1;12.9)] and girls [4.4 
(1.3;14.8)], but SPT for CO was not associated. Sleeping on a mattress was dependent 
on age and sex. Boys (72.3%) were more often sleeping on a mattress then girls 
(57.4%). Boys who were sleeping on a mattress more often had a positive SPT for 
HDM [8.8 (1.0;73.5)] and a positive HDM IgE [2.4 (0.61;9.4)] and also more often 
AD [2.4 (0.68;8.3)] compared to boys who were not sleeping on a mattress. However, 
among boys a positive CO IgE was also associated with sleeping on a mattress 
[5.6 (1.1;29.6)] and among girls, the above associations were not found. Genetic, 
environmental or behavior differences could explain the different associations 
between a positive SPT for HDM and AD among boys and girls. It is tempting to 
speculate that sleeping on a mattress leads to higher exposure to HDM with a higher 
percentage of positive SPT for HDM and more often AD, but the similar association 
with CO and the absent association among girls, are not in favor of this hypothesis. 
166 [Oral 042]
The Prevalence of Papulopustular Rosacea and Relationship to Cutaneous 
Photodamage
M McAleer1, P Fitzpatrick2, FC Powell1 1Mater Misericordiae University Hospital, 
Dublin, Ireland 2University College Dublin, Dublin, Ireland
The true prevalence of rosacea is unclear with results from 0.09% - 10% reported. The range 
in reported prevalence rates could be explained by the imprecise definitions of rosacea used 
in these studies. The role of ultraviolet exposure in the pathogenesis of this disease has been 
disputed. Our aim was to determine the prevalence of papulopustular rosacea and to investigate 
the relationship between rosacea and skin type, UV exposure, and cutaneous photodamage. 
A two phase, prospective epidemiological study investigating 2 sub populations: 500 indoor 
workers (predicted low UV exposure) and 500 island dwellers (predicted high UV exposure). 
Sample size was determined to allow sensitivity of 0.5, power 80%, estimated prevalence 1 
-3%. During a face to face consultation, variables were recorded including age, sex, occupation, 
skin type, hair and eye colour, recreational UV exposure and history of rosacea. The facial skin 
was examined for rosacea, photodamage and cutaneous malignancy. The diagnosis of rosacea 
was determined using the National Rosacea Society Expert Committee’s standard classification. 
Phase 1(n=500) is completed. 17% male, 83% female, mean age 36 years, 94% indoor workers, 
40% spent >10hrs/week outdoors. 80% skin type I or II. Photodamage scores peaked at 2&3, 
and scores >6 in 3%. Prevalence of papulopustular rosacea was 2.6%. Phase II is ongoing. To 
date, we have examined 311 subjects. 43% male, 57% female, mean age 44yrs, 47% outdoor 
workers, 80% spent >10hrs/ week outdoors. 83% were skin type I or II. Photodamage scores 
peaked at 4&5, 40% having scores >6. Prevalence of papulopustular rosacea was 2.9%. In 
both sub-populations, there was no association between papulopustular rosacea and UV 
exposure, cutaneous photodamage, actinic keratoses or cutaneous malignancy. The prevalence 
of papulopustular rosacea is 2.7%. There was no association between papulopustular rosacea 
and UV exposure, cutaneous photodamage, actinic keratoses or cutaneous malignancy.
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Recruitment strategies for a hand dermatitis prevention programme in the food 
industry
A Bauer1, R Ladermann2, M Kaatz2, M Stadeler3, P Elsner2 1University Hospital Carl 
Gustav Carus, Dresden, Germany 2University Hospital FSU Jena, Jena, Germany 
3Research Centre for Applied System Safet, Erfurt, Germany
Employees in the food industry are at risk of developing occupational hand dermatitis. 
Besides other strategies, an interdisciplinary ‘skin disease prevention programme 
in the baking, hotel and catering industries’ with proven efficacy, was established. 
However, only 30% of the eligible employees suffering from occupational hand 
dermatitis took part in the programme. The aim of this study was to increase the 
participation rate in the skin disease prevention programme from 30% up to 50%. 
92 baker and catering trade employees from Saxony and Thuringia (mean age 28; 
age-range 16-61 years) suffering from occupational hand dermatitis were included 
in a prospective controlled intervention study. The employees were invited to join 
the skin disease prevention programme using a standard invitation letter (n=40) or 
a newly developed personalized and targeted invitation letter (n=52), which was 
based on major principles of communication and models of behaviour change. 
The commitment of the employees to join the skin disease prevention programme 
increased significantly from 30% to 54% (p<0.022), by using the new personalized 
and targeted invitation letter. The new strategy to recruit employees for the skin 
disease prevention programme was successful in increasing the participation rate. 
However, we still could not reach 46% of the eligible employees. There is a need 
for further studies to identify possible barriers, which might negatively influence the 
decision making process. 
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Evidence based approach in Dermatologic treatment: A guide to apply the best 
evidence to the specific patient
A Sadighha Ilam University of Medical Science, Ilam, Iran
Unfortunately, evidence based approach in the treatment of dermatologic disease is 
summarized to systematic review and meta-analysis and is widely concealed in many 
articles; although use of evidence for practice in daily management and making 
clinical decision analysis based on specific patients characters is not concealed 
anywhere, evidence based dermatology textbooks also made merely systematic 
review and grading of the evidence. We intended to design and solve example 
problemes in dermatologic treatments with an evidence based approach and to 
define various ways to aquqire maximum objectivity in clinical decisions. We used 
basic concepts such as NNT,NNH,ARR, RRR and Ft(decimal fraction) in the example 
problems design. Cost-benefit evaluation was made with use of Ft coefficient.primary 
data is extracted of available mata-analysis in the journals with impact factor ≥1.5.Ft 
coefficient was used as a tool for made variables comparable.QOL was quantified 
with use of scaling questionary and calculated in cost benefit with proper Ft. Absolute 
attention to NNT is not useful in patient management and leads to bias in decision 
and configure cost- benefit evaluations.Ft evaluation for any patients’ features and 
characters included skin type, disease severity and economic status could able to 
prevent any bias in clinician decision. Our findings revealed that basic concepts 
adjustment with use of a few Ft ,improve the decision quality similar to multi-logistic 
regression in definitive statistic. Also our results showed that QOL needs to a separate 
Ft and attention to this Ft is necessary in clinical decision analysis. We concluded that 
contrary to current practice among clinicians, an evidence based approach with use 
of all the individual features including clinical and social characters could improve 
the clinical decision quality in the daily practice. We would like to introduce Ft as 
Gold-Connection between clinicians’ experience and evidence based knowledge. 
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Epidemiological study of atopic dermatitis in the 1st and the 4th grade students of 
Nagasaki University from 1995 to 2006
M Takenaka, S Sato Nagasaki University Hospital, Nagasaki, Japan
We have carried out the epidemiological survey on atopic dermatitis (AD) in the 1st 
and the 4th students of Nagasaki University every year in April from 1995 to 2006.
The number of the 1st grade students was 18,784 (male: 12,353, female: 8,151) 
and that of the 4th grade was 10,718 (male: 6,289, female: 4,429). Fluctuation 
in morbidity of 1st grade was from 4.9% (minimum) to 7.3% (maximum) with an 
average rate of 6.5%. The AD morbidity was significantly higher in female students ( 
%) than in male students ( %). The average AD morbidity of the 4th grade was 6.1% 
(male: 5.6%, female: 6.9%); however, there was no difference between 1st grade and 
4th grade. The average severity score of the 1st grade was higher than that of the 4th 
grade. As for the exacerbation factors in the 1st grade, house dust and mite (>50% 
of patients) were identified as the worst factor in 1995, which decreased to 32% in 
2006. By contrast, the frequency of sweating (52.5%), dryness (50.8%), and emotion 
stress (26.3%) are increasing recently. The frequency of emotional stress as the worst 
factor was higher in the 4th grade than in the 1st grade. Among the students who were 
recognized as AD at the 1st grade, 10.1% was exacerbated, 23.3% was stationary, 
37.9% was improved, and the symptom disappeared at 28.7% for 3 years in Nagasaki 
University. Although 21.7% of students who exhibited the symptom at 4th grade were 
not recognized as AD in the 1st grade, their diseases were not so severe. In addition, 
the results of treatment history, medical history, family history, and blood examination 
were also investigated. 
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Effects of Biologic Therapies on the Severity of Skin Symptoms and Quality of Life in 
Patients with Plaque-type Psoriasis: A Meta-Analysis
K Reich1, R Sinclair2, G Roberts3, CEM Griffiths4, M Tabberer3, JN Barker5 
1Dermatologikum Hamburg, Germany 2University of Melbourne, Australia 3Oxford 
Outcomes Ltd, UK 4 University of Manchester, UK 5St Johns Inst of Dermatology, UK
The efficacy of biologic treatments is well established in the treatment of moderate-to-severe plaque 
psoriasis. The purpose of this research was to compare PASI-75 response rates from randomized 
controlled trials (RCTs) and review quality of life data for biologic therapies. A literature search was 
conducted to identify RCTs evaluating labeled doses for alefacept, efalizumab, etanercept and 
infliximab in psoriasis patients. A Mantel-Haenszel fixed-effects model was used to calculate relative 
risk (RR) with 95% confidence intervals for patients achieving PASI-75 responses after induction 
therapy (10 to 12 weeks of therapy) with a biologic versus placebo. Due to data limitations, quality 
of life (QOL), as measured by the disease-specific Dermatology Life Quality Index and generic 
Short Form 36, could not be assessed through statistical modeling. However, published data from 
RCTs were reviewed to assess the impact of treatment on QOL. Patients treated with infliximab 
5mg/kg were most likely to achieve PASI-75 vs. placebo (RR=25.48; CI=14.04-46.23); followed 
by etanercept 50 mg twice weekly (RR=11.92; CI=8.17-17.39); etanercept 25 mg twice weekly 
(RR=10.68; 6.15-18.57); efalizumab 1-2 mg/kg per week (RR=7.47; CI=5.20-10.73); and alefacept 
(RR=3.37; CI=2.18-5.23). Relative risks of achieving PASI 50 and 90 were also higher for infliximab; 
results for all PASI scores were confirmed with a random-effects model. Improvement in PASI-75 was 
consistent with better quality of life. A literature synthesis revealed that significantly higher numbers 
of patients on treatment with biologics achieved a clinically meaningful decrease in DLQI vs. 
placebo-treated patients. Additionally, 47% of the patients treated with infliximab achieved a DLQI 
of 0 at week 10 vs. 28% of the patients treated with etanercept 50mg BIW at week 12. This analysis 
suggests that treatment with infliximab in the first 10/12 weeks is more effective than other biologics 
for chronic plaque psoriasis and leads to improvement’s in the patient’s quality of life. 
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Age, Gender, Disease Duration or Self-assessed Disease Severity: Which is the Best 
Predictor of Dermatological Patients’ Quality of Life?
MKA Basra, AY Finlay Cardiff University School of Medicine, Cardiff, UK
Examine the contribution of age, gender, disease duration and self-assessed disease 
severity to the patients’ quality of life and determine which one of these variables is 
best at predicting the QoL of patients. Patients attending the dermatology out-patients 
clinic of a secondary referral centre were asked to complete the Dermatology Life 
Quality Index (DLQI) and to answer a global question regarding the self-assessment of 
the severity of their skin disease on a 0-10 visual analogue scale. A stepwise multiple 
regression analysis was carried out to examine the strength of relationship between 
different variables and patient’s QoL and determine the best predictor of QoL among 
these. Patient’s age, gender, disease duration and self-assessed disease severity were 
used as the independent variables while the DLQI score was used as the dependent 
variable. A total of 111 patients (M=48, F=63), suffering from different skin conditions 
(n=42, mean disease duration=8.7 years), participated in the study. The mean DLQI 
score was 8.2 (SD=7.2); the mean self-assessed disease severity score was 5.3 
(SD=2.8). There was no significant difference between male and female patients in 
terms of age (p=0.26), disease duration (p=0.88), self-assessed disease severity scores 
(p=0.14) and the DLQI scores (p=0.83). The results of stepwise regression analysis 
showed that only the variable self-assessed disease severity score entered into the 
regression equation while patient’s age, gender and duration of skin disease failed to 
meet the entry criteria to be entered into the equation shown by their non-significant 
t-values (p=0.46-0.55). Patients’ self-assessed disease severity (regression coefficient 
β = 0.622) explained 38% of the total variance (Adjusted R Square= 0.381) and 
emerged as the only significant predictor of their DLQI scores, F (1,109) = 68.641, 
p<0.0001.The self-rated severity of skin disease is a significant predictor of patients’ 
QoL while age, gender and duration of the skin disease have no contribution.
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Distribution of Congenital Melanocytic Nevi in a Survey of 3,406 Italian 
Schoolchildren
S Gallus, L Naldi Centro Studi GISED, Bergamo, Italy
Scant information is available on the prevalence of congenital melanocytic nevi 
(CMN). We considered the issue using data from a survey conducted in 13 Italian 
areas on 3,406 schoolchildren (1,746 boys and 1,660 girls) aged 13-14 years. Children 
were examined by dermatologists who assessed pigmentary traits and made a count 
of small (6-15 mm in diameter) and medium/large (≥15 mm) CMN on 19 anatomical 
areas. Overall, 592 children (17.4%) had at least one CMN (443 children (13.0%) had 
one, 104 (3.1%) two, 24 (0.7%) three, and 21 (0.6%) four to nine CMN). Prevalence 
of small CMN was 16.1%, and that of medium/large CMN was 1.8%, in the absence 
of differences between sexes. Overall, 2.8% had small and 0.1% had medium/large 
CMN on the head and neck. Corresponding percentages for upper limbs were 2.2% 
and 0.4%, for lower limbs 4.2% and 0.6%, for anterior trunk 4.8% and 0.4%, and 
for posterior trunk were 5.1% and 0.6%, respectively. CMN were more frequent in 
children with higher number of common melanocytic nevi (multivariate odds ratios, 
OR=6.5 for the highest vs the lowest quartile), consistent in small (OR=6.6) and 
medium/large CMN (OR=5.7). Family history of malignant melanoma (OR=1.5) was 
directly associated to total number of CMN. Conversely, CMN did not appear to be 
related to pigmentary traits, anthropometric characteristics, diet, freckles, sunburns, 
sunscreen use, and history of selected diseases. This is one of the first studies providing 
data on small CMN, and adds further relevant information on the prevalence 
and the anatomic distribution of CMN, and their relationship with other factors. 
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Assessment of health utilities of standardized scenarios of controlled and 
uncontrolled psoriasis and atopic eczema
J Schmitt1, M Klon1, KD Frick2, M Meurer1 1Medical Faculty, TU Dresden, Dresden, 
Germany 2Johns Hopkins School of Public Health, Baltimore, USA
The introduction of topical calcineurin inhibitors for atopic eczema and of biologic treatments 
for psoriasis have raised questions concerning the efficiency of these new treatment options. 
Conclusions drawn from cost-utility analyses depend on the health utilities placed on the health 
states of interest. Concerns have been raised concerning the validity and generalizability of the health 
utilities previously applied in economic evaluations of interventions for atopic eczema and psoriasis. 
We assessed preference-based health utilities of standardized scenarios of controlled (low intensity of 
symptoms, objectively mild lesions, quality of life impact mild to moderate, intermittent course) and 
uncontrolled (high intensity of symptoms, objectively severe lesions, significant quality of life impact, 
chronic course without remissions) atopic dermatitis and psoriasis vulgaris. Between February and 
September 2006 we performed a single-centre study based at the Dept of Dermatology, Medical 
Faculty Dresden, Germany. The study population included a random sample from the general 
population (n=139), and consecutive patients with atopic eczema (n=58) and with psoriasis (n=62). 
Standardized interactive computer-assisted interviews were conducted to assess preference-based 
health utilities by means of the time tradeoff method. Information on the health states included a 
characteristic clinical picture and a short text explaining etiology, signs, symptoms, and quality of 
life impact. The mean (95%-CI) health utility for controlled and uncontrolled atopic eczema were 
0.90 (95%-CI 0.88-.93) and 0.63 (95%-CI 0.59-0.67), respectively. For psoriasis the corresponding 
health utilities were 0.87 (95%-CI 0.84-0.90) and 0.57 (95%-CI 0.53-0.61). Health utilities were 
independent of age, gender, socio-economic position and participant status (healthy participant 
vs. patient). Thus, the assessed health utilities appear to be robust and generalizable. Our findings 
will facilitate that appropriate cost-utility analyses of interventions to control atopic eczema and/or 
psoriasis vulgaris can be performed in the future. 
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Evidence for elevated stress and anxiety in stable vitiligo
C Krüger1, JW Smythe1, A Panske2, KU Schallreuter1 1University of Bradford, Bradford, 
UK 2Institute for Pigmentary Disorders, Greifswald, Germany
Vitiligo is an acquired depigmentation disorder affecting 0.5-1% of the world 
population. The aim of this study was to assess the levels of social avoidance and 
anxiety of affected individuals during a 21 day stay at the Dead Sea in Jordan in May 
and June 2006 using the Marburg Skin Questionnaire. In order to further validate 
the results, we evaluated the influence of stress on the patient’s daily life during 
this period analysing cortisol levels in saliva. The study included 26 patients with 
vitiligo (female n=19, male n=7, mean age 43.2 years, range 20-65 years) with skin 
phototypes II-V (Fitzpatrick classification). The results showed that values of social 
anxiety and avoidance were significantly increased in patients with stable vitiligo 
compared to active disease. Moreover, these findings correlate with increased levels 
of stress as shown by elevated cortisol levels in the pm phase of the circadian rhythm.
In summary, to the best of our knowledge our data show for the first time that patients 
with stable vitiligo show increased anxiety levels and suffer under significant stress 
as confirmed by the saliva cortisol analysis. These data also validate that stress plays 
a major role in stable vitiligo, implying that this patient group warrants more clinical 
and psychological attention. 
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Pruritus in patients with chronic plaque psoriasis: A questionnaire-based study
B Amatya1, G Wennersten2, K Nordlind1 1Karolinska University Hospital, Stockholm, 
Sweden 2Utsikten Medical Center, Stockholm, Sweden
Pruritus in psoriasis vulgaris has not been regarded as a major symptom. The aim 
of this study was to investigate the pattern of pruritus in chronic plaque psoriasis. 
A comprehensive questionnaire, a modification of the McGill pain questionnaire, 
which relates to various clinical characteristics of pruritus, was sent out to 109 
patients with a diagnosis of chronic plaque psoriasis, who attended our outpatient 
departments during the period of January 2006 to January 2007. Pruritus was reported 
in 80% of the patients, with an intensity of 5.2±2.6 (±SD) using a visual analogue 
scale (0-10). The frequency and intensity of pruritus were higher in women (OR=3.8, 
95% CI 2-15, P<0.05) compared to males. Lower leg ((56%) and scalp (47%) were 
reported to be the most commonly affected sites. The most common descriptions 
given by the patients for pruritus were stinging, tickling, and crawling sensations. 
Major aggravating factors for pruritus were stress and dryness of skin. Some foods 
like nuts, milk, and sweet products aggravated pruritus, in a less number of patients. 
Forty-eight percent of patients reported that bathing in sea water, and 33 % reported 
that a cold bath relieved pruritus. In summer pruritus was better (68%), but worsened 
(63%) in winter. The most commonly preferred antipruritic treatments were topical 
steroids (44%), followed by topical vitamin D (26%), emollients (20%), PUVA (17%), 
and antihistamines (2%). Five patients were on immunomodulatory therapies with 
methotrexate, retinoids or biological therapies, but none of these medications could 
relieve pruritus. Mood (60%), concentration (47%), and sleep (35%) were negatively 
affected by pruritus. Pruritus is a common symptom in patients with chronic plaque 
psoriasis, with complex mechanisms and with so far no optimal treatment.
 
176
Do tagging SNPs evidence the strong association between two functional DNA 
variants in the Filaggrin gene and atopic dermatitis?
E Rodríguez1, H Baurecht1, N Novak2, N Klopp3, T Illig3, S Weidinger1 1TU, Munich, 
Germany 2University of Bonn, Germany 3GSF-Forschungszentrum, Neuherberg, 
Germany
Two filaggrin null mutations with rather low allele frequencies (R501X and 2282del4) 
have been shown to exert substantial susceptibility to atopic eczema (AE) in European 
populations. A common approach to facilitate genetic association studies is to select a 
reduced set of ‘tag’SNPs that retains maximum genetic information within the region 
of interest. Tagging SNPs are a good approach in the common disease - common 
variant hypothesis. We wanted to evaluate the performance of FLG tagging SNPs for 
the detection of associations between FLG and AE. In addition to R501X and 2282del4 
five SNPs selected from the HapMap online database (http://www.hapmap.org) using 
default parameters to tag all SNPs with a minor allele frequency of ≥0,05 and an r2 
value of >0,8 (haploview 3.3) were genotyped in 476 parents-affected offspring trios. 
Association with AE was evaluated using the programmes R 2.4.1 and haploview 
3.3 (TDT), which were also used to calculate pairwise LD for SNP pairs. In contrast 
to R501X and 2282del4, the five selected tagging SNPs showed no association with 
AE in our cohort. Tag SNPs retrieved from HapMap do not serve as surrogates for the 
two FLG null mutations R501X and 2282del4 associated with AE. This observation 
demonstrates that exhaustive tagging may fail for several disease susceptibility genes 
and emphasizes the importance of analysing relatively rare functional DNA variants. 
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Immunomodulators for seborrheic dermatitis: A systematic review of randomized 
controlled trials
F Gorouhi, M Mohammadipour, L Sayyah, AF Firooz, A Khatami, H Salmasian Tehran 
University of Medical Sciences, Tehran, Iran
Seborrheic dermatitis is a chronic, relapsing inflammatory disease that presents with 
erythema, scaling and pruritis primarily on the face, scalp and chest. It affects about 
3% to 5% of general population. There is no complete and permanent cure for this 
disease. The purpose of this study was to systematically search the literature to find the 
best evidence about the efficacy and safety of immunomodulators in the treatment of 
seborrheic dermatitis. We searched Medline, Embase and Cochrane CENTRAL up to 
the end of 2006, to find relevant randomized controlled trials. Strategies of search to 
locate trials of seborrheic dermatitis and immunomodulators were: ‘((seborrh* AND 
(dermat* OR eczema)) OR dandruff OR pityriasis capitis OR steatoid pityriasis OR 
pityriasis simplex OR cradle cap)’and ‘(pimecrolimus OR tacrolimus OR sirolimus 
OR FK-506 OR ASM 981 OR protopic OR elidel OR immunomodulator)’respectively. 
Adverse events were searched with a separate strategy to find all possible unwanted 
side effects even in non-randomized studies. After comprehensive search, we found 
nine potentially relevant articles to be considered. Out of them, three randomized 
controlled trials were entered the study. All of them were assessed pimecrolimus in 
comparison with placebo (one trial) and active routine controls (two trials). Surprisingly, 
there was not any trial on tacrolimus cream. Meta analysis could not be performed due 
to clinical heterogeneity of included studies. Pimecrolimus is an effective alternative 
for corticosteroids with acceptable and transient side effects. Larger sample sizes 
for such trials are highly recommended to provide conclusive results. Randomized 
controlled trials on tacrolimus, sirolimus and other similar immunomodulators are 
essential to calculate their exact effect sizes and considering their cost in this context. 
 
178 [Oral 018]
Mechanisms of cell migration induced by laminin 5 alpha3 LG4 domain-derived 
peptide and its application to wound repair
A Utani1, E Araki1, Y Momota2, T Togo1, M Nomizu3, Y Miyachi1 1Kyoto University 
School of Medicine, Kyoto, Japan 2Dept of Veterinary Internal Medicine, Morioka, 
Iwate, Japan 3Tokyo University, Tokyo, Japan
Laminin-5 is an extracellular matrix glycoprotein specific to the basement membrane. 
Keratinocyte (KC) migration over the wound is known to depend on newly synthesized and 
deposited Laminin-5, suggesting that it is one of the key molecules in the wound repair 
process. We previously found the synthetic peptide A3G756 (KNSFMALYLSKGRLVFALG), 
containing syndecan (Sdc)-binding sequence within the laminin-5 alpha3 chain LG4 module, 
stimulated KC migration in vitro. In the present study, we demonstrated that A3G756-
induced KC migration was dependent on p38MAPK using its specific chemical inhibitor 
SB203580. When Sdc4-overexpressing HaCaT cells were incubated with A3G756, surface 
Sdc4 translocated to microvilli-like protrusion. These protrusion formations were abolished 
by addition of SB203580, suggesting the induction of morphological changes may be linked 
to the KC migration-inducing activity of the laminin-5-derived synthetic peptide.A3G756-
induced KC migration in vitro was also dependent on integrin apha5/beta1, which was 
revealed by addition of neutralizing antibodies. Pulse-chase study showed that internalization 
of Sdc-4 as well as activated form of integrin beta1 was impaired in the presence of A3G756. 
These results suggest that retardation of cell surface Sdc4 and integrin beta1 internalization 
may result in enhanced cell migration. For in vivo study, we topically applied A3G756 to 
cutaneous wound made on rabbits and mice. Application of A3G756 significantly accelerated 
reepithelialization. This A3G756-induced wound healing effect was blocked by SB203580, in 
accordance with the in vitro result. A3G756 peptide was shown to accelerate wound closure 
in vivo, and is likely a potential therapeutic reagent for chronic cutaneous ulcer. 
 
179 [Oral 045]
The EBS K14 R125P mutation induces the down-regulation of intercellular adhesion 
components
M Liovic1, M D’Alessandro1, M Tomic-Canic2, V Bolshakov3, EB Lane4 1University of 
Dundee, UK 2Weill Cornell Medical College, New York, USA 3University of Reading 
Biocentre, Reading, UK 4Institute of Medical Biology, Proteos, Singapore
To study the function of keratin intermediate filaments and their role in epithelial fragility 
development we used epidermolysis bullosa simplex (EBS) patient-derived cell lines. Two 
K14 mutant cell lines, representative of the severe EBS (K14 R125P) and mild EBS (K14 
V270M) skin fragility phenotypes were analysed using microarray technology, and compared 
to the gene expression profile of a control cell line derived from a healthy individual. Sets 
of isogenic cell lines expressing identical K14 gene mutations were also engineered, to 
exclude differences in gene expression arising from different genetic backgrounds. We 
found that in the K14 mutants a variety of cytoskeletal proteins were differentially expressed 
(up or down-regulated) in comparison to the control cells, regardless of the phenotype 
severity. However, about 20 different genes encoding for intercellular adhesion components 
were specifically found down-regulated in the severe K14 mutants (cells expressing the 
K14 R125P mutation), below the -2-fold ratio and with a p-value less than 0.05. The 
microarray data was confirmed both on mRNA level by real-time PCR and on protein level 
by western blotting. On the other hand, these genes were not significantly differentially 
expressed in the mild K14 mutants (cells expressing K14 V270M mutation). Our data 
suggests that the differences in phenotype severity between the mild and the severe K14 
mutant may be consequence of two components: (1) Fragility caused by the structural and 
functional abnormalities of the keratin intermediate filament network due to the type of 
K14 mutation in question, and (2) Fragility induced only in the severe mutant and due to 
the generated interference with the stoichiometry of cell adhesion complex constituents. 
 
180 [Oral 046]
The association of plectin (PL) with various intermediate filament (IF) proteins is 
regulated by phosphorylation of a serine residue in its COOH-terminal extremity
L Fontao, L Borradori, Y Schneider, F Jaunin Univ Hospital of Geneva, Switzerland
Plectin is a ubiquitous cytolinker protein of the plakin family playing a key role in 
cytoskeleton organization and dynamics. Inherited defects of PL underly potential 
devastating diseases, such as epidermolysis bullosa (EB) with pyloric atresia or 
muscular dystrophy (MD). Mechanisms regulating the association of PL with IF 
proteins have been poorly investigated. We have here assessed the ability of the COOH 
extremity of PL to associate with various types of IF proteins as well as the impact of 
its phosphorylation on IF binding. Our results show that: 1. the COOH extremity of 
PL is an in vitro substrate for PKC and PKA; 2. a distinct serine residue in the COOH 
extremity is phosphorylated in vitro as confirmed by mass spectroscopy analysis; 3. 
the same serine is also phosphorylated in vivo in transfected cells; 4. substitution 
of the phosphorylatable serine by a glycine increases the colocalization potential 
of PL with various IF networks in transfection studies. Finally, 5. this specific serine 
regulates the association of PL with various IF proteins, such as keratins K5/K14, K8/
K18, vimentin, GFAP, peripherin and neurofilaments in yeast two/three-hybrid assays. 
Noteworthy, inherited PL mutations leading to a disruption of this phosphorylatable 
region have been described in EB-MD patients. Taken together, these results indicate 
that phosphorylation of a distinct serine residue within the PL COOH extremity is 
crucial for its interaction with various IF proteins and thereby represents a mean by 
which the linkage of IF via PL to plasma membrane sites is dynamically regulated. 
These findings provide new insights into mechanisms regulating PL-IF association. 
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The neonatal Fc receptor promotes tissue injury in experimental epidermolysis 
bullosa acquisita
A Sesarman, AG Sitaru, F Olaru, D Zillikens, C Sitaru University of Lübeck, Germany
Epidermolysis bullosa aquisita (EBA) is an autoimmune blistering disease caused by 
autoantibodies against type VII collagen. Passive transfer of autoantibodies to type VII 
collagen, or immunization with autologous type VII collagen induces EBA in mice. 
The neonatal Fc receptor (FcRn) regulates IgG homeostasis by controlling serum levels 
of antibodies. Modulation of serum IgG levels, by FcRn inhibition, represents a novel 
treatment approach of antibody- mediated autoimmune diseases such as EBA. In this 
study, we investigated the role of FcRn for the maintenance of levels of antibodies 
against type VII collagen and blistering in EBA. For this purpose, rabbit IgG against 
murine type VII collagen were passively transferred in FcRn deficient (n=8) and wild 
type (n-8) mice. Levels of serum IgG against type VII collagen, as measured by ELISA, 
were significantly lower in mutant compared with wild-type mice. Analysis of serum 
levels of specific autoantibodies induced in FcRn deficient and wild type mice (n=10/
group) by immunization with type VII collagen confirmed the results of the passive 
transfer experiment. Thus, FcRn deficient mice showed lower serum levels of IgG 
against type VII collagen compared with wild type animals. Importantly, the extent 
of blistering disease after injection of IgG against type VII collagen was significantly 
reduced in FcRn deficient mice compared to wild type controls. Mutant and wild type 
mice receiving normal rabbit IgG (n=2 per group) did not develop skin lesions. Our 
data demonstrate that FcRn maintains levels of pathogenic autoantibodies against 
type VII collagen and thereby promotes tissue injury in experimental EBA. Therefore, 
modulation of FcRn function using inhibitors may reduce pathogenic IgG levels 
in vivo, offering therapeutic benefit in patients with antibody-mediated diseases. 
 
182 [Oral 048]
Role of ADAM-9 disintegrin-cysteine rich domains for keratinocyte migration
P Zigrino1, J Steiger1, JW Fox2, A Schild1, R Nischt1, C Mauch1 1University of Cologne, 
Cologne, Germany 2University of Virginia, Charlottesville, USA
ADAM-9 belongs to a family of transmembrane disintegrin-containing metallo-proteinases 
(ADAMs) involved in protein ectodomain shedding, cell-cell and cell-matrix interactions. 
Although the functions of many ADAM family members are known the specific biological 
function of ADAM-9 is still unclear. The aim of this study was to analyse the expression 
of ADAM-9 in skin and to assess the putative role of this proteolytic/adhesive protein in 
skin physiology. In normal healthy skin, ADAM-9 mRNA and protein expression has been 
detected in both, the dermal and epidermal compartments and in vitro in keratinocytes 
and fibroblasts. Here we report that ADAM-9 functions as a cell adhesion molecule via 
its disintegrin-cysteine domain. Using solid phase binding assays and antibody inhibition 
experiments, we demonstrated that the recombinant disintegrin-cysteine rich domain 
of ADAM-9 binds to the integrin subunit b1 on the surface of HaCaT cells and primary 
keratinocytes in a specific manner. In addition, ADAM-9 and b1 integrin directly interact as 
indicated by co-immunoprecipitation. Engagement of integrin receptors by the disintegrin-
cysteine rich domain resulted in ERK phosphorylation and lead to an increase in MMP-9 
synthesis. A similar increase in MMP-9 secretion was observed by ADAM-9 overexpression. 
Treatment with the ERK inhibitor PD98059 inhibited MMP-9 induction. Furthermore, the 
presence of the soluble disintegrin-cysteine domain did not interfere with cell migration 
on different substrates. However, keratinocytes adhering to the immobilized disintegrin-
cysteine domain showed increased motility, which was partially due to the induction of 
MMP-9 secretion. In summary our results indicate that the ADAM-9 disintegrin-cysteine rich 
domain may play a role in regulating the motility of cells by interaction with b1 integrins by 
modulating MMP synthesis.
 
183 [Oral 049]
Fibronectin regulates the assembly of Latent TGF-beta Binding Protein 4, LTBP-4 
into the extracellular matrix
A Kantola, J Keski-Oja, K Koli University of Helsinki, Helsinki, Finland
Extracellular matrix (ECM) is a structural framework for cells and tissues, and provides 
signals to modulate cell behaviour. TGF-β is a multifunctional growth factor, targeted 
into the matrix as latent complexes with its LAP-propeptide and an LTBP molecule. 
ECM targeting is important, since the surrounding structures define the susceptibility 
of the complexes to activation processes. LTBP isoforms are deposited into the ECM 
of fibroblasts in spatially and temporally different manner. Knowledge about the 
targeting of LTBPs into the ECM is essential for understanding TGF-β activation and the 
functional diversity of LTBP isoforms. In the current study, we have analyzed the role of 
fibronectin (FN) in the matrix targeting of LTBP-4 in FN(-/-) and control mouse fibroblast 
cultures. FN is assembled early into the ECM and it acts as an organizer for the other 
ECM proteins including LTBP-1 and fibrillin-1. We found that FN plays a central role 
in the ECM assembly of LTBP-4. Endogenous LTBP-4 was not targeted into the matrix 
of FN(-/-) fibroblasts. By exogenous FN the LTBP-4 assembly could be rescued. To 
characterize the FN binding region of LTBP-4, N-terminally shortened constructs were 
analyzed for their ECM association by IF-microscopy. When the N-terminal part of the 
molecule was deleted (first exon), ECM deposition of LTBP-4 was reduced and delayed. 
However, during extended culture minor quantities of LTBP-4 accumulated into the 
ECM, suggestive of alternative protein-protein interactions. LTBP-4 has a C-terminal 
ECM binding site. This region can bind fibrillin-1 (Fbn-1) directly, suggesting that the 
observed minor binding could be Fbn-1 dependent. LTBP-4/Fbn-1 double staining 
profiles support this notion. We also found that LTBP-4 has heparin binding sites, 
which may mediate cell attachment. Current analyses revealed a direct interaction 
between FN and LTBP-4, which evidently plays divergent roles in ECM assembly. 
 
184 [Oral 050]
Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and 
wound healing
S Guan, M Chen, DT Woodley, W Li Univ of Southern California, Los Angeles, USA
Hypoxia plays a critical role in the pathophysiology of a variety of human disorders, such 
as ischemic cardiovascular disease, stroke, chronic lung disease, acute skin wounds and 
cancer. After acute injury, the microenvironment of a skin wound is hypoxic, likely due 
to vascular disruption and high oxygen consumption by cells at the edge of the wound 
and in granulation tissue. Previous studies of our and other laboratories showed that 
hypoxia supports wound healing by promoting human skin cell motility. The mechanism 
by which hypoxia promotes cell motility was not known. Here, we provide evidence 
for the first time that hypoxia promotes human dermal fibroblast (HDF) migration by 
inducing the secretion of heat shock protein-90alpha (hsp90alpha) into the extracellular 
environment and the secreted hsp90alpha in turn executes hypoxia’s pro-motility effect. 
Hypoxia inducible factor-1alpha (HIF-1alpha) mediates hsp90alpha secretion. Expression 
of an activated HIF-1alpha mimicked hypoxia-induced hsp90alpha secretion and HDF 
migration. In contrast, expression of an inactive HIF-1alpha or down-regulation of 
endogenous HIF-1alpha blocked both events. Interestingly, the hypoxia-HIF-1 pathway-
induced hsp90alpha secretion required no changes in the steady-state level of hsp90alpha 
mRNA or in its promoter activity. The addition of recombinant hsp90alpha fully duplicated 
the hypoxia’s pro-motility effect on the cells. Inhibition of the extracellular hsp90alpha 
function completely blocked hypoxia-HIF-1-stimulated HDF migration. Clinically more 
intriguingly, topical application of hsp90alpha accelerated wound healing by increasing 
the re-epithelialization process in mice. This study has demonstrated a novel mechanism 
of hypoxia > HIF-1 > hsp90alpha secretion > skin cell migration > wound healing and 
identified extracellular hsp90alpha as a potential therapeutic agent for skin wounds. 
 
185 [Oral 051]
Ablation of Integrin-Linked Kinase in Fibroblasts: Altered Mechanical Properties 
Resulting in Disturbed Wound Healing
B Eckes1, MC Zweers1, A Peters1, CP Denton2, R Fässler3, T Krieg1 1University of 
Cologne, Cologne, Germany 2University College London, London, UK 3Max Planck 
Institute of Biochemistry, Martinsried, Germany
Integrin-mediated interaction of fibroblasts with the surrounding extracellular matrix 
(ECM) is essential for various biological processes, e.g. proliferation, differentiation and 
migration. Ligand binding initiates the assembly of a multiprotein complex, the focal 
adhesion, of which integrin-linked kinase (ILK) is a key cytoplasmic component. ILK binds 
to the intracellular tail of β1, β2 and β3 integrins and recruits several adaptor proteins, 
thus connecting the ECM to the actin cytoskeleton. Here, we report the generation of 
an inducible fibroblast-specific ILK-deficient mouse. ILK-deficient skin fibroblasts show 
impaired cell spreading, focal adhesion assembly and stress fiber formation on collagen 
and fibronectin substrates. The transduction of mechanical forces is reduced, as ILK-
null fibroblasts show a greatly impaired capacity to contract collagen lattices. This was 
associated with reduced mRNA levels of the collagen-binding integrins α1, α2 and α11, 
as well as decreased cell surface expression of β1 integrin. In addition, the expression of 
α-smooth muscle actin was diminished, indicating that myofibroblast differentiation was 
hampered. Since all of the before mentioned processes are pivotal during cutaneous wound 
healing, we wounded fibroblast-specific ILK-deficient animals and control littermates. 
Fibroblast-specific ILK-deficient animals show strongly reduced wound contraction and 
greatly disturbed granulation tissue formation. Fewer myofibroblasts were present in the 
granulation tissue, most likely due to reduced proliferation of the ILK-deficient fibroblasts. 
In conclusion, ILK plays an important role in fibroblasts in sensing environmental cues and 
thereby maintaining connective tissue homeostasis. 
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Lupeol stimulates the production of high quality type I collagen in human skin 
through HSP47 induction
C Baudouin, D Naaimi, S Bredif, P Msika Laboratoires Expanscience, Epernon, France
Heat shock protein (HSP) 47 is a specific chaperone of procollagen. It is responsible 
for the correct three-dimensional organization of procollagen and its control-quality 
prior to secretion. Thus, HSP47 ensures the formation of high quality collagen I that 
is responsible for the strength and elasticity of the skin, mechanical properties that 
are altered during aging. We have investigated the in vitro effects of Lupeol, a natural 
patented triterpenic alcohol obtained from White Lupine seeds, on the positive 
regulation of collagen I through HSP47 expression modulation in human fibroblasts.
Fibroblasts were treated with Lupeol. HSP47 and Collagen I gene expression were 
studied by quantitative RT-PCR. HSP47 protein production was followed by Western 
Blot and immunolabelling. Collagen I protein secretion was evaluated by ELISA in 
normal and inflammatory conditions.The QRT-PCR has allowed to show that Lupeol 
induced an overexpression of HSP47 gene (+21%), confirming the previous results 
obtained by microarray screening on fibroblasts cultures (+29%). Moreover, Lupeol 
stimulated the production of HSP47 protein. Lupeol strongly induced production and 
secretion of collagen I (X2 to X4.4) through an overexpression of the gene (+46%). 
Moreover, we have demonstrated the anti-inflammatory activity of Lupeol that was 
able to restore and stimulate production of collagen I in the presence of IL1b (X1.5 
to X3). Our results suggest that Lupeol could stimulate the production of collagen I 
through a targeted action on HSP47. It’s important to mention that Lupeol stimulates 
the production of high quality collagen I, that is the predominant collagen in the 
dermis. Thus, Lupeol seems to counteract the collagen I depletion due to aging 
or insult (inflammation) and strengthen dermis. Moreover, by a clinical study, we 
confirmed that Lupeol improves skin elasticity and remodelling.
 
2007 ESDR Abstracts v2.indd   31 8/13/07   11:31:36 PM
ABSTRACTS
S32  Journal of Investigative Dermatology (2007), Volume 127 
187
Anti-oxidative enzyme catalase controls proliferation of HaCaT cells through the 
regulation of heparan sulfate 2-O-sulfotransferase
F Nakayama, A Hagiwara, M Akashi Nat Inst of Radiological Sciences, Chiba, Japan
Heparan sulfate (HS) chains can interact with a variety of growth factors possessing 
heparin-binding domains, such as fibroblast growth factors (FGFs), enabling them 
to transfer to their high-affinity signaling receptors on the cell surface. In this study, 
we demonstrated the correlation between the expression of anti-oxidative enzymes 
and the HS chain in the human HaCaT keratinocyte cell line. The overexpression of 
catalase induced an increase of anti-HS antibody (10E4) epitope expression in these 
cells; however the MnSOD transfectant expressed it at the same level as the control 
cells. Western blotting showed that the smeared bands of HSPG were obviously shifted 
to higher-molecular-weight in the catalase transfectants owing to glycosylation. The 
levels of glycosyltransferases (XT-II, EXTL2, GLCE, HS2ST1 and HS6ST1) transcripts 
were significantly increased in the transfectants. In contrast, siRNA-mediated 
repression of catalase decreased 10E4 epitope expression, the transcript level of 
HS2ST1, and proliferation of HaCaT cells; however it did not significantly down-
regulate the transcript level of HS6ST1. In addition, siRNA-mediated repression of 
HS2ST1 decreased HaCaT cell proliferation, although repression of HS6ST1 did not 
reduce it. These findings suggest that catalase may be able to modify the HS chains in 
the keratinocytes through the regulation of HS2ST1 to control HaCaT cell proliferation. 
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Surface Morphology and Mechanical Properties of Fibroblasts from Scleroderma 
Patients
A Reich1, M Meurer2, B Eckes3, T Krieg3, J Friedrichs4, DJ Muller4 1Wroclaw Medical 
University, Wroclaw, Poland 2TU Dresden, Dresden, Germany 3University of Cologne, 
Cologne, Germany 4Biotechnological Center, Dresden, Germany
Overproduction of extracellular matrix components by fibroblasts plays a key role in 
the pathogenesis of scleroderma. To investigate whether these functional alterations 
are accompanied by changes in fibroblast morphology and mechanical properties we 
compared with the help of atomic force microscopy (AFM) the surface morphology 
and viscoelastic characteristics of dermal fibroblasts derived from scleroderma 
patients or from healthy donors as control. We detected significant differences in 
viscoelastic properties of dermal fibroblasts from scleroderma lesions. These cells were 
softer than normal fibroblasts, both when the mechanical properties were tested by a 
sharp AFM tip (small contact area) or by the 5 µm bead glued to the AFM cantilever 
(large contact area). In contrast, we did not detect significant differences in shape 
and surface structure between fixed dermal fibroblasts from scleroderma patients and 
those from controls. All cells had prominent long fibres located submembranously 
and irregularly distributed protrusions on their surface. The density and height of 
these structures were similar in all cell lines. These altered viscoelastic properties o 
fibroblasts may be important in the pathogenesis of scleroderma, e.g. by altering the 
responsiveness of fibroblasts to mechanical stimuli. 
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Is the TACE (ADAM17) take part in destruction of basement membrane in bullous 
pemphigoid?
A Zebrowska, M Wagrowska-Danilewicz, A Sysa-Jedrzejowska, R Pawliczak, 
E Waszczykowska1 Medical University of Lodz, Lodz, Poland
Reports in recent literature reveal the role of metalloproteinases and their tissue 
inhibitors in the pathogenesis of bullous pemphigoid (BP). Some papers confirm their 
important role in destruction of the basement membrane and formation of blisters. 
However there are no data in available literature concerning the expression and role 
of adamalisynes (ADAMs), in this process. Recent studies established biochemical 
properties of these enzymes and their high affinity to components of the basement 
membrane. One of adamalisynes, ADAM 17, releases from cellular surface TNF-α, 
L-selectn, as well as receptor for IL-6. Last year studies showed that also collagen 
XVII, i.e. BPAG 2, may serve as a substrate for ADAM 17 synthesized in inactive 
form by keratinocytes. The aim of the study was evaluation of the expression of 
TACE, TIMPs and TNF-α in course of the BP patients (n=25) in active stage through 
examination of their expression and distribution in lesional skin, normally appearing 
skin as well as in healthy skin (n=10) by immunohistochemistry. Moderate expression 
of ADAM 17 in skin lesions was observed mostly in the basal keratinocytes as well 
as focally in the other layers of epidermis. In cellular infiltrate we found a expression 
for the ADAM17 and TNF-α. TIMPs were detected in dermal part of the blister and in 
the basal keratinocytes. In normally appearing skin from BP patients the expression 
of ADAM 17 was single and weaker as well as TNF-α expression. In healthy biopsies 
expression of ADAM 17 was single but there was no TNF-α expression. Obtained 
results will enlarge the state of knowledge concerning the subepidermal bullous 
diseases and confirm the role of TACE as proteases and adhesive molecules in BP. 
The obtained results may in future serve as therapeutic advice for introduction of new 
group of drugs that influence the activity of ADAMs.
190
Expression and characterization of tensin1 in cultured normal and aged human 
dermal fibroblasts
G Saintigny1, N Pedretti2, FX Bernard2, F Juchaux2, C Mahé3 1Chanel, Pantin, France 
2BIOalternatives, Gencay, France 3Chanel PB, Neuilly/Seine, France
Tensin1, a 220 kDa protein, is a focal adhesion molecule that binds to actin filaments 
and participates in signalling pathways. Recent studies have shown that tensin1 is 
also concentrated at fibrillar adhesions sites (Extra Cellular Matrix, ECM-contacts), 
a structure that also contains integrin a5b1. Tensin1 seems to be critical for integrin 
a5b1 translocation away from focal adhesion to fibrillar adhesion, fibrillogenesis 
and eventually cell migration. We investigated the differential expression of tensin1 
in cultured human dermal fibroblasts. As revealed by immuno-histochemistry 
and RT-QPCR, tensin1 is expressed in dermal fibroblasts and strongly stimulated 
in the presence of transforming growth factor beta (TGFb). Comparing tensin1 
expression in normal, foreskin and replicative senescent, ‘aged’fibroblasts, a 50% 
reduction was observed in the aged cells, based on immunofluorescent and RT-
QPCR data. Transfection of the normal dermal fibroblasts with SiRNA directed 
to tensin1 resulted in a 60% inhibition of its expression and affected the cellular 
distribution of integrin a5b1 and fibronectin. The collagen lattice contraction assay 
revealed that lattice contraction was markedly reduced in lattices populated with 
aged or siRNA treated fibroblasts. Based on these results, one might speculate that 
in human dermal fibroblasts, tensin1 plays an important physiological role and 
that it’s reduced expression in aged cells might contribute to the dermal alterations 
observed during aging, in particular, the loss of dermal elasticity and firmness. 
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Pemphigoid Gestationis Autoantigen, Transmembrane Collagen XVII, Promotes the 
Migration of Cytotrophoblastic Cells of Placenta
L Huilaja1, T Hurskainen1, H Autio-Harmainen1, SC Hofmann2, R Sormunen1, M 
Ilves1, CW Franzke2, L Bruckner-Tuderman2, K Tasanen1 1University of Oulu, Oulu, 
Finland 2University of Freiburg, Freiburg, Germany
Pemphigoid gestationis (PG) is a pregnancy associated autoimmune skin disease, in which 
circulating autoantibodies are directed against collagen XVII (BP180). Our aim was to assess 
the expression and function of collagen XVII during pregnancy in order to understand its 
role during placental development and in the pathogenesis of PG. In contrast to previous PG 
autoantigen studies, we have recently shown that collagen XVII is expressed already in the 
first trimester syncytial and cytotrophoblastic cells in the placenta and in epithelial cells of 
the amniotic membrane. Thus the onset of the clinical symptoms of PG during the second or 
third trimester of occurs only after the expression of collagen XVII during the first trimester. 
Examination of three PG placentas showed mild villitis but otherwise normal morphology. 
There were no differences between collagen XVII mRNA expression levels or immunostaining 
signals in the villous epithelium as compared to normal placenta. Also invasive HTR-8/
SVneo cells, which exhibit phenotypic features of extravillous cytotrophoblasts, expressed 
collagen XVII, as demonstrated by RT-PCR and direct sequencing. Treatment with growth 
factors and analysis with TaqMan quantitative RT-PCR showed that collagen XVII expression 
was upregulated by PMA and TGF-β1. Addition of Col15, the cell migration domain of 
collagen XVII, into the lower chamber of Transwell chambers resulted in 2- fold increase in 
the transmigration of HTR-8/SVneo cells. These data suggest that collagen XVII contributes to 
the invasion of extravillous trophoblasts during placental development. Although the exact 
pathomechanism of PG is still largely unknown, the clinical symptoms of PG are initiated only 
after the expression of collagen XVII in placenta during the first trimester of pregnancy. 
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Amber extract activity on dermal fibroblasts: A DNA array approach
J-H Cauchard, S Talbourdet, J-C Archambault, E Perrier, F Bonté LVMH Recherche, 
Saint Jean de Braye, France
Dermal fiber proteins and extracellular matrix are fundamental for the skin properties. 
Their modifications during photo-ageing has been linked to the age related loss 
of firmness and wrinkles formation. The present study describes fibroblast genes 
modulation following their treatment with a specific amber extract. Amber extract 
(Pinus species) originated from the Baltic sea area, was investigated using human 
normal skin fibroblast cultures. Cells were incubated with purified glycolic amber 
extract for 4 hours, followed by gene expression analysis using DNA microarray 
technology. The Piqor Skin Microarray mainly used reflects the expression profile 
of 1308 genes expressed in healthy skin and comprises specific genes that play a 
pivotal role in skin aging. The effect of amber extract at 2% (v/v) added to the culture 
medium was investigated to identify changes in gene expression between untreated 
and treated cells. A statistical and biological pathway analysis of microarray data was 
performed. After a 4 hours amber extract treatment, modulations in gene expression 
were observed for a set of 92 genes compared to the non-treated cells. The main 
proportion of the regulated genes can be directly related to dermal metabolism. 
Expression level of type I, III and V collagen genes increased about 3.4, 2.2 and 1.9 
fold respectively after amber extract treatment, whereas the expression of MMP-1 
level decreased 0.65 fold. Moreover, the expression of dermatopontin, Small Leucin 
Rich Proteoglycans (SLRP) such as biglycan, proteoglycans such as versican increased 
2.4, 3 and 2.1 fold respectively after amber extract treatment. Amber extract not 
only directly stimulates dermal extracellular matrix and fibers biosynthesis genes by 
fibroblasts, but also modulates their assemblage and degradation genes. 
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Characterization of cultured keloid cells and their application to in vivo keloid model
E Araki, M Naitoh, K Nagata, Y Miyachi, A Utani Kyoto Univ School of Medicine, 
Kyoto, Japan
Keloids are a refractory disease of the human skin characterized by excessive deposition 
of extracellular matrices (ECMs). Our final goal is to establish a sufficient in vivo model of 
keloids to develop effective treatment. In this study, we investigated the ECMs-producing 
properties of cultured cells derived from keloid tissue (keloid cells). cDNA microarray 
analysis revealed upregulation of various ECM molecules including cartilaginous 
collagens, proteoglycan versican and aggrecan. Immunohistochemistry of keloid tissues 
showed increased versican deposition in the keloid lesions compared to control skin. RT-
PCR studies verified increased expression of versican mRNA in keloid cells as well as in 
keloid tissues. These data indicated that increased versican expression may be one of the 
key features that characterize keloid cells. Next, in order to generate an in vivo model 
of keloids, keloid cells were implanted with collagen sponge scaffolds in the subcutis of 
nude mice (n=18). After four weeks, collagen sponges with keloid cells had formed solid 
and elastic materials that appeared thicker and more opaque than those with normal 
fibroblasts. These keloid sponges weighed significantly heavier than normal fibroblast 
sponges. Immunohistochemistry showed increased versican in keloid sponges, while 
hyaluronic acid deposition was less. These results indicated that cultured keloid cells 
could maintain their ECMs-producing properties in in vivo conditions. Finally, versican 
regulation pathways in keloid cells were studied using inhibitors. SB431542 (TGF-beta 
inhibitor) and LY294002 (PI3K inhibitor) showed that versican expression in both keloid 
and normal fibroblasts was predominantly regulated by the PI3K pathway. The involvement 
of beta-catenin in versican transcription is currently being investigated. In conclusion, 
keloid cells were shown to deposit versican both in vitro and in vivo. Possible reagents 
inhibiting versican expression in vitro can now be tested in vivo using our keloid model. 
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Sera from patients with bullous pemphigoid depletes cultured keratinocytes of type 
XVII collagen
H Iwata, Y Yamamoto, N Kamio, Y Aoyama, Y Kitajima Gifu Graduate School of 
Medicine, Gifu-City, Japan
Type XVII collagen, which is the 180-kDa bullous pemphigoid antigen (BP180), is distributed 
on the lateral-apical (as a pool) and ventral (at hemidesmosomes) cell membranes of 
monolayer-cultured keratinocytes and basal cells in the epidermis. We have previously shown 
that addition of BP-IgG causes the internalization of immune complex of BP180 and BP-IgG 
from the lateral-apical cell membrane. The purpose of this paper is to examine whether this 
BP180 internalization can deplete cells of BP180, comparing with other hemidesmosomal 
components; α6 and β4 integrins by quantitative Western blot analysis using monoclonal 
antibodies to these molecules and β catenin. All BP-IgG or BP-sera with high titers of BP180-
ELISA from 10 BP-patinets before and after treatments, but none of normal human IgG or sera, 
decreased dramatically (50 to 90% compared to control) the ratios of BP180/α6 integrin, 
BP180/β4 integrin and BP180/β catenin from the cell lysates of cultured keratinocytes 
(DJM-1 cells) by 6 hr of their treatments. Even BP-IgGs of patients without active blistering 
because of oral corticoid treatments can deplete cells of BP180 as long as they keep a high 
titer of BP180 ELISA, suggesting that corticosteroids may interfere with inflammatory process 
for blistering. Since it is known that BP180-knockout patients show blisters along the lamina 
lucida, these results suggest that BP-IgG reduces the BP180 content from hemidesmosomes 
resulting in reducing the adhesiveness to the lamina densa and the inflammation caused 
by BP180 immune-complex formation tears the weakened lamina lucida due to BP180 
depletion. This may generate the BP-specific split at lamina lucida in combination 
with non-specific inflammatory enzymatic activity exerted at dermal-epidermal zone. 
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Drastic alterations of dermal elastic fibers in sun-exposed skin observed with 
scanning electron microscopy
YK Matsunaga, S Amano Shiseido Life Science Center, Yokohama, Japan
Elastic fibers are major insoluble extracellular matrix assemblies that are critical for 
the resilience or deformability of skin and all other dynamic connective tissues. It is 
well known that the elasticity of sun-exposed skin is significantly decreased and an 
amorphous matrix of elastotic material is deposited in the upper dermis. However, 
the ultrastructural features of the accumulated elastotic materials and the underlying 
mechanisms involved remain unclear. Scanning electron microscopy (SEM) is a good 
method to study the changes of elastic fibers in sun-exposed skin. We examined the 
sample preparation method for SEM and succeeded in establishing a new method 
to observe cutaneous elastic fibers in thin sections of skin. Briefly, sections 10 ˜ 20 
mm thick were mounted on micro cover glasses having the same size and shape as 
the SEM sample holder, and immersed in 90% formic acid to digest extracellular 
matrix components except for elastic fibers. The elastic fibers of normal human skin 
were found to be distributed sparsely, but as a complicated network of curved fibers 
in the upper dermis. On the other hand, the narrow elastic fibers of sun-exposed 
skin initially aggregated with each other in a parallel orientation, and then formed 
intricate structure throughout the dermis. The aggregated structure of elastin fibers 
observed with SEM corresponded well with the materials stained with anti-elastin 
antibody. The drastic accumulation of elastic fibers resulted in an extreme reduction 
of the amount of collagen fibers in sun-exposed skin. Such drastic alterations in the 
structure of elastic fibers in sun-exposed skin may be associated with the changes of 
cutaneous physical properties and enhanced wrinkle formation. 
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Modulation of SPARC synthesis in human fibroblasts and adipocytes
F Pellicier, C Gondran, S Dehault, S Schnebert, R Kurfürst LVMH Recherche, Saint 
Jean de Braye, France
SPARC (Secreted Protein Acidic and Rich in Cystein) is a multifunctional glycoprotein that 
belongs to the matricellular group of proteins. It is expressed by different cell types and is 
associated with development, remodelling, cell turnover, angiogenesis and adipogenesis. 
The purpose of this study was to investigate the effects of several growth factors (TGF-β, 
β-FGF, EGF) on SPARC synthesis by human fibroblasts and adipocytes during adipogenesis. 
SPARC levels were measured on cell supernatant using ELISA method.TGF-β enhances 
SPARC synthesis in a dose dependent-manner (2-10 and 50ng/mL) whereas β-FGF and EGF 
show inhibitory effects (significant effect after 24h or 48 h adipocyte treatment and after 
48h or 72h fibroblast treatment). We have shown that SPARC level increases during the 
first steps of adipogenesis and we supposed it could play a role in adipogenesis induction. 
Three-dimensional collagen gels were performed with native type I collagen, containing 
fibroblasts, adipocytes or both cell types to study the ability of cells to contract collagen 
network. Fibroblasts contract collagen lattices more rapidly than adipocytes and than 
mixture of fibroblasts and adipocytes. SPARC level was measured on collagen lattice 
supernatants: SPARC production is more important in lattices with adipocytes than in lattices 
with fibroblasts (respectively +25% at D9 and +64% at D16). SPARC immuno-staining was 
performed on monolayer cultures of fibroblasts and adipocytes during differentiation. The 
staining of SPARC protein is located in cytoplasm of fibroblasts and adipocytes. SPARC has 
an important role in modulating interactions between cells and extracellular matrix. SPARC 
increase during the first step of adipocyte differentiation suggests that it could play a role in 
adipogenesis induction. Modulation of SPARC synthesis could be a relevant approach for a 
combined action on both dermis and hypodermis.
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Basement membranes in mouse skin are differently affected by the loss of nidogen 1 
and 2 or the nidogen binding site on the laminin gamma 1 chain
S Mokkapati1, A Baranowsky1, N Mirancea2, D Breitkreutz3, U Mayer4, N Smyth5, 
R Nischt1 1Univ of Cologne, Germany 2Romanian Academy of Sciences, Bucharest, 
Romania 3German Cancer Research Center, Heidelberg, Germany 4Univ of East 
Anglia, Norwich, UK 5Univ of Southampton, UK
Nidogen 1 and 2 are ubiquitous basement membrane (BM) proteins which share a common 
domain structure and comparable binding activities. Studies in mice lacking both nidogen 
isoforms showed abnormalities in certain organs which are directly related to BM defects. 
However, in some tissues normal BMs form demonstrating that nidogens are not essential for 
BMs and that different BMs have different requirements for nidogens. In the skin of embryos 
(E18.5) the lack of both nidogen isoforms did not interfere with deposition and formation of 
the dermal-epidermal BM zone and the overall skin morphology. However, formation of the 
capillary BMs was severely affected being almost completely absent as shown by electron 
microscopy. In these BMs deposition of other major BM proteins was dramatically decreased 
demonstrating that nidogens are needed for the retention of these components within the 
capillary wall. Mice lacking the nidogen-binding site upon the laminin gamma 1 chain showed 
also no ultrastructural alterations of the dermal-epidermal BM. However, in contrast to nidogen 
double null mice, the capillary BMs of mice lacking this nidogen-binding site were not affected 
as shown by immunofluorescence and electron microscopy. Although both nidogen isoforms 
have been shown to bind in vitro with comparable affinities to this site, only nidogen 2 is retained 
within the capillary wall while nidogen 1 deposition is completely abolished. This demonstrates 
that in vivo nidogen 1 is indeed retained in the BM via binding to the nidogen-binding site on 
the laminin gamma 1 chain. In contrast, nidogen 2 recruitment and retainment appears to occur 
via interaction with another binding site on laminin or another binding partner. In conclusion, 
these data indicate that the current BM model is incomplete.
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Melanocortin peptides suppress bleomycin-induced collagen synthesis in human 
dermal fibroblasts
A Kokot, M Schiller, C Kerkhoff, TA Luger, M Böhm University of Münster, Germany
α-Melanocyte-stimulating hormone (α-MSH) exhibits a variety of anti-inflammatory effects 
on different cell types. As previously reported human dermal fibroblasts (HDF) express high-
affinity binding sites for α-MSH which were identified as melanocortin-1 receptors. Here we 
investigated the effect of α-MSH on bleomycin (BLM)-induced collagen synthesis in HDF, 
an in vitro model corresponding to the animal model of BLM-induced fibrosis and also to 
the clinical observations made in patients treated with this anticancer drug. α-MSH as well 
as several related peptides including NDP-α-MSH, adrenocorticotropic hormone, and the 
tripeptide KPV significantly reduced BLM-induced collagen synthesis as shown by real-
time RT-PCR analysis and western immunoblotting. To identify the effector mechanism of 
α-MSH and related peptides in this model we first addressed the still unknown mechanism 
by which BLM upregulates collagen synthesis in HDF. Promoter-reporter assays and 
immunofluorescence analysis revealed neither an involvement of the smad2/3 nor the NF-
kB-pathway in BLM-induced collagen synthesis. However, co-treatment of HDF with BLM 
plus ascorbate or MnCpx3 markedly suppressed BLM-induced collagen synthesis indicating 
reactive oxygen species (ROS) play a crucial role in the action of BLM. To test the idea 
that the antagonistic effect of α-MSH on BLM-induced collagen synthesis could involve 
reduction in intracellular ROS, we examined the expression and regulation of various ROS-
detoxifying enzymes by real-time RT-PCR analysis and western immunoblotting. α-MSH 
induced expression of heme oxygenase-1 (HO-1) and superoxid-dismutase-2 (SOD2) in a 
time-dependent manner. Interestingly, although BLM alone also induced HO-1 expression 
co-treatment with α-MSH had a significant additive effect. These data indicate that oxidative 
stress is crucially involved in the mechanism of BLM-induced collagen synthesis in HDF. 
The modulatory effects of α-MSH and related peptides in this vitro model appear to be 
mediated by enhanced expression of ROS-detoxifying enzymes, e. g. HO-1 and SOD2. 
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Differential susceptibility of isolated extracellular matrix components to direct 
ultraviolet radiation
REB Watson, P Bayley, NK Gibbs, J Sherratt The University of Manchester, UK
UV radiation (UVR) plays a major role in skin ageing, acting via cells to perturb extracellular 
matrix (ECM) homeostasis by differential regulation of matrix component synthesis and by 
promoting the expression of matrix degrading enzymes. In contrast, the direct effects of UVR 
on matrix components remain poorly defined.In photoprotected skin, type I collagen plays 
a major role in resisting tensile forces and the glycoprotein fibronectin aids cell binding to 
the matrix. Using SDS-PAGE and atomic force microscopy (AFM), we have examined the 
effects of exposure to physiological doses of broad-band UVR (Philips TL12, 280-400nm; 0, 
20, 100 and 500mJ/cm2; MED ≈ 70mJ/cm2) on suspensions of isolated monomeric type I 
collagen and dimeric fibronectin. SDS-PAGE analysis of UVR-exposed type I collagen failed 
to identify any change in the resultant banding profile. Type I collagen monomers, in the 
form of a semi-flexible rod with a pronounced terminal globular region, were visualised 
by AFM at all UVR exposures. In contrast, exposure to UVR profoundly influenced the 
structure of isolated fibronectin. High molecular weight aggregates, induced at greater doses 
of UVR, were identified by SDS-PAGE. In native conditions, fibronectin dimers visualised 
by AFM appear as an extended string of three beads. Exposure to UVR caused extensive 
disruption of this quaternary structure, aggregation and fragmentation. This study identifies 
direct UVR as a potential causative agent of ECM degradation. The differential sensitivity 
of fibronectin and type I collagen to UVR may be due to their relative UV chromophore 
composition. The amino acids Cys, His, Phe, Trp and Tyr constitute 12.9% of the fibronectin 
sequence compared with only 2.1% of the type I collagen α1 chain. We suggest therefore 
that stable dermal proteins with high chromophore content will be susceptible to direct 
UVR damage.
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Reduction of Transforming Growth Factor-β/Smad/Connective Tissue Growth Factor 
Axis Contributes to Loss of Type I Collagen in Aged Human Skin in vivo
GJ Fisher, TH Quan, TY He, Y Shao, S Kang, JJ Voorhees University of Michigan, Ann 
Arbor, USA
Thin fragile skin of the elderly results largely from age-dependent loss of type I collagen 
production. Connective tissue growth factor (CTGF/CCN2), downstream target of the 
transforming growth factor-ß (TGF-ß)/Smad pathway, is overexpressed in numerous fibrotic 
disorders, where it is thought to mediate excessive collagen production. Although CCN2 is 
constitutively expressed in normal human skin dermis, its physiological role in regulation of 
type I procollagen (COL) gene expression has not been investigated. We report that CCN2 
mRNA and protein are significantly reduced (52% and 56%, respectively, n=6 p<0.05) in 
chronologically-aged (80+years) human skin dermis in vivo. This reduction is likely caused by 
reduction of upstream effectors of CCN2 expression, TGF-ß1 and Smad3, which are reduced 
87% (n=6) and 65% (n=6), respectively. To address mechanisms, we explored the role of 
CCN2 in COL expression in human skin fibroblasts, the major collagen producing cells in 
human skin. Suppression of endogenous CCN2 by siRNA resulted in reduced expression of 
basal (63%, n=5, p<0.05) and TGF-ß-induced (65%, n=5, p<0.05) COL mRNA expression. In 
contrast, overexpression of CCN2 stimulated basal (7-fold, n=5 p<0.05) and TGF-ß-induced 
(4-fold, n=5 p<0.05) COL mRNA levels. Furthermore, basal or TGF-ß-induced type I (a2) 
procollagen promoter activity was dependent on CCN2 levels (manipulated by overexpression 
or knockdown), indicating that CCN2 regulates procollagen gene transcription. The ability 
of CCN2 to stimulate COL expression was completely abrogated by specific TGF-β type I 
receptor (ALK5) inhibitor (SB431542), or knockdown of Smad3, indicating that CCN2 
regulation of COL expression is dependent on TGF-β/Smad pathway. Taken together, these 
data support the concept that reduced expression of TGF-β1/Smad3/CCN2 axis is a critical 
mediator of decreased COL production observed in chronologically-aged human skin in vivo. 
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Antifibrotic effect of inhibitors of dipeptidyl peptidase IV-like activity in normal and 
keloid-derived skin fibroblasts
A Thielitz1, R Vetter1, P Lindenlaub1, S Ansorge2, D Reinhold1, H Gollnick1 1Otto-von-
Guericke University, Magdeburg, Germany 2IMTM, Magdeburg, Germany
Suppression of collagen and matrix synthesis and inhibition of the fibrogenic cytokine 
transforming growth factor-β1 (TGF-β1) is a major therapeutic goal in the treatment of fibrosis 
and keloids. Inhibitors of dipeptidyl peptidase IV (DP IV)-like activity affect cell growth and 
cytokine production and are currently under investigation for the treatment of metabolic, 
autoimmune and inflammatory diseases. The aim of our present study was to investigate the 
effect of these inhibitors on skin fibroblast physiology. We used a variety of in vitro methods, 
including [3H]-thymidine and [3H]-proline incorporation assays, Gly-pro-pNA hydrolysis, 
qualitative mRNA expression, flow cytometry, ELISAs, Western blot, a matrix metralloprotease 
protein array, as well as an in vivo model of skin fibrosis. We show here that the DP IV-
like enzymes DP IV, DP8 and DP9 are expressed on human dermal fibroblasts and keloid 
fibroblasts in vitro and that the inhibitors of DP IV-like activity, Lys[Z(NO2)]-thiazolidide 
and Lys[Z(NO2)]-pyrrolidide, dose-dependently suppress proliferation in these cells. They 
significantly decrease TGF-β1 expression and the secretion of procollagen type I C-terminal 
peptide in supernatants of both cell types. Furthermore, they abrogate the TGF-β1-induced 
stimulation of collagen synthesis, matrix deposition, and TGF-β1 and fibronectin expression 
and reverse TGF-β1-induced alterations in the MMP expression profile in both cell types. Both 
inhibitors lead to dephosphorylation of mitogen activated protein kinases pp38 and pERK1/2, 
which are activated upon TGF-β1-stimulation and have been implicated in fibrogenesis. In 
a mouse model of dermal fibrosis, induced by repetitive intracutaneous injections of TGF-
β1, the profibrotic effect of TGF-β1 detected by dermal thickening, collagen I and α-smooth 
muscle actin expression, is significantly suppressed in the presence of inhibitors. Inhibition 
of DP IV-like enzymatic activity may therefore represent a novel therapeutic approach for the 
treatment of fibrotic skin disorders and keloids. 
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Accelerated Aging in Mice with Connective Tissue Specific Deficiency of the Manganese 
Superoxide Dismutase - In Vivo Evidence for the Free Radical Theory of Aging
N Treiber1, M Kohn1, AF Keist1, S Schorlemmer1, L Claes1, L Florin2, P Angel2, 
M Wlaschek1, K Scharffetter-Kochanek1 1University of Ulm, Ulm, Germany 2German 
Cancer Research Center, Heidelberg, Germany
Until now the free radical theory of aging is heavily debated as it lacks final experimental 
evidence. This theory postulates that increased mitochondrial production of free 
radicals during oxidative phosphorylation is the major determinant of life span, and 
age-related diseases / malfunctions including skin aging, osteoporosis, artherosclerosis 
and neurodegeneration among others. The manganese superoxide dismutase (SOD2) is 
localized in mitochondria and represents the first line of defense against superoxide anions. 
To circumvent the early lethality of SOD2 deficient mice, we have used a connective tissue-
specific strategy, breeding the collagen type I (α2 I) promoter Cre transgenic mice to a SOD2 
‘floxed’mouse. Analysis of the Cre transgenic mouse showed that the Cre recombinase 
is distinctly active in connective tissue cells of all organs including skin, brain, bone, 
liver, kidney and heart to mention, the most important. Southern blot analysis of dermal 
fibroblasts generated from the connective tissue specific SOD2 deficient mice revealed a 
complete excision of exon 3 of the SOD2 gene resulting in a functional deficiency for 
SOD2. Mice deficient for the connective tissue specific SOD2 displayed a complex aging 
phenotype with a reduction of life span, skin atrophy of the dermis with decrease in 
interstitial collagens, atrophy of the subcutaneous tissue, severe osteoporosis, as assessed 
by bone densitometry as well as neurodegeneration. These data provide strong in vivo 
evidence for the free radical theory of aging. This connective tissue specific SOD2 deficient 
mouse model will be particularly suited to close persistent gaps and to answer fundamental 
questions regarding the nature of the relevant intracellular targets of reactive oxygen 
species and how oxidative modification of these target molecules drive the aging process. 
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H2O2-Induced Senescent Human Skin Fibroblasts are Regulated by Blue Algae 
Pigmentary Extract
H Hernandez-Pigeon, M-J Haure, M Segur-Derai, R Tarroux, P Bogdanowicz, 
M Charvéron Institut de Recherche Pierre Fabre, Toulouse, France
The mechanical properties of the dermis are determined, primarily, by the extracellular matrix 
(ECM). These mechanical properties change dramatically as a function of age, as a direct 
result of the known age-related changes in the molecules of the dermal ECM: collagens, elastin 
or matrix metalloproteinases (MMP). In order to evaluate blue algae pigments extracts (from 
Phormidium uncinatum) on skin aging, we have developed an in vitro model of stress-induced 
premature senescence (SIPS). The antioxydant capacity of the pigmentary extract was evaluated 
by chemiluminescence: a potent scavenging superoxide anions activity was shown. By using 
quantitative RT-PCR, we clearly showed that catabolic enzymes are up regulated in SIPS human 
fibroblasts, since we measured an increase of MMP-1 and MMP-3 expression. Moreover, we 
observed a decrease of mRNA level of two ECM components: type I collagen and elastin. We have 
also showed that pre-incubation of SIPS human fibroblasts with pigmentary extract strongly reduced 
senescence effects. On the other hand, we demonstrated that Fibroblast Growth Factor-2 (FGF2) 
concentration is reduced in SIPS fibroblasts and stimulated by pigmentary extract preincubation. We 
have also studied the effect of conditioned medium (CM) from SIPS fibroblasts, preincubated or not 
with pigmentary extract, on HaCaT keratinocytes proliferation. Our results showed that CM issued 
from SIPS fibroblasts inhibited HaCaT keratinocytes proliferation. Interestingly, CM issued from SIPS 
fibroblasts preincubated with pigmentary extract restored HaCaT keratinocytes proliferation. One 
of the mechanisms involved in this effect could be a stimulation of FGF2 synthesis by pigmentary 
extract. In conclusion, our results demonstrated the anti-aging properties of blue algae pigmentary 
extract. Aging affect, both, the morphology and function of skin. Remarkably, our finding indicate 
that blue algae pigmentary extract is able to counteract the age dependent decline or surexpression 
of molecular signals regulating an active exchange between epithelial and mesenchymal cells.
204
Expression of epidermal proteoglycans in various culture systems of normal human 
keratinocytes. Modulation with retinoic acid
M-A Le Bitoux1, S Callejon1, M Rodriguez Aller1, A Denis2, I Pernet2, M Haftek1 
1EA 4169, Lyon, France 2Laboratoire Bioderma, Lyon, France
Proteoglycans are complex glycoproteins associated with the extracellular matrix and 
cell surfaces. They participate in various biological processes such as assembly of 
the extracellular matrix, attachment and storage of growth factors, cation fixation 
and ion filtration, tissue hydration, or cell attachment and adhesion. In order to 
observe their protein and mRNAs expression in various differentiation states of 
the human epidermis, we performed immersed and emerged keratinocyte cultures 
in fully defined conditions. Modulation of the medium composition allowed us 
to produce a highly proliferating or an “aged” epidermis in vitro, and to test the 
effects of all-trans retinoic acid application. The protein expression patterns of 
four epidermal proteoglycans, syndecans -1, -2, -4, and CD44 and their mRNAs’ 
expression were studied with immunohistochemistry and quantitative RT-PCR. In 
both culture conditions, we obtained a well differentiated epidermis with an earlier 
differentiation and atrophy in the presence of incomplete, ‘ageing’medium. All four 
proteoglycans were synthesized in these two culture conditions and the differences 
in their distribution were mostly related to the epidermal architecture, when 
compared to the normal skin. However, the all-trans retinoic acid treatment induced 
epithelial acanthosis, combined with a slight variation of CD44, an up-regulation 
of syndecan-2 and syndecan-4 genes in both ‘aged’and ‘normal’ epidermis, and 
a down-regulation of Syndecan-1 mRNA in ‘normal’, slightly hyperproliferative 
keratinocyte cultures. Our defined culture model is suitable for testing of 
pharmacological agents potentially modulating epidermal proteoglycan expression. 
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Keratinocytes regulate expression of fibroblast genes involved in extracellular 
matrix remodelling in organotypic skin culture
AH Koskela1, M Ivarsson1, D Nowinski2, M Hakelius2, B Gerdin2, K Rubin2, K 
Engström1 1Clinical Research Center Univ Hospital, Örebro, Sweden 2Uppsala 
University, Uppsala, Sweden
Fibroblasts play a crucial role during wound healing by reconstructing the connective 
tissue and potentially interact with keratinocytes during re-epithelialization. The aim 
of the study was to investigate the role of keratinocytes for fibroblast expression of five 
groups of genes involved in extracellular matrix remodelling in a tissue-like skin model. 
Using such model, human fibroblasts were cultured in a three-dimensional collagen gel 
with human keratinocytes proliferating on top of the gel, thus imitating re-epithelialization 
during wound healing. Air-exposed keratinocytes formed a well-differentiated stratified 
epidermis on top of the gel matrix within 7 to 10 days. Gene expression in fibroblasts was 
analysed by real-time PCR seventy-two hours after seeding keratinocytes on top of the gel. 
The five groups were 1) growth-factor-like (connective tissue growth factor), 2) structural 
extracellular matrix proteins (collagen I, III and fibronectin), 3) plasmin system regulators 
(urokinase plasminogen activator and plasminogen activator inhibitor-1), 4) matrix 
metalloproteinases (MMP-1,-2 and -3) and 5) tissue inhibitors of metalloproteinases (TIMP-
1,-2 and -3). Gene expression in presence or absence of keratinocytes and/or transforming 
growth factor-β (TGF-β) were analysed. At least one gene from each group was regulated 
by TGF-β (p<0.05). Keratinocytes regulated one or several genes of each group except the 
plasmin system both in absence or presence of TGF-β (p<0.05). Overall, these changes 
support that keratinocytes regulate fibroblasts to act catabolically on the extracellular 
matrix. In conclusion, the results show that keratinocytes regulate fibroblast genes 
important for extracellular matrix remodelling in a skin-like model of re-epithelialization. 
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Anti-Aging Effects of Chondroitin Sulfate on H2O2-Induced Senescent Human Skin 
Fibroblasts and HaCat Keratinocytes
P Bogdanowicz, M Charvéron, M-J Haure Institut de Recherche Pierre Fabre, 
Toulouse, France
The ability of human skin to rejuvenate itself diminishes with the passage of time, resulting in 
increased fragility. This increased fragility reflects both reduced growth of skin cells and loss 
of connective tissue, such as collagens, proteoglycans or elastin.Chondroitin sulfate (ACS) is 
a glycosaminoglycan, which exerts anti-inflammatory and anabolic effects on chondrocyte 
matrix molecules, promotes cell-cell and cell-matrix interaction, and facilitates growth factor 
response. Surprisingly, much less is known about its biological properties in other tissues 
such as dermis and epidermis. In order to evaluate ACS on skin aging, we have developed 
an in vitro model of stress-induced premature senescence (SIPS), which is closely related 
to chronological-aging. We have evaluated the effects of ACS on matrix metalloproteinases 
(MMP) and ECM components, which are dysregulated during skin aging. We have also studied 
the effect of ACS on collagen synthesis in HaCaT keratinocytes. By using quantitative RT-PCR, 
we clearly showed that MMP-1 and -3 are up regulated, and type I collagen and elastin 
slightly decreased in SIPS fibroblasts. We have also showed that ACS strongly inhibited MMP 
over-expression and slightly induced type I collagen and elastin mRNA level. On the other 
hand, we have also demonstrated that, in HaCaT keratinocytes, ACS stimulated collagen 
synthesis, a component of basal membrane, which is quantitatively reduced during aging. This 
result suggests that ACS could counteract the structural changes observed in basal membrane.
Alterations of skin observed during skin aging are both due to modification of dermal matrix and 
structural changes in the basal membrane, probably giving a less effective tissue regeneration. 
Our findings illustrated the anti-aging properties of ACS on two different targets. ACS is able 
to reduce the exacerbated catabolic activity in dermis, by reducing MMP expression, and to 
stimulate the anabolic activity in epidermis, by stimulating collagen synthesis.
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Evidence of additional roles of plasmin in the pathology of bullous pemphigoid
CW Franzke, SC Hofmann, U Voith University Medical Center Freiburg, Freiburg, 
Germany
The hemidesmosomal transmembrane protein collagen XVII is an important anchoring 
element of the dermal-epidermal junction zone and represents the major autoantigen 
in skin blistering diseases of the pemphigoid group. Its collagenous ectodomain 
is constitutively shed from the cell surface by metalloproteinases of the ADAMs 
family, harboring most of the autoantibody epitopes. In previous studies we have 
identified the collagen XVII ectodomain in blister fluids of autoimmune blistering 
diseases, as well as in vacuum induced bullae on normal skin by immunoblot 
analysis. Further investigation revealed, that beside the 120 kDa band, representing 
the full-length ectodomain, a 97 kDa fragment of collagen XVII, already known 
as LABD97 in linear IgA bullous dermatosis, was also present in the blister fluids. 
This fragment showed positive immunostaining with NC16A directed antibodies, 
but did not react with antibodies against the distal C-terminus. Since our previous 
analysis of bullous pemphigoid blister fluids revealed significantly higher trypsin-
like serine protease activity than in control blisters, we incubated the purified 120 
kDa collagen XVII ectodomain with human serine proteases, like neutrophil elastase, 
trypsin, kallikrein 7 and plasmin. Only the addition of plasmin resulted in the 
production of a stable fragment, which showed the same size and immunoreactivity 
as the 97 kDa fragment derived from the blister fluids. In vitro treatment of HaCaT 
keratinocytes with plasmin resulted in the production of the similar 97 kDa fragment. 
This fragment was also generated in the presence of ADAM metalloproteinase 
inhibitors and remained stable over more than 12 hours incubation, which point 
to an ADAM independent cleavage of collagen XVII. Here, we have shown for the 
first time that plasmin has the capability to cleave collagen XVII directly, which 
possibly has impact in the pathogenesis of pemphigoid skin blistering diseases. 
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Platelet-activating factor reduced cohesive potential and E-cadherin expression of 
basal cell carcinoma cells
T Takahashi1, I Ando2
1University of Tsukuba, Tsukuba, Ibaraki, Japan 2Teikyo University, Kawasaki, 
Kanagawa, Japan
Basal cell carcinoma (BCC) cells invade into the dermis after the long-term 
existence within epidermis. The invasion process requires the dissociation from 
the primary tumor nest and surrounding keratinocytes in epidermal tissue. Cell-
cell adhesiveness of epidermal components is maintained by various adhesion 
molecules. E-cadherin, a 120 kDa transmembrane glycoprotein, is a major adhesion 
molecule which mediates cell-cell communication, adhesion, cellular polarity and 
morphogenesis by interacting with each other in a calcium-dependent homophilic 
manner. The present study showed the regulatory effect of platelet-activating factor 
(PAF) on E-cadherin expression and cohesion of BCC cells. PAF dose- and time-
dependently reduced E-cadherin expression at mRNA and protein levels on BCC 
cells, which was confirmed by Northern blot, Western blot and flow cytometry 
analyses. In accordance to the down-regulation of E-cadherin expression, PAF 
reduced cohesive activity of BCC cells in aggregation assay and augmented motile 
activity in the invasion assay using modified Boyden chambers. Those PAF effects 
were significantly attenuated by PAF-R antagonist TCV309. PAF is a pleiotropic ether 
phospholipid involved in various immune responses. Its production is transiently 
induced by some stimulation to the restricted types of cells such as lymphocytes 
and fibroblasts. PAF-mediated pathogenesis in various events may therefore require 
certain trigger and not be lasting. Our results suggest that PAF could participate 
in dermal invasion process of indolent BCC cells via E-cadherin down-regulation. 
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Regulation of palladin expression in normal and scleroderma skin fibroblasts
NK Hieta, R Hautala, O Carpen, V-M Kähäri University of Turku, Turku, Finland
Prolonged exposure of dermal fibroblasts to TGF-beta results in their differentiation 
to myofibroblasts, which play an important role in dermal wound contraction and 
dermal fibrosis. Palladin is a recently identified cytoskeletal protein which controls 
integrity of stress fibers. Palladin is expressed in several isoforms, including major 3Ig 
(90 kDa) and 4Ig (130 kDa) isorms. Here, we have studied the expression of palladin 
in comparison with the classic myofibroblast specific cytoskeletal protein, alpha-
smooth muscle actin (alpha-SMA), in normal and scleroderma skin fibroblasts in 
culture and in vivo. In scleroderma skin, expression of palladin 4Ig isoform was noted 
in fibroblasts by immunohistochemistry. In normal skin fibroblasts treated with TGF-
beta, palladin 4Ig isoform appeared by 12 h, wheras alpha-SMA is noted later, by 24 
h. In normal dermal fibroblasts, up-regulation of palladin 4Ig isoform expression by 
TGF-beta1 is further enhanced by adenoviral overexpression of wild-type Smad3, 
and it was inhibited by dominant negative Smad3 and by inhibitory Smad, Smad7. 
In sclerodema fibroblasts, up-regulation of 4Ig and alpha-SMA expression by TGF-
beta1 was enhanced by Smad3, and even more potently by Smad7. The expression 
of 4Ig induced by TGF-beta1 was not enhanced by activation of ERK1,2 signaling 
by constitutively active MEK1 in normal or scleroderma skin fibroblasts. These 
data show, that the TGF-beta induced early expression of palladin 4Ig isoform in 
scleroderma fibroblasts is regulated differently from normal human skin fibroblasts. 
The results may be of use in development of early diagnosis and targeted therapy for 
dermal fibrosis in scleroderma.
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Potential role of a novel transmembrane collagen (collagen XXIII) in epidermal 
homeostasis?
G Veit1, E Zimina2, CW Franzke2, J Käpylä3, MC Zweers1, S Stickler4, B Eckes1, MK 
Gordon5, J Eble6, J Heino3, L Bruckner-Tuderman2, M Koch1 1Univ of Cologne, Germany 
2Univ of Freiburg, Germany 3Univ of Turku, Finland 4Max Planck Inst Mol Genetics, 
Berlin, Germany 5Rutgers Univ, Piscataway, USA 6Univ of Münster, Germany
Collagen XXIII, a transmembrane collagen, belongs to the growing subclass of type II orientated 
membrane-bound collagens. These proteins exist in two versions: a membrane-bound and a shed 
form. Expression of collagen XXIII in mouse is restricted to skin, lung, gut, brain and kidney. 
Collagen XXIII occurs predominantly in the epidermis and hair follicles as full-length protein, while 
the shed form is detected in the brain, indicating that shedding is regulated in a tissue-specific 
fashion. To further analyze the shedding process of collagen XXIII, mutations were introduced in 
the two putative cleavage sites. This study clearly indicated furin as major physiological protease 
required for shedding. The microenvironment in the plasma membrane is a further important 
regulator of the shedding process, as most collagen XXIII is present in lipid rafts, and the disruption 
of lipid rafts by partial removal of cholesterol clearly enhanced shedding. Cellular receptors for 
collagens belong to the family of β1 integrins. Using immunofluorescence studies with antibodies 
against collagen XXIII, we observed a distribution that was similar to the cellular distribution of 
integrin α2β1. Solid phase assays and SPR-spectroscopy revealed binding of collagen XXIII to 
α2β1, but not to any of the other collagen-binding integrins. This data was confirmed by cell 
attachment assays using primary keratinocytes from the skin of mice lacking integrin α2β1, which 
we generated. Cell spreading and focal contact formation on collagen XXIII substrate further 
requires interaction with heparin sulphate proteoglycans. In tissue and cell culture, plasma 
membrane-localized collagen XXIII is concentrated at sites of cell-cell contacts suggesting that 
collagen XXIII is a component of cell-cell attachment complexes and together with α2β1 integrin 
mediates cell-cell binding of keratinocytes. These studies demonstrate a novel mechanism for cell-
cell binding of keratinocytes via a transmembrane collagen ligand and integrin α2β1.
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Epidermal Insulin and IGF-1 signaling cooperatively regulate skin morphogenesis 
and homeostasis
CM Niessen, H Ibrahim, L Koch, H Lübken, C Wickenhauser, JC Brüning University 
of Cologne, Cologne, Germany
Epidermal morphogenesis and homeostasis is a complex process involving signaling interactions 
between the epidermal and mesenchymal compartment. Disruption of the IGF-1 receptor in mice 
disturbed epidermal morphogenesis but at present it is unclear if this stems from autonomous 
signaling in the epidermal compartment or results from impaired epidermal-mesenchymal cross 
talk. To address if epidermal IGF-1 signaling directly regulates epidermal morphogenesis we 
inactivated the IGF-1 receptor (IGF-1R) and its close relative the insulin receptor (IR) specifically 
in this compartment. Whereas the IRepi-/- mice have a macroscopically normal looking skin, 
the IGF-1Repi-/- and IR/IGF-1Repi-/- mice show a shiny and translucent skin, associated with 
perinatal lethality. Nevertheless, histological analysis revealed a decrease in epidermal thickness 
in the in the IRepi-/- mice, which was more substantial in the IGF-1Repi-/- mice and most dramatic 
in the IR/IGF-1Repi-/- double knockout mice. This shows that the number of epidermal layers is 
cooperatively determined by cell autonomous IGF-1 and Insulin signaling. Differentiation was 
not obviously disturbed as normal staining was observed with several markers for the different 
epidermal layers. However, keratin 6 expression was upregulated in the IGF-1Repi-/- and IR/
IGF-1Repi-/- mice, indicating a disturbance of normal epidermal homeostasis. Surprisingly, no 
difference was observed in either apoptosis or proliferation in perinatal epidermis. In contrast, 
IGF-1R-/- but not IR-/- keratinocytes showed impaired growth in vitro when cultured in the 
absence of fibroblasts. The epidermal progenitor marker Keratin 15 was reduced in both the 
IRepi-/- and IGF-1Repi-/- mice, suggesting that insulin and IGF-1 signaling regulate the number 
of epidermal progenitor cells. Pathway analysis suggests the involvement of AKT but not MAPK 
in the regulation of epidermal IR and IGF-1R signaling. Overall, our data clearly show that IR 
and IGF-1R cooperatively regulate epidermal morphogenesis in a cell autonomous manner. 
212 [Oral 044]
Kindlin-1 regulates proliferation, polarity and motility of epidermal keratinocytes 
through EGF- and integrin-mediated signaling pathways
CB Herz, MJ Recknagel, L Bruckner-Tuderman, C Has Univ of Freiburg, Germany
Kindlin-1 is an epithelial-specific focal adhesion phosphoprotein in the skin. Mutations 
in the kindlin-1 gene, KIND1, cause the Kindler syndrome (KS), a human disorder 
characterized by skin blistering, progressive poikiloderma, mild photosensitivity and 
increased risk of mucocutaneous malignancy. It is the first genetic skin disease associated 
by abnormalities of focal adhesions and the actin cytoskeleton, but the disease mechanisms 
are not well understood. Our previous in vivo and in vitro studies demonstrated that the 
molecular mechanisms underlying the phenotypic features include diminished proliferation 
and adhesion, abnormal cell shape and polarity, and impaired directional migration of 
kindlin-1 deficient keratinocytes. Here we show that these functional defects are kindlin-1 
mediated, since they can be reverted by transfection with normal kindlin-1. Subsequently, 
the signalling pathways involved in these processes were analyzed in primary keratinocytes 
from normal and KS skin. Kindlin-1 deficiency led to a 2.2-fold increase of Rac-1 activity. 
Accordingly, the phosphorylation of the downstream mediator cofilin was reduced by 40%, 
reflecting higher cofilin activity and consequently the activation of actin polymerisation 
in lamellipodia and filopodia. Phosphorylation of MAPK Erk1 and Erk2 was decreased 
by 60%, while paxillin and phosphorylated JNK were increased in kindlin-1 deficient 
keratinocytes as compared to normal cells. EGF, an important player in these pathways, 
induced kindlin-1 expression and phosphorylation. These results demonstrate that EGF 
activates kindlin-1 through phosphorylation and that kindlin-1 controls the activity of Rac-1, 
cofilin, MAPK and JNK. Taken together, kindlin-1 is involved in integrin- and EGF-mediated 
signalling pathways, which regulate actin polymerization, cell-cycle progression and 
survival, cell polarity, cell - extracellular matrix interactions and migration in the epidermis. 
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Synergy between Rambazole (R115866) and retinoic acid alters the gene expression 
of heparin-binding EGF-like growth factor and involucrin in autocrine cultures of 
keratinocytes
S Giltaire1, F Herphelin1, P Stoppie2, Y Poumay1 1University of Namur (FUNDP), 
Namur, Belgium 2Barrier Therapeutics, Geel, Belgium
Retinoic acid is known to regulate keratinocyte proliferation and differentiation and 
is used in treatment of acne, photoaging or psoriasis. The heparin-binding EGF-like 
growth factor (HB-EGF) is induced by retinoic acid treatment of cultured human 
keratinocytes and this growth factor has been shown to be responsible for retinoic acid-
mediated epidermal hyperplasia. Rambazole (R115866, from Barrier Therapeutics) 
is a novel inhibitor of the cytochrome P450 (specifically CYP26). The inhibition of 
these enzymes results in a selective block of hydroxylases involved in the metabolic 
inactivation pathway of retinoic acid. Therefore, Rambazole increases the levels 
of endogenous retinoic acid in plasma and skin. In the present study we analysed 
the mRNA and protein level in autocrine culture of normal keratinocyte (which 
means a culture without exogenous growth factors), and observed that retinoic acid 
treatment induces HB-EGF expression and upregulates involucrin expression (a late 
marker of differentiation). Rambazole alone did not induce HB-EGF, nor involucrin 
expression. However, when Rambazole at different concentrations (10-9 to 10-6 M) 
was combined with retinoic acid (10-9 and 10-8 M), we observed a very significant 
increase in the expression of HB-EGF and involucrin. Keratin 10 expression does 
not seem to be influenced by Rambazole combined with retinoic acid. These results 
show that Rambazole combined with retinoic acid modifies gene expression (HB-
EGF and involucrin) in epidermal keratinocytes, in opposition to Rambazole alone.
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Epidermal Growth Factor Receptor trafficking after ligand-independent activation 
in keratinocyte is partially dependent on p38 activation
S Lambert, H Ameels, M Herin, Y Poumay Univ of Namur (FUNDP), Namur, Belgium
Keratinocyte is the major epidermal cell type and its proliferation is tightly regulated 
by the Epidermal Growth Factor Receptor (EGFR) present in the plasma membrane. 
In absence of ligand, the EGFR is mainly located in membrane micro-domains 
called lipid rafts, which act as traps for the receptors and inhibit its downstream 
signalisation. We have previously shown in keratinocytes that lipid raft disruption 
induced by cholesterol depletion with methyl-beta-cyclodextrin activates the EGFR 
in a ligand-independent manner, as well as the MAPKinases ERK 1/2 and p38. We 
focus here on cellular events that usually follow EGFR activation after ligand binding 
(i.e. dimerization, internalization) in cholesterol depleted keratinocytes. Ligand-
independent EGFR activation is also followed by receptor dimerization but not by 
immediate internalization. Rather, we observe a delayed phosphorylation of Tyr 1068 
on EGFR which is concomitant with observation by confocal microscopy showing a 
re-localisation of the EGFR towards the cell cytoplasm. This internalization is partially 
dependent on p38 MAPK activation as its specific inhibitor PD169316 is able to 
slow down EGFR internalization. Taken together, our results show that disruption of 
lipid rafts induces activation and dimerization of the EGFR. Slow internalization of 
EGFR, possibly linked to phosphorylation of Tyr 1068 and partly dependent of p38 
activation suggests that temporary removal of EGFR from the cell surface this could be 
a protective step impeding keratinocyte to proliferate under stress conditions. 
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Lipid raft disruption induces Heparin-binding-EGF-like growth factor (HB-
EGF) Signalling in Keratinocytes and is reminiscent of Oxidative Stress and Skin 
Wounding
C Mathay, S Giltaire, Y Poumay University of Namur (FUNDP), NAMUR, Belgium
Maintenance of epidermal homeostasis is of greatest physiological importance for our 
body. Keratinocytes responding at several signal transduction pathways function to 
restore tissue homeostasis. The integrity of lipid rafts, plasma membrane microdomains, 
is essentially dependent on the presence of cholesterol and sphingolipids. To analyse 
lipid raft-dependent signalling, we incubated confluent keratinocyte cultures with the 
cholesterol-sequestering agent methyl-beta-cyclodextrin. In this study, we show that 
lipid raft disruption induces a p38MAPK-dependent expression of the growth factor 
HB-EGF. This induction is reminiscent of other stresses like oxidative stress caused 
by hydrogen peroxide or cutaneous injury. In these in vitro and in vivo situations 
high HB-EGF expression levels were detected. Immunolabelling of wounded human 
skin shows that expression of HB-EGF is induced in the epidermal margin of the 
wounded skin and serial sections reveal that the epidermal margin also presents 
alterations in the expression of differentiation markers. Intriguingly, identical 
alterations are engendered in cultured keratinocytes treated with recombinant HB-
EGF. In addition, increased HB-EGF expression levels are also observed in vitro 
in a wounded epidermis. All together, these results support the hypothesis that 
keratinocytes induce stress-like signalling pathways resulting in the synthesis of HB-
EGF when sensing oxidative stress or following disorganization of their lipid rafts. 
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TNF-α Represses Connexin43 Expression in HaCat Cells via Activation of JNK 
Signaling
F Verrecchia, C Tacheau, C Leroy, J Laboureau, A Mauviel INSERM U697, Paris, France
We used both pharmacological and gene knockout approaches to elucidate the 
specific roles played by the Jun-N-terminal kinase (JNK) and NFkB pathways 
downstream of TNF-α in the context of connexin43 (Cx43) gene expression. We 
demonstrate that TNF-α reduces the expression of Cx43 in HaCat cell lines at the 
protein and mRNA levels, and transcriptionally. We also demonstrate that TNF-α 
decreases gap junctional intercellular communication (GJIC) between HaCat cells. 
Using pharmacological inhibitors of the NFkB signaling pathway, we determined that 
the NFkB signaling cascade is not implicated in TNF-α effect on Cx43 expression 
and in the subsequent decrease of GJIC. Conversely, in NFkB essential modulator 
(NEMO-) fibroblasts, lack of NFkB activation did not influence both the effect of 
TNF-α on Cx43 expression and on GJIC. In contrast, pharmacologic inhibition of JNK 
abolishes TNF-α-driven repression of Cx43 gene expression and GJIC between HaCat 
cells. Using JNK1-/--JNK2-/- (JNK-/-) fibroblasts, we demonstrate that similar regulatory 
mechanisms take place in fibroblasts. Together, these results identify JNK and not 
NFkB, as a critical mediator of TNF-α repressory effect on Cx43 gene expression. 
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Hypoxia impairs myofibroblast function: a possible cause of chronic wounds?
SAMG Modarressi1, B Pittet1, B Hinz2 1University Hospital of Geneva, Switzerland 
2EPFL, Lausanne, Switzerland
Acute hypoxia supports dermal wound healing by promoting inflammation, but leads to 
the development of chronic wounds when persisting. Wound contraction is promoted by 
myofibroblasts, specialized fibroblastic cells that generate contractile activity by de novo 
expressing smooth muscle actin (SMA). We here investigated how hypoxia influences 
myofibroblast development and function in vivo and in vitro. To first study the effect of 
hypoxia on wound healing, we created wounds in lower limbs of rats and induced ischemia 
by excising the left external iliac and femoral artery. Expression of SMA and wound surface 
reduction was compared with normally healing control limb. Second, to decipher the direct 
effect of hypoxia on rat subcutaneous fibroblasts and myofibroblasts in vitro, we assessed 
proliferation and SMA expression after 5d culture in normoxia (21% O2) and hypoxia (2% 
and 5% O2). Levels of TGFbeta1 were measured and contraction was evaluated using 
deformable silicone substrates. In vivo, ischemia delayed wound closure by 10d compared 
with control, correlating with decreased myofibroblast differentiation (p<0.01). In vitro, 
cell proliferation increased significantly in hypoxia (p<0.01). However hypoxia decreased 
expression of myofibroblast markers and myofibroblast contraction (p<0.01); myofibroblast 
differentiation was not restored by exogenous TGFbeta1. Moreover, the level of active 
TGFbeta1 in the supernatant of cells in hypoxia was significantly higher compared with 
normoxia. (p<0.01). At the same time, expression levels of TGFbeta1 receptor type II were 
down-regulated. Hypoxia impairs myofibroblast differentiation and function in vitro and in 
vivo. This phenomenon occurs despite increased autocrine production of active TGFbeta1 
and is not rescued by exogenous TGFbeta1 treatment. We are further exploring how hypoxia 
uncouples SMA expression in fibroblasts from TGFbeta1 signaling with the aim to develop 
new therapeutic strategies that target altered healing in chronic wounds.
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Fibroblast growth factor receptors 1 and 2 are crucial regulators of skin 
morphogenesis and wound repair
S Werner1, J Yang1, M Meyer1, F Böhm1, M Ornitz2, M Partanen3 1ETH Zurich, 
Switzerland 2Washington Univ Medical School, St Louis, USA 3University of Helsinki, 
Helsinki, Finland
Fibroblast growth factors (FGFs) comprise a family of 22 different mitogens, which 
regulate development, homeostasis and repair of different tissues and organs. They 
exert their functions by binding to four different tyrosine kinase receptors, designated 
FGFR1-FGFR4. Since FGFR1 and FGFR2 are highly expressed in keratinocytes, we 
generated and characterized mice, which lack these receptors in the epidermis. The 
loss of these receptors in keratinocytes was confirmed at the RNA and protein level. 
Furthermore, cultured keratinocytes from these mice had lost the responsiveness to 
FGF-7 and FGF-10. The double knockout mice showed a very severe phenotype, 
including complete loss of hair and sebaceous glands, smaller body size and sterility. 
Surprisingly, they showed epidermal hyperthickening, enhanced proliferation of 
basal keratinocytes and altered keratinocyte differentiation as determined by the 
expression of differentiation-specific proteins. This phenotype is most likely indirect 
and mediated via the stroma, since primary keratinocytes from the double knockout 
mice proliferate normally. Upon skin injury, a severe delay in reepithelialization 
was observed, which predominantly results from impaired keratinocyte migration 
as determine by in vitro studies. Taken together, our results revealed important 
functions of FGFR1 and FGFR2 in skin morphogenesis and wound repair. 
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Short term hyperoxia induces long-lasting effects on cultured skin cells
L Kolbe, N Peters, F Staeb, C Mummert, H Wenck, T Blatt Beiersdorf AG, Hamburg, 
Germany
It is well known, that short term hyperoxia during the hyperbaric oxygen therapy 
has beneficial effects on healing of chronic wounds. In this study we evaluated the 
effects of various concentrations of oxygen on skin cell physiology. Dermal, human 
fibroblasts were incubated in an atmosphere of 40 % oxygen for different periods 
of time (5 minutes to 72 hours). 24 hours after oxygen treatment we measured 
proliferation, status oxidative stress markers, glutathione peroxidases activity 
and cell vitality. We were able to show that short time hyperoxia (< 2h) induced 
a significant rise in cell vitality and proliferation without inducing oxidative stress. 
long-term hyperoxia (> 24h) induced the opposite effect with increased oxidative 
stress and a decline in cell vitality and proliferation. Taken together our data show 
that short-term hyperoxia (5 minutes to 2 hours) induces long-lasting beneficial 
effects on vitality and proliferation, whereas the adverse effects of oxygen treatment 
are evident only after prolonged hyperoxic incubation for 24 hours or longer. 
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Oxygen activates skin cells by triggering the ERK 1/2 signal transduction pathway
N Peters, L Gonda, C Mummert, F Staeb, H Wenck, L Kolbe Beiersdorf AG, Hamburg, 
Germany
In previous experiments we were able to show that short term hyperoxia for 10 
minutes enhances the proliferation of human skin cells. The aim of this in vitro study 
was to evaluate the signal transduction pathway which triggers the oxygen-induced 
proliferation of human fibroblasts. We analysed several MAP Kinases under various 
hyperoxic conditions. Dermal, human Fibroblasts were cultured under hyperoxic 
conditions (=40 % O2) and analyzed directly after different times of incubation. The 
ratio between phosphorylated and total MAP Kinase was measured and calculated. 
The results show, that short term hyperoxic incubation (1-5 minutes) activates the 
MAP-Kinase ERK 1/2 but not p38 and JNK in dermal human fibroblasts. Repeated 
oxygen exposure experiments showed that ERK1/ 2 cannot be activated again within 
2 hours of the first trigger. The responsiveness slowly recovered over time and was 
fully restored 6 hours after the first exposure. The data show that oxygen activates 
a not yet identified oxygen sensor which triggers the ERK 1/2 pathway leading to 
enhanced proliferation of human fibroblasts.
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The expression of the immediate early gene IEX-1 (IER-3) is increased in psoriasis 
and up-regulated by TNF-α
F Scholz, M-L Kruse, A Arlt, H Schäfer, E Proksch University of Schleswig-Holstein, 
Kiel, Germany
The stress response gene IEX-1 (immediate early gene-X-1) regulates apoptosis, 
differentiation and cellular growth in many different cell types. IEX-1 is a highly 
regulated gene with binding sites in the promoter sequence for p53, SP1, and nuclear 
factor-kB (NF-kB). IEX-1 is known to be expressed in keratinocytes and to regulate the 
growth rate of keratinocytes in cell culture. Overexpression of IEX-1 in keratinocytes 
leads to enhanced proliferation. Psoriatic skin is characterized by inflammation and 
keratinocyte hyperproliferation. Antibody treatment shows the crucial role of TNF-α in 
the patho-physiology of the disease. We were interested in the regulation of IEX-1 in 
keratinocytes and in the expression of the gene in psoriasis. We analysed the expression 
of IEX-1 in the epidermis of psoriatic plaques and in non-lesional skin of psoriatic 
patients by quantitative realtime PCR and by confocal laser scanning microscopy. 
We found that IEX-1 is significantly up-regulated in psoriatic plaques, but not in 
non-lesional skin. Confocal microscopy revealed that IEX-1 is localized in the entire 
nucleated epidermis and concentrated in the granular layers of the psoriatic skin which 
reappear during psoriatic hyperplasia. Stimulation of keratinocytes in HaCaT cells by 
TNF-α led to an enhanced expression of IEX-1. Electro Mobility Shift Assay (EMSA) 
showed that the stimulation led to a shift of NF-kB from the cytoplasma to the nucleus. 
In summary, IEX-1 is up-regulated in psoriatic plaques, enhanced levels of TNF-α in 
HaCaT cells cause a shift of NF-kB to the nucleus which leads to the activation of IEX-1. 
IEX-1 may be involved in keratinocyte hyperproliferation well known in psoriasis. 
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P75 neurotrophin receptor exerts pro-apoptotic functions in human keratinocytes: 
a role in psoriasis
A Marconi1, F Truzzi1, R Lotti1, K Dallaglio1, C Vaschieri1, R Tiberio2, C Pincelli1 
1University of Modena and Reggio Emiliana, Modena, Italy 2University of Piemonte 
Orientale, Novara, Italy
P75 neurotrophin receptor (p75NTR) belongs to the TNF-receptor superfamily and signals 
apoptosis in many cell settings. We have previously shown that p75NTR is detected in 
a subpopulation of basal keratinocytes. Moreover, p75NTR is more expressed in transit 
amplifying cells (TA) that are more susceptible to apoptosis, than in stem keratinocytes, 
which are completely protected from cell death. The aim of the present study was to 
evaluate whether p75NTR mediates apoptosis in human keratinocytes. We report that beta-
amyloid, a ligand for p75NTR, induces apoptosis in human keratinocytes, as shown by 
the activation of caspase-3 in p75NTR expressing cells. Brain-derived neurotrophic factor 
(BDNF) and neurotrophin-4 (NT4) which signal through p75NTR, induce a higher rate of 
apoptosis in HaCaT cells overexpressing p75NTR, as compared to mock cells. On the other 
hand, NT4 fails to induce cell death in p75NTRsiRNA transfected HaCaT cells. Psoriasis 
is characterized by keratinocyte hyperproliferation and by a reduced rate of apoptosis. In 
psoriasis, NGF levels are increased, while TrkA is expressed throughout the epidermal layers, 
as compared to normal skin. TrkA up-regulation in psoriasis is also confirmed by western 
blotting. By contrast, p75NTR protein disappears in psoriatic lesional skin. In addition, 
p75NTR levels are significantly lower in psoriatic than in normal keratinocytes, as shown 
by flow cytometry. Beta-amyloid fails to induce apoptosis in psoriatic keratinocytes likely 
because of the lack of p75NTR. As p75NTR is predominantly expressed in TA cells, we 
compared these subpopulations in psoriatic versus normal keratinocytes. We found that the 
rate of apoptosis in psoriatic TA cells is significantly lower as compared to normal TA cells. 
These results indicate that p75NTR acts as a proapoptotic receptor in human keratinocytes. 
Absence of p75NTR could account for the resistance of psoriatic keratinocytes to apoptosis. 
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Identification of a novel 54 kDa hepatocyte growth factor (HGF) isoform during 
wound repair
N Buchstein1, M Piekarek1, M Gerharz1, C Niemann2, T Krieg1, S Eming1 1University of 
Cologne, Germany 2Center for Molecular Medicine Cologne, Germany
Hepatocyte growth factor (HGF) is a mesenchymal derived 64 kDa cytokine that is proteolytically 
generated from a HGF pro-form (94 kDa). Binding its receptor MET leads to stimulation of 
proliferation, motility, and morphogenesis in different epithelial cell types, supports angiogenesis, 
modulates fibrinolysis and monocyte performance, thus suggesting an important function in tissue 
repair. Recently, a kallikrein mediated 54 kDa HGF-isoform of unknown biological significance 
was identified. However, so far kallikrein mediated processing of HGF in vivo has not been 
reported. Further, the impact of the 54 kDa/64 kDa HGF/c-MET axis on cutaneous tissue repair 
remains elusive. Goal of the project is the functional analysis of proteolytically processed HGF 
and ligand/receptor signalling in cutaneous wound repair. As revealed by immunohistochemistry 
of murine and human wounds expression of HGF and c-MET were highly upregulated during 
cutaneous repair. Whereas HGF expression was localized in the granulation tissue, epithelial 
wound edges and cells within the granulation tissue stained highly positive for c-MET. In 
wound fluid of healing and chronic non-healing human wounds high levels of HGF protein 
were detected. As indicated by SDS-PAGE and western blot analysis the HGF form present 
in wound fluid was predominantly detected by 54 kDa; the 64 kDa form was detected at low 
levels. Kallikrein activity was increased in wound fluid of healing and non-healing wounds and 
might be involved in HGF processing at the wound site. Kallikrein processing of HGF attenuated 
keratinocyte proliferation and migration in vitro, whereas scatter activity was not affected. Our 
data indicates that next to the known 64 kDa HGF protein a novel, alternative 54kDa HGF 
isoform influences HGF/c-MET signalling in cutaneous wound repair. Kallikrein processing 
of HGF might modulate HGF activity during repair. Under conditions in which proteases are 
imbalanced, such as in chronic non-healing wounds, this process might compromise HGF activity. 
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Metabolism and Biological Activities of Topical 4-Oxoretinoids in Mouse Skin
O Sorg, C Tran, P Carraux, C Barraclough, JF Arrighi, P Descombes, V Piguet, 
JH Saurat, D Grand Geneva University Hospital, Geneva, Switzerland
Retinoic acid mediates most of the biological actions of vitamin A. It is oxidised by 
CYP26 to 4-oxoretinoic acid, considered as an inactive catabolite of retinoic acid. 
However, a few studies demonstrated the presence of 4-oxoretinal or 4-oxoretinol 
as the predominant retinoids during morphogenesis in various in vitro models. In 
this study, we analysed the retinoid-like biological activity of these 4-oxoretinoids in 
mouse skin in vivo, using well-established pharmacologic models of retinoid activity. 
In order to correlate the biological activity, if any, with the retinoid metabolites 
generated in the epidermis by topically applied oxoROL and oxoRAL, epidermal 
retinoids were analysed by HPLC. Topical 4-oxoretinal and 4-oxoretinol promoted 
significant epidermal hyperplasia and metaplasia in mouse tail. They induced a 
moderate response for epidermal inflammation, compared to retinal, whereas 
neither 4-oxoretinal nor 4-oxoretinol prevented menadione-induced epidermal 
lipid peroxidation, unlike to retinal and retinol. As analysed by quantitative PCR, 
4-oxoretinal and 4-oxoretinol did not reproduce the dramatic increased expression 
of genes coding for keratin 4, amphiregulin, HB-EGF and CYP26, that did induce 
retinal and retinol. However both retinal and 4-oxoretinal significantly inhibited 
the LPS-induced maturation of human dendritic cells in vitro. As analysed in vivo 
and in vitro, 4-oxoretinal and 4-oxoretinol were not converted to retinoic acid. We 
conclude that 4-oxoretinal and 4-oxoretinol exert a moderate direct retinoid-like 
activity in vivo, thus confirming previous in vitro studies in amphibians showing 
4-oxometabolites of vitamin A as bioactive agents rather than inactive catabolites. 
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Role of human skin resident T cells in wound healing
A Toulon1, D Bhavsar2, M Tenenhaus2, N Pineau3, L Breton3, J Jameson1, WL Havran1 
1The Scripps Research Institute, La Jolla, USA 2UCSD, San Diego, USA 3L’Oréal 
Recherche, Clichy, France
Cutaneous wound healing is a complex process requiring constant communication 
between cells in the form of cytokine release, cell-to-cell contacts and cell-to matrix 
interactions. Skin gammadelta T cells have been shown to play unique roles in tissue 
homeostasis and during tissue repair through local secretion of distinct growth 
factors in mice. However, because the distribution of resident T cells (gamma delta 
vs alpha beta) is different in mice and humans we aimed to characterize the role 
of epithelial resident T cells in wound repair in humans. To address this question 
we used flowcytometry on freshly isolated T cells from normal skin (epidermis and 
dermis) and acute wounds from burn patient to analyse their ability to secrete Insulin-
like Growth Factor-1 (IGF-1), a growth factor that has been shown to be critical for 
wound healing. We report here, that both cell types are present in normal skin and 
at the wound site. Moreover, we show that the freshly isolated Vdelta1 gamma delta 
and alpha beta resident T cells secrete IGF-1 after in vitro stimulation. Interestingly 
both cell types are activated in acute wounds and secrete IGF-1 to promote 
wound healing at an early stage of the wound process. These data introduce a new 
type of cells at an early phase of the cascade of the wound healing process. The 
characterization of the functional activity of resident T lymphocytes in acute wounds 
should help to develop of new therapeutic strategies against chronic wounds. 
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HIF-1α: a key factor in keratinocyte response to UVB exposure
H Rezvani1, S Dedieu2, S North2, F Belloc1, R Rossignol3, T Letellier3, H De Verneuil1, 
A Taieb1, F Mazurier1 1Inserm U876, Bordeaux, France 2Inserm 0113, Bordeaux, 
France 3Inserm U668, Bordeaux, France
UV radiations are the major risk factor for the development of skin cancer (the most common 
malignancy in the world). To develop a strategy for the prevention and the therapy of skin 
cancers, relationships between the various cellular signaling pathways that modulate cellular 
responses to UV irradiation in skin cells need a more in-depth understanding. Within the 
complex group of UV-induced cellular responses, the role of reactive oxygen species (ROS) 
appears central with dual effects. On the one hand, increase in ROS levels following UVB 
irradiation lead to cytotoxicity through protein, lipid and DNA oxidation. On the other hand, 
ROS act as second messengers mediating the cell response to UVB. We have previously reported 
that reinforcement of the antioxidant defense of epidermis reduces the deleterious effects of 
UVB-induced ROS. In the present study, we addressed the possible role of ROS as second 
messengers after UVB irradiation and their relationship with a stress-inducible transcription 
factor, the hypoxia inducible factor-1 alpha (HIF-1α). We found that UVB irradiation induces 
a biphasic HIF-1α protein (but not RNA expression) variation through reactive oxygen species 
(ROS) generation in normal human keratinocytes. We demonstrated, using transduction of 
keratinocytes with different lentiviral vectors expressing catalase, CuZnSOD and MnSOD, 
that rapid production of cytoplasmic ROS down-regulate HIF-1α expression, whereas delayed 
mitochondrial ROS generation result in its up-regulation. Indeed, our experiments revealed 
that activation of p38 MAPK and JNK1 mediated by mitochondrial ROS were required for 
HIF-1α phosphorylation and accumulation after UVB irradiation. We also showed, using a 
lentivector expressing shRNA against HIF-1α, a key role of HIF-1α in mediating UVB-induced 
apoptosis. We conclude that the broad impact of the HIF-1 transcription factor on gene 
expression could make it a key regulator of UV-responsive genes and photocarcinogenesis. 
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Secreted Hsp90alpha promotes human epidermal and dermal cell migration via 
the CD91/LRP/alpha2-macroglobulin receptor, but independently of its chaperon 
function
W Li, S Guan, M Chen, DT Woodley Univ of Southern California, Los Angeles, USA
Re-epithelialization is a critical event in human skin wound healing, in which epidermal 
keratinocytes are induced to migrate laterally to close a wound. In chronic wounds, the re-
epithelialization process is blocked and the wounds remain open, causing patient morbidity 
and even fatality. The lack of effective therapeutic targets in this process remains as a major 
challenge for new and effective treatments. Transforming growth factor-alpha(TGFalpha) 
is a critical inducer of human keratinocyte (HK) migration. Therefore, we investigated 
how TGFalpha’s pro-motility signal travels in HKs. First, we found that TGFalpha-induced 
secretion of HKs retained the full HK migration-promoting effect of TGFalpha. Second, 
protein purification followed by mass spectrometry analyses of the secretion allowed us 
to identify the heat shock protein-90alpha (hsp90alpha) as the secreted protein that carries 
the TGFalpha’s pro-motility effect on HKs. Consistently, TGFalpha selectively stimulated 
membrane translocation and secretion of hsp90alpha in HKCs, but not in dermal fibroblasts 
(DFs) or dermal microvascular endothelial cell (HDMECs), in the absence de novo protein 
synthesis. Third, however, highly purified hsp90alpha fully duplicates TGFalpha’s pro-
motility effect and potently promotes migration of DFs and HDMECs, as well. Fourth, unlike 
the chaperon action of intracellular hsp90alpha, extracellular hsp90alpha promoted the cell 
migration without ATP binding, ATPase activity or binding to co-factors. Fifth, our results of 
1) genetic, 2) silencing RNA and 3) neutralizing antibody approaches clearly demonstrated 
that the CD91/LRP/alpha2-macroglobulin receptor mediated hsp90alpha-stimulated skin 
cell migration. Finally, topical application of recombinant hsp90alpha markedly accelerated 
wound re-epithelialization and closure in mice. Thus, the extracellular hsp90alpha 
secreted by migrating HKs acts as a potent autocrine motogen for all major skin cell types. 
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Towards the pathogenesis of cutaneous side-effects induced by inhibitors of the 
epidermal growth factor receptor
PA Gerber, S Kellermann, E Enderlein, P Ansari, R Kubitza, R Guadarrama-Gonzalez, 
C Mackenzie, B Homey Heinrich-Heine-University, Düsseldorf, Germany
In this study we analyze the function of the receptor of the epidermal growth factor 
(EGFR) for the cutaneous expression of chemokines and antimicrobial peptides. Recently, 
inhibitors of the EGFR (EGFRI), like the small molecule tyrosine kinase inhibitors erlotinib 
(Tarceva®) and gefitinib (Iressa®), or the monoclonal antibody cetuximab (Erbitux®) have 
been established successfully as [quotleft]targeted cancer drugs’ in the clinical practice. 
Most frequent and most severe side-effects of this class of drugs are cutaneous toxicities 
occurring in more than 50 percent of the patients. Patients treated with EGFRI develop 
a characteristical inflammatory papulopustular rash, xerosis cutis, as well as hair and 
periungual alterations. In the course superinfections of the rash occur frequently. These 
clinical observations assume, that the EGFR critically regulates cutaneous inflammation and 
infection. Nevertheless, the pathogenesis of EGFRI induced cutaneous side-effects has yet to 
be elucidated. This study analyses the in vitro expression of chemokines and antimicrobial 
peptides in primary human keratinocytes treated with inhibitors of the EGFR (EGFRI) using 
quantitative realtime PCR. Moreover, we examine the in vivo expression of chemokines in 
skin samples of patients treated with the EGFRI erlotinib using immunohistochemistry. Our 
results demonstrate that the EGFR in fact controls the cutaneous expression of chemokines 
and antimicrobial peptides. In particular, we show that the blockade of the EGFR induces 
an overexpression of proinflammatory chemokines as well as a suppression of antimicrobial 
peptides in human keratinocytes. In line with these findings, cell supernatants of EGFRI 
treated kertinocytes demonstrate a reduction of the cytotoxic activity against Staphylococcus 
aureus as compared to medium controls. Our results present interesting new insights into 
the pathogenesis of cutaneous side-effects associated with the use of EGFRI. 
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Impaired Akt-signalling in keratinocyte derived cell lines in response to hepatocyte 
growth factor stimulation
V Mlitz, M Mildner, E Tschachler Medical University of Vienna, Vienna, Austria
Recently we have shown, that hepatocyte growth factor (HGF) potently protects human 
primary keratinocytes (KC) from UVB induced apoptosis. In contrast to KC, HGF had no 
protective effect on the KC-derived cell lines A431 and HaCaT. Here we investigated the 
molecular mechanisms underlying this phenomenon. Since both cell lines are known to 
bear several mutations in the p53 gene, we analyzed whether or not p53 is involved in the 
anti-apoptotic action of HGF. By using siRNA technology we knocked out wildtype as well 
as mutant p53 in KC and KC-derived cell lines, respectively. Twenty-four hours later the cells 
were exposed to UVB with or without the addition of HGF. Knock down of wildtype p53 
in KC did not abrogate the anti-apoptotic effect of HGF. Interestingly, silencing of mutated 
p53 in KC-derived cell lines induced apoptosis by itself, which could not be inhibited by 
the addition of HGF. Binding of HGF to its receptor cMet leads to phosphorylation of Akt 
and consequently the activation of multiple downstream targets, which are involved in 
the anti-apoptotic machinery of KC. For full activation, Akt needs to be phosphorylated at 
Ser473 and Thr308. We found that in KC HGF rapidly induced the phosphorylation of both 
residues. In contrast, in KC-derived cell lines the induction of phosphorylation of Thr308 
was completely missing, resulting in incomplete Akt signalling. Our data demonstrate 
that the anti-apoptotic activity of HGF in KC is independent of p53 activation, and that 
mutant p53 in the KC-derived cell lines A431 and HaCaT is not responsible for the lack of 
protection by HGF. Our additional finding that signalling via cMET results in incomplete 
activation of the Akt pathway in these cell lines, provides the most likely explanation for the 
absence of the HGF-mediated anti-apoptotic effect.
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Analyses of a new antagonist of TGF-β/BMP signalling which plays a role in skin 
sclerosis
S Arndt, S Karrer, A Bosserhoff University of Regensburg, Regensburg, Germany
Fibrotic diseases like skin sklerosis is characterized by excessive scaring due to an 
increased production, deposition and contraction of extracellular matrix. There 
is evidence that transforming growth factor-beta (TGF-β) is involved in sklerosis 
formation. Expression of TGF-β, TGF-β receptors or downstream mediators of 
TGF-β signalling cascade are known to be disregulated in dermal fibrotic lesions of 
scleroderma patients. However, the underlying mechanisms are poorly understood. 
We identified a novel molecule with inhibitory function on bone morphogenic 
protein (BMP) signalling pathway. BMPs belong to the TGF-β family. Due to its 
function we named this molecule Fussel-15, for Functional smad suppressing element 
on chromosome 15. To analyse the expression of Fussel-15 and other TGF-β/BMP 
members in vitro, we used a collagen contraction model. To determine the function 
of Fussel-15 in vitro, knockdown and overexpression experiments were established. 
In addition, we used immunohistochemistry to analyse the expression of Fussel-15 
in vivo. We detected a specific expression pattern of Fussel-15 and BMP molecules 
in fibroblasts of early wound healing processes and deregulation of this molecules 
in fibroblasts of skin sclerosis. Fussel-15 knockdown delayed and an overexpression 
enhanced collagen contraction in vitro. Further analysis of Fussel-15 in normal and 
abnormal scar formation has to reveal the molecular function of Fussel-15 in this 
process. All together, understanding the exact process of normal and abnormal scar 
formation will help to define better ways to successfully manage and potentially 
prevent abnormal healing like sclerosis.
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Ultraviolet Radiation Activates NFAT: Derivation of the NFAT Action Spectrum and 
Involvement in COX-2 Induction
R Flockhart, B Diffey, P Farr, NJ Reynolds University of Newcastle, Newastle Upon 
Tyne, UK
Nuclear factor of activated T-cells (NFAT), a Ca2+/calcineurin regulated transcription factor, 
is functionally active in skin but the range of physiological and environmental signals that 
activate NFAT and the biological consequences of NFAT activation remain to be defined. 
COX-2 is induced by ultraviolet radiation (UVR) and has been implicated in the pathogenesis 
of UV-induced inflammation and carcinogenesis. As NFAT binds to and activates the COX-2 
promoter, we investigated the role of NFAT in regulating UV-induction of COX-2. 5 UVR 
sources with differing spectral emission were used to determine the wavelength-dependency 
of transcriptional activity (luciferase assay) and cellular localisation (GFP-NFAT2 and 
immuno-cytochemistry) of NFAT in HaCaT keratinocytes. All 5 UV sources increased NFAT 
transcriptional activity (n=3x3, p=<0.001) in a dose-dependent manner with effectiveness 
inversely associated with wavelength. The dose required to induce a 3 fold increase in NFAT 
activity was 238 times greater with Arimed B (4% UVB) compared to TL12 (53% UVB). The 
action spectrum for NFAT activation was determined by mathematical induction exploring 3 
candidate models and was distinct from the action spectra for DNA damage and erythema. 
UVR also induced NFAT2 nuclear translocation, (n=3x3, p=<0.001) in a parallel wavelength-
dependent fashion. COX-2 promoter activity was increased by UVR irradiation with TL12 
lamps being more effective than Arimed B lamps. COX-2 luciferase reporter plasmids lacking 
either one or both NFAT binding sites were activated less or not at all by UVR indicating that 
NFAT is involved in UV-induction of COX-2. Cyclosporin A, an inhibitor of calcineurin/NFAT 
reduced COX-2 protein expression induced by UVR. These data identify the action spectrum 
for NFAT activation and indicate requirement for NFAT in UVR-induced COX2 induction, 
suggesting a role for NFAT in non-melanoma skin cancer pathogenesis. 
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Secretion of chemotactic cyclophilin B by keratinocytes is regulated through its 
cyclosporin binding site
P Fearon1, AA Lonsdale-Eccles1, K Ross1, C Todd1, A Allain2, NJ Reynolds1 1Univ of 
Newcastle, Newcastle Upon Tyne, UK 2Univ des Sciences et Technologies, Lille, France
Cyclophilin B (CypB) is an endoplasmic reticulum (ER) resident member of the cyclophilin family 
of proteins, which are characterised by their peptidyl prolyl cis-trans isomerase (PPIase) activity 
and their ability to bind cyclosporin A (CsA). As extracellular CypB is chemotactic and CsA exerts 
direct effects on keratinocytes, we assessed the sub-cellular localisation, mobility and secretion 
of endogenous and GFP-tagged CypB (CypBWT-GFP) in response to CsA. The effect of alanine 
substitution of the conserved tryptophan residue required for CsA binding (W128A mutation) 
was also examined.  Endogenous CypB and CypBWT-GFP localised to the ER and nucleus of 
keratinocytes. Real-time confocal imaging of CypBWT-GFP and Western blotting of conditioned 
medium, showed that CsA (1mM) induced dissociation of CypB from the ER and CypB 
secretion. Fluorescence recovery after photobleaching (FRAP) studies showed that CsA reduced 
mobility of the CypBWT-GFP. Both the speed of diffusion (t1/2) and the mobile fraction (MF) 
were reduced compared to un-treated controls (Means (n=10): t1/2 control= 3.9s, MFcontrol= 
72.8%; t1/2 CsA= 6.1s (p<0.05), MFCsA= 54.5% (p<0.05)). Mobility of CypBW128A-GFP was 
reduced compared to CypBWT-GFP (t1/2 W128A= 7.5s (p<0.01), MFW128A= 46.1% (p<0.05)) 
in the absence of CsA. Moreover, CypBW128A-GFP was secreted into the media in the absence 
of CsA, suggesting that the CsA binding domain is necessary for ER retention. Supporting this, 
co-localisation co-efficients, Pearsons (PE) and overlap (OE), between CypBWT-GFP and an ER 
marker were lower after CsA treatment (two-way ANOVA interaction: PE p<0.019, OE p<0.02) 
and lower in the mutant CypBW128A-GFP (PE p<0.005, OE p<0.0002) (n=23-26 cells). Thus, 
both CsA and W128A mutation within the CsA-binding domain of CypB resulted in dissociation 
of CypB from the ER, altered mobility and increased secretion of CypB. The CsA binding domain 
may represent a novel molecular mechanism retaining CypB in the ER.
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Bone morphogenetic protein signaling differentially regulate gene expression 
programs in the epidermal keratinocytes and dermal fibroblasts
MY Fessing1, R Atoyan2, B. Schander2, T Efimova3,  VA Botchkarev1 1Univ of Bradford, 
Bradford, UK 2Boston Univ, Boston, USA 3Washington Univ, St Louis, USA
Bone morphogenetic proteins (BMP) are members of TGF-beta superfamily regulating 
a large variety of biological responses in several cells and tissues, including skin and 
hair follicles. Following BMP binding to the BMP receptors, downstream signaling is 
activated through BMP-Smad and BMP-MAP kinase pathways. To gain insights into the 
role of BMP signaling in skin epithelium and mesenchyme, we studied the effects of 
BMP-4 on human primary epidermal keratinocytes (KCs) and dermal fibroblasts (FBs). 
RT-PCR analysis showed that primary human KCs and dermal FBs express transcripts 
for all three BMP receptors (BMPR-IA, BMPR-IB, BMPRII). Treatment of KCs and FBs 
with BMP-4 resulted in dynamic phosphorylation of BMP-dependent SMAD1/5/8. In 
KCs, BMP-4 did not show any effects on phosphorylation of key MAP kinases (p38, 
p42/p44 and JNK/SAPK). However, phosphorylation of ERK1/2, p38 MAPK and JNK 
kinases was seen in FBs after BMP-4 treatment, thus suggesting activation of the BMP-
MAPK pathway. Global genome microarray analysis and quantitative RT-PCR revealed 
that BMP-4 treatment results in increase of expression of a number of established BMP 
target genes (such as DLX2, ID1/2/4, SMAD6/7) in both KCs and FBs. However, BMP-4 
treatment also resulted in distinct changes in gene expression profiles in KCs versus 
FBs including changes in expression of genes encoding distinct signaling molecules/
transcription factors, extracellular matrix/cell adhesion molecules, as well as selected 
matrix metalloproteinases and their inhibitors. These data suggest that epidermal 
KCs and dermal FBs serve as targets for BMP signaling and that BMP signaling is 
capable of activating distinct transcription programs in these cells most likely via 
differential recruitment of the BMP-Smad and/or BMP-MAPK signaling pathways. 
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Tyrosine kinase dependent apoptosis induced by terfenadine on A375 human 
melanoma cell line through intracellular Ca2+ level modulation
JL Diaz-Perez1, JS Muhialdin2, F Nicolau-Galmés2, I Ortega-Martinez2, Y Arrollo-
Berdugo2, MB Ruiz-Larrea2, N Andollo2, J Gardeazabal1, JL Diaz-Ramon1, B Blaya1, 
D Boyano2 1Cruces University Hospital, Baracaldo- Bilbao, Spain, 2University of the 
Basque Country Leioa-Bizkaia, Spain
In our previous work we have demonstrated that terfenadine, an H1 histamine 
receptor antagonist, induces DNA damage and apoptosis in human melanoma cell 
lines. Despite histamine stimulated cell proliferation, histamine partially inhibited 
terfenadine-induced apoptosis. In addition, down-regulation of H1 histamine 
receptor expression by siRNA protected the cells only partially from cytotoxic effect 
induced by terfenedine. These results suggest that terfenadine may be activating other 
cellular pathways independent of the histamine signalling system. To explore the 
molecular mechanisms responsible for histamine and terfenadine effect, we analyzed 
intracellular Ca2+ homeostasis by spectrofluorimetry using Fura-2. Terfenadine 
induced a very sharp and sustained increase in cytosolic Ca2+ levels in A375 
melanoma cells, while histamine did not modulate intracellular Ca2+ levels. Thus, 
terfenadine effect is mediated by the release of Ca2+ from endoplasmic reticulum 
stores, followed by Ca2+ influx from extracellular medium through Store Operated 
Ca2+ Channels (SOCs). Finally, we have found that the inhibition of tyrosine kinase 
activity by genistein abolishes cytosolic Ca2+ rise and DNA fragmentation in 
terfenadine treated melanoma cells. These results suggest that tyrosine kinase activity 
is an essential point in the terfenadine signalling pathway on human melanoma cells. 
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Jagged 2, a Notch Ligand, is Expressed in Suprabasal Epidermal Keratinocytes and 
HaCaT Cells Committed to Terminal Differentiation
PE Bowden, T Easter, RM Porter, S Han Cardiff University, Cardiff, UK
Notch-Delta-Jagged signalling plays a key role in cell fate determination and growth 
control during embryonic development. Recently, the role played by this cell signalling 
pathway in adult tissues has been investigated. We have been particularly interested in 
the expression of Notch 1 (N1), Notch 3 (N3) and two notch ligands, Jagged 1 (J1) and 
2 (J2), during terminal differentiation of human keratinocytes. In our studies, we have 
consistently found cytoplasmic expression of Jagged 2 (J2) in keratinocytes committed 
to terminal differentiation, as defined by keratin 10 (K10) expression. Frozen sections of 
normal skin were treated with antibodies to K10, N1, N3, J1 or J2 and these were detected 
by immunofluorescence (IMF) microscopy. In addition, HaCaT keratinocytes were grown 
in low calcium (0.06 mM) medium and when cells were 70-80% confluent, shifted to high 
calcium (1.8 mM) and cultured for a further 1, 3, 7 and 10 days. Cells were treated with 
the antibodies detailed above as well as antibodies to K14, K17 or Ki-67 and detected by 
IMF. N1 was expressed in the granular layer of human epidermis while N3 was found in 
basal cells and upper suprabasal cells. HaCaT cells in low calcium (undifferentiated) did 
not express K10, had prominent Ki67, N3 and J2 nuclear staining and K14 cytoplasmic 
staining while K17 (cytoplasmic) and N1 (nuclear) staining was more variable. Once 
shifted to high calcium (differentiated), HaCaT cells increased cytoplasmic N1 and N3 
expression, reduced nuclear Ki67 expression and progressively increased cytoplasmic K10 
expression with time. Furthermore, all cells that expressed K10 were observed to co-express 
cytoplasmic J2. These IMF results were confirmed by western blotting and RT-PCR. Thus, we 
conclude that both in vivo and in vitro, cytoplasmic expression of the notch ligand Jagged 
2 appears closely linked to the commitment of keratinocytes to terminal differentiation. 
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Fibroblast growth factor-10 contributes to survival of basal cell carcinoma cells
H Sato, M Kawashima, T Takahashi, Y Fujisawa, Y Nakamura, F Otsuka University of 
Tsukuba, TSUKUBA, IBARAKI, Japan
Fibroblast growth factor (FGF) -10, also known as keratinocyte growth factor -2, is a 
member of FGF family comprising 23 members. FGF-10 is produced by mesenchymal 
cells and acts on epithelial cells via FGFR2-IIIb which is a high affinity receptor specific 
to FGF-1, FGF-3, FGF-7, FGF-10 and FGF-22. FGF-10 plays important roles in varing 
developmental events, general wounding response, and keratinocytes proliferation. Its 
production has been detected in normal adult skin as well as embryonic or wounded 
skin. This suggests the possible contribution of FGF-10 to normal or abnormal 
components of adult skin. We examined FGF-10 effect on basal cell carcinoma (BCC) 
cells whose putative origin is basal cells possessing both the differentiation potential 
and the survival potential against apoptotic stimuli in basal layer. FGF-10 showed 
Akt activation and inhibited interferon-gamma-induced apotosis of BCC cells while 
it did not influence the proliferation and morphological appearance of those cells 
despite of activated MEK/ERK pathway. Our findings suggest the cytoprotective effect 
of FGF-10 on BCC which usually shows a long-term course and a gradual growth. 
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Srcasm modulates the activity of Src kinases and Ras
E Ayli, W Li, C Marshall, J Seykora University of Pennsylvania, Philadelphia, USA
Aberrant Ras activation is associated with many human malignancies, including 
cutaneous squamous cell carcinoma. Ras is an important downstream effector of 
tyrosine kinases, including non-receptor tyrosine kinases such as Src and Fyn. Srcasm 
is a substrate of Src-family tyrosine kinases (SFKs) and associates with Grb2, an 
activator of Ras, via phospho-tyrosine residue 392. In this study, we characterize the 
effect of Srcasm and Srcasm Y392F upon EGF-dependent Ras activation. We report 
that Srcasm appears to activate Ras in a manner that requires phosphorylation at 
tyrosine 392, its Grb2 binding site. In quiescent COS cells, levels of activated Ras 
are low. COS cells transfected with Fyn exhibit increased levels of Ras activation 
as assessed by a GST-Raf pulldown assay. EGF-stimulation of COS cells transfected 
with Fyn resulted in higher levels of Ras activation than with Fyn alone. Interestingly, 
co-transfection of native Srcasm with Fyn promotes Ras activation compared with 
Fyn alone, and Ras activation by Srcasm is more pronounced in EGF-treated cells. 
The Y392F Srcasm mutant did not promote Ras activation as efficiently as did 
native Srcasm. Both native Srcasm and Srcasm Y392F downregulate Fyn levels, 
and the Srcasm Y392F appears to be a more potent downregulator of Fyn. These 
data suggest that Srcasm promotes Ras activation after EGF stimulation, and the 
ability of Srcasm to optimally activate Ras requires its Grb2 binding site. The ability 
of Srcasm to modulate Ras activity appears to be inversely related to its ability to 
downregulate Fyn, suggesting a competitive interaction between Grb2 and Src 
kinases for Srcasm binding. Therefore, Srcasm appears to be a novel effector of 
Ras, and may be an important modulator between SFKs, Grb2, and Ras signaling. 
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Src kinase activation in psoriasis and squamous cell carcinoma
E Ayli, W Li, J Seykora University of Pennsylvania, Philadelphia, USA
Src-family tyrosine kinases (SFKs) are important regulators of keratinocyte growth 
and differentiation. In general, persistent activation of SFKs correlates with increased 
cell proliferation. In this study, we wanted to determine if SFK activity is increased 
in common hyperproliferative epidermal disorders such as psoriasis, squamous cell 
carcinoma (SCC), and precursor lesions of SCC. Randomly selected formalin-fixed 
tissue samples were retrieved from archives and included: 14 psoriasis biopsies, 
6 actinic keratoses (AKs), 5 squamous cell carcinomas in situ (SCIS), 4 invasive 
SCCs, and 6 specimens of unremarkable epidermis. Using a phosphorylation- state 
specific antibody, staining for activated SFKs was detected in a membrane-pattern 
with a lesser degree of cytoplasmic staining; nuclear staining was not seen. All 
psoriasis specimens displayed significant staining for activated SFKs, compared 
with sections of unremarkable skin. In addition, the intensity of activated SFK 
staining was proportional to the degree of psoriatic epidermal hyperplasia. Of 
the AKs, SCISs, and SCCs, all demonstrated more extensive staining for activated 
SFKs than did sections of unremarkable epidermis. Furthermore, actinic keratoses, 
potential precursor lesions for SCC, displayed less staining than SCC specimens. No 
discernable difference was seen between in situ and invasive specimens. The results 
of our study show the presence of elevated levels of SFKs in human biopsy specimens 
of psoriasis and cutaneous neoplasia. This data provides direct evidence for the 
role of activated SFKs in the pathogenesis of hyperproliferative epidermal disorders. 
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Interleukin-23 prevents UV-induced immunosuppression and inhibits the suppressive 
activity of regulatory T cells
S Majewski, T Schwarz, A Maeda, C Jantschitsch, A Schwarz University of Schleswig-
Holstein, Kiel, Germany
The immunomodulatory cytokine interleukin (IL)-12 prevents UV-induced suppression of 
the induction of contact hypersensitivity and breaks UV-induced tolerance. While the first is 
caused by the reduction of UV-induced DNA damage, the latter may be due to yet unknown 
effects of IL-12 on UV-induced regulatory T cells (UV-Treg). IL-23 is similar to IL-12 by 
sharing the p40 chain and exerts similar biologic effects. We studied the effect of IL-23 
on UV-induced DNA damage and immunosuppression. Since apoptosis is related to the 
amount of UV-induced DNA damage, keratinocytes were exposed to UV. Apoptosis was 
significantly reduced in cells pretreated with IL-23. IL-23 also supported the long term cell 
survival after UV-exposure in a colony formation assay. Southwestern dotblot analysis with 
an antibody against cyclobutane pyrimidine dimers (CPD) revealed lower amounts of CPD 
in UV-exposed cells after IL-23 treatment. IL-23 also significantly reduced the amounts of 
CPD and the number of sunburn cells in vivo. To study the effect of IL-23 on UV-induced 
immunosuppression which is mediated via DNA damage IL-23 was injected into mice 
3h before application of dinitrofluorobenzene onto UV-exposed skin. Mice in the control 
group were significantly suppressed in their sensitization response, whereas mice injected 
with IL-23 could be fully sensitized. Accordingly, UV-Treg did not develop upon injection of 
IL-23 as demonstrated by adoptive transfer experiments. IL-23 prevented the development 
of UV-Treg, but also inhibited their activity since suppression could not be transferred 
with UV-Treg when preincubated with IL-23. Accordingly, UV-tolerized mice could be 
sensitized upon injection of IL-23, indicating that IL-23 breaks UV-induced tolerance. Thus, 
IL-23 prevents UV-induced immunosuppression via reducing DNA damage. In addition, it 
paralyses the suppressive activity of UV-Treg which so far has only been described for IL-12. 
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241 [Oral 006]
Mast cell-derived 5-HT is required for the induction of PUVA-induced systemic 
immune suppression but not local inflammation
P Wolf1, S Byrne2, G Ramos2, AY Limon-Flores2, G Hoefler1, HN Ananthaswamy2, SE 
Ullrich2 1Medical Uni of Graz, Austria 2MD Anderson Cancer Center, Houston, USA
PUVA can lead to immune suppression, inflammation, and apoptosis, effects possibly being 
responsible for its therapeutic efficacy. We have previously shown by the use of platelet-activating 
factor (PAF) receptor antagonists that PAF is critically involved in those PUVA-induced effects 
(Wolf et al, AJP 2006). Because certain PAF receptor antagonists have been shown to have dual 
activities blockading both PAF and serotonin (5-hydroxytryptamine, 5-HT) receptor binding, we 
tested the hypothesis that 5-HT might be a key mediator in PUVA-induced immune suppression 
as well. The i.p. injection of mice with 5-HT2 receptor antagonists or an anti-5-HT antiserum 
immediately before PUVA exposure totally abrogated immune suppression (in the model of 
systemic suppression of delayed-type hypersensitivity to C. albicans) but had no significant effect 
on inflammation or apoptosis. Importantly, the i.p. injection of 5-HT led to immune suppression 
in a manner similar to PUVA exposure but did not induce inflammation or apoptosis in the skin. 
Mast cells are an important source of 5-HT and therefore we have now used mast cell deficient 
KitW/KitW-v and KitW-sh/KitW-sh mice on C57Bl/6 background to substantiate our findings 
on the role of 5-HT in PUVA-induced immune suppression. We found that mast cell deficient 
mice were resistant to topical PUVA-induced immune suppression compared to their wild 
type littermates. In contrast, PUVA-induced inflammation, as measured by macroscopic skin 
swelling did not differ between mast cell deficient mice and their wild type controls. Moreover, 
immunohistochemical 5-HT and mast cell stainings did not reveal an upregulation of 5-HT-positive 
cells in the skin upon PUVA exposure. These results indicate that (prestored) mast cell-derived 
5-HT is a key mediator of PUVA-induced immune suppression. The fact that 5-HT is selectively 
responsible for PUVA-induced immune suppression but not inflammation or apoptosis opens 
the doors to selective dissection of PUVA’s therapeutic from its harmful (i.e. carcinogenic) effects. 
242 [Oral 009]
Infrared irradiation confers resistance to UVB-induced apoptosis in vivo and in vitro
C Jantschitsch, T Schwarz, A Maeda, S Majewski, A Schwarz University of Schleswig-
Holstein, Kiel, Germany
Infrared irradiation (IR), the predominant electromagnetic solar spectrum reaching 
the earth’s surface, nowadays is increasingly used often combined with artificial UV 
irradiations for cosmetic and wellness purposes. We were interested to elucidate the 
interactions between IR and UV radiation with special emphasis on carcinogenesis. 
We focused on UV-induced apoptosis since this is a protective mechanism which 
prevents malignant transformation by eliminating UV-damaged cells. In freshly 
prepared murine keratinocytes, IR (IR-A, 760-1400nm) 3 hours before UVB irradiation 
led to a significantly reduced apoptotic rate. In vivo similar results were observed; 
pretreatment of C57/BL6 mice with IR prior to UVB irradiation decreased the number 
of apoptotic keratinocytes. To confirm these findings, intracellular FACS analysis was 
performed and revealed that IR pretreatment decreased the pro-apoptotic protein Bax 
and induced the anti-apoptotic protein Bcl-xL. Furthermore, IR pretreatment restored 
UVB-induced suppression of the expression of the anti-apoptotic protein FlipL. 
There is evidence for an inhibitory effect of heat shock on UVB-induced apoptosis. 
Interestingly, the FlipL-restoring effect was only observed after IR irradiation but not 
after heat pretreatment (heat shock 42° followed by a 3 hours recovery phase at 
37°). This indicates that IR and heat-shock might activate different anti-apoptotic 
pathways. Since UV-induced apoptosis is a protective mechanism preventing 
malignant transformation, it remains to be seen whether the observed anti-apoptotic 
effect of IR is beneficial or harmful. Hence experiments investigating the impact of 
IR on DNA damage and repair and in vivo photocarcinogenesis studies are planned 
in the future. 
 
243 [Oral 016]
UVB-mediated induction of antimicrobial peptides in human keratinocytes is 
regulated by AP-1 and p53
C Holtmeier, A Schwarz, T Schwarz University of Schleswig-Holstein, Kiel, Germany
It is known that superinfected dermatoses improve upon UVB exposure without 
antibiotic or antiseptic treatment. This might be due to the fact that UVB radiation 
induces the expression of antimicrobial peptides (AMPs) including beta-defensin-2 
and -3 (HBD-2, HBD-3), RNase7 and psoriasin in human keratinocytes. In this study 
we aimed to elucidate the molecular mechanisms which are responsible for the 
dose- and time-dependent induction of AMPs by UVB. HaCaT cells were transfected 
with a reportergene construct of the HBD-2 promoter and exposed to 10 mJ/cm² 
UVB. Dual luciferase assays revealed an enhanced activity of the HBD-2 promoter in 
irradiated compared to unirradiated cells. Western Blot and FACS analyses revealed 
an increased phosphorylation of the signaling proteins ERK, JNK and p38 in HaCaT 
cells within 24 hours after UVB-exposure. Furthermore UVB-irradiated HaCaT cells 
which were transfected with dominant negative plasmids for the Fos protein showed 
a significantly diminished activity of the HBD-2 promoter in comparison to the 
corresponding control, indicating that AP-1 might be involved in the induction by 
UVB. To study the influence of p53 on the UVB-mediated induction of AMPs, p53 
was down-regulated in human normal keratinocytes (HNKs) by use of the siRNA 
technique. RTqPCR analysis revealed significantly decreased induction of HBD-2, 
HBD-3, RNase7 and psoriasin upon to UVB exposure in comparison to HNKs with 
normal p53 levels. Together, these data demonstrate that the transcription factor 
AP-1 is involved in the UVB-mediated activation of the HBD-2 promoter in HaCaT 
cells. In addition, p53 appears to be involved in the UVB-mediated induction of 
HBD-3, RNase7 and psoriasin. These findings provide an insight into the molecular 
mechanisms underlying the induction of AMPs in keratinocytes upon exposure to 
low doses of UVB. 
244 [Oral 020]
Reduction of UVA-induced oxidative stress in human dermal fibroblasts - A novel functional 
facet of a-melanocyte-stimulating hormone with future implications for photoaging 
A Mastrofrancesco1 2, A Kokot2, M Schiller2, TA Luger2, EP Healy3, M Picardo1, M Böhm2 1S 
Gallicano Derm Inst, Rome, Italy 2Univ of Münster, Germany 3Univ of Southampton, UK
The skin is exposed repeatedly to ultraviolet A (UVA) radiation which generates reactive oxygen 
species (ROS) from the interaction of molecular oxygen with photosensitizers. If not detoxified, 
UVA-induced intracellular ROS can shift the cellular redox state to an oxidized one leading 
to amplification of intracellular oxidative stress. Moreover, ROS directly attacks sensitive 
biomolecules including DNA, proteins or lipids thereby promoting the process of photoaging and 
the development of skin cancer. We evaluated the protective effect of α-melanocyte-stimulating 
hormone (α-MSH), a tridecapeptide endogenously produced by the skin and increased after 
sun exposure. We demonstrate that a 24 hr-pre-treatment of human dermal fibroblasts with 
α-MSH dose-dependently suppresses UVA-induced ROS production. The reduction of 
UVA-induced ROS production by α-MSH was paralleled by reduced expression of matrix 
metalloproteinase-1, a central mediator of photoaging. The protective effect of α-MSH appears 
to be mediated by the melanocortin-1 receptor (MC-1R) expressed by human dermal fibroblasts. 
The role for MC-1R in the observed UVA-protective effect of α-MSH was further investigated 
in murine 3T3 fibroblasts stably expressing human wild-type MC-1R. The MC-1R transfectants 
but not vector-alone transfected cells were markedly protected against UVA-induced ROS 
generation. To elucidate the molecular mechanism of cytoprotection by α-MSH against UVA 
we next analyzed the expression of Nrf1 and 2, two key transcription factors orchestrating 
gene expression of various ROS detoxifying enzymes. α-MSH significantly increased the RNA 
levels of both Nrf1 and 2 in human dermal fibroblasts. Moreover, α-MSH treatment led to an 
upregulation of heme oxygenase-1 and sodium dismutase-2, possibly explaining the UVA 
cytoprotective properties of α-MSH. These findings highlight a novel dimension in the functional 
repertoire of α-MSH and point towards novel future strategies in the prevention of photoaging. 
245 [Oral 052]
Survivin modulates cell cycle and interferes with UV-induced apoptosis in human 
keratinocytes
K Dallaglio1, A Marconi1, M Dumas2, F Bonté2, R Lotti1, F Truzzi1, C Gemelli1, 
C Pincelli1 1Univ of Modena and Reggio Emiliana, Modena, Italy 2LVMH Recherche, 
St Jean-de Braye, France
Survivin is a bifunctional member of IAP (Inhibitor of Apoptosis Proteins) family: it 
is able to inhibit apoptosis and to regulate cell cycle. Survivin is strongly expressed 
in keratinocyte stem cell. At the subcellular level, highly proliferating keratinocytes 
express survivin in the nucleous, while survivin is detected in the cytoplasm of more 
differentiated cells. Keratinocytes also express pro- and anti-apoptotic survivin splice 
variants. Here we show that wild-type survivin is down-regulated by ultraviolet (UV) 
B radiation in normal human keratinocytes both at the protein and at the mRNA 
level, in a dose-dependent manner. UVB radiation increases putative pro-apoptotic 
(2alpha and 3B) and decreases anti-apoptotic (DeltaEx3 and 2B) survivin splicing 
variants. UVB radiation (25 mJ/cm2) induce a higher rate of apoptosis in keratinocytes 
transfected with SurvivinsiRNA than in mock cells. UVA radiations modulate wild-type 
survivin expression at the RNA and at the protein level, but fail to modulate survivin 
variants. Low-dose UVA decrease HaCaT cell viability independently of survivin. 
Survivin siRNA causes a G2-M cell cycle arrest at 24 hrs in HaCaT cells. 48 hrs after 
transfection, apoptosis is higher in survivin siRNA transfected HaCaT cells than in 
mock cells, while the number of cells in S-phase is lower in HaCaT siRNA than in 
mock cells. 120 hrs after treatment, the rate of cells in G2M phase and apoptosis is still 
higher in survivin siRNA transfected than in mock cells. Taken together, these results 
indicate that not only survivin and its isoforms interfere with UV-induced apoptosis, 
but wilde-type survivin seems also to modulate cell cycle in human keratinocytes. 
 
246 [Oral 053]
In Graft versus Host disease Extracorporeal Photopheresis increases number and 
function of regulatory T cells
S Schmitt, K Mahnke, K Schönfeld, S Karakhanova, AH Enk University of Heidelberg, 
Heidelberg, Germany
Extracorporeal Photopheresis (ECP) is a procedure commonly used to reduce transplant 
rejection. It is also applied in diseases like GvHD, cutaneous T cell lymphoma and 
other medical conditions involving overboarding immune reactions.The mechanism 
by which ECP exerts its immunosuppressive properties remains elusive. However, 
since regulatory T cells (Treg) are a major cellular component that contributes to 
immunosuppressive mechanisms, we set out to investigate whether ECP affects Treg 
function. For this end we analysed peripheral blood of patients with GvHD after 
bone marrow transplantation who received ECP-treatment. The patients were ECP 
treated on 2 consecutive days and blood samples were taken before and after each 
session. First, we prepared PBMC and compared the respective amounts of various 
cell types within the peripheral blood of the patients before and after treatment via 
FACS analysis. Here we observed an increase of CD4+ CD25+ FoxP3+ Treg directly 
after each ECP cycle and also in the general course of treatment (6 cycles, over 3 
months analysed). Moreover, to study functional properties of this distinct population 
we analysed the suppressive effect of MACS-bead isolated Treg before and after ECP 
using conventional suppression assays. As controls Treg were isolated from untreated 
healthy volunteers. These assays revealed that Treg before ECP showed a significantly 
reduced suppression of T cell proliferation, whereas after ECP, Treg equalled Treg 
isolated from healthy volunteers in their suppressive capacity. In conclusion ECP 
may exert its immunosuppressive functions by upregulating the number and the 
suppressive capacity of regulatory T cells and may thus be an appropriate therapy to 
prevent over-reactions of the immune system after stem cell transplantations.
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Ultraviolet radiation exposure accelerates the accumulation of the aging-dependent 
T414G mitochondrial DNA mutation in human skin
MA Birch-Machin, J Birket Newcastle University, Newcastle Upon Tyne, UK
The accumulation of mitochondrial DNA (mtDNA) mutations has been proposed as 
an underlying cause of the aging process. Such mutations are thought to be generated 
principally through mechanisms involving oxidative stress. Skin is frequently exposed 
to a potent mutagen in the form of ultraviolet radiation and mtDNA deletion mutations 
have previously been shown to accumulate with photoaging. Here we report that the 
age-related T414G point mutation originally identified in skin fibroblasts from donors 
over 65 years of age also accumulates with age in skin tissue. Moreover there is a 
significantly greater incidence of this mutation in skin from sun-exposed sites (χ2 
= 6.8, p<0.01). Identification and quantification of the T414G mutation in dermal 
skin tissue from 108 donors ranging from 8 to 97 years of age demonstrated both 
increased occurrence with photoaging as well as an increase in the proportion of 
molecules affected. In addition we have discovered frequent genetic linkage between 
a common photoaging-associated mtDNA deletion and the T414G mutation. This 
linkage indicates that mtDNA mutations such as these are unlikely to be distributed 
equally across the mtDNA population within the skin tissue, increasing their likelihood 
of exerting focal effects at the cellular level. Taken together these data significantly 
contribute to our understanding of the DNA damaging effects of UV exposure 
and how resultant mutations may ultimately contribute towards premature aging. 
 
248 [Oral 055]
Immunosuppressive Effects of Psoralen Photochemotherapy and Photodynamic Therapy 
may be Realized through Production of Photosensitizer Photooxidation Products
A Kyaqgova1, L Kozir1, G Mansurova1, I Moshnina2, E Kozhinova2, V Ponomarev1, 
A Potapenko1 1Russian State Med Univ, Moscow, 2Psoriasis Centre, Moscow
Application of photosensitizers (PSs) in medicine [Psoralen+UVA-therapy (PUVA) or Photodynamic 
Therapy (PDT)] is frequently accompanied by induction of systemic immunosuppression. Photolysis of 
PSs occurs during PUVA or PDT-treatment. The role of PSs photoproducts in PUVA or PDT is not clear. 
Our aim was to assess immunosuppressive potential of photooxidation products of photosensitizers, which 
are: i) extensively used in the PUVA-treatment, namely, psoralen (Ps), 8-methoxypsoralen (8-MOP) and 
5-methoxypsoralen (5-MOP); ii) applied in the PDT, namely, protoporphyrin IX (PPIX) and merocyanine 
540 (MC540).Psoralens and PPIX were photooxidized by UVA-light (365 nm, 23 W/m2) and MC540 was 
photodecomposed at 546 nm (27 W/m2). Immunosuppressive efficiency of PSs photoproducts was assessed 
on contact hypersensitivity (CSH) in mice, the experimental model of human contact dermatitis. We found 
that oral administration of photooxidized Ps, 8-MOP and 5-MOP induced suppression of the CHS to 2,4-
dinitrofluorobenzene or oxazolone in mice. Immunosuppressive efficiency decreased in a row: 5-MOP=8-
MOP>Ps. All photooxidized psoralens induced suppression of the CHS in a dose dependent manner. 
Intravenous injection of preirradiated solution of PPIX or MC540 to mice resulted in dose-dependent 
suppression of the CHS. Solutions of photodecomposed PPIX contained chlorin-type products, namely, two 
isomers of photoprotoporphyrin (pPP) as main photoproducts exerting equal immunosuppressive activity. 
Suppression of the CHS induced by pPP, preirradiated Ps or MC540 was adoptively transferable and was 
associated with generation of cells with suppressive functions. Suppression induced by preirradiated Ps 
was antigen-specific, in contrast to that suppression induced by preirradiated MC540 or PPIX was non-
specific. Our results strongly indicate that induction of systemic immunosuppression by PDT or PUVA may 
proceed through photooxidation of photosensitizers and generation of photoproducts, which can affect T 
cell immunity. New methods of photochemotherapy may be developed, based on administration of PSs 
photoproducts to patients without irradiation of their tissues.
249 [Oral 056]
Reduced Antigen-Presenting Ability of Bone Marrow-Derived Dendritic Cells from 
Ultraviolet-B-Irradiated or Hapten-Painted Mice
S Gorman, J Lee, H Hart Institute for Child Health Research, Subiaco, Australia
The purpose of this study was to determine whether irradiation of skin with 
ultraviolet-B (UVB, 280-320nm) alters the capacity of bone marrow-derived dendritic 
cells (BMDC) to present antigen to naïve T cells. The shaved backs of BALB/c mice 
were administered one of four different skin treatments. Mice received no treatment or 
were irradiated with a single erythemal dose of UVB (8 kJ/m2), administered chronic 
UVB twice weekly for 4 weeks (2 kJ/m2, 8 times) or their backs were painted with the 
experimental hapten dinitrofluorobenzene (DNFB, 0.5%). Four days later, bone marrow 
cells were extracted and cultured for 7 days with GM-CSF (1 µg/ml) and IL-4 (1 µg/
ml) to promote the differentiation of DC from bone marrow precursors in vitro. These 
BMDC were enriched for CD11c+ cells (>90%) and co-cultured with purified CD4+ T 
cells at various ratios. The antigen-presenting capacity of the BMDC was determined 
by the degree of T cell proliferation observed in these cultures, which was detected by 
the incorporation of tritiated-thymidine by proliferating cells. Significantly increased 
bone marrow cell numbers were obtained four days after mice were irradiated with 
either of the UVB protocols or treated with DNFB. There was significantly reduced 
proliferation by CD4+ T cells co-cultured with CD11c+ cells derived from the bone 
marrow of mice irradiated with either of the UVB protocols or sensitised with DNFB. 
These results suggest that skin-based inflammation caused by either erythemal UVB 
irradiation or application of chemical hapten increases bone marrow cell turnover 
and reduces the antigen-presenting capacity of newly formed BMDC. Thus, some 
of the systemic immunosuppressive effects of UVB may be due to reduced antigen-
presenting ability of CD11c+ cells from the bone marrow of UVB-irradiated mice. 
 
250
Thrombomodulin protects human epidermal keratinocytes against low dose UVB
M Iwata, K Kawahara, H Kawabata, T Kanekura, T Hashiguchi, I Maruyama
Kagoshima University, KAGOSHIMA, Japan
Thrombomodulin (TM), an endothelial cell surface anticoagulant glycoprotein, acts 
as a cofactor for protein C. TM has been also detected in epidermal keratinocytes, and 
has been recognized as a keratinocyte differentiation marker. It is recently reported 
that TM has cell protective effect. However, the role of TM expressed in the epidermal 
keratinocytes are not fully characterized. Epidermal keratinocytes are exposed 
to ultraviolet (UV) rays. High-dose UVB irradiation is known to induce apoptosis 
of keratinocytes. In the present study, we examined the relation between TM and 
UVB irradiation in keratinocytes. TM expression in human epidermal keratinocyte 
cell line, HaCaT cell by Western blotting and Northern blotting. Cell viability is 
analyzed by MTT assay. Phosphorylation of MAPKs (ERK,JNK,p38MAPK) is evaluated 
by Western blotting. TM mRNA level and cAMP response element binding protein 
(CREB) activation with SB203580,p38MAPK inhibitor, is analyzed with nuclear 
extract preparation and electrophoresis-mobility shift assays (EMSA). TM expression 
decreased in 2 hours and consequently recovered in 16 hours after 10 mJ/cm2 UVB 
irradiation in HaCaT cells. The mRNA of TM was up-regulated within 1 hour after 
10 mJ/cm2 UVB irradiation. The mRNA of TM decreased with the irradiation of 
high (>25 mJ/cm2) UVB dose. TM siRNA treated HaCaT cells resulted in reducing 
cell viability after 10 mJ/cm2 UVB irradiation. 10 mJ/cm2 UVB induced p38MAPK 
activation, but not ERK,JNK. SB203580 down-regulated TM mRNA level after 10 mJ/
cm2 UVB exposure and inhibited UVB induced CREB activation. Our results suggest 
that p38MAPK-CREB signaling pathway by low-dose UVB induced TM expression 
and that TM plays important role to protect keratinocytes after low-dose UVB. 
 
251
UVA induces granzyme B in human keratinocytes: implication in extracellular 
matrix remodelling
H Hernandez-Pigeon1, C Jean2, A Charruyer2, M-J Haure1, C Baudouin3, M Charvéron1, 
A Quillet-Mary2, G Laurent2 1Institut de Recherche Pierre Fabre, Toulouse, France 
2INSERM U563, CPTP, Toulouse, France 3Laboratoires Expanscience, Epernon, France
In a previous study, we have described that UVB induces granzyme B (GrB) in 
human keratinocyte cells, and that conferres potent cellular cytotoxicity against 
various cellular models including immune cells. In the present study, we have 
found that, in contrast to UVB, UVA failed to enhance keratinocyte cellular 
cytotoxicity but was still able to trigger GrB production. We show here that GrB 
is accumulated through a p38MAPK-dependent transcriptional mechanism 
stimulated by redox-dependent macrophage migration inhibitory factor release. 
Moreover, GrB purified from UVA-treated cellular extracts was found to degraded 
fibronectin in vitro. Treatment with antisense oligonucleotide directed against GrB 
resulted in the inhibition of UVA-induced cell detachment and cell death, and 
facilitates cell migration through fibronectin and vitronectin matrix upon UVA 
exposure. Altogether, these results suggest another function for GrB in the context 
of the UV response. Indeed, combined with our previous study, it appears that, 
whereas this enzyme mediates keratinocyte cellular cytotoxicity following UVB 
irradiation, GrB supports the capacity of keratinocyte to degrade extracellular 
matrix components following UVA irradiation. UV-mediated GrB production 
may thus have important consequences in photoaging and photocarcinogenesis. 
 
252
A porcine skin model - suitable to evaluate penetration and Protoporpyhrine IX 
detection of different 5-Aminolevulinic acid formulations?
T Maisch, C Worlicek, M Landthaler, R-M Szeimies University of Regensburg, 
Regensburg, Germany
Topical photodynamic therapy is an established treatment modality for localized epithelial 
skin cancer. Of particular interest is the application of 5-aminolevulinic acid (5-Ala), which 
is metabolized to protoporphyrine IX (PpIX), the actual photosensitizer. In this study we 
investigated the skin penetration of five different 20% 5-Ala formulations and fluorescence 
induction of PpIX using a new ex vivo porcine skin model. Fluorescence signals of PpIX were 
detected first in intact epidermis at 2h after topical application of a 5-Ala/HCl-ethanol solution 
(DUSA Pharmaceuticals, USA). Detection of fluorescence signals of PpIX was further delayed 
in order of 5-Ala gel (+ 40% DMSO) > 5-Ala gel (without 40% DMSO) > 5-Ala lipophilic 
ointment > 5-Ala hydrophilic ointment (GMP guidelines). The 5-Ala hydrophilic ointment 
fluorescence intensity was 10-fold lower as compared to the 5-Ala/HCl-ethanol solution. 
In all cases the maxima of PpIX intensity were reached between 18-24 h after application. 
Penetration of 5-Ala within the epidermis was increased in order of 5-Ala hydrophilic < 5-Ala 
lipophilic < 5-Ala gel < 5-Ala gel (+40% DMSO) < 5-Ala/HCl solution. PpIX fluorescence 
signals were restricted to the epidermis of all tested formulations; no fluorescence in the 
dermis was detected. Upon illumination (550-700nm; 40mWcm-2, 24Jcm-2), skin areas 
incubated with the different 5-Ala formulations did show a marked increase of dead cells 
(10-45%) in the epidermis in a penetration-dependent manner. Controls (+ 5-Ala without 
light) did not show an increase in dead cells (NBTC staining). In conclusion it has been 
demonstrated that an ex vivo porcine skin model is able to discriminate penetration depth 
and fluorescence induction of different 5-Ala formulations. The commercially available 
5-Ala/HCl solution showed a significant earlier fluorescence induction of PpIX as compared 
to the different 5-Ala formulations, even those containing DMSO as a penetration enhancer. 
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(Cys-Gly)2: An antioxidant dimer peptide that displays a whitening effect on the 
skin
C Gondran, E Bauza, T Marchand, A Perrin, C Dal Farra, N Domloge Vincience ISP 
Global Skin Research Center, Sophia-Antipolis, France
It is well known that UV irradiation results in many harmful effects on the skin, such as 
oxidative stress, and the dysfunction of melanocytes in the epidermis. Recent studies have 
suggested that oxidative stress could be closely linked to melanin synthesis. Therefore, we 
were interested in studying the antioxidant and whitening properties of the (Cys-Gly)2 dimer 
peptide. For antioxidant studies, cultured fibroblasts were treated with 1% of this peptide for 
24 h, irradiated with 5 J/cm² of UVA, and then treated again, either for 24 h to study lipid 
peroxidation, or for 4 h to study SOD and catalase activity, and protein carbonylation. In 
parallel, we studied the whitening effect of the dimer peptide on skin biopsies. Skin samples 
were treated twice a day with 1% of the peptide for 24 h, irradiated with 100mJ/cm² of UVB, 
and then were treated again for 24 h. Melanin synthesis was evaluated by Fontana-Masson 
staining. Using the same protocol, similar comparative studies were performed in order 
to evaluate the whitening effect of the dimer peptide versus that of kojic acid (1mM and 
50mM). The results showed that cells irradiated and treated with the dimer peptide exhibited 
enhanced enzymatic activities of +33% for SOD and +23% for catalase, compared to the 
control. Moreover, these results were confirmed by a reduction in protein carbonylation 
(-137%) and lipid peroxidation (-34%). Interestingly, studies on ex vivo skin pigmentation 
revealed that skin treated with the dimer peptide exhibited a noticeable decrease in melanin 
content, in irradiated and unirradiated biopsies; and this effect was greater with the dimer 
peptide than with kojic acid. These results demonstrate that this dimer peptide exhibits a 
remarkable antioxidant protective effect and a whitening effect, and can be of great use in 
anti-aging and whitening skin care products.
 
254
A new active ingredient that enhances skin tanning and improves UV protection
E Bauza, C Gondran, G Bressier, A Perrin, T Marchand, C Dal Farra, N Domloge 
Vincience ISP Global Skin Research Center, Sophia-Antipolis, France
Tanned skin has been described as being more resilient to the harmful effects of solar 
radiation than fair skin. In the field of cosmetics, the use of melanin-inducing active 
ingredients provides an interesting way to improve skin tanning while reducing sun-
induced skin injuries. In this study, we characterized the activity of a new melanin-inducing 
active ingredient (MI) by using ex vivo skin biopsies submitted or not to UVB irradiation. 
Melanin content was visualized by Fontana-Masson staining. A time-dependent increase in 
melanin staining was observed when skin biopsies were treated for 24, 48, and 72 hours 
with 1% of MI applied twice daily. Moreover, MI exhibited a dose-dependent increase 
in melanin intensity from 1% to 3%, for a 48-hour treatment. For skin biopsies exposed 
to UVB-irradiation, a 24-hour treatment with 1% of MI was performed. MI was applied 
twice, once before and once after irradiation with 100 mJ/cm2 of UVB. In these conditions, 
irradiated skin biopsies showed a greater melanin intensity than non-irradiated biopsies, 
and irradiated MI-treated biopsies revealed a melanin content that was clearly greater 
than that of irradiated control biopsies. Finally, in order to evaluate the anti-inflammatory 
activity of MI, secreted IL-1 beta was measured in human fibroblasts. 1% or 3% of MI was 
applied 24 hours before and after irradiation with 100 mJ/cm2 of UVB. Treated fibroblasts 
exhibited a significant decrease in IL-1 beta level (-38% and -45% with 1% and 3% of MI, 
respectively), indicating that this extract can prevent inflammation, especially under UVB-
stress induction. Taken together, these results indicate that this new melanin-inducing active 
ingredient can help prevent sun-induced damage by enhancing skin tanning and limiting 
UV-induced skin inflammation. The study thus suggests that this melanin-inducing active 
ingredient can be of great use in sun care products.
 
255
Brassicaceae extract exhibits a whitening effect on the skin. Ex vivo comparative 
studies with kojic acid
C Gondran, E Bauza, G Bressier, A Perrin, C Dal Farra, N Domloge Vincience ISP 
Global Skin ResearchCenter, Sophia-Antipolis, France
Developing active ingredients that can whiten the skin or act on pigmentation disorders 
has become an important challenge for the cosmetic industry. We were thus interested in 
studying further the whitening effects of Brassicaceae extract on the skin, and in comparing 
it with kojic acid. To do this, histological studies were performed on dark human skin 
biopsies (type V). Skin samples were pretreated with 1% and 3% Brassicaceae extract for 
24 h, irradiated with 100 mJ/cm2 of UVB, and then treated with Brassicaceae extract for 
additional 48 hours. The extract was applied twice daily. Parallel studies were conducted 
with kojic acid (1 and 50 mM), a positive control for whitening active ingredients. Skin 
sections were stained with either hematoxylin-eosin (H&E) or Fontana-Masson. H&E staining 
revealed many signs of UV-induced damage in the irradiated control skin. By contrast, a 
remarkable decrease in signs of sun damage was observed in Brassicaceae extract-treated 
skin. Moreover, in these H&E sections, a net decrease in melanin content was observed 
in Brassicaceae extract-treated skin, compared to control skin. Interestingly, skin samples 
treated with kojic acid exhibited a similar reduced content of melanin in the skin, but 
exhibited many signs of UV damage, indicating no protective effect of kojic acid against 
UV skin damage. Fontana-Masson staining confirmed the reduction in melanin content 
in Brassicaceae extract-treated skin, compared to untreated control skin. Furthermore, 
irradiated control skin exhibited an increase in melanin content in the basal layer of the 
epidermis, while Brassicaceae extract-treated skin exhibited a noticeable decrease in 
melanin content in the basal layer. Surprisingly, kojic acid also reduced melanin level in 
non-irradiated and irradiated skin biopsies, but to a lesser degree than Brassicaceae extract. 
This histological study provides valuable evidence of the interest of using Brassicaceae 
extract in whitening cosmetic products and in sun care products. 
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In vivo study of a new active ingredient that induces melanin in the skin
G Oberto, E Bauza, C Gondran, A Berghi, C Dal Farra, N Domloge Vincience ISP 
Global Skin Research Center, Sophia-Antipolis, France
Consumer interest in tanning products has grown significantly in the last number of years. 
Accompanying this growth has been an increasing desire for a natural tanned complexion 
without excessive UV exposure or the use of irritating self-tanning products. In line with 
this trend, we developed a new melanin-inducing active ingredient . Ex vivo studies have 
revealed its remarkable efficacy in inducing melanin in the skin. Therefore, we were 
interested in studying, in vivo, the tanning effect of this active ingredient, in the following 
double-blind study. 18 healthy volunteers (16 women and 2 men), age 25 to 55, participated 
in this study. They applied a cream formula containing 1.5% of the new active ingredient, 
or placebo cream, twice a day, for 4 weeks. The application zones were defined on the 
top of the arms. Measures of the melanin index were carried out on D0, D7, and D28, 
using a Mexameter MX18. Clinical evaluations were also performed. As early as D7, the 
results showed a highly significant increase (p=0.0016) in the melanin index on the active 
ingredient side. This corresponded to an improvement of skin tanning of 186%, and was 
detected in 78% of the volunteers. At D28, the results showed in 61% of volunteers a 
significant increase of 147% in the melanin index on the active ingredient-treated side 
(p=0.0320). Finally, analysis of the area under curve (AUC) for the whole duration of the 
test showed a highly significant improvement of 163% in the melanin index (p=0.0022). 
This improvement was observed in 83% of the volunteers. Moreover, clinical examination 
revealed a visible increase in skin pigmentation in 67% of the volunteers. These studies 
demonstrate that this new active ingredient rapidly and efficiently induces melanin content 
in the skin, and can be of great use in self-tanning and sun care products.
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In vivo study of a new botanical extract that enhances skin tanning
E Bauza, G Oberto, A Berghi, F Portolan, C Dal Farra, N Domloge Vincience ISP 
Global Skin ResearchCenter, Sophia-Antipolis, France
Consumers are increasingly seeking skin care products that offer a nice suntan while 
protecting the skin from UV-induced premature aging. In response to this demand, 
we developed a new botanical extract that acts specifically on melanin synthesis. 
As our studies have demonstrated the remarkable in vitro effects of this botanical 
extract on enhancing melanin synthesis, we were interested in investigating its in vivo 
effects in the following clinical study. 20 healthy volunteers of both sexes, age 25 to 
55, participated in this double-blind study. Volunteers applied a cream formula with 
1.5% of the botanical extract, or placebo, on the forearm, twice a day for 28 days. 
Using a mexameter, measurements of melanin content in the skin were performed 
at the beginning of the study, after one week, and at the end of the study. Clinical 
evaluations were also performed. The new botanical extract showed a rapid action 
on enhancing melanin content in the skin of volunteers, as early as within 7 days 
of the test, with a highly significant enhancement of melanin content compared to 
placebo (p=0.00038). After four weeks, the difference between the botanical extract-
treated and placebo sides was also highly significant (p=0.00054) and the results 
revealed an increase in melanin of 194% on the botanical extract-treated side. For the 
duration of the test, enhancement of the melanin index reached 244% and was very 
highly significant (p=0.00005). Moreover, this effect was observed in more than 80% 
of volunteers. The improvement of the botanical extract-treated side was confirmed 
clinically, and was clearly seen in 75% of volunteers. These results demonstrate that 
this new botanical extract significantly enhances melanin content in the skin, and can 
be of great use in skin care, sun care, and self tanning products. 
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In vitro evaluation of the effects of a new extract on stimulating melanin synthesis 
in the skin
E Bauza, C Gondran, G Bressier, R Chabert, C Dal Farra, N Domloge Vincience ISP 
Global Skin Research Center, Sophia-Antipolis, France
Self tanning has become an important focus of cosmetics and skin care products in 
recent years. Consumers increasingly aim to enhance tanning while improving skin 
protection from UV damage. In line with this goal, we developed a new melanin-
inducing extract and evaluated its effect on stimulating melanin synthesis in vitro 
and on human ex vivo skin. We also evaluated its effect on protecting the skin from 
UV damage and reducing cytokine synthesis in irradiated cells. Time course studies 
and dose studies were performed on ex vivo human skin. These studies showed that, 
after Fontana Masson staining, melanin-inducing extract clearly enhanced melanin 
content in the skin. Melanin staining was darker, and reached the upper layers of the 
epidermis in the extract-treated samples, compared to the untreated control skin. In 
parallel studies, melanin-inducing extract stimulated melanin synthesis in cultured 
B16F10 melanocytes. These cells exhibited a net increase in melanin pigment in their 
cytoplasm. Interestingly, H&E staining showed that, compared to control samples, skin 
samples treated with 1% of the melanin-inducing extract exhibited fewer UV damage 
signs after irradiation with 200mJ/cm² of UVB. Moreover, tyrosinase activity studies 
revealed an interesting stimulation by melanin-inducing extract of 20%. Furthermore, 
ELISA studies showed that melanin-inducing extract exhibited an anti-inflammatory 
effect and down-regulated IL-1 beta in irradiated fibroblasts by 41% (p=0.02089) 
with 1% of the extract, and by 49% (p=0.01589) with 3% of the extract. These studies 
show that this new melanin-inducing extract enhances melanin synthesis in skin 
cells, and reduces UV-induced skin damage and inflammation. This new product can 
therefore be of great use in skin tanning and sun care products. 
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Peripheral blood mononuclear cells apoptosis enhanced by repeated 
exposure of human volunteers to low doses of solar simulated radiation 
A Lesiak1, J Narbutt1, B Cebula1, A Sysa-Jedrzejowska1, M Norval2, T Robak1, 
P Smolewski1 1Medical University of Lodz, Poland 2University of Edinburgh, UK
It is proven that moderate and high doses of UV radiation are well-known inducers of 
kertatinocytes apoptosis. However the effect of low doses of solar simulated radiation 
(SSR) on apoptosis of circulating peripheral blood mononuclear cells (PBMCs) in 
human subjects has not been established. The aim of study was to establish whether 
exposure of the human skin to suberythematogenic doses of SSR may influence 
systemic immunity and induce apoptosis in circulating PBMC. 29 healthy volunteers 
were whole-body irradiated with 1.2 SED of SSR daily on 10 consecutive days 
followed by a single UVB dose of 3 MEDs on a small body area 24 h later Blood 
samples were collected before irradiation, 24 h after final whole-body irradiation, 
and 24 h after the single high UVB dose. Apoptosis of PBMCs was assessed by the 
TUNEL and the poly(ADP-ribose) polymerase cleavage assay. Expression of several 
apoptosis-regulating proteins belonging to the Bcl-2: (bax, bak, bcl-2, mcl-1). A 
significantly higher AI was found following the 10 repeated SSR exposures, while 
irradiation with the single erythemal UVB dose on a small body area following 
the repeated SSR doses did not cause any significant alteration in the AI. Repeated 
SSR exposures induced a significant increase in the expression of the proapoptotic 
proteins Bax (p= 0.0015) and the Bax/Bcl-2 ratio increased approximately 3-fold 
(p=0.007). There was no significant change in expression of any of these proteins in 
the PBMCs after the subsequent irradiation with 3 MEDs UVB. Our results indicate 
that repeated suberythemal doses of SSR are sufficient to induce PBMC apoptosis in 
healthy volunteers and influence human immunity. 
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ECP inhibits contact hypersensitivity and induces regulatory T cells through different 
mechanisms
A Maeda1, A Schwarz1, A Bullinger2, DP Peritt2, T Schwarz1
1University of Schleswig-Holstein, Kiel, Germany 2Therakos, Exton, USA
Extracorporeal photopheresis (ECP) is effective in autoimmune diseases, transplant rejection 
and GvHD, implying that it exerts immunosuppressive properties. An experimental in vivo 
model for ECP demonstrated that ECP induces regulatory T cells (ECP-Treg). In this murine 
model, ECP suppressed not only the induction but also the elicitation of contact hypersensitivity 
(CHS). To further investigate the mechanism of the inhibition of the elicitation of CHS by ECP, 
leukocytes obtained from DNFB-sensitized donors were exposed in vitro to 8-MOP and UVA. 
Cells were injected i.v. into DNFB- sensitized mice. 3 days later, splenocytes obtained from 
the recipients were injected i.v. into naïve or DNFB-sensitized mice. 5 days later ear challenge 
was performed. ECP-Treg suppressed CHS only in naive but not in sensitized mice, indicating 
the ECP-Treg suppress only the induction but not the elicitation of CHS. This discrepancy 
to the previously observed effects of ECP might be solved by the explanation that probably 
the inhibition of CHS by ECP and the induction of ECP-Treg are mediated by different 
mechanisms. IL-10 is known to inhibit both the induction and the elicitation of CHS. Therefore 
we analyzed serum obtained from mice after injection of either untreated or PUVA-exposed 
leukocytes. In mice which had received PUVA-exposed leukocytes significantly elevated IL-
10 levels were found but not in mice which received untreated leukocytes. Thus, we speculate 
that the inhibition of the elicitation phase of CHS upon infusion of PUVA-treated leukocytes 
is a process which does not require Treg but may be mediated via enhanced IL-10. In parallel 
but independently Treg are induced as demonstrated by the adoptive transfer experiments. 
Together, this demonstrates that experimental ECP inhibits both the induction and the 
elicitation phase of CHS and induces Treg, though most likely through different mechanisms. 
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Dermoscopic valuation of acquired melanocytic nevi in patients in suberythemal 
NB-UVB or UVA1 therapy
PG Calzavara-Pinton, A Manganoni, G Tucci, M Venturini, C Farisoglio University of 
Brescia, Brescia, Italy
The aim of the present study was to investigate whether repeated exposures to 
equally effective sub-erythemogenic doses of UVA or UVB can induce changes in the 
dermoscopic features of acquired melanocytic nevi and whether a commercial highly 
protective UVA- UVB sunscreen can prevent them. Twenty volunteers with skin type II 
and III were randomized to receive equally effective doses of narrow- band (NB)- UVB 
(emission peak 312±2 nm) or UVA1 (emission range: 340- 400 nm). Three weekly 
exposures were delivered for 4 weeks. Three acquired melanocytic nevi with similar 
size and dermoscopic features were selected in each patient. During exposures, a 
nevus was covered with a opaque tape, another was shielded with the sunscreen and 
the remaining was left unprotected. At baseline and after 12 exposures (cumulative 
effective dose: 3000Jeff m-2), size and dermoscopic features (degree of pigmentation, 
pigment network, branched streaks, brown globules and dots) of nevi were evaluated 
under standardized conditions by means of a digital dermatoscope. In comparison to 
baseline, nevi exposed to NB-UVB showed similar statistically significant changes: 
increased size, increase of pigment network, overall color darkening, formation of 
focal branched streaks, increased number and size of brown dots and globules. The 
same changes were seen in nevi exposed to UVA1. Nevi that were covered with the 
adhesive opaque tape and nevi shielded with the UVA-UVB remained unchanged.
Therefore paracrine and endocrine signals do not seem effective in change size and 
pattern of unexposed nevi, under the present experimental conditions. In conclusion, 
the present investigation demonstrates that acquired melanocytic nevi show similar 
changes of size and dermoscopic pattern following either UVB and UVA exposures 
and that changes may be prevented by the application of a UVA-UVB sunscreen.
262
MAL-PDT of in situ, microinvasive and invasive squamous cell carcinoma
PG Calzavara-Pinton, C Zane, R Capezzera, M Venturini, R Sala Univ of Brescia, Italy
PDT with methyl-MAL is an approved non- invasive treatment option for AK, a precursor 
of squamous cell carcinoma (SCC). A total of 112 biopsy-proven SCC in 55 outpatients 
were treated. A MAL cream (160 mg/g) was applied for 3 hours prior to illumination 
from a LED source (wavelength range: 635±18 nm; light dose 37 J/cm2). Nodular lesions 
(prominent above skin surface >2mm) were debulked surgically prior to be treated. 
A second MAL PDT session was given 7 days later. The overall complete response 
rates were 73.2 % at 3 months and 53.6 % at two years. Clinical thickness, atypia and 
lesion depth were significant predictors when using a univariate analysis (p<0.001). A 
multivariate logistic regression model, with robust variance estimation, showed that cell 
atypia was the only independent predictor of the treatment outcome. The time (mean± 
SD) to recurrence was 6.55±4.10 months. The relapse rate at follow-up was influenced 
by cellular atypia (HR=5.23; 2.12-12.87;p=<0.001) and maximal diameter (HR=1.21;1.03-
1.41;p=0.018) of the lesion according to the Cox model with adjustment for correlated 
data. Local adverse effects consisted of strong erythema followed by erosion or ulceration. 
The cosmetic outcome was good or excellent in the majority of patients with a very 
good concordance of evaluation among patients and investigators. The most important 
predictor for cosmesis was cell atypia. We concluded that MAL-PDT may represent a 
valuable, effective and well tolerated treatment option with a good cosmetic outcome for 
superficial, well- differentiated (Broders’ scores I and II), in situ SCCs. In contrast, its use 
for superficial SCCs with a microinvasive histological pattern and for nodular, invasive 
lesions, particularly if poorly differentiated (Broders score III and IV) keratinocytes are 
present, should be avoided and, if surgery and other invasive procedures are not applicable, 
other therapeutic alternatives, (radiotherapy or local chemotherapy), should be used. 
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In vivo three-dimensional birefringence analysis of the aged human skin using 
polarization-sensitive optical coherence tomography
S Sakai1, M Yamanari2, A Miyazawa2, M Matsumoto1, N Nakagawa1, K Kawabata1, T 
Yatagai3, Y Yasuno2 1Kanebo Cosmetics Inc., Odawara, Japan 2Computational Optics 
Group, Tsukuba, Japan 3University of Tsukuba, Tsukuba, Japan
Polarization-sensitive optical coherence tomography (PS-OCT) permits non-
invasive visualization of dermal birefringence, mainly in the collagenous structure. 
The purpose of this study is to three-dimensionally the dermal birefringence of 
intrinsically aged and photoaged skin using PS-OCT. We measured the cheek 
(photoaged skin) and interior upper arm (intrinsically aged skin) of old and young 
volunteers. The algorithm that we used automatically produces a transversal map 
of the dermal birefringence from the polarization-sensitive OCT volume, which 
enables quantitative comparison and visualization of the transversal distribution of 
the dermal birefringence. Dermal birefringence of the cheek skin was significantly 
smaller in the old group than in the young group (old group: 0.295± 0.037 degree/
µm; young group, 0.207± 0.03 degree/µm; p= 0.003), while the interior upper arm 
showed no age-dependent difference. The transversal map of the cheek showed a 
heterogeneous decrease in dermal birefringence due to photoaging. The map and 
histological observation demonstrated that the peripheral regions of some infundibula 
are surrounded by strongly oriented collagen fibers. Three-dimensional analysis of 
the dermal birefringence using PS-OCT may provide quantitative and histological 
information about the dermal collagenous structure for diagnosing photoaging. 
 
264
The effect of topical capsaicin pretreatment on the induction of polymorphous light 
eruption (PLE) by solar simulated light
FJ Legat, A Bretterklieber, M Haar, G Sepic, A Hofer, A Wackernagel, F Quehenberger, 
H Kerl, P Wolf Medical University of Graz, Graz, Austria
PLE is the most common idiopathic photodermatosis. One of the present hypotheses 
about the pathogenesis of PLE is a failure of normal UVR-induced immunosuppression. 
Neuropeptides from cutaneous sensory nerve fibers play a role in UVR-induced 
immunosuppression. We investigated whether capsaicin-induced depletion of 
neuropeptides from cutaneous sensory nerve fibers would affect the induction of PLE 
by solar simulated radiation (SSR). Fifteen patients (12F/3M) administered a capsaicin 
0.05% cream or its vehicle, respectively, 4 times per day for 14 days to one PLE-
prone skin area on each of two contralateral body sides. Within the contralateral 
pretreated skin areas, then test fields of 5x5cm were irradiated with SSR (Oriel® 
1 kW Xenon arc solar simulator) once per day for 4 consecutive days. SSR-dose 
was 70% of the individual minimal erythema dose at the start, and according to 
the erythema reaction was increased by up to 40% on each consecutive day. Both 
test fields always received equal SSR doses. At 24, 48, 72, 96, and 168h after the 
first SSR exposure, test fields were evaluated for the induction of PLE and erythema, 
using clinical scores, as well as for itch sensation, using a visual analogue scale 
(VAS) from 0 to 10. Twelve of 15 patients developed PLE within the test fields 
during the observation period of 7 days. There was no significant difference in 
the clinical scores for PLE lesions or erythema, or in VAS values for itch sensation 
comparing the contralateral test fields pretreated with capsaicin 0.05% cream or 
vehicle, respectively. We conclude that neuropeptides may not play a significant 
role in the induction of the clinical signs for PLE by solar simulated irradiation, at 
least based on the experimental depletion conditions we had used in this study. 
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Rapid photolysis of nitric oxide stores in human skin is induced by ultraviolet A 
radiation
M Mowbray, R Weller The University of Edinburgh, Edinburgh, UK
Nitric Oxide’s (NO) properties in the skin include wound healing, keratinocyte proliferation/
differentiation, regulation of inflammation and antimicrobial activities. The inducible 
NO synthase (iNOS) enzyme peaks 24 hours after ultraviolet radiation(UVR), producing 
erythema. An alternative source of NO has recently been described in the form of 
Nitrosospecies (nitrate, nitrite, nitrosothiols) stored in the skin. These enzyme independent 
sources release NO by a process of photolysis which is maximal 20 minutes following 
UVR. We have measured in vivo release of NO in human skin following exposure to 
UVA. Using dermal microdialysis and chemiluminesence based analysis of dialysate, 
we measured nitrosospecies in normal human skin during 60 minutes exposure to UVA 
(60J/cm2). Inter-individual variability was found in resting nitrosospecies levels in the 
superficial dermis (mean 13.96±3.54mM Nitrite). There was a significantly higher yield of 
NO species in the irradiated than the unirradiated group, peaking 30 minutes after the 
start of irradiation. The mean total NO species recorded over 60 minutes was: irradiated 
63.64mM Nitrite, unirradiated 53.19mM Nitrite. The yield of nitrosospecies was reduced 
on dialysing noradrenaline compared with normal saline. We concluded that exposure to 
UVA results in rapid release of NO in the superficial dermis. This may be derived from 
the dermal microvasculature. We hypothesise that photolysis of nitrosospecies in the skin 
releases NO which plays an important role in the cutaneous response to UVR (absorption 
nitrite 354nm, nitrosothiols 330-340nm). Significant inter-individual variability exists in 
nitrosospecies levels in normal human skin. We have previously shown that skin nitrite 
levels correlate with blood nitrite levels. Dietary nitrate intake influences blood nitrite levels 
and may account for the inter-individual variability seen in tissue nitrosospecies, and may 
influence an individual’s response to UVR.
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Ultraviolet-Induced Cutaneous Irritation Measured by Spectral Imaging
GN Stamatas, S Gorski, D Miller Johnson & Johnson Consumer, Issy Les Moulineaux, 
France
The effects of ultraviolet radiation (UVR) on the cutaneous tissue are often based on 
subjective evaluation of skin erythema one day following irradiation. Spectral imaging 
is a novel objective non-contact method developed for the study of skin irritation. In 
this study we applied this method to document UVR-induced skin reactions and 
we tested the sensitivity with regards to UVR-induced erythema. Nine volunteers 
with skin phototypes II-III were irradiated on six sites on the back with UVR doses 
in the range 5-20 mJ/cm2. The following day the irradiated sites were evaluated for 
the determination of minimal erythema dose (MED). Visual assessment, orthogonal 
polarization imaging, and spectral imaging at specific wavelengths were employed to 
document the skin reactions. Oxy- and deoxy-hemoglobin concentration maps were 
calculated from the spectral images. These maps are quantitative representations of 
the hemoglobin distribution in the skin. We demonstrate that the oxy-hemoglobin 
map directly relates to the perception of skin erythema and is 2-3 times more 
sensitive than either clinical observation or orthogonal polarization imaging. 
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Tumor necrosis factor alpha converting enzyme in psoriasis patients treated with 
narrowband ultraviolet B
B Serwin, E Dylejko, B Chodynicka Medical Unversity of Bialystok, Poland
Our aim was to examine the tumor necrosis factor alpha converting enzyme (TACE) 
concentration in peripheral blood mononuclear cells (PBMC) and its relationship 
with plasma concentration of soluble tumor necrosis factor alpha receptor type 1 
(sTNF-R1) and with the disease severity in psoriasis patients treated with narrowband 
ultraviolet B (NB-UVB). The study has been conducted among patients with plaque-
type psoriasis vulgaris: 23 had skin lesions only (psoriasis vulgaris - PV) and 17 had 
co-existing, inactive, psoriatic arthritis (PsA). Control blood samples were obtained 
from twenty healthy subjects. The assessment of the severity of skin lesions (using 
Psoriasis Area and Severity Index - PASI), TACE and sTNF-R1 concentrations (using 
quantitative sandwich enzyme immunoassays) have been performed at baseline (T 
0) and after twenty NB-UVB irradiations (T 20). The baseline sTNF-R1 and TACE 
concentrations in all patients was higher than in controls (2.55±1.67 ng/mL vs. 
1.70±0.15 ng/mL, P<0.001, respectively, and 2.62±0.32 ng/mL vs. 1.31±0.30 ng/mL, 
P<0.001, respectively). The sTNF-R1 and TACE concentrations were lower in PV than 
in PsA patients (2.47±0.15 ng/mL vs. 2.65±0.13 ng/mL, and 2.52±0.22 ng/mL vs. 
2.76±0.39 ng/mL, P<0.05, respectively). The baseline TACE concentration correlated 
to that of sTNF-R1 (R=0.52, P<0.05). The PASI correlated to sTNF-R1 and to TACE 
concentrations (R=0.48 and R=0.39, P<0.05, respectively). The significant decline 
in sTNF-R1 and TACE concentrations at T 20 was noticed, TACE reached control 
values (1.20±0.44 ng/mL in PV and 1.16±0.48 ng/mL in PsA patients, respectively). 
We concluded that TACE from PBMC can contribute to up-regulation of sTNF-R1 in 
patients with active psoriasis vulgaris and with psoriatic arthritis. It also be a sensitive 
marker of the disease severity. 
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Melanoma cell lines are susceptible to UV-A mediated enhancement of melanoma 
progression
W Schuller, M Röcken, M Berneburg Eberhard-Karls University, Tübingen, Germany
We have previously shown that aging associated mutations of mitochondrial (mt)DNA as 
well as senescence mediated growth control is induced in normal melanocytes by repetitive 
sublethal irradiation with ultraviolet (UV)-A but reduced in malignant melanoma. However, 
the question whether UV-A irradiation is involved in tumour progression of melanoma cells by 
altering their metabolism has not been adressed. Due to the fact that enhanced glucolysis is a 
distinctive marker of cancer progression, we examined the effect of UVA irradiation on aerobic 
glycolysis, the so called Warburg effect. The pentose phosphate pathway (PPP) allows glucose 
conversion to ribose for nucleic synthesis and glucose degradation to lactate. The nonoxidative 
part of the PPP is controlled by thiamine-dependent transketolase (TK) enzyme reactions, 
which have been related to cancer progression. High aerobic glycolysis is associated with 
high levels of TKTL1 (transketolase-like 1) expression. As inhibition of transketolase enzyme 
reactions suppresses tumour growth and progression, TKTL1 could be a relevant target for 
novel anti-transketolase melanoma therapies. We irradiated melanoma cell lines of different 
progression levels repetitively with UVA, measuring TK enzyme activity and lactate levels. 
Following UV-A-irradiation lactate production of melanoma cells correlated with enhanced 
transketolase enzyme activity. Incubation with the transketolase inhibitor oxythiamine 
abolished TK activity. UV-A exposure was accomplished by the induction of senescence. 
Applying real-time PCR we assessed the adhesion molecule CD171, Akt kinase, insulin 
growth factor binding protein-3 (IGFBP-3) and TKTL1 levels. mRNA levels of these proteins 
were increased after UV-A exposure. Thus, UV-A exposure increases peptide levels which are 
involved in tumor migration (CD171) and tumor progression (Akt and, TKTL1), suggesting an 
involvement in melanoma progression. We postulate a novel concept for the understanding 
of the physiological changes in malignant conversion in melanoma cells after UV-A exposure. 
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Clinical and Histological Evaluation of Topically Applied Pro-Xylane™ on 
Photodamaged Skin in Healthy Volunteers
C Bredoux, H Zucchi, S Pallard, D Lombard, A Rolland L’OREAL Research, Aulnay 
Sous Bois, France
A double-blind vehicle-controlled study, randomized on treatment side, was carried out to 
investigate the effects of topically applied Pro-Xylane™ (C-β-D-xylopyranoside-2-hydroxy-
propane) cream on photoaged skin in healthy volunteers after study approval by an ethics 
committee. 15 postmenopausal women were selected based on mild to severe aging 
level of their facial skin. Each volunteer applied the Pro-Xylane™ and vehicle creams on 
the pretragian areas (ear fold) of the face twice daily for 3 months. Clinical parameters 
were scored and biophysical parameters were evaluated on the pretragian areas before 
and after 1, 2, and 3 month product applications. Skin biopsies were collected before 
and after treatment and processed for classical histology and immunohistochemistry. On 
treated facial areas, major clinical criteria including wrinkle’s score (p=0.01), sagging 
score (p=0.03) and global aging score (p=0.003) were significantly improved on the 
Pro-Xylane™-treated side compared to before treatment from 2-month applications; 
global aging score also tended to be better (p=0.08) on Pro-Xylane™-treated side versus 
vehicle-treated from 2-month treatment. No changes in elastin network, in type III to type 
I procollagen ratio and collagen IV were noticed in both Pro-Xylane™ and vehicle-treated 
skin. However, differences in Grenz zone thickness (p=0.03) and fibrillin-1 expression 
(p=0.05) were revealed in papillary dermis in favour of Pro-Xylane™ -treated skin 
compared to vehicle-treated. Furthermore, at 3-months Pro-Xylane™-treated skin showed 
an increase in GAG deposits (p=0.003) and chondroitin-sulfate expression (p=0.08), a 
GAG that was found to disappear where wrinkle depression occurs. These data suggest 
that Pro-Xylane™ has a beneficial effect on the major clinical aging features and on 
the expression of components of dermal structure which are altered during photoaging. 
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Association of the extracellular chaperone clusterin with altered elastic fibers in 
vivo and in vitro
E Janig1, M Haslbeck2, J Buchner2, A Aigelsreiter1, H Denk1, K Zatloukal1, P Wolf1 
1Medical University of Graz, Graz, Austria 2TUM, Garching - Munich, Germany
Clusterin is a secreted chaperone with stress-induced expression in various diseased and 
aged tissues. Since dermal connective tissue alterations occur due to ageing and ultraviolet 
(UV) radiation and since we found clusterin in association with elastic material in cirrhotic 
human livers, we aimed to obtain closer insights into the interaction of clusterin with 
elastin in intrinsically and extrinsically aged skin. Therefore, we performed histological and 
immunohistochemical studies of young and aged as well as sun-exposed and -protected 
human skin. All cases of sun-aged skin showed a massive accumulation of elastotic material 
(solar elastosis) with strong immunohistochemical staining and constant co-localization of 
clusterin. In intrinsically aged skin clusterin was associated with thickened elastic fibers. 
The immunoreaction of clusterin correlated with the extent of abnormal elastin. In contrast, 
young sun-exposed and -protected skin had a well-organized elastin fiber network, which 
was constantly negative for clusterin. Because of the striking co-localization of clusterin 
with abnormal elastotic material, we investigated the interaction of clusterin and elastin in 
vitro. To explore a possible chaperone action of clusterin, we performed an in vitro assay, 
where elastin was treated with UV light in the absence or presence of clusterin. Whereas UV 
irradiation of elastin resulted in degeneration and aggregation of elastin, addition of clusterin 
effectively inhibited the formation of elastin aggregates. The interaction of both proteins 
was further analyzed by size exclusion chromatography, mass spectrometry and electron 
microscopy, where clusterin was found in a stable complex with elastin after UV exposure. 
In summary, we show that clusterin specifically co-localizes with altered elastic fibers in 
vivo, especially in chronic UV-damaged skin. In addition, clusterin prevented UV-induced 
aggregation of elastin in vitro, providing evidence that elastin is a target protein of clusterin. 
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Effects of narrow-band ultraviolet B phototherapy on the epidermal gene expression 
profile in psoriasis
E Racz, R Kant, K Schellekens, E Prens, L Van der Fits Erasmus University Medical 
Center, Rotterdam, Netherlands
Our aim was to investigate the molecular effects of narrow-band ultraviolet B (NB-
UVB) radiation on inflamed human skin and to identify the molecular pathways 
that play a role in the resolution of inflammation during NB-UVB phototherapy. Ten 
patients with plaque-type psoriasis have been treated with NB-UVB phototherapy 
according to standard protocols for a maximum of 3 months, or until complete 
remission. Gene expression profiling was performed on RNA isolated from lesional 
and non-lesional epidermal samples taken before and after phototherapy. To study 
the short-term effects of NB-UVB, additional skin samples were collected 6 hours 
after the first irradiation. Phototherapy modulated 557 genes in lesional skin and 215 
genes in non-lesional skin in the long term (≥ 2-fold difference), whereas only 52 
genes were modulated in both lesional and non-lesional skin. These included genes 
with a role in pigment synthesis, apoptosis, cell cycle regulation and inflammation. 
The gene expression profile of lesional psoriatic skin normalized after completion 
of phototherapy. The short-term UVB-response involved 7 genes in lesional skin 
and 124 genes in non-lesional skin. Surprisingly, there was no overlap between the 
two groups. Our results show that the remission of inflammation after completion 
of phototherapy is accompanied by normalization of the global gene expression 
profile of epidermal cells. In the short term, NB-UVB modulated a different set of 
genes in lesional and non-lesional epidermis, with far less genes affected in lesional 
skin. These results imply that effects of UVB in non-inflamed skin cannot simply be 
extrapolated to inflamed skin. 
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A new role of Phase I and Phase II enzymes in keratinocytes UVB induced apoptosis
L Benassi, G Bertazzoni, S Giudice, A Giannetti, C Magnoni Univ of Modena and 
Reggio Emiliana, Modena, Italy
UVB is the major cause for cutaneous malignancies in the human population. The skin is 
able to activate anti-oxidants and enzymatic detoxification reactions to neutralize reactive 
photochemical products. Apoptosis, removing irreversibly DNA-damaged and potentially 
neoplastic cells, represents a major defence mechanism towards malignant transformation. 
Very little is known about the role of cutaneous cytochrome P450 (CYP450) isoenzymes and 
glutathione S-transferase (GST) in UVB response. Although not yet fully investigated, it has 
been studied a possible relationship between CYP450 inductors and UVB initiated apoptosis 
in rat hepatocytes. Altered high levels of GST has been directly correlated to resistance to 
chemotherapeutic drugs suggesting that GST plays a role in prevention of apoptosis. Our study 
is focused on phase I and phase II enzyme activities in normal human keratinocytes. In the 
first part of the study we demonstrated that CYP450 (1A1 and 2B1) and GST are induced not 
only by classical inducers such as β-naphthoflavone, 3-methylcholanthrene, phenobarbital 
but also by UVB radiations (50 mJ/cm2). Differentiated keratinocytes were employed for all 
experiments as confirmed by immunoblotting with Cytokeratin 10, a specific marker of the 
basal spinous transition. In the second part we evaluated a possible involvement of these 
enzymes in UVB mediated apoptosis process. Western blot analysis of Bcl2 expression and 
PARP cleavage showed that inhibition of CYP450 by Proadifen prevented UVB induced 
apoptotic cell death. In contrast, the diuretic drug, ethacrinic acid, a GST inhibitor, was able 
to improve UVB induced apoptosis. In order to confirm the anti-apoptotic activity displayed 
by GST, when GST activity was increased by Phenobarbital, UVB apoptosis was prevented.
These results suggest that UVB radiations may play a critical role as tumour promoters 
through the regulation of CYP450 and GST metabolising enzymes.
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Substrate competition regulates nitric oxide production in irradiated human skin
M Mowbray1, L Van Overloop2, N Bredenkamp1, M Matsui2, L Declercq2, R Weller1 
1The University of Edinburgh, Edinburgh, UK 2Estee Lauder, Oevel, Belgium
Nitric oxide (NO) is a free radical with a range of activities in human skin. Arginine is 
the common substrate for nitric oxide synthase (NOS) and arginase, which produce 
NO and citrulline or urea and ornithine respectively. Inducible NOS is up-regulated 
by UVB radiation (UVB). The aim of this experiment was to determine whether 
competition for the common substrate arginine by arginase influences the activity of 
NOS following UVB. We irradiated the backs of 8 healthy volunteers with 0, 0.75, 
1 and 2 MEDs of TL0-1. We treated an adjacent site with the NO donor, Zeolite-
NO, before and for 24 hours after irradiation. 1 hour, 24 hours, and 2 weeks after 
irradiation, stratum corneum from each treated site was sampled by 20 sequential 
tape strips. Basal epidermal activity is represented in the stratum corneum after 2 
weeks. The 10th strip was analysed by HPLC for arginine, ornithine and citrulline 
and corrected for protein concentration. There was no change in stratum corneum 
concentration of the amino acids at 1 hour or 1 day after irradiation. Two weeks after 
irradiation we observed a significant dose dependent increase in ornithine and urea, 
representing arginase activity. Zeolite-NO treated skin also produced an increase in 
ornithine comparable to that of 0.75 MEDs. Citrulline levels showed a decreasing 
trend with increasing UV doses. Dose-dependent changes in ornithine and citrulline 
levels were negatively associated in irradiated skin (R2= 0.8). We believe that NO 
exerts a negative feedback on its own production via arginase. NO is released from 
human skin following UVR by enzyme-dependent and independent mechanisms, 
this in turn increases arginase activity. The Km of NOS for arginine approximates 
to physiological arginine concentration whereas that for arginase is much greater, 
therefore substrate competition by arginase will have a significant regulatory effect 
on NO production. 
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Heliotherapy and narrow-band UVB improves vitamin D balance
L Reunala1, K Vähävihu1, L Ylianttila2, C Lamberg-Allardt3, P Tuohimaa1, E Snellman4 
1Tampere University Hospital, Finland 2Non Ionizing Radiation Laboratory, Helsinki, 
Finland 3University of Helsinki, Finland 4Päijät-Häme Central Hospital, Lahti, Finland
Solar UVB exposure is crucial for vitamin D synthesis but in winter very little, if 
any, vitamin D is produced in the skin. Due to this many people living in northern 
Europe suffer from vitamin D insufficiency. Our objective was to study the effect 
of heliotherapy (HT) and narrow-band (UVB 311) on serum calcidiol (25-
hydroxyvitamin D) concentration. Methods: A 2-week course of HT was given to 23 
patients with atopic dermatitis (mean age 36 years) in the Canary Islands in winter. 
Daily solar UV radiation was measured and personal UV exposure calculated as 
standard erythema doses (SED). A 1-week course of whole-body UVB 311 was given 
to 19 healthy adults (mean age 42 years) in winter. Blood samples were taken before, 
during and 1-2 months after HT and UVB 311. Serum calcidiol was measured by 
radioimmunoassay. Initially 65%-75% of the subjects had vitamin D insufficiency 
(calcidiol <50 nmol/L). In HT total UV doses were 60 SED and 109 SED, and they 
both increased significantly serum calcidiol (13.4 and 24.0 nmol/L: P<0.01). 1-week 
UVB 311 course (13 SED) increased also significantly serum calcidiol (11.4 nmol/L). 
Increase persisted for 1-2 months after HT and UVB 311. We concluded that mild or 
moderate vitamin D insufficiency is common during winter in Finland. A 2-week HT 
in Canary Island or a 1-week whole-body UVB 311 at out-patient clinic improved 
significantly serum calcidiol. This effect persisted for 1-2 months and should be 
taken in account when considering efficient ways to improve vitamin D balance. 
 
275
Repetitive UVA irradiation increases the release of cathepsin L but not cathepsin B 
in dermal fibroblasts
N Hunzelmann1, A Klose1, J Brinckmann2 1Univ of Cologne, Germany 2Univ of 
Luebeck, Germany
UVA-therapy is increasingly used to treat fibrotic skin disorders such as scleroderma. 
The mechanisms by which UVA exerts its anti-fibrotic effects are poorly understood. 
Recent studies indicate that the lysosomal cysteine proteases Cathepsin B and L act 
also extracellularly and are able to degrade a number of extracellular matrix proteins 
as collagen telopeptides or elastin. Therefore we investigated whether single or 
repetitive irradiation with UVA regulates the expression and release of Cathepsin 
B and L. Human dermal fibroblasts were irradiated with increasing doses of UVA 
(0-40 J/cm2) as well as on consecutive days (2-4) with a single dose each (20 J/cm2). 
Thereafter supernatants, cell extracts and RNA were analysed. Whereas no alteration 
of protein synthesis and release of cathepsin B and L was found after single irradiation, 
a clear increase of the extracellular release of pro-cathepsin L and two mature forms of 
cathepsin L was found after repeated irradiation using western blot and zymographic 
analysis. This release correlated with the number of consecutive irradiations. Detection 
of extracellular cathepsin L was associated with a significant reduction of intracellular 
levels. This reduction was found to be due to a blockade of the lysosomal pathway of 
cathepsin processing thereby leading to the extracellular release of Cathepsin L. This 
is the first study which demonstrates the extracellular release of a cysteine protease by 
repetitive UVA irradiation having important implications for the understanding of UVA 
induced connective tissue turnover as in UVA therapy of fibrotic diseases or skin aging. 
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No induction of DNA repair capacity after pre-treatment of fibroblasts with UVB 
or UVA
Z Hatvani1, M Bercht2, TM Rünger2 1Semmelweis University, Budapest, Hungary 
2Boston University, Boston, USA
Capacity of nucleotide excision repair has been reported to be inducible through 
induction of XPC via activation of p53. P53 activation occurs after exposure of cells 
to UVB, but is much weaker after exposure to UVA. Therefore, we hypothesized 
that UVB may be more efficient in increasing DNA repair capacity. We used two 
different types of plasmid-based DNA repair assays to assess efficiency of DNA 
photoproduct removal from plasmids that had been damaged with UVB in-vitro, 
prior to introduction into fibroblasts for repair. In addition, we also used an ELISA, 
in which DNA repair efficiency is assayed by measuring removal of cyclobutane 
pyrimidine dimers (CPDs) and 6,4-photoproducts (6,4-PP) from genomic DNA after 
irradiation of cells with UVB. 24 hours prior to these DNA repair assays, cells were 
pre-treated with sham or various doses of UVA or UVB. Pretreatment with either UVA 
(50, 100, or 200 kJ/m2) or UVB (50, 100, or 200 J/m2) did not result in improved 
overall repair, as shown by the plasmid-based repair assays. With the ELISA assay, 
a slightly improved repair of CPDs was observed after UVA-, but not after UVB-
preirradiation. The removal of 6,4-PPs was not affected by any pre-treatment. Western 
blot analysis demonstrated that XPC was induced both by UVA- and UVB, albeit 
more by UVB. Our data indicate that damage signaling mediating upregulation of 
rate-limiting DNA repair proteins such as XPC is activated both by UVA and UVB, 
but does not result in an improved repair capacity. This is most likely due to UV-
induced damage to the repair machinery itself that offsets the effects of repair protein 
upregulation. This was confirmed by the observation that inhibition of p53 activation 
by p53-siRNA resulted in reduced DNA repair capacity after UVB-pretreatment. 
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Correlations between tissular effects, PPIX fluorescence and the pain induced by 
PDT on normal skin
D Salomon1, J Barges2, T Glanzmann2, G Wagnieres2 1HUG, Geneva, Switzerland 
2EPFL, Lausanne, Switzerland
The pain induced during topical PDT based on the production of protoporphyrin IX 
(PPIX) precursors is a significant problem in dermatology. Although various more or 
less effective approaches are proposed to reduce the pain, it is of major importance 
to determine if it is correlated with pa-rameters such as the PPIX fluorescence and the 
“tissular effect”. Photosensitization tests were performed on the normal skin of the 
legs of 5 volunteers with various drug doses (between 10 and 100 %; 6 mg/cm2) and 
formulations of diethyleneglycol-monoethylether aminolevilinate (ALA-DGME), the 
PPIX precursor showing an optimal selective photosensitization of the pilosebaceous 
unit. Circular spots (3 cm in diameter) were homogenously illuminated at 635 nm 
with frontal light distributors coupled to a diode laser. The irradiance, light doses and 
drug-light intervals (DLI) ranged between 50 and 200 mW/cm2, 10 and 200 J/cm2, 
and 1 and 6 hours respectively. The PPIX fluorescence above 665 nm was quantified 
using a filtered ca-mera, with the fluorescence excitation at 635 nm in order to probe 
“deep seated” PPIX. The tissular effects were assessed by reflectance spectroscopy 
between 1 and 8 weeks after PDT. The pain was scored using a numerical scale 
ranging from 0 to 5 during illumination. A clear correlation exists between the pain 
and the irradiance, the larger irradiances being more painful. The pain also increases 
with long DLIs. Although less marked, the pain exhibits a relation with the PPIX 
fluorescence and the tissular effects if the data are analyzed on a per-patient basis.
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Comparison of ultraviolet A-induced antioxidant response in human fibroblast and 
keratinocyte cultures
T Saguet1, L Nicod2, S Robin3, D Binda1, I Lascombe1, S Fauconnet1, P Humbert1 
1Universite de Franche-Comté, Besancon, France 2SSB, Besancon, France 3BioExigence, 
Besancon, France
Ultraviolet A radiations (UVA) contribute to the development of various deleterious 
cutaneous effects, such as photoaging and photocarcinogenesis. UVA damages are related 
to oxidative stress. We proposed to compare the antioxidant status of keratinocytes and 
fibroblasts in response to UVA. Human primary cultures of fibroblasts and keratinocytes 
were exposed to 1 and 3 J/cm² and biological analyses were carried out 2h and 24h 
after irradiation. Cell death was evaluated by cytometric flow after propidium iodide 
staining. Lipid peroxidation was appreciated by TBARS concentration measurements, and 
antioxidant enzymatic activities (superoxide dismutase, catalase, glutathione peroxidase 
and reductase) by biochemical assays. In basal conditions of culture (without irradiation), 
there were no difference between fibroblasts and keratinocytes for cell death fraction, lipid 
peroxidation and antioxidant enzymes. 2h after UVA irradiation, we observed a stronger 
mortality in fibroblasts compared to keratinocytes, which coincided with a high lipid 
peroxidation level in fibroblasts. Then, superoxide dismutase and catalase showed higher 
activities at 3 J/cm² in fibroblasts whereas the other markers did not significantly vary. Even if 
antioxidant capacities of fibroblasts were increased by UVA, lipid peroxidation levels were 
high and probably might depend on the balance of the two enzyme activities: superoxyde 
dismutase promotes the oxidative damage and catalase protects against it. Besides, 24h after 
irradiation, fibroblasts and keratinocytes recovered their basal antioxidant values. The two 
cell populations showed different behaviours towards UVA-induced oxidative stress when 
human fibroblasts seemed more susceptible. These data might explain the major deleterious 
UVA effects on the dermis, involving photoaging.
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Effects of chronic sun exposure in epidermal cell cycle and DNA replication of 
human skin
L Barnes1, M Dumas2, A Gandarillas1 1IURC, UMI, INSERM, Montpellier, France 
2LVMH Recherche, St Jean-de Braye, France
The mechanisms linking cell cycle with differentiation must control skin homeostasis 
and its response to environmental factors such as sun-exposure. How they protect the 
skin or are altered by sun exposure leading to skin damage or ageing is also uncertain. 
We have previously unravelled a novel relationship between cell cycle and epidermal 
differentiation that results in endoreplication. This allows DNA replication, and cell 
mass increase during differentiation. Through a mitosis-defective checkpoint, this 
phenomenon might have a physiological role in homeostasis and regeneration. We 
are studying whether this checkpoint is involved in the skin response to sun exposure. 
To this aim, we determine the expression of cell cycle markers, DNA replication 
and DNA content, in sun-exposed or sun-protected areas of human skin. We have 
performed this study on: i) a panel of clinical biopsies of normal skin from circumcisions 
or plastic surgery and, ii) a monitored panel from a series of volunteers. In the latter 
case, for each donor we obtained skin biopsies from the external forearm area, to be 
considered as photo-exposed, and from the internal arm area, to be considered as 
photo-protected. In photo-exposed skin the expression of cell cycle markers, notably 
DNA replication cyclin E, was significantly increased with respect to photo-protected 
areas. This increase was especially marked in suprabasal, differentiating layers of 
epidermis. Interestingly, in situ DNA replication assays on skin sections indicated 
a correlation between cyclin E expression and DNA synthesis, also significantly 
augmented in skin biopsies from chronically exposed areas. We are also exploring 
the variation of nuclear volume and DNA content. Altogether the results suggest 
that increased cell cycle regulators in non-dividing keratinocytes, might constitute 
a physiological response to chronic sun exposure to maintain skin homeostasis. 
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Mechanism of selection against large scale mtDNA deletions on the cellular level in 
Cockayne syndrome after repetitive UVA-irradiation
Y Kamenisch, W Schuller, J Wenz, M Röcken, M Berneburg Eberhard-Karls-University, 
Tübingen, Germany
Mutations of mitochondrial DNA (mtDNA) are involved in pathological processes such 
as cancer and aging. One of the best described mutations in the mitochondrial genome 
is the common deletion, a 4977bp large deletion which can be induced in vitro by UVA 
irradiation. In normal human fibroblasts and in fibroblasts from patients suffering from 
Cockayne syndrome (CS), a rare autosomal recessive disease with progeroid symptoms 
and sun sensitivity, these mutations have been shown to increase up to a maximum 
followed by their disappearance, whereas in vivo these mutations persist for up to 1.5 
years. In order to determine the mechanism by which these mutations disappear, we 
induced the mitochondrial common deletion in healthy fibroblasts and fibroblasts of 
CS patients by repetitive UVA-irradiation (8J/cm2), sorted viable (annexin V-, propidium 
iodide-), apoptotic (annexin V+, propidium iodide-) and necrotic (propidium iodide+), 
cells and measured the common deletion by real-time PCR in these particular cell 
populations. We confirmed the observation that CS cells show premature UV-induced 
accumulation of mitochondrial common deletion compared to wildtype cells. 
Furthermore we could show that after maximum induction of the common deletion in 
viable cells the common deletion increases in necrotic and apoptotic cells. Furthermore, 
UV-irradiated CS cells exhibit a higher amount of apoptotic cells compared to UV-
irradiated normal fibroblasts.Taken together these results indicate that both induction 
of necrosis and apoptosis of cells bearing too high amounts of mtDNA mutations may 
be involved in maintenance of the mitochondrial genome to protect from aging and 
carcinogenesis-associated processes.
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All-trans retinoic acid suppresses the expression of histidase in epidermal 
keratinocytes
L Eckhart, M Schmidt, V Mlitz, M Mildner, A Abtin, C Ballaun, P Mrass, E Tschachler
Medical University of Vienna, Vienna, Austria
Histidase (histidine ammonia lyase) converts histidine into urocanic acid, the 
main UV absorption factor of the stratum corneum. Here we investigated the 
transcriptional regulation of histidase expression in epidermal keratinocytes. 
Quantitative real-time PCR analysis showed that the epidermis contained higher 
levels of histidase transcripts than all other tissues investigated and that keratinocytes 
strongly expressed histidase. Expression of histidase increased more than 100-fold 
during differentiation of primary keratinocytes in vitro. Genome-wide microarray 
analysis showed that histidase was among the genes most strongly induced by shifting 
keratinocytes from growth in monolayer culture to differentiation in an epidermal 
equivalent. Treatment of keratinocytes with UV-A and UV-B did not significantly 
change the expression level of histidase. By contrast, all-trans retinoic acid (ATRA) 
(1 µM) suppressed histidase expression virtually completely. Taken together, our 
results show that histidase is transcriptionally upregulated during keratinocyte 
differentiation and that ATRA but not UV irradiation modulates the expression level 
of histidase. Suppression of histidase-mediated production of urocanic acid may 
contribute to the increase in UV-sensitivity that is caused by treatment with retinoids. 
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Post-Irradiational UV-Damage Counterbalanced by Topical Cytoprotective Therapy
M Wikonkal1, G Paragh1, L Wunderlich1, K Tory2, P Literáti2, J Mandl1 1Semmelweis 
University, Budapest, Hungary 2N-Gene Research Labs, Inc, Budapest, Hungary
Non-melanoma skin cancers show the highest prevalence among human malignancies 
with their incidence dramatically increasing. Ultraviolet radiation (UV) is undoubtedly 
the most important environmental risk factor in the development of non-melanoma 
skin cancer, making UV induced changes the primary target of skin cancer prevention 
strategies. Several agents have already been designed to prevent UVR from reaching 
the epidermis, but the establishment of pre- or post UV irradiation prevention methods 
has so far been less successful. A straightforward way to analyze UV-induced DNA 
damage in vivo is to assess the number of apoptotic keratinocytes, so called sunburn 
cells, by H&E staining. Backs of C57Bl6 mice were shaved and on the following 
day animals were administered 750, 1250 and 2000 mJ/cm2 UVB radiation using a 
Kodacel filter and FS20TL12 light source. Irradiation was immediately followed by 
topical treatment with 2µg/cm2 BGP-15 cream in one group of animals whereas this 
treatment was absent in controls. 24 hours later mice were sacrificed. Cross-sections 
of the back skin of mice were prepared by routine histological procedure and were 
stained with H&E. Three non-adjacent sections of each mouse were scored by light 
microscopy. Sunburn cells were counted and measurements were normalized to the 
length of the analyzed epidermis. Assessment of results revealed that post irradiation 
application of the cytoprotective cream markedly decreased the number of apoptotic 
sunburn cells. The difference between the cream treated and control groups was most 
prominent after 2000mJ/cm2 irradiation. These finding suggest that cytoprotective 
agents may be successfully used to prevent UVB induced skin changes at the level 
of apoptosis regulation.
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Ultraviolet (UV) Radiation Up-Regulates CD1d Expression in Human Keratinocytes 
and Melanoma Cells
M Vihanto, D Hohl, A Moodycliffe Univ Hospital Center of Lausanne, Switzerland
UV radiation found in sunlight is the primary cause of non-melanoma skin cancer (NMSC) 
and has been implicated in the induction of malignant melanoma. It is the combined 
mutagenic and immune suppressive effects of UV exposure that are considered to be the 
primary cause of NMSC. CD1d is a major histocompatibility complex (MHC) class 1-like 
lipid antigen-presenting molecule that controls the development and function of natural 
killer T (NKT) cells. Previously we showed that the incidence of chronic UV-induced p53 
mutations and skin tumors were reduced in CD1d knockout mice, and their development 
was dependent on CD1d promoting skin cell survival in response to UV, by inhibiting 
apoptosis. We also showed that UV-induced CD1d-dependent NKT cells are critical for 
suppressing skin tumour immunity. Thus, these studies in mice indicate a significant role 
for the CD1d-NKT cell arm of innate immunity in the etiology of skin cancer. Since the 
biological significance of CD1d expression in human skin is currently unknown, the 
aim of this study was to investigate in vitro if UV regulates CD1d gene expression in 
human keratinocytes and melanomas. Here we demonstrate that CD1d is expressed in 
immortalized human keratinocytes (HaCaTs), primary human keratinocytes and melanoma 
cell lines using quantitative PCR, i.p/westernblot and immunofluorescence techniques. 
Moreover, we show that CD1d mRNA and protein levels are significantly up-regulated by 
UV in keratinocytes and melanoma cell lines in a dose and kinetic dependent manner. In 
conclusion, CD1d gene expression is regulated by UV in human skin, suggesting that CD1d 
function is likely to be altered by UV and, that the CD1d-NKT cell arm of innate immunity 
may play a significant role in the pathogenesis of UV-induced human skin disorders. 
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Study of the Role of SCF/KIT Pathway in the Treatment of Vitiligo with 308nm 
Monochromatic Excimer Light
Y Zhang, LH Xiang, ZZ Zheng Huashan Hospital, Fudan University, Shanghai, China
Our objective was to investigate the effects of 308 nm MEL on SCF expression in 
keratinocytes and KIT expression in melanocytes. The expression of SCF and KIT was 
detected by immunohistochemistry in trichromatic vitiligo. Flow cytometry was used to 
examine the apoptosis and cell cycle of keratinocytes and melanocytes. The mRNA and 
protein expression of SCF in keratinocytes and KIT in melanocytes were detected by RT-
PCR and Western blotting, respectively. The c-kit mRNA and protein expression were also 
detected after the soluble SCF was added into the medium. Higher SCF and lower KIT 
expressed in vitiligo lesions. The concentration of soluble SCF was higher in lesions, and the 
expression of soluble SCF was related to the recovery of vitiligo lesions. In keratinocytes, 
308 nm MEL induced cell apoptosis and up-regulated SCF mRNA and protein expression. 
In melanocytes, the cell apoptosis increased and S phase cell decreased irradiated by 
308nm MEL at the dose of 400mJ/cm2. However at the dose of 80mJ/cm2, the S phage 
cell increased. The expression of mRNA and protein of c-kit were both upregulated 
at the low doses group, and both down-regulated at the dose of 400mJ/cm2. There was 
no difference of the c-kit mRNA expession in melanocytes between the co-culture of 
melanocytes and keratinocytes and the melanocytes added with soluble SCF. But the 
expression of KIT protein decreased at 4h and incteased at 24h. And at 72h, the number 
of melanocytes was increased in the sSCF group, but the melanogenesis of melanocytes 
increased only in the co-culture of melanocytes and keranocytes.We concluded that 
the expression of SCF and KIT is abnormal in vitiligo lesions. 308 nm MEL promotes 
the expression of SCF in keratinocytes and KIT in melanocytes at appropriate doses, 
which may be involved in the mechanisms of 308 nm MEL in the treatment of vitiligo. 
 
285 [Oral 005]
The Transforming Growth Factor β Receptor I Kinase Inhibitor SD-208 Reduces the 
Development and Progression of Melanoma Bone Metastases
A Mauviel1, D Javelaud1, KS Mohammad2, EG Stebbins3, M Niewolna2, CR McKenna2, 
X Peng2, LA Kingsley2, PGJ Fournier2, LS Higgins3, DH Wong3, TA Guise2 1INSERM 
U697, Paris, France 2Univ of Virginia, Charlottesville, USA 3Scios Inc., Fremont, USA
Melanoma often metastasizes to bone where it is exposed to high concentrations of TGF-β. 
Constitutive Smad signaling occurs in human melanoma. Because TGF-β promotes metastases 
to bone by several types of solid tumors including breast cancer, we hypothesized that TGF-β 
may contribute to melanoma metastases to bone. Consistent with this, overexpression of the 
inhibitory Smad7 blocked the capacity of 1205Lu melanoma cells to form bone metastases 
by preventing the TGF-ß induction of genes known to mediate osteolytic breast cancer bone 
metastases such as PTHrP, IL-11, CXCR4, osteopontin and CTGF. We herein tested the effect of 
a small molecule inhibitor of TGF-β receptor I kinase (TGF-ßRI), SD-208 on development and 
progression of bone metastases due to 1205Lu melanoma. In vitro, SD-208 blocked TGF-β 
induction of Smad3 phosphorylation,TGF-ß-induced Smad3/4-specific transcription in several 
melanoma lines: 1205Lu, WM852, 501mel and 888mel, as well as invasion through Matrigel™ 
by 1205Lu. We therefore hypothesized that pharmacologic blockade of TGF-ß signaling using 
SD-208, would be effective treatment for melanoma metastasis to bone. Nude mice were 
inoculated with 1205Lu melanoma cells into the left cardiac ventricle and treated with SD-
208 (20 and 60 mg/kg po qd administered via oral gavage) in both prevention and treatment 
protocols. In the former, SD-208 (60mg/kg/d), started 2 days before tumor inoculation, prevented 
the development of osteolytic bone metastases compared with vehicle. In the latter, mice 
given SD-208 (60/mg/kg/d) after confirming the presence of osteolytic lesions by radiography 
2 weeks after inoculation, had significantly smaller osteolytic lesions vs. vehicle treated mice 
(p=0.0009) at the time of termination of the experiment, 4 weeks later. These data indicate 
that therapeutic targeting of TGF-ß may decrease the osteolytic bone metastases caused by 
malignant melanoma by mechanisms similar to those implicated in breast cancer osteolysis. 
286 [Oral 012]
Identification and functional characterization of ASK/Dbf4, a novel cell survival 
gene in cutaneous melanoma
S Nambiar, A Mirmohammadsadegh, M Hassan, A Marini, A Alaoui, J Hegemann, UR 
Hengge Heinrich-Heine-University, Düsseldorf, Germany
The molecular and genetic events that contribute to the development and progression 
of malignant melanoma are only partly understood. To identify novel determinants 
for tumor development and progression, we performed oligonucleotide microarray-
based comparison on a series of nevi (n=11), primary cutaneous melanomas (n=10), 
cutaneous melanoma metastases (n=11) and melanoma cell lines (n=5) with normal 
human melanocytes (NHM) as calibrator. Multiclass significance analysis identified 
two novel genes, activator of S-phase kinase (ASK/Dbf4) and translocated promoter 
region (Tpr) that were confirmed in 51 additional samples by qRT-PCR. We also show 
that a 4-gene signature of ASK/Dbf4 and Tpr in combination with the established 
markers melanoma cell adhesion molecule (MCAM/MUC18) and hepatocyte growth 
factor receptor (c-MET) can distinguish benign nevi from malignant melanoma. In 
keeping with its expected role as a cyclin-like regulatory subunit of mammalian 
Cdc7, our data suggest that upregulated ASK is localized to the nucleus and binds 
to human Cdc7 to form Cdc7-ASK/DBF4 complexes in several analyzed melanoma 
cell lines. Further, we demonstrate that ASK has an essential function in cell 
growth by showing that siRNA-mediated depletion of ASK retarded cell survival 
and proliferation. In summary, we suggest that upregulation of ASK/Dbf4 is a novel 
molecular determinant conferring a proliferative advantage in cutaneous melanoma. 
 
287 [Oral 057]
Genome-wide RNAi-Screen Identifies Novel Regulators of Melanin Secretion
AK Ganesan1, H Ho1, MA White2 1University of California, Irvine, Irvine, USA 2UT 
Southwestern, Dallas, USA
Vitiligo and melasma are two highly prevalent disorders of pigmentation that are treatment 
refractory. A fundamental knowledge of the molecular components required for the synthesis 
and secretion of melanin is necessary to understand the pathogenesis of these diseases and 
design specific therapies to treat them. Genome wide siRNA screening was used to identify 
a collection of gene targets that support melanin pigmentation in MNT-1 cells. Preliminary 
data demonstrated that an siRNA directed towards tyrosinase, the rate limiting enzyme 
in melanin biosynthesis, can visually and quantitatively inhibit melanin pigmentation in 
MNT-1 pigmented melanoma cells. Using a comprehensive genome wide siRNA library and 
spectrophotometric based quantitation of melanin, we have identified a set of genes that are 
absolutely required for melanin synthesis and secretion in MNT-1 melanoma cells. The low 
coefficient of variance (12.82) of the data set reflects the specificity and fidelity of the high 
throughput approach. Retesting of putative gene targets demonstrated the low false positive 
rate and low off-target rate of the screening approach. Gene annotation data and literature 
searches were used to classify gene targets into functional categories. Putative genes 
involved in transcription, translation, and secretion were identified. In particular, several 
novel proteins that bind to phosphatidylinositol (PI) lipids were identified. Previous studies 
document that these phosphatidylinositol binding proteins play key roles in regulating 
vesicle secretion in other biological systems. Immunofluorescence microscopy studies 
using both standard and confocal microscopy demonstrated that these putative PI binding 
proteins play a role in melanosome secretion. Together, these data indicate that novel 
phosphatidylinositol binding proteins play a critical role in regulating melanosome secretion. 
 
288 [Oral 058]
In vitro and in vivo studies of proliferative and invasive signature melanoma cells
O Eichhoff, NC Schlegel, U Döbbeling, S Hemmi, R Dummer, KS Hoek University 
Hospital of Zürich, Zürich, Switzerland
Microarray analyses have revealed two major expression signatures in melanoma. One 
signature contains many genes known to be regulated by Wnt signalling (proliferative 
signature), including the microphthalmia-associated transcription factor (Mitf). The 
second signature is composed of genes regulated by TGFbeta or TGFbeta-like signalling 
(invasive signature). These phenotypes of proliferation and invasiveness correlate 
appropriately with the results of in vitro growth and migration studies. Furthermore, 
considering that susceptibility to TGFbeta-mediated growth inhibition is a marker 
for decreased metastatic potential, we show that cells harbouring a proliferative 
phenotype are susceptible to TGFbeta while cell lines with an invasive signature 
are not. We believe that Mitf expression is critical to maintaining the proliferative 
signature and therefore may be a mediator of TGFbeta susceptibility. We show that by 
interfering with Mitf expression using siRNA approaches, proliferative signature cells 
become as resistant to TGFbeta as invasive signature cells. To investigate further the 
identified signatures in vivo we injected two proliferative and two invasive cell lines 
into the flanks of immunocompromised mice and monitored tumor growth. While 
cell lines with a proliferative signature form tumors rapidly, cell lines with an invasive 
signature establish tumors more slowly over time. Growth of tumor mass and in vitro 
growth of tumor cells strongly correlate with each other indicating the maintenance 
of their in vitro growth. Interestingly, immunohistological examination of the excised 
tumors show that all have a heterogeneous pattern for Mitf staining (a marker for the 
proliferative phenotype) regardless of the original phenotype used. This indicates that 
melanoma cells may switch between proliferative and invasive phenotypes in vivo. 
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Beta-catenin induces immortalisation of melanocytes by suppressing p16INK4a 
expression and co-operates with N-Ras in melanoma development
V Delmas1, F Beermann2, S Martinozzi1, S Carreira3, J Ackermann2, M Kumasaka1, L 
Denat1, J Goodall3, F Luciani1, A Viros4, N Demirkan1, BC Bastian4, CR Goding3, L 
Larue1 1Institut Curie, Orsay, France 2ISREC, Lausanne, Switzerland 3MCRI, Oxted, UK 
4UCSF, San Francisco, USA
Tumor progression is a multistep process in which pro-proliferation mutations must be 
accompanied by suppression of senescence. In melanoma, pro-proliferative signals are 
provided by activating mutations in NRAS and BRAF, whereas senescence is bypassed 
by inactivation of the p16Ink4a gene. Melanomas also frequently exhibit constitutive 
activation of the Wnt/β-catenin pathway that is presumed to induce proliferation, 
as it does in carcinomas. We show here that, contrary to expectations, stabilized 
β-catenin inhibits melanoblast proliferation in vivo and immortalizes primary skin 
melanocytes by silencing the p16Ink4a promoter. Significantly, in a novel mouse 
model for melanoma, stabilized β-catenin bypasses the requirement for p16Ink4a 
mutations and together with an activated N-Ras oncogene, leads to melanoma with 
high penetrance and short latency. The results reveal that synergy between the Wnt 
and MAP kinase pathways may represent an important mechanism underpinning 
the genesis of melanoma, a highly aggressive and increasingly common disease. 
 
290 [Oral 060]
Phosphodiesterases mediate cross-talk between the cAMP and the RAS/RAF/MEK/
ERK pathways in melanoma
N Dumaz1, A Marquette1, M Bagot2, A Bensussan1 1INSERM U841, Créteil, France 
2Hôpital Henri Mondor, Créteil, France
Both the RAS/RAF/MEK/ERK pathway and the cyclic AMP (cAMP) pathway play a major role 
in melanocyte proliferation and differentiation and cross-talks exist between these pathways 
with important consequences in the development of melanoma. In mammals, there are 
three kinases of the RAF family (A-RAF, B-RAF and C-RAF), which phosphorylate MEK 
but display differences in their biological activities. We have previously shown that cAMP 
inhibits C-RAF activity in melanocytes and that this is essential to suppress its oncogenic 
potential. As a consequence B-RAF alone is responsible for signalling to MEK. However 
in some melanoma B-RAF loses its importance. Indeed, RAS mutations, in around 15% 
of melanoma, are accompanied by a switch in cell signalling from B-RAF to C-RAF. This 
switch is linked to disrupted cAMP signalling, a step necessary to allow C-RAF to signal to 
MEK. We were able to show that, even in absence of C-RAF, B-RAF was not able to activate 
MEK in response to oncogenic RAS in melanoma because, in these cells, B-RAF could not 
bind oncogenic RAS, whereas C-RAF could. Both RAF isoform switching and disruption 
of the cAMP pathway are linked in RAS transformed melanoma, suggesting that inhibition 
of the cAMP pathway may be linked to B-RAF inhibition. Our data showed that elevated 
phosphodiesterase (PDE; a family of proteins degrading the cAMP) expression or activity 
not only inhibits the cAMP signalling in melanoma cell lines but also acts on the RAS/
RAF/MEK/ERK pathway. Because ERK can phosphorylate and regulate PDE isoforms, these 
PDEs provide another point of cross-talk between the RAS/RAF/MEK/ERK pathway and the 
cAMP pathway in melanocytes and melanoma cells. The use of specific phosphodiesterase 
inhibitors allows the cAMP pathway to be rescued in melanoma cells. This suggests 
that phosphodiesterase inhibitors could be used to inhibit melanoma proliferation. 
291
Reduced pSmad2 immunodetection correlates with increased primary melanoma 
thickness.
C Mnich, KS Hoek, PA Oberholzer, B Seifert, J Hafner, R Dummer, D Mihic University 
Hospital of Zurich, Switzerland
Cutaneous melanoma is the most aggressive of cutaneous neoplasms. Identifying 
patients with an increased risk for the development of metastases is critical. The 
present study investigates phospho-Smad2 (pSmad2), a central factor of the TGFβ 
pathway, on formalin-fixed, paraffin-embedded tissues from 60 primary cutaneous 
melanomas (Breslow > 1mm), for its candidacy for being a prognostic marker in 
primary cutaneous melanoma. pSmad2 positivity was assessed for correlation with 
clinical parameters including Breslow index, melanoma type, survival, development 
of metastases, sentinel lymph node status and age. pSmad2 positivity was not 
associated with survival or development of metastases, suggesting that it would 
not be a useful prognostic marker. Despite this, we found pSmad2 positivity to be 
correlated with low tumour thickness, indicating that as the primary tumour grows 
there is an increased inhibition of TGFβ signalling resulting in suppressed Smad2 
phosphorylation. Additionally, phosphorylation of Smad2 in neighbouring melanoma 
cells and keratinocytes was interrelated, which is a further indication that Smad2 
phosphorylation in primary melanoma is affected by local area microenvironmental 
factors. We hypothesize that the observed decrease in TGFβ signalling in thicker 
primary melanomas is due to the increased production of signalling inhibitors. 
292
In vivo confocal laser-scanning microscopy: bringing melanoma histopathology to 
the bedside
A Gerger, R Hofmann-Wellenhof, U Langsenlehner, S Koller, W Weger, E Richtig, 
M Horn, H Samonigg, J Smolle Medical University of Graz, GRAZ, Austria
In vivo confocal laser-scanning microscopy (CLSM) represents a novel imaging tool that 
allows the non-invasive examination of skin cancer morphology in real-time at a ‘quasi-
histopathologic’resolution viewing micro-anatomic structures and individual cells. In 
the present study, we used a total of 3709 un-selected CLSM tumor images obtained 
from 20 malignant melanoma and 50 benign nevi. The entire set of images derived 
from each tumor was evaluated by independent observers. Classification tree analysis 
based on a subsample of 857 tumor images was performed to develop a diagnostic 
algorithm. Overall, sensitivity and specificity of 97.5 and 99% could be achieved 
by the independent observers (positive predictive value 97.5%, negative predictive 
value 99%). Classification tree analysis yielded a 3-step algorithm based on only 
three morphologic CLSM features, facilitating a correct classification in 92.4% of the 
benign nevus images and 97.6% of melanoma images. In vivo confocal laser scanning 
microscopy augurs a sea change in the way we will view skin tumor processes clinically 
at the bedside and merits application for use as a screening tool in skin oncology. 
 
293
Potential Role of the HLA Class I Antigen - Processing Machinery in the Development 
of Sentinel Lymph Node Metastases in Patients with Melanoma
R Lang1, B Alinger1, C Hauser-Kronberger1, W Hitzl1, J Koller1, S Ferrone2 1Paracelsus 
Private Medical Univ, Salzburg, Austria 2Roswell Park Cancer Institute, Buffalo, USA
Malignant transformation of melanocytes is frequently associated with defects in HLA 
class I antigen processing machinery (APM) component expression and/or function. The 
association of these abnormalities with the clinical course of the disease has been taken as 
evidence to suggest that they play a role in the clinical course of the disease by providing 
melanoma cells with an escape mechanism from host’s immune system. To the best of our 
knowledge, no information is available about the role that HLA class I APM component 
defects in melanoma cells play in the development of lymphnode metastasis. In the present 
study we have compared the expression of HLA class I APM components in primary tumors 
and autologous sentinel lymph node metastases from 16 patients with cutaneous melanoma 
and in primary tumors from 22 patients with tumor -free sentinel lymph nodes. To this 
end, formalin-fixed, paraffin-embedded melanoma lesions were stained with 13 APM 
component-specific mAb in the immunoperoxidase reaction. With the exception of TAP2 
and calnexin, all the APM components were downregulated in at least 50% of the lesions 
analyzed. Primary lesions with tumor positive SNL had a significantly higher expression of 
MB1, Z and β2-microglobulin displayed than those with tumor-free sentinel lymph nodes 
resulting in a significant association between MB1, Z and β2-microglobulin expression and 
development of SNL metastases. If this association is not fortuitous, but reflects a cause-
effect relationship, these findings might reflect a lower efficiency of proteasome than of 
immunoproteasome in generating tumor antigen derived peptides to be presented to CTL. 
This mechanism may also account for the association between MB1 expression in primary 
melanoma lesions and survival we found in the patient population analyzed.
294
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma 
cells from cisplatin-mediated apoptosis
A Mirmohammadsadegh, R Mota, A Gustrau, S Nambiar, M Hassan, A Marini, 
UR Hengge Heinrich-Heine-University, Düsseldorf, Germany
Activation (phosphorylation) of mitogen-activated protein kinase (MAPK) signal 
transduction through BRAF and RAS causes a variety of functional effects 
including cell survival and cell death. In the present study, we observed high 
ERK1/2 phosphorylation levels in clinical melanoma metastases. Treatment of 
melanoma cell lines with cisplatin, a potent antitumor agent, increased the level 
of P-ERK1/2 and enhanced chemoresistence through activation of the cell survival 
protein RSK1. The MEK inhibitor (U0126) was able to block this effect, reduced 
cell viability and sensitized cells to cisplatin-induced apoptosis, as shown by 
PARP cleavage, caspase 3 expression and annexin-V staining. In conclusion, the 
MAP kinase-ERK pathway is activated in melanoma and affects the sensitivity of 
melanoma to cisplatin. Thus, inhibition of ERK1/2 in combination with selected 
chemotherapeutic agents may hold promise for more effective therapy of melanoma. 
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Prediction of Non Sentinel Lymph Node Metastasis in Malignant Melanoma
A Cadili1, K Dabbs1, J Danyluk1, JH Hanson2 1University of Alberta, Edmonton, 
Canada 2Cross Cancer Institute, Edmonton, Canada
Sentinel lymph node biopsy (SLNB) is the current standard of practice for Malignant 
Melanoma patients with clinically negative lymph nodes and primary tumors more 
than 1 mm in thickness, ulcerated or of Clark’s level IV. All those with positive 
Sentinel lymph node (SLN) biopsy results are currently offered completion lymph 
node dissection (CLND) of the affected lymph node basin. This procedure entails 
considerable morbidity and is often applied in the context of patients with significantly 
shortened overall survival. Combined with the fact that 80% of CLNDs yield negative 
results, it is apparent that criteria to limit this procedure to those most likely to 
harbor non SLN metastasis are necessary. A retrospective chart review of 349 cases 
of malignant melanoma from January 1999 to April 2007 that underwent sentinel 
lymph node biopsy at a single institution was done. Statistical analysis was used to 
compare two subgroups of patients: a positive CLND group and a negative CLND 
group. These two groups were compared with regards to multiple variables related 
to patient demographics, primary tumor characteristics, and SLN tumor burden. Age, 
and total size of SLN tumor deposit were the factors with the strongest correlation 
with non SLN positivity. By applying a risk score model that uses the cutoff values 
of age 55 years and SLN tumor deposit of 5 mm, it is possible to predict non SLN 
positivity in SLN-positive melanoma patients. The likelihood of non SLN metastasis in 
SLN-positive melanoma patients can be predicted from two criteria readily available: 
size of SLN tumor deposit and patient age.
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The BH3-only member Noxa causes apoptosis in melanoma cells by multiple 
pathways
M Hassan1, A Alaoui1, O Feyen1, A Mirmohammadsadegh1, A Marini1, F Essmann1, A 
Tannapfel2, E Gulbins3, K Schulze-Osthoff1, UR Hengge1 1Heinrich-Heine-University, 
Düsseldorf, Germany 2Institute of Pathology, Ruhr-University, Bochum, Germany 
3University of Duisburg-Essen, Essen, Germany
The molecular causes for resistance of melanoma to apoptosis are currently only 
partly understood. Some therapeutic agents not only induce pro-apoptotic Bcl-2 
family members (e.g. Noxa), but also lead to the accumulation of anti-apoptotic 
proteins (e.g., Mcl-1). We examined Noxa gene transfer as an alternative approach 
to chemotherapy and investigated the molecular mechanism(s) regulating Noxa-
induced apoptosis. Noxa-induced apoptosis in melanoma cells caused dysregulation 
of mitochondria and endoplasmic reticulum (ER), and was associated with reactive 
oxygen species (ROS) generation, cytochrome c release, and activation of caspase-9, 
caspase-3 and PARP cleavage. In addition, Noxa induced apoptosis via apoptosis 
signal-regulating kinase1 (ASK1) and its downstream pathways c-Jun N-terminal 
kinase (JNK) and p38. The inhibition of Noxa-induced apoptosis by the ROS 
scavenger N-acetylcysteine (NAC), dominant-negative ASK1, specific inhibitors of JNK 
(SP600125) and p38 (SB203580) or caspase inhibitors confirmed their involvement in 
Noxa-induced apoptosis. Our data elucidate the multiple pathways in Noxa-induced 
apoptosis in melanoma cells, including an important role of the ER and suggest Noxa 
gene transfer as an alternative approach to chemotherapy.
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Mutant CDK4 increases the penetrance and decreases the latency of UV-induced, 
metastasizing melanoma in the skin of C57BL/6 HGF mice
E Gaffal1, J Landsberg1, J Kohlmeyer1, D Tormo1, J Wenzel1, G Merlino2, T Tüting1 
1University of Bonn, Bonn, Germany 2NCI, Bethesda, USA
Novel mouse models of melanoma are being generated which recapitulate the histopathology 
and molecular pathogenesis observed in the human disease. Deregulated receptor tyrosine 
kinase signalling and impaired cell cycle control are hallmarks of both familial and 
sporadic melanoma. We previously observed that C57BL/6 mice which carry a mutant 
cyclin-dependent kinase 4 (Cdk4R24C) and overexpress hepatocyte growth factor (HGF) 
rapidly develop multiple pigmented primary melanomas in the skin following carcinogen 
treatment. These carcinogen-induced autochthonous melanomas spontaneously metastasize 
in lymph nodes and lungs. Here we investigated the impact of neonatal UVB exposure on 
melanomagenesis in Cdk4R24C x HGF C57BL/6 mice. New born mice were irradiated with 
a total dose of 6 kJ/m2 UVB. In a cohort of 12 UV-treated Cdk4R24C x HGF mice nevi (1mm 
Ø) appeared at an age of 4-6 months in all animals. Every mouse developed progressively 
growing either nodular or superficially spreading melanomas (>2mm Ø) at an age of 6-9 
months. When sacrificed, each mouse displayed enlarged and heavily pigmented draining 
lymph nodes, 3-10 mm in diameter, and numerous small black nodules on the lung surfaces. 
Histopathologic examination confirmed primary melanoma of the skin with lymph node 
and lung metastases. 1 of the 12 mice also showed prominent melanoma metastases in liver 
and kidney. Importantly, tumors of other histology were not observed. Untreated Cdk4R24C 
x HGF mice developed nevi between 8-12 months and first melanomas appeared in their 
second year of life. UV-treated HGF C57BL/6 mice developed melanocytic tumors several 
months later and showed progressively growing melanomas only in part of the mice. We 
conclude that mutant CDK4 in addition to HGF increases the penetrance and decreases 
the latency of UV-induced melanoma. This new experimental mouse model can now be 
exploited to further study the biology of melanoma and evaluate new treatment modalities. 
298
C-SKI expression in human melanoma cells does not antagonize TGF-β-dependent 
transcriptional responses
A Mauviel1, D Javelaud1, E Le Scolan2, VI Alexaki1, K Luo2 1INSERM U697, Paris, 
France 2University of Berkeley, Berkeley, USA
Ski has been implicated in melanoma development, yet its role is still controversial. 
Following its identification as an important negative regulator of transforming growth factor 
β (TGFβ) signaling, it has been suggested that c-SKI expression in melanoma allows the 
latter to escape the anti-proliferative activities of TGF-β. We previously reported constitutive 
TGF-β signaling in melanoma cells. Also, we recently demonstrated that interfering with 
the TGF-β/Smad pathway in melanoma cells inhibits tumorigenesis and metastasis to bone. 
In this study, a dozen human melanoma cell lines were screened for c-SKI expression and 
TGF-β responsiveness. In accordance with the literature, we found high c-SKI protein 
levels in all melanoma lines, while c-SKI was not detectable by Western blotting in normal 
melanocytes. In contrast, c-SKI mRNA steady-state levels were relatively constant across all 
melanoma cell lines and similar to those in normal melanocytes. Elevated c-SKI levels in 
melanoma cells were independent from their BRAF status. Incubation of melanoma cells 
with TGF-β resulted in rapid degradation of c-SKI protein, followed by delayed induction 
of c-SKI gene expression. Transcriptional responses to TGF-β, measured using either a 
Smad3/4-specific reporter construct in transient cell transfections or as the induction of 
the TGF-β immediate-early target gene GLI2, was not affected by high basal c-SKI protein 
levels. However, proteasome blockade with either MG132 or ALLN resulted in further 
increased c-SKI accumulation and to partial reduction in TGF-β-driven c-SKI degradation, 
accompanied with attenuated TGF-β-dependent gene transcription. Together, these results 
suggest that endogenous c-SKI is not able to antagonize TGF-β-dependent transcription in 
melanoma cells, unless stabilized by proteasome blockade. Mechanisms leading to c-SKI 
accumulation in melanoma, and subsequent biological outcome, remain to be elucidated. 
299
Endogenous c-Jun N-Terminal Kinase (JNK) Activity Controls Growth and Survival 
of Human Melanoma Cells
A Mauviel, VI Alexaki, D Javelaud INSERM U697, PARIS, France
The c-Jun N-terminal kinase (JNK) subgroup of mitogen-activated protein kinases has 
been largely implicated in mediating apoptosis, mainly in response to stress stimuli. 
Accumulating evidence also suggests a role of JNK in cell proliferation and survival. 
In the present study, we examined the role of the JNK pathway on cell growth and 
apoptosis in human melanoma cell lines. We found that constitutive, yet highly 
variable, basal levels of phospho-JNK protein in all 8 melanoma cell lines tested. 
Pharmacological blockade of JNK activity with SP600125 induced a dose- and time-
dependent inhibition of cell growth in all melanoma cell lines, suggesting that the 
JNK pathway inhibit melanoma cell proliferation. JNK inhibition was more efficient 
to block melanoma cell growth than pharmacological blockade of either the MEK/
ERK or p38/MAPK pathways, and was independent from the BRAF status of the cells. 
Induction of apoptosis and cell cycle arrest at the G2/M phase both accounted for 
the growth inhibitory effect of SP600125. Accordingly, specific inhibition of both 
JNK isoforms, JNK1 and JNK2, by mean of short interfering RNAs also reduced cell 
growth. In all cell lines, JNK inhibition was accompanied by an elevation of p21Cip1/
Waf1 expression, due to transcriptional activation of the corresponding promoter. On 
the other hand, no effect of JNK inhibition was observed on p15INK4B expression. 
Together, these observations suggest that JNK activity is required for growth and 
survival of melanoma cells. Work is in progress to determine whether p21Cip1/Waf1 
repression is directly responsible for the growth inhibitory activity of the JNK pathway. 
 
300
Color Doppler Sonographic and Elastographic Differential Diagnosis of Skin Tumors
Y Kiyohara1, M Shimizu2, M Nakajima2, K Ishihara3 1Shizuoka Cancer Center, 
Sunto-Gun Shizuoka, Japan 2Saitama Medical University, Iruma-Gun Saitama, Japan 
3Analysis of SkinCancer Prognostic Factor, Tokyo, Japan
Our purpose was to determine skin tumors were malignancy or not, we used color 
Doppler sonography and elastography (a new technique of the ultrasound equipment).
Forty lesions of malignant skin tumors and 40 of benign skin tumors. During our 
conventional examination, we obtained B-mode images first, and then color Doppler 
US was performed. On the same day, we next obtained elasticity images as motion 
images. The principle of elastography is that tissue compression produces strain 
within the tissue and that the strain is smaller in harder tissue than in softer tissue. 
Elastography used this time expressed distortion as the rate, and expressed this as the 
color. In color Doppler sonography, malignant tumors showed hypervascular pattern. 
Neurofibroma, granuloma and eccrine poroma, there were benign tumors, showed 
hypervascular pattern but most of benign tumors did not show hypervascular image. 
And we measured FFT analysis, malignant tumors showed RI 0.81(mean) and benign 
tumors showed RI 0.71(mean). It was significant difference between malignant lesions 
and benign tumors. In elastography, while benign tumors showed evenly shaded 
green or mosaic of green and blue (green predominance), malignant tumors showed 
deep blue.We concluded that the combined study of color Doppler sonography and 
elastography has usefulness in ultrasound diagnosis of the skin tumors
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Downregulation of melanosome-interacting isoforms of myosin Va by exon-specific 
RNA interference blocks melanosome transport in primary human melanocytes
JL Van Gele, B Geusens, JM Naeyaert, J Lambert Ghent University Hospital, Belgium
Myosin Va is an actin-dependent motor protein known to co-localize with melanosomes 
in human melanocytes. We previously reported that in humans six myosin Va isoforms 
are generated by alternative splicing in the C-terminal region. Three out of six transcripts 
contain exon F and are abundantly expressed in melanocytes. Only the exon F transcripts 
are involved in intramelanocytic transport through the formation of a Rab27a, Slac-
2a, and myosin Va-exon F tripartite complex. Defects in the formation of this complex 
result in perinuclear melanosome aggregation because of failure of melanosome transfer 
from the microtubules to actin filaments, as seen in for example melanocytes of coat-
color mutant mice. Based on these findings we decided to examine if RNA interference 
(RNAi) could be used as a tool to knockdown myosin Va exon F-containing transcripts 
in a specific and efficient way. Two different strategies will be presented: 1) transfection 
of chemically synthesized siRNAs, targeting exon F, into primary human melanocytes 
leading to a transient silencing of exon F isoforms and 2) transduction of shMyoVa exon 
F-expressing lentiviral vectors into melanocytes inducing a stable silencing effect at both 
the RNA and protein level as detected by respectively quantitative RT-PCR and Western 
blotting. The resulting phenotypic effect was studied by immunohistochemical analysis 
on myosin Va-exon F silenced melanocytes with the melanosomal marker NKI-beteb. 
Interestingly, in melanocytes with an absent or reduced myosin Va-exon F expression we 
observed an abnormal distribution of the melanosomes as previously reported in patients 
with Griscelli syndrome. In conclusion, we developed a novel exon-specific RNAi 
strategy to block the intracellular melanosome transport in primary human melanocytes. 
This opens new perspectives in the treatment of certain hyperpigmentary disorders. 
 
302
The Central Role of SLC24A5 in Mouse and Human Skin Pigment Synthesis
MR Green1, S Wilson2, S Askew2, PPM Schnetkamp3, RM Ogborne2, D Cox4, RS 
Ginger2, F Van der Ouderaa2 1Unilever Research, Bedford, UK 2Unilever Corporate 
Research, Bedford, UK 3Uni of Calgary, Canada 4Perlegen Inc, Mountain View, USA
We have completed a whole genome scan to identify single nucleotide polymorphisms 
(SNPs) associated with natural skin colour variation in a South Asian population. Non-
synonymous SNPs in SLC24A5, SLC45A2 and TYR demonstrated genome-wide significant 
allele frequency differences between darker and lighter volunteers (38.7%, 12.3% and 
11.2% respectively). Polymorphisms in these three genes probably account for much of 
the natural skin colour variance seen in South Asia while data from the HapMap project 
suggest that these genes also partially account for skin colour differences between African 
and European populations. SLC24A5 encodes a putative K+ regulated Na+/Ca2+ exchanger 
(NCKX5) and is essential for correct melanin production in early zebra fish embryos (Lamason 
2005). The nsSNP (rs1426654) associated with human skin colour variation encodes an 
amino acid change (Ala111Thr) in a region of SLC24A5 that is highly conserved between 
NCKX proteins. Site-directed mutagenesis of heterologously expressed NCKX2 suggests that 
switching this residue from the ‘dark’ skin allele (Ala) to the ‘light’ skin allele (Thr) reduces 
Na+/Ca2+ exchange function without impacting ion dependencies. SLC24A5 in skin is 
almost exclusively expressed in melanocytes and is the predominant SLC24 transcript in 
cultured melanocytes. Using siRNA-mediated knock-down we show that SLC24A5 plays 
an essential role in melanin synthesis in human and mouse (B16) melanocytes. Using 
anti-peptide polyclonal antibodies against human NCKX5 we have localised the protein 
to an intracellular compartment, and confirmed this by siRNA-mediated knock-down. The 
cellular mechanism by which SLC24A5 changes human skin colour is under investigation. 
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Enhanced maternal and fetal derived angiogenesis in melanomas during pregnancy
S Nguyen-Huu, S Aractingi, M Oster, K Khosrotehrani Pierre et Marie Curie University, 
Paris, France
Melanomas represent 8% of malignancies associated with gestation. These tumours are 
thicker in pregnant women compared to controls. During gestation, women acquire fetal 
stem cells able to reach lesional maternal tissues and adopt various phenotypes including 
endothelial. Our objective was to evaluate the presence of endothelial cells of fetal origin 
in melanoma and investigate tumoral angiogenesis during gestation. Melanoma and nevi 
from pregnant and non pregnant matched women were obtained. C57 Bl6 mice were 
mated or not with EGFP transgenic males and subcutaneously injected with B16 melanoma 
cells. Fetal cells were detected by X and Y chromosome probes (FISH) in women bearing 
male children or with anti EGFP in mice bearing transgenic fetuses and their phenotype 
was assessed. Labelling with CD34 and D2-40 (humans), CD31 and Lyve-1 (mice) was 
performed and the number, size and relative surface of vessels in tumoral and peritumoral 
areas quantitatively analysed. Fetal cells were detected in 10/16 human melanomas and 
1/8 nevi during pregnancy (p=0.034) and in 11/17 tumours of pregnant mice but never in 
normal skin (p=0.000087). 52% to 56% of fetal cells expressed endothelial cell markers 
with sometimes a morphology of blood vessels. Metastasis developped in 6/17 pregnant 
versus 1/15 non-pregnant mice (p=0.08). The relative lymphatic vessel areas in melanomas 
in pregnant women and mice was significantly higher (p=0.03 both). A similar increase 
in relative blood vessel areas was observed in pregnant mice and women (p=0.008 and 
p=0.087 respectively). Fetal cell microchimerism did not significantly influence the level 
of angiogenesis in pregnant females. In conclusion, during pregnancy melanoma shows 
frequent presence of fetal endothelial cells and enhanced lymphatic angiogenesis. The 
previously described implication of lymphangiogenesis in the development of metastasis 
may explain how gestation affects the prognosis of this tumour.
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Detection of the Homozygous Proline-48-Threonine Mutation of p16 in a 
Hungarian Multiple Primary Melanoma Patient with Unaffected Heterozygous 
Family Members
K Balogh, M Széll, A Dobozy, L Kemény, J Oláh University of Szeged, Hungary
The P48T germ line mutation of p16 was detected in a Hungarian multiple primary 
melanoma patient (deceased at the age of 39) with no affected family members. 
Genetic analysis of the patient and his family revealed that the patient was homozygous 
for the mutation, while his parents (father currently aged 69 and mother 63), who 
are free from any malignancies and atypical moles, are both heterozygous for the 
mutation. Our data suggest that the P48T mutation of p16 is a strong melanoma-
predisposing factor, but the fact that the heterozygous mutant parents have not yet 
exhibited melanoma or atypical moles indicates that the penetrance of this allele 
might depend on modifying factors. The rare P48T germ line mutation of p16 has 
been reported previously in only four independent studies, all in patients with Italian 
ancestry. Here we first report the inheritance of the rare P48T mutation of CDKN2A 
in a Hungarian family with a homozygous multiple primary melanoma member and 
unaffected heterozygous family members. The question of whether the mutation 
detected in Hungary is the result of an independent event, or migration of the founder 
mutation occurred at some time in the past, necessitates further investigations. 
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Non-destructive vital histological depiction of malignant melanoma by high 
resolution optical coherence tomography
D Hoeller Obrigkeit1, FS Spoeler2, M Foerst2, C Beckmann1, HF Merk1, F Abuzahra1 
1RWTH Aachen, Germany 2Inst of Semiconductor Electronics, Aachen, Germany
Currently, diagnosis of malignant melanoma is made exclusively by excision and consecutive 
histology. To date no non-invasive method exists to distinguish benign from malignant lesions in 
vivo. In recent years optical coherence tomography (OCT) has been developed as method for 
non-invasive in vivo histology. OCT tomograms are based on an interferometric method using 
low-coherent light with an axial resolution based on the light source’s coherence length. At a 
wave length of 1300 nm a resolution of 15 µm is achieved with commercially available OCT 
solutions. Depiction of single cells or dermal cell conglomerates necessary for tumor diagnosis 
is not possible with these systems. We developed a high resolution OCT (HR-OCT) system using 
a Ti:Sapphire femtosecond laser with a spectral bandwidth of 80 nm and improved resolution to 
3 µm with a scan rate of 6 sec./tomogram. To establish feasibility of OCT scanning in melanoma, 
we performed HR-OCT on excisions of malignant melanoma prior to histological examination. 
Histology revealed a pagetoid distribution of atypical large melanocytes occurring singly and 
in tumor cell aggregates forming melanoma cell nests of different size and morphology. HR-
OCT tomograms correlate to histological findings. Melanoma cell nests form homogenous 
low-scattering structures within the surrounding high-scattering epidermis. At higher resolution, 
a melanoma nodule in HR-OCT shows a demarcated area of lower scattering within a high-
scattering area. In the corresponding H&E slide this low-scattering area resembles a nest of 
melanoma cells surrounded by a ring of atypical melanocytes. Our results demonstrate that 
HR-OCT is capable of detecting melanoma cell nests in the epidermis and dermis. At present 
we are implementing a compact real-time HR-OCT setup expecting faster acquisition of 
tomograms to use HR-OCT as a diagnostic tool in vivo. Overall HR-OCT is a promising tool for 
future in vivo histology of melanoma providing faster diagnosis and therefore better treatment. 
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Imiquimod treatment of Lentigo maligna: An open study of 34 lesions in 32 patients 
N Yawalkar, L Braathen, R Hunger Inselspital Bern, Switzerland
Imiquimod cream 5% has recently been described as a treatment option for lentigo 
maligna. This small synthetic molecule binds to toll like receptor 7 and induces the 
secretion of various proinflammatory cytokines such as IFN-γ, TNF-α and interleukins 
leading to a strong inflammation of the skin. Single case reports and small case series 
have reported the successful treatment of lentigo maligna with imiquimod. In this 
study we aimed to study the response rate and follow up of patients with lentigo 
maligna treated with imiquimod. 34 histologically confirmed lentigo maligna of 31 
immunocompetent and 1 immunodeficient patient were treated with imiquimod 
cream (Aldara®). The cream was applied until a weeping erosion of the whole 
pigmented skin area developed. If a complete clinical clearance was not certain the 
lesion was biopsied. The median time of imiquimod application was 7 weeks (range 
2-20 weeks). In most patients the cream was applied 1-2x/d. All 34 lentigo maligna 
completely cleared as assessed clinically, including one lesion in the immunodeficient 
patient which recurred after the first treatment course and then was retreated a second 
time. A histological analysis confirmed complete response in six lesions. No patients 
showed recurrence or persistence of the lentigo maligna (mean follow-up time 17.2 
month, range 5-31). We concluded that imiquimod is an effective treatment option 
for lentigo maligna. The major advantage of this therapy is the excellent cosmetic 
result. Controlled trials focusing on long time follow-up results are required.
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The 3,3’,4,4’,5,5’ hexahydroxystilbene impairs melanoma progression
V Paulitschke, T Szekeres, W Jäger, C Gerner, L Elbling, A Holzweber, H Pehamberger, 
R Kunstfeld Medical University of Vienna, Vienna, Austria
Stilbenes comprise a group of polyphenolic compounds and exert beneficial effects 
on various malignancies. We aimed to increase the anti-tumor effects of stilbenes by 
generating a novel stilbene derivative, 3,3’,4,4’,5,5’-hexahydroxystilbene termed M8. 
In vitro, M8 dramatically inhibits the proliferation of human melanoma cells including 
the metastatic M24 met melanoma cell line. Cell cycle analyses of this metastatic cell 
line treated with M8 showed that the compound promotes G2/M arrest accompanied 
with a dose- and time- dependent upregulation of p21 and the downregulation of 
CDK-2. The pro-apoptotic activity of M8 was demonstrated by Annexin V staining 
and upregulation of the pro-apoptotic protein Bak. To further evaluate the underlying 
mechanisms, we performed proteomic analysis of the metastatic M24 met cell line. 
Proteomic analysis revealed that M8 interferes with pathways, which are critically 
involved in the regulation of apoptosis, tumor progression and metastasis, DNA 
damage and p53 activation. Consistently, p53 and proteins involved in the mismatch 
machinery (MSH6, MLH1, MSH2) were upregulated by M8. In a comet assay M8 was 
shown to induce a robust tail moment. Moreover, M8 inhibits cell migration as shown 
in a Matrigel assay via blockade of ROCK-1 in vitro. We confirmed our data in vivo 
in a metastatic human melanoma SCID mouse model. In this model, we demonstrate 
that M8 significantly impairs tumor growth and inhibits cell proliferation. Importantly, 
M8 also interferes with the metastatic process, as M8 treatment could prevent 
metastatic spread of melanoma cells to distant lymphnodes in vivo. Our data indicate 
that M8 treatment is a novel and potent approach for the treatment of metastasising 
melanoma.
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P75 neurotrophin receptor (NTR) mediates chemotherapy-induced apoptosis in 
melanoma cells
F Truzzi, A Marconi, R Lotti, K Dallaglio, R Borroni, C Pincelli University of Modena 
and Reggio Emiliana, Modena, Italy
The low-affinity neurotrophin (NT) receptor p75 (NTR) cooperates with the high-affinity NT 
receptors trk for inducing survival signals, whereas, in absence of trk, it mediates apoptosis 
through its own signal transduction. p75NTR belongs to the tumor necrosis factor receptor 
(TNFR) superfamily and shares with the other members a death domain which is responsible 
for proapoptotic functions. In the skin, p75NTR is expressed by both keratinocytes and 
melanocytes. Melanoma, which originates from human melanocytes, is the most aggressive 
form of skin cancer and is notoriously resistant to chemotherapy. Failure of anticancer drugs 
to work in melanoma is reportedly due to alteration of the apoptotic machinery. The aim of 
the present work is to evaluate the role of the NT receptors in melanoma chemoresistance. 
WM266-4, WM115 and Skmel28 melanoma cell lines express both p75NTR and trks, 
though at different levels. Treatment with cisplatin, carmustine or dacarbazine up-regulate 
p75NTR at the mRNA and at the protein level. On the contrary, chemotherapeutic agents 
down-regulate trkA, trkB and trkC. Despite this effect, chemotherapy only induces a low 
rate of apoptosis. Beta-amyloid which specifically binds p75NTR induces apoptosis in 
melanoma cell lines, as a function of p75NTR expression levels. Combined treatment 
with beta-amyloid and chemotherapeutic agents induce a higher rate of apoptosis than 
chemotherapy alone in all melanoma cell lines, by MTT and subG1 peak analysis. To provide 
evidence that apoptosis is actually mediated by p75NTR, we infected WM266-4 cell line 
with p75NTRsiRNA. We show that beta-amyloid fails to induce apoptosis in p75NTRsiRNA 
treated cells. These results indicate that up-regulation and binding of p75NTR induce 
apoptosis and overcome chemoresistance in melanoma.
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Strategy for studying human melanoma gene regulation using transcriptional analysis
M Bonnet Duquennoy1, S Guenin1, L Schwartz2, G Bens1, J-C Madelmont1, 
A Demidem1 1INSERM Unité 484, Clermont Ferrand, France 2SRC, Paris, France
Gene expression study is one of strategies developed to understand biological processes. In 
order to study mechanisms of melanocyte transformation, we used the TaqMan Low Density 
Array technique (Applied Biosystems) to screen 96 genes associated with cell proliferation, 
glucose and phospholipids metabolisms and melanocyte differentiation. We validated the set 
of probes comparing expression profiles in normal human melanocytes (NHM), in one ocular 
melanoma (IPC227) and in 3 melanoma metastasis (M4Beu, M3Dau, NTP2 with cutaneous 
primary tumour origins) cell lines. The M4Beu expression pattern was the least divergent 
from that of NHM followed by IPC227, NTP2 and the achromic M3Dau cells. For the 4 
malignant strains, melanocyte-differentiation-related genes such as tyrosinase, Kit and MITF 
were highly decreased. IL8 expression described as potential prognostic factor for tumour 
progression was strongly increased. Moreover expression of hTERT gene was detected only 
in tumoral cells. These results confirmed the low degree of differentiation of all these tumour 
cells.Each melanoma cell line showed specific gene expression modifications leading to 
alteration of the major pathways previously described. So we confirmed inactivation of Rb 
tumour suppressor pathways and activation of oncogenes in the ras cascade. These alterations 
were associated with a decrease of suppressor gene PTEN and its regulator PINK. Concerning 
the 41 metabolism related genes, IPC227 (ocular origin) exhibited a most divergent profile. 
We observed regulation of only 2 genes (phosphate cytidylyltransferase, phospholipaseA2 
receptor) in the 4 tumoral strains. For the cutaneous primary melanoma origins cell lines, 
we showed increases of glycolysis enzyme genes as previously described. In conclusion, 
we characterized the specific genetic alterations of these malignant cells particularly for 
cell proliferation and metabolism related genes. This method provides a good strategy for 
characterizing tumoral cells, understanding melanocyte transformation and testing effect of 
anti-cancer treatment.
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Prognostic loss of heterozygosity patterns in melanoma
KS Hoek1, WM Lin2, NC Schlegel1, C Mnich1, N Kobert1, M Storz1, D Mihic1, 
H Moch1, LA Garraway3, R Dummer1 1University Hospital of Zurich, Switzerland 
2Broad Institute, Cambridge, USA 3Dana-Farber Cancer Institute, Boston, USA
Previous studies of loss of heterozygosity (LOH) in melanoma indicated a link 
between certain LOH patterns and location of the primary lesion. We performed 
comparative genomic hybridization studies on 46 different melanoma lines to look 
for LOH patterns that are relevant to patient survival. Class discovery methods were 
used to uncover the presence of intrinsic sample classes with class-specific LOH 
patterns. Correlation with patient survival data revealed that samples in one class, 
characterized by amplifications in both chromosomes 7 and 20, had for those 
patients a significantly poorer prognosis. We also compared the incidence of MITF 
gene amplification against anti-Mitf immunohistochemistry as performed using a 
cell line array. We found that seven of eight samples showing amplification of MITF 
also showed nuclear Mitf staining, but we also found several examples showing 
staining for Mitf in the absence of MITF gene amplification. Interestingly, there 
were three samples which showed MITF amplification discretely restricted to Mitf 
preRNA-coding regions. We conclude from subgroup-specific studies that certain 
LOH patterns correlate with a significantly worsened prognosis for patients, and we 
present evidence suggesting that MITF gene amplification is linked to gene activity. 
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Augmenting the Depigmenting Effect of Retinoids by Chemical Modification
B Kasraee, O Sorg, JH Saurat Geneva University Hospital, Geneva, Switzerland
Retinoic acid (RA) and retinaldehyde are used as skin depigmenting agents. In order to 
increase their depigmenting properties, novel retinoids were designed to increase their 
penetration profile and their efficiency through the eterification of hydroxyretinoids, 
esterification of RA with known depigmenting phenols or the conjugation of 
retinaldehyde with phenolic or non-phenolic depigmenting compounds. Cultured 
murine B16 melanocytes and BDV-II keratinocytes were treated during 4 consecutive 
days with increasing concentrations of each substance, then (i) cell viability was 
determined through the MTT assay, (ii) the cellular melanin content in B16 melanocytes 
was measured spectrophotometrically following melanin extraction, and (iii) uptake 
and metabolism of each molecule in BDV-II keratinocytes and B16 melanocytes were 
analysed by HPLC. The lightening index, defined as the ratio between IC50 for viability 
and that for melanin content, was used to identify potential depigmenting agents. 
Among the synthesised molecules, esters of RA, 4-oxoRA and 4-hydroxyRA showed 
the highest lightening indices with methyl 4-oxoretinoate having the highest lightening 
index (125 compared to 83 for RA). Another RA ester, arbutin retinoate, had a higher 
lightening index than arbutin and was less cytotoxic than RA towards melanocytes 
and keratinocytes. These molecules were easily taken up by cultured keratinocytes 
and melanocytes, but did not release free RA into the cytoplasm. According to our 
in vitro screening model, esterification of RA and of its oxidation derivatives was the 
best chemical modification to increase the depigmenting effect of RA while showing 
a low melanocytotoxicity. These molecules might serve as new skin depigmenting 
products if they prove to be more effective and less irritant than RA in vivo. 
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Prohormone convertases in transformed human melanocytes - a novel twist in 
melanoma research
M Böhm1, A Mastrofrancesco1 2, A Koch1, M Schiller1, TA Luger1, D Metze1, M Picardo2, 
JD Spencer3, KU Schallreuter3, R Mains4, AJ Klein-Szanto5 1Univ of Münster, Germany 
2S Gallicano Dermatological Inst, Rome, Italy 3Dept of Biomedical Sciences, Bradford, 
UK 4Dept of Neurosci, Farmington, USA 5Univ of Pennsylvania, Philadelphia, USA
Prohormone convertases (PCs) have been previously investigated in cutaneous biology mostly with regard 
to processing of proopiomelanocortin into peptide hormones such as alpha-melanocyte-stimulating 
hormone, adrenocorticotropin or beta-endorphin. There is increasing evidence from various solid tumors 
that distinct members of this evolutionary conserved family of serine proteases with homology to the 
subtilisin-kexin type-proteases however can also play an important role in tumor biology via activating 
growth factors, growth factor receptors, adhesion molecules and matrix metalloproteases (MMPs). We 
examined if paired basic amino-acid-cleaving enzyme 4 (PACE4) could play a role in melanoma biology. 
Quantitative real-time PCR and Western immunoblotting of normal human melanocytes and 9 different 
melanoma cells lines disclosed aberrant RNA and protein expression in the majority of transformed cell 
lines. Of note, overexpression of PACE4 in the tested melanoma cell lines was not a global phenomenon 
of PC expression in transformed cells since the RNA amounts of other PCs such as PC1, PC2 or furin 
were similar or even less abundant than in normal melanocytes. Immunohistochemical studies of 47 
human melanomas derived from different stages of disease progression confirmed expression of PACE4 in 
melanoma cells in situ in 89% of the samples. To study the direct consequences of PACE4 overexpression 
in melanoma cells we generated transfectants stably expressing rPACE4. Ectopic expression of rPACE4 in 
A375 melanoma was confirmed by RT-PCR and Western immunoblotting. The PACE4 transfectants cells 
did not exhibit changes in proliferation but displayed increased melanin content compared with vector-
alone transfected cells. Importantly, ectopic rPACE led to increased MMP activity as shown by zymography 
and which was paralleled by increased MMP1 and MMP2 expression. These data suggest that PCs such 
as PACE4 could play an important yet unrecognized role in melanoma progression presumably via 
enhanced MMP expression, increased collagen degradation thereby facilitating tumor cell invasiveness. 
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Polo-like kinase 1: a cell cycle regulator, a critical gene in human melanoma survival 
and an attractive therapeutic target
A Jalili1, A Moser1, M Pashenkov1, C Wagner1, G Stingl1, S Ramaswamy2, JP Brunet2, 
TR Golub2, SN Wagner1 1Medical University of Vienna, Vienna, Austria 2Massachusetts 
Institute of Technology, Cambridge, USA
Melanoma, the most malignant skin tumor, has been showing a steadily growing incidence and 
prevalence over the last decades. After metastatic spread to vital organs it becomes a devastating 
and as yet incurable illness. This necessitates a search for identification of cellular alterations that 
essentially contribute to the biology of melanoma cells. We used cDNA microarray technique to 
evaluate gene expression of 125 samples including melanocytic nevi, primary melanomas and 
melanoma metastases. By combining pathway enrichment analysis (GSEA, Biocarta and KEGG) 
with top 50 gene expression in primary melanomas and melanoma metastases as compared to 
nevi we could identify cell cycle pathway and its member polo-like kinase 1 (plk1, a mitotic 
serine/threonine kinase) but not plk2, 3 or 4 to be significantly overexpressed in primary 
melanomas and melanoma metastases. This finding could be confirmed using real-time RT-PCR 
analysis on an independent set of specimens. In in vitro analysis of human melanoma cell lines 
we observed the peak expression of the plk1 to be at the G2/M phase of the cell cycle. To explore 
the role of plk1 in human melanoma cell biology, melanoma cell lines (n = 4) were transfected 
with pDNA vector transcribing plk1 siRNA. This strategy as compared to control pDNA vector 
led to: (i) significant reduction of plk1 mRNA and protein, (ii) reduced cell proliferation, (iii) 
G2/M phase arrest with increased numbers of tetraploid/octoploid cells, and only in TP53 wild 
type cells: (i) cell death with apoptotic features and, (ii) induction of chemosensitization to 
campthotecin. This study shows that: (i) plk1 expression is dynamically regulated during the cell 
cycle of human melanoma cell lines and (ii) knock down of plk1 can lead to inhibition of human 
melanoma cell proliferation, survival and induction of chemosensitization. Our data suggest 
plk1 to represent a potentially attractive target in melanoma therapy.
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Differential analysis of transcripts with alternative splicing reveals a novel melanoma 
tumor suppressor gene
R Correa1, S Abraham1, S Colombetti2, F Leuba1, F Levy2, V Piguet1, F Jaunin1 
1University Hospital of Geneva, Geneva, Switzerland 2Ludwig Institute for Cancer 
Research, Epalinges, Switzerland
Melanoma is an aggressive cancer largely resistant to conventional chemotherapy, and 
with a propensity to cause widespread metastatic disease. New methods based on the 
study of global gene expression are needed in order to understand the events underlying 
melanoma carcinogenesis. Global analysis of alternative splicing of benign nevus and 
metastatic melanomas was studied using the global gene profiling technology called 
Differential Analysis of Transcripts with Alternative Splicing (DATAS). A library including 
217 differentially expressed clones between benign nevus and metastatic melanomas 
was generated. After an initial screen of specific candidates by Real-Time PCR, we found 
that LOH11CR2A expression was consistently downregulated in patients with metastatic 
melanoma. We analyzed LOH11CR2A expression in a cohort of 70 skin biopsies from 
patients with benign nevus, atypical nevus, primary melanoma or metastatic melanoma. 
The results showed that LOH11CR2A expression was decreased in melanoma patients in 
comparison with healthy donors. These results were confirmed in melanoma cell lines. 
Importantly, when we expressed ectopically LOH11CR2A in melanoma cell lines, melanoma 
cells decreased their proliferation. Ectopic expression of LOH11CR2A in melanoma cell 
lines induced a block in the G2-M transition of the cell cycle. Finally, we could show that 
ectopic expression of LOH11CR2A in B16 melanoma cells decreased metastasis in vivo 
in a murine model.In conclusion, we show that LOH11CR2A gene is downregulated in 
metastatic melanoma. When we restore its expression in melanoma cells we block tumor 
progression suggesting a potential role for this gene in the pathogenesis of melanoma. 
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Bone morphogenetic proteins activate metalloproteinases in melanoma cells and 
fibroblasts
T Rothhammer, A Bosserhoff University of Regensburg, Germany
Bone morphogenetic proteins are secreted growth factors, which belong to the TGFβ 
superfamily. In recent studies, we showed that the expression of BMP-4 and -7 is induced in 
melanoma cells in comparison to normal melanocytes. Functional analyses revealed, that 
BMPs are capable of enhancing the migration and invasion capacity of melanoma cells. 
Moreover, BMPs act as chemo-attractants and pro-angiogenic factors for endothelial cells. 
This leads to the induction of endothelial cell migration to the tumor site and to enhanced 
formation of vasculogenic networks. It is known that the dissemination of melanoma cells 
from the primary tumor and the invasion of surrounding tissues involves the degradation 
and remodeling of the extracellular matrix and the basement membrane. Therefore, we 
now analyzed the influence of BMPs on the expression and activity of proteolytic enzyme 
systems, like the plasminogen activator system and the matrix-metalloproteinase (MMP) 
family. We found that melanoma cells clones with reduced BMP activity, generated by 
stable transfection with the BMP inhibitor chordin, showed reduced expression of matrix 
metalloproteinases -1, -2, -3, -9 and -13. The expression of uPA and tPA, members of the 
plasminogen acticator system, was not altered in the melanoma cell clones with reduced 
BMP activity compared to control cells. It is known that BMPs are secreted growth factors, 
so we additionally analyzed paracrine effects of BMPs on stromal fibroblasts. Treatment 
of fibroblasts with BMP-2, -4 or -7, respectively, led to an increase in MMP-3 and -13 
expression. Again the expression of uPA and tPA was not altered. These data show, that 
BMPs induce expression of matrix metalloproteinases, especially MMP-3 and -13, in 
melanoma cells as well as in fibroblasts. The induction of proteolytic enzymes by BMPs 
leads to increased degradation and remodelling of the extracellular matrix and facilitates the 
invasion of melanoma cells into the surrounding tissues.
 
316
Id2 is involved in TGF-beta’s effects on melanoma growth and proliferation
NC Schlegel, KS Hoek, R Dummer University Hospital Zürich, Zürich, Switzerland
Inhibitor of DNA binding (Id) proteins are important signalling molecules in cell cycle 
and tumorigenesis. While Id1 has already been shown to be involved in melanoma 
growth, Id2 has been identified in at least two melanoma microarray studies but its 
role has not been further investigated. Resistance to the growth-inhibitory effects of 
TGF-beta is a hallmark of aggressively metastatic melanomas, however nothing is 
known about the mechanism of this resistance. Therefore, we sought to investigate the 
role of Id2 in the mediation of this phenotype. A marked downregulation of Id2 RNA 
induced by TGF-beta is associated with the extent of growth inhibition observed in 
different cell lines. Protein levels were also shown to be decreased by western blotting 
in susceptible cells. Furthermore, overexpression of Id2 in formerly susceptible cells 
induces resistance to TGF-beta. Cell cycle analysis could show that overexpression 
of Id2 counteracted the G1-block induced by TGF-beta. Id2 RNA expression tends 
to be low in susceptible cell lines and high in resistant ones. Interestingly, a resistant 
cell line with significantly low levels of Id2 RNA was shown to have significantly 
higher and more stable protein levels than susceptible cells. Id2’s known role in the 
regulation of the cell cycle, the modulation of its expression by TGF-beta and its 
potential to reverse TGF-beta’s growth inhibitory effect suggest the involvement of 
this gene in the mediation of TGF-beta effects on melanoma growth and proliferation. 
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ADAM10, but not MMP14 is critically involved in CD44 shedding from human 
melanoma cells
U Anderegg1, T Parthaune1, T Eichenberg1, C Haiduk1, A Saalbach1, L Milkova1, 
A Ludwig2, JC Simon1 1University of Leipzig, Leipzig, Germany 2University Hospital, 
RWTH Aachen, Aachen, Germany
CD44 belongs to a family of plasma membrane glycoproteins involved in adhesion 
processes and cell movement. It is the functional cellular receptor of hyaluronic acid 
(HA), a major component of the extracellular matrix. The interaction of HA and CD44 on 
malignant and non-malignant cells has multiple impact on cell proliferation, cell motility 
or cell survival. Our group has shown that CD44-HA interactions promote cell proliferation 
of malignant melanoma (MM) cells. CD44 can be shed from the cell surface by proteolytic 
cleavage. The promoting effect of HA on cell proliferation could be abolished by secretion 
of soluble CD44 into the culture supernatant in vitro and in vivo. Increased plasma levels 
of soluble CD44 have been observed in various malignancies. Therefore, the mechanism of 
CD44 shedding is of major interest for tumor biology and consequently putative shedding 
proteases are studied towards their ability to cleave CD44 from the surface of tumor cells. 
Among them MMP14, ADAM10 and ADAM17 are the most interesting candidates that are 
in the focus of the present study. We could detect ADAM10, ADAM17 and little amounts of 
MMP14 in tumor cells from MM by immunohistochemistry. ADAM10 is critically involved 
in the constitutive shedding of native CD44 from human MM cell lines shown by inhibitor 
studies and siRNA techniques. ADAM10 specific inhibitors were able to block CD44 release 
from MM cells. All, ADAM10-, ADAM17- and MMP14-expression could be inhibited by 
siRNA techniques on mRNA and protein levels, but only ADAM-10 blocking was able to 
reduce the constitutive CD44 shedding from MM cell lines. Different from earlier studies 
using overexpressed MMP14 and CD44 we conclude, that ADAM-10 but not MMP14 is the 
native and essential protease for CD44 shedding from melanoma cells. 
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Polypseudolysine (PPL) enhances topical antisense delivery
P Kumar1, C Pickard1, A Fara2, M Bradley2, PS Friedmann1, EP Healy1 1University of 
Southampton, Southampton, UK 2University of Edinburgh, Edinburgh, UK
The delivery of antisense agents as an approach to treat skin disease is limited due to 
poor penetration by antisense compounds into skin. Although delivery of these agents 
can be improved by physical methods (for example electroporation / iontophoresis and 
microinjection), there are limitations to this approach over large areas of skin. We have 
previously shown that polypseudolysine (PPL) can transport alpha-melanocyte stimulating 
hormone (αMSH) into cells in vitro and into skin ex vivo. The aim of the current study was 
to investigate whether PPL can similarly transport antisense compounds into skin. The cargo 
antisense compounds included a 19mer oligonucleotide (ON) and a 15mer peptide nucleic 
acid (PNA) which targeted the translational start site of the tyrosinase gene. The ability of 
PPL-ON and PPL-PNA to inhibit tyrosinase gene function was tested in an in vitro B16F10 
cell based assay and skin penetration was assessed using fluoresceinated compounds. The 
results show that 10-5M 15merPNA-PPL significantly inhibited 10-10M αMSH-induced 
pigmentation and reduced tyrosinase activity of B16F10 cells whereas PNA alone did 
not (n=3). In addition, 10-5M PPL-ON also suppressed the increase in tyrosinase activity 
induced by 10-10M αMSH (n=3). In vitro penetration studies using confocal microscopy 
showed that 10-4M fluorescein-PNA-PPL readily enters into live unfixed B16F10 cells at 
3 hours, but that fluorescein-PNA alone failed to do so. Ex vivo skin penetration studies 
using Franz’s diffusion chambers indicated that 10-3M fluorescein labelled PNA-PPL 
entered into skin whereas fluorescein-labelled PNA did not. Interestingly, a 12merPNA-PPL 
had penetrated deep into the dermis at 3 hours, whereas the 15merPNA-PPL was situated 
mainly in the epidermis at this time point. By contrast, fluorescein labelled PNA without PPL 
did not penetrate into the epidermis or dermis. The results indicate that topical delivery of 
antisense compounds may be enhanced by conjugation to PPL.
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IP-10 and other Lymphocyte Secreted Factors Modulate Melanoma Invasion
FD Antonicelli, J Lorin, R Le Naour, S Kurdykowski, F Grange, W Hornebeck, 
P Bernard University of Reims, Reims, France
Stromal reaction surrounding tumour invasion is characterized by extracellular matrix 
remodelling/degradation by proteolytic enzymes. Besides the classical Breslow index, increased 
in situ level of MMP-2 was associated to a poor prognostic value, highlighting the potential 
therapeutic target linked to this molecule. MMP expression is not restricted to tumour cells but is 
also found in stromal cells, indicating that stroma-derived proteases may contribute to melanoma 
progression. We here investigated the modulation of melanoma stromal reaction by lymphocyte. 
The study has been performed using blood lymphocytes from healthy donors (group1, control), 
patients with melanoma<1 year and clinical remission (group2), or with metastatic melanoma 
(stage III-IV AJCC-UICC, group3). Lymphocytes, obtained by density-gradient centrifugation 
from heparinised venous blood (Lymphoprep, Abcys,), were seeded at 106cells/ml (RPMI-1640 
Glutamax-II) in 6 well-plates for 6 hours. SK-Mel28 melanoma invasiveness was measured in 
vitro using Transwell® chambers model coated with matrigel, either following co-culture with 
lymphocytes or in presence of lymphocyte culture media. MMP-2 and -9 expressions were 
determined by zymography analysis. Cytokines were determined using the Luminex technology 
(CliniSciences). In vitro invasion tests show that addition of lymphocyte culture medium to 
melanoma cells mimics the inhibitory effects of melanoma-lymphocytes co-culture. Interestingly, 
these effects were stronger with lymphocytes from group2 than with those from group3 (60% 
and 40% respectively). Thus, these results show the essential role of secreted factors for this 
modulation. Among 30 secreted cytokines screened in this study, IP-10 level was much higher in 
group2 compared to group3, whereas MMP-9 expression was not statistically different in those 
2 groups. A special focus was given to patients in remission for more than 2 years or with rapid 
metastatic progression. Although they differed on their lymphocyte MMP-9 profile, the MMP-2 
expression during melanoma invasion did not correlate with tumour progression. 
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Solar UV exposure, vitamin D status and course of disease in patients with 
melanoma
B Nürnberg1, C Pföhler1, W Tilgen1, D Schadendorf2, J Reichrath1 1The Saarland 
University Hospital, Homburg, Germany 2Medical Center Mannheim, Germany
Sun exposure, particularly intensive short-time and recreational sun exposure, is 
considered to be the major etiologic factor for melanoma. But on the other hand 90% 
of all requisite vitamin D has to be formed in the skin through the action of the sun - a 
serious problem due to the fact that new scientific findings convincingly demonstrate 
vitamin D deficiency to be associated with a variety of severe diseases including various 
types of cancer (e.g. colon, prostate and breast cancer). According to recent reports 
sun exposure is associated with a relatively favorable prognosis and increased survival 
rate in various malignancies, including malignant melanoma. It has been speculated 
that these findings were related to UV exposure-induced relatively high serum levels 
of vitamin D which may lead to a more favorable course of melanoma. To prove this 
hypothesis the present study aimed to correlate the serum level of 25-hydroxyvitamin 
D (which represents the readily measurable ‘storage’precursor form of vitamin D) with 
tumor thickness at time of diagnosis and course of disease in patients with melanoma. 
The study population consisted of 212 patients with histologically proven cutaneous 
melanomas of different stages: stage I (n=50); stage II (n=20); stage III (n=20); stage 
IV (n=122). Basal 25-hydroxyvitamin D levels were analyzed (DiaSorin LIAISON 25-
OH Vitamin D-Assay) in those patients and compared with a control group (n=80). 
Additionally, each participant was requested to fill out a questionnaire about the 
history of sun exposure. The attention was particularly directed to whether an early 
progress of disease was associated with low serum levels of 25- hydroxyvitamin D. 
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Diclofenac gel (SolarazeTM) inhibits invasion and suppresses growth of actinic 
keratoses and squamous cell carcinoma cell lines
D Marsh1, KJ Purdie1, CA Harwood1, CM Proby1, CC Jones2, GJ Thomas1 1Bart’s & 
London School of Med &Dentistry, London, UK 2Shire Pharma Ltd, Basingstoke, UK
Actinic keratoses (AKs) are premalignant skin lesions caused by excessive sun exposure. Up 
to 10% of AKs transform into squamous cell carcinomas (SCCs), characterised by invasion 
of keratinocytes through the epidermal basement membrane. At present however, there 
are no reliable markers that identify lesions which become malignant. Cyclo-oxygenases 
(COX) catalyse the key step in prostanoid biosynthesis, and are targets of non-steroidal anti-
inflammatory drugs (NSAIDs). COX-2 is induced by inflammatory or oncogenic stimuli and 
is upregulated in many tumours. NSAIDs have anti-tumour activity via COX-2 inhibition 
and have been shown to exhibit chemopreventive effects on cutaneous SCCs, although 
the underlying mechanisms remain unclear. The aim of this study was to determine levels 
of COX-2 expression in normal, AK and SCC skin, and to examine the functional effect of 
diclofenac, an NSAID, on keratinocyte cell lines derived from AK and SCC. COX-2 expression 
was examined by immunochemistry in normal (n=7), AK (n=19) and SCC (n=19) skin and 
scored as negative, weak/focal or strong. The keratinocyte cell lines used were AK-derived 
PM1, SCC-derived Met1 and SCC-derived IC1. The effect of diclofenac gel (SolarazeTM) was 
tested on cell growth and in Transwell invasion assays at dilutions ranging from 1:4000-1:10 
(diclofenac concentration = 20uM to 8mM, respectively).COX-2 was expressed strongly 
in 26% of AK and 53% of SCC skin, but only weakly in normal skin. At 20uM, diclofenac 
inhibited Transwell invasion in all cell lines (by 32% in Met1; 34% in PM1; 54% in IC1), but 
produced little growth inhibition. However, at 8mM, diclofenac-treated cells were markedly 
growth-suppressed, and showed morphological features of apoptosis. Data from this study 
suggests that diclofenac inhibits keratinocyte invasion and cell growth, functions which 
contribute to malignant transformation. The effect of diclofenac on tumour growth and 
progression is likely to be concentration-dependent, acting via multiple mechanisms.
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Features of melanomas identified in dermoscopy screening versus self-detected by 
patients
T Stasiak1, M Pawlowska1, M Olszewska1, M Slowinska2, J Sicinska2, M Majsterek2, 
M Maj2, B Goralska2, E Piekarczyk2, J Czuwara2, A Wiergowska2, E Oledzka2, E 
Szymanska2, L Rudnicka3 1Warsaw Medical School, Poland 2CSK MSWiA, Warsaw, 
Poland 3Polish Academy of Sciences & CSK MSWiA, Warsaw, Poland
Melanoma is a malignancy of melanocytes located predominantly in the skin. The incidence 
of melanoma is increasing worldwide. Many physicians encourage patient’ self-detection of 
melanoma, others suggest regular dermoscopy screening of all pigmented skin lesions. The 
objective of the study was to analyze and evaluate histopathological and clinical profile of 
cutaneous melanoma in patients with melanoma diagnosed during regular dermoscopy screening 
versus melanoma in patients who approached our offices with a specific lesion of concern. 
The study included 49 consecutive patients with histopathologically confirmed cutaneous 
melanoma in the years 2004-2007. In all patients epidemiological parameters as well as factors 
of prognostic significance (Breslow thickness and Clark level) were evaluated. Our results show 
that 27/49 (55%) were detected during routine dermoscopy screening and 22/49 (45%) of 
melanomas were pre-diagnosed by patients themselves. Self-pre-diagnosed melanomas were 
detected predominantly in summer. In this group 7/22 (31%) lesions were diagnosed in June, 
July or August. In these months only 3/27 (11%) melanomas were detected during dermoscopy 
screening. Average Breslow thickness was significantly lower in the dermoscopy screening 
group (0.5+/-0.5 mm) as compared to the self-detection group (1.6+/-2.7 mm, p<0.01). Average 
Clark level was 2.0+/-0.9 and 2.5+/-1.3 respectively (p<0.05). There were no differences in age 
or sex between the two investigated groups of patients. In conclusion, our results show that 
patients’ self-examination remains important in accomplishing earlier melanoma detection, but 
melanomas diagnosed during regular dermoscopy screenings allow diagnosing melanoma at an 
earlier stage and thus guaranty better prognosis. 
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Mast cells as modulators of cutaneous tumours
M Artuc, S Guhl, B Magda, D Mangold, T Zuberbier Charité Berlin, Germany
The expression of mast cells (MC) is increased in the vicinity of various tumours. 
However, little is known about MC actions on tumour homeostasis. There is evidence 
that the number of peri-tumorous MC is positively correlated with the probability 
of metastasis and with a poor prognosis. Since MC express a number of cytokines 
and growth factors, it can be assumed that they have an impact on tumour growth 
and tumour invasion. Different melanoma and squamous cell carcinoma cell lines 
were co-cultivated with or without primary, dermal MC for 24 h, and the release of 
cytokines IL-6, IL-8 and TNF-alpha in each individual cell line as well as in co-cultures 
was estimated in order to look for a potential modulation of cytokine production as a 
result of tumour-MC interaction. In addition to native MC, this panel was expanded 
by the use of pre-activated MC: this activation was achieved by incubation of MC 
with stimuli like a-IgE, Stem Cell Factor (SCF) and a combination of SCF plus a-IgE. 
Activation of MC by the combination of SCF plus a-IgE led to a maximal release 
of cytokines. Co-culturing of MC with different tumours led to a reduction of TNF-
alpha release from MC. The maximal inhibitory effect was observed in the squamous 
cell line SCL-1. The release of Il-6 was differentially regulated in combination with 
melanoma cell lines or squamous cell carcinoma lines, respectively. While co-
cultivation with melanoma cells resulted in a slight increase in IL-6 release, co-
cultivating MC with SCL-1 caused a strong upregulation of IL-6 release. The release of 
Il-8 was increased three fold in MC-melanoma co-culture, but remained unchanged 
in MC-squamous cell carcinoma co-culture. Our data suggest an interplay between 
MC and tumour cells which results in altered cytokine release and may thus have an 
impact on tumour growth, invasion and neovascularisation.
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KLK5 transgenic mice reproduce NS phenotype
C Deraison, C Bonnart, A Robin, C Besson, A Briot, M Lacroix, A Hovnanian INSERM 
U563, Toulouse, France
Netherton syndrome (NS) is a severe genetic skin disorder caused by mutation in 
SPINK5. SPINK5 encodes LEKTI, a Kazal-type serine proteinase inhibitor. The NS 
mouse model (Spink5-/-) demonstrated that LEKTI is a key regulator of epidermal 
proteases, including KLK5, KLK7 and the newly identified pancreatic elastase 2. 
These proteolytic hyperactivities resulted in desmosomal protein degradation and 
accelerated proteolytic-processing of filaggrin. In order to document the consequences 
of unregulated KLK5 activity in the terminally differentiated layers of the epidermis, we 
have developed a tissue-specific hKLK5 transgenic mouse in which KLK5 expression 
is under the control of the involucrin promoter (INV). Among the eight transgenic 
mice (INV-KLK5), five presented a dramatic skin fragility with superficial peeling and 
died shortly after birth suggesting a profound defect in skin barrier function. Three 
other transgenic mice lived for a few days to 3 months. They developed exfoliative 
erythroderma and scaling predominant on the back. They presented also failure to 
thrive and hair growth retardation. The intensity of transgene expression correlated 
with phenotype severity. Histological analysis showed intercellular separation 
at the granular layer-stratum corneum interface. Ultrastructural analysis showed 
asymmetrical splits of desmosomes underlying stratum corneum detachment. This 
correlated with a marked reduction of desmoglein-1 staining in suprabasal epidermis. 
Interestingly, no keratohyalin granule could be observed which was concordant with 
decreased filaggrin immunostaining. Our study demonstrates a direct role of KLK5 
in the desquamation process in vivo. INV-KLK5 mice show a much more severe 
phenotype than transgenic KLK7 mice and reproduce the main features of Spink5-/- 
mice. This demonstrates that KLK5 initiates the proteolytic cascade involved in the NS 
phenotype and identifies KLK5 as a major target of LEKTI in vivo.
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Two models for isolation to study Merkel cells
N Boulais1, U Péreira1, N Lebonvallet2, G Dorange1, N Rougier3, C Chesne3, L Misery1 
1EA 3879 U.P.C.I., Brest, France 2CHU de Brest, France 3BIOPREDIC International, 
Rennes, France
Epidermal Merkel cells (MC) remain mysterious cells believed to modulate sensory neurones. 
The major publications revealed their neural crest origin and their synaptic capability but their 
functions are still unknown. We used MC from rat foot-pads and pig snout to perform two 
different models which allowed us to analyse stimuli affecting MC. MC from pig snout are 
numerous and easily reachable. We carried out a magnetic selection to obtain an epidermal 
cell-suspension enriched with 60% of MC. These cells were cultured some days and sequentially 
incubated with exogenous substances. The release of neuropeptides in the supernatant was 
analysed by Western-blot or ELISA. We also transfect rat epidermal cells with an expression 
vector of βgalactosidase under the control of Atonal homolog 1, a transcription factor specific 
to MC within epidermis. In presence of X-gal, transfected MC became blue. Hence they 
can be distinguished which allowed electrophysiological analysis.Immunocytochemistry 
and electron microscopy analysis revealed that enriched MC still contained neurosecretory 
granules. After a short exposition to the 4αphorbol ester didecanoate, an activator of TRPV4, 
we could elicit that MC release of VIP in the culture medium from their granules. Blue MC 
from rat were analyzed by electrophysiology in whole cell configuration using a macro-patch 
technique. We found 2 currents identified as voltage-gated calcium channels. One with a 
slow accommodation and that reacted to suction, the other with a quick current typical to 
secretory cells and unfeeling membrane deformation. In conclusion we bring two new models 
to study MC. The first would help us to analyse the role of MC in neurogenic inflammation and 
the effects of various products onto MC releasing peptides. The second offers the opportunity 
to study the intimate mechanisms of MC through activation of ionic channels, their role in the 
touch perception and the modulation of excitability of MC.
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Interfollicular Keratinocyte Stem Cell Mapping by Multi-Epitope Ligand Cartography 
(MELC) Reveales the Existence of Two Subpopulations
R Böckelmann1, AJ Pommer2, H Hofmeister2, L Philipsen3, H Gollnick4, B Bonnekoh4 
1O.v.-Guericke-Uni/Skinsystec GmbH, Magdeburg, Germany 2SkinSysTec GmbH, 
Magdeburg, Germany 3Meltec GmbH, Magdeburg, Germany 4Otto-von-Guericke 
University, Magdeburg, Germany
Candidate interfollicular keratinocyte stem cells (KSC) can be distinguished from other basal epidermal 
interfollicular keratinocytes by the up-regulated expression of e.g. integrins (CD29, CD49), cytokeratins 
(CK14, 15, 19) and CD34 as well as by the down regulation of CD71, CK10 and CK18. Moreover, 
KSC are proposed to be negative for transglutaminase 1, desmoglein 3, involucrin, and for Ki67. Since 
its recent introduction, multi-epitope ligand cartography (MELC) opens the possibility to identify KSC 
by such a complex marker combination in situ and to map their distribution in a single skin tissue 
section. We hereby further characterize KSC by MELC robot technology which relies on a core process 
comprising an iterative sequel of I) incubation of a tissue section with fluorochrome tagged antibodies 
II) fluorescence imaging and III) fluorescence photo-bleaching. Biomathematical postprocessing allows 
pixel-precise overlay of corresponding images in order to generate epitope co-location maps. Using 
this approach we detected KSC defined by the cellular phenotype pan-CKpos/CK14pos/CD29pos/
CD49dpos/CD49fpos/CK10neg/Ki67neg/CD71dim in biopsies from involved skin of psoriasis patients 
(n=6) and healthy control skin (n=6). Two subpopulations of KSC were observed, both showing a 
C-KITpos/bcl-2pos phenotype. The major subpopulation of KSC was found to be extracellular signal-
related kinase (ERK) 1/2neg. The minor subpopulation was ERK 1/2pos. Thus, the interfollicular KSCs 
are armed with C-KIT tyrosine-kinase receptors and bcl-2 proto-oncogene which blocks apoptosis 
and programmed cell death. Furthermore, KSC form two subpopulations in relation to the expression 
of the mitogen-activated protein kinase ERK 1/2. Overall, we adopted a novel strategy for the in situ 
characterization of distinct cell types, such as interfollicular epidermal stem cells, by combining a variety 
of epitopes and other markers in skin sections using MELC robot technology.
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Topical Hyaluronate Fragments Prevent Corticosteroid-Induced Skin Atrophy in 
Mouse Without Interfering with Anti-Inflammatory Effect
G Kaya, C Tran, O Sorg, D Grand, R Hotz, P Carraux, JH Saurat Geneva University 
Hospital, Geneva, Switzerland
We previously demonstrated that selective suppression of CD44 expression in mouse 
epidermis leads to skin atrophy and that topical application of intermediate size hyaluronate 
fragments (HAFi) results in an epidermal hyperplasia and increases the expression of CD44 
and HA in mouse skin. In this study, we examined the effect of topically applied HAFi 
on corticosteroid-induced skin atrophy in SKH1 hairless mice. Dorsal skin of mice was 
treated twice daily for 5 days with vehicle, steroid (0.05% clobetasol propionate or 0.1% 
desonide) or steroid plus 1% HAFi. Topical application of steroid caused an epidermal 
(0.018±0.004 mm) and dermal (0.137±0.026 mm) atrophy when compared to epidermal 
(0.054±0.005 mm) and dermal (0.245±0.079 mm) thickness of vehicle-treated mouse skin, 
and a decrease of CD44 and pro-HB-EGF protein expression. Topical application of HAFi, 
(but not HAF of small or large size), prevented steroid-induced epidermal (0.134±0.023 
mm) and dermal (0.206±0.042 mm) atrophy, as well as the epidermal loss of CD44 and 
pro-HB-EGF protein. Topical HAFi applied with steroid also increased the HA content of 
the epidermis (6.86±2.91 µg) and dermis (171.8±18.6 µg) when compared to epidermal 
(2.87±1.41 µg) and dermal (123.4±14.9 µg) HA content of steroid-treated mouse skin. HAFi 
also correct the decrease of dermal collagen and elastic fiber content caused by steroids, 
demonstrated by special histological stainings. In addition, as shown by MPO measures in 
vivo, HAFi do not inhibit (104±7 % of control) the anti-inflammatory effect of steroids (83±8) 
on TPA-induced skin inflammation (3273±308) and show a moderate anti-inflammatory 
effect (2626±320). Our results show that HAFi prevent steroid-induced skin atrophy and 
induce CD44 and pro-HB-EGF expression and HA production in the presence of steroid 
in hairless mouse, without interfering with the anti-inflammatory effect of the steroid. 
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Restin is associated with epidermal lamellar bodies
A-A Raymond, A Gonzalez de Peredo, A Stella, G Serre, B Monsarrat, M Simon 
CNRS-University of Toulouse III, Toulouse, France
Lamellar bodies (LB) are tubulo-vesicular secretory organelles of keratinocytes, 
which play a crucial role in the formation and function of the stratum corneum. Their 
content, including lipids, structural proteins, proteases, protease inhibitors and anti-
microbial peptides, is secreted into the extracellular spaces at the apical surface of 
the upper granular keratinocytes. The way their transport is controlled is unknown. 
In a systematic characterization of the proteome of a LB-enriched fraction by mass 
spectrometry, we identified new lysosomal proteins, confirming these organelles as 
related to the secretory lysosomes described in other cell types. We also recognized 
proteases, protease inhibitors and a new acid ceramidase-like which could play a role 
in the stratum corneum barrier function. Finally, we identified membrane proteins 
related to vesicle trafficking, such as several Rab proteins, and restin. Restin belongs 
to a class of proteins, designated cytoplasmic linker proteins (CLIPs) that mediate 
interactions of organelles with microtubules. Use of the knowledge-based software 
developed by Ingenuity Systems Inc, highlighted a number of direct and indirect 
restin effectors. Western blotting experiments confirmed the presence of restin and 
its known effectors IQGAP1 and cdc42 in the LB-enriched fraction. Confocal laser 
microscopy detected restin in differentiated keratinocytes, first at the periphery of 
the nucleus then with a granular cytoplasmic labeling evocative of LB. Restin was 
preferentially colocalized with Cdc42 and with the known LG-protein cathepsin 
D. Restin was also largely colocalized with Rab7. This strongly suggests that restin 
together with Rab proteins plays a role in the intracellular trafficking of LB. 
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Identification and characterization of three new putative lipases specifically 
expressed in granular keratinocytes
E Toulza1, N Mattiuzzo1, M-F Galliano1, N Jonca1, C Dossat2, D Jacob3, A De Daruvar3, P 
Wincker2, G Serre1, M Guerrin1 1CNRS-UPS UMR 5165, Toulouse, France 2Genoscope 
& CNRS UMR 8030, Evry, France 3Victor Segalen Uni, Bordeaux, France
The last living cells of epidermis, the granular keratinocytes, produce almost all of the proteins 
and lipids required for the protective barrier function before their programmed cell death 
gives rise to corneocytes. Our pioneer analysis of the in vivo transcriptome of these cells 
aimed to identify new genes to improve the understanding of barrier function and regulation 
of desquamation in normal epidermis. Starting from granular keratinocytes enriched fractions, 
we described the expression of 3,387 genes, a proportion of which are expressed in these cells 
in a highly specific manner. Among them, we identified the new LIPK, LIPM and LIPN genes, 
which encode proteins containing a signal peptide, an α/β hydrolase fold and the abhydrolase 
associated lipase region. These three new putative lipases are specific for the epidermis as 
shown by PCR on a panel of 16 human cDNAs prepared from various organs. Moreover, these 
putative lipases are highly overexpressed in granular keratinocytes as revealed by real-time 
RT-PCR experiments. Phylogenetic studies showed that LIPK, LIPM and LIPN proteins are very 
close to LIPA (ubiquitous lysosomal cholesterol ester hydrolase) and LIPF (secreted triglyceride 
lipase), two well-characterized lipases also encoded by genes located in 10q23.31. LIPK, 
LIPM, and LIPN might have a low optimum pH as is the case for LIPA and LIPF, in agreement 
with the acidity of the extracellular space in the stratum corneum. We produced specific 
rabbit antisera against LIPK, LIPM and LIPN, and the characterization of these proteins is in 
progress. The new LIPK, LIPM and LIPN lipid hydrolase genes may play an essential function 
in lipid metabolism and participate in the establishment of the barrier function by catalyzing 
the maturation of extracellular lipids of the most differentiated epidermis layers, and are thus 
interesting gene candidates for genodermatoses of unknown origin.
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Expression of aquaporins in human skin keratinocytes: relationship to 
differentiation
JM Verbavatz1, M Boury-Jamot1, J-H Cauchard2, JE Daraspe1, E Noblesse2, K Lezou2, 
M Dumas2 1CNRS URA2096, CEA-Saclay, Gif-Sur-Yvette, France 2LVMH Recherche, 
Saint Jean de Braye, France
Skin epidermis is a stratified and keratinised epithelium. It is permanently renewed 
by continuous keratinocytes proliferation and differentiation. Basal keratinocytes 
proliferate then differentiate in the suprabasal layers to finally undergo corneification 
and desquamation. The present study investigates the expression of aquaporin water 
channels (AQPs) in human keratinocytes during differentiation. We previously 
demonstrated that functional AQP3 was expressed in all the living layers of human 
epidermis. We also reported using RT-PCR that primary cultures of normal epidermal 
keratinocytes as well as the Hacat keratinocyte cell line expressed AQP3 and AQP10 
mRNA. In total mRNA from human epidermis, AQP3 and AQP10 mRNA were 
found, but AQP9 mRNA was also detected. Since keratinocytes account for around 
90% of the cells in the epidermis and according to the high level of AQP9 mRNA 
detected, we hypothesized that this AQP is expressed by keratinocytes. Reconstituted 
epidermis containing only keratinocytes mainly engaged in differentiation 
confirmed that in addition to AQP3 mRNA, AQP9 mRNA is also expressed. In 
addition, postconfluent cultures of normal human keratinocytes treated by CaCl2 
(1.5mM) known to induce stratification and differentiation exhibited increased 
AQP9 mRNA and decreased AQP10 mRNA expression. Therefore, whereas AQP3 
mRNA is always expressed, AQP10 mRNA expression seems to be restricted to 
undifferentiated proliferating keratinocytes and AQP9 to the more differentiated cells. 
Preliminary results obtained by western blotting and indirect immunofluorescence 
suggest that the AQP9 protein is expressed in the human epidermis and 
that its cellular location in keratinocytes has a different pattern than AQP3. 
2007 ESDR Abstracts v2.indd   55 8/13/07   11:31:41 PM
ABSTRACTS
S56  Journal of Investigative Dermatology (2007), Volume 127 
331 [Oral 068]
Purification and Characterization of Vaspin in human skin - a new epidermal serine 
protease inhibitor
U Meyer-Hoffert, Z Wu, E Ziernig, RS Sreseli, J Bartels, J-M Schröder University of 
Schleswig-Holstein, Kiel, Germany
Proteolytic degradation of extracellular proteins plays a crucial role in the physiological 
detachment of corneocytes from human stratum corneum. The presence of protease inhibitors 
regulates their proteolytic activity and contributes to the integrity and protective function of the 
skin. Their importance in diseases has been revealed impressively in principal in Netherton’s 
disease, where the Kazal-type protease inhibitor LEKTI is absent. We speculate that decreased 
expression of protease inhibitors in human skin are involved in inflammatory skin diseases like 
eczema and that enhanced expression leads to thickening of the cornified envelope as seen 
in plantar callus. Therefore we analyzed human callus for the presence of protease inhibitors, 
which might contribute to the stratum corneum architecture. After purification by high 
performance liquid chromatography (HPLC) we identified by Nano-Electrospray-Ionisation Mass 
Spectrometry (ESI-MS) and MS/MS-sequence analyses the serine protease inhibitor (SERPIN) A12, 
also named vaspin, in the extracts of human callus. Vaspin was previously only described as a 
visceral adipose tissue-derived serine protease inhibitor with the function of a insulin-sensitizing 
adipocytokine in obesity. Primary cultured keratinocytes exhibited vaspin mRNA-expression 
by RT-PCR after a four-day-long pretreatment with 1.2 mM calcium to induce differentiation 
of keratinocytes. Immunohistochemical analysis of paraffin-embedded skin samples revealed 
vaspin expression at the apical part of the epidermis and the stratum corneum. The expression 
of vaspin was observed at various localizations of healthy human skin including face, trunk as 
well as palmar and plantar localizations. In conclusion we identify the protease inhibitor vaspin 
in human skin. Our finding that keratinocytes express vaspin suggests a new physiological 
role for this protease inhibitor than the previously described function in adipose tissue. We 
speculate that vaspin contributes to the epidermal barrier function of healthy human skin. 
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Caspase-14 protects against epidermal UVB photo-damage and water loss
G Denecker1, E Hoste1, B Gilbert1, T Hochepied1, P Ovaere1, S Lippens1, C Van 
den Broucke1, P Van Damme1, K D’Herde1, JP Hachem2, G Borgonie1, R Presland3, 
L Schoonjans4, C Libert1, J Vandekerckhove1, K Gevaert1, P Vandenabeele1, 
W Declercq1 1University of Ghent, Belgium 2University of Brussels, Belgium 3University 
of Washington, Seattle, USA 4University of Leuven, Belgium
Caspase-14 belongs to a conserved family of aspartate-specific proteinases. It is a 
short prodomain caspase whose expression is almost exclusively restricted to the 
suprabasal layers of the epidermis and the hair follicles. Moreover, its proteolytic 
activation of caspase-14 is associated with stratum corneum formation. In order to 
determine the role of caspase-14, we generated caspase-14 deficient mice. The skin of 
these was shiny and lichenified, indicating an altered stratum corneum composition. 
However, no major histomorphological or immunohistochemical differences were 
observed. Electron microscopic analysis revealed a significantly higher number of 
alveolar keratohyalin F-granules, the profilaggrin stores, in the caspase-14 deficient 
epidermis. Accordingly, caspase-14 deficient epidermis is characterised by an altered 
profilaggrin-processing pattern and by reduced skin hydration levels and increased 
water loss. We show that recombinant caspase-14 can directly cleave profilaggrin 
in vitro. Importantly, the skin of caspase-14 deficient mice was highly sensitive to 
the formation of cyclobutane pyrimidine dimers upon UVB irradiation, leading 
to increased levels of UVB-induced apoptosis. Our data indicate that the UVB 
filtering capacity of the stratum corneum is reduced in the absence of caspase-14. 
Taken together, these results demonstrate that caspase-14 deficient mice can serve 
as a model to better understand the pathways that lead to proper development 
of skin barrier functions preventing water loss and protecting against UVB light. 
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Protection against oxidative stress and modulation of skin pigmentation by Cucurma 
Longer extract
P Bhatt, C Wallaert, A D’Arcangelis, E Fedorova, C Lasserre Chanel Inc, Piscataway, 
NJ, USA
The majority of changes in skin pigmentation associated with aging are caused by photoaging 
and reflect cumulative sun exposure. Aging and photoaging affect skin pigmentation resulting 
in solar lentigines, age spots, and uneven skin tone. Cytokines that are known as mitogens 
or melanogens for melanocytes, including endothelin-1 (ET-1) and stem cell factor (SCF) 
also play an important role in epidermal melanization. Exposure of skin to UV irradiation 
along with stimulation of pigmentation, induce a wide range of effects including formation 
of reactive oxygen species. Searching for the agent capable of both scavenging radicals and 
affecting skin pigmentation is an efficient approach for skin care products. We have studied 
the effect of a novel extract of Cucurma Longer or Turmeric on skin pigmentation and anti-
oxidant activity. Several concentrations of Turmeric extract were evaluated for direct anti-
oxidant activity against superoxide anion, hydroxyl radical, peroxinitrite and halogenated 
oxidants. Human melanocytes were treated with Turmeric extract for 24 hours in order 
to evaluate the tyrosinase activity and tyrosinase expression by PCR, and for 5 days to 
determine the melanin content. Furthermore, keratinocytes treated with Turmeric were then 
evaluated for ET-1 and SCF expression by ELISA. These experiments revealed that Turmeric 
significantly inhibits all radicals and oxidants tested. It also inhibits SCF and ET-1 production 
in keratinocytes and melanin synthesis in melanocytes. Turmeric had no effect on tyrosinase 
activity and expression. These studies reveal that Turmeric can play an important role in 
reduction of melanin synthesis and has a strong anti-oxidant activity, and thus can be of use 
in skin care products and cosmetics designed for lightening, anti-aging, and anti-photoaging 
application. Turmeric extract demonstrates strong multiple biological activities that not only 
provides protection of skin from oxidative stress but also modulates skin pigmentation. 
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Ceratonia Siliqua: a polyfunctional ingredient acting on key regulators of skin 
barrier hydration
E Fedorova1, P Bhatt1, A D’Arcangelis1, C Wallaert1, M Mildner2, E Tschachler3, 
C Lasserre1 1Chanel Inc, Piscataway NJ, USA 2Medical Uni of Vienna, Austria 
3CE.R.I.E.S., Neuilly Sur Seine, France
Stratum corneum provides an essential barrier to water loss, penetration of exogenous substances, 
and environmental insults. The proper maintenance of hydration as well as correct differentiation 
of stratum corneum are important elements resulting in functionally active skin barrier. Filaggrin 
is a key protein expressed during terminal differentiation of the epidermis and is involved in the 
production of natural moisturizing factor. Matriptase plays an important role in the formation of 
a functional barrier and is involved in the processing of filaggrin. Caspase14 is expressed during 
terminal differentiation of keratinocytes and is active in the Stratum corneum. The aim of our study 
was to find an active ingredient capable of polyfunctional activity on the expression and distribution 
of proteins involved in terminal differentiation of epidermal keratinocytes i.e. filaggrin, matriptase, 
and caspase14. Keratinocytes were treated with Ceratonia Siliqua extract and tested for expression 
of caspase14 by RT-PCR and for expression of matriptase and filaggrin by RT-PCR and Western blot. 
Matriptase, caspase14, and filaggrin expression was also evaluated in skin equivalent treated with 
Ceratonia extract by immunohistochemical or immunofluorescent staining and by Western blot. Our 
results show that Ceratonia extract stimulates RNA expression of matriptase in keratinocytes and 
increases expression of matriptase, filaggrin, and caspase14 in skin equivalent. Immunohistochemical 
and immunofluorescent data indicate the increased intensity and distribution of matriptase, 
filaggrin, and caspase14 staining in the epidermis. Western blot confirms the stimulation of protein 
expression found in skin equivalent. Ceratonia extract stimulates expression of filaggrin, matriptase, 
and caspase14 that play a role in the terminal differentiation of epidermis. Since multifunctional 
biological activities of Ceratonia Siliqua can contribute to the proper formation and maintenance of a 
skin barrier, this extract is an excellent candidate to be used for improving Stratum corneum hydration. 
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In vitro evaluation of a new nutraceutical for post-partum body remodelling: 
efficacy at each level of the skin organization
C Baudouin, M Moreau, S Bredif, D Naaimi, P Msika Laboratoires Expanscience, 
Epernon, France
The components of an innovative nutraceutical, specifically formulated for post-partum body 
remodelling, have been evaluated in vitro on each part of the skin: hypodermis, dermis, 
dermal-epidermal junction and epidermis. This patented food supplement is composed of 
borage oil, fish oil, magnesium oxide, pineapple extract, zinc sulfate and a blend of vitamins 
B. Normal human adipocytes have been treated by borage and fish oils. Lipolysis was 
evaluated by measurement of glycerol release and lipogenesis was followed by measurement 
of incorporated 14C-acetate. Normal human dermal fibroblasts and normal human epidermal 
keratinocytes have been treated by the blend of vitamins B with the trace elements (Mg, Zn). We 
examined cell proliferation (MTT assay) and fibroblasts metabolism (total proteins synthesis). 
ELISA tests were performed to study keratinocytes differentiation (involucrin, cytokeratin 
10) as well as synthesis of extracellular matrix proteins (collagen I, elastin, fibronectin) and 
dermal-epidermal junction molecules (collagen VII) by fibroblasts. We have shown that 
borage and fish oil were able to stimulate lipolysis and to inhibit lipogenesis.Moreover, in 
our model, the mixture of vitamins B and trace elements activated keratinocytes proliferation 
and differentiation; stimulated fibroblasts metabolism and synthesis of extracellular matrix 
key components and stimulated collagen VII synthesis. By this study, we demonstrated that 
this new nutraceutical is able to restructure and firm up post-partum skin by acting at each 
level of the skin organization. Actually, it promotes reduction of adipose tissue, enhances 
dermis elasticity and density, reinforces epidermal-dermal junction and activates renewal of 
epidermis. These results are supported by a clinical study conducted on post-partum women. 
Together, the in vitro and in vivo evaluations confirm that the nutraceutical accelerates the 
decrease of fat accumulated during pregnancy and improves skin aspect.
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A new and innovative emollient with Cu-Zn-Mn triad for irritant and allergic 
dermatitis
C Baudouin1, D Naaimi1, C De Belilovsky2, B Chadoutaud3, P Msika1 1Laboratoires 
Expanscience, Epernon, France 2Institut Alfred Fournier, Paris, France 3Clinreal, 
Toulouse, France
Irritant, allergic contact dermatitis (ICD, ACD) and atopic dermatitis (AD), beside therapeutic 
prescriptions, need a specific cosmetic management with emollient, anti-irritant, anti-
microbial and healing products. A new emulsion for ICD and ACD with no antiseptic, no 
common preservative, no perfume and no colorant has been developed. It contains the first 
oligo-element triad (Cu-Zn-Mn), phytosphingosines, a Glycerol/Capryl Glycol complex and 
Dimethyl Oxobenzo Dioxasilane. First, we investigated the in vitro effect of [Cu-Zn-Mn] triad 
on the skin repair improvement. Then, the clinical efficacy and tolerance of the new emulsion 
have been performed. After treatment of fibroblasts or keratinocytes with [Cu-Zn-Mn] triad, 
we examined cell migration and proliferation by the scratch-Assay and we evaluated the 
markers of keratinocytes proliferation (b1-integrin), differentiation (involucrin) and Dermal-
Epidermal Junction (b4-integrin) using ELISA. Clinical efficacy of the emulsion has been tested 
on 139 patients with 67% of children. They were affected by various pathologies: irritation 
from external origin; AD and ACD and superficial cutaneous alterations. The tested product 
was applied twice daily for 10 days. In vitro, we have shown that the [Cu-Zn-Mn] triad 
acted at different levels of the skin in order to enhance wound healing by promoting re-
epithelialisation, reinforcing DEJ and improving dermal wound recovery. Moreover, in clinical 
study, overall, the product was efficient on 81% of the patients. The comparison of different 
groups revealed that the Cu-Zn-Mn triad was efficient for all conditions tested, and that this 
product is totally adapted for children. A new Cu-Zn-Mn emollient has been developed for 
various irritant, allergic and traumatic dermatitis and give excellent results for adults and 
children. It was the first time that we could demonstrate that the Mn addition to the Cu-Zn 
complex stimulates the epidermal regeneration and restores skin barrier function.
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Calcium Influx as an Initiator for the Inflammatory Reaction in Ultraviolet Irradiated 
Keratinocytes
Y Ochiai, S Yahagi, Y Okano, H Masaki Cosmos Technical Center Co., Ltd., Tokyo, 
Japan
Ultraviolet B (UVB) irradiation of the skin accelerates the release of inflammatory mediators 
in various types of cells, such as keratinocytes, and finally results in inflammation. Since 
calcium ions are known to play an important role in regulating signal transduction as well as 
the differentiation of keratinocytes, we examined the involvement of calcium ions with the 
inflammatory reaction in cultured human keratinocytes. UVB irradiation of keratinocytes 
immediately increased the intracellular calcium concentration and that increase was 
maintained at least 10 min later. Interleukin-1alpha (IL-1alpha) and prostaglandin E2 (PGE2) 
are critical response substances against UVB irradiation. Particularly, IL-1alpha is stored as 
a pro-form in cells. We speculated that calpain, one of the proteases activated with calcium 
ions, plays an important role in the maturation of pro-IL-1alpha to IL-1alpha. Thus we next 
examined the influence of an exogenous calcium ionophore upon IL-1alpha release. As 
expected, treatment of keratinocytes with the calcium ionophore A23187 immediately 
increased IL-1alpha release into the culture medium. On the other hand, since UVB 
easily generates reactive oxygen species (ROS) in the skin, it was thought that ROS might 
contribute to IL-1alpha release and we examined the influence of an antioxidant on that 
process. The UVB-induced IL-1alpha release did not change strongly after pre-treatment with 
vitamin E as a typical antioxidant. However, PGE2 was significantly suppressed by treatment 
with vitamin E. In addition, vitamin E also failed to suppress the intracellular calcium 
concentration. These results suggest that IL-1alpha release is more remarkably regulated by 
intracellular calcium ions compared with ROS signals. The study also shows that IL-1alpha 
itself stimulates the production of PGE2 in keratinocytes. Thus, we propose the existence 
of a calcium triggering cascade that regulates the UVB-induced inflammatory process. 
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Keratin K77 (K1b) - A useful marker in eccrine tumor diagnosis
L Langbein1, B Cribier2, P Schirmacher3, S Praetzel-Wunder1, B Peltre2, J Schweizer1
1German Cancer Research Center, DKFZ, Heidelberg, Germany 2University of 
Strasbourg, France 3University of Heidelberg, Germany
Currently we have described K77 (K1b) as a specific keratin of the luminal cells of 
the eccrine sweat gland duct including the total keratin patterns of such structures. 
This keratin is absent from any other epithelium including apocrine gland formations. 
Therefore, this keratin might be a “marker” for such types of cells. These results 
were the basis for a “diagnostic strategy” of adnexal tumors by investigating their 
staining pattern of at least K77, K1, K10, K14, K8, smooth muscle actin and Ki-
67. Consequently, we started a series of investigations of neoplasia assumed to 
be originated from sweat glands, including syringoma, chondroid syringoma and 
cylindroma which were positive for K77 in their ductal structures. Otherwise, 
eccrine poroma, hidradenoma and porocarcinoma were negative. In a first study 
we showed, that syringoma are benign tumors (low proliferation) showing a keratin 
pattern for keratins K77, K1, K10, K5 and K14 widely comparable to that of the 
normal eccrine duct with K77 staining in the luminal ductal structures. Together with 
the failure of staining of sm-actin and K8 in the tumor areas the data indicate that 
these tumors originate from the lower/middle part of the eccrine sweat gland duct. 
Otherwise, eccrine poroma showed a keratin pattern indicative for their origin in the 
lower suprabasal layers of the epidermal acrosyringium. Future studies will include 
skin adnexal tumors and salivary gland tumors with great similarity in morphology. 
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The Effect of Ultraviolet Irradiation on Sirtuin Expression in Human Skin
C Lasserre1, A D’Arcangelis1, M Mildner2, P Bhatt1, E Tschachler2 1Chanel, Inc, 
Piscataway, USA 2Medical University of Vienna, Vienna, Austria
Both physiological and environmental factors lead to skin aging. An inescapable 
assault on the skin is UV-B irradiation resulting from repeated sun exposure. 
The physiological consequences of photoaging only accentuate the effects of 
chronological aging of the skin. The Silent Information Regulator 2 (Sir2) enzyme was 
initially linked to longevity and aging. More recently the mammalian homologues, 
the sirtuin or SIRT family of NAD+-dependent deacetylases, have been shown 
to impact critical cellular processes such as aging, metabolism, cell cycle and 
apoptosis. The role of these enzymes in skin is just beginning to be elucidated. In 
cultured keratinocytes and fibroblasts, SIRT1 expression regulates cellular lifespan. 
We were therefore interested to see if a link exists between SIRT expression and 
chronological age in human skin. We examined sections of skin biopsies from 
several donors aged 30-70 for SIRT1, 3, 5 and 7 expression. We did not observe 
a clear link between chronological age and expression of SIRTs in these samples. 
However, when we compared skin samples irradiated with UV-B to non-irradiated 
samples, we did observe changes in SIRT expression. Preliminary results show 
a decrease in SIRT1, 3 and 7 expression following UV irradiation. We have also 
carried out analogous expression analyses on cultured skin cells from neonatal and 
adult donors. Our initial results suggest that SIRTs expression in these cells is also 
modulated by UV irradiation. Implications of the response of SIRT genes to UV 
exposure in skin and cell culture requires further research, but suggests that this gene 
family may contain suitable targets for the treatment and/or prevention of photoaging. 
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How is Keratinocyte Proliferation Induced by Interleukin 20?
CR Kjedsen1, K Stenderup1, JT Clausen2, E Hasselager2, TN Dam3 1Aarhus University 
Hospital, Aarhus, Denmark 2Novo Nordisk, Bagsvaerd, Denmark 3Roskilde Hospital, 
Roskilde, Denmark
Since the finding that transgenic mice over-expressing IL-20 presented an altered skin 
phenotype resembling psoriasis, has interleukin 20 (IL-20) been implicated in skin 
homeostasis. A role in epidermis maintenance and keratinocyte proliferation has been 
suggested, however, the link between IL-20 and keratinocyte proliferation in normal or 
psoriatic skin is still not apparent. The aim of our present study was to investigate the effect 
of IL-20 on the proliferation of human and mouse keratinocytes.  In vitro we stimulated 
normal human epithelial keratinocytes (NHEK), HaCaT and A431 cell lines with IL-20 for 
18 and 48hrs, and proliferation was then measured. In vivo we employed the xenograft 
transplantation model were non-lesional psoriatic skin was transplanted to SCID mice and 
exposed to IL-20, subcutaneously administered through inserted osmotic pumps. Epidermis 
thickness in the transplanted skin as well as the mouse skin surrounding the pump outlet 
was measured. In vitro IL-20 did not affect proliferation of NHEK or the established cell 
cultures HaCaT and A431. Yet, in vivo we observed an increased epidermal thickness in 
both transplanted human non-lesional psoriatic skin and mouse skin when mice were 
exposed to IL-20 continuously for 28 days. Since NHEK, HaCaT and A431 were shown to 
express all three IL-20 receptors (IL-20R1, IL20R2, and IL22R), the lack of IL-20-induced 
changes in proliferation could be expected to reside in the simplified environment of a cell 
culture. Whether a three-dimensional structure is needed in vitro for IL-20 to explicate its 
proliferative action, or the presence of other cell types, such as leukocytes or dendritic cells, 
is not known. Upon our observations, we suggest that IL-20 explicates an indirect effect on 
keratinocyte proliferation supposedly by interacting with other cell types.
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Topical treatment with an oxygen-containing cream increases epidermal 
regeneration in vivo
L Kolbe, N Peters, H Wenck, C Mummert, T Blatt, F Staeb Beiersdorf AG, Hamburg, 
Germany
In previous studies we measured oxygen induced increase in cell vitality and 
proliferation of human skin cells in vitro. This in vivo study was designed to evaluate 
the efficacy of topical treatment with an oxygen containing skin care product on skin 
regeneration in comparison to a product containing nitrogen. The subjects applied 
the oxygen-containing cream twice daily for 2 weeks to one arm, the other arm 
served as a control. In one study a vehicle containing 15% nitrogen was used as 
treatment for the control arm, in a second study the vehicle contained no additional 
gas. After the treatment phase suction blisters were raised on the volar forearms to 
collect epidermal skin cells for further analysis. The keratinocytes of the suction 
blister roofs were separated and labeled with the proliferation marker antibody Ki-67. 
The fluorescence of the FITC-conjugated antibody was measured by FACS analysis. 
Our data show a significant rise in cell regeneration of the oxygen-treated skin area 
in comparison to the nitrogen treated skin. These findings were confirmed by an 
additional study where corneocyte size was used as a measure of epidermal turnover 
Thus oxygen increases the epidermal regeneration in vivo.
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Oxygen from topical treatment rapidly penetrates into the skin and reaches all 
living layers
L Kolbe, N Peters, U Wensorra, T Blatt, H Wenck, F Staeb Beiersdorf AG, Hamburg, 
Germany
Since the middle of the 19th century, it is known that humans consume atmospheric 
oxygen via the skin with a rate of approximately one percent of the total oxygen our 
body needs. There is an ongoing controversy in the scientific literature questioning 
the penetration of oxygen into the skin after topical application. We therefore studied 
the penetration of oxygen from an oxygen-containing cream into the skin. By using 
a ‘needle-type micro sensor’, which was placed inside a suction blister we were 
able to measure the penetration of oxygen through the epidermis. The epidermal 
concentration of oxygen increased two times after topical application of the oxygen-
containing cream on the suction blister roofs. Within seconds there was a sharp 
rise in tissue oxygen content which lasted between 5 and 20 minutes. No changes 
were detected after applying a nitrogen-containing cream or the vehicle with no 
additional gas content. In conclusion, we were able to show that topical application 
of an oxygen-containing cream delivered a rapid short-term rise in cutaneous oxygen 
content.
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Analysis of Skin Collagen Using Synchrotron X Ray Radiation
O Lopez1, M Cocera2, A De la Maza1, M Costa3, C Texeira3, L Barbosa-Barros1, JL 
Parra1, M Fernandez4, M Sabes3 1IIQAB-CSIC, Barcelona, Spain 2Unitat de Biofisica, 
UAB, Barcelona, Spain 3CEB-UAB, Barcelona, Spain 4INSERM, Grenoble, France
Collagen accounts for about 75% of the skin total dry weight and it is located predominantly 
in dermis. Changes in orientation and arrangement of this macromolecule during aging and 
diseases processes are partly responsible for alteration in skin morphology and mechanical 
properties. Thus, analysis of collagen characteristics can provide insight concerning skin 
functions and conditions. Small angle X-ray scattering (SAXS) using Synchrotron source is an 
excellent tool for retrieving the structural organization of tissues rich in collagen. However, 
the use of this powerful technique for skin collagen evaluation has still to be explored. In 
the present work, skin samples from subjects of different ages were evaluated using SAXS 
with Synchrotron radiation. Additionally, samples containing areas with melanoma and with 
stretch marks were studied and compared with healthy skin. Healthy skin samples presented 
the characteristic collagen pattern showing series of narrow rings associated to the repeat 
distance of 67 nm. SAXS patterns of samples from younger subjects presented higher number 
of diffraction orders and marked anisotropy probably due to a higher degree of orientation 
of collagen. Comparison of the scattering pattern from normal and stretched skin indicated 
different organization in the collagen. In tissue invaded by melanoma, this macromolecule 
showed very intense scattering bands, instead of the narrow rings detected in the other skin 
samples. This fact indicates degradation of collagen fibrils of the invaded tissue. This work 
introduces SAXS using Synchrotron radiation to study skin collagen and to characterize 
different skin layers. The evaluation of collagen arrangement reports information about aging, 
disfunctions and pathology of the tissue and the systematic study of different samples allows 
obtaining scattering signatures characteristic of each skin layer. All in all, the potential of this 
methodology as a diagnostic tool for skin purposes should be considered.
344
The Role of CASK in Skin Development and Keratinocyte Proliferation
N Ojeh, A Maatta, V Pekovic Durham University, Durham, UK
CASK is a multi-domain scaffolding protein that is required for the molecular organization 
of proteins at cell junctions. This PDZ adaptor protein binds to the cytoplasmic tail of 
syndecans. Previously, CASK has been shown to play a role in embryonic development, 
and could potentially act as a regulator of cell proliferation. Furthermore, it has also been 
implicated in transcriptional regulation in hippocampal neurons where it has been shown 
to translocate into the nucleus. No studies of CASK have been reported on skin to-date. We 
found that CASK is expressed in the basal layer of the epidermis by immunofluorescence 
staining. CASK was localised to cell nuclei in newborn mouse epidermis whereas in adult 
epidermis, cytoplasmic expression was observed. Abundant nuclear expression of this 
protein was found at all stages of development in rat hair follicles. In cultured keratinocytes, 
a change in the sub-cellular distribution of CASK was seen from nuclear to cytoplasmic 
upon keratinocyte differentiation. Sub-nuclear localisation was further investigated by 
biochemical fractionation. To investigate the function of CASK in keratinocytes, CASK siRNA 
knock-down was carried out in HaCaT cells using organotypic cultures. Knock-down of 
CASK leads to increased cell proliferation as measured by MTT proliferation assay, cell cycle 
analysis of DNA content, expression of cell proliferation markers and epidermal thickness 
of the skin equivalents. Furthermore, CASK knock-down enhances the proliferative effect of 
growth factors such as TGF-α and FGF-7.We also investigated the expression of CASK during 
skin wound healing and showed that nuclear localisation of CASK was decreased at the 
migrating wound edge. Furthermore, cell adhesion assays performed on CASK knock-down 
cells reveal that they adhere quicker to collagen-coated substrates than control transfected 
cells. We conclude that expression and nuclear localisation of CASK plays an important role 
in skin development, proliferation and in wound healing. 
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Characterization of Sequences Important for Plectin-Desmin Interaction. Towards 
Understanding of the Molecular Basis of Inherited Skin Disorders Associated with 
Myopathies
M-F Steiner-Champliaud1, Y Gonthier1, Y Schneider1, K Lapouge1, F Jaunin1, A Chirita1, 
Z Li2, Z Xue2, K Green3, L Borradori1, L Fontao1 1University Hospital of Geneva, 
Switzerland 2Université Paris-7, France 3Northwestern University, Chicago, USA
Plectin (PL), a versatile cytolinker of the plakin family, connects the intermediate filament (IF) 
system to other cytoskeletal networks and at distinct membrane sites, such as desmosomes, 
hemidesmosomes and beta-dystroglycan complexes. Inherited PL gene defects result in 
epidermolysis bullosa (EB) in association with muscular dystrophy (MD). PL association with 
epidermal keratins and vimentin has been previously characterized. However, its potential to 
interact with desmin has been poorly investigated. We have here performed a comparative study 
to assess sequences within the PL tail important for its binding to desmin and vimentin by yeast 
two-hybrid, cell transfection and biochemical assays. Our results indicate that: 1) PL interacts with 
desmin and vimentin via a region encompassing the B5 subdomain and the linker between the 
B5 and C subdomains; 2) a region encompassing the C subdomain and COOH extremity binds 
to vimentin but not to desmin; 3) the interaction of PL with non-filamentous desmin requires 
sequences contained within the desmin NH2-terminal rod portion; 4) truncation of a 35-amino 
acid stretch from the PL COOH extremity does not significantly impaired plectin-desmin interaction 
in yeast assays. Nevertheless, a similar mutation in the PL gene leading to the expression of a 
protein lacking the COOH extremity is accompanied with the disorganization of the desmin 
network in a patient EB-MD; 5) the potential of PL to interact with desmin and vimentin in yeast 
appears to be differently affected by phosphorylation of a serine residue within its COOH extremity. 
Together, these results demonstrate that PL directly interacts with desmin and that the linker region 
and COOH extremity of plectin contain recognition sites critical for binding. These observations 
provide novel insights into the cytoskeletal organization of striated muscle cells and increase our 
understanding of plakin-related human diseases associated with both skin and muscular defects. 
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The B2-adrenoceptor is a negative regulator of wound healing in vivo
E Pullar1, R Isseroff2 1University of Leicester, UK 2University of California Davis, USA
We have established a role for the B2 adrenoceptor (B2-AR) in regulating human skin 
wound re-epithelialisation and contraction using in vitro and ex-vivo models. Here we 
use a mouse wound model to determine if the B2-AR regulates wound healing in vivo. 
Murine keratinocytes and dermal fibroblasts were isolated from 1-2 day old neonates. 
Two 6mm full-thickness wounds were created along the dorsal mid-line of 8-12 week old 
mice. Wounds were treated daily, topically, with gel alone or gel containing 0.1% B2-AR 
agonist or antagonist (n = 5) and excised after 3/5 days, fixed, embedded and sectioned 
for both hematoxylin/eosin and smooth muscle-a-actin (SmaA) immunostaining. B2-
AR agonists decrease while antagonists increase ERK phosphorylation, migration and 
galvanotaxis of murine keratinocytes, respectively. In contrast, both B2-AR agonists and 
antagonists increase ERK phosphorylation and motility in murine dermal fibroblasts. Finally, 
we detected catecholamine synthesis enzymes and measured epinephrine in keratinocyte 
extracts. Untreated wounds are 50% re-epithelialized after 5 days. B2-AR agonist-treatment 
decreases (30%), while B2-AR antagonist-treatment increases wound re-epithelialization 
(57%), respectively. While untreated wounds are 86% of their original size by day 2, the 
size of B2-AR agonist-treated wounds is virtually unchanged. In contrast, B2-AR antagonist-
treated wounds are only 70% of their original size. Wound contraction correlates with 
the appearance of SmaA expressing myofibroblasts in the granulation tissue. While SMaA 
staining is reduced (62%) in B-AR agonist-treated wounds, it is markedly increased in B2-AR 
antagonist-treated wounds (2.2 fold).In summary, we have demonstrated that while B2-AR 
agonist treatment delays wound healing, antagonist treatment significantly augments wound 
healing in vivo, by modulating both re-epithelialization and wound contraction. Our work 
demonstrates that the B2-AR is a negative regulator of wound healing in vivo and B2-AR 
antagonists could be a potential therapy for promoting healing in chronic wounds. 
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The sodium channel ENaC is required for the post-natal maturation of the epidermal 
permeability barrier function
R Charles1, M Guitard1, C Leyvraz1, B Breiden2, JC Stehle1, K Sandhoff3, E Hummler1 
1University of Lausanne, Switzerland 2University of Bonn, Germany
ENaC is a non voltage-gated sodium channel studied in organs like kidney and 
lung due to its importance in regulating sodium homeostasis and fluid volume. It is 
composed of three sub-units α, β and γ which are forming a sodium selective channel 
through the cell membrane. Its presence in the skin has been demonstrated, but little 
is known about its physiological role. Previous work has shown that αENaC knockout 
mice displayed an abnormal epidermis, suggesting a role in differentiation processes 
that might be implicated in the epidermal permeability barrier (Mauro et al 2002). 
Our recent data on ENaC-deficienct mice show that the physiological consequences 
are not obvious right after birth. Nevertheless, few hours later (24h), mice deficient 
for the alpha subunit of the highly amiloride epithelial sodium channel (αENaC/
Scnn1a) suffer from a significantly increased dehydration. This is characterized by 
a loss of body weight and an increased transepidermal water loss (TEWL) which is 
accompanied by a higher skin surface pH in one day old pups. While early and late 
differentiation markers, as well as tight junction protein distribution and function 
seem not affected, deficiency of αENaC severely disturbs the stratum corneum (SC) 
lipid composition. In conclusion, ENaC-deficiency results in incomplete post-natal 
skin surface acidification and progressive dehydration due to severe impairment 
of lipid maturation. Our data demonstrate that ENaC is involved in the postnatal 
maturation of the epidermal barrier, which is required for the transition from wet to 
dry environment that is birth.
 
 
348
The role of Arnt gene in the control of epidermal desquamation
A Panteleyev, S Kalachikov, A Mezentsev, S Geng Columbia University, NY, USA
Epidermal desquamation is not just a mechanical shedding of superficial corneocytes 
but a specific physiological process tightly regulated at the molecular and biochemical 
levels. Abnormal desquamation is a complication characteristic of certain skin disorders 
including psoriasis and ichthyosis. One of the major regulators of desquamation is a 
stratum corneum chymotryptic protease (SCCE) which is involved in timely-regulated 
degradation of corneosomes - specific intercellular junctions that provide mechanical 
connection between corneocytes in the corny layer. Targeted ablation of Arnt (aryl 
hydrocarbon receptor nuclear translocator) in mouse epidermis using K14-driven Cre 
recombination resulted in early postnatal death associated with impairment of the 
epidermal barrier and abrogation of desquamation. The latter was associated with 
failure of corneosome degradation and increased intercorneocyte cohesion. Our 
expressional studies in Arnt-null keratinocytes in vivo and in vitro showed dramatic 
upregulation of secretory leukocyte protease inhibitor (Slpi) - a key negative regulator 
of SCCE. Slpi is a direct target of activity of oncogen Bcl3 which was also significantly 
upregulated in Arnt-null epidermis. The results of ChIP assay and in vitro experiments 
with TSA (HDAC suppressor) imply chromatin remodeling as a potential mechanism 
of Arnt-dependent suppression of Slpi and Bcl3 in wild type keratinocytes. These 
data suggest that, via recruitment of HDAC co-repressors, Arnt negatively regulates 
expression of epidermal Bcl3 and Slpi, thus controlling activity of serine proteases 
(SCCE) and the process of corneosome degradation in mouse epidermis. Therefore, 
our studies reveal a hitherto unknown role of Arnt in the maintenance of epidermal 
homeostasis, and elucidate a novel mechanism of desquamation control. Since Slpi 
also plays a pivotal role in skin inflammation, wound healing, pathogen defense, 
and carcinogenesis, our findings may provide an insight into the role of Arnt/Slpi 
interactions in these critical aspects of epidermal homeostasis as well.
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Binding of A2ML1 to the multifunctional cell surface receptor LRP1
M-F Galliano, G Serre, M Guerrin CNRS-UPS UMR 5165, Toulouse, France
We have recently characterized A2ML1 (alpha-2 macroglobulin-like 1), a novel protease 
inhibitor of the alpha-2 macroglobulin family expressed in the epidermis. Alpha-2 
macroglobulin (A2M) is a broad-spectrum protease inhibitor and a growth factor/cytokine-
carrier which regulates multiple aspects of cell physiology. Because the clearance of A2M-
bound cytokines and proteases is mediated by the low-density lipoprotein receptor-related 
protein (LRP1), we asked whether LRP1 is a possible receptor for A2ML1. Immunoblotting 
experiments revealed that LRP1 was expressed in epidermis and by primary human 
keratinocytes in culture. Immunofluorescence labelling of LRP1 in cultured keratinocytes 
showed an intracellular labelling in proliferative cells whereas a pronounced membrane 
surface labelling was evidenced in differentiated ones. In epidermis, LRP1 labelling was 
found pericellularly within the granular layer. Binding experiments were performed using 
the RAW 264.7 macrophage-derived cell line which expresses high levels of LRP1 at the 
cell surface. A recombinant fragment of the C-terminus of A2ML1, corresponding to the 
putative receptor binding domain (RBD), as deduced from that of A2M, was used for in vitro 
experiments. The recombinant RBD protein specifically co-precipitated with LRP1 upon 
binding to the cell surface at 4°C. The recombinant RBD protein, when incubated at 37°C, 
was internalized by endocytosis. Confocal analyses showed that a biotinylated, recombinant 
RBD protein co-localized with LRP1 upon internalisation. Addition of RAP, a protein 
chaperone which inhibits the binding of A2M to LRP1, had no effect on the internalization 
of the recombinant RBD protein, suggesting regulatory mechanisms for A2ML1 for binding 
to LRP1 distinct from A2M. In conclusion, our work shows binding of a C-terminal fragment 
of A2ML1 to LRP1 and suggests a role for A2ML1-coupled LRP1 complexes in proteases or 
cytokines homeostasis within the epidermis.
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Development of Human Psoriatic Skin Equivalents
G Tjabringa, M Bergers, D Van Rens, EN Lamme, J Schalkwijk UMCN, Nijmegen, 
Netherlands
Psoriasis is an inflammatory skin disease that putatively results from an interplay between 
epidermal cells and the immune system. Anti-psoriatic drugs can therefore target either the 
keratinocytes or the immune system. The aim of the present study was to develop a human 
reconstructed skin model displaying histological and molecular characteristics of psoriatic 
skin to use for in vitro screening of drugs that act on the epidermis. Normal human skin 
equivalents were generated from adult human keratinocytes seeded on de-epidermised 
dermis, cultured submerged for 3 days followed by air-exposed culture for 10 days. For the 
generation of psoriatic skin equivalents, we tested various combinations of pro-inflammatory 
cytokines known to be present in lesional skin, such as TNFα, IL-1α and IL-6. The equivalents 
were analysed by histology (H&E), immunohistochemistry and qPCR for the psoriatic 
surrogate markers hBD-2 and SKALP/elafin. The model was evaluated by addition of anti-
psoriatic drugs. The normal skin equivalent displayed a well differentiated epithelium as 
demonstrated by expression of the differentiation marker cytokeratin-10, and absence of 
expression of the psoriasis-associated proteins hBD-2 and SKALP/elafin. Stimulation of the 
skin construct with mixtures of pro-inflammatory cytokines induced a protein- and gene-
expression profile characteristic of psoriasis. Furthermore, addition of retinoic acid inhibited 
the cytokine-induced gene expression, suggesting a therapeutic effect of retinoic acid, and 
illustrating the potential use of the model for drug screening. Retinoic acid also inhibited the 
expression of normal differentiation markers such as cytokeratin-10, indicating a well known 
side-effect of retinoic acid. In conclusion, we demonstrate that stimulation of a normal human 
skin equivalent model with a mixture of pro-inflammatory cytokines results in induction of a 
psoriatic phenotype. These results are a first step towards an in vitro disease model that would 
enable screening of anti-psoriatic drugs, both for therapeutic actions and side-effects. 
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Altered Epidermal Homeostasis in Transgenic Mice Overexpressing 14-3-3 Sigma in 
Basal Keratinocytes
F Cianfarani1, S Bernardini1, N De Luca1, M Pascucci1, E Dellambra2, C Tiveron3, G 
Zambruno1, T Odorisio1, D Castiglia1 1IDI, Rome, Italy 2IDI, Pomezia, Italy 3Istituto 
Regina Elena IRCCS, Rome, Italy
14-3-3 sigma (here referred as sigma) is the epithelial-specific isoform of the 14-3-3 protein 
family, whose members are involved in the control of diverse biochemical processes. In the 
skin, sigma is highly expressed in suprabasal differentiated keratinocytes and in vitro evidence 
indicates that its downregulation leads to keratinocyte immortalization. To define the role 
of sigma in skin homeostasis, transgenic mice overexpressing this gene under the control 
of the keratin 14 promoter (K14-sigma mice) have been generated. Depending on sigma 
expression levels, transgenic mice manifest localized desquamating skin lesions and erosions 
associated with sparse hair loss and atrophic skin appearance, or only the early onset of 
wrinkles. Microscopically, the epidermis of transgenic mice shows hyperkeratosis and reduced 
thickness. BrdU analysis in vivo indicates that the number of proliferating keratinocytes is 
significantly reduced in the epidermal basal layer of transgenic mice compared to wild-type 
littermates. In accordance with this finding, cultured keratinocytes from newborn transgenic 
mice show reduced proliferation associated with increased features of a differentiated 
phenotype. Immunohistochemical studies show no gross abnormalities in the expression 
pattern of epithelial markers. However, western blot analysis of cell extracts from freshly 
isolated newborn mouse keratinocytes reveals reduced expression of basal cell markers (K14, 
K15) and increased levels of differentiated cell ones (involucrin, loricrin) in transgenic mice 
compared to controls. Wound healing is delayed, with a significant increase in the wound 
area at early time points of analysis in K14-sigma mice. Hair growth after shaving or epilation 
is strongly retarded in transgenic mice with respect to wild-type littermates. All together, these 
results indicate that 14-3-3 sigma overexpression in basal keratinocytes alters epidermal 
homeostasis. This effect is associated with impaired basal cell proliferation
352
Dysregulation of channel activating protease 1 in the epidermis of the mouse
S Frateschi1, M Membrez2, R Charles3, B Breiden4, K Sandhoff5, F Beermann6, A Porret1, 
JC Stehle1, S Rotman1, E Hummler1 1UNIL, Lausanne, Switzerland 2Nestlé Research 
Center, Lausanne, Switzerland 3University of Lausanne, Switzerland 4University of 
Bonn, Germany 5Kekulé Institut für Organische Chemie, Bonn, Germany 6ISREC, 
Lausanne, Switzerland
The aim of this study is to investigate the importance of the regulated channel activating 
protease 1 (CAP 1 / Prrs8 / prostasin) expression in the epidermis by addressing the 
CAP 1 transgenic expression to the stratum basale (SB). Transgenic mice harboring 
the coding sequence of CAP 1 under the control of the keratin 14 promoter have 
been generated by micro-injection into fertilized mouse oocytes. The genotypes and 
phenotypes of the transgenic mice were assessed using standard molecular, cellular, 
histological means. The epidermal permeability barrier integrity was evaluated by 
measuring the trans epidermal water loss (TEWL). Two independent transgenic 
lines (K14::CAP1) have been generated that show a skin phenotype characterized 
by red, scaly and un-elastic skin with less hair. These transgenic animals exhibit 
also lower body weight, higher TEWL, thicker and hyperkeratotic epidermis and 
increased postnatal mortality. Mice with an altered CAP 1 expression in the skin 
present impaired epidermal barrier function and symptoms of cornification disorders 
like ichthyosis. This study shows that regulated CAP 1 expression in the epidermis is 
important for the skin physiology. The K14::CAP1 transgenic mice can be used as a 
model for skin diseases that present defects of the epidermal barrier function.
 
 
353
Epidermal Skin Test 1000 (EST-1000) covers the main targets of in vitro hazard 
identification in the skin
J Hoffmann, S Hopf, R Grochtmann, HW Fuchs CellSystems Biotechnologie Vertrieb 
GmbH, St Katharinen, Germany
Reconstructed human skin has proven to be suitable for hazard identification in 
multiple surveys and even official validation studies. Like other reconstructs, EST-
1000 meets all morphological and functional requirements of OECD TG 431 to 
reliably classify skin corrosive potency of compounds. Interlaboratory reproducibility 
was shown by an extensive multicentre trial and the statistical analysis of results is 
to be reviewed by ESAC. The development of a prediction model establishing EST-
1000 for the more subtle task of skin irritation has led to evidentiary predictability 
according to the EU classification system. The prediction model is based on a simply 
executable protocol with two parameter analysis. As a current challenge the process 
of developing an in vitro prediction model for the hazardous effects and the reliable 
classification of compounds revealing (photo-)genotoxic potency is shown with first 
promising data. The prediction model is intended to combine high reproducibility 
of EST-1000 with simple performance and robust end-points. Both the aspired 
correctness of results and the effectiveness of in vitro testing itself will make the 
model a competitive alternative to animal testing in routine analysis. 
 
 
354
Identification of new regulators of the peptidylarginine deiminase gene expression 
in human keratinocytes
V Adoue1, S Chavanas1, H Duplan2, S Ying3, M Charvéron2, A-M Schmitt2, H Takahara3, 
G Serre1, M Simon1 1CNRS-University of Toulouse III UMR5165, France 2Institut de 
Recherche Pierre Fabre, Toulouse, France 3Ibaraki University, Ibaraki, Japan
Peptidylarginine deiminases (PADs) convert protein-bound arginine residues into 
citrulline in a Ca2+-dependent manner. The five human isoforms (PAD1- 4, 6) are 
encoded by the genes PADI1-4 and 6 which are clustered on chromosome 1p35-
36. Three of them are expressed in the epidermis: PAD1 is detected throughout the 
epidermis, PAD2 in the stratum spinosum and granulosum, PAD3 is detected in the 
granular and lower cornified layers. PAD1 and 3 are involved in the deimination of 
filaggrin and keratin K1 and K10. We have previously characterized the PADI1-3 
minimal promoter regions. In the search for other PADI transcription regulators, 
we identified conserved noncoding segments (CNS), distant from the PADI gene 
promoters and potentially binding transcription factors. We subcloned these 
sequences upstream from the PADI3 promoter in luciferase reporter plasmids, and 
performed reporter gene assays in primary human keratinocytes. We found three 
CNS which increase the promoter activity upon calcium-induced differentiation 
in vitro. Complementary experiments suggest that these enhancers present 
different cell and promoter specificities. Moreover, DNase I hypersensitivity assays 
confirmed the potential regulatory function of these sequences. These results identify 
new potential PADI gene transcriptional regulators. This work helps for a better 
understanding of deimination and its regulation during epidermal differentiation. 
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Molecular Insights into Stratum Corneum Lipid Organization and the Development 
of Functional Lipid Technologies for Skin Barrier Health
J Moore1, C Flach2, G Zhang2, R Mendelsohn2, M Gorcea1, X Bi1, B Gomez1 1ISP, 
Wayne, USA 2Rutgers University, Newark, USA
It is well recognized that epidermal barrier function substantially resides in the 
lamellar lipid phases that constitute the extracellular matrix of the stratum corneum. 
In many areas of research dermatology the molecular nature of lipid organization 
within these lamellae remains a topic of considerable interest, and relevance, 
to understanding normal skin barrier function. Lipid conformational order and 
intermolecular interactions govern the barrier properties of lipid lamellae from 
alkanes to phospholipids. Historically, there have been few reported studies of 
these parameters in stratum corneum lipids and consequently we have made the 
development of such measurements in stratum corneum lipids a key focus of our 
skin research program. The current study describes our measurements of lipid order 
in skin lipids, including pure ceramides and intact stratum corneum, and correlates 
these measurements to physiological skin barrier function. By building upon our 
understanding of the molecular biophysical characteristics necessary for stratum 
corneum function it is possible to develop mimetic lipid technologies mixtures can 
which organize into lamellar structures analogous to the skin barrier. In this presentation 
biophysical data will be presented describing lipid organization in endogenous 
skin lipids and in mimetic lamellar lipid systems across a range of physiologically 
relevant skin temperatures. The correlation between these measurements and skin 
barrier function will be illustrated, including in vivo data illustrating the efficacy 
of lipid mimetic technologies in restoring and preserving skin barrier health. 
 
356
Confocal Raman studies of the skin permeation of an anti-inflammatory tocopheryl 
phosphate lipophilic complex
J Moore, X Bi ISP, Wayne, USA
Tocopheryl phosphate (TP) is a naturally occurring form of tocopherol that exhibits 
anti-inflammatory properties and anti-oxidant properties, but no free radical 
scavenging capability. In vitro studies from this laboratory have demonstrated that the 
biological mechanisms of tocopheryl phosphate include inhibition of prostaglandin 
E2 (PGE2) release from keratinocytes. In addition, several clinical studies of stressed 
skin have demonstrated that tocopheryl phosphate, when topically applied as a 
lipophilic complex, can significantly mediate skin inflammation. The current study 
utilized confocal Raman spectroscopy to measure the skin permeation of a lipophilic 
complex of tocopheryl phosphate into full thickness skin. The penetration of tocopheryl 
phosphate was observed into the deep stratum corneum (15 microns) within hours of a 
single application. In addition, no chemical breakdown of tocopheryl phosphate into 
tocopherol was observed in the skin which is consistent with tocopheryl phosphate 
being chemically stable and biologically active in the phosphorylated molecule. The 
current study demonstrates that confocal Raman microscopy can non-destructively 
measure the skin permeation of a lipophilic tocopheryl phosphate molecule and 
simultaneously monitor the physico-chemical properties of such molecules in the skin 
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Tight junction proteins in photoaged skin
REB Watson, M Armer, A O’Neill, CEM Griffiths The University of Manchester, 
Manchester, UK
Claudins are key tight junction (TJ) proteins critical to the development of functional epithelial 
barriers. Oxidative stress appears to modulate the expression of these proteins in a number 
of organ systems, including the gastrointestinal tract. Skin is subject to oxidative stress via 
chronic exposure to solar ultraviolet (UV) irradiation. In the current study, we have examined 
the expression of TJ proteins in photoprotected and photoaged human skin. Subjects with 
clinically moderate to severe photoageing of the extensor forearm were recruited (age range 
65-72 years; n = 8; 4 male). Four mm punch biopsies were taken under local anaesthesia 
from 3 distinct anatomical sites: photoaged extensor forearm, photoprotected hip and 
upper inner arm (anatomical site control). Biopsies were embedded in optimal cutting 
temperature compound (OCT) and 7um frozen sections prepared for immunohistochemistry 
of TJ proteins claudins-1, -3 and -12 using standard immunoperoxidase techniques. Sections 
were randomised and blinded, prior to quantification of staining using a 5-point ordinal 
scale (0 = absence of staining, 4 = maximal staining; 3 high power [x400] fields/section; 3 
sections/site). Sections were randomised and blinded and the quantity and distribution of 
staining assessed. Differences were analysed by repeated measures ANOVA. Claudin-1 was 
strongly expressed throughout the epidermis in photoprotected hip and upper arm skin in 
a distinctive ‘chicken wire’ pattern; photoaged forearm samples expressed significantly less 
claudin-1 [mean ± SE: hip: 2.71±0.22; upper inner arm: 2.64±0.26; forearm: 2.15±0.25; 
p < 0.05]. This was also observed for claudin-12 [mean ± SE: hip: 3.17±0.20; upper inner 
arm: 2.56±0.29; forearm: 1.94±0.23; p < 0.05]. There was no difference in claudin-3 
staining between photoprotected and photoaged sites. These findings demonstrate that 
key TJ proteins are compromised in photoaged skin. Such altered expression within the 
epidermis may contribute to impaired barrier function and enhance susceptibility to other 
enviromental insults.
358
Human Skin and Keratinocytes Express Cholesterol Transporters and Primary 
Keratinocytes are Capable of Metabolising Progesterone into Cortisol
RF Hannen1, AE Michael2, JM Burrin3, M Philpott1 1Queen Mary University of London, 
UK 2St George’s University of London, UK 3Barts & the London University, UK
The skin is capable of synthesising the steroid precursor cholesterol de novo from acetate 
and is also able to metabolise androgens and oestrogens. However, although the P450scc 
system has been identified in skin, the ability of skin to synthesise steroids from cholesterol 
and metabolise progesterone into cortisol has yet to be established. In order for steroid 
synthesis to occur, cholesterol must be transported across the mitochondrial membrane 
by specific cholesterol-transporting proteins, StAR in testes, adrenals and ovaries and 
probably MLN64 in placenta. The aim of this study was to assess the expression of 
MLN64 and StAR protein in different skin cells and whole skin sections and to determine 
whether primary human keratinocytes were able to synthesise and metabolise steroids. 
MLN64 protein expression was found in all cells tested except primary dermal fibroblasts 
and immunofluorescent histochemistry showed that MLN64 expression increased with 
keratinocyte differentiation in the suprabasal layers of the epidermis. StAR protein was not 
detected in a range of skin cells including keratinocytes, sebocytes and dermal fibroblasts 
by Western analysis but was demonstrated by immunofluorescent histochemistry in the 
basal layer of the epidermis and outer root sheath of the hair follicle in skin. Although we 
have not yet demonstrated pregnenolone synthesis, using thin layer chromatography, we 
show that primary human keratinocytes can metabolise pregnenolone and progesterone. 
In particular, progesterone was converted into the anti-inflammatory steroid cortisol. These 
results suggest that the skin could be a steroidogenic tissue. Future research will investigate a 
functional role for MLN64 and StAR in steroid synthesis in keratinocytes. In addition, further 
analysis of progesterone metabolism and its implications in skin diseases will be conducted. 
 
359
A C10 hydroxy-alcenoic acid regulates epidermal terminal differentiation and lipid 
homeostasis in epidermis
H Duplan, M Jacquin, A Caruana, I Ceruti, S Julié, F Belaubre, M Charvéron Institut 
de Recherche Pierre Fabre, Toulouse, France
It has been proven that impaired skin barrier function has an important role in the etiology of 
atopic dermatitis (AD) which is characterized by alterations in the cutaneous lipid metabolism 
of terminally differentiated keratinocytes. Previously, we showed that a C10 hydroxy-
alcenoic acid up-regulated profilaggrin expression in vitro and decreased proliferation and 
inflammatory infiltrate in an in vivo model of barrier function disruption. The objectives 
of this study were to further investigate the effects of this molecule on epidermal terminal 
differentiation and lipid homeostasis. We used a normal human keratinocyte differentiation 
model and a reconstructed epidermis model to study the long lasting effect of the product on 
the differentiation process of lipid barrier. We analysed the protein and lipid epidermal markers 
of terminal differentiation with Q-PCR and analytical biochemistry methods. We also assayed 
lipid enzyme activity with in situ zymography, after in vitro barrier disruption. Our results 
demonstrated that our C10 hydroxy-alcenoic acid induced the mRNA expression of lipid 
metabolism enzymes such as Sphingolipid delta4-desaturase and beta-glucocerebrosidase. 
We also showed that lipid transporters, FATP4 and ABCG1, were stimulated at the protein 
level. Moreover, during in vitro epidermis reconstitution, topical treatment with the C10 
hydroxy-alcenoic acid induced lipid synthesis to a level close to vitamin D3 (fatty acids and 
phospholipids). lastly, It improved the in situ activity of sphingomyelinase acid, an enzyme 
involved in the ceramide synthesis of the stratum corneum. Together these data demonstrated 
that the C10 hydroxy-alcenoic acid improve the epidermal terminal differentiation and 
the lipid homeostasis of the SC. In conclusion, by supporting physiological mechanisms 
to restore a healthy protective skin barrier, this molecule could be proposed as an active 
principle of choice for the treatment of dry skin associated with a barrier dysfunction in AD. 
360
Expression of the Epidermal Stem Cell markers in acute/chronic psoriasis and 
Human papilloma virus infections; similarities and differences
O Kose, M Demiriz Gulhane School of Medicine, ANKARA, Turkey
Our aim to investigate the epidermal stem cell behaviour in two different 
hyperproliferative skin conditions. The pattern of epidermal stem cells location 
and how it is influenced in hyperproliferative skin disease is not clear. We have 
investigated the expression of main four epidermal stem cell markers (Beta-1 integrin, 
alpha-6 integrin, Keratin 15 and p63). Five perilesional normal skin, ten acute and ten 
chronic psoriatic skin, five verruca vulgaris from renal transplant patients, four verruca 
genitalis, six verruca vulgaris and four perilesional normal skin from nontransplant 
patients tissue samples were immunostained with monoclonal antibodies against 
these epidermal stem cell markers. K15, p63, Beta-1 integrin were confined the 
basal layer in normal skin. Alpha-6 was localized on suprabasal and basal layer in 
epidermis. In acute psoriatic samples, these stem cell markers showed basal and 
suprabasal expression but in chronic psoriatic samples, stem cell markers were 
especially confined basal layer but more stronger than perilesional normal skin. On 
the other hand, we detected different pattern from human papilloma virus infected 
samples. In perilesional skin samples, these markers showed weak expressions but 
verruca vulgaris from transplant patients stem cell expressions were moderate and 
localized on basal and suprabasal epidermis. In genital verru, these markers showed 
strong basal and suprabasal expression but they prominent especially on dermal 
papilla. Also in verruca vulgaris samples were showed similar pattern. These markers 
expression could help explain the localizations and behaviour of the epidermal stem 
cells. Also characterizations of epidermal stem cell and determine of their role in 
keratinocyte biology in normal skin and hyperproliferative skin conditions may be 
helpful to clarify the pathogenesis of these diseases. 
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12R-Lipoxygenase is essential for the epidermal barrier function: lessons from 12R-
lipoxygenase deficient mice
S De Juanes1, N Epp1, G Fürstenberger1, K Müller1, M Leitges2, I Hausser3, F Thieme4, 
G Liebisch4, G Schmitz4, HJ Stark1, P Krieg1 1German Cancer Res Center, Heidelberg, 
2Biotech Centre Oslo, Norway 3Univ Heidelberg, Germany 4Inst of Clin Chem, 
Regensburg, Germany
12R-lipoxygenase (12R-LOX) and the epidermal LOX-3 (eLOX-3) are members of the epidermal subfamily 
of mammalian LOX and are preferentially expressed in human and mouse skin. Both enzymes are part of 
a novel eicosanoid pathway involved in terminal differentiation in skin. This view is supported by recent 
studies showing that inactivating mutations in 12R-LOX and eLOX-3 are linked to the development 
of autosomal recessive congenital ichthyosis (ARCI) a skin disease associated with hyperkeratosis and 
impaired barrier function.To analyse the impact of 12R-LOX in the establishment of the epidermal barrier 
and to investigate its physiological role we generated a 12R-LOX-deficient mouse model by using the 
Cre/LoxP system. Targeted inactivation of 12R-LOX in mice results in early neonatal death which is due to 
a severely impaired inwards and outwards permeability barrier function. Loss of barrier function occurs 
without alterations in proliferation and stratified organization of the keratinoyctes but is associated with 
ultrastructural anomalies in the upper granular layer suggesting perturbance of the assembly/extrusion of 
lamellar bodies. Cornified envelopes (CE) from skin of 12R-LOX-deficient mice show increased fragility. 
In addition, lipid analyses revealed an aberrant composition of CE bound lipids in 12R-LOX-/- mice, 
which are essential for normal barrier function. Furthermore, processing of profilaggrin to filaggrin is 
impaired indicating that both lipid metabolism as well as protein processing is affected by 12R-LOX 
deficiency. While neonatal 12R-LOX-/- mouse skin morphologically and histologically did not display 
an obvious phenotype, transplanted 12R-LOX-/- mouse skin resembled that seen in ichthyosis, with 
epidermal acanthosis, hypergranulosis and marked hyperkeratosis. The data document a crucial role of 
12R-LOX in the establishment of the epidermal barrier function. Moreover, 12R-LOX knockout mice may 
be a useful model for ARCI forms associated with an impaired LOX metabolism.
362
Analysis of the Cutaneous In Vivo and Ex Vivo Expression of the Antimicrobial 
Protein RNase 7
B Köten, J-M Schröder, R Gläser, J Harder Univ of Schleswig-Holstein, Kiel, Germany
Human skin is able to mount a fast response against invading microorganisms by the 
release of various antimicrobial proteins like beta-defensins and ribonucleases such as 
RNase 7. RNase 7 is a broad spectrum antimicrobial protein with high activity against 
different bacteria and fungi. To explore the in vivo expression of RNase 7 we analysed 
washing fluids derived from various skin locations of healthy volunteers as well as 
patients suffering from psoriasis. Analysis of RNase 7 levels in skin washing fluids 
using an ELISA with a novel generated RNase 7 antibody revealed expression of RNase 
7 on various skin surfaces (e.g. nose, arm, leg, hand, head, forehead). Surprisingly, the 
non-affected skin surface of patients suffering from psoriasis showed increased levels 
of RNase 7 as compared to the same skin locations of healthy persons. Highest RNase 
7 amounts were recovered from psoriatic lesions. These results suggest that RNase 
7 may contribute to the low infection rate of psoriatic skin. Recently we detected 
that contact with bacterial culture supernatants led to increased levels of RNase 7 in 
keratinocytes. To analyse whether bacterial contact also entails an increase of RNase 
7 on the skin surface we treated skin explants with bacterial culture supernatants. This 
ex vivo experiment revealed that bacterial supernatants induce the release of RNase 7 
on the skin surface. These findings demonstrate that RNase 7 is not only constitutively 
expressed in high amounts in healthy human skin but also inducibly expressed at sites 
of bacterial infection thus contributing to enhanced innate cutaneous defense. 
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Human Ifapsoriasin, a Novel Member of the ‘S100 Fused Type Protein’ Family, is 
Expressed in Healthy Skin
B Hansmann, U Meyer-Hoffert, J-M Schröder Univ of Schleswig-Holstein, Kiel, Germany
S100 fusion type proteins (SFTPs) are members of a protein family that localize to the 
“Epidermal Differentiation Complex” on chromosome 1q21.3. They share a structure 
with an N-terminal S100 domain and EF hand domain and different numbers of 
varying sequence repeats at the C-terminus, so that the SFTPs “fuse” the characteristic 
sequence structures of the S100 proteins and the repeat structure of the Cornified 
Envelope (CE) proteins. Recently ifapsoriasin (IFPS), a novel 248 kDa-member of this 
family, was discovered and cloned. To get insight into the possible function, peptides 
characteristic for different parts of IFPS, an N-terminal spacer and part of the repeat 
domain B plus C-terminus, were recombinantly produced; antibodies for those 
fragments were generated and affinity-purified. Immunohistochemistry analyses 
revealed IFPS expression exclusively in the stratum granulosum and stratum corneum 
of healthy skin, whereas lesional psoriatic skin barely showed IFPS-expression. 
Western blot analyses of skin- and stratum corneum-extracts showed a major band at 
60 kDa mainly when extraction was performed at reducing conditions. Surprisingly, 
immunoreactive IFPS was detected with both, the N-terminal spacer region- and the 
C-terminal part-generated antibodies. Due to the distance between N-terminal spacer 
region and C-terminus which is nearly 2000 amino acids (corresponding to an MW of 
190,000) we conclude that IFPS is present in skin as an extractable peptide complex 
that contains both, part of the C-terminus and part of the N-terminal spacer. Western 
blot analyses of recombinant IFPS peptides confirmed complex formation, as revealed 
by the presence of several bands higher than the monomer. The reasons for the unusual 
behavior of these IFPS fragments and its biological function remain to be elucidated. 
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Characteristics of nerve fibers in the subepidermal nervous plexus - an electron 
microscopical view
C Reinisch, D Födinger, E Tschachler Medical University of Vienna, Vienna, Austria 
Being located just beneath the epidermal basement membrane, the subepidermal nervous 
plexus is enveloping our whole body surface. It is the most distal part of the nervous system still 
containing a schwann cell sheath around the delicate nerve fibers enabling uncomplicated 
access to the peripheral nervous system. As we were interested in the ultrastructure of its 
fibers, we did immunohistochemical stainings with Nerve Growth Factor receptor antibody 
on horizontal sections of papillary dermis and performed electron microscopy thereof. A 
total of 9 sections containing 61 nerve fibers were analysed in detail. The thickness of the 
single nerve fibers ranged from 1.244nm to 35.303nm with a median diameter of 4.737nm. 
The median axon number ensheathed per Schwann cell was 2 with a range from 1 to 
27. Axon diameter ranged from 197nm to 1.925nm with a median caliber of 610nm. In 
approximately 15% of the axons, the Schwann cell sheath was found to be incomplete, 
only invaginating one part of the axon, allowing the other part to be closely associated with 
the extracellular space. All of the nerve fibers found were unmyelinated. Strikingly, 5 nerve 
fibers contained each one axon which was wrapped by two or three layers of the mesaxon 
beside further axons, which were wrapped by only one layer of mesaxon. Potentially, this 
rudimental multi-layered sheath depicts the beginning of myelination in the periphery. 
However, myelinated and unmyelinated axons have never been shown to occur in one 
Schwann cell. In conclusion, we were able to provide morphological data being useful in 
the further evaluation of physiological and pathological changes of the superficial dermal 
nerve plexus. This is of importance as only few ultrastructural descriptions of the nerve 
fibers in the subepidermal nerve plexus are available and as skin biopsies are increasingly 
discovered an exciting tool to evaluate peripheral neuropathies.
 
365
Imaging the pH in intact and recovering mouse skin by FLIM
N Kirschner, I Moll, MJ Behne Uni Hospital Hamburg-Eppendorf, Hamburg, 
Germany
The uppermost layer of the epidermis, the stratum corneum (SC) exhibits an acidic surface pH. 
In contrast, the viable layer below, the stratum granulosum, shows a neutral pH. It is known 
that acidification is essential for the epidermal permeability barrier. The acidic surface of the 
SC forms a functional endpoint late in epidermal differentiation and regulates extracellular 
lipid processing and desquamation. To better understand the role of pH in epidermis and 
barrier-influenced diseases we use fluorescence lifetime imaging microscopy (FLIM). With 
this measurement technique it is possible to acquire quantitative and localization information 
on pH. FLIM is dye-concentration independent, the method depends on low light intensities 
and is therefore not prone to photobleaching or phototoxic artefacts. Also with the longwave 
light used it is possible to penetrate deep into intact tissue without damaging the samples. 
In the experiments presented here we use 2’,7’-bis-(2-carboxyethyl)-5/6-carboxyfluorescein 
(BCECF) as the pH dependent probe. In this study we first localize pH in the skin of hairless 
mice (SKH1-hrBR) with an intact barrier and we show the changes of localization during 
the recovery period in skin disturbed by tape stripping. In addition, measurements of 
transepidermal water-loss (TEWL) are employed to monitor damage and repair of the skin 
barrier. We find that the surface of mouse skin has an acidic character (˜ pH 6) and in deeper 
layers acidic pH domains are present in undisturbed tissue. After tape stripping, using a flat 
electrode the pH on the surface becomes neutral, while the deeper extracellular domains 
of SC remain acidic determined by FLIM. This is important, because the re-acidification is 
necessary for barrier repair by lipid- and protein-processing enzymes. Further experiments 
should allow to characterize the mechanistic role of pH in epidermal physiology and disease. 
 
366
Disruption of lipid rafts causes mitochondrial perturbation in HaCaT keratinocytes
D Vind-Kezunovic1, U Wojewodzka2, M Schauen3, R Eefsen1, R Gniadecki1 1Bispebjerg 
Hospital, Copenhagen NV, Denmark 2Polish Academy of Sciences, Warsaw, Poland 
3Institute of Vegetative Physiology, Cologne, Germany
Lipid rafts are cholesterol-enriched microdomains in plasma membranes, which 
play a pivotal role in cellular signaling cascades. Evidence suggests that membrane 
cholesterol can be perturbed by free radicals and ultraviolet radiation. The cellular 
response to cholesterol depletion by methyl-beta-cyclodextrin (MβCD) is often taken 
as evidence for a role of lipid rafts in cell function. We have previously shown that 
lowering of membrane cholesterol by MβCD reduces the generation of reactive 
oxygen species and causes the formation of autophagosomes. Since the autophagic 
stress response is accompanied by loss of mitochondrial potential and release of Bcl-2 
proteins, we investigated the mitochondrial structure and function in cholesterol 
perturbed HaCaT cells. MβCD treatment caused loss of mitochondrial membrane 
potential. The integrity of the outer mitochondrial membrane was disrupted with 
increased cellular and nuclear accumulation of apoptosis-inducing factor (AIF) and 
cytochrome c. Electron microscopy confirmed that AIF and cytochrome c release 
were accompanied by ultrastructural changes, including loss of cristae, swelling 
and fragmentation in the mitochondria. Unexpectedly, cholesterol depletion did not 
affect mitochondrial respiration. Our data indicate that cholesterol depletion leads 
to mitochondria dysfunction and mitochondria-induced stimulation of the intrinsic 
apoptotic pathway in keratinocytes.
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Transient receptor potential vanilloid 3 (TRPV3) regulates cell growth and death of 
human and mouse epidermal keratinocytes
E Páyer, I Borbíró, N Dobrosi, BI Tóth, A Szegedi, T Bíró University of Debrecen, 
Debrecen, Hungary
Recent reports strongly suggest that certain members of the transient receptor potential 
vanilloid (TRPV) channel family, originally described on sensory structures, are also expressed 
on various non-neuronal cell types of the skin. Accordingly, we have previously shown that 
the activation of the heat and capsaicin-sensitive TRPV1 results in inhibition of human hair 
shaft elongation and keratinocyte (epidermal, follicular) proliferation, as well as induction of 
apoptosis. In the current study, we investigated the involvement of another thermosensitive 
molecule, TRPV3, in the regulation of in vitro growth of human epidermal HaCaT keratinocytes 
(for control, the TRPV3-positive mouse 308 epidermal keratinocyte cell line was employed). 
Using immunocytochemistry, Western blotting, and quantitative ‘real-time’Q-PCR, we 
provide the first evidence that HaCaT keratinocytes (similar to 308 cells) express TRPV3, both 
at the protein and mRNA levels. Furthermore, using fluorimetric FLIPR Ca-imaging, we have 
also shown that the molecule is functional since various monoterpenoid plant-derived TRPV3 
agonists (e.g. eugenol, thymol) transiently elevated intracellular calcium concentration in a 
dose-dependent manner. In addition, series of fluorimetric measurements also revealed that 
prolonged treatment of cells with the above monoterpenoids markedly suppressed proliferation 
of both cell types in time- and dose-dependent fashions. Finally, we have also found that 
the inhibition of cell growth was accompanied by decreased cell viability, presumably due 
to the concomitant induction of apoptotic and necrotic pathways upon TRPV3 stimulation. 
In conclusion, our findings strongly suggest the functional existence of TRPV3 on human 
epidermal keratinocytes with potential novel role in human skin biology and pathophysiology, 
and, futhermore, invite future trials to explore its therapeutic impact in dermatological practice. 
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Generation of active recombinant human caspase-14
P De Groote, P Ovaere, E Hoste, G Denecker, S Lippens, P Vandenabeele, W Declercq 
Ghent University, Zwijnaarde-Gent, Belgium
Caspase-14 is an atypical caspase (cysteinyl aspartate-specific proteinase) whose 
expression is mainly restricted to the skin. It is a non-apoptotic caspase that is processed 
during terminal differentiation of keratinocytes. Recently, we have shown that caspase-14 is 
involved in protection of the epidermis against UVB photodamage and water loss (Denecker 
et al., Nat Cell Biol. 2007 May 21; Epub ahead of print). In view of these observations, 
the availability of recombinant active caspase-14 is of major importance in the search 
for caspase-14 substrates. Since caspase-14, in contrast to all other caspases, does not 
undergo autoprocessing upon overexpression, we developed alternative strategies. The first 
strategy was based on the production of recombinant procaspase-14 that was subsequently 
processed, at the correct cleavage site, by a partially purified epidermal extract containing 
caspase-14 activating activity. In a second strategy, as already described for other caspases, 
we made use of a reversed form of caspase-14 in which the order of the p20 and p10 subunit 
was genetically reversed. The third strategy was to separately express the p20 and p10 
subunits in E. coli. These subunits were then separately purified from inclusion bodies. The 
denaturated subunits were combined in equimolar amounts and subsequently refolded in 
each others presence. All three caspase-14 forms had similar substrate specificity (WEHD-
amc as optimal substrate) and were inhibitable by the pan-caspase inhibitor z-VAD-fmk. 
The recombinant full length caspase-14 processed by an epidermal extract had the strongest 
activity and the reverse form was least active. Since the preparation of the epidermal 
extract, to process full-length caspase-14, is laborious and since this extract is non-defined, 
we consider this strategy less optimal. In our opinion the best alternative to generate larger 
amounts of recombinant caspase-14 is through refolding of purified p20/p10 subunits. 
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TLR 9 is not constitutively expressed in mouse skin in vivo, but is inducible by 
barrier injury
R Panzer, J-M Jensen, E Proksch, K Hinrichsen Uni of Schleswig-Holstein, Kiel, Germany
The physical barrier is the first line of defence against microbial infection. The 
innate immune system supports antimicrobial defence in several organs. Human 
keratinocytes constitutively express various members of the toll-like receptor (TLR) 
family, important for innate immunity including TLR9. TLR9 is known to recognize 
unmethylated CpG motifs, which are very frequently found in bacterial DNA. We asked 
whether impairment in the physical barrier stimulates the innate immune system and 
whether TLR 9 is constitutively expressed or inducible in mouse skin in vivo. Murine 
TLR9 mRNA expression was investigated after various degrees of barrier disruption 
in mouse skin in vivo by realtime PCR with intron spanning primers for analysis and 
subsequent gel electrophoresis for verification. TLR9 was not constitutively expressed 
in mouse epidermis. A slight degree of barrier disruption by stratum corneum injury 
using tape strips did not induce TLR9 expression. In contrast, severe skin barrier 
injury by scraping with a scalpel blade induced pronounced TLR9 expression in mice 
48 hours after treatment. We suggest that barrier disruption, which is a prerequisite of 
bacterial infection, induces the innate immune system including up-regulation of TLR9. 
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Transgenic mice for Elastase 2, a new epidermal proteinase, display impaired skin 
barrier
C Bonnart1, C Deraison1, C Besson1, A Robin1, A Briot1, M Lacroix1, M Gonthier2, 
B Monsarrat2, A Hovnanian1 1INSERM U563, Toulouse, France 2IPBS, Toulouse, France
Mutations in SPINK5 cause Netherton syndrome (NS), a severe genetic skin disorder 
with a profound defect in skin barrier. SPINK5 encodes LEKTI, a Kazal-type serine 
proteinase inhibitor expressed in the granular layer (GL) of the epidermis. Spink5-
deficient mice display abnormal desmosome cleavage in the GL resulting from KLK5 
and KLK7 hyperactivity. We identified by mass spectrometry pancreatic elastase 2 (Ela2) 
as a new epidermal protease, which is hyperactive in Spink5-/- epidermis. We showed 
that Ela2 is expressed and active in the GL and the stratum corneum (SC). In order to 
gain insight into the role of Ela2 in vivo, we generated mEla2 transgenic mice using 
an involucrin (INV) promoter-bearing cassette. Three INV-Ela2 transgenic mice were 
obtained, the phenotype severity of which correlated with the number of integrated 
transgene copies. A few days after birth, the first two mice developed a thick and wrinkled 
skin with generalized scaling, which spontaneously regressed with hair growth. The 
third mouse died at birth and displayed a severe skin phenotype: the epidermis was 
acanthotic, the differentiation pattern was abnormal and proliferation markers were 
up-regulated. The SC was abnormally compact and slightly hyperkeratotic. Electron 
microscopy examination showed a delayed lamellar body secretion, which correlated 
with the presence of intracellular lipid droplets as shown by Oil Red O staining. This 
indicates an impaired formation of the skin permeability barrier. INV-Ela2 transgenic 
mice showed no evidence of premature detachment of SC, but displayed several 
skin abnormalities highly reminiscent of Spink5-/- or NS phenotype. These results 
suggest a specific contribution of Ela2 hyperactivity in the pathophysiology of NS. 
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Recombinant Expression of Murine β-Defensin 14
K Hinrichsen, J Harder, E Proksch University of Schleswig-Holstein, Kiel, Germany
Our skin needs to be protected against infection because it is constantly exposed 
to a variety of microbial challenges. The permeability barrier, localized in the 
stratum corneum, is a mechanical protective barrier against bacterial infection. 
Impairment of the physical barrier by injury is a prerequisite for experimental skin 
infection by application of a bacterial suspension. After disruption of the physical 
barrier additional defense mechanisms are necessary and these are carried out by 
antimicrobial proteins of the innate immune system. For the skin’s antimicrobial 
defence β-defensins, which are produced by epithelial cells, are most important. 
A potent antimicrobial protein of human skin is β-defensin 3 (hBD3) which is 
antimicrobial active against many potentially pathogenic microbes including 
multiresistant Staphylococcus aureus and vancomycin-resistant Enterococcus 
faecium. Sequence analysis revealed that murine β-defensin 14 (mBD14) is the 
murine ortholog of hBD3 with a homology of 68-72%. Because the antimicrobial 
activity of hBD3 is known we wanted to examine whether mBD14 is antimicrobial 
active, too. For this we established the recombinant production of mBD14 in E. coli 
and tested its antimicrobial activity. Preliminary results showed antibacterial activity 
of the recombinant protein in an agar diffusion test. In summary, we performed 
successful cloning of murine β-defensin 14 and examined its antimicrobial activity. 
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Involvement of intermediates of the cholesterol synthesis pathway in the physiology 
of epidermal keratinocytes
F Minner, P Delescaille, M Herin, Y Poumay Uni Namur (FUNDP), Namur, Belgium
The epidermis is mainly composed of keratinocytes that proliferate in the basal layer and 
undergo a complex differentiation program in the suprabasal layers, leading to keratinisation. 
Membrane cholesterol depletion by methyl-beta-cyclodextrin in keratinocytes induces Akt 
dephosphorylation and a p38MAPK-dependent HB-EGF expression. Moreover, keratinocyte 
late differentiation is induced by membrane cholesterol extraction. This process is amplified 
when combined with lovastatin in order to inhibit cholesterol neosynthesis. Lovastatin prevents 
mevalonate production by inhibition of the HMG-CoA reductase, the key enzyme regulating the 
cholesterol synthesis pathway. To investigate the role of certain intermediates of the cholesterol 
synthesis, normal cultured keratinocytes were treated with the inhibitors such as lovastatin, 
triparanol or NB598, associated or not with membrane sterol depletion. Presence of mevalonate 
in cells leads to lanosterol synthesis by a chain of reactions including squalene epoxidation. When 
lanosterol is produced, two biochemicals pathways can be followed to generate cholesterol: the 
Bloch or the Kandutsch-Russel pathways. The inhibition of the squalene epoxidase by NB598 
head off the lanosterol synthesis without perturbation of the other mevalonate-dependent 
pathways. Triparanol inhibits 24-dehydrocholesterol reductase which converts desmosterol to 
cholesterol in last step of the Bloch pathway but also blocks completely the Kandutsch-Russel 
pathway. Our results show that the viability of cells treated with the inhibitors is not altered but 
the cellular proliferation can be prevented. The treatments induce Akt dephosphorylation in 
parallel with proliferation arrest. The expression of epidermal differentiation markers, keratin10 
and involucrin, is differentially altered depending on the inhibitor used. Finally, conversely to 
lovastatin or triparanol, the use of NB598 alone induce a HB-EGF expression probably dependent 
on p38MAPK activation and an inhibition of keratin10 expression and increase in involucrin 
expression. These preliminary data suggest that intermediates of the cholesterol pathway, 
downstream of the squalene synthesis, are involved in the differentiation program in keratinocytes. 
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Towards a Major Risk Factor for Atopic Eczema: Meta-Analysis of Filaggrin Mutation 
Data
S Weidinger1, H Baurecht1, AD Irvine2, T Illig3, S Wagenpfeil1, N Novak4 1TU, Munich, 
Germany 2Our Lady’s Childrens’ Hospital, Dublin, Ireland 3GSF, Neuherberg, 
Germany 4University of Bonn, Germany
With an impressive series of replication studies, filaggrin (FLG) has become the gene 
with the most widely replicated association to atopic eczema (AE). However, studies 
published to date demonstrate differences concerning study design and strength 
of associations. Our objective was to establish the contribution of FLG mutations 
prevalent in European populations (R501X and 2282del4) to risk of AE based on 
published studies, and to provide a more accurate estimate of effect sizes. We 
searched Medline and ISI Web of Knowledge databases for relevant studies that were 
published through April 30, 2007. Initially we accounted for different study types and 
evaluated an overall estimate for case-control and family studies. In a second step 
we combined those two study types and used a random-effects analysis approach to 
calculate overall odds ratios (ORs). Tests of asymmetry were applied in order to detect 
potential publication bias. 9 studies that met the inclusion criteria were included in the 
meta-analysis. For the combined genotype (R501X or 2282del4) we found an overall 
OR of 4.09 (95% CI, 2.64-6.33) from the case-control studies and a summary OR of 
2.06 (95% CI, 1.76-2.42) from the family studies. We found evidence that differences 
between the case-control studies may be attributed to population stratification and 
confounding. We concluded that the powerful effect of FLG variation on AE-risk 
exceeds that of any other investigated candidate gene for AE so far and makes FLG 
one of the strongest genes known to date for complex diseases.
 
 
374
Obtaining and expressing fluorescent and inducible forms of Cyclin E in primary 
keratinocytes, and in vitro reconstituted epidermis
L Barnes1, M Dumas2, A Gandarillas1 1IURC, UMI, INSERM, Montpellier, France 
2LVMH Recherche, St Jean-De Braye, France
We have found that epidermal keratinocytes are capable of DNA replication once 
differentiation is initiated and mitosis is blocked, leading to an endoreplication 
phenomenon. This phenomenon associates a marked increase of the DNA replication 
marker cyclin E during differentiation, both in culture and in human epidermis in situ. 
In order to study the effect of constitutive overexpression of cyclin E in keratinocytes, 
we have generated pBabe retroviral constructs carrying fluorescent and conditional 
forms of this cyclin. For the fluorescent construct, the gene coding for GFP was fused 
to the cyclin gene. For the inducible construct, the cyclin gene was fused to a mutant-
binding domain of the oestrogen receptor (ER) that is activatable by 4-hydroxy-
tamoxifen (OHT). The constructs are efficiently expressed and functional when 
introduced in mouse fibroblasts and human primary keratinocytes. Overexpression 
of cyclin E in primary keratinocytes overactivates DNA-replication cdk2, alters 
the ratio proliferation-differentiation, and provokes increased multinucleation and 
ploidy. This affects the degree of differentiation, both in conventional submerged 
cultures and in in vitro reconstituted epidermis of air-liquid interface cultures. 
 
375
Implication of ENaC-mediated sodium fluxes in wound healing
P Suarez, R Charles, E Hummler University of Lausanne, Switzerland
The highly amiloride-sensitive epithelial sodium channel ENaC (Scnn1a, sodium 
channel non-voltage-gated) is composed of 3 homologous subunits α, β and γ that 
are all needed to confer maximal channel activity. ENaC is found in tight epithelia 
like e.g. in the distal nephron, where it is important for whole body Na+ homeostasis. 
In a previous study of mice deficient of the αENaC subunit, we showed that ENaC 
might be required for differentiation processes in skin. Furthermore, when exposed 
to an electric field, we recently found that keratinocytes isolated from mice deficient 
for the αENaC subunit exhibit a different migration behaviour compared to wild-
type keratinocytes. This strongly suggests that ENaC may play an important role in 
the wound healing processes. The aim of the study is to investigate the role of ENaC 
in wound healing. For this purpose, we use a conditional knockout mouse model, 
which specifically abrogates the αENaC subunit expression in the basal layer and 
thereby abolishing the whole channel activity in the epidermis. In these animals, 
we performed wound healing studies and determined full thickness wound closure 
in function of time. Our data revealed a tendency to delayed wound closure in 
conditional knockout mice but did not reach statistically significance. Nevertheless, 
TEWL values differed between knockout and wild-type following wound closure, 
suggesting an altered skin remodeling. Real-time PCR on biopsies from these animals 
will unveil the knockout status in these animals. Further physiological studies and 
genetic analysis will allow use to show that ENaC is an important gene for wound 
repair.
 
 
376 [Oral 007]
How to make a skin-tight dress: the p63/claudin-1 connection
T Lopardo1, N Loiacono1, F Galli1, D Cyr2, A Costanzo3, L Guerrini1 1University of 
Milan, Italy 2University of Quebec, Canada 3Univerity of Rome Tor Vergata, Italy
Both p63 and claudin-1 null mice die within a few hours from birth due to 
dehydration resulting from severe skin abnormalities. These observation suggested to 
us the possibility that the two genes might be linked to the same regulatory pathway 
or belong to a common signaling cascade with p63 possibly regulating claudin-1 
expression. In this study we show that silencing of ΔNp63 but not TAp63 in pimary 
mouse keratinocytes (by ΔNp63 specific siRNA), results in a severe downregulation 
of claudin-1 expression (- 87%). Claudin-3 and claudin-10 expression was also 
reduced although to a lesser extent (-55%). Moreover, ΔNp63α can activate both the 
endogenous claudin-1 gene and a reporter vector containing a -1400 bp promoter 
fragment of the claudin-1 gene while TAp63 isoforms acts as transcriptional repressors. 
Natural p63 mutations, in particular the AEC mutation, were indeed altered in their 
capacity to regulate claudin-1 transcription thereby reinforcing the hypothesis that 
these two genes might be linked to a common regulatory pathway. In addition, since 
AEC patients display developmental defects in the dermoepidermic junctions similar 
to those observed in the epidermis of knockdown ΔNp63 mice, our findings suggest 
that claudin-1 may act as an important target gene of p63 and is involved in the 
pathogenesis of ectodermal dysplasias.
 
 
377 [Oral 011]
A multipotent ectodermal cell population derived from human embryonic stem 
cells for skin and cornea cell therapy
D Aberdam1, E Aberdam1, E Barak2, M Rouleau1, J Itskovitz-Eldor2 1INSERM, Nice, 
France 2TECHNION, Haifa, Israel
Embryonic stem (ES) cells represents a unique cellular model to recapitulate in vitro early 
steps of embryonic development, but also as an unlimited source for cell-based therapy for 
many diseases and targets for drug discovery and toxicology screens. Among the different cell 
types that can be generated from ES cells, ectodermal cells are of particular interest since they 
represent the precursors of many epithelial tissues and organs. While human ES cells provide 
a potential cellular source for tissue engineering application, a major limitation resides in 
the heterogeneity of the committed cell population. The absence of known epithelial-specific 
stem cell surface marker usually prevents cell sorting of the desired cell type, retaining thus 
contaminated undifferentiated huES which can still produce teratoma. Here we report the 
reproducible isolation of an ectodermal cell population from human ES cells (IT1). IT1 shows 
a stable morphological appearance, has a somatic cell cycle kinetics and does not produce 
teratoma in nude mice. Remarkably, like adult somatic cells, IT1 cells undergo senescence 
after about 60 doubling population and their karyotype remains normal. Exogenous 
expression of p63 or Pax-6 efficiently induces their differentiation into K14+-keratinocytes or 
K12+-corneal cells, respectively. Interestingly, post confluent IT1 cells form a firm sheet that 
could be transplanted in vivo and thus may provide a ready source of ectodermal progenitor 
sheets for cell therapy transplantation and the development of new-drug-screening strategies. 
IT1 cell line could be thus a particularly useful tool to design in vitro models that would 
recapitulate the embryonic early events of epithelial lineage specification but also as a source 
of different cells for clinical trials of epithelial stem cell loss. Finally, it demonstrates that, 
contrary to what has been suggested elsewhere, huES-derived somatic cell types do not need 
to be immortalized for growth and expansion.
378 [Oral 024]
P63 and Dlx3 reciprocal regulation: possible relevance in the molecular pathways 
underlying skin differentiation
V Calabro1, A Di Costanzo1, L Festa1, V Franci1, F Galli1, L Guerrini2, M Morasso3, 
G La Mantia1 1University of Naples  Federico II , Italy 2University of Milan, Italy 3NIH-
NIAMS, Bethesda, USA
P63, a member of p53 family of transcription factors, plays a pivotal role in 
skin development. P63 functions as a molecular switch that initiates epithelial 
stratification while regulating proliferation and differentiation of developmentally 
mature keratinocytes. P63 mutations are associated to several human hereditary 
syndromes characterized by ectodermal dysplasia and limb defects. P63 acts 
upstream to Distal-less3 (Dlx3) gene, in a transcriptional regulatory pathway relevant 
for the development of epidermis and embryonic appendages. Dlx3 mutations are 
associated with the human Tricho-Dento-Osseus syndrome. We have investigated 
the functional relationship between the p63 and dlx3 protein. Specific p63 isoforms 
can transcriptionally regulates Dlx3 gene transcription. We have recently found that 
Dlx3, in turn, is able to regulate p63 protein abundance. Carbossiterminal truncated 
versions of p63 show an increased resistance to Dlx3-mediated degradation. By site-
directed mutagenesis we have identified particular serine/threonine residues that, 
when mutated, confer to p63 resistance to Dlx3-mediated degradation. These residues 
are phosphorylated as a consequence of Ras/Raf signaling pathway activation since 
the use of specific inhibitors of this pathway impairs Dlx3-mediated p63 degradation. 
Our data support the hypothesis that activation of Dlx3 expression reduces p63 
protein abundance providing a key molecular switch that might be relevant during 
differentiation of stratified epithelia. 
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TAK1 regulates hair follicle development in EDA receptor signaling
K Sayama1, K Kajiya2, Y Shirakata1, Y Hanakawa1, S Hirakawa1, S Akira3, J Kishimoto2, 
K Hashimoto1 1Ehime University School of Medicine, Toon, Japan 2Shiseido Life 
Science Center, Yokohama, Japan 3Osaka University, Osaka, Japan
Transforming growth factor-β-activated kinase 1 (TAK1) is a member NF-kB pathway and is 
involved in IL-1R and TNFR signaling. Previously, we generated keratinocyte-specific TAK1-
knock out (TAK1-KO) mice by breeding TAK1 flox/flox mice with K5-cre mice. Histological 
analyses of TAK1-KO mice revealed thickening of the epidermis with keratinocyte apoptosis 
and abnormal expression patterns of keratins 5, 14, 1, and 10. Ablation of TAK1 in cultured 
keratinocytes resulted in apoptosis, indicating that TAK1 regulates the differentiation and 
apoptosis of keratinocytes. In this study, we focused on hair development. EDA receptor 
(EDAR) signaling is important for hair placode formation and mutations in the genes cause 
ectodermal dysplasia. EDAR belongs to TNFR family and activates NF-kB. EDAR associated 
death domain (EDARADD) is an adapter protein of EDAR. Recently, TAK1-binding protein 2 
has been identified as a binding partner of EDARADD, suggesting that TAK1 regulates hair 
follicle development. Hair follicle development was histologically analyzed in embryo and 
newborn mice. Hair germ and dermal condensation were noted in control mice at E15.5, 
while apparent hair follicle development was absent in TAK1-KO mice. At E16.5, hair peg 
formation was obvious in control mice. Although placode and dermal condensation were 
noted in the TAK1-KO mice, hair follicle development was apparently delayed. At P1-6, 
the hair development was retarded in the TAK1-KO mice. Since TAK1-KO mice die by P7, 
we transplanted the mouse skin of P1 to nude mice. Normal hair growth was observed in 
the transplanted skin of control mice, while hair elongation was absent on the transplanted 
skin of TAK1-KO mice. Therefore, TAK1 has a pivotal role for hair follicle development. 
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Prostaglandin metabolism in hair follicle: PGE2 and PGF2α synthesis and 
interconversion
L Colombe, A Vindrios, JF Michelet, B Bernard L’Oréal Recherche, Clichy, France
Prostaglandins regulate a wide number of physiological functions. Recently PGF2α 
analogue such as latanoprost was shown to have a real impact on hair regrowth. The 
aim of this study was to investigate and describe the expression profile in human hair 
follicle of prostaglandin (PG) metabolism key enzymes, i.e. Carbonyl reductase-1 
(CBR1), microsomal Prostaglandin E synthase-1 (mPGES-1) and microsomal 
Prostaglandin E synthase-2 (mPGES-2), cytosolic Prostaglandin E synthase (cPGES), 
the aldoketoreductase AKR1C1 and the Prostaglandin F synthase AKR1C3. 
Quantitative RT-PCR evidenced i) the expression of all these enzymes in plucked hair 
follicles and ii) a higher expression of mPGES-2 and AKR1C3 in female hair follicles. 
Using Western blot, PGE2- and PGF2α ELISA assays and immunohistochemistry, 
we observed that most of hair follicle cell types were able to produce PGE2 and/or 
PGF2α and synthesized all PG metabolism enzymes. Moreover, a specific distribution 
in hair follicle was noted for each of these enzymes. These results demonstrated 
that an active but intricate prostaglandin metabolism could take place in human 
hair follicle, mainly oriented towards PGE2 synthesis and concentrated in the bulb, 
including dermal papilla, matrix and keratogenous area. Local production of PGF2α 
might equally rely on PGE2 conversion and direct synthesis through AKR1C3/PGFS. 
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Specificity of ‘cadaverized hair’ in different hair and scalp disorders
E Kowalska-Oledzka1, M Slowinska1, A Rakowska1, M Olszewska2, L Rudnicka1
1Central Clinical Hospital MSWiA, Warsaw, Poland 2Private Practice Office, Warsaw, 
Poland
Based on available literature a cadaverized hair is a specific sign observed in alopecia 
areata. The mononuclear CD4/CD8 cell infiltrate invades the dermal papilla and hair 
matrix causing vacuolization and necrosis of hair matrix. Nowadays noninvasive 
videodermoscopic examination enables to detect cadaverized hairs during routine 
diagnostic procedures of different alopecias. We examined dermoscopically 134 
patients with different types of alopecias: 40 female pattern hair loss, 20 acute and 
chronic telogen effluvium, 3 anagen (dystrophic) effluvium, 31 alopecia areata, 8 
cases of different types of cicatrical alopecia, 2 congenital hypotrichosis and 30 
healthly controls. The examination was conducted with videodermoscope Fotofinder 
Mole Analyser and magnification 20-70x. Videodermoscopy of cadaverized hairs 
showed very characteristic pattern: black, round structures localized in follicular 
ostium, resembling macrocomedo. We found cadaverized hairs in 16 (25,3%) cases 
of alopecia areata, 1 case of perifolliculitis capitis abscendens and suffodiens, 1 case 
of lichen planopilaris, 1 case of anagen dystrophic alopecia, 2 cases of hypotrichosis 
simplex and 2 healthy controls. Histopathology was conducted in cases with the 
presence of cadaverized hair. We concluded that cadaverized hair are not a specific 
sign of alopecia areata, but additional phenomenon in cases of hair disorders with 
acute necrosis of hair matrix.
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Gene expression profiling of intrinsic skin aging
G Klosner1, R Varecka2, M Matsui3, N Muizzuddin3, C Kokesch1, M Binder1, F 
Trautinger4 1Med Uni of Vienna, Austria 2Boehringer-Ingelheim Austria GmbH, Vienna 
3Estee Lauder Res, Melville, USA 4Karl Landsteiner Inst Derm Res, St Poelten, Austria
Gene expression profiling was used to assess for age-related alterations in sun-protected normal 
human skin. Punch biopsies were taken from the upper inner arms of 43 healthy female volunteers 
(phototypes II and III) and total RNA was extracted and pooled according to age group (group 
I: age 19 - 28, n=23; group II: age 55 - 65, n=20). The expression of over 47,000 transcripts in 
each pool was analyzed by Affymetrix Human Genome U133 Plus 2.0 microarrays. We found 
statistically robust changes in 1,657 genes of which 1,371 were upregulated and 286 showed 
downregulation. 301 of these transcripts were induced (n=148) or suppressed (n=153) > 2-fold. 
According to Ingenuity Pathway Analysis (IPA, www.ingenuity.com) the genes with induction > 
2-fold belong to the following functional groups: ‘cellular growth and proliferation’(n=39), ‘cellular 
movement’(n=13), ‘immune response’(n=16), ‘cellular assembly and organization’(n=12), ‘cell 
to cell signaling and interaction’(n=20). Functional groups of transcripts showing suppression 
> 2-fold are: ‘lipid metabolism’(n=22), ‘small molecule biochemistry’(n=26), ‘molecular 
transport’(n=10), ‘behaviour’(n=1), ‘carbohydrate metabolism’(n=3), ‘cell death’(n=7). In 
addition, composite functional categories were analyzed by ADGO (array.kobic.re.kr/adgo): 
A significant upregulation was found for genes annotated with ‘integral to plasma membrane/
receptor activity’(n=23). Downregulation was detected for genes associated with ‘intermediate 
filaments’(n=37) and with the composite annotation ‘intermediate filament/structural molecule 
activity’(n=14). According to these results intrinsic skin aging is associated with the increased 
expression of genes mainly associated with regulatory cellular functions and concomitant 
suppression of genes mainly related to metabolism and structure. Members of the recently identified 
family of keratin associated proteins (KRTAPs) seem to be particulary affected by age-related 
downregulation and might be prominent new candiate genes for further research in skin aging. 
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Key Role of DNP63 in Epidermal Fate of Embryonic Stem (ES) Cells and ES-Derived 
Ectodermal Cell Line
A Medawar1, P Rostagno1, D Suter2, K-H Krause2, M Rossi3, G Melino3, D Aberdam1, 
M Rouleau1 1INSERM U634, Nice, France 2University Hospital of Geneva, Geneva, 
Switzerland 3University of Leicester, Leicester, UK
In vivo studies, transgenic and knock-out mice have demonstrated that p63 isoforms 
play complex and pivotal roles in epithelial development and cancer but their 
respective function remains highly controversial. Since embryonic stem (ES) cells can 
be differentiated into many cell types, they represent an effective tool to recapitulate 
in vitro the main steps of embryonic development. We recently reported the efficient 
derivation of ectodermal and epidermal cells from murine ES cells and demonstrated 
their ability to reconstitute in vitro a functional skin. We further clarified the function 
of BMP-4 in the binary neuroectodermal choice by stimulating sox-1+ neural 
precursors to undergo specific apoptosis while inducing epidermal differentiation. 
We demonstrate here that DNp63 is early activated during the BMP-4 induced 
ES cells ectodermal differentiation and further expressed all along the epidermal 
commitment. With an ES-derived ectodermal cell line, we show that DNp63 enhances 
cell proliferation but is also critical for the epidermal commitment and stratification. 
Surprisingly, TAp63 is not expressed at those critical embryonic stages thus appearing 
unnecessary for the epidermal commitment process. This unique cellular model 
further provides a powerful tool for identifying the molecular mechanisms controlling 
normal skin development and implicated in human congenital p63-ectodermal 
dysplasia pathologies.
 
 
384
Development of a drug permeation model through human infected nails and 
relationship with bovine hoof slices
D Monti1, L Saccomani1, P Chetoni1, S Burgalassi1, F Mailland2 1University of Pisa, 
Pisa, Italy 2Polichem SA, Lugano, Switzerland
We investigated the permeation of ciclopirox (CPX), through bovine hoof slices 
and excised human infected toenails, from a water soluble nail lacquer (8% CPX) 
containing hydroxypropyl-chitosan (HPCH) as film-forming agent. A new permeation 
apparatus, suitable for both substrates, was designed; it consisted on a 0.5 ml glass 
vial, provided with a pierced cap, containing phosphate buffer pH 7.4; at the 
beginning, substrates were clamped between vial openings and pierced caps, and 
50 µl of formulation evenly applied on the exposed surface; at the end (1-7 days) 
the amount of drug permeated through (Q%) and penetrated into (Q’%) the substrate 
was evaluated by HPLC. CPX proved to permeate both substrates even with different 
experimental durations due to their different thickness; Q% raised as experimental 
duration increased, while Q’% reached a maximum value indicating saturation of 
the substrate; hoof slices required about two days to be saturated by the active (Q’% 
≈ 0.2%) and Q% at day 4 resulted 0.14 ± 0.02% thus suggesting a CPX transungual 
flux of about 7 µg/cm2 day; in the case of human toenails, saturation was achieved 
after day 4 (Q’% ≈ 0.75%) and Q% at day 7 resulted 0.16 ± 0.05%, so that a CPX 
flux of 0.5 µg/cm2 day was hypothesized. Lower permeation data were achieved by 
a reference insoluble CPX nail lacquer. In conclusion, our technique was suitable to 
in vitro investigate the delivery of antimycotic agents through and into the nails, by 
application of nail lacquers; the results suggested a substantial equivalence between 
infected human toenails and bovine hoof slices as a model of in vivo nail permeation. 
The model is suitable to predict availability of actives at the action site, within and 
under the nail plate. 
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Selective and hair cycle-dependent expression of nephronectin (POEM) in the hair 
follicle: New leads to the enigmatic functions of a putative extracellular matrix 
component
A Bosserhoff1, S Wallner1, E Bodó2, R Paus2 1University of Regensburg, Germany 
2University of Lübeck, Lübeck, Germany
The biological functions of nephronectin, also known as PreOsteoblast EGF-like 
repeat protein with MAM domain (POEM), are still unclear. Originally identified in 
developing mouse organs, with prominent expression at epithelial-mesenchymal 
interfaces, strong POEM expression has also been found in breast cancer. In 
the current study, we collected the first evidence for POEM expression in human 
skin, namely in human hair follicles. By immunohistology, specific, appropriately 
controlled POEM-like imunoreactivity (IR) was found in the hair matrix and hair shaft 
medulla, while no IR was seen in the hair cortex, the outer and inner root sheaths 
and the dermal papilla. Intrafollicular POEM transcription was confirmed by RT-PCR, 
showing strong expression of POEM mRNA in human hair follicle RNA extracts. In 
contrast, POEM transcripts were undetectable in cultured normal human epidermal 
keratinocytes (NHEK) or HaCaT cells. Thus, POEM may also serve as a new marker 
for hair matrix and medulla. Interestingly, array analysis has revealed substantial, 
hair-cycle-associated changes in POEM expression in mouse skin, reflecting an ‘anti-
hair growth pattern’, with a decline during anagen. Since POEM may have adhesion 
molecule properties (e.g. RGD integrin binding site, binding to alpha3beta1 integrins), 
while integrin alpha3 beta1 is important for normal hair follicle maintenance and 
morphogenesis (Conti et al., 2003), POEM-alpha3beta1 integrin interaction may be a 
modulator of normal hair follicle topobiology. 
 
 
386
Thyroid hormones stimulate pigmentation and energy metabolism of human hair 
follicles
N Van Beek1, E Bodó1, E Gáspár1, W Funk2, BE Wenzel1, R Paus1 1University of Lübeck, 
Lübeck, Germany 2Clinic Dr Koslowski, Munich, Germany
Hair follicles (HFs) rank among the most thyroid hormone-sensitive organs of the mammalian 
body. Both insufficient and excess levels of thyroid hormones (T3, T4) result in altered hair/
skin structure and function (e.g. effluvium, hyperpigmentation, myxedema). However, 
it is still unclear which direct effects T3/T4 exert on human HFs. Therefore, we have 
investigated the effect of thyroid hormone receptor activation in human HF organ culture, 
employing microdissected frontotemporal HFs from normal human scalp. As revealed 
by quantitative Masson-Fontana histochemistry, both T3 and T4 significantly stimulate 
human HF melanin synthesis, with supraphysiological concentrations of T4 showing the 
strongest stimulation of HF melanogenesis. By quantitative immunohistochemistry, T3 and 
T4 upregulated immunoreactivity (IR) for cytochromoxydase- c (=key respiratory chain 
enzyme). Intriguingly, T3 and T4 also increased intrafollicular IR for erythropoietin (=main 
stimulator of blood cell production under hypoxia, which is produced by HFs themselves). 
Our preliminary data indicate that of the proliferation of hair matrix keratinocytes is also up-
regulated by T3 and T4, which prolongs anagen duration in vitro. However, the rate of hair 
shaft formation in vitro remained essentially unaltered. These pilot data, which are currently 
complemented by further functional analyses, suggest that thyroid hormones exert direct 
hair cycle- and hair pigmentation-modulatory effects on human scalp HFs, and stimulate 
HF melanogenesis, energy metabolism, mitochondrial ATP-production, and hair matrix 
keratinocyte proliferation. Furthermore, metabolically (already maximally active!) anagen 
HFs produce elevated levels of erythropoietin by T3/T4-stimulation, possibly in order to 
maintain normoxic conditions and as a cytoprotective strategy.
 
387
May intact human adult skin stem cells be detected in vivo by combined GFP-
labelling and intravital two-photon microscopy?
S Tiede, G Hüttmann, R Paus University of Lübeck, Lübeck, Germany
To identify human adult stem cells in the hair follicle, we have presented a human 
cytokeratin 15 (K15)-promotor GFP expression construct that shows K15 promotor 
activity in the bulge region as well as in unexpected regions of intact human hair 
follicles. Functionally, these cells have clonogenic properties (clonogenicity assay), 
suggesting that they exhibit at least the properties of immature progenitor cells. By using 
this method in combination with two-photon microscopy fluorescent lifetime imaging 
(FLIM), which allows non-invasive intravital-imaging of microdissected human hair 
follicles, we show here that stem cell-specific cellular, subcellular and environmental 
structures (e.g. hair follicle stem cell niche) can be visualized in principle, based 
on tissue autofluorescence or cell-specific endogenous fluorescence. While it is 
still a long way from these organ culture conditions to the clinical examination of 
intact human skin, these data certainly encourage one to pursue the basic strategy 
of highlighting human epithelial stem cells via K15 promoter-driven GFP labelling 
(e.g. after topical vector administration via follicle-targeting liposomes), followed by 
selective intravital cell visualisation by FLIM.
 
 
388
Human dermis-derived cells show features of pluripotent adult stem cells
S Tiede1, S Danner2, C Zechel1, V Tronnier1, C Kruse2 1University of Lübeck, Lübeck, 
Germany 2Fraunhofer-Institute, Lübeck, Germany
Multiple tissue niches in the human body are now recognized to harbour adult stem 
cells. Here, we have examined a panel of putative stem cell/progenitor markers on 
progenitor cells derived from mechanically and enzymatically processed adult human 
scalp skin, which may serve as a convenient and abundant source of adult human 
progenitor cell populations. After removal of the epidermis, adherent growing cells 
of a purposely heterogenous mixture of intradermal cells (including sweat glands, 
fibroblasts, and hair follicle-derived cells), were propagated up to 18 passages in 
serum free or serum-supplemented medium as well as in specific minimal media with 
defined supplements (‘B27 supplement’, BIT 9500), cocktails of selected mitogens/
peptides, as well as defined growth supports (fibronectin, laminin, or otherwise coated 
flasks and glass coverslips). The diverse cell populations generated in this manner 
were then tested for spontaneous differentiation markers (immunocytochemistry, RT-
PCR. Interestingly, human skin-derived stem/progenitor cells obtained in this manner 
exhibit diverse differentiation patterns across lineage bounderies into cell types of 
neuroectoderm (e.g. nestin+ and NF+), mesoderm (e.g. alpha-SMA+) and entoderm 
(e.g. amylase+ and albumin+). This intriguingly wide differentiation potential of 
progenitor cells contained in normal, aging human scalp skin (mean age: 50+/- 5 
years) warrants systemic follow-up, since it raises the possibility that adult human 
skin-derived progenitor cells can serve multiple cell-based therapy purposes for 
regenerative medicine.
 
 
389
A New Three-dimensional Hair Follicle Model To Investigate Epidermal-Mesenchymal 
Interactions In Vitro
M Giesen1, K Schlotmann1, G Fuhrmann1, T Goerlach1, R Paus2, D Petersohn1 1Phenion 
GmbH & Co. KG, Düsseldorf, Germany 2University of Lübeck, Lübeck, Germany
The human hair follicle is a highly specialized skin appendage continuously renewing 
itself to produce the visible hair shaft. However, the complex biological mechanisms 
controlling hair growth, fibre formation and pigmentation as well as the reasons 
for biological alterations such as hair loss or loss of pigmentation are still poorly 
understood. In order to evaluate principles of epidermal-mesenchymal interactions 
it is essential to provide a test system as close to nature as possible. The cell-cell 
communication of various, highly specialized cell types in this complex microcosm as 
well as the spatial cellular orientation determines the system’s response to endocrinal 
and environmental stimuli. Therefore we established a novel three-dimensional in 
vitro model, which allows different cell types to interact concordantly to the in-vivo 
situation. In this hair follicle model we integrated reconstructed dermal papillae into 
a pseudo dermis with dermal fibroblasts, covered by a layer of ORS keratinocytes. 
To show the high similarity between the reconstructed model and native human 
hair follicles we demonstrate the expression of characteristic follicular markers, 
amongst others versican and NCAM, as well as the effect of a well-recognized potent 
stimulator of human hair growth in vivo, Cyclosporin A. With this test system we set 
up a powerful tool to study hair follicle metabolism and epidermal-mesenchymal 
interactions. In combination with advanced molecular techniques it enables a deeper 
insight into the molecular events within the hair follicle and discloses new possibilities 
to elucidate the mechanisms controlling the ‘living’part of the hair.
 
 
390
Antimicrobial defense of human hair follicle epithelium: Inducible expression of 
RNAse 7 and psoriasin
KI Reithmayer1, KC Meyer1, W Funk2, R Gläser3, J Harder3, J-M Schröder3, R Paus1 
1University of Lübeck, Lübeck, Germany 2Clinic Dr Koslowski, Munich, Germany 
3University of Schleswig-Holstein, Kiel, Germany
An ever-increasing number of potent antimicrobial peptides is being identified in 
human epidermis (e.g. RNAse7, psoriasin). Although the hair follicle (HF) ostium 
represents the major skin port for microbial invasion in immunocompetent hosts, the 
HF is exceptionally well-defended against infection. This suggests the presence of 
effective antimicrobial peptides. Indeed, by immunohistochemistry of normal human 
scalp skin sections, the HFs’s outer root sheath showed specific immunoreactivity (IR) 
for RNAse7. However, this was significantly weaker staining than in the epidermis. 
Psoriasin is only found in the distal part of the outer root sheath and in the hair shaft 
keratin, mostly distal of the orifice of the sebaceous gland.Interestingly, stimulation 
of full-thickness human scalp skin fragments in serum-free organ culture with 
lipopolysaccharides appeared to upregulate RNAse 7 and psoriasin IR. (validation 
by quantitative immunohistomorphometry in progress). In a single patient who 
had developed the typical, generalized sterile perifolliculitis under treatment with 
cetuximab (=EGF-R signalling inhibitor that is known for its drug-induced pustular 
exanthemas), RNAse 7 and psoriasin IR were massively upregulated in the distal outer 
root sheath. It is tempting to speculate that this might have attracted the neutrophil 
infiltrates.This pilot study suggests that RNAse 7 and psoriasin are important inducible 
actors in the antimicrobial HF defense system. Drugs that induce a sterile pustular 
perifolliculitis may do so by inappropriately stimulating the HF’s antimicrobial 
peptide defense system.
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Trichoscopy in differential diagnosis of alopecia areata
M Pawlowska1, T Stasiak1, M Olszewska1, A Rakowska2, M Slowinska2, E Oledzka2, L 
Rudnicka3 1Warsaw Medical School, Warsaw, Poland 2CSK MSWiA, Warsaw, Poland 
3Polish Academy of Sciences, Warsaw, Poland
The term ‘trichoscopy’defines videodermoscopy of hair and scalp. The aim of the study 
was to define specific trichoscopic features of alopecia areata. 23 patients with established 
diagnosis of alopecia areata were included into the study. In each patient trichoscopic 
images of alopetic patches (AA) and images of unaffected scalp skin (US) were evaluated 
and registered with the use of FotoFinder II videodermoscope at 20-fold and 70-fold 
magnification. Images were compared to healthy persons’ trichoscopy from a previously 
established database. Alopetic patches evaluated at 70-fold magnification revealed 
prevalence of micro-exclamation-mark hairs (mean: 0.45 in visual area), broken hairs 
(mean: 5.8 in v.a.) (p = 0.0230), tiger tail hairs (mean: 0.4 in v.a.), bulbs with no hair 
shaft (mean: 8.65 in v.a.) (p = 0.0056), bended hairs (mean: 0.3 in v.a.) and crochet hook 
hairs (mean: 0.5 in v.a.). These features were not seen in patients’ unaffected scalp skin 
or in healthy individuals. Moreover, percentage predominance of vellus hairs (27.24%), 
perifollicular tint areas (35.48%), hyperkeratotic plugs in hair follicles, perifollicular fibrosis 
and skin exfoliation in AA images at a 20-40-fold magnification was observed. The hair 
diameter was 0.0572+/-0.1911 mm (mean +/- SD) in AA as compared to 0.0706+/-0.0079 
mm in US (p = 0.05). There was no significant difference between area of perifollicular tint 
in AA 0.0931+/-0.7329 mm² and in US 0.0911+/-0.672 mm². In conclusion, presence of 
features specific for alopecia areata in trichoscopy, such as micro-exclamation-mark hairs 
and high percentage of broken hairs, tiger tail hairs, bulbs with no hair shaft, crochet hook 
hairs and hyperkeratotic plugs in hair follicles, make trichoscopy a useful tool in supporting 
the diagnosis of alopecia areata. 
 
392 [Oral 017]
T-B cell interaction is crucial for the induction of desmoglein 3-specific IgG 
autoantibodies in an HLA-class II transgenic mouse model of pemphigus vulgaris
R Eming1, M Hertl1, J Schmidt1, E Podstawa1, C Feliciani2, G Sonderstrup3 1Philipps 
University Marburg, Marburg, Germany 2Universita Cattolica, Rome, Italy 3Stanford 
University, Medical School, Stanford, USA
Pemphigus vulgaris (PV) represents a potentially life-threatening blistering autoimmune disease 
of the skin and mucous membranes. In PV, IgG autoantibodies are directed mainly against 
desmoglein 3 (dsg3) a transmembranous component of desmosomes. Previous in vitro studies 
suggest a decisive role for dsg3-reactive CD4+ T cells in providing help for the production of 
dsg3-specific IgG by autoreactive B cells. We developed an in vivo mouse model for PV using 
HLA-class II transgenic mice carrying the PV-associated haplotype HLA-DRB1*0402-DQ8. 
Immunizing these HLA-class II transgenic mice with human dsg3 (entire ectodomain) induces 
autoaggressive CD4+ T cells recognizing dsg3-epitopes identical to those previously identified in 
PV patients. Repetitive immunizations with human dsg3 leads to the generation of dsg3-reactive 
IgG that can be detected by ELISA and indirect immunofluorescence. These in vivo induced 
dsg3-reactive IgG antibodies are pathogenic and lead to loss of keratinocyte adhesion as shown 
by a keratinocyte dissociation assay. The current study aims at investigating the role of dsg3-
reactive CD4+ T cells for the secretion of dsg3-specific IgG antibodies. HLA-class II transgenic 
mice were treated with the CD4+ T cell depleting antibody GK1.5 (500µg i.p./mouse) prior to 
and during immunization with dsg3. Compared to isotype control treated mice, GK 1.5-injected 
animals demonstrated a dramatically reduced IgG response to dsg3 (optical density values of 
GK1.5-treated mice: 0.73 vs 4.0 in isotype controls). Moreover, using the monoclonal anti-
CD40L antibody MR-1 (500µg i.p./mouse) which blocks the T-B-cell (CD40-CD40L) interaction 
the development of dsg3-reactive IgG was completely abrogated. These data strongly suggest that 
autoreactive CD4+ T cells recognizing dsg3-eptopes in an HLA-class II-restricted manner initiate 
and drive the autoantibody response in PV through close interaction with autoreactive B cells. 
393 [Oral 023]
UV-inducible autoimmune skin disease in mice lacking epidermal JunB
L Kenner1, P Pflegerl1, A Soleiman1, P Wolf2, P Petzelbauer1, A Meixner1, EF Wagner1, 
E Janig2 1Medical University of Vienna, Austria 2Medical University of Graz, Austria
JunB is a member of the activator protein (AP)-1 transcription factor, regulating cell 
cycle progression, differentiation and apoptosis. To investigate the role of junB in the 
epidermis, we took advantage of mice carrying floxed alleles of JunB and K5-Cre 
mice for specific deletion in the epidermis (JunBδep). The phenotype of the mice 
was investigated by light microscopy, imunohistochemistry, immunofluorescence 
microscopy, electron microscopy, quantitative rt-PCR, FACS-ELISA and western blot. 
JunBδep mice are born with mendalian ratio, however keratinocytes hyperproliferate 
and mice develop an UV-light inducible skin disease. We could demonstrate that 
these mice specifically overexpress G-CSF and IL-6 protein and RNA. JunBδep 
mice spontaneously produce ANAs and increased levels of anti-Histone H1, H2A, 
H2B, H3 and H4 serum antibodies. At 6 months of age, kidneys of JunBδep mice 
revealed massive subendothelial IgG positive immunecomplex-depots, indicating 
a full blown immunecomplex glomerulonephritis. Furthermore, CD3+ lymphocyte 
infiltrations were found in blood vessels of liver, lung, and kidney. JunBδep mice 
showed described phenotype in both the backgrounds of BL6 and sv129/BL6 mouse-
strains. The outbreak of the autoimmune disease can be induced by 2 weeks of UV- 
irradiation. In summary, this study describes a novel mechanism by which the loss of 
epidermal JunB protein causes an UV-inducible skin disease with production of high 
IL-6 and G-CSF levels, as well as ANAs and anti-Histon antibody levels. The results 
demonstrate that the epidermis can act as an endocrine-like organ and epidermal loss 
of JunB can result in a severe autoimmune disease with multi-organ participation. 
 
394 [Oral 070]
Genetic characterization of human Dsg3-specific B cells isolated by flow cytometry 
from peripheral blood of patients with pemphigus vulgaris
J Yamagami, H Takahashi, T Ota, M Amagai Keio University School of Medicine, 
Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune bullous disease caused by anti-desmoglein 
3 (Dsg3) IgG. Mechanisms of antibody pathogenicity are difficult to characterize using 
polyclonal patient sera. In this study we developed a method to isolate Dsg3-specific B 
cells by flow cytometry from peripheral blood of patient with active PV, PCR amplify cDNA 
for heavy and light chains from a single B cell, and analyze their gene usage. We used 
recombinant human Dsg3 with E-tag (rDsg3-E-His) as a probe to detected Dsg3-specific 
B cells that express surface IgG as CD3-IgD-PI-Dsg3+ population, and visualized them by 
Alexa488-conjugated anti-E tag antibody. To optimize the staining protocol, we used mouse 
AK23 and AK9 hybridoma cells that react and do not react with human Dsg3, respectively. 
With our protocol, we detected Dsg3-specific B cells in a PV patient, whose frequency 
was higher than that in a healthy individual (87 in PV; 20 in control, out of 500000 total 
events). Then using this protocol, we isolated single Dsg3-specific B cells by FACS from 4 PV 
patients, and performed RT-PCR on them and direct sequencing. We obtained 19 sequences 
for heavy chain, 16 for kappa chain, and 17 for lambda chain from those 4 patients. We 
also defined the third complementarity-determining region (CDR3) of variable region by 
comparing the human genome database. We found some shared identical gene usages of 
variable region as well as CDR3 sequences in several single B cells isolated from the same 
PV patient, suggesting clonal expansion of autoreactive B cells. Our isolation method for 
Dsg-specific B cells will provide a valuable tool to systematically analyze immunoglobulin 
gene usages in PV patients for elucidating the immunopathogenesis of disease. 
 
395 [Oral 071]
Suppressive effects of CD4+ CD25+ regulatory T cells on the development of 
phenotypes in a mouse model of pemphigus vulgaris
T Yokoyama, S Matsuda, Y Takae, M Amagai, S Koyasu Keio University School of 
Medicine, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune blistering disease that is caused by IgG 
autoantibodies against the cadherin-type adhesion molecule desmoglein3 (Dsg3). We 
have previously established an active mouse model for PV by adoptive transfer of Dsg3-/- 
splenocytes into Rag2-/- mice which express Dsg3. The CD4+ CD25+ regulatory T cells 
(Tregs) play critical roles in maintaining immunologic self-tolerance and their deficiency 
can cause autoimmune diseases. The purpose of this study was to determine whether Tregs 
suppress the development of the PV phenotypes in our mouse model. CD4+ CD25+ Tregs 
and CD4+ CD25- conventional T cells (Tconvs) were obtained from splenocytes of wild-
type mice. The same numbers of purified Tregs or Tconvs were transferred into syngenic 
Rag2-/- mice, along with splenocytes from Dsg3-/- mice immunized with recombinant 
Dsg3. The titers of anti-Dsg3 antibodies were significantly lower in the Treg-transferred 
mice than those of Tconv-transferred group. The development of PV phenotypes, such as 
body weight loss and hair loss, was also delayed by approximately 1 week in the Treg-
transferred mice compared with Tconv-transferred mice. The suppressive effects of Tregs 
were dose dependent. We further examined the effect of endogenous Treg on PV onset. 
The titers of anti-Dsg3 antibodies were significantly higher in the mice transferred with 
naïve Dsg3-/- splenocytes depleted of endogenous Tregs than those transferred with the 
untreated splenocytes. Constantly, the severity of PV phenotypes was more significant in the 
former group. In contrast, control mice, which were transferred with wild-type splenocytes 
depleted of endogenous Tregs, had neither apparent PV phenotypes nor detectable 
levels of anti-Dsg3 antibodies. These results collectively suggest that CD4+ CD25+ Tregs 
are involved in the regulatory mechanisms of antibody production in PV model mice. 
396 [Oral 072]
Characterization of autoreactive B cell response to BP230 and identification of an 
immunodominant region targeted by bullous pemphigoid autoantibodies
V Calabresi1, L Borradori2, G Zambruno1, G Di Zenzo1 1IDI-IRCCS, Rome, Italy 
2University Hospital of Geneva, Geneva, Switzerland
Bullous pemphigoid (BP) is a subepidermal bullous disease of skin and mucosae 
associated with autoantibodies against BP230 and BP180, two hemidesmosomal 
components. Although the majority of BP sera react with an immunodominant 
domain of BP180, termed NC16A, approximately 20% of BP sera do not bind to 
the NC16A domain, but recognise different epitopes on BP180 and/or BP230. To 
better characterize the humoral response to BP230, we generated a BP230 random 
epitope library displayed on lambda bacteriophage. The library was first validated by 
mapping three anti-BP230 monoclonal antibodies (10D, C-319 and BP3) and one 
polyclonal antibody (E14). Subsequently, library selection with 9 well-characterized 
BP sera led to the identification of 10 BP230 epitopes, located predominantly in 
the COOH-terminal region. Fifty BP and 60 control sera were then assayed against 
the 10 selected epitopes using independent ELISAs based on the correspondent 
recombinant phages. Twenty-seven of 50 BP sera (54%) recognized at least one 
isolated BP230 epitope and 21 sera (42%) reacted with epitopes in the C-terminal 
region of BP230. Specifically, the latter strongly reacted with an immunodominant 
region of BP230 encompassing residues from 2370 to 2437. In addition, this 
BP230 immunodominant region appeared to be frequently recognized by NC16A-
negative BP sera. In fact, a retrospective analysis of 102 BP patient sera showed that 
12 of 20 (60%) NC16A negative sera bound to this immunodominant epitope by 
ELISA. Together, our results: 1) provide further insight into the humoral response 
to BP230 in BP, and 2) allow the development of a diagnostic ELISA utilizing the 
newly identified immunodominant region of BP230. The latter may be extremely 
useful for the detection of circulating autoantibodies in NC16A-negative BP sera. 
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T and B cell responses targeting distinct regions of the non-collagenous domain 1 
(NC1) of Collagen VII correlate with the clinical activity of EBA
R Müller1, C Dahler1, C Möbs1, E Wenzel1, CM Veldman1, G Messer2, SC Hofmann3, M 
Hertl1, A Niedermeier1 1Philipps University Marburg, Germany 2Ludwig-Maximilians-
University of Munich, Germany 3University Medical Center Freiburg, Germany
EBA is a chronic subepidermal bullous disease of the skin and mucosa characterized by the 
presence of autoantibodies (auto-ab) against type VII collagen (Col VII), a major component 
of anchoring fibrils. Epitopes recognized by the majority of EBA sera were mapped to the 
NC1 domain of Col VII. The aim of this study was to develop a highly sensitive and specific 
ELISA for the detection of Col VII-reactive auto-ab to identify early patients with EBA and 
prevent long-term complications of the disease due to late onset of immunosuppressive 
therapy. Utilizing a baculovirus-derived ELISA with three overlapping recombinant proteins 
of the Col VII-NC1 (NC1(1), aa17-610; NC1(2), aa273-857; NC1(3), aa611-1253), EBA 
(n=15), bullous pemphigoid (n=20), unrelated bullous diseases (n=20) and healthy control 
sera (n=30) were tested for the presence of Col VII-specific IgG. A total of 10/15 (67%) of 
the EBA sera showed IgG reactivity with the Col VII-NC1 recombinants while none of the 
pemphigoid and healthy control sera showed IgG reactivity by ELISA. Moreover, 7/20 sera 
of yet unclassified bullous disease patients showed IgG reactivity with Col VII-NC1. Two 
patients with severe mechano-bullous EBA showed a direct correlation of IgG reactivity 
against Col VII-NC1 and disease severity determined by the autoimmune bullous severity 
and intensity score (ABSIS) over a period of 20 months. Col VII-reactive T cells were detected 
in a patient with EBA and recognized epitopes within Col VII-NC1(3). Our findings suggest, 
that 1) our established Col VII-NC1 ELISA is a powerful tool for diagnosis of EBA, 2) Col VII-
specific IgG titers correlate with disease activity and 3) IgG auto-ab reactivity is associated 
with T cell recognition of similar/identical epitopes of Col VII-NC1. 
 
398 [Oral 076]
Possible involvement of mast cells in the pathogenesis of xanthoma and 
atherosclerosis upon stimulation with oxidized low-density lipoprotein
M Matsumoto, K Wada, M Kurokawa, M Ikeda, R Kamijima, H Kodama, S Sano Kochi 
Medical School, Nankoku, Japan
The common histological feature of atherosclerosis and cutaneous xanthomas is the 
infiltration of the lesions by macrophage-derived lipid-laden foam cells. Degranulated mast 
cells are also present in these lesions, thus implying that mast cells are involved in the 
pathogenesis of these diseases. However, the precise role of mast cells in developing these 
diseases is yet largely unknown. We examined whether mast cells could respond to oxidized 
low-density lipoprotein (Ox-LDL), which is one of aggravating factors for both conditions. 
Mouse skin- and peritoneum-derived mast cells were used in this study. The expression of 
scavenger receptors (SRs), responsible for Ox-LDL, was identified using RT-PCR and flow 
cytometry. Mast cell degranulation and cytokine/chemokine secretion in response to Ox-LDL 
were analyzed by beta-hexosaminidase assay and ELISA, respectively. Skin- and peritoneum-
derived mast cells both expressed class B, D, E, F and G SRs. These mast cells released 
beta-hexosaminidase upon Ox-LDL stimulation. Ox-LDL increased macrophage colony 
stimulating factor (M-CSF) secretion from these mast cells while monocyte chemoattractant 
protein-1 (MCP-1) secretion was decreased. Macrophages reportedly incorporate activated 
mast cell-derived proteoglycan-LDL complexes, resulting in conversion to foam cells. M-SCF 
prevents the progression of atherosclerosis by increasing hydrolysis of cholesteryl esters in 
macrophages and MCP-1 is a potent monocyte chemoattractant, suggesting that the increased 
M-SCF and decreased MCP-1 production may result in regressing the lesions. Our findings 
suggest that mast cells may be involved in the development of xanthoma and atherosclerosis 
through promoting and inhibiting actions upon macrophages after stimulation with Ox-LDL. 
399 [Oral 077]
A crucial role of inflammatory caspase-1 in non-classical protein secretion from 
fibroblasts and keratinocytes
M Keller, A Rüegg, S Werner, HD Beer Inst of Cell Biology, ETH Zurich, Switzerland
Caspase-1 is an inflammatory protease responsible for cleavage und activation of 
the pro-inflammatory cytokines interleukin(IL)-1β and IL-18, which are subsequently 
released by various cell types. Caspase-1 itself is activated by the inflammasome, 
an innate immune protein complex, which is also active in keratinocytes. IL-1β and 
-18 lack signal peptides and are therefore secreted by a poorly characterized ER/
Golgi-independent pathway. In this study, we demonstrate that caspase-1 is directly 
involved in such an alternative pathway, which is activated by UV irradiation in 
skin-derived keratinocytes and fibroblasts. Using cells from caspase-1 null mice, 
siRNA-mediated suppression of caspase-1 expression, and caspase inhibitors 
in human keratinocytes or fibroblasts, we demonstrate that secretion of IL-1α, of 
some inflammasome proteins and of basic fibroblast growth factor (bFGF; FGF-2) 
is actively mediated by caspase-1. All these proteins lack signal peptides and are 
not substrates of the caspase. Remarkably, bFGF is involved in tissue repair and 
angiogenesis, suggesting that caspase-1 simultaneously regulates different processes. 
On the mechanistic level, we show that caspase-1 directly binds to these proteins. 
Furthermore, protein secretion requires the active protease. Finally, using an iTRAQ 
based proteomics approach, we identified additional proteins lacking a signal peptide 
that are secreted from keratinocytes after UVB-irradiation in a caspase-1 dependent 
manner. These findings suggest that active caspase-1 serves as a transport aid in 
non-classical protein secretion. This is a novel function of this protease and affects 
also proteins, which are not substrates of caspase-1. It might thereby interconnect 
inflammation with other processes such as tissue repair and angiogenesis. 
 
400
Expression profile of matrix metalloprotainases in cutaneous lupus erythematosus
TM Jarvinen1, P Kanninen1, L Jeskanen1, S Koskenmies1, J Panelius1, T Hasan2, A 
Ranki1, U Saarialho-Kere1 1University of Helsinki, Finland 2Tampere University 
Hospital, Finland
Our aim was to investigate the expression of matrix metalloproteinases (MMPs) in skin 
lesions of patients with discoid (DLE), subacute cutaneous (SCLE) or systemic lupus 
erythematosus (SLE) and their relation to apoptosis and epidermal changes. Altogether 58 
lesional skin biopsies from LE patients and biopsies from UVA/UVB photoprovocated skin 
of healthy volunteers were immunostained for several MMPs, and for tissue inhibitors of 
metalloproteinases (TIMPs). Apoptotic keratinocytes were detected by the TUNEL method. 
Abundant expression of MMPs-3, -10 and -26 was observed in keratinocytes in patients with 
DLE, SCLE and SLE. MMP-7 was detected in keratinocytes characterised by vacuolization 
especially in SCLE and SLE, while MMP-14 was only occasionally found in keratinocytes. 
MMP-9 and -14 were also expressed by stromal cells. In contrast to low epithelial TIMP-1 
expression, TIMP-3 was abundantly expressed in the epidermis, endothelial cells and 
macrophages. Photoprovocation did not induce MMP-10 or -26 expression in healthy 
skin. Although several MMPs are capable of regulating apoptosis, only MMP-14 expression 
colocalized with apoptotic keratinocytes. We conclude that different LE subphenotypes 
resemble each other in their MMP expression profile. MMPs-3 and -10 mediate both 
epidermal changes and dermal tissue remodelling but are not present in lymphocytes. 
Stromal expression of MMPs-9 and -14 reflect their possible role in dermal remodelling. Our 
findings suggest, in agreement with previous studies, that MMPs as well as TIMPs may have 
multiple, important roles in the progression of inflammation and tissue damage seen in LE. 
Low TIMP-1 expression implicates that proteolytic events characterise lupus skin and targeted 
action using selective MMP inhibitors may reduce lupus-induced damage in inflamed tissues. 
 
401
In vitro modulation of Toll-like receptor-2, CD1d and interleukin-10 by adapalene 
on normal human skin and acne inflammatory lesions
I Tenaud, A Khammari, B Dréno University of Nantes, Nantes, France
The anti-inflammatory mechanisms of adapalene, a synthetic retinoid used for the 
treatment of acne patients are partially understood. They seem particularly related to 
the modulation of the non-specific immunity. Recent studies have shown that TLR-2 
expression, a receptor of the innate immune system was increased in acne lesions 
and could play an essential role in acne-linked inflammation. The aim of our study 
was to investigate new mechanisms of the anti-inflammatory activity of adapalene 
in vitro, and more specifically the modulatory effect of adapalene on the expression 
of TLR-2, CD1d a cell surface glycoprotein that plays a role as antigen presenting 
molecules and is responsible for the development of cutaneous inflammation and 
also on the expression and the secretion of the anti-inflammatory IL-10 cytokine. 
Both explants of normal human skin and explants of acne patients were incubated 
with Adapalene (10-7 or 10-6M) or the control medium during 24 hours. Epidermal 
expression of TLR-2, CD1d and IL-10 was evaluated by immunohistochemistry and 
IL-10 secretion by an ELISA method. Our results showed a decreased expression of 
TLR-2 and IL-10 in explants of normal skin and explants of acne with adapalene. 
On the contrary, adapalene increased CD1d expression in explants of acne patients. 
Thus, adapalene can modulate the epidermal immune system by increasing 
the CD1d expression and by decreasing the IL-10 expression by keratinocytes. 
Moreover, these modulations could increase the interactions between dendritic 
cells and T lymphocytes and could strengthen the antimicrobial activity against P. 
acnes. The decreased expression of TLR-2 by the keratinocytes can contribute to 
explain the anti-inflammatory activity of adapalene observed in clinical practice. 
 
402
Skin microcirculation in systemic sclerosis
A Waszczykowska1, K Kaluzna2, B Dziankowska-Bartkowiak1, E Waszczykowska1, 
R Gos1 1Medical University of Lodz, Poland 2Technical University, Lodz, Poland
Scleroderma (SSc) is a chronic connective tissue disease. Changes in medium and 
small diameter vessels, defined as a microangiopathy, are characteristcs for SSc. The 
aim of this study was to asses skin microcirculation in distal parts of upper limbs in 
sclerodermic patients using laser doppler flowmetry and thermovision examination.
18 SSc patients were preliminarily studied (age:37-76) and ten healthy patients 
served as a control group (age:35-73). Laser Doppler perfusion imaging was used 
to assess superficial skin circulation. The first probe was placed to the dorsal part of 
the hand , the second one was on distal phalanx of index finger. After a 5-minut of 
rest flow RF measurement microcirculation reaction after post-ischaemic hyperaemia 
test (reactive hyperemia test-RH) and thermal stimulation test (TSR) were performed. 
Results were compared with patients hands temperature before and after local cold 
exposure (18ºC). This examination was recorded using thermovision camera A40 ME 
Flir Systems. The RF measurment in SSc patients assessed by laser doppler flowmetry 
was lower than controls. RH reactions detected on the hands in a healthy volunteers 
were normal in 100%, in 20% of cases fingers RH measurement was border. In SSc 
patients RH reactions measured on the hands were normal only in 41,7%, in 33,3% 
were disturbed. RH test results detected on the fingers of SSc patients were abnormal 
in 83,3% of cases. TSR test performed on the hands and the fingers was normal in 
100% of healthy patients. In SSc patients the TSR reactions were normal only in 
8,3% subjects while in the 91,7% of the patients these reactions were disturbed. 
These results correlated positively with thermovision examination outcomes. Our 
study showed usefulness of laser doppler flowmetry and thermovision examination 
in assessment of vascular circulation disturbances presents in SSc patients.
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UV irradiation of human keratinocytes activates the inflammasome
HD Beer1, L Feldmeyer1, M Keller1, D Hohl2, S Werner1 1ETH Zurich, Switzerland 
2University Hospital Center of Lausanne, Switzerland
Human keratinocytes represent a potent source of the pro-inflammatory cytokines pro-
interleukin(IL)-1α and -β. ProIL-1β requires processing by caspase-1 (IL-1β-converting 
enzyme, ICE) for activation and receptor binding. ProIL-1α and -β lack a signal peptide 
and leave the cell via the alternative secretion pathway, which is independent of the 
classical ER/Golgi pathway. Both cytokines are stored in the cytoplasm and can be 
activated and released upon UV irradiation. In macrophages maturation of proIL-1β 
requires the activation of inflammasomes, innate multiprotein immune complexes, 
which are essential for the activation of caspase-1 and thereby for processing of 
proIL-1β. However, the intracellular pathways, which are responsible for activation of 
proIL-1β and secretion of IL-1β in keratinocytes, are unknown. We show that human 
keratinocytes express inflammasome proteins in vitro and in vivo. UVB irradiation of 
keratinocytes results in an increase of cytoplasmic Ca2+ from intracellular stores. This 
shift is required for inflammasome-dependent activation of caspase-1 and subsequent 
processing of proIL-1β and secretion of IL-1β. In contrast to macrophages, caspase-1 
cannot activate proIL-18 in keratinocytes, although secretion of this cytokine is also 
induced by UVB irradiation. In vivo, caspase-1 is also essential for UVB-induced 
inflammation in the skin, since caspase-1 knockout mice showed a strongly reduced 
inflammatory response after UVB irradiation. Our results suggest that keratinocytes are 
important immuno-competent cells under physiological and pathological conditions. 
 
404
Anti-Dsg3 and anti-Dsg1 antibodies isolated from sera of healthy relatives of PV 
patients do not up-regulate expression of uPAR, IL-1, IL-6 and TNF-alpha mRNAs 
in HaCaT cells
J Narbutt1, J Boncela2, K Smolarczyk2, C Kowalewski3, K Wozniak3, A Lesiak1, 
A Sysa-Jedrzejowska1 1Medical University of Lodz, Lodz, Poland 2Polish Academy of 
Science, Lodz, Poland 3Medical University of Warsaw, Warsaw, Poland
Pemphigus is an autoimmune blistering disease characterized by bound in vivo and circulating 
pemphigus autoantibodies directed against transmembrane cadherines of the desmosome, 
desmogleins (Dsg) 3 and 1. Although pemphigus autoantibodies are detected by IIF and (in 
some cases) by ELISA in about 30-60% of healthy relatives of PV patients, their pathogenic and 
clinical relevance is not well elucidated. Thus, the aim of the study was to assess the ability of 
those autoantibodies to alter uPAR, IL-1, IL-6 and TNF-alpha mRNAs expression in HaCaT cells. 
The study group consisted of 8 sera obtained from PV patients in active stage of the disease, 
5 taken from PV patients in clinical remission (mean length of treatment 2.5 years) and 4 sera 
obtained from their healthy relatives. In all the examined sera ELISA test revealed the presence 
of circulating anti-Dsg3 and anti-Dsg 1 antibodies. At next stage of the experiment we isolated 
anti-Dsg 3 antibodies from the sera with the using the recombinant fragment of desmoglein 
3 extracellular domain. After the incubation of isolated anti-Dsg3 and anti-Dsg1 antibodies 
with HaCaT cells we assessed the expression of uPAR, IL-1, IL-6 and TNF-alpha mRNAs (RT-
PCR method). In the groups of active and remission patients the expression of the examined 
proteins’ mRNAs was significantly higher when compared to the control group whereas 
stimulation of the cells with the antibodies isolated from healthy relatives gave no changes in 
mRNAs expression of the studied proteins. The obtained results suggest lack of pathogennicity 
of the circulating antibodies present in the healthy relatives of PV patients and partially 
provide explanation why in sera(+) relatives direct immunofluorescence gives negative result. 
 
405
In vivo clustering of IgG, desmoglein 3 and plakoglobin in the skin and mucous 
membranes of pemphigus vulgaris patients
DAM Oktarina, MCJM De Jong, MF Jonkman, HH Pas University Medical Centre 
Groningen, Netherlands
Immunologically, pemphigus is characterized by circulating IgG antibodies that 
deposit between epithelial cells, and histopathologically by intraepidermal separation. 
The cadherin desmoglein 3 has been suggested as the main autoimmune target of 
pemphigus vulgaris (PV) IgG. Recent research suggests that cell-cell dissociation is not 
due to steric hindrance of cadherin binding sites but rather a result of cell-signalling 
events with a prominent role for plakoglobin. Here we have analyzed in vivo events in 
skin and mucous membranes of PV patients by studying the deposition pattern of IgG 
in relation to the distribution of desmosomal and non-desmosomal components. A 
strict inclusion criterion was that the patients’ IgG was directed to desmoglein 3 only to 
rule out pathogenic effects of anti-desmoglein 1 IgG. The majority of these PV patients 
had the oral form but some also showed cutaneous lesions. Healthy PV-skin biopsies 
displayed clustered IgG. The autoimmune target desmoglein 3 co-clustered but the 
other cadherines, desmoglein 1, desmocollins 1 and 3, kept their smooth intercellular 
distribution. Intracellular plaque proteins desmoplakin, envoplakin, periplakin, plectin 
and plakophilin 3 also remained normally distributed as did the adherens junction 
proteins beta-catenin and desmoyokin. The only other component that co-clustered 
was plakoglobin. This was especially noted in diseased mucosa. In healthy PV-skin 
the plakoglobin largely kept its normal distribution with only a slight tendency to 
cluster. We conclude that the IgG aggregates not with complete desmosomes, but with 
selected desmosomal components instead. Clustering of only IgG and desmoglein 3 
is not enough to induce complete pathogenesis in vivo, as demonstrated by such 
clusters in never blistering skin in oral PV. Co-clustering of IgG with desmoglein 
3 is an early phase of disease, but additional factors are needed for acantholysis. 
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ASAP syndrome in acute lupus erythematosus succesfully treated with etanercept
B Didona, F Canzona, T Tonanzi, SC Starita, G Antonelli IDI, Rome, Italy
ASAP syndrome (Acute Syndrome of Apoptotic Pan Epidermolysis) is a rare and 
newly recognised cutaneous-systemic condition clinically characterized by Toxic 
Epidermal Necrolysis (TEN)-like appearance. Ting and Sontheimer have delineated 
clinical and laboratoristic features of this syndrome that can appear-in addition to 
classic TEN- in settings of LES, Graft Versus Host Disease and pseudoporphyria. We 
describe a 25-year old caucasian women, suffering from LES since teen-age with 
renal and cerebral involvement, who developed acute, diffuse, erythematous rash 
followed by flaccid bullae and sheet-like epidermal detachements remembering TEN. 
She denied drug intake.The patient had high fever, fatigue, arthritis. Blood test were 
remarkable for leucopenia, anemia and low C4. Autoimmune serology revealed ANA 
1/1280 with omogeneous fluorescence pattner; SM pos.311 U/ml; RNP pos.272 U/
ml; anti-histone antibodies pos. 89 U/L. Histological examination of skin sample 
showed a full thickness epidermal necrosis with a cleavage at dermo-epidermal 
junction level. Direct immunofluorescence microscopy revealed a linear granular 
staining at basement membrane zone for Ig M, C1q and fibrinogen. No circulating 
autoantibodies to type VII collagen are detected. On the basis of these risults we 
maked the diagnosis of ASAP syndrome in TEN-like acute LES. Initially the patient 
was given etanercept(50 mg. s.c./die) at the first and fifth day. The fever disappeared 
fast and cutaneous lesions improve in few days. Subsequently the patient was treated 
with prednisone(80 mg/die e.v. for one day and then 50 mg/die per os at home). 
One month before the dismission only a mild erythema on the face was seen. The 
pathogenetic aspect of this syndrome and the therapeutic option are discuss. 
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Circulating regulatory T cells (CD4+/CD25++) in patients with psoriasis
M Gonçalo1, R Nunes2, J Morgado3, A Paiva3, A Figueiredo1 1University Hospital, 
Coimbra, Portugal 2Escola Superior de Tecnologia da Saúde, Coimbra, Portugal 
3Centro de Histocompatibilidade do Centro, Coimbra, Portugal
Immune-inflammatory, autoimmune and innate immune reactions play a role in psoriasis 
in a still incompletely understood way, which regulatory CD4+CD25++T cells (Treg) seem 
to be unable to control, as in other autoimmune diseases. We characterized Tregs in the 
peripheral blood of psoriatic patients and correlated the values with the body surface area 
(BSA) and presence of psoriatic arthritis. Studies were performed on peripheral blood of 18 
patients with psoriasis without systemic treatment for more than 4 weeks (8M/10F; mean 
age 47±19 years) and 8 individuals without the disease (4M/4F, mean age 44± 9 years). 
Subpopulations of CD4+ T cells (CD4+CD25++, CD4+CD25+ and CD4+CD25-) and their 
expression of the chemokine receptors CCR7 and CCR6 and skin homing receptor CLA were 
quantified by flow cytometry. mRNA for TGF-β was quantified in circulating leukocytes by 
real time PCR. There was a significant decrease in the percentage of CD4+ T cells exhibiting 
the T regulatory phenotype (3,6±1,1% versus 6,3±1,5%), more intense for patients with 
>10% BSA or with psoriatic arthritis. Also, these cells expressed less CCR7 (13±5% versus 
19±8%), CCR6 (2,1±1,7% versus 2,5±1,9%) and CLA (16±8% versus 23±5%) than in 
controls. TGF-β mRNA showed a high variability in psoriatic patients (185±154) compared 
to controls (20±4). As in other autoimmune diseases and in agreement with a previous 
work, psoriatic patients have less circulating Tregs compared to controls, especially in worse 
patients. Moreover, these cells show phenotypic modifications in the expression of receptors 
involved in cell migration to the skin (CLA, CCR6) and secondary lymphoid organs (CCR7), 
which may further difficult their access to the psoriatic lesion.
 
 
408
Regulatory T cells suppress the psoriasiform skin disease through TGF-beta signals in 
the CD18 hypomorphic murine model of psoriasis
H Wang1, T Peters1, D Kess1, A Sindrilaru1, T Oreshkova1, XZ Yu2, JM Weiss1, AM 
Seier1, K Scharffetter Kochanek1 1University of Ulm, Germany 2Dept of Experimental 
Therapeutics, South Florida, USA
Dysfunctional CD4+CD25+ regulatory T (Treg) and CD4+CD25- effector T cells have 
been identified in human psoriasis, however, their role in its pathogenesis remains 
unclear. We previously showed that CD18 hypomorphic (CD18hypo) PL/J mice with 
reduced levels of the common chain of beta2 integrins (CD11/CD18) to only 2-16% 
of wild-type levels develop a psoriasiform skin disease strongly resembling human 
psoriasis. Here, we report that the reduced expression of CD18 is responsible for an 
impaired cell-cell contact between CD4+ and dendritic cells (DCs) as shown by 4PI 
microscopy, leading to a defect in expansion and activation of antigen-experienced 
Treg cells, eventually resulting in a dysfunctional Treg cell population. In contrast, low 
expression of CD18 does not disturb the cell-cell contacts between dendritic cells 
and CD4+CD25- responder T cells in that they are antigen specifically activated and 
converted into pathogenic memory T cells. Dysfunctional CD18hypo Treg cells do not 
sufficiently produce TGF-beta1, whereas CD18 wild-type (CD18wt) Treg cells produce 
a large amount of TGF-β1 after adoptive transfer into affected CD18hypo mice. CD18wt 
Treg cells, but not CD18hypo Treg cells, suppress pathogenic T cells, thus resulting 
in a significant improvement of the psoriasiform skin disease as assessed by adapted 
PASI score. The suppressive function of CD18 wild-type Treg cells is mediated through 
TGF-β1. These findings may imply a potential immunotherapeutic strategy to boost 
immunity by TGF-beta-producing Treg cells in autoimmune diseases, such as psoriasis. 
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Psoriatic fibroblasts-mast cells interactions enhance inflammation
J Grabarczyk1, J Wyczolkowska2, A Zalewska1 1Medical University of Lodz, Lodz, 
Poland 2Centre for Medical Biology, PAN, Lodz, Poland
Fibroblasts and mast cells interactions have been suggested to participate in 
neurogenic inflammation in psoriatic plaques development. The aim of the study was 
to evaluate nitric oxide production (NO) upon substance P (SP) stimulation in psoriatic 
fibroblasts-mast cells co-cultures. Fibroblasts were obtained from psoriatic lesions, 
perilesional skin and healthy subjects skin by enzymatic dispersion. Immature mast 
cell line (HMC-1) was also employed. For co-cultures both fibroblasts and mast cells 
were used at a density of 2x104 cells/experiment. HMC-1 cells were preincubated 
with mitomycin (15mg/ml). Cells were stimulated by SP (10-15, 10-13, 10-11, 10-10, 
10-9 , 10-8 M). The experiments were performed in duplicate. When stimulated with 
SP (10-9 , 10-8 M ) co-cultures of lesional psoriatic fibroblasts with HMC-1 produced 
significantly higher NO levels in comparison to lesional psoriatic monocultures 
(p<0.05). Using all the employed SP concentrations, perilesional psoriatic fibroblasts 
monocultures and co-cultures with HMC-1 produced significantly higher NO levels 
than normal fibroblasts and co-cultures with HMC-1, respectively (p<0.05). The 
obtained results suggest that perilesional psoriatic fibroblasts actively participate 
in the early phases of psoriatic lesion development, before inflammatory infiltrate 
develops and the lesion is clearly visible with the naked eye. Furthermore, lesional 
psoriatic fibroblasts-mast cells interactions significantly stimulated NO production 
thus they could be responsible for inflammation maintenance. 
 
 
410
Influence of stress on white blood cells and oxidation index and its relationship with 
severity in acne patients
HK Ikeno1, M Takahashi2, S Kimura2 1ikeno Clinic, Tokyo, Japan 2Pola Chemical 
Industry, Yokohama, Japan
As a pathophysiologic factor of acne, reactive oxygen came to the fore recently, and it was 
reported that antioxidant vitamin derivatives had a beneficial effect on acne. It is suggested 
that stress makes sympathetic nerve dominant, and disruption of the balance in autonomic 
nerve affects immunity function and inflammatory reaction, which lead to the increase of 
neutrophils and reactive oxygen from neutrophils. Therefore, we investigated the relationship 
between stress and oxidation in body, and exacerbation of acne lesion with oxidation. After 
blood samples were taken from 98 newly diagnosed acne patients and 24 healthy volunteers, 
these samples were subjected to FRAS4 to measure the antioxidant index (BAP) and oxidative 
stress (d-ROMs). The ratio of neutrophils and lymphocytes in white blood cells was measured 
with auto blood cell analyzer. The subjective stress level was investigated with a questionnaire. 
Furthermore, severity was classified into three grades and the relationship between oxidation 
and severity was investigated with additional patients, in total of 127 acne patients. BAP in 
the acne patients was significantly lower (p=0.0001) than that of healthy subjects. The acne 
patients had a higher proportion of neutrophils and a lower lymphocytes compared to the 
healthy subjects. Subjective stress level in the acne patients was higher than that in the healthy 
subjects. Among the acne patients, the neutrophils ratio was significantly higher (p=0.05) in 
the patients with high subjective stress. The ratio of acne patients with high oxidant stress 
was correlated with severity of acne (P=0.0029). We concluded that the acne patients had a 
lower antioxidant index and higher neutrophils ratio. The degree of oxidation in body may be 
elevated by the reactive oxygen from neutrophils. It is suggested that elevation of oxidation in 
body affects severity of acne and exacerbates the acne lesion. 
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Upregulation of CD26 / Dipeptidyl peptidase IV in psoriatic lesions
RG van Lingen, PCM Van de Kerkhof, MMB Seyger, EMGJ De Jong, DWA Van Rens, 
M Poll, PL Zeeuwen, PEJ Van Erp Univ Medical Centre St Radboud Nijmegen, 
Nijmegen, Netherlands
The objective of this study was to assess the expression of CD26 / DPPIV in order 
to expand on the search for complementary (discriminating) biomarkers related to 
inflammation and proliferation in psoriasis.The expression pattern of CD26 / DPPIV in 
psoriasis was investigated at mRNA, protein and enzyme functionality level using qPCR, 
immunohistochemical, immunofluorescent labeling techniques as well as a cytochemical 
enzyme activity assay. An 11-fold statisticallly significant increase of CD26 / DPPIV was 
found on mRNA level in the examined psoriatic epidermal sheets compared to normal 
epidermis. When immunohistochemical staining procedures were performed on frozen 
sections of psoriatic lesions, a distinct patchy honeycomblike moderate to pronounced 
CD26 staining was observed in the suprapapillary layers of the epidermis. In addition, a 
clearly distinguishable columnlike staining pattern from the basal layers throughout the 
suprabasal compartment along the rete ridges was seen, whereas in normal skin these 
patterns were absent. DPPIV enzyme activity was distributed in a similar pattern compared 
to the just-mentioned immunohistochemical positivity for the CD26 protein. The T-cell 
bound expression of CD26 in psoriatic skin was explicitly present, albeit in small quantities. 
Our data provide evidence for a strong upregulation of CD26 / DPPIV in psoriatic (epi)
dermis on mRNA-, protein- and enzyme functionality level alike the T-cell bound expression 
of CD26 / DPPIV. This study reveals that CD26 / DPPIV can exert a crucial function and can 
act on the major pathogenetic key players in psoriasis. This points to a versatile, complex 
yet possibly important role for this protein in epidermal proliferation and T-cell signalling in 
psoriasis. Although the exact functional contribution remains speculative, the topographical 
distribution of this complex suggests a suitable role as a complementary biomarker in psoriasis. 
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Expression of serotonin transporter protein in psoriasis
K Thorslund, S-B Lonne-Rahm, K Nordlind Karolinska Institute, Stockholm, Sweden
Psoriasis is a chronic skin inflammatory disease. It may worsen in connection to 
stress or mood disorders. Serotonin (5-HT) is an important transmitter and released at 
high concentrations at sites of inflammation. The serotonergic response is determined 
regarding its duration and magnitude through action of the serotonin transporter 
protein (SERT). The aim of this study was to investigate the expression of 5-HT and 
SERT in psoriasis skin in correlation with apoptotic markers. Biopsies were taken from 
involved and non-involved skin of the back in 13 otherwise healthy psoriasis patients, 
7 males and 6 females, with a plaque/guttate type of psoriasis, and from normal 
skin in 10 healthy individuals, 5 male and 5 females. The biopsies were sectioned 
and processed for immunohistochemistry using a biotinylated streptavidine method. 
Immunoreactivity for 5-HT was found mainly in the vessel walls and in platelets. 
There was an increase (P<0.05) of epidermal dendritic SERT positive cells in involved 
psoriatic skin, 14±9 cells per section, compared to normal control skin, 5±7, with no 
difference compared to non-involved psoriatic skin, 9±10. There was also an increase 
(P<0.01) of SERT positive mononuclear cells in the papillary dermis of the involved 
skin, 121±47, compared to normal control skin, 58±12, and to non-involved skin, 
82±23, also with an increase (P<0.05) in the non-involved skin, compared to normal 
control skin. The SERT positive cells were CD1a, CD3 or tryptase positive. There 
was a co localization of SERT with the apoptosis regulating enzyme caspase-3 in 
some of the dermal cells, however not with TUNEL positivity. It might be that the 
SERT expressing cells are under apoptosis and the resulting balance between viable 
and apoptotic cells may have an impact on the inflammatory process of psoriasis. 
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Neutrophil-derived NADPH oxidase is required for antibody-induced tissue damage 
in experimental bullous pemphigoid
T Chiriac, F Olaru, D Zillikens, C Sitaru University of Lübeck, Germany
Bullous pemphigoid (BP) is a blistering disease characterized by autoantibodies against 
hemidesmosomal proteins. Both specific inhibition of NADPH-oxidase from normal 
granulocytes or the use of granulocytes from chronic granulomatous disease patients lacking 
NADPH-oxidase abolished dermal-epidermal separation induced by BP autoantibodies in 
cryosections of human skin. In addition, NADPH oxidase is required for antibody-induced 
tissue damage in experimental epidermolysis bullosa acquisita in vivo. Here, we show that 
NADPH oxidase is a prerequisite for the antibody-induced blistering in a newly established 
model of BP. Initially, we generated rabbit antibodies against a fragment of the murine 
BP180 corresponding to the immunodominant region of human BP180 in BP. Subsequently, 
adult mice deficient in the p47 subunit of NADPH oxidase (p47phox-/-) and wild type mice 
(n=8/ group) were injected with rabbit IgG specific to murine BP180. 7-10 days after the first 
injection of pathogenic antibody, all wild type mice developed blisters, erosions covered by 
crusts and alopecia. By histopathology, the blisters were subepidermal and associated with 
linear deposition of IgG and complement at the dermal-epidermal junction, as revealed 
by immunofluorescence microscopy. In contrast to wild type animals, p47phox-/- mice 
failed to develop blistering following the passive transfer of antibodies against BP180, 
despite similar levels of anti-BP180 antibodies in their serum when compared to controls. 
Both deficient and wild type (n=5) mice passively transferred with control antibody were 
free of lesions. Our findings establish a novel animal model for BP, which allows for a 
longer follow-up of animals. In addition, we identify granulocyte-derived NADPH oxidase 
as a key molecular effector in experimental BP and suggest that therapeutically targeting 
reactive oxygen species may prevent tissue damage in autoantibody-mediated diseases. 
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‘Eczemas’ and leptin
M Nino, N Balato, G Matarese, S Fontana, A Balato, V De Rosa, F Ayala University 
Federico II of Naples, NAPLES, Italy
Leptin, mainly secreted by adipocytes, belongs to the helical cytokine family and has 
structural similarity to IL-6, IL-12, IL-15, prolactin and growth hormone. Its plasma 
concentrations correlate with fat mass and respond to changes in energy balance. Initially, 
leptin was considered as an anti-obesity hormone, but experimental evidence has also 
shown pleiotropic effects of this molecule on hematopoiesis, angiogenesis, lymphoid organ 
homeostasis and T lymphocyte functions. Recent evidence indicates that leptin modifies 
T cell immunity promoting T helper 1 pro-inflammatory immune responses and cytokine 
production. Decreased leptin concentrations during conditions of food deprivation lead to 
impaired immune capabilities. These findings support the hypothesis that leptin plays a key 
role in linking nutritional state to the T cell function. This has prompted several studies of 
targeted intervention with leptin antagonists in rodents to suppress onset and/or progression 
of chronic inflammation and autoimmunity. The importance of leptin in the inflammatory 
response is demonstrated by evidence that mice defective in leptin or its receptor present an 
impaired T-cell immunity due to a deficit of T CD4+ lymphocytes with reduced biosynthesis 
of inflammatory cytokines. Administration of leptin to mice restores nutritional, immunitary 
and metabolic functions. The aim of the present study was to evaluate leptin serum levels 
in patients with allergic contact dermatitis (ACD) and atopic dermatitis and its correlation 
with different patterns of lymphocytes subpopulations. We found that ACD patients serum 
leptin levels (17.4 + 14.5 ng/ml) were higher than healthy controls (10.1 + 9.3 ng/ml) (p = 
0.02). In the same patients an inverse correlation between serum leptin and percentage of T 
CD4+CD25+ lymphocytes were observed (p = 0.002). Leptin is involved in T cell function, 
immune homeostasis and autoimmune disease susceptibility. Leptin may represent an 
important target for immune intervention.
 
2007 ESDR Abstracts v2.indd   69 8/13/07   11:31:44 PM
ABSTRACTS
S70  Journal of Investigative Dermatology (2007), Volume 127 
415
Human apolipoprotein C1 transgenic mice: a unique novel model of atopic 
dermatitis
R Verbeek1, P Verzaal1, T Lagerweij1, C Persoon-Deen1, E Prens2, LM Havekes1, AP 
Oranje2, AM Nagelkerken1 1TNO, Leiden, Netherlands 2University Medical Center 
Rotterdam, Rotterdam, Netherlands
Atopic dermatitis is a chronic inflammatory skin disease characterized by clinical symptoms 
such as a dry and scaly skin, hyperplasia of the dermis, lichenification and pruritus. In acute 
lesions, inflammation in atopic dermatitis is associated with an initial increased Th2 response 
while Th1 cells, eosinophils and mast cells are involved in the more chronic phase. Animal 
models are indispensable in obtaining insight into the pathogenesis of atopic dermatitis and 
in the development of new therapeutic strategies. Mice with a chronic overexpression of 
human apolipoprotein C1 in the liver and skin develop spontaneously clinical symptoms 
of atopic dermatitis i.e. scaling, lichenification, papules, and excoriation from an age of 
7 weeks onwards. Development of atopic dermatitis in these mice is accompanied by 
an increased pruritus during aging. Histological analysis shows a hyperplasia of both the 
epidermis and dermis and increased numbers of CD4+ T cells, eosinophils, mast cells and 
IgE-positive cells in the dermis. Serum levels of IgE are increased as well. Impairment of the 
skin barrier is most likely the underlying cause of the development of atopic dermatitis in this 
model since these mice show a loss of skin-barrier function as is evident from an increased 
trans-epidermal water loss. Development of atopic dermatitis in this model was found to 
be sensitive to topical treatment with triamcinolone-acetonide, fluticasone-isoproprionate 
and tacrolimus. Moreover, oral treatment with dexamethasone successfully inhibits several 
aspect of disease in this model. In conclusion, this animal model is useful for identifying new 
therapeutic strategies and obtaining new insight into the pathogenesis of atopic dermatitis. 
 
416
Psoriasis patients show signs of insulin resistence
S Boehncke, D Thaci, H Beschmann, RJ Ludwig, H Ackermann, K Badenhoop, 
WH Boehncke Johann Wolfgang Goethe-University, Frankfurt, Germany
Recent observations suggest that psoriasis is a risk factor for the development of 
coronary artery calcification which in turn represents an indicator for atherosclerosis. To 
clarify a possible pathogenetic link between psoriasis and atherosclerosis, we studied 
the metabolic state of patients with psoriasis. 40 consecutive patients with moderate-
to-severe plaque-type psoriasis were enroled in the study. Detailed informations were 
obtained on the patients´ clinical picture and history of psoriasis, smoking habits, 
and medication. The patients´ body mass indices (BMI) were calculated. Laboratory 
investigations focussed on parameters for inflammation, lipid profile, and multiple 
cytokines. Intima-media thickness of the carotid artery was measured by ultrasound, 
and an oral glucose tolerance test was performed to calculate the homeostasis model 
assessment of insulin resistance (HOMA). Numerous well-recognized correlations 
such as between BMI and HOMA (p<0.02) as well as BMI and vessel wall thickness 
(p<0.05) were successfully reproduced, thus confirming consistency of our data set. 
With regard to psoriasis, we observed a significant correlation between the PASI score 
and insulin secretion. Moreover, the PASI was significantly correlated with serum 
resistin levels - a cytokine known to be increased in insulin resistence. Taken together, 
several parameters indicative for insulin resistence were found to be significantly 
correlated with the PASI. The concept of insulin resistence as a consequence of 
chronic inflammation and possible pathogenetic cause for co-morbidities known to 
be associated with psoriasis is supported by these data. Our findings validate further 
studies on larger cohorts as well as interventional studies. 
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Suppression of inflammatory responses in human sebocyte by K(D)PT, a peptide 
fragment related to the C-terminal domain of alpha-melanocyte-stimulating 
hormone
A Mastrofrancesco1, A Kokot2, E Strozyk2, M Schiller2, CC Zouboulis3, M Picardo1, 
TA Luger2, M Böhm2 1S Gallicano Dermatological Institute, Rome, Italy 2University of 
Münster, Germany 3Dessau Medical Center, Germany
Sebocytes are central players in the pathogenesis of acne vulgaris by responding to 
interleukin-1 (IL-1) with secretion of IL-6 and IL-8. Since α-melanocyte-stimulating 
hormone (α-MSH) has been identified as a potent anti-inflammatory neuropeptide in 
many different cell types and sebocytes express melanocortin receptors it is reasonable 
to envision therapeutic strategies using this hormone as a novel anti-inflammatory 
agent in acne and related disorders. However, α-MSH is a tridecapeptide which due 
to its high molecular weight hardly penetrates the skin when topically applied. Using 
the immortalized human sebocyte cell line SZ95 as an in vitro model, we show that a 
small peptide derivative related to the last 3 amino acids of the C-terminal domain of 
α-MSH, K(D)PT, has profound anti-inflammatory actions on IL-1-mediated sebocyte 
responses. Accordingly, K(D)PT dose-dependently suppresses IL-1beta-induced IL-6 
and IL-8 expression at RNA and protein level. The mechanisms of this anti-inflammatory 
action of K(D)PT involves inhibition of IL-1beta-mediated cytoplasmic degradation 
of IkBalpha, decreased activation of p50, and reduced DNA binding of NF-kB to 
its consensus oligonucleotide sequence. Interestingly, K(D)PT did not modulate 
phosphorylation of several members of the mitogen- and stress-activated protein 
kinases including MAPK1/2 and p38, the latter markedly phosphorylated in response 
to IL-1beta alone. Our data point towards a novel therapeutic concept in the treatment 
of acne and related disorders, that is, the use of anti-inflammatory small molecular 
weight peptide fragments such as K(D)PT related to the C-terminal domain of α-MSH 
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A clinically relevant humanized mouse model of psoriasis for the identification and 
evaluation of candidate drugs
P Verzaal, M Smits, C Persoon-Deen, K Van Der Mark, A Plomp, AM Nagelkerken 
TNO Quality of Life, Leiden, Netherlands
We here describe a clinically relevant humanized mouse model of psoriasis allowing 
functional testing of therapeutic compounds. Full-thickness skin biopsies of non-lesional skin 
from psoriasis vulgaris patients were transplanted onto the back of hairless immunodeficient 
bg-nu-xid mice. After a period of 3 weeks the psoriatic process was triggered by intradermal 
injection of autologous peripheral blood derived T cells, after their activation in vitro by SEB 
superantigen. Activated T cell populations contained both CD4 and CD8 positive T cells and 
- at the moment of injection - expressed T cell activation markers like HLA-DR, CD25, and 
CD69. The induction of skin inflammation was evident from expression of activation markers 
HLA-DR and CD1a, production of inflammatory mediators including TNF-alpha, and increased 
proliferation and differentiation of keratinocytes, as illustrated by increased expression of Ki-
67 and CK-16. Determination of epidermal hyperplasia was used as main read-out parameter 
for the development of a psoriatic lesion, and evaluated to demonstrate a potential therapeutic 
effect of new drug candidates. In multiple studies this model was proven to represent a 
reliable platform for the functional pre-clinical testing of new therapeutic compounds. 
Inhibitory effects of a wide range of compounds including inhibitors of TNF-alpha, antibodies 
directed against growth factors, MMP-inhibitors, calcipotriol, metothrexate, betamethasone, 
and cyclosporine A could be demonstrated. In addition, we showed that inhibition of fatty 
acid oxidation had an anti-psoriatic effect in this model. To evaluate the clinical relevance 
of our induced psoriasis model, we performed similar analyses after direct transplantation 
of lesional skin biopsies. In this model we were able to confirm inhibition of the ongoing 
psoriatic process by several compounds. In conclusion, the humanized mouse model of 
psoriasis is a powerful tool for the identification or validation of new therapeutic compounds. 
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Functional analysis of interleukin-17 in the pathogenesis of psoriasis
C Conrad1, G Tonel1, JZ Qin2, E Oldham3, R Kastelein3, BJ Nickoloff2, FO Nestle4 
1University Hospital of Zurich, Switzerland 2Loyola University, Chicago, USA 
3Schering-Plough Biopharma, Palo Alto, USA 4St John’s Institute of Dermatology, 
London, UK
It has been proposed that the key effector cells in psoriasis are IFN-gamma secreting 
T helper (TH)-1 lymphocytes. Recently, a novel IL-17 producing T helper (TH-17) 
cell subset has been described and the functional relevance of TH-17 cells suggested 
in animal models of autoimmunity. Here, we analyzed the functional role of IL-17 
in psoriasis tissue samples as well as a clinically relevant psoriasis animal model. 
IL-17A mRNA was overexpressed in lesional psoriatic skin compared to non-
lesional or normal skin. IL-17 mRNA was induced in peripheral blood cells in a 
TNF-alpha dependent manner upon stimulation with staphylococcal enterotoxin 
B. Flow cytometry analysis of T cells revealed a significant increase of intracellular 
IL-17 protein production in psoriasis patients compared to healthy controls. IL-17 
producing T cells were enriched in psoriatic skin compared to blood. A significant 
proportion of T cells produced IL-17 but not IFN-gamma suggesting the existence of a 
committed lineage of TH-17 cells in psoriasis. We functionally assessed the role of IL-
17 using immunosuppressed AGR mice grafted with skin from psoriasis patients. While 
injection of anti-TNF-alpha monoclonal antibody (moAb) significantly reduced signs 
of psoriasis pathology compared to isotype control, injection of anti-IL17 moAb did not 
reduce pathology in a significant manner. Our data demonstrate an increased number 
of IL-17 producing helper T cells in a common human inflammatory disease and 
leave room for effector cytokines in addition to IL-17 for inducing psoriatic pathology. 
Future studies are indicated to study IL-17 in the context of disease maintenance. 
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Functional evidence for a role of interleukin-23 in the pathogenesis of psoriasis
G Tonel1, C Conrad1, JZ Qin2, H Xin2, P Di Meglio3, E Oldham4, R Kastelein4, 
BJ Nickoloff2, FO Nestle3 1University Hospital of Zurich, Switzerland 2Loyola 
University, Chicago, USA 3St. John’s Institute of Dermatology, London, UK 4Schering-
Plough Biopharma, Palo Alto, USA
IL-12 family members IL-23 and IL-12 are heterodimeric cytokines, sharing a 
common p 40 chain. Recent studies point to a potential role of these cytokines in 
the pathogenesis and therapy of psoriasis. Supportive evidence includes clinical 
efficacy of an anti-p40 monoclonal antibody in psoriasis and the association of a 
single nucleotide polymorphism in the IL-23R gene with psoriasis. Here we provide 
a comprehensive analysis of IL-23 and demonstrate its functional relevance in 
psoriasis patient samples and humanized model systems. IL-23 was expressed at the 
message and protein level in psoriatic skin. IL-23 receptor was expressed on psoriatic 
keratinocytes and its expression significantly increased on psoriatic helper T cells. 
IL-23 impacted on epidermal differentiation in human reconstituted skin equivalents 
(EE) suggesting a reprogramming of the epidermis. In vitro studies demonstrated 
that IL-23 was induced in psoriatic blood cells by bacterial superantigen in a TNF-α 
dependent manner. Administration of a neutralizing anti-human IL-23 monoclonal 
antibody inhibited psoriasis development comparable to the use of anti-TNF-α 
blockers in a clinically relevant humanized mouse model of psoriasis. Together, our 
results identify a critical role for IL-23 in psoriasis with possible downstream activity 
through both the immunological and epidermal compartment and provide the 
rationale for new treatment strategies in chronic epithelial inflammatory disorders. 
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CAF-1 p60 as a new marker of cell proliferation in plaque psoriasis
S Staibano, A Longobardi, G Salvatore, M Di Benedetto, M Mascolo, M Nino, N 
Balato, G De Rosa, F Ayala University Federico II of Naples, Italy
Previous studies of psoriatic epidermis showed that keratinocytes within psoriatic plaques 
have a resistance to apoptosis and are characterized by increased cell proliferation if 
compared with normal skin. The resistance to apoptosis has been particularly linked 
to the absence of a significant amount of double-stranded DNA breaks, in spite of the 
reported TUNEL (Terminal deoxynucleotidyl Transferase Biotin-dUTP Nick End Labeling) 
reactivity of most psoriatic lesions. This phenomenon has been interpreted as due to the 
increase in the number of DNA nicks resulting from active DNA replication, instead that 
DNA double-strands breaks resulting from the apoptotic process. CAF-1 p60 is a newly 
proposed proliferation marker, which plays a key role in chromatin assembly during cell 
replication and DNA repair. It is a part of a heterotrimeric complex (CAF-1) that regulates, in 
particular, DNA chromosome assembly during cell replication and the resulting chromatin 
structure after nucleotide excision repair (NER)-mediated DNA repair. CAF-1 has to interact 
with PCNA (Proliferating Cell Nuclear Antigen); p60, in particular, is down-regulated in 
quiescent cells, whereas it is over-expressed in hyperproliferating and neoplastic cells. We 
analyzed the immunohistochemical expression of p60 and PCNA in a series of plaque 
psoriasis samples (formalin-fixed, paraffin-embedded). A significant higher labelling 
of psoriatic keratinocytes for p60 than to PCNA was found. Our data suggest that the 
immunohistochemical p60 expression could represent a sensible instrument to evaluate the 
deregulation of cell proliferation in psoriasis, giving useful informations on both the cell-
cycle progression and DNA-repair status of keratinocytes. In addition p60 expression could 
represent a valuable tool to evaluate the effect of therapy in follow-up of psoriatic patients. 
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Anti-oxidative and anti-inflammatory properties of licochalcone A from Glycyrrhiza 
inflata on human skin in vitro and in vivo
L Kolbe, K Eggers, J Immeyer, U Wensorra, G Neufang Beiersdorf AG, Hamburg, 
Germany
Licorice extract is frequently used in the western world as a basis for candies and 
as a sweetener in the food and tobacco industry. In the Far East, however, licorice 
is well known as a basic compound of several traditional medicines for a broad 
range of diseases. Pharmacological activities have been attributed to several phenolic 
ingredients and terpene saponins found in different Glycyrrhiza species. Licochalcone 
A from Glycyrrhiza inflata has previously been shown to possess anti-bacterial and anti-
parasitic activity. In this study we focused on the anti-oxidative and anti-inflammatory 
properties of licochalcone A. The production of reactive oxygen species (ROS), induced 
by UV irradiation and environmental stress leads to oxidative tissue damage and is 
one of the major causes of premature skin aging. We examined the in vitro inhibitory 
effects of licochalcone A of various pro-oxidative/ pro-inflammatory reaction cascades 
including: fMLP or zymosan induced oxidative burst of neutrophils, UV-induced 
lipidperoxidation, and interference with signal transduction cascade in fibroblasts 
and keratinocytes. An in vivo study with a Licochalcone A containing formulation 
confirmed anti-oxidative efficacy on UV-induced ultra weak photon emission. Taken 
together these data demonstrate the potent inhibitory capability of topically applied 
licochalcone A against oxidative skin damage caused by ROS. This anti-oxidative 
acitvity of Licochalcone A at submicromolar concentrations and the broad action 
profile makes it a promising candidate for dermatological and cosmetic applications. 
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Efficacy and safety of cyclophosphamide in systemic sclerosis
E Szymanska, J Sicinska, M Majsterek, L Rudnicka CSK MSWiA, Warsaw, Poland
Systemic sclerosis (scleroderma) is an autoimmune disease, characterized by fibrosis 
of the skin and internal organs. Abnormal activation of the immune system and 
immunologically induced fibrosis plays crucial role in development of the disease. 
Thus, immunosuppressive therapy has become the treatment of choice in these 
patients. The aim of our study was to evaluate the efficacy and adverse events of 
cyclophosphamide therapy in scleroderma patients. The study included 34 patients 
(30 women and 4 men), who received cyclophosphamide at a daily dose of 0.5-1.0 
mg/kg. A regular checkup of all patients was performed every 4 weeks. During every 
visit laboratory evaluation (blood count, biochemistry and urine) was performed 
and Rodnan skin score was calculated. In all patients improvement in Rodnan skin 
score was observed (p< 0.05). Following adverse events were observed: transient 
abdominal pain (in 4/34 patients; 11,8%), transient partial telogen hair loss (3/34; 
8,8%), transient moderate lymphopenia (2/34; 5,9%), transient erytrocyturia (1/34; 
2,9%), headache (3/34; 8,8%) and dysmenorrhea (3/34; 8,8%). Neoplastic diseases 
were found in two patients. One female patient developed urinary bladder cancer 
during unsupervised cyclophosphamide therapy, after a total dose of 39 g (600mg/
kg) cyclophosphamide. Another patient developed cancer of the nasopharynx during 
cyclophospamide therapy, after a total dose of 18g (300mg/kg). However there are no 
clear data indicating a relationship between this neoplasm and cyclophosphamide 
therapy. In conclusion, our experience shows that in severe systemic sclerosis 
cyclophosphamide efficacy by far surpasses its potential adverse events. However 
the patients need to be carefully monitored for adverse events and a total dose of 15 
g should not be exceeded. 
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Recognition of BP230 in elderly patients with pruritic disorders
C Feliciani1, G Caldarola1, A Kneisel2, E Podstawa2, M Pfütze2, M Hertl2 1Universita 
Cattolica, Rome, Italy 2Philipps University Marburg, Germany
BP180 has been identified as the major target antigen recognized by pathogenic 
autoantibodies (auto-ab) in bullous pemphigoid (BP) while IgG against BP-230 has 
presumably only a proinflammatory effect. To verify the contribution of auto-ab in 
the development of BP, we screened the sera of patients with BP (Group I, n-25; 74 ± 
16 years), elderly patients with pruritic dermatoses (‘pre-pemphigoid’; group II, n-20; 
76 ± 6 years) and age-matched donors with immediate allergy (group III, n-10; 68 ± 
3 years). In contrast to the BP patients who experienced tense blisters of the skin +/- 
mucous membrane involvement., patients from group II experienced acute or chronic, 
mild to intense pruritus but did not develop blisters. The 25 BP sera (group I) showed 
IgG reactivity against BP180 only (36%), BP230 only (16%), or against BP180 and 
BP230 (48%). In the group II, 20 sera showed IgG reactivity with BP180 (5%),BP230 
(25%), or both antigens (20%). The sera from the control subjects (group III) were not 
reactive with the BP autoantigens. Group I sera recognized the BP180 antigen in 84% 
of cases, particularly 15 (60%) sera reacted against the N-terminus and 12 (48%) sera 
against the C-terminus. Group I sera recognized BP230 in 16/20 (64%) patients, 8/20 
(32%) the N-terminal domain and 12 (48%) the C-terminal domain. In group II, of 
the 10 BP180-reactive sera, 3 (30%) recognized the N-terminal domain and 3 (30%) 
the C-terminal domain. Of the BP230-reactive sera (group II), 8 (80%) recognized 
the C-terminus and 2 (20%) the N-terminus of BP230. Our findings suggest that IgG 
reactivity against BP230 is an early event in the ‘pre-pemphigoid’syndromes which 
may present clinically as pruritic disorders. 
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Pivotal role of endothelin_converting enzyme 1 in neurogenic inflammation
D Roosterman1, GS Cottrell2, BE Padilla2, NW Bunnett2, M Steinhoff1 1University 
Munster, Germany 2University of California, San Francisco, USA
The mechanisms of recycling and resensitization of G protein-coupled receptors 
(GPCRs) are poorly understood. We demonstrate a new biological process by which 
an endopeptidase, endothelin-converting enzyme-1 (ECE-1), regulates resensitization 
of the substance P (SP) neurokinin 1 receptor (NK1R). SP and NK1R traffic to 
acidified early endosomes, where ECE-1 degrades and inactivates SP to promote 
dissociation of the NK1R from β-arrestins. The NK1R, freed from SP and β-arrestins, 
quickly recycles and resensitizes. This mechanism also regulates resensitization 
of receptors for neurokinin B and calcitonin gene-related peptide. We propose 
that peptidases such as ECE-1 degrade peptides in endosomes to control receptor 
recycling and the sensitivity of cells to peptide hormones and neurotransmitters. 
The discovery that ECE-1 regulates recycling and resensitization of GPCRs such as 
NK1R establishes a new function of intracellular endopeptidases in the regulation 
of NK1R-mediated processes such as inflammation, pain and psychiatric disorders. 
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ECE-1 regulates receptor recycling-independent resensitization
D Roosterman1, GS Cottrell2, BE Padilla2, NW Bunnett2, M Steinhoff1 1University 
Munster, Germany 2University of California, San Francisco, USA
Phosphorylation of G protein-coupled receptors plays an important role in regulating 
their function. Endothelin-converting enzyme 1 (ECE-1) inactivates internalized SP 
within early endosomes thereby accelerating resensitization of these cells. The time 
course of degradation of internalized SP by ECE-1 is independent from the concentration 
of the ligand. Confocal laser scanning microscopy shows that intracellular degradation 
of SP by ECE-1 allowed dissociation of β-arrestin-1 from early endosomes and 
trafficking of β-arrestin-1 to the cell membrane. Resensitize of NK1R to a second 
challenge of SP is not mediated by recycling of the internalized NK1R but rather by 
dephosphorylation of cell membrane-located receptors by a fostriecin-senitive protein 
phosphatase 2A (PP2A). Surface receptor binding assays demonstrate that SP binding 
sites did not recover 2h after challenge of cells with SP, a time point where cells are 
normally fully resensitized. The stimulation with SP induced association of PP2A on 
cell membrane-located NK1R. We have thus identified that resensitization of NK1R-
expressing cells is mediated by reactivation of cell membrane-associated NK1R by PP2A 
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Vasointestinal Peptide (VIP) induces immediate hypersensitivity-like skin responses 
and contributes to allergic skin inflammation
M Metz, A Smorodchenko, MH Torvinen, F Siebenhaar, M Maurer Charité Berlin, 
Germany
Vasointestinal peptide (VIP) has recently been shown to induce inflammation in murine 
and human lung. Because of this, VIP has been proposed to contribute to chronic 
inflammatory lung diseases including asthma and COPD. In contrast, little is known 
about the effects and functions of VIP on other organs including the skin. To assess skin 
responses to VIP we injected C57BL/6 mice intracutaneously with VIP and assessed its 
effects. Interestingly, we found that VIP induced strong and dose-dependent immediate 
hypersensitivity-like skin reactions in concentrations ranging from 100nM to 100µM 
as assessed by measuring skin thickness. Response maxima were detected 30 minutes 
after injection for all concentrations tested, and swelling responses and ear thickness 
in all reactions returned to baseline levels at 6 hours after injection. These findings 
suggested that VIP-induced inflammation involves the activation of skin mast cells. 
Therefore, we assessed the effects of VIP on mast cell-dependent skin inflammation 
by investigating passive cutaneous anaphylaxis in mice treated with the VIP receptor 
antagonist D-p-Cl-Phe6, Leu17 or vehicle. Notably, we found that mast cell-driven 
skin inflammatory responses to IgE and allergens are markedly down-regulated in 
VIP antagonist-treated as compared to vehicle-treated mice (-52.0%, p<0.05). Taken 
together, our observations indicate that the pro-inflammatory effects of VIP in murine 
skin are, at least in part, mast cell-mediated, and that VIP contributes to type-I allergic 
skin inflammation by activating mast cells. These results characterise VIP as a potential 
target for novel anti-inflammatory strategies of treating allergic skin disorders. 
 
428
Agonist-induced endocytosis of the rat somatostatin receptor 2A
D Roosterman1, GS Cottrell2, BE Padilla2, NW Bunnett2, M Steinhoff1 1University 
Munster, Germany 2University of California, San Francisco, USA
Agonist-induced internalization of somatostatin receptors determines subsequent 
cellular responsiveness to peptide agonists and influences the quality of somatostatin 
receptor scintigraphy. To investigate sst2A trafficking, an epitope-tagged rat sst2A was 
expressed in human embryonic kidney (HEK) cells and tracked by antibody-labeling. 
Confocal laser scan microscopy revealed that stimulation with somatostatin (SST-14) 
induced internalization of the sst2A receptor and the formation of hollow core vesicles 
positive for the early endosome marker protein rab5a. Of note, internalized sst2A 
remained colocalized with β-arrestin1-EGFP and endothelin-converting-enzyme-1 
(ECE-1) 60 min after stimulation within early endosomes. Internalized 125I-Tyr11-SST-
14 was cotransported with sst2A to early endosomes where the ligand was inactivated 
by different endopeptidases, and released as radioactive-labeled peptide metabolites. 
Thus, we identified ECE-1 as one of the endopeptidases responsible for the inactivation 
of internalized SST-14. ECE-1-mediated cleavage of SST-14 was further inhibited by the 
ECE-1 inhibitor SM-19712 and by neutralization of acidic vesicles using bafilomycin 
A1. Moreover, ECE-1 cleaved SST-14 but not octreotide in an acidic invironment. 
Our data show that the complex of sst2A and SST-14 is sequestrated into early 
endosomes and that endocytosed SST-14 is degraded by ECE-1 in early endosomes 
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IFN-alpha enhances poly-IC responses in human keratinocytes by inducing 
expression of cytosolic innate RNA receptors: relevance for psoriasis
L Van der Fits, M Kant, G Van Dijk, LI Van der Wel, S Mourits, E Prens
Erasmus University Medical Center, Rotterdam, Netherlands
Keratinocytes play a key role in innate immune responses of the skin to bacterial and 
viral pathogens. Viral double-stranded RNA (dsRNA) can be recognized via multiple 
pathways involving the receptors TLR3, PKR, and the recently described cytosolic 
RNA helicases RIG-I and MDA5. We demonstrate that human primary keratinocytes 
and HaCaT respond strongly to poly-IC, a synthetic analogue of dsRNA. This 
response is characterized by increased expression of pro-inflammatory cytokines and 
chemokines, and of the adhesion molecule ICAM-1. Pre-incubation of keratinocytes 
with IFN-alpha significantly augments the pro-inflammatory responses to poly-IC. 
Kinetic analyses suggest that this is mediated via upregulation of the receptors TLR3, 
PKR, RIG-I and MDA5. Interestingly, in lesional skin from patients with psoriasis, a 
chronic non-infectious inflammatory skin disease that is characterized by high IFN-
alpha levels, the mRNA expression of RIG-I, MDA5 and PKR is significantly increased, 
whereas TLR3 expression is unaltered. Furthermore, immunohistochemical analysis 
demonstrates increased RIG-I and MDA5 protein expression in psoriasis lesional skin. 
These results suggest that psoriatic keratinocytes show increased sensitivity to viral 
RNA intermediates, thereby leading to excessive pro-inflammatory responses and 
maintenance of the inflammatory skin phenotype. Thus, we here provide evidence 
that point towards a novel role for the recently described cytosolic innate RNA 
receptors in non-viral chronic inflammatory diseases.
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Evaluating the role of non-HLA genetic factors in gluten sensitive enteropathies - 
MBL2 polymorphisms in dermatitis herpetiformis
AZ Blazsek1, S Silló1, Z Kornseé1, R Lepesi-Benko1, M Németh2, Z Hatvani1, I Kosnai1, 
K Preisz1, M Medvecz1, S Kárpáti1 1Semmelweis University, Budapest, Hungary 2HAS-
SU Molecular Medicin RG., Budapest, Hungary
Dermatitis herpetiformis is a dermal manifestation form of gluten sensitive enteropathy (GSE) which 
affects genetically susceptible individuals. A strong association of HLA-DQ allels with GSE has been 
long known, however only few patients with GSE develope dermatitis herpetiformis (DH). Recent 
studies have demonstrated that certain coding polymorphisms of the mannose binding lectin gene 
(mbl2) show correlation with disease manifestation in patients with coeliac disease (CD). In a study 
only 5 of 114 Italian patients had signs of some undefined dermatitis.We wanted to determine whether 
MBL2 coding and non-coding promoter polymorphisms are associated with DH. For this we genotyped 
genomic DNA isolates of 48 patients with clinical signs of DH for 5 MBL2 polymorphisms (MBL2-52 
(CGT>TGT,p.R52C,rs5030737); MBL2-54 (GGC>GAC,p.G54D,rs1800450); MBL2-57 (GGA>GAA,p.
G57E,rs1800451), found in exon 1 of mbl2, MBL2-H/L (C-550G,rs11003125) and MBL2-X/Y 
(G-221C,rs7096206) promoter polymorphisms. DNA from 90 voluntary healthy blood donors were also 
examined. Genotyping was based on Taqman methodics, and was carried out on a Roche LC 480. We 
found by comparing both homozygous/heterozygous genotype and major/minor allele frequencies that 
both the minor allele carrying genotypes and minor allele frequencies were elevated in DH, although 
only the MBL2-54 (DH A/a:67/32%vs88/12%) and MBL2-XY (DH A/a: 70/30%vs86,5/15,5%) variants 
showed significant (p<0,05) differences. We for the first time examined patients with DH for MBL2 
polymorphisms and for the first time GSE (in DH) patients for mbl-2 promoter polymorphisms. Hungarian 
DH patients demonstrated equally higher minor allele frequencies for the coding polymorphisms as did 
Italian CD patients examined in a previous study. Furthermore we found that not only the coding, but the 
non-coding promoter polymorphisms of MBL2 show significant differences. This study further provides 
evidence that mbl-2 should be considered as a non-HLA genetic factor in GSE. 
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Increased serum levels of B cell activating ligand (BAFF) after therapeutic B cell 
depletion with rituximab in pemphigus vulgaris (PV)
A Nagel, E Podstawa, M Hertl, R Eming Philipps University Marburg, Germany
PV is a severe blistering autoimmune disease affecting the skin and mucous 
membranes which is primarily associated with autoantibodies against desmoglein3. 
Treatment with rituximab leads to rapid and prolonged B cell depletion, followed by 
a good clincal response. In contrast to desmoglein3-specific IgG, which decreased 
after rituximab treatment, titres of tetanus toxoid (TT)-specific IgG were found to 
be largely unaffected by rituximab treatment, which is in line with previous reports 
of stable antimicrobial antibody tires in rituximab-treated rheumatoid arthritis 
patients. Increased serum levels of BAFF during anti-CD20-induced B cell depletion 
may account for the persistence of TT-specific IgG due to its promotional role in 
survival of long lived bone marrow plasma cells. Thus, serum levels of BAFF were 
investigated in 10 PV patients before and during a 12 months’ follow up period 
after rituximab treatment. Prior to rituximab there were no differences in serum 
BAFF levels between PV patients and healthy controls (1,054 ± 0,4 ng/ml). Upon 
rituximab-induced B cell depletion BAFF levels increased significantly (5,084 ± 
2,7 ng/ml) and remained elevated until repopulation of peripheral B cells (between 
6 and 12 months; 2,880 ± 1,7ng/ml). Once B cell numbers were back to normal, 
serum BAFF levels decreased further on (1,762 ± 0,5 ng/ml). Patients developing a 
relapse, which was accompanied by an increase in pathogenic desmoglein3-specific 
autoantibodies, showed higher BAFF levels immediately after B cell depletion 
(9,152 ± 1,0 ng/ml) and an earlier repopulation of B cells than patients in remission 
(3,922 ± 1,6 ng/ml). These results suggest that BAFF is critical for the recovery of 
peripheral autoaggressive and protective B cells in rituximab-treated patients with PV. 
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TNF-alpha, TNFR1 and TNFR2 in monitoring disease activity in pemphigus vulgaris
M Olszewska, M Malejczyk, A Skiendzielewska, H Labecka, S Majewski, M Blaszczyk 
Warsaw Medical School, WARSAW, Poland
Pemphigus vulgaris is an autoimmune bullous disease of the skin and mucous 
membranes. It has suggested that tumor necrosis factor alpha (TNF-alpha) could 
play a mediator role in development of pemphigus lesions by increasing epithelial 
damage and that serum levels of TNF-alpha are increased in these patients.The aim of 
this study was to analyze potential usefulness of TNF-alpha and TNF-alpha receptors 
1 and 2 (TNFR1 and TNFR2) as disease activity markers in pemphigus vulgaris. In 48 
patients with pemphigus vulgaris TNFalpha, TNFR1 and TNFR2 serum levels were 
evaluated with the use of enzyme- linked immonosorbent assay (ELISA). Our results 
show that mean levels of TNF-alpha in patients’ serum were significantly increased 
(15.9 +/- 16.7 pg/ml as compared to 4.8 +/- 1.9 pg/ml in healthy donors, p<0.05). 
Also serum levels of TNFR1 (7,5 +/- 3.1 ng/ml as compared to 1.5 +/- 5.7 ng/ml in 
healthy donors, p<0.001) and TNFR2 (8.7 +/- 4.7 pg/ml as compared to 4.3 +/- 1.0 
pg/ml in healthy donors, p<0.0001) were significantly increased. High TNF-alpha 
levels correlated with pemphigus skin score (r = 0,022) and pemphigus mucosal 
score (r=0,012). There was no correlation between TNFR1 or TNFR2 and extend of 
cutaneous or mucosal lesions. Serum levels of TNF-alpha, TNFR1 and TNFR2 were 
normal during clinical remission despite persistence of other immunological markers 
of pemphigus vulgaris, including continual presence of circulating anti-desmoglein 
1 and anti-desmoglein 3 antibodies. In conclusion, these results show that serum 
levels of TNF-alpha, but not TNFR1 or TNFR2 may serve as a marker of clinical 
disease activity in pemphigus vulgaris. The value of TNF-alpha returns to normal 
after clearance of cutaneous and mucosal changes, despite persistence of circulating 
pathogenic anti-desmoglein 1 and anti-desmoglein 3 antibodies. 
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Evidence for synthesis of p200, the autoantigen in anti-p200 pemphigoid, by 
keratinocytes and fibroblasts
SC Hofmann1, U Voith1, TS Sasaki2, RM Trüeb3, RN Nischt4, L Bruckner-Tuderman1 
1University of Freiburg, Germany 2Shriners Hospital for Children, Portland, USA 
3University Hospital Zurich, Switzerland 4University of Cologne, Germany
In 1996, anti-p200 pemphigoid was first described as a subepidermal immunobullous 
disorder associated with circulating IgG4-autoantibodies reactive with the dermal side of 
human salt-split skin and with a 200 kDa protein by immunoblotting of dermis extracts. The 
autoantigen, named p200, has been characterized as a non-collagenous glycoprotein located 
at the lamina lucida-lamina densa border of the epidermal basement membrane. However, 
its identity and cellular origin remain elusive. In this study, we used biochemical and genetic 
approaches to characterize the autoantibody reactivity in three new patients with anti-p200 
pemphigoid. Circulating autoantibodies of these patients recognized a 200 kDa-protein in 
extracts of cultured human keratinocytes, immortalized keratinocyte cell lines and in dermal 
fibroblasts. Biochemical analysis of cell-culture derived p200 revealed that the protein is 
disulphide-bonded, participates in calcium-dependent molecular interactions and displays 
the identical biochemical characteristics as dermis-derived p200. Lack of collagen XVII 
(BP180), collagen VII or laminin 332 (laminin 5) from the dermal-epidermal junction does 
not destabilize p200. Colocalization within the basement membrane zone and an identical 
molecular weight suggested nidogen-2 as candidate autoantigen in anti-p200 pemphigoid, 
but immunoblot analysis using recombinant nidogen-2 demonstrated that p200 is distinct 
from it. In conclusion, the results identify p200 as an extracellular matrix protein produced 
by keratinocytes and fibroblasts, define further the biochemical characteristics of p200 and 
thus provide a basis for identification and further characterization of this autoantigen. 
 
 
434
Correlation between anti-DSG antibodies and HSV infection
G Caldarola1, A Kneisel2, M Hertl2, C Feliciani1
1Universita Cattolica, Rome, Italy 2Philipps University Marburg, Germany
Different environmental factors have been shown to be implicated in the pathogenesis 
of pemphigus vulgaris (PV). Among infectious triggers of PV, several reports have 
described PV cases in association with herpes simplex virus (HSV), varicella-
zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus(CMV) and human 
herpesvirus-8 (HHV8) infections. In addition, particularly HSV infection in these 
patients could simply be a new opportunistic infection or a reactivation of a latent 
one, because they are treated with immunosuppressive therapy for a long time. While 
several studies and case reports show this association few data about the misleading 
clinical pictures are available. In 3 PV patients, HSV antigen detection was correlated 
with anti-desmoglein (DSG) 1 and 3 titres (by ELISA) and with clinical severity (as 
determined by the recently described ABSIS score) over a follow-up period of >18 
months. Although the very small number of patients and the possible confusing 
effect due to the concomitant assumed therapy, we showed that the presence of HSV 
does not increase dramatically the autoantibody titres and only anti-DSG1 seems 
to increase (occasionally) after HSV infection. Although they clinically appear very 
differently from PV lesions, when the two conditions were present concomitantly it 
was very difficult to suspect the viral superinfection. Our study points out the clinical 
and therapeutic dilemma of secondary HSV infections and underlying autoimmune 
blistering disorders and show that there is not a clear correlation between HSV 
infection and an increase of PV antibodies. 
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Differences in the expression of HLA class I molecules in skin of uninvolved and 
lesional psoriatic skin
J Gudjonsson, T Tejasvi, A Aphale, S Stoll, R Nair, J Voorhees, JT Elder University of 
Michigan, Ann Arbor, USA
Psoriasis is a common chronic inflammatory autoimmune skin disease mediated 
by T cells. Psoriasis has a strong genetic association within the MHC region and 
newly published data support HLA-Cw6 being the major causative gene. HLA class 
I molecules are believed to be expressed ubiquitously on nucleated cells, however, 
no data has been published on the levels of expression of any of the HLA-class I 
molecules in skin. To address this we developed a quantitative real-time PCR (QT-
PCR) for evaluating HLA-A, -B and -C mRNA expression in tissue. Sequence specific 
primers were designed by comparing the sequences of all known alleles of HLA-A, B 
and C. Biopsies were obtained from 20 normal controls and 23 patients (uninvolved 
and lesional). RNA from 5 lymphoblast and 3 keratinocyte cell lines was also isolated. 
QT-PCR was performed on LightCycler 2.0 System. Primer efficacy was calculated and 
used to determine absolute levels of mRNA. PCR products were analyzed by agarose 
gel electrophoresis and sequenced, conforming primer specificity. HLA-B had the 
highest expression in skin, whereas HLA-C had the lowest. HLA-A was expressed at 
a lower level in skin compared to keratinocytes or lymphoblasts (P<0.001), whereas 
HLA-B and C were expressed at similar levels in skin and keratinocytes although 
lower than in lymphoblasts (p<0.001). Increased expression of HLA-A, B and C was 
observed in lesional skin compared to combined uninvolved and control skin (HLA-A 
3 fold, p <0.02; HLA-B 2.8-fold, p <0.004; HLA-C 5-fold, p <0.02). HLA-C expression 
was higher in uninvolved skin of HLA-Cw6 positive patients compared to HLA-Cw6 
negative patients (7-fold, p=0.05), but no such difference was observed in normal or 
involved skin. These results measure locus-specific HLA Class I mRNA levels in skin 
for the first time and demonstrate that these transcripts are upregulated in lesional skin. 
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Predictors of disease remission in patients with pemphigus
M Saha, B Bhogal, M Black, RW Groves St Johns Inst of Dermatology, London, UK
Pemphigus is an autoimmune, chronic blistering disorder mediated by autoantibodies 
to desmoglein 1 and 3 (Dsg 1 and 3). Although anti-desmoglein antibody levels 
correlate to some extent with disease activity, variables that predict eventual disease 
remission remain unclear. We identified 40 patients with pemphigus (31 vulgaris, 9 
foliaceus) with 2 distinct patterns of clinical response and disease duration; ‘Slow 
Responders’ (SR, n=20) with long term active disease and ‘Fast Responders’ (FR, n=20) 
in whom disease remitted within 6 years of presentation. Demographic, genetic and 
immunological parameters were analysed at presentation and during the course of 
the disease. Average age at presentation was 37yrs in SR and 45yrs in FR. Women 
outnumbered men (1.5:1 F: M) in the SR group whereas the reverse was true in FR 
(1.5:1 M: F). 36% FR patients were smokers compared to 13% SR patients. There 
were more Asian patients in the SR group (11/20, 55%) compared to 4/20 (20%) in 
the FR (p=0.0484). The frequency of the MHC pemphigus susceptibility alleles; HLA 
DRB1*04 and *14 was similar in the two groups. There were no significant differences 
in initial indirect immunofluorescence titres between the groups. Moreover, there was 
no difference in the proportion of PV patients with anti-Dsg1 and 3 antibodies or anti-
Dsg 3 alone at diagnosis in the 2 groups. However, nine of 17 (53%) SR PV patients 
had initial positive indirect immunofluorescence on both normal human skin and 
monkey oesophagus substrates compared to 5/14 (36%) patients in the FR group. 
Our findings confirm that smoking appears to have a protective effect in patients 
with pemphigus and that other significant differences exist between patients whose 
disease remits rapidly and those with longer term disease. 
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Influence of different polyphenolic phytochemicals on prostanoid synthesis in 
HaCaT cells in vitro and in vivo using microdialysis
R Quist, I Wiswedel, I Döring, H Gollnick O-von-Guericke Uni, Magdeburg, Germany
UVB irradiation strongly induces oxidative stress and inflammation in human skin. The role of 
different polyphenolic phytochemicals as oligomeric procyanidins, resveratrol, indole-3-carbinole, 
extracts from blueberry, pomegranate and ginkgo biloba were tested for potential antiinflammatory 
and antioxidative effects regarding isoprostane (8-iso-PGF2α) and prostaglandin synthesis (9α,11α-
PGF2α and PGE2) in skin and keratinocytes induced by UVB irradiation. HaCaT cells were irradiated 
with 100 mJ/cm2 of UVB and incubated with increasing doses of oligomeric procyanidins, resveratrol, 
indole-3-carbinole, extracts from blueberry, cranberry and ginkgo biloba (containing 0,1, 1, 10, 100 
and 1000 µM) for 22.5 h, 1.5 h after irradiation. For cutaneous microdialysis, areas of 3 cm2 on the 
volar forearm of a 24 years old female volunteer were exposed to UVB irradiation (2-fold MED, 550 
mJ/cm2) and treated with amphiphilic cream containing 5% urea and 10% blueberry extract or 5% 
resveratrol or 5% oligomeric procyanidins all 2h over 8h under occlusion. Microdialysate samples 
were collected 22.5 h after irradiation at 30-min intervals up to 8h. The lipid mediators F2-isoprostane 
(8-iso-PGF2α) and prostaglandins 9α,11α-PGF2α and PGE2 in cells, supernatants and microdialysate 
samples were measured by sensitive gas chromatography-mass spectrometry/negative ion chemical 
ionization.Addition of all phytochemicals demonstrated decreased synthesis of 8-iso-PGF2α and PGE2 
in irradiated HaCaT cells and supernatants (medium) dose dependently. The lowest prostanoid levels 
were observed with resveratrol and indole-3-carbinole. Synthesis of F2-isoprostanes 8-iso-PGF2α 
were very low in irradiated cells and medium. Microdialysate samples of all 3 treated spots showed 
decreased levels of F2-isoprostane (8-iso-PGF2α) and 9α,11α-PGF2α compared to UVB irradiated 
spots but higher than of normal skin. We concluded that polyphenolic phytochemicals as oligomeric 
procyanidins, resveratrol, indole-3-carbinole, extracts from blueberry, pomegranate and ginkgo biloba 
seems to be potential inhibitors of UVB induced prostaglandin and isoprostane synthesis in vitro as 
well as oligomeric procyanidins, resveratrol and blueberry extract in vivo. 
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High expression of Ro52 in Cutaneous Lupus Erythematosus
V Barkauskaite, M Nyberg, L Strandberg, M Wahren-Herlenius
Karolinska Institute, Stockholm, Sweden
Autoantibodies to Ro52 are serological markers for subacute cutaneous LE (SCLE), 
but expression of the Ro52 protein in the skin is less well characterized. The aim of 
the current study was to test four novel anti-Ro52 monoclonal antibodies (mAbs) for 
their performance in immunohistochemistry (IHC) and to investigate Ro52 expression 
in CLE. Four anti-Ro52 mAbs: one binding zinc-finger domain, and three against 
different epitopes within coiled-coil region were tested in IHC to stain fresh frozen, 
acetone fixed or formalin fixed, paraffin embedded skin biopsy material acquired from 
spontaneous (n=24) and experimentally UV induced CLE lesions (n=4), uninvolved 
buttock skin of CLE patients (n=7) and healthy individuals (n=4). Either fixation method 
and all antibodies gave similar staining patterns. The monoclonal giving the strongest 
signal, was chosen for staining of formalin fixed, paraffin embedded skin specimens. 
Ro52 was highly expressed in the epidermis of all CLE lesions with a band-like 
staining for both nuclear and cytoplasmic Ro52 in the basal cell layers in a majority 
of the lesions. In non-lesional skin, cells positive for nuclear Ro52 were spread within 
the epidermis, and only 5% of cells expressed Ro52 in their cytoplasm. Around half of 
the cells in the dermal infiltrates were strong Ro52 expressers. In experimentally, UV 
radiation-induced active lesions similar staining patterns were seen as in spontaneous 
lesions, but in biopsies from fading lesions Ro52 expression declined.We concluded 
that the use of monoclonals against Ro52 in paraffine-embedded biopsies can clarify 
the role of Ro52 antigen in the autoimmune target organ. Ro52 expression in the basal 
cell layers of epidermis may be responsible for the typical autoimmune inflammation 
in CLE. Activation of Ro52-expressing CD4+ T cells can result in enhanced 
production of Th1 type cytokines, to trigger and maintain the inflammatory process. 
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HLA Class II Alleles in Patients with Pemphigus Vulgaris in the UK
M Saha1, K Harman2, NJ Mortimer2, M Black1, E Kondeatis3, R Vaughan3, RW Groves1 
1St Johns Institute of Dermatology, London, UK 2University Hospitals Leicester, 
Leicester, UK 3Guy’s Hospital, London, UK
Pemphigus is an autoimmune, chronic blistering disorder mediated predominantly by 
autoantibodies to desmoglein 1 and 3. Population studies have shown that both pemphigus 
vulgaris (PV) and pemphigus foliaceus (PF) have been associated with particular MHC class 
II alleles.155 patients with PV (58 Indo-Asians (IA) and 97 White Europeans (WE)) were 
recruited from two UK dermatology centres. A control group consisted of 156 matched 
individuals. Medium to high-resolution PCR-SSP was used to analyze HLA-DRB1 and DQB1 
alleles. Consistent with previous studies, we found that DRB1*04 and DRB1*14 were major 
risk factors for the disease (OR 4.2, CI 2.5-7.2 and 10.2, CI 5.6-18.6 respectively). In Indo-
Asians DRB1*14 appeared to be a stronger risk factor (OR 22, CI 8-66) than DRB1*04 (OR 
3, CI 1-10) whereas the two were equally active in the WE population (DRB1*14 OR 10, 
CI 4-24; DRB1*04 OR 10, CI 5-21). When individual DRB1*04 alleles were further sub-
typed, *0402 was the strongest risk factor (OR 93, CI 13.5-1830, p<0.0001) in the group as 
a whole. The effect of this allele was much more pronounced in the WE group (OR 83, CI 
12-1667) than in the IA group (OR 17, CI 2-356). This study represents the largest European 
cohort of PV patients with HLA typing. Our results confirm that DRB1*04 and DRB1*14 are 
major disease susceptibility alleles in both the White European and Indo-Asian populations 
in the UK. Other groups with smaller IA cohorts have also shown an increase in frequency 
of HLA DRB*14 namely *1404. Our data suggest that genetic susceptibility differences in 
ethnic groups are maintained in patients living away from their countries of ethnic origin, 
underlining the importance of genetic risk factors in this disease. 
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DMBA induces excessive skin inflammation in mice which lack keratinocyte-derived 
VEGF-A
C Barresi, H Rossiter, E Tschachler Medical University of Vienna, Austria
We have previously shown that the inactivation of Vascular Endothelial Growth Factor 
A (VEGF A) in murine epidermal keratinocytes (KC) completely abrogates papilloma 
development induced by DMBA, applied as both tumor initiator and promoter. Instead, 
after 21 weeks, at the end of the carcinogenesis treatment protocol, the skin of mutant 
mice showed evidence of extreme inflammation, epidermal hyperplasia and a parakeratotic 
stratum corneum. We have now focused on the early phase of DMBA treatment, with the 
aim of studying the mechanism of this DMBA-induced inflammation in absence of KC-
derived VEGF-A. A concentration of 1 µg/µl DMBA diluted in ethanol for the first 8 weeks, 
then in acetone, was applied to the backs of mutant and control mice (beginning at 1 day 
of age) once a week for 1, 4, 6, 10, and 15 weeks. H&E staining revealed mild hyperplasia 
in the mutant, but not control epidermis after only 5 treatments. In addition, focal areas 
of parakeratosis and some follicular hyperplasia was also present in the mutant, but not 
control DMBA-treated skin at this time. After 10 and 15 weeks of DMBA treatment, the 
skin of mutant mice showed inflammation, massive epidermal hyperplasia, parakeratosis, 
and keratotic cysts, whereas that of control mice developed papillomas, but was otherwise 
normal. When basal KC proliferation was measured, significantly more (~50%) Ki67-
positive KC were detected in DMBA-treated mutant mice as compared to controls. However, 
blood vessel densities were similar in both groups at 10 and 15 weeks of treatment, and 
very few apoptotic endothelial cells were present in both hyperproliferative epidermis of 
mutant mice and tumor-free DMBA-treated skin of control mice. These preliminary findings 
suggest that in the absence of KC-derived VEGF-A, other mechanisms than the regulation of 
blood vessel density are involved in the induction of inflammation in DMBA treated skin. 
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PPAR delta is a type 1 interferon target gene and inhibits apoptosis in T cells
J Foerster, N Al-Yacoub, M Romanowska Charité Berlin, Germany
Peroxisome proliferator activater receptor beta/delta (PPARδ) is a nuclear hormone 
receptor regulating diverse biological processes including the β-oxidation of fatty 
acids, glucose metabolism, and epithelial cell differentiation. The role of PPARδ in 
the immune system has not been thoroughly studied to date. Here we show that 
PPARδ is expressed in activated human T cells purified from peripheral blood, 
as well as in activated T cells isolated from affected lesions of the skin disease 
psoriasis. The expression of PPARδ in T cells is induced by activation of the T cell 
receptor. Moreover, we identify PPARδ as a direct transcriptional target of type 1 
interferon in T cells. Functionally, PPARδ enhances proliferation of T cells, and 
blocks apoptosis induced by type 1 interferon or serum deprivation. We show 
that these cellular functions are mediated by activation of ERK1/2 signalling. Our 
results (1) establish a direct molecular link between type 1 interferon signalling 
and PPARδ, (2) define a functional role for PPARδ in human T cells, and (3) 
suggest that the induction of PPARδ by type 1 IFN contributes to the persistence 
of activated T cells in psoriasis. The data presented here should prompt a more 
detailed analysis of immune response parameters in patients enrolled in clinical 
trials with synthetic activators of PPARδ for the treatment of metabolic syndrome. 
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PPAR delta enhances keratinocyte proliferation in psoriasis and induces heparin-
binding EGF-like growth factor
J Foerster1, M Romanowska1, N Al-Yacoub1, S Philipp1, S Schweiger2, H Seidel3, M 
Artuc1, S Donandt1, W Sterry1 1Charité Berlin, Germany 2Max Planck Institute for 
Genetics, Berlin, Germany 3Bayer-Schering AG, Berlin, Germany
Psoriasis is a common skin disease involving keratinocyte proliferation and 
altered differentiation, as well as T cell activation. Here we show that altered gene 
transcription in psoriatic skin lesions is highly reproducible between independent 
data sets. Analysis of gene expression confirmed dysregulation in all expected 
functional categories, such as interferon-signalling and keratinocyte differentiation. 
Unexpectedly, a large group of dysregulated transcripts was related to fatty acid 
signalling and adipocyte differentiation, exhibiting a pattern consistent with the 
activation of peroxisome proliferator activated receptor delta (PPARδ). PPARδ itself 
was strongly induced in psoriasis in vivo. In primary keratinocytes, PPARδ was induced 
by the transcription factor AP1, in particular by junB, but not by canonical WNT 
signalling, in contrast to its regulation in colon carcinoma cells. Activation of PPARδ 
enhanced proliferation of keratinocytes, while this was inibited by knock-down of 
PPARδ. Finally, heparin-binding EGF-like growth factor (HB-EGF), known to induce 
epidermal hyperplasia and itself overexpressed in psoriasis, was identified as a direct 
target gene of PPARδ The present data suggest that activation of PPARδ is a major event 
in psoriasis, contributing to the hyperproliferative phenotype by induction of HB-EGF. 
 
443 [Oral 008]
Proinflammatory Staphylococcus cell wall component lipoteichoic acid potently 
suppresses skin inflammation by direct inhibition of T cell activation
K Chen1, S Kaesler1, U Hein1, C Draing2, T Hartung2, M Röcken1, T Biedermann2 
1Eberhard-Karls University, Tübingen, Germany 2University of Konstanz, Germany
Surface organs like the skin contact microbes continuously and microbial pathogen associated 
molecular pattern (PAMP) contribute to signals that determine cutaneous responses. 
Staphylococcus aureus is a known trigger for inflammatory skin diseases, especially atopic 
dermatitis, whereas Staphylococcus epidermidis is part of the normal skin microflora. Both 
species release enormous amounts of the cell wall component lipoteichoic acid (LTA) and 
we aimed to disclose the role of LTA for cutaneous immune responses. Therefore, fluorescein 
isothiocyanate (FITC) contact hypersensitivity (CHS), which mimics atopic dermatitis with 
high IgE levels and Th2 cells, was established and effects of LTA on FITC-CHS were studied. 
Presence of LTA during repeated contacts with FITC enhanced FITC-specific cutaneous 
inflammation and induced Th1-immunity demonstrating a role of LTA as type I PAMP. In 
contrast, limited application of LTA during initial contacts to FITC significantly suppressed 
lesional T cell cytokine expression such as IL-4 and IFN-γ. This LTA application also had 
functional consequences as T cells from draining lymph nodes demonstrated significantly 
suppressed T cell proliferation ex vivo. To understand the underlying mechanisms of this effect, 
CD4+ T cell activation was analyzed in vitro in the absence of other cell types by polyclonal 
activation. Strikingly, whereas other TLR2 ligands acted as T cell costimulators as previously 
published, LTA significantly suppressed T cell proliferation. Taken together, we identified two 
opposing biological functions of LTA: 1) Enhancement of severe or ongoing inflammation 
through induction of type I immunity as clinically observed in atopic dermatitis and 
Staphylococcus aureus colonization. 2) Suppression of mild inflammation by direct inhibition 
of T cell responses. This may be of great relevance as it indicates a strategy to stabilize the 
cutaneous immunological barrier by resident microflora such as Staphylococcus epidermidis. 
444 [Oral 015]
Identification of an arsenic sensitive block to primate lentiviral infection of human 
dendritic cells
V Piguet1, M Pion1, RS Stalder1, R Correa1, B Mangeat1, G Towers2
1University Hospital of Geneva, Switzerland 2Royal Free and University College 
Medica, London, UK
Dendritic cells (DC) are central for the early events of HIV infection. HIV-1 
can productively infect immature dendritic cells, but only very inefficiently as 
compared to activated CD4+ T cells. We have recently shown that there is a 
strong post-entry restriction to HIV-1 infection, partly mediated by the cellular 
restriction factor APOBEC3G in DC. Here we reveal that arsenic trioxide (As2O3) 
treatment of immature dendritic cells relieves an APOBEC3G, TRIM5 independent 
restriction to HIV-1 replication in iDC. Arsenic markedly increases HIV infection of 
immature and mature DC, in multiple as well as single-round replication studies. 
The enhancement is cell-type specific, since it is only weakly observed in the 
more permissive CD4+ T cell lines. Arsenic-mediated augmentation of infection 
in iDC was virus specific and apparent for HIV-1, HIV-2 or SIV, but not the more 
distantly related equine lentivirus, EIAV. Arsenic greatly increased the levels of 
viral reverse transcripts in iDC. Our data suggest the presence of powerful, arsenic 
sensitive antiviral activities in primary human immune cells of the DC lineage. 
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Epigenetic control of CD14 and antimicrobial peptide cathelicidin in keratinocytes 
by histone acetylation
J Schauber1, Y Oda2, A Büchau3, A Steinmeyer4, U Zügel4, D Bikle2, R Gallo3 1LMU, 
Munich, Germany 2University of California San Francisco, USA 3University of 
California San Diego, USA 4Schering AG, Berlin, Germany
Hormonally active vitamin D3 - 1,25 dihydroxy vitamin D3 (1,25D3) - acts as a 
signaling molecule in cutaneous innate immunity by increasing pattern recognition 
through Toll-like receptors (TLRs) and increasing antimicrobial peptide expression. 
Genomic effects of 1,25D3 are mediated through the vitamin D receptor (VDR) 
and require coactivator activity of steroid receptor cofactor 3 (SRC3) which acts 
as a histone acetylase. In skin, SRC3 localized to suprabasal and granular layers 
similar to antimicrobial peptide expression. To study the significance of histone 
acetylation on vitamin D3 regulated defense genes keratinocytes were exposed 
to histone deacteylase inhibitors (HDACi) and stimulated with 1,25D3. HDACi 
such as butyrate or trichostatin A, as well as TLR2 activation resulted in increased 
histone acetylation in keratinocytes and increased 1,25D3 induced expression of the 
antimicrobial peptide cathelicidin, TLR2 cofactor CD14, and antimicrobial function. 
1,25D3 induced gene expression was dependent on the VDR and SRC3 expression 
as siRNA silencing of VDR or SRC3 blocked innate defense gene induction. This 
effect could not be reversed by HDACi suggesting that SRC3 acetylase activity was 
necessary for function. In conclusion, our studies suggest that HDACi treatment might 
offer an alternative treatment option to increase innate immune function in skin. 
 
446 [Oral 075]
Experimental disruption of the human skin barrier results in enhanced secretion of 
the antimicrobial proteins Psoriasin (S100A7) and RNase 7
R Gläser1, J Harder1, B Köten1, H Lange1, E Proksch1, M Weichenthal2, J-M Schröder1
1Univ of Schleswig-Holstein, Kiel, Germany 2Christian-Albrechts-Univ, Kiel, Germany
Recently we identified the S100 protein Psoriasin as well the ribonuclease RNase7 as 
potent antimicrobial proteins (AMP) from healthy human stratum corneum extracts. 
The antimicrobial activity of Psoriasin is mainly directed against E. coli, whereas 
RNase 7 reveales broad spectrum antimicrobial activity including vancomycin-
resistant Enterococcus faecium. Disruption of the epithelial barrier (e.g. by micro-
wounds) very seldom results in skin infection. Therefore we hypothesized that the 
release of potent AMP like Psorasin and RNase 7 may be upregulated after superficial 
skin injuries.Healthy volunteers (n=7) were included in this pilot study. Tape-stripping 
of a standardized area of the forearm skin was performed until a transepidermal 
waterloss (TEWL) of 40g/m²/h was reached. In vivo washing fluids (10 mM sodium 
phosphate buffer, pH 7.4) derived from the untreated forearm and the pre-treated area 
were collected at different timepoints and the amount of both AMP was determined 
by ELISA. In 6/7 persons Psoriasin secretion above the detection limit (1,25 ng/ml) 
could be determined in the samples derived from the untreated forearms, whereas 
RNase 7 was identified in 4/7 persons (detection limit 0,3 ng/ml). One hour after 
tape-stripping all washing fluids contained measurable amounts of both AMP and 
an increased secretion of AMP could be identified up to 7 days after tape stripping 
in individual persons.In summary, this study demonstrates for the first time that 
enhanced secretion of the antimicrobial proteins Psoriasin and RNase 7 after barrier 
disruption may contribute to the low infection rate observed after skin injuries.
 
 
447 [Oral 078]
HPV26 and HPV88 infections are carcinogenic in immunosuppression causing 
squamous cell carcinoma of the nail unit
A Handisurya1, J Kullander2, O Forslund2, A Rieger1, A Bankier1, A Koller1, A Salat1, G 
Stingl1, J Dillner2, R Kirnbauer1 1Medical University Vienna, Austria 2Lund University, 
Malmoe, Sweden
High-risk mucosal human papillomaviruses (HPV) have been implicated in the 
pathogenesis of a subset of digital squamous cell carcinoma (SCC). A possible role 
in keratinocyte skin cancer at other locations is less clear. In an HIV-infected patient 
suffering from verrucous SCC of all fingertips, HPV26 and a new type, HPV88, were 
identified in all SCC. HPV26-specific real-time PCR determined high viral load (56-
4.4*10^4 copies/cell) in all right hand tumours, whereas left hand SCC had copy 
numbers ranging from 0.4-1.2/cell. Conversely, the viral load of the left hand SCC 
had very high HPV88 copy numbers with up to 1.3*10^6/cell, whereas SCC of the 
right hand had low copy numbers (0.09-1.6/cell), suggesting major roles for the 
respective dominant HPV in SCC development. By in situ hybridization HPV26 E6 
DNA was detectable in a majority of suprabasal tumour cells indicating productive 
viral infection. Tumour cells stained positive for p16INK4a, a marker of high-risk 
HPV-associated neoplasia. No missense or synonymous nucleotidic changes in the 
E6 ORF were detected that could account for abnormal biologic properties. The 
newly cloned HPV88 had a genome of 7326 bp (61% similarity to HPV60) and 
represents a new species of genus gamma. A survey of skin tumours and normal skin 
biopsies from immunocompetent (n=362) and immunosuppressed (n=26) patients 
detected HPV88 DNA in 7 specimens. These showed 10-logarithms lower viral loads, 
implying that HPV88 infection is not generally associated with immunosuppression 
or SCC. HPV26 has been rarely detected in cervical cancer and in SCC of the nail unit 
in HIV-infected individuals. Here we identify HPV26 and HPV88 as primary causes 
of digital SCC in immunosuppression. 
448
Detection and Genotyping for Human Papillomaviruses by a Multiplexed Luminex 
Assay 
QL Dang1, C Chen2, YH Du3, P Du3 1Shaanxi Provincial People’s Hospital, Xi-An, 
China 2Northwest University, Xi-An, China 3Life Sciences Col Northwest University, 
Xi-An, China
Though many different multiplexing technologyies for analysis HPV types have been explored, 
it cannot be analyzed in number of samples in a reasonable time frame at acceptable costs are 
limited. It should develope a simple, quick, sensitive and high throughout method for detecting 
genotyping of HPV. General consensus PCR primer GP5+/GP6+ was used to amplify.Probes for 
HPV6, HPV11, HPV16, HPV18, HPV31, HPV33, HPV35, HPV45, HPV51, HPV53, HPV56, 
HPV58 were selected and modified with 5’-amino C14.Plasmids containing HPV genomic 
DNA were kindly provided by Prof.E.-M.de Villiers, Heidelberg (HPV45, HPV51, and HPV53); 
Prof. Attila Lörincz Development Digene Research and Corporation, USA (HPV31,HPV35 and 
HPV56); Prof. Toshihiko Matsukura Tokyo(HPV58); Dermatology department of Fourth Military 
Medical University Xi’an (HPV6, HPV11, HPV16, HPV18 and HPV 33);Samples came from 
Plasmids and clinical patients in cervical scrapings and biopsy specimens of Genital warts.
standard curve was calculation by using a five-Parameter logistic curve fit on the Bio-Plex Manager 
3.0 software. Genotypes of HPV assay were validated by using PCR-amplified target DNA from 
plasmids DNA samples. A set of 13 unique probes, validated for non-cross-reactivity, and was 
coupled to 13 different microspheres, for capturing each of the PCR products were pooled in 
one well for each DNA sample.Signal-noise ratio is 3-17. The coefficient of variation(CV%) is 
0.4%-14.9%.126 CA and 100 CE samples were analyzed, 96% CA and 55% CE were HPV 
DNA positive;HPV type diversity was broad, and multiple HPV infections occurred in one and 
fourths of the HPV positive samples. We concluded that Luminex xMAP technology provides a 
simple, quick, sensitive and high throughout analysis platform HPV genotypes and Viral Load 
Quantitation assay can be readily integrated into a clinical laboratory setting
449
Matrix-assisted laser desorption/ionization time of flight mass spectrometry 
(MALDI-TOF) as a new tool in diagnostic investigation of nail disorders
C Pföhler1, K Hollemeyer1, E Heinzle1, W Altmeyer2, A Stark1, CSL Müller1, S 
Graeber3, SU Jager4, W Tilgen1 1The Saarland University Medical Scool, Homburg/
Saar, Germany 2Gene Facts Analytical laboratory, Saarbrücken, Germany 3Institute 
for Medical Biometry, Homburg/Saar, Germany 4Dermatologische Praxis, Sulzbach/
Saar, Germany
The incidence and prevalence of onychomycosis of toe- and fingernails is rising steadily 
worldwide. Common diagnostic techniques as KOH preparation, fungal culture or 
histological investigation of nail material often lack of sensitivity or specificity. These 
techniques are usually only able to prove or to rule out onychomycosis. Differentiation 
between several non-infectious nail disorders is not possible. The aim of this study was 
to establish a better diagnostic routine procedure based on modern mass spectrometric 
peptide analysis techniques. 156 nail samples from 143 patients with clinically 
suspected onychomycosis (n=90), nail psoriasis (n=40) and nail dystrophy resulting 
from eczema (n=26) were investigated using MALDI-TOF fingerprinting in comparison 
to common standard techniques. We could demonstrate that MALDI-TOF represents a 
precise, robust, fast and cheap tool in diagnostic investigation of nail disorders which 
is superior to common standard methods concerning sensitivity and that further is 
able to discriminate easily between infectious and non-infectious nail disorders. 
 
450
Analysis of the Function of Tsg101 and AP-3 Delta-Adaptin in the Trafficking of 
HIV-1 to the Dendritic Cell - T Cell Infectious Synapse
S Nikolic, G Blot, E Garcia, V Piguet University Hospital of Geneva, Switzerland
Dendritic cells (DCs) capture and internalize HIV at mucosal surfaces and 
efficiently transfer the virus to CD4+ T cells in trans via an infectious synapse (Trans 
pathway). Alternatively, HIV can replicate in DCs and produce new viral particles 
(Replication pathway). In this study, we characterized the trafficking pathways used 
by HIV during both trans and replication pathways. For that purpose we focused our 
analysis on two main intracellular trafficking machineries, the ESCRT-I and adaptor 
proteins complexes. Our previous confocal microscopy studies demonstrated 
that HIV-1 accumulates in intracellular vacuoles that are enriched in specific 
teraspanins (CD81, CD82 but not CD63), indicating that HIV-1 is localized in a 
non-conventional endocytic compartment during the trans pathway. Here we show 
that the trans pathway is genetically separable from the replication pathway since 
Tsg101 (ESCRT-I) knockdown in DCs suppressed HIV-1 replication in DCs but 
not transfer of HIV-1 infection to T cells. Similarly, AP-3 Delta-Adaptin (adaptor 
proteins) knockdown in DCs did not prevent transfer of HIV-1 infection to T cells.
Together, this study demonstrates that HIV-1 transfer across a Dendritic Cell - T cell 
infectious synapse via either the trans or the replication pathways is genetically 
separable through the involvement of the ESCRT-I complex. This points out towards 
a better understanding of the early events of Dendritic Cell - T cell HIV transfer. 
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Serum IG E Level in Lupoid Leishmaniosis
A Sadighha Ilam University of Medical Science, Ilam, Iran
It appears that lupoid leishmaniosis is the result of type 2 predominant T helper 
response to parasite and defect in down regulation of IL-4 production during 
infection The objective was to declare underlying immune status in patients and their 
predominant T helper activity,we considered serum IG E level as an indicator of Th2 
and IL-4 activity as it has been shown in atopic diathesis. In 19 cases of lupoid 
leishmaniosis serum IG E level was measured and compared with 23 ages and sex 
matched healthy people without atopic diathesis. p<0.05 was considered statistically 
meaningful.there were 12 female and 7 male with mean age of 16.63+-9.477 years 
in patients group. Mean age of control group was 17.12+-10.02(p=0.549). 6 cases 
of patients had atopic diathesis. Mean serum IG E level in patients was 108+-254.6 
and in control group was 122.7+-27.7(p>0.05).mean serum IG E level in patients 
without atopic diathesis(13 cases)was 70.2+-12.2 and significantly lower than 
control group(p=0.012). It seems that Th2 cytocin model in lupoid lishmaniosis is 
different of routin cytocin model in hypersensivity disorder. We intend to plan a new 
inflammatory model based on IL-4 without IG E pathway
 
 
452
Parvovirosis B19 in small children
B Kamer, H Rotsztejn, E Malafiej, K Pyziak, M Rogalska-Kuropatwinska1 Polish 
Mother’s Memorial Hospital, Lodz, Poland
The aim of our study was to estimate the skin changes, infections and other symptoms 
in small children with parvovirosis B19. 157 children aged 1-36 months were 
examined in 2nd Department of Peadiatrics and Allergology. The boys were in the 
majority - 110. All children had maculate skin changes and infection of the respiratory 
tract. In each child we measured the level of antibodies in IgG and IgM class with 
immunoenzymatic test of Elisa method. Active parvovirosis B19 was confirmed in 78 
children (49,7%). 44 children (56,4 %) had maculo-girland changes. Apart from the 
infection we confirmed other symptoms in 42 children (53,8%): thrombocytopenia 
in 6 children, arthritis in 4 children and anaemia in 32 children.The results of our 
examination showed frequent infections of parvovirosis B19 with skin changes in 
small children, which could be connected with the above-mentioned symptoms.
 
 
453
Validation of the Williamson and Kligman scrub technique for enumeration of skin 
surface microorganisms
L Rawcliffe, C Lindley, E Emmott, J Ali, RA Bojar University of Leeds, UK
The Williamson and Kligman (WK) scrub technique used for the recovery of 
mircoorganisms from the surface of human skin was reported in 1965. Since 
publication there have been few reports regarding its efficacy and limitations. In this 
study we determined whether the method was fit for purpose for the quantitative 
recovery of the skin microflora. Validation was achieved through experimentation 
and examination of Quality Assurance data for the isolation of skin mircoorganisms. 
Experiments included: investigating the recovery achieved from sequential double 
scrub washes from the face of 30 subjects, and assessment of diluting, plating 
and counting methods using both pooled WK samples and defined stock cultures 
(lenticules) of well characterized laboratory strains of Propionbacterium acnes P37, 
Staphylococcus epidermidis S1695 and Malassezia furfur CBS 1878. Total viable 
counts from 3 double washes were calculated and an average of 55% of total 
Micrococcaceae, 39% total Propionibacterium spp and 57% of Malassezia spp were 
removed in one double wash. The variation between each subject was considerable 
(σ = 15%, 18% and 36% respectively) and total removal was not achieved in 3 
double washes. Lenticule processing showed that the Standard Operating Procedures 
using an automated spiral plater and colony counter were highly consistent for 
quantifying S.epidermidis, P.acnes and M.furfur (CV = 1.22%, 0.99% and 1.11% 
respectively). Variation in operators dilution and processing techniques were 
insignificant (p=0.2997) and the effect of sample storage for up-to 1 hour was also 
insignificant (p=0.1457). These results demonstrate that the SOPs used in the Skin 
Research Centre are both repeatable and fit-for-purpose. Results demonstrate the 
difficulty in evaluation of the technique due to the inherent variation of the microbial 
population on human skin. 
454
Limited genetic diversity of Propionibacterium acnes bacteriophages from human 
skin
M Farrar1, KM Howson1, D West2, RA Bojar1, KT Holland1 1University of Leeds, UK 
2Sarum Biosciences Ltd, Salisbury, UK
The human skin commensal Propionibacterium acnes is associated with inflammatory 
acne vulgaris has been implicated in a wide range of opportunistic infections. 
Bacteriophages that infect P. acnes can be readily isolated from human skin and we 
have previously sequenced the genome of one such phage with a view to utilising 
phages for genetic manipulation of P. acnes and phage therapy of acne. The genomes 
of 14 P. acnes phages were analysed by restriction endonuclease digestion. Several 
DNA fragments appeared to be shared between the phages. To analyse the phages 
in further detail, four phages were selected for genome sequencing. All four phages 
showed similar plaque morphology on lawns of P. acnes and only one demonstrated 
evidence of lysogeny. All phages were able to infect and lyse all of 32 strains of 
P. acnes tested. The phages possessed similar sized genomes (29kb) with strikingly 
similar gene organisation. Structural genes were organised on the left arm and DNA 
replication genes on the right arm similar to the previously sequenced phage PA6. 
As with PA6, these phages did not infect other species of propionibacteria. The 
lack of diversity within phages of P. acnes suggests limited diversity between strains 
of P. acnes. This may indicate that phage therapy for P. acnes-associated diseases 
is a possibility with low potential for the development of bacterial resistance. 
 
455
Escape of human papillomavirus from skin immune system by a decreased 
Langerhans cell number and diminished MIP-3alpha expression
K Asagoe, Y Nakayama, A Yamada, T Yamamoto, G Nakanishi, K Iwatsuki Okayama 
University Graduate School, Okayama, Japan
Human papillomavirus (HPV) causes recalcitrant warts for a long period, evading host immune 
surveillance. It has been a controversial issue why immune cells are less responsive against HPV. 
To elucidate the immune escape mechanisms of HPV, we examined the association between 
the density of dendritic cells (DCs) in the skin and the epidermal expression of macrophage 
inhibitory protein-3alpha (MIP-3alpha) and E-cadherin. Tissue samples obtained from patients 
with HPV-associated skin diseases (common wart, myrmecia, flat wart, condyloma acuminatum, 
bowenoid papulosis and HPV-associated Bowen’s disease: HPV-Bowen) with or without 
inflammation were immunostained with various DC markers, MIP-3alpha or E-cadherin. The 
cDNA array was performed to compare the gene expression by a non-inflammatory common 
wart with that of an inflammatory HPV-Bowen developed in a same patient. Few epidermal 
Langerhans cells (LCs) were observed in the most lesions of HPV-associated skin diseases 
without inflammation except for condyloma acuminatum. Contrarily, a considerable number 
of epidermal LCs, dermal immature or mature myeloid DCs and dermal plasmacytoid DCs 
were observed in the inflammatory warts and HPV-Bowen accompanied by CD8-dominant 
lymphocytic infiltration. MIP-3alpha expression was reduced in most of the HPV-associated 
lesions, but recovered in inflammatory warts. The cDNA array also revealed that Langerin and 
MIP-3alpha gene expression was lower in the non-inflammatory common wart than in the 
inflammatory HPV-Bowen. Meanwhile, the membranous expression of E-cadherin expression 
was decreased in HPV-associated diseases to various degrees. Decreased expression of MIP-
3alpha and E-cadherin by the lesional keratinocytes may inhibit LC migration into epidermis 
and its adhesion to keratinocytes, respectively, resulting in the paucity of LCs in the lesional skin. 
 
456
Malassezia furfur isolated from seborrheic dermatitis skin lesions produces the AhR 
ligands malassezin and indole[3,2-b]carbazole
G Gaitanis1, P Magiatis1, K Stathopoulou1, EC Alexopoulos2, ID Bassukas3, A 
Velegraki1, A-L Skaltsounis1 1University of Athens, Greece 2Medical School Patras, 
Greece 3Medical School Ioannina, Greece
Malassezia yeasts are implicated in the pathogenesis of seborrheic dermatitis (SD) and 
dandruff (DF) through obscure mechanisms. Malassezia furfur produces novel indole 
derivatives with pluripotent biological actions as is malassezin which induces apoptosis 
in cultured human melanocytes through arylhydrocarbon receptor (AhR) activation and 
pityriacitrin which filters UV radiation. The aim of this study was to compare M. furfur 
isolates from SD lesions and healthy individuals for the production of indole derivatives, 
semi-quantitatively analyze the HPLC pattern produced by each one and subsequently 
isolate and characterize substances that are preferentially produced by M. furfur strains 
isolated from diseased skin. The Type M. furfur ATCC 14521 and 10 SD isolates were 
compared against 7 isolates from healthy skin. Investigation of the ethyl acetate extracts of 
M. furfur strains grown on L-tryptophan agar, using preparative HPLC, led to the isolation 
and structure elucidation by NMR and MS of several known indole derivatives such as 
malassezin, pityriacitrin, malassezindol A, indol-3-carboxaldehyde, and indole[3,2-b]
carbazol (ICZ). ICZ which is a known highly potent ligand of the AhR is described 
as a metabolite of M.furfur. All the isolated compounds were used as standards for the 
development of an analytic methodology using HPLC-DAD. HPLC analysis of the extracts 
coming from the 18 reference and clinical strains (7 healthy, 10 SD) revealed for the first 
time the preferential in vitro production of malassezin and ICZ (p<0.005) by M. furfur strains 
isolated from SD lesions and not from healthy ones. The selective production of active AhR 
ligands offers indirect, statistical significant evidence for the implication of pathogenic M. 
furfur strains in SD development through AhR dependent mechanisms that could inflict the 
characteristic epidermal hyperproliferation and inflammation of the disease. 
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Staphylococcus Aureus Resistance to Topical Fusidic Acid in an Irish Pediatric 
Population
M McAleer1, C O’Neill2, M McCafferkey2, BF O’Donnell2 1Mater Misericordiae 
University Hospital, Dublin, Ireland 2Children’s University Hospital, Dublin, Ireland
Staphylococcus aureus is the most common skin pathogen in the pediatric population. It is 
especially significant in children with atopic eczema. Topical fusidic acid is effective against 
staphylococcus aureus. However, resistance of staphylococcal aureus to fusidic acid is 
increasingly recognised, thus limiting its effectiveness. To determine the resistance rates of 
staphylococcus aureus to fusidic acid in an Irish pediatric population over a ten year period, and 
to compare with resistance in other patient groups where fusidic acid is used. To investigate if an 
educational initiative, implemented in 2000, had any impact in resistance levels. A retrospective 
study was performed. Data was extracted from a laboratory data base in the Children’s University 
Hospital, Temple Street, Dublin. All surface swabs that isolated Staphylococcus aureus, 
originating from dermatology, accident & emergency, orthopedics and ophthalmology patients, 
over a ten year period (1997-2006), were reviewed. In the dermatology patient group 5887 
swabs isolated staphylococcus aureus. In 1997, 15.4% were resistant to fusidic acid. Resistance 
rates peaked in 2000, with 53.4% resistance. Thereafter, rates fell annually until 2004, when 
resistance was 20.3%. Rates increased from 2004-2006 to a resistance rate of 28.7% in 2006. In 
orthopedic patients fusidic acid is predominately administered systemically in combination with 
another agent. In this group, 298 swabs isolated staphylococcus aureus between 1997 - 2006. 
Resistance rates in 1997 were 7.5%. In 2002, there was an isolated peak in resistance rates of 
38.5%. Since 2002, resistance rates have remained below 10%. Data analysis for other patients 
groups and for methicillin-resistant staphylococcus aureus (MRSA) is ongoing. Following an 
educational initiative in 2000 encouraging judicious use of topical fusidic acid, the incidence of 
resistance to fusidic acid fell. This highlights the importance of careful prescribing of fusidic acid 
to prevent further resistance developing.
458
Regulation of Epidermal Tight Junctions (TJ) during Infection with Exfoliative-Toxin 
Negative Staphylococcus Strains
U Ohnemus, K Kohrmeyer, P Houdek, H Rohde, E Wladykowski, M Aepfelbacher, N 
Kirschner, MJ Behne, I. Moll, JM Brandner University Hospital Hamburg-Eppendorf, 
Hamburg, Germany
Tight Junction (TJ) proteins have been shown to exert an inside-out barrier function 
within the skin. Here, we study the fate of TJ proteins during the challenge of outside-
in barrier by bacterial colonization and infection. We investigated the influence of 
various exfoliative toxin negative staphylococcus strains on TJ-, adherens-junction- 
(AJ), desmosomal proteins and actin in a human keratinocyte infection culture and in a 
porcine skin infection model. We found that the pathogen S. aureus downregulates TJ 
and subsequently AJ- and desmosomal proteins, including atypical protein kinase C, 
an essential player in TJ formation, at the cell-cell borders of keratinocytes in a time and 
concentration dependent manner. Little changes in protein and RNA levels were seen, 
indicating redistribution of proteins. S. epidermidis shows only minor effects. All strains 
induced enhanced expression of occludin and ZO-1 at the beginning of colonization/
infection. Thus, we demonstrate that TJ are likely to be involved in skin infection of 
exfoliative toxin negative S. aureus. As we did not find a change in actin, and as changes 
of TJ preceeded alterations of AJ and desmosomes, we suggest that S. aureus primarily 
targets TJ. We conclude that TJ are part of the outside-in barrier system of the skin. 
 
459
Investigating the Presence of Beta Human Papillomaviruses in Paraffin-Embedded 
Skin Biopsy Specimens Utilising a PCR-Reverse Hybridisation Assay
LJ Mackintosh1, MNC De Koning2, WGV Quint2, J Ter Schegget2, I Morgan1, 
RM Herd1, S Campo1 1University of Glasgow, UK 2DDL Diagnostic Laboratory, 
Voorburg, Netherlands
Human Papillomaviruses (HPV) of the genus beta have been linked to non-melanoma skin 
cancer. Previous studies used differing methods of HPV detection with limitations regarding 
sensitivity and specificity. HPV detection from paraffin-embedded tissue may be limited due 
to the DNA quality coupled with small copy number of viruses.  Functional data exists on the 
transforming capabilities in vitro and in vivo of beta HPV types HPV-5, 8 and 38 but further 
characterization of beta HPVs in vivo is needed. We wished to ascertain HPV prevalence in 
a Scottish population of skin cancer patients as HPV prevalence may exhibit geographical 
variation.We utilised a technique for detecting all 25 known beta HPV types in a novel PCR-
reverse hybridisation assay.140 skin biopsies (77 immunosuppressed; 63 immunocompetent) 
were examined. DNA was isolated with proteinase K . then amplified using a general primer set 
which targets the relatively conserved E1 open reading frame and is suitable for identifying all 
25 known beta HPV genotypes. The PCR product was applied to specific oligonucleotide probes 
immobilized as parallel lines on membrane strips and visually analysed against a reference 
sheet. 66/140(47%) samples were positive for beta HPV. In immunosuppressed patients 
34/77(44%) were beta HPV positive, in immunocompetent patients, 32/63(51%) were beta HPV 
positive. 21 of the 25 known beta HPV genotypes were isolated, the most common were HPV 
types HPV-24, HPV-15 and HPV-38. 15/66(23%) of the beta HPV positive samples could not be 
genotyped. 34/66(52%) of positive samples harboured 1 HPV genotype, 32/66(48%) of positive 
samples harboured 2 or more genotypes (range 2-8). Multiple infections were more common 
in immunocompetent patients. HPV-prevalence was higher in immunocompetent patients, this 
differs to previous studies and may reflect HPV detection at low copy number. We confirmed 
that HPV-38 which we will utilise in further studies, is prevalent in our population.
460
Hypoxic condition induces the difference of survival and mitogenic potential 
between mature B lymphoblastoid cells and immature B lymphoblastoid cells
M Kawashima1, T Takahashi1, S Hitomi1, I Ando2 1University of Tsukuba, Tsukuba, 
Ibaraki, Japan 2Teikyo University, Kawasaki, Kanagawa, Japan
Oxygen is necessarily required by cellular metabolism. Its shortage leads to various 
cellular responses including the reduction of mitogenic activity and the elicitation 
of apoptosis. The hypoxic condition can occur in the inflammatory and tumor 
environments where numerous cells actively execute their actions and utilize 
oxygen. One of such situations could be the dense infiltration of lymphoma cells 
in cutaneous and subcutaneous tissues. The present study evaluated the influence of 
hypoxia on survival and mitogenic activity of mature and immature subsets of Epstein-
Barr-transformed B lymphoblastoid cells (BLCs). Hypoxia more strongly reduced the 
mitogenic activity of immature BLC subsets, which was confirmed by an MTT [3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl tetrazolium bromide] colorimetric bioassay and 
cell cycle analysis. A long-term culture under hypoxic condition therefore resulted 
in the increased population of mature BLC subsets while normal condition did not 
affect the growth rate of both BLC subsets. This trend was more prominent when BLCs 
were cultured in type I collagen-coated culture plate which was closer to the dermal 
environment. Western blot analysis showed the Akt activation of mature BLCs but not 
immature BLCs under hypoxic condition. Our results suggest that the larger number of B 
lymphoma cells infiltrating into skin might induce the earlier apoptosis of immature cells 
and the apparent increase of mature cell population compared with the original rate. 
 
461 [Oral 014]
Treatment of Canine Dystrophic Epidermolysis Bullosa by Transplantation of 
Genetically Modified Epidermal Autografts
Y Gache1, D Pin2, C Carrozo2, G Meneguzzi1 1INSERM U634, Nice, France 2National 
Veterinary School of Lyon, Marcy L’Etoile, France
We have assessed the feasibility of a gene therapy approach for recessive dystrophic 
epidermolysis bullosa (RDEB) in an immunocompetent dog model of spontaneous RDEB 
associated with a missense point mutation in collagen VII (Col7). Primary keratinocytes obtained 
from skin biopsies of two consanguineous dogs suffering from this skin blistering condition were 
transduced using a retroviral vector expressing the full-length dog Col7 cDNA. The transduction 
efficiency of the epidermal stem cells was 100% in dog 1 and 65% in dog 2. Two partial-
thickness skin resections were performed on the animals’ back. An epithelium made in vitro using 
autologous genetically-modified keratinocytes was grafted onto one wound and an autologous 
non-reverted graft on the other wound as a control. Epidermal regeneration was observed at 
day 8 and a normal-looking epidermis was maintained throughout the 5-month follow-up, with 
no sign of inflammation or immune rejection. While spontaneous blistering was observed in 
the control grafts, the transgenic epidermis remained robust and did not form blisters when 
submitted to mechanical stress, which correlates with restoration of the epidermal adhesion 
and strong immunoreactivity of the basement membrane to anti-Col7 antibodies. In dog 1, the 
presence and expression of the transgene were confirmed for the duration of the follow-up by 
PCR examination of skin biopsies. In dog 2, presence and expression of the transgene were 
observed in the first month post-grafting, but were lost at month 2. The different results obtained 
with the two transplanted dogs correlated well with the content in transduced epidermal 
stem cells of the respective primary cell cultures. Our data demonstrate the feasibility of ex-
vivo gene therapy of immunocompetent RDEB animals and emphasize the importance of an 
efficient transduction of stem cells to achieve a permanent reversion of the diseased phenotype. 
 
462 [Oral 019]
Mini-type VII collagen corrects dystrophic epidermolysis bullosa mouse
JM Remington, X Wang, DT Woodley, M Chen, S Guan, W Li University of Southern 
California, Los Angeles, USA
Dystrophic epidermolysis bullosa (DEB) is a family of inherited mechano-bullous disorders 
caused by mutations in the type VII collagen (C7) gene. We previously generated a 
recombinant C7 ‘minigene’containing the intact noncollagenous domains, NC1 and NC2, 
and half of the central collagenous domain and demonstrated that the ‘minigene’product 
retained the function and characteristics of full-length C7 and when expressed in RDEB 
keratinocytes induced reversion of the RDEB cellular phenotype. In this study, we evaluated 
if mini-type VII collagen (Mini-C7) could reverse RDEB in preclinical, C7 null, RDEB mice. 
We intradermally injected purified Mini-C7 (10-15 microgram/per injection) daily for 3 days 
into the mid-back of 1 day old RDEB mice (N = 40). Skin biopsies were obtained at various 
times after injection and subjected to immunostaining and immunoelectron microscopy 
using an antibody specific for human C7. We found that the injected Mini-C7 transported 
and incorporated into the mouse’s basement membrane zone (BMZ) as early as 2 days after 
injection and formed anchoring fibrils. Most interestingly, the injected Mini-C7 was not only 
detected at the BMZ of injection sites, but also at remote areas far away from the injection site. 
The expression of Mini-C7 corrected the RDEB disease features, including dermal-epidermal 
separation, new blister formation, and anchoring fibril defects. In addition, Mini-C7-mediated 
therapy also significantly increased the life span of the animals. Our studies provide the first 
evidence for using Mini-C7 to correct RDEB in a preclinical animal model. One potential 
advantage over full-length C7 is that Mini-C7 is highly stable and lacks the 39 amino acid 
interruption in the helical sequences which contains a site highly susceptible to degradation 
by proteases. The enhanced stability of Mini-C7 over authentic C7 may better withstand 
proteolytic digestion in RDEB wounds and provide a more sustained gene product in patients. 
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463 [Oral 022]
Syndrome of ichthyosis, follicular atrophoderma, and hypotrichosis is associated 
with loss-of-function mutations in matriptase
T Alef1, H-C Hennies1, S Kolberg1, S Torres1, I Hausser2, D Metze3, U Türsen4, GG 
Lestringant5 1Uni of Cologne, Germany 2Uni of Heidelberg, Germany 3Uni of Münster, 
Germany 4Uni of Mersin, Turkey 5Tawam Hospital, Al Ain, United Arab Emirates
Autosomal recessive congenital ichthyosis encompasses a large, heterogeneous group of disorders 
of cornification. Isolated forms and ichthyosis associated with other signs of disease can be 
differentiated. We have recruited two consanguineous families with a similar phenotype from the 
United Arab Emirates and Turkey. Five sibs of the Emirati family, three girls and two boys, showed 
normal stature, diffuse congenital ichthyosis, patchy follicular atrophoderma, generalized and diffuse 
non-scarring hypotrichosis, and marked hypohidrosis. The affected girl of the Turkish family showed 
also dispersed congenital ichthyosis, follicular atrophoderma, hypotrichosis, and additionally woolly 
hair. Histopathologically, the epidermis was of regular thickness, with the stratum granulosum thinned 
and the stratum corneum orthohyperkeratotic. Hair follicle epithelium was thinned, hair infundibulum 
showed hyperkeratosis and a very thin stratum granulosum. EM analysis showed deposits of lamellar 
bodies in the lower lamellae of the stratum corneum. By genome wide linkage analysis we identified 
two regions with LOD scores >3 on chromosomes 2 and 11. The interval on chromosome 11q24-q25 
contained the suppression of tumorigenicity 14 gene (ST14), which has 19 exons and spans ˜50 kb of 
genomic DNA. Its gene product, matriptase, is a type II transmembrane serine protease expressed in 
most human epithelia. We found a homozygous splice site mutation (c.2269+1G>A) in the Emirati 
patients and a 1-base deletion (c.2034delG) leading to a premature stop codon in the Turkish patient. 
These mutations confirm the role of matriptase as an essential enzyme in the process of epidermal 
differentiation. Furthermore, Western blot analysis showed reduced proteolytic activation of prostasin 
and loss of processing of filaggrin. Since filaggrin monomers play a pivotal role in epidermal barrier 
formation, we suggest that matriptase acts upstream of prostasin in a zymogen activation cascade that 
regulates terminal epidermal differentiation.
464 [Oral 079]
Biochemical association between kindlin-1, kindlin-2 and migfilin and relevance to 
Kindler syndrome
JE Lai-Cheong1, S Ussar2, K Arita3, I Hart4, JA McGrath1 1St John’s Inst of Dermatology, 
London, UK 2Max-Planck Institute for Biochemistry, Munich, Germany 3Hokkaido 
University, Sapporo, Japan 4Institute of Cancer, Tumour Biology Lab, London, UK
Loss-of-function mutations in the KIND1 gene, encoding kindlin-1, have been demonstrated in 
individuals with the autosomal recessive skin blistering and poikilodermatous genodermatosis, Kindler 
syndrome (KS). Kindlin-1 is an actin cytoskeleton/focal contact protein and reduced expression has 
been shown to affect keratinocyte adhesion, migration, proliferation and polarity. Nevertheless, little 
is currently known about the biochemical interactions of kindlin-1. To assess this further, we carried 
out immunofluorescence microscopy labelling of skin biopsies from 13 individuals with KS with 
known KIND1 mutations using antibodies to kindlin-1 and other focal contact proteins expressed in 
keratinocytes. Kindlin-1 immunoreactivity was markedly reduced/absent in 7 biopsies but only slightly 
reduced/near-normal in the remaining 6 cases. Of interest, we also noted that a reduction in kindlin-1 
labelling was accompanied by a similar decrease in migfilin immunostaining and, to a lesser extent, 
kindlin-2. Conversely, patients with normal/near-normal labelling patterns for kindlin-1 had normal 
immunostaining patterns for migfilin and kindlin-2, suggesting that these three molecules may indeed 
interact at the protein level. At a molecular level, reduced kindlin-1 labelling was associated with a decrease 
in KIND1 mRNA whilst bright kindlin-1 staining was paralleled by normal KIND1 mRNA expression. 
In both groups, however, the levels of KIND2 and FBLIM1 (encoding migfilin) were normal, suggesting 
that low or even normal levels of mutated kindlin-1 protein may lead to defective binding to kindlin-2 
and migfilin. Co-immunoprecipitation studies performed on HaCaT keratinocytes showed that all three 
proteins are biochemically linked. Moreover, confocal microscopy studies on HaCaT cells transfected 
with EGFP-kindlin-1 and FLAG-migfilin, and then probed for endogenous kindlin-2, demonstrated that 
all three proteins co-localise at focal contacts. This study thus provides new data about the biochemical 
associations of kindlin-1 in keratinocytes and offers new insight into the cellular pathology of KS. 
465 [Oral 080]
Chronic colitis due to epithelial barrier defect: role of kindlin-1 isoforms
JS Kern1, CB Herz1, E Haan2, L Bruckner-Tuderman1, C Has1 1University of Freiburg, 
Germany 2University of Adelaide, Australia
Kindlin-1 is an epithelium-specific phosphoprotein and focal adhesion adaptor 
component. Mutations in the corresponding gene (KIND1) cause Kindler syndrome 
(KS), which manifests with skin blistering, poikiloderma, photosensitivity and 
carcinogenesis. Some patients also exhibit gastrointestinal symptoms, but it has 
remained unclear whether these represent a feature of KS or a coincidence. We 
examined kindlin-1 in human gastrointestinal epithelia and show that it is involved 
in the etiopathology of KS associated colitis. Kindlin-1 expression was assessed by 
indirect immunofluorescence, Western blot and RT-PCR. Kindlin-1 is expressed in oral 
mucosa, colon and rectum. In CaCo2 cells, both the full-length 74 kDa kindlin-1 protein 
and a 43 kDa isoform were detected, the latter resulting from alternative splicing. In 
the first months of life, patients (homozygous for null mutations), had severe intestinal 
involvement with hemorrhagic diarrhoea, and showed morphologic features of severe 
ulcerative colitis. Later in childhood, histopathology demonstrated focal detachment 
of the epithelium in all segments of the colon, chronic inflammation, and mucosal 
atrophy. These findings define an intestinal phenotype for KS as a consequence of 
a primary epithelial barrier defect. The different clinical intestinal manifestations 
in KS patients may be explained by partial functional compensation of kindlin-1 
deficiency by the intestinal isoform or by the presence of truncated mutant kindlin-1. 
 
466 [Oral 081]
Rescue of lethal dystrophic epidermolysis bullosa model mice by corrective COL7A1 
gene transfer
K Ito1, D Sawamura1, W Nishie1, H Nakamura1, M Goto1, A Shibaki1, J Uitto2, M 
Akiyama1, H Shimizu1 1Hokkaido University, Sapporo, Japan 2Thomas Jefferson 
University, Philadelphia, USA
Recessive dystrophic epidermolysis bullosa (DEB) is a severe hereditary bullous 
disease caused by mutations in COL7A1, the gene encoding type VII collagen (COL7), 
a major component of anchoring fibrils. Col7A1 knockout mice (COL7m-/-) exhibit 
a severe, recessive DEB phenotype, which is lethal and these mice die within several 
days after birth. To develop novel therapeutic approaches for recessive DEB patients, 
we attempted to rescue COL7m-/- mice by introducing human COL7A1 cDNA. We 
first generated transgenic mice that express human COL7A1 cDNA specifically in 
epidermal keratinocytes (under the K14 promoter) or dermal fibroblasts (under the 
COL1 promoter), respectively. We then performed transgenic rescue experiments by 
crossing these transgenic mice with COL7m+/- heterozygote mice. Surprisingly, human 
COL7 expressed either by keratinocytes or fibroblasts could rescue the COL7m-/- 
mice, and abolish the DEB phenotype seen in COL7m-/- mice. These data suggest that 
this approach might also work in human DEB patients. Furthermore, we generated 
transgenic mouse that expresses mutant human COL7A1 gene (7528delG resulting 
in premature termination codon and truncated COL7 protein), and produced mice 
that only express the human COL7A1 mutant gene. Interestingly, these mice survived 
despite demonstrating clinical manifestations very similar to human DEB. In conclusion, 
we have proven effective gene delivery of COL7A1 in DEB models after targeting 
either keratinocyte or fibroblast, and our human mutant COL7 expressing mice with 
non-lethal DEB phenotype will serve as an ideal model for future therapeutic studies. 
 
467 [Oral 082]
The collagen VII hypomorph, a viable mouse model for dystrophic epidermolysis 
bullosa, allows testing of molecular therapies
A Fritsch1, S Loeckermann1, JS Kern1, R Fässler2, L Bruckner-Tuderman1 1University of 
Freiburg, Germany 2Max Planck Institute of Biochemistry, Martinsried, Germany
Dystrophic epidermolysis bullosa (DEB), a hereditary skin blistering disorder caused by 
mutations in the collagen VII gene, COL7A1, is a prime target for gene-, protein- or cell-
based therapies. However, despite successful proof-of-principle experiments, the evaluation 
of efficacy and adverse effects of the therapeutic approaches have been impeded by the 
lack of suitable animal models. Therefore, we developed a collagen VII hypomorph mouse 
model by introducing a pgk-neo-cassette in intron 2 of Col7a1. Homozygous mice (Col7a1 
flNeo/flNeo) display hemorrhagic plantar blisters shortly after birth. Starting in the third 
week of life, blistering in the oral mucosa causes severe growth retardation and death by 
malnutrition at the age of 8-9 weeks. Adult animals display dystrophic nails and frequently 
miss digits. Whole body MRI, hematological and immunological characterization of 4-5 
week old animals showed no further abnormalities. RT-PCR analysis of murine keratinocytes 
revealed an abnormal splicing pattern of the collagen VII mRNA in Col7a1 flNeo/flNeo, 
with only a minor percentage of correctly spliced mCol7. Quantitation of protein levels 
in skin shows a 90% reduction of collagen VII. Electron microscopy showed normal 
hemidesmosomes in Col7a1 flNeo/flNeo skin but strongly reduced numbers of anchoring 
fibrils and sub-lamina densa blistering. Removal of the pgk-neo-cassette completely reverted 
the phenotype. Taken together, Col7a1 flNeo/flNeo represents a viable mouse model for 
DEB which displays all clinical and biological characteristics of human generalized DEB. 
Beside analysis of disease pathogenesis and anchoring fibril biology, it is used for analysis 
of the efficiency and adverse effects of novel fibroblast-, gene- or protein therapies for DEB. 
468 [Oral 083]
Harmless selection of genetically manipulated human stem keratinocytes
T Magnaldo1, V Bergoglio1, E Warrick1, F Larcher2, O Chevallier1, M DelRio2 1CNRS, 
Villejuif, France 2CIEMAT, Madrid, Spain
Ex-vivo gene therapy of monogenic and recessively inherited genodermatoses prone 
to cancer require the selection of transduced epidermal keratinocytes in a manner 
compatible with skin graft perspectives. We have set up a selection system which 
aims at: i-preserving growth and differentiation potentials of transduced keratinocytes, 
ii-reduce the risk of immune response in grafted patients, iii-maintain sustained 
expression of the corrective gene. In this system, selection is based on ectopic 
expression of the small cell surface marker CD24 in proliferative keratinocytes. 
In human epidermis, CD24 is normally expressed in post mitotic, differentiated 
keratinocytes. Several primary strains of normal keratinocytes could be successfully 
transduced using a CD24-IRES-GFP MoMLV retroviral viral vector. CD24-selected 
cells could be passaged serially over more than one year, attesting the conservation 
of stem cell growth potential. Reconstruction of organotypic skin cultures using 
transduced cells, indicated normal differentiation and proliferation capacity. 
Transduced cells were grafted onto the nu/nu athymic mouse and regenerated a full 
thickness, normally differentiated epidermis, over a period of 20 weeks. Expression of 
the GFP reporter gene was maintained without attenuation. The encouraging results 
strongly stimulate our prospects of genetic correction of epidermal keratinocytes from 
patients suffering from the DNA repair deficient / cancer prone disease, xeroderma 
pigmentosum or for any other genodermatose candidate for ex vivo cutaneous gene 
therapy. In addition, our system now allows any application of long term and harmless 
gene transfer such as gene extinction or mutation expression in human primary cells. 
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Functional model systems for congenital ichthyosis: Basic and long way to therapy
KM Eckl1, S Torres1, S Juanes2, D Metze3, P Krieg2, H-C Hennies1 1University of 
Cologne, Germany 2German Cancer Research Center, Heidelberg, Germany 
3University of Münster, Germany
In the last four years several new genes for autosomal recessive congenital ichthyosis (ARCI) 
were identified. However, still only little is known about the pathophysiology of this clinically 
and genetically heterogeneous group of severe disorders of keratinization. In order to investigate 
the role of proteins involved in the development of ARCI, we have established 3D organotypic 
skin models (epidermis equivalents) with primary keratinocytes and fibroblasts. Here we were 
able to analyse histopathologically and immunohistochemically the structure of the 3D model, 
especially the suprabasal layers including the stratum corneum. To stratify the effects of inactivation 
of different genes involved in ARCI, primary keratinocytes from healthy donors were transfected 
with siRNA to knock down specific genes. This was done for TGM1, ALOX12B, ALOXE3, 
ABCA12, Ichthyin, and FLJ39501. We found the typical histopathological features seen in patient 
samples. Quantitative RT-PCR analysis was performed in samples from transfected keratinocytes 
and 3D models showing knock-down rates of 95% on average. Analysis of keratinocytes from 
patient biopsies demonstrated the impact of passage number, mutation type etc. We used double 
knock downs for ALOX12B and ALOXE3, which code for subsequent members of the same 
pathway, to investigate the effect of intermediate products. Importantly, these samples showed 
still knock-down efficiencies of 80% and 99%. We compared our results in humans (patients 
and 3D models) with those from 12R-LOX-deficient mice by expression profiling and qRT-PCR 
analyses. Knock-down efficiency did not always reflect phenotypical/histological findings. 
Since knock-down efficiencies were very high even after seven days, we are increasing the 
differentiation period to study time-dependent changes in hyperkeratosis and forming a marked 
stratum corneum. Our models clearly mimick congenital ichthyosis and give us the chance to 
establish approaches for therapy under controlled and identical, patient independent conditions. 
470 [Oral 085]
The interferon-inducible, anti-apoptotic G1P3 protein is under the control of the 
non-coding RNA, PRINS and is highly upregulated in psoriasis
K Szegedi1, E Sonkoly1, Z Bata-Csörgo1, I Németh1, A Dobozy1, L Kemény1, M Széll2 
1University of Szeged, Hungary 2Hungarian Academy of Sciences, Szeged, Hungary
Expression data of the non-coding RNA gene, PRINS (Psoriasis Susceptibility-Related 
RNA Gene Induced by Stress) identified and characterized by our workgroup, 
suggests a role for PRINS in psoriasis susceptibility and in cellular stress response. 
In order to asses the function of PRINS, gene specific silencing experiments were 
carried out in HeLa cells. The results of these experiments have suggested a protective 
role for PRINS in stress response. Additionally, cDNA microarray experiment was 
performed to identify genes that might be regulated by PRINS. The microarray 
experiment revealed 66 transcripts that were either up- or down-regulated due to 
the silencing of the non-coding gene, PRINS. One of them, G1P3, an interferon-
inducible antiapoptotic gene was down-regulated in the chip experiment as well 
as in the validating real-time RT-PCR experiments, therefore we aimed to further 
characterize this transcript. The results of our in vitro experiments suggested that 
G1P3 was highest expressed in proliferating keratinocytes. Real-time RT-PCR and 
immunohistochemical detection showed that G1P3 was expressed in all human 
organs and tissues we examined. We examined the expression of G1P3 mRNA in 
psoriatic tissue samples and found it 400-times up-regulated in the involved (n=5) 
psoriatic epidermis compared to healthy epidermis (n=5). Immunohistochemical 
staining also showed a marked increase in G1P3 protein in the involved psoriatic 
epidermis. Our results suggest that G1P3 is under the control of the non-coding RNA 
gene, PRINS, and it may have a role in the hiperproliferation of psoriatic keratinocytes. 
 
471 [Oral 086]
Early onset psoriasis is associated with SNPs in the PTPN22 region
RL Smith1, RB Warren1, S Eyre1, X Ke1, HS Young1, M Allen1, JN Barker2, CEM Griffiths1, 
J Worthington1 1University of Manchester, Manchester, UK 2St Johns Institute of 
Dermatology, London, UK
The haematopoietic-specific protein tyrosine phosphatase (PTPN22) gene is 
a regulator of T-cell activation. The R620W polymorphism within this gene is 
associated with various autoimmune diseases, but not psoriasis. However, as T-cell 
recruitment and activation at the site of new plaques of psoriasis are considered to 
be of primary importance, PTPN22 remains a plausible candidate susceptibility gene 
for the disease.The purpose of this study was to investigate the role of the PTPN22 
locus in Type I psoriasis (age of disease onset ≤ 40 years). Using Sequenom MassArray 
technology, 13 SNPs across the PTPN22 region (˜60kb) were genotyped in a study of 
647 Type I psoriasis patients and 566 healthy volunteers. Two SNPs were associated 
with psoriasis when genotype frequencies were compared against controls; 
rs1217414 (p = 0.0014) and rs3789604 (p = 0.0048). The associated SNPs were 
investigated further in a combined analysis of 900 patients and 2590 controls when 
an additional 253 unrelated Type I psoriasis patients and 2024 controls were made 
available to this study. Both SNPs remained significantly associated to psoriasis with 
rs1217414 (p = 0.003), located in intron 1 of PTPN22, conferring risk by carriage 
of two copies of the minor allele (Odds ratio (OR) = 1.56; 95% CI 1.16 - 2.08, p 
= 0.0027); and rs3789604 (p = 0.0002), residing in exon 1 of a neighbouring gene 
(RSBN1), conferring risk under a dominant model for the major allele (OR = 1.35; 
95% CI 1.16-1.58, p = 0.0001) with permutation testing of the data supporting both 
associations (p = 0.0127 and 0.0004 for rs1217414 and rs3789604, respectively). 
This large study reports a potential role for variants within the PTPN22 gene region 
in Type I psoriasis susceptibility that is not conferred by the R620W polymorphism 
previously associated with other autoimmune diseases. 
472 [Oral 087]
Association analysis of the IL12B and IL23R genes in clinical variants of psoriasis
JN Barker1, RC Trembath2, F Capon2, C Dunster2, M Allen3, FO Nestle2, AD Burden4, 
J Worthington3, CEM Griffiths3 1St Johns Inst of Dermatology, London, UK 2King’s 
College, London, UK 3Uni of Manchester, UK 4Western Infirmary, Glasgow, UK
The familial recurrence of psoriasis vulgaris (PV) is well-established and the disease is widely 
regarded as a multifactorial trait, resulting from gene-gene and gene-environment interactions. 
Linkage studies have repeatedly identified a primary disease susceptibility locus, lying within the 
Major Histocompatibility Complex (MHC) on chromosome 6p21. We and others have reported 
the presence of PV-associated alleles within the IL23R and IL12B genes, which encode two 
subunits of the interleukin-23 receptor complex. The objective of this study was to establish 
whether IL23R and IL12B polymorphisms were also associated with clinical variants of psoriasis. 
For this purpose, we analysed three UK datasets including individuals affected by late-onset 
psoriasis (n = 160), palmo-plantar pustulosis (n = 117) and guttate psoriasis (n = 129). We 
matched these patients to a large control group including a total of 1,241 unaffected individuals. 
We typed both case and control samples for the two sequence variants that had shown the 
highest disease association in previous studies, namely rs3212227 (mapping to the 3’UTR of 
IL12B) and rs11209026 (corresponding to an Arg to Gln substitution in the IL23R protein). 
We observed a significant association between IL23R-rs11209026 and guttate psoriasis (chi-
square = 6.0; P = 0.014). We also found that IL12B-rs3212227 was marginally associated with 
palmo-plantar pustulosis (chi-square = 3.99; P = 0.046). Neither SNP was associated with late-
onset psoriasis. Our findings indicate that IL-23 signalling may contribute to the pathogenesis 
of guttate psoriasis (strongly associated with PV and PSORS1) and palmo-plantar pustolosis, 
for which no association with PSORS1 exists. Late-onset psoriasis is not associated with either 
PSORS1 or IL12B/IL23R, further suggesting that it is a distinct entity. Our association results also 
support the therapeutic approaches targeting the IL-23 inflammatory pathway and suggest that 
these treatments may benefit patients affected by some atypical forms of the disease. 
473
Novel Information on Stress Theory
H Zelenkova1, P Barták2 1DOST Private Clinic, Svidník, Slovakia 2Praha Private Clinic, 
Prague, Czech Republic
The presentation shall deal with experimental animal stress manifestations in 
connection with a new pituitary gland hormone production. Stress can be defined 
as the sum of physical and mental responses. Mental responses to stress include 
adaptive (good) stress, anxiety, and depression. Where stress enhances function 
(physical or mental) it may be considered good stress, however, as far as the stress 
activity is concerned it is unimportant if the stress is pleasant or unpleasant. Stress is 
not only the tension of nerves, but can be brought in connection with for example 
the level of cholesterol, the so called stress-influenced cholesterol, as a precursor of 
sexual hormones, causing changes of the hormonal level. Stress can be brought into 
connection with sudden greying of hair as well as with hair proliferation inhibition and 
the induction of perifollicular infiltrate and start of apoptosis. Experiments have been 
performed to show that sonic stress in mice causes of hair growth inhibition. Stress 
has got influence also on wound healing, and acute stress regulates immunity, where 
chronic stress suppresses it, causing obvious danger of carcinogenesis, interfering 
with the proinflammatory function of the mast cells or exacerbating acne. As regards 
stress and psoriasis, it was found out that chronically highly stressed patients react 
to PUVA with difficulties, which leads us to the idea that additive anti-stress therapy 
might be quite helpful. Hypocortisol answer was found in those patients who were 
stressed experimentally. The clinical manifestations of stress are polymorphous. 
Cases of comb-like indentations of the tongue circumference or cholinergic urticaria 
following emotional stress will be presented. It is a very interesting to find out that 
stress depends on the mental state - fragrances can regulate stress reactions.
 
474
Inherited Susceptibility to Hyperandrogenic Manifestations In Pubertal Females: 
Idiopathic and Dyshormonogenesis
A Hassan, H Ahmed, M El-Ziny, M Hafez, M Hawas, M Abou-Hashem, A Baghdady 
Mansoura Faculty of Medicine, Mansoura, Egypt
The objective was to study the genetic susceptibility in pubertal females having 
hyperandrogenic manifestations without an evident cause. This study included 31 
pubertal females, presented by hirsutism, acne and androgenic alopecia in various 
combinations. Exclusion criteria were ovarian and suprarenal tumors, classical congenital 
adrenal hyperplasia, ambiguous genitalia or receiving drugs that may give androgenic 
manifestations. Parents and sibs of the multicase families were included. In addition 
40 normal females of matched age were taken as control group. Patients, their affected 
mothers and sibs plus control groups (30 out of 40) were subjected to history, clinical 
examination and endocrinal evaluation. Pelvic ultrasonography was done and blood 
samples were withdrawn (in the fifth day of menstrual cycle for estimation of serum cortisol, 
dehydroepiandrosterone sulfate, 17-hydroxyprogesterone, testosterone, E2, LH and FSH. 
For all the parents and female sibs, affected and unaffected, of the multicase families, 
HLA class I (A&B) and class II (DR & DQ) were determined in addition to the 40 control 
female. According to the results, patients were enrolled into 3 groups; Group1 included 11 
cases with normal hormonal profile. Out of them 7 have female sib(s) affected (7 multicase 
families) with hormonal levels in the normal range. Group2 included cases with increased 
hormones and LH/FSH ratio <2. Out of them 8 are members of multicase families with 
the same hormonal profile. Group3 included cases with increased hormones and LH/
FSH ratio >2. Non of them has affected female sib. The genetic analysis included HLA-
haplotype concordance, Lod score for linkage and identity by descent. The results lead to 
the conclusion that the hyperandrogenic manifestations in G1 are due to dominant inherited 
hypersensitivity to hormones. G2 and G3 may result from dyshormonogenesis due to 
recessive gene(s) leading to non-classical congenital adrenal hyperplasia or PCO syndrome. 
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TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) gene polymorphism 
in leprosy cases from the Nile Delta region of Egypt
A Hassan1, H Ahmed1, M Elmongy1, RM Elbaz1, M Nassar2, A Settin1, M Hassan2 
1Mansoura Faculty of Medicine, Mansoura, Egypt 2Tanta Faculty of Medicine, Tanta, 
Egypt
The objective was detection of the genotype frequencies of three promoter 
polymorphic sites in the TNF-alpha, IL-10 and IL-6 genes as well as IL-1Ra VNTR 
in our leprotic patients to investigate whether genetic regulation of their production 
could be implicated in leprosy pathogenesis and prognosis. DNA from 47 leprotic 
patients, 42 healthy controls all from Delta, Egypt, were examined with the 
polymerase chain reaction in case-controlled study. Polymorphic sites in genes of 
the TNF-alpha at position -308, IL-10 at position -1082 and IL-6 at position -174 
as well as 86-base pair variable number tandem repeat within intron 2 of the IL-
1Ra gene were determined. The present study demonstrates the definite influence 
of IL-10-1082 and TNF-alpha(-308) promoter polymorphisms on susceptibility 
and prognosis of leprosy and roll out the effect of IL-6(-174) polymorphism and 
IL-1Ra VNTR on the same disease in the studied Egyptian locality. In Conclusion, 
Our results suggest that both TNF-α(-308) and IL-10-1082 could be used as 
genetic markers for the development of severe or disseminated disease. We 
speculate that there is complex interaction between cytokine gene polymorphisms 
and phenotypic diversity of cell network that contribute to the host defense. 
 
476
Matrix Metalloproteinase-21 (MMP-21) Expression is Associated with Differentiation 
and Upregulated by Retinoic Acid in Keratinocytes
T Skoog1, K Ahokas2, I Tiala2, S Pasonen-Seppanen3, R Tammi3, O Elomaa2, U Saarialho-
Kere2 1Karolinska Inst, Sweden 2Uni of Helsinki, Finland 3Uni of Kuopio, Finland
Human matrix metalloproteinase-21 cloned by our group has been implicated in embryogenesis, tumor 
progression and apoptosis, being expressed in developing skin and invasive tumor cells of basal and 
squamous cell cancers. Furthermore, also neutrophils, fibroblasts and macrophages can produce MMP-
21 in certain skin disorders. We have earlier shown, that MMP-21 mRNA is induced by TGF-beta1 in 
HaCaT cells. We have further characterized the biology of MMP-21 on tissue level, in HaCaT cells and in 
two cell lines overexpressing MMP-21. In HaCaTs, retinoic acid induced its expression, but MMP-21 was 
not regulated by hormones. Activin A did not affect MMP-21 mRNA expression, whereas staurosporine 
induced its expression. When the staurosporine-treated cells were examined by immunocytochemistry, 
we saw an induction of K10, a marker of keratinocyte differentiation. Anisomycin, menadione or the 
tumor promoters PMA or okadaic acid had no effect on MMP-21 expression. Our tissue data indicate 
that MMP-21 expression is not only related to tumorigenesis, as suprabasal keratinocytes in lichen 
planus, actinic keratoses, Bowen’s disease and keratoacanthoma occasionally express MMP-21. Further, 
apoptotic keratinocytes in graft-versus-host and SLE samples did not stain for MMP-21 in agreement 
with cell culture data using apoptosis-inducing chemicals. Overexpression of MMP-21 in two human 
epithelial cell lines did not induce any obvious changes in cell morphology or epithelial mesenchymal 
transition when compared to control cells. Our results show that MMP-21 overexpression does not alter 
proliferation, but promotes differentiation of the cells as also shown by experiments using calcium for 
HaCaT differentiation. In an organotypic culture constructed using rat keratinocytes plated on type I 
collagen, MMP-21 was expressed by differentiated keratinocytes and partly colocalized with filaggrin. 
In summary, based on cell culture data on keratinocytes and observations in skin diseases, MMP-21 is 
related to differentiation of epithelial cells but does not colocalize with MMP-9, previously implicated 
in keratinization.
477
The PSORS1 locus gene CCHCR1 affects keratinocyte proliferation
S Suomela1, I Tiala1, J Wakkinen1, P Puolakkainen1, K Kainu1, R Tammi2, J Kere1, 
U Saarialho-Kere1, O Elomaa1 1Uni of Helsinki, Finland 2Uni of Kuopio, Finland
The CCHCR1 (Coiled-Coil α-Helical Rod protein 1) gene within the major psoriasis 
susceptibility locus PSORS1, is a plausible candidate gene for the risk effect. We 
have previously generated transgenic mice overexpressing either the psoriasis-
associated risk allele CCHCR1*WWCC or the normal allele of CCHCR1 under 
the K14 promoter. All transgenic CCHCR1 mice appeared phenotypically normal, 
but exhibited altered expression of genes relevant to the pathogenesis of psoriasis, 
including upregulation of, e.g., hyperproliferation markers keratins 6, 16, and 17. 
We challenged the skin of these mice with wounding and 12-O-tetradecanoyl-
13acetate (TPA) treatment, manipulations able to induce psoriasis-like phenotype. 
Remarkably, wounds of the CCHCR1*WWCC risk allele mice healed more slowly 
in the early phase than those of the normal allele or wild-type mice, and TPA-treated 
skin of transgenic mice was significantly thinner than that of wild-type mice, having 
less proliferating Ki67-positive cells. Transgenic CCHCR1 mice did not, however, 
develop histological features of human psoriatic lesions. Inflammation, formation of 
granulation tissue, and neovascularization did not differ between the mouse lines, 
implicating keratinocyte proliferation and/or migration to be responsible for retarded 
healing. By using keratinocytes isolated from newborn transgenic and wild-type mice 
in Transwelll chamber or in vivo scratch systems and by employing an in vitro/vivo 
migration assay, we found migration to be unaltered. However, cultured keratinocytes 
isolated from risk allele mice proliferated more slowly than wild-type cells when 
measured by BrdU and ELISA. Our results support the role of CCHCR1 as a negative 
regulator of keratinocyte proliferation. Thus, aberrant function of CCHCR1 may lead to 
abnormal keratinocyte proliferation which is relevant in the pathogenesis of psoriasis. 
 
478
Cytokeratin gene expression profiling in intrinsic skin aging
A Tros, K Önder, H Hintner, JW Bauer Paracelsus Private Medical University, Salzburg, 
Austria
Aging of the skin is a consequence of both a genetic program (intrinsic aging) and 
cumulative environmental wear and tear (extrinsic aging). Intrinsically aged skin 
appears thin and pale, shows increased fragility and loss of elasticity suggesting 
contributions from the extracellular matrix and the cytoskeleton. We focused our 
studies on the keratin gene family, comprising the main constituents of the skin. We 
performed real-time PCR analysis with 20 different cytokeratins, transcript profiling 
was complemented on the protein level by western blotting and immunofluorescence. 
We show that keratin 5, expressed in the basal layer of the epidermis shows equal 
expression on gene and protein level when comparing old and young skin. Keratin 
19, defined as a biochemical marker for skin stem cells was upregulated in young 
skin and absent in old skin samples detected by immunofluorescence. Keratin 16, 
which is known as a marker for hyperproliferative keratinocytes was upregulated in 
the skin of elderly people, both on gene and protein expression level. Furthermore 
other cytoskeletal proteins including alpha tubulin, actin beta and plakoglobin were 
downregulated in old on gene expression as well as on protein expression level. 
Functional analysis and participation of differentially expressed keratins in biological 
pathways will be the next step of analysis. 
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EB-associated squamous cell carcinoma (SCC): a profile of matrix metalloproteinases 
expression at the mRNA level 
C Gruber1, I Gratz1, A Volz2, L Bruckner-Tuderman2, G Meneguzzi3, JW Bauer4 1EB-
Haus-Austria, Salzburg, Austria 2University of Freiburg, Germany 3INSERM U634, 
Nice, France 4Paracelsus Private Medical University, Salzburg, Austria
Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) often suffer from 
squamous cell carcinoma (SCC), which is the main cause of precocious death in 
this patient group. Due to the fact that EB SCC does not respond to conventional 
chemo- or radiotherapeutical therapy, cancer gene-therapy using SMaRT technology 
(splicesosome mediated RNA trans splicing) might constitue a novel approach 
for treatment.This work focuses on evaluating an mRNA profile of EB SCC tissue, 
an EB SCC cell line and the corresponding peritumoral tissue or cell line. Due to 
the fact that RDEB SCC is characterized by its rapid tumor growth traversing the 
extracellular matrix, the expression of selected matrix metalloproteinases (MMP-3, 
MMP-7, MMP-9 and MMP-13) was examined using real time RT-PCR. We show an 
upregulation of MMP-3, MMP-9 and MMP-13 mRNA in tumor tissue. The RDEB cell 
lines differed from the tissue samples in that MMPs are not equally upregulated. But 
nevertheless we were able to see significant increased MMP-9 mRNA in the RDEB 
SCC cell line compared to the non- SCC cell line. Based on these data MMP-9 was 
used to generate a cancer gene-therapy approach using splicesosome mediated RNA 
trans splicing. Vectors carrying intronic regions of MMP-9 and cDNAs of cell-death 
inducing peptides were constructed. In transfected cancer cells the pre-messenger 
RNA of MMP-9 is transspliced with the mRNA of a peptide, e.g. diphtheria toxin, 
leading to its specific expression. As a result the tumor cell should be killed by 
producing its own toxin. 
 
480
Epidermolysis bullosa simplex (EBS) in the Netherlands: novel and recurrent 
mutations in the genes KRT5 en KRT14 and genotype-phenotype correlation
MC Bolling, MF Jonkman, HH Pas Uni Medical Centre Groningen, Netherlands
EBS is a hereditary mechanobullous skin disease characterized by rupture through the 
basal keratinocytes and subsequent intraepidermal blister formation. The majority of 
EBS cases is caused by dominant missense mutations in the genes KRT5 and KRT14 
coding for the basal epidermal keratins 5 en 14. In this study we give an overview 
of the Dutch EBS population. The diagnosis EBS was based on clinical features, 
electron microscopic analysis and antigen mapping of skin biopsies. Subsequently 
sequence analysis of patient genomic DNA was performed on all exonic and intronic 
sequences of KRT5 and KRT14. Fifty-two EBS families were included. Nine new 
mutations and 17 previously described mutations were identified. Considerable 
clinical variation was observed within families as well as between families with the 
same mutation. Patients with previously reported KRT5 and KRT14 mutations had 
an EBS-subtype as described before except for one. The most severe EBS Dowling-
Meara families had mutations in the highly conserved ends of the rod domain. In 
the less severely affected Weber-Cockayne and Koebner patients the mutations 
were located over the entire protein. In 12 EBS families (23%) no KRT5 or KRT14 
mutation was found. To check for larger heterozygous deletions or insertions that 
might be missed with regular mutation detection techniques we performed long-
range PCR including the complete KRT5 and KRT14 genes in these families. 
Analysis of the product size on agarose gels did not reveal any large insertions or 
deletions. Since careful re-evaluation of electron microscopic data confirmed 
intraepidermal blistering it is probable that besides KRT5 and KRT14 other genes 
are involved in EBS. These data add a substantial amount of new KRT5 and KRT14 
mutations and give further insight in the genotype-phenotype correlation in EBS. 
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Role of a lipid activated transcription factor peroxisome proliferation activated 
receptor gamma in sebocytes
A Dozsa1, BI Tóth1, T. Bíró1, E Remenyik1, B Dezso1, CC Zoubulis2, L Nagy1 1University 
of Debrecen, Hungary 2Dessau Medical Center, Dessau, Germany
Sebaceous gland is a holocrine gland with accelerated lipid metabolism. On the other 
hand, peroxisome proliferation activated receptor gamma (PPARγ) is a nuclear receptor, 
functioning as a transcriptional factor. Together with retinoid X receptor alpha (RXRα) it forms 
a heterodimer and regulates gene expression. Certain lipid ligands activate or inactivate this 
receptor complex. PPARγ has a key role in adipocyte lipid metabolism and differentiation; 
sebaceous glands were also reported to express PPARγ. Our goal is to assess if PPARγ has 
a role in sebocyte function and/or diseases associated with this cell type. Human SZ95 
sebocytes and skin samples of healthy individuals and patients with dermatoses were used 
for immunhistochemistry to determine the presence of the receptor proteins. In addition, 
we isolated mRNA from laser microdissected sebaceous glands to detect gene expression 
with RTqPCR. The function of the receptor was studied in SZ95 sebocytes by adding the 
PPARγ agonist rosiglitazone (RSG), the PPARγ antagonist GW9668, interleukin4 (IL4), the 
RXRα agonist LG268 or arachidonic acid (AA). Quantitative fluorimetric analyses were 
used to detect changes in lipids. We detected PPARγ and RXRα proteins in samples from 
heathy individuals, patients with sebaceous hyperplasia, sebaceous carcinoma and in 
SZ95 sebocytes. The expression of PPARs in SZ95 sebocytes and also expression of target 
genes (ie. ADRP, LXRα) were detectable. By adding RSG, IL4 and AA no change in certain 
PPARγ target genes was detected, however changes in sebocyte lipid content occurred. 
GW9668 treatment decreased sebaceous lipids. Our data suggest that PPARγ is likely 
to play a role in sebaceous lipid synthesis, thus it is possibly a relevant target for further 
investigation in sebaceous gland-associated dermatoses and a potential target of therapy. 
 
482
Genomic ABCA12 mutations in ichthyosis patients with multiple skin malignant 
neoplasia
K Natsuga1, M Akiyama1, N Kato2, K Sakai1, Y Sugiyama-Nakagiri1, M Nishimura1, H 
Hata1, M Abe1, K Arita1, Y Tsuji-Abe1, T Onozuka1, S Aoyagi1, K Kodama1, H Ujiie2, 
Y Tomita2, H Shimizu1 1Hokkaido University, Sapporo, Japan 2Hokkaido Cancer 
Institute, Sapporo, Japan
Recently, mutations in the gene encoding the adenosine triphosphate (ATP)-binding cassette 
transporter protein ABCA12 have been reported to cause ichthyosis such as type 2 lamellar 
ichthyosis and harlequin ichthyosis. Here, we identified two novel ABCA12 mutations in two 
unrelated non-bullous congenital ichthyosiform erythroderma (NBCIE) patients presenting with 
multiple skin malignancies including malignant melanoma (MM). Patient 1 had MM at the age 
of 37 and cutaneous lymphoma at the age of 39. Patient 2 developed cutaneous squamous 
cell carcinoma at the age of 42 and MM at the age of 47. Mutational analysis of the ABCA12 
gene revealed a homozygous c.1033A>C transversion (p.Thr345Pro) in exon 9 in Patient 1 and 
c.4481T>C transition (p.Ile1494Thr) in exon 30 was detected only in one allele in Patient 2. 
Immunofluorescence studies revealed that ABCA12 staining was significantly reduced in the 
both patients’ epidermis. Electron microscopic examination revealed that, in the cytoplasm 
of granular layer keratinocytes, abnormal, defective lamellar granules (LGs) were assembled 
together with some normal-appearing LGs. Culture of keratinocytes from patient 2 under high-
Ca2+ conditions induced a large number of cells to express condensed glucosylceramide 
staining around the nuclei. Our cases demonstrate that ABCA12 mutations lead to abnormalities 
in lipid transfer and malformation of intercellular lipid layers, an important component of the 
skin barrier, resulting in this NBCIE phenotype. Due to defective keratinocyte lipid transport 
and malformation of intercellular lipid layers in the stratum corneum, the skin surface is likely 
to be easily irritated, resulting in a chronic state of inflammation. These recurrent and long-
lasting irritation and inflammation processes may increase the likelihood of skin carcinogenesis. 
483
Loeys-Dietz Syndrome and vascular Ehlers-Danlos Syndrome: differential diagnosis 
by clinical and molecular approaches
G Tadini1, B Drera2, N Zoppi2, E Bruni1, S Marchetti1, PG Calzavara-Pinton2, S Barlati2, 
M Colombi2 1Cen for Inherited Cutaneous Diseases, Milan, Italy 2Uni of Brescia, Italy
Loeys-Dietz syndrome (LDS) is a rare autosomal dominant disorder characterized by 
hypertelorism, bifid uvula and/or cleft palate, and arterial tortuosity with widespread 
vascular aneurysm and dissection. LDS, presenting the involvement of cutaneous, 
cardiovascular, craniofacial and skeletal systems, has been classified in LDS type I (LDSI) 
and type II (LDSII) based on the presence or the absence, respectively, of cranio-facial 
involvement. Furthermore, LDSII patients display at least two of the findings associated 
with the vascular type of Ehlers-Danlos syndrome (vEDS): visceral rupture, easy bruising, 
wide and atrophic scars and translucent or velvety skin. LDS is due to mutations in the 
genes encoding transforming growth factor receptor I (TGFBR1) and II (TGFBR2); vEDS is 
caused by mutations in COL3A1 gene encoding type III collagen. In this work we report 
the clinical and molecular characterization of two patients affected with LDSI (Patient 1) 
and LDSII (Patient 2) with two different mutations in TGFBR1. Patient 1, a six year-old boy, 
displayed: dolicocephaly, blue sclerae, micro/retrognathia, high-arched palate, bifid uvula; 
scoliosis, pectus excavatum, pes planus, joints hypermobility; velvety and translucent skin; 
aortic bicuspid valve, aortic root diameter 23 mm; tortuosity and elongation of the basilar 
and internal carotids arteries. Patients 2, a 42-years old man, did not show neither the facial 
nor the skeletal LDS typical signs. He showed a classic vEDS phenotype: typical facies, 
small joints hypermobility, atrophic scars, mild skin hyperextensibility and dissection of 
internal iliac arteries occurred at 40. In this patient no COL3A1 gene mutation was found. 
Sequencing analysis of Patients 1 and 2 DNA disclosed two different TGFBR1 missense 
mutations. Since LDS and vEDS phenotypes show similar cutaneous and cardiovascular 
involvement, molecular analysis of candidate genes is mandatory to clarify the diagnosis, 
prognosis, and genetic counselling. 
484
Mutation in the Gene KRT10 Leading to Bullous Congenital Ichthyosiform 
Erythroderma Without Palomoplantar Hyperkeratosis
C Kowalewski1, K Wozniak1, T Hamada2, T Hashimoto2 1Medical University of 
Warsaw, Poland 2Kurume University, Japan
Bullous congenital ichthyosiform erythroderma (BCIE) is a dominantly inherited ichthyosis 
resulting from mutations in either the keratin 1 or keratin 10 genes. Clinically BCIE is 
characterized by erythroderma and blistering at birth, and after neonatal period of the live by 
development of ichthyotic hyperkeratosis. Palmoplantar keratoderma is present, especially 
if associated with the mutation in keratin 1 gene. We report 3-year-old girl born in time 
from non-consanguineous healthy parents who presented at the birth generalized blisters 
and erosions accompanied by Nicolsky’s sign. Mucous membranes were not involved. On 
the beginning of third month of the live patient developed slight hyperkeratotic plaques on 
localized on extensor surfaces of the forearms and on the lower abdomen. While patient was 
6-months-old she developed hyperkeratotic plaques on the face whereas blisters appeared 
occasionally. After 12-months of the live blisters stopped to appear and hyperkeratotic 
scales dominated in the clinical picture. Palmoplantar hyperkeratosis have never been 
observed. Histopathology performed in third month of the live showed hyperkeratosis, 
acanthosis and the presence of numerous cells in the upper part of stratum spinosum with a 
large keratohyaline granules, whereas electron microscopic study disclosed keratin clumps 
reflecting the disturbances in keratin assembly process. Molecular analysis in the proband 
showed the mutation (g>a467) in the hot spot 1A domain of gene KRT10 encoding keratin 10 
resulting in an arginine-to-histidine substitution. This mutation was not found in her healthy 
parents. Our study confirms previous observations concerning absence of palmoplantar 
keratoma in patients with BCIE associated with the mutations in the KRT10 gene. 
 
485
Phenotypic reversion of human keratinocytes from a patient suffering from 
Cockayne Syndrome
E Dellambra1, R Maurelli1, S Bondanza1, T Nardo2, L Panacchia1, M Stefanini2, 
L Guerra1, S Cordisco1 1Istituto Dermopatico dell’Immacolata, Pomezia, Italy 2Istituto 
di Genetica Molecolare CNR, Pavia, Italy
As cellular DNA is under constant challenge by genotoxic stress, all cells are equipped with DNA 
damage response pathways that trigger DNA repair, cell cycle arrest, and apoptosis, to eliminate 
damaged cells. The consequences for stem cells (SC) is diminution in SC pools or increase of SC 
differentiation /malignant transformation. A number of DNA repair abnormalities are linked to 
premature aging syndromes, and these are associated with defects in the SC population. Our studies 
are focused on recessive autosomal syndromes, such as Xeroderma Pigmentosum (XP), Cockayne 
syndrome (CS) and Trichothiodystrophy (TTD), caused by defects in nucleotide excision repair 
mechanisms and characterized by skin premature aging. Self-renewal of epidermis relies on the 
presence of SCs and transient amplifying (TA) cells. Transition from SCs to TA cells, named clonal 
evolution, is a process that occurs during natural aging and keratinocyte subcultivation. Replicative 
senescence, considered the cellular counterpart of in vivo aging, occurs when all SCs have completed 
their clonal evolution. We have stably transduced CS-A deficient keratinocytes with a transduction 
efficiency near to 100%, using a retroviral infection method. In order to study defects in replicative 
senescence, CS-A-transduced keratinocyte cultures were serially passaged and showed a proliferative 
potential similar to normal keratinocytes, different from patient and empty vector-transduced cultures. 
Exogenous protein was translocated into the nucleus and its expression was maintained during serial 
passages. Moreover, CS-A-transduced keratinocyte cultures were able to survive and to recover RNA 
synthesis after UVC irradiation such as normal keratinocytes, different from defective keratinocytes. 
CS-A protein was able to restore 8-oxo-guanine levels, physiologic clonal evolution and a normal 
ratio of proliferation/differentiation markers in deficient keratinocytes. Further functional studies will 
let us to obtain new knowledge about a link between DNA repair systems and SC maintenance.
486
TGM1 mutations in bathing suit ichthyosis: A functional understanding
K Aufenvenne1, V Oji1, T Walker1, H-C Hennies2, N Seller1, P Bruckner1, H Traupe1 
1University Hospital Münster, Germany 2University of Cologne, Germany
Bathing suit ichthyosis (BSI) is described as striking and unique clinical subtype 
of transglutaminase-1 deficient lamellar ichthyosis (LI type 1) with large dark-grey 
or brownish scales restricted to the bathing suit areas. Recently, in a group of ten 
individuals of independent families we identified new mutations in the TGM1 gene 
which differ from those which can be found in patients with generalized lamellar 
ichthyosis. Previous clinical analysis, atomic modelling and immunohistochemical 
studies suggest a temperature depending activity of the identified TGM1 mutations in 
BSI patients. To further elucidate the molecular basis of this unusual phenotype we 
performed in situ mutagenesis studies and expressed eleven mutations in HEK 293 
cells. Eight were only identified in BSI patients, three had previously been found in 
patients with generalized lamellar ichthyosis due to transglutaminase-1 deficiency. 
Wildtype TGase-1 served as a control. To analyse TGase-1 activity we performed a 
fluorimetric assay at different temperatures ranging from 21°C to 45°C. The presented 
data show that the recombinant proteins including BSI-mutations were less active than 
the wildtype protein and show a shift in temperature-optimum from 37°C/39°C to 
31°C/33°C. We suggest that TGase-1 proteins including BSI-mutations in comparison 
to the wildtype TGase-1 show less thermal stability. By use of circulardicroism (CD)-
spectroscopy with four selected mutations and the wildtype TGase-1 protein we 
want to elucidate the mechanism of temperature sensitivity. These investigations are 
currently in process. 
 
 
2007 ESDR Abstracts v2.indd   81 8/13/07   11:31:47 PM
ABSTRACTS
S82  Journal of Investigative Dermatology (2007), Volume 127 
487
A novel COL7A1 branch point mutation leads to a complex splicing pattern and a 
mild recessive dystrophic epidermolysis bullosa phenotype
B Drera1, G Floriddia2, F Forzano3, S Barlati1, M Colombi1, G Zambruno2, D Castiglia2 
1University of Brescia, Italy 2Istituto Dermopatico dell’Immacolata, Rome, Italy 
3Genetics Laboratory, Galliera Hospital, Genova, Italy
Dystrophic epidermolysis bullosa (DEB) is characterized by blistering and scarring of skin 
and mucous membranes, and phenotypic heterogeneity. DEB is due to either dominant 
or recessive mutations in COL7A1 gene coding for type VII collagen (COLVII), the major 
component of anchoring fibrils ensuring dermal-epidermal adhesion. COL7A1 is a 
complex and compact gene comprising 118 exons in approximately 32 kb of genomic 
DNA. Up to 20% of all known COL7A1 mutations are predicted to affect splicing. 
Here, we report a patient with mild recessive DEB due to compound heterozygosity 
for the novel c.976+1G>A and c.5236-23A>G substitutions. We determined mutation 
effects by RT-PCR analysis of splicing pattern in patient’s cultured fibroblasts. Mutation 
c.976+1G>A abolishes the donor splice site of intron 7 and results in a null allele due 
to intron retention. Mutation c.5236-23A>G affects the branch point adenosine of 
intron 58 and results in: (1) wild type transcripts; (2) in-frame exon 59 skipping leading 
to COLVII monomers lacking 12 amino acids; (3) retention of introns 58 and 59; (4) 
cryptic 3’ splice site activation in exon 59 leading to the loss of 28 coding nucleotides 
and retention of the downstream intron; (5) intron 58 retention. Our results show that a 
branch point A>G substitution, here reported in the COL7A1 gene, can induce full intron 
retention, cryptic splice site and exon skipping resulting in both out-of-frame and in-frame 
transcripts. Our analysis also indicates that some pre-mRNA could be correctly spliced. 
These findings correlate with the slightly reduced expression of COLVII and the presence 
of altered anchoring fibrils observed in patient’s skin and thus explain his mild phenotype. 
 
488
SPINK5 expression is regulated by interferon-gamma and retinoic acid
M Berretti, P Fortugno, G Zambruno, M D’Alessio IDI-IRCCS, Rome, Italy
SPINK5, encoding the multi-domain serine protease inhibitor LEKTI, is the defective gene 
in the severe autosomal recessive ichthyosiform skin condition, Netherton syndrome (NS, 
OMIM 266500). Strongly expressed in the uppermost epidermis and in primary keratinocytes 
induced to differentiate by in the presence of high calcium, SPINK5/LEKTI represents a key 
regulator of proteases involved in the cutaneous barrier turnover and hair development. Still, 
the severe atopic manifestations of NS suggest the involvement of LEKTI in inflammatory 
and/or immune allergic responses. In a previous work we noticed that in psoriasis and 
neonatal/infantile erythrodermas (due to immune deficiency or atopy), LEKTI expression is 
decreased in particular at sites of intense lympho-mononuclear infiltration in the epidermis. 
We thus decided to investigate the SPINK5/LEKTI expression regulation. The proinflammatory 
cytokine interferon-gamma (IFN-gamma) and the vitamin-A derivative all-trans-retinoic acid 
(RA) were shown to be able to modulate SPINK5 transcription in vitro. Specifically, the 
addition of 1000 U/ml IFN-gamma or 10-6 M RA to cultured human keratinocytes induced 
to differentiate in 1.2 mM Ca++ for 6 days resulted in a significant SPINK5 transcript 
decrease already evident at 4-8 hrs of treatment. Interestingly, western blot analyses showed 
that, while the protein amount is reduced of 40-60% by IFN-gamma within 48-72 hrs, cell 
treatment with RA results in a much stronger protein decrease culminating in an almost 
complete abolishment of LEKTI expression. On the other hand, no SPINK5 transcriptional or 
post-transcriptional modulation by two other cytokines, TNF-alpha and IL-22, was seen in our 
experimental conditions. Our results indicate that the SPINK5 transcription down-regulation 
by the IFN-gamma may finely tune the LEKTI protease inhibitor function during inflammatory 
processes. On the other hand, the almost complete loss of LEKTI protein expression by RA 
could be related to the decreased cohesiveness of the stratum corneum induced by retinoids. 
 
489
The state of the transcription machinery determines response of dermal fibroblasts 
from different individuals to retinoic acid and TGFbeta
T Neuman, H Sadam, A Liik FibroTx, Tallinn, Estonia
Dermal fibroblasts from different individuals show variation in the expression of 
different components of extracellular matrix (ECM). Also, induction or repression 
of specific ECM related genes varies significantly (up to tenfold) in different 
isolates of dermal fibroblasts following retinoic acid and TGFbeta treatment. 
Transcription of individual genes is regulated by different classes of transcriptional 
regulators such as DNA binding transcription factors, chromatin modifying factors, 
transcriptional co-regulators and basal complex components that all together 
form a large multiprotein transcriptional complex. Analysis of transcriptional 
complexes using variety of techniques including immunoprecipitation and mass 
spectroscopy revealed differences in fibroblasts isolated from different individuals. 
Both expression level and presence of isoforms of components of transcriptional 
complexes varies in individual fibroblast isolates that translates into functional 
differences of transcriptional machinery. These variations may also explain 
different response of fibroblast isolates to retinoic acid and TGFbeta. Modification 
of expression of components of transcriptional complexes (over-expression and 
supression using siRNA) enabled us to identify several transcriptional co-regulators 
that coordinate expression of many ECM related genes and are responsible for 
the variation in response of fibroblasts to retinoic acid and TGFbeta treatments. 
 
490
Type I interferon response to adenoviral vector participates in the regression of 
cutaneous lymphoma lesions following adenovirus-mediated IFN-γ gene transfer
M Urosevic1, K Fujii2, B Calmels3, E Laine1, B Acres3, R Dummer1 1University Hospital 
Zurich, Switzerland 2Okayama University, Japan 3Transgene SA, Strasbourg, France
Adenoviral vectors belong to commonly used gene delivery systems enabling 
transient expression of the delivered gene as in cytokine gene therapy. These vectors 
activate innate immunity thereby inducing type I interferons (IFNs), such as IFN-α 
and β. Type I IFNs influence different aspects of human immune response that are 
believed to be crucial in mounting of efficient antitumor immunity. We performed 
transcriptional profiling to characterize in vivo response of cutaneous lymphomas to 
intralesional adenovirus-mediated IFN-γ (Ad-IFN-γ) gene transfer. Gene expression 
profiles of skin lesions obtained from 19 cutaneous lymphoma patients before and 
after treatment with Ad-IFN-γ, revealed a distinct gene signature in treated lesions 
consisting of IFN-γ (type II IFN) as well as numerous IFN-α (type I IFN)-inducible 
genes. Additional in vitro experiments with an empty adenoviral vector (Ad-null) 
versus Ad-IFN-γ revealed that this IFN-signature is vector dependent and that its 
magnitude and complexity, in terms of immune activation, is potentiated by the 
IFN-γ gene insert. Mounting of combined type I/II IFN response to Ad-IFN-γ in the 
treated cutaneous lymphoma lesions may have clinical benefits. The display of 
combined type I/II IFN-signature in the treated lesions was associated with objective 
(measurable) response later in the course of the treatment. Biological effects of type 
I IFNs seem to enhance those set in motion by the transgene, in our case IFN-γ. 
Combined effects of transgene expression and the innately induced type I IFNs may 
prove to be of therapeutic importance in cytokine gene delivery using adenoviruses. 
 
491
Cell-death induction in primary cultures of human melanocytes by transfection of 
pHSV-TK with the synthetic reagent KLN-47 followed by ganciclovir treatment 
D Legoupil1, M Denizot2, P Delépine2, U Péreira3, P Lehn2, C Férec2, L Misery3, 
T Montier2 1CHU de Brest, Brest, France 2Unité INSERM 613 - UBO, Brest, France 3EA 
3879 U.P.C.I., Brest, France
Malignant melanoma is a skin cancer with a poor prognosis at metastatic stage, because 
currently available treatments are not very efficient. Hence, there is a need to find new 
therapeutic alternatives, such as gene therapy. The HSV-tk ‘pro-drug / suicide gene’approach 
may be one of the most promising. In this context, we investigated the transfection potentiality 
of synthetic vectors such as monocationic lipophosphoramidate KLN-47. First, we transfected 
the GFP reporter gene using two different cationic lipids (KLN-47 and DOTAP/DOPE) to 
evaluate their efficiency on human melanoma derived cells lines (SKMEL28 and A375) and 
primary healthy melanocytes. At 48h, the efficiency was significant higher with KLN-47 and 
its toxic impact was lower than DOTAP/DOPE. Then, the HSV-tk plasmid was transfected into 
primary melanocytes. 24h later, ganciclovir was added in the medium and continued during 
12 days. On days 8 and 12, the number of viable cells decreased with finally reached less 
than 11% of living cells with KLN-47 (DOTAP/DOPE ˜  45%). In a second time, our aim was to 
evaluate the suicide gene strategy in vivo. Xenografts were made by injection subcutaneously 
of 3.106 SKMEL28 cells in twenty nude mice. When tumors reached a sufficient volume, we 
defined four groups: two groups have been transfected with 50 µg of HSV-tk plasmid coupled 
with KLN-47 and 24h post-transfection, they received either sodium chloride or ganciclovir 
(GCV-50 mg/kg), twice a day intraperitoneally during 7 days. The last groups received either 
ganciclovir or NaCl alone. In the ‘HSV-TK + GCV’group, the tumor’s volume increased slower 
than in the others groups during the first 4 days. Then, the growth became similar to the 
controls. Thus, we performed a second transfection 8 days after the first one but the effects 
seem to be shorter and only one mouse conserves a stable tumor.
492
Second hit mutation analysis in melanocytes, keratinocytes and fibroblasts obtained 
from NF1 café-au-lait macules reveals presence of two NF1 hits in the melanocytes
S De Schepper1, T Callens2, O Maertens1, JM Naeyaert1, J Lambert1, L Messiaen2
1Ghent University Hospital, Belgium 2University of Alabama at Birmingham, USA
Neurofibromas and café-au-lait macules (CALM) are major cutaneous manifestations of 
neurofibromatosis type 1. Schwann cells harbor the second NF1 mutation and this triggers 
the formation of neurofibromas. The hypothesis that alterations in the NF1 gene also play a 
crucial role in the pathogenesis of another benign NF1 complication, the CAL-spots, is poorly 
examined. We showed recently that the melanocyte density is increased in NF1 CALM skin 
compared with normal skin, control normal skin and control CALM skin. We decided to 
revisit the abovementioned hypothesis using a more powerful approach for NF1 mutation 
analysis, allowing identification of LOH as well as minor lesion mutations. We obtained 
CALM skin biopsies from 13 NF1 patients with known germline mutation. Using selective 
culture conditions, 11 fibroblast, 3 keratinocyte and 6 melanocyte cultures for further DNA 
and RNA-based studies were obtained. First, LOH was assessed by comparing constitutional 
DNA with DNA extracted from the melanocyte, fibroblast and keratinocyte cultures. 
Genotype analysis was performed on amplified products using 4 intragenic microsatellite 
markers. No LOH was observed in any of the cell types. Hereafter long-range RT-PCR and 
direct sequencing of the entire NF1 coding region was performed. The germline mutation only 
was identified in the 11 fibroblast cultures as well as in the 3 keratinocyte cultures. However, 
in all 5 melanocyte cultures (having sufficient RNA for the entire analysis), a different second 
hit was identified: 3 were nonsense mutations, 1 was a splice mutation and finally one culture 
showed loss of expression of the wild type allele without identifiable mutation at the cDNA 
level. In conclusion, these data improve our understanding of the molecular mechanisms 
underlying the formation of CAL-spots and will boost further research aiming to understand 
the phenotypes associated with somatic mutations in melanocytes and their precursors during 
development and their association with segmental NF.
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The Role of Gasdermin in Sebaceous Gland Differentiation
A Glavini1, PE Bowden1, M Philpott2, RM Porter1 1Cardiff University, Cardiff, UK 
2Centre for Cutaneous Research, London, UK
Defolliculated (Dfl) is a mouse mutation that has altered sebaceous gland 
differentiation, a defective hair cycle, and chronic inflammation ultimately leading 
to hair follicle destruction. The gene underlying the phenotype is gasdermin 3 which 
is expressed in the epidermis, sebaceous gland and hair follicle. The purpose of 
this study was to investigate the potential role gasdermin plays in sebaceous gland 
differentiation. The expression of sebaceous gland differentiation markers such as 
stearoyl-coenzyme A desaturase (SCD), indian hedgehog, peroxisome proliferator-
activated receptors (PPAR), sterol response-element binding protein-1 and CCAAT/
enhancer binding proteins (C/EBP) was compared at different stages of the hair 
cycle in the skin of wild type and Dfl mice by RT-PCR and immunohistochemistry. 
SCD1 and SCD3 were dramatically decreased in the sebaceous gland of Dfl mice. 
PPARalpha and PPARgamma transcription was also reduced at all stages of the 
hair cycle. C/EBPalpha was consistently unchanged and C/EBPbeta appeared to 
be still present in the nucleus of Dfl sebocytes. Since gasdermin and C/EBPs both 
contain leucine zippers, the mutation may cause aberrant interaction with these 
transcription factors leading to reduced expression of SCD and PPARs. These 
results explain the similar phenotypes shared by Dfl and the asebia mouse mutant 
which is caused by a homozygous mutation in SCD1. Thus, Dfl mice offer an 
opportunity to investigate the control of SCDs expression and sebum production 
which would contribute to our understanding of over-production of sebum in acne. 
 
494
Molecular genetic studies in erythropoietic protoporphyria
V Varga, A Balogh, G Emri, I Horkay, E Remenyik University of Debrecen, Hungary
Erythropoietic protoporphyria (EPP) is an autosomal dominant disease showing 
incomplete penetrance, which is marked by photosensitivity. Mutations of the 
ferrochelatase (FECH) gene are responsible for the disease phenotype. This gene 
codes for the FECH enzyme found in the mitochondria of cells, which catalyzes the 
incorporation of iron into protoporphyrin creating functional heme molecule. The 21 
Kbp long gene is located on the the 21st chromosome and contains 11 exons. There 
are 23 EPP patients at the Department of Dermatology of the University of Debrecen 
in our care. We aimed to map the mutations of this patient group by analyzing DNA 
samples from them and their family members, and to correlate the clinical picture 
and biochemical findings with the mutations. After extraction of genomic DNA, exons 
1 to 11 of the FECH gene, and the associated splice donor and acceptor sites were 
amplified by PCR. PCR products were purified and automatically sequenced using 
ABI 3100 Avant machine. The mutations were analyzed using the Chromas program 
and were compared to publised DNA sequences or published recommendations. 
Our preliminary results showed IVS1-23c>t (9 patients) and g1059G>A (1 patient) 
polymorphisms. Furthermore IVS1-1g>c (1 patient) and pY160C (4 patients) known 
missense mutations, and in case of 3 patients IVS1+57t>c previously undescribed 
base change were found. The family members and the healthy Hungarian population 
are under investigation. No biochemical and clinical liver involvement has been 
described suggesting that additional factors might account for these manifestations. 
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The ABCC4 and ABCG2 transporter genes are expressed in a proliferation dependent 
manner in human keratinocytes
A Bebes1, K Kis1, N Nagy2, Z Bata-Csörgo1, L Kemény1, A Dobozy1, M Széll1 1University 
of Szeged, Szeged, Hungary 2SOLVO Biotechnology, Szeged, Hungary
Keratinocytes go through a proliferation-differentiation process and form a 
mechanical and chemical barrier, the epidermis of the skin. It has been recently 
suggested, that adenosine triphosphate binding cassette (ABC) transporters may 
contribute to the barrier function of the epidermis, similar to other tissues where 
they provide barrier-like protection to the organs. The aim of our work was to 
screen the mRNA expression profile of several xenobiotic transporters from the ABC 
transporter superfamily in keratinocytes. The expression profiles were studied in 
two keratinocyte proliferation-differentiation models: in synchronized HaCaT cells, 
and in normal human keratinocytes, forced to differentiate by increased calcium 
concentration. The relative mRNA levels were determined by Real-Time RT-PCR. 
The differentiation state of normal human keratinocytes was monitored by the 
expression of involucrin and cytokeratine 1 and 10. The expression of ABCC6 gene 
was not detectable in HaCaT cells, but showed a low-level expression in cultured 
keratinocytes. ABCB1, ABCC1, ABCC3 and ABCC5 genes were expressed both in 
HaCaT cells and in keratinocytes, but their expression did not show any changes 
during the proliferation-differentiation program of the cells. ABCC2 was expressed in 
a proliferation dependent manner in HaCaT cells, but not in cultured keratinocytes. 
The ABCC4 and ABCG2 genes presented a highly proliferation associated pattern 
of expression both in HaCaT cells and in cultured keratinocytes. We hypothesize 
that these two ABC transporter genes may be under similar transcriptional regulation 
and may play a role in the transport of xenobiotics in proliferating keratinocytes. 
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Functional characterization of different Connexin 26 mutants identified in KID 
Syndrome patients: impairment of membrane trafficking and connexon assembly
A Terrinoni, A Codispoti, M Paradisi, B Didona, G Melino IDI-IRCCS, Rome, Italy
The KID (MIM 148210) syndrome is a congenital disorder that affects the epidermis 
and other ectodermal tissues such as the inner ear, and has been associated to 
mutations in the Cx 26 (GJB2) gene. Connexins (Cx), share a common pattern of 
structural motifs or domains, four trans-membrane (M1 to M4), two extra cellular 
(E1, E2), and three cytoplasmic (NT, CL, CT), and they are components of the gap 
junctions allowing the exchange of different molecules. In this work, we analysed 
two heterozygous mutations (G11E, D50N) found in two unrelated KID patients. Both 
patients presented xerodermic eyelids, diffuse ichthyosis with large hyperkeratotic; 
erythematous and verrucous plaques, and palmo-plantar keratoderma (PPK). In 
addition, both patients presented bilateral, profound sensorineural hearing loss. The 
G11E mutation is located in the cytoplasmic NT domain of Cx26, that presumably 
control the voltage gating and the calcium fluxes, while the D50N mutants is 
localized in the trans-membrane domain M1. Normal human epidermal keratinocytes 
(NEHK), transfected with wild type Cx26 showed a classical punctate staining at 
the plasma membrane, indicating that the wt Cx26 localizes correctly. On the other 
hand, both Cx26 mutants are miss-localized, they did not form aggregates at the 
plasma membranel, while showed cytoplasmic localization with some perinuclear 
distribution. In addition, overexpression of G11E mutant is lethal in different cell 
lines. Preliminary experiments indicate a different behaviour of this mutant in 
the management of the calcium fluxes. In conclusion both mutants cause, by the 
impairment of protein trafficking to the plasma membrane, failure in the assembly 
of connexons and gap junction. Moreover, the G11E mutation is lethal for cell by 
deregulation of calcium managment.
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Dermokine Delta: A Novel Actor of the Endovesicular Traffic?
E Leclerc, L Gazeilles, E Toulza, G Serre, M Guerrin, N Jonca UMR 5165 CNRS - UPS, 
Toulouse, France
To identify epidermis late expressed genes, we analysed the human granular keratinocyte 
transcriptome. In spite of the limited redundancy of the method we used, a few genes 
encoding major components of the cornified layer were highly represented, such as filaggrin 
(FLG) or keratin 1 (KRT1). Surprisingly, one of the most represented genes was a gene of 
unknown function, the dermokine (DMKN) gene. We identified 4 groups of transcripts of 
this gene in normal human epidermis. The secreted α, β and γ isoforms share an epidermis 
restricted expression pattern, whereas the δ isoform is intracellular and ubiquitous. Our 
aim is to characterize dermokine δ function. By yeast two-hybrid analysis, we identified 
the small GTPases Rab5a, -b and -c as potential partners for dermokine δ. The interaction 
of dermokine δ with Rab5b was confirmed in vitro by GST-pull-down experiments and in 
vivo by co-immunolocalization. We also demonstrated using the yeast two-hybrid system 
that the minimum region of dermokine δ necessary for the interaction is restricted to the 
first 25 amino acid residues of the protein. Rab5 proteins regulate membrane docking and 
fusion in the early endocytic pathway. Like other GTPases, they cycle between an inactive 
(GDP-bound) and an active (GTP-bound) state. By yeast two-hybrid analysis, GST pull-
down and co-transfection of HEK293 cells, we showed that dermokine δ is able to bind 
both the active and inactive forms of Rab5b. We are currently analyzing the affinity of these 
interactions by surface plasmon resonance. This work suggests a role for dermokine δ in the 
intracellular traffic. Rab5 interacts with many partners that regulate its function or act as 
effectors. Experiments in progress will help determining the impact of dermokine δ on Rab5 
function, and the underlying molecular mechanisms. 
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Interactions of the NAV3 protein, deleted/translocated in Cutaneous T-Cell 
lymphomas
PE Carlsson1, V Hayry1, U Aapola2, P Silakka1, I Virtanen1, T Visakorpi3, A Ranki1 
1University of Helsinki, Finland 2Dermagene Oy, Tampere, Finland 3University of 
Tampere, Finland
We have previously reported that deletion/translocation of the Nav3 gene in 12q21 is a common 
aberration in Cutaneous T-cell lymphomas (CTCL). Nav3 is a potential haploinsufficient tumor 
suppressor gene, and in order to shed light on its poorly known function in neuronal and 
lymphoid tissues, we have used two approaches to mimic the in vivo gene deletion. Firstly, 
several siRNA constructs were cloned into the lentiviral vector pLL3.7, and the derivative (a 
23-nt sequence from exon 19) with most efficient inhibition has been used. In parallel, we 
use pooled siRNA Oligos (Dharmacon, Chicago, IL, USA) for rapid, but less long-lasting, 
knock-down, compared to the lentiviral contruct. With both methods, we demonstrate equally 
efficient decrease of Nav3 expression (85-90%) in A172 glioblastoma cells. We have studied 
the expression of NAV3 in the following cell lines: human neuronal stem cells (HNSC, self-
renewing cells from the subventricular zone of human fetal brain), inducible to differentiate into 
astrocytes, neurons and oligodendrocytes, and glioblastoma cell lines A172 and U118 MG. As 
lymphoid cells, Jurkat- and CEM-cells have been used. Expression of NAV3 has been confirmed 
by RT-PCR, western blot and immunocytochemistry, using a purified polyclonal peptide 
antibody. Furthermore, proteins interacting with NAV3 are identified by immunoprecipitation 
and confocal microscopy. Potential interacting proteins, the stem cell transcription factor Nanog, 
signalling factor Grb2 and centrosomal γ-tubulin, have been identified with respective antibodies. 
Confocal microscopy has shown potential co-localisation with Tuj1 (HNSC) and Nanog (A172), 
which is being confirmed with immunoprecipitation. In addition, gene-expression profiling of 
Nav3-silenced cells with agilent 4*44K chips is performed to identify additional interacting 
proteins. Our results, although as yet preliminary, will bring us new knowledge regarding the 
interactions and functions of the NAV3 protein in relation to the molecular pathogenesis of CTCL. 
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Biochemical characteristics of collagen VII mutants - what determines the degree of 
skin fragility in dystrophic epidermolysis bullosa?
SC Elfert, A Fritsch, L Bruckner-Tuderman University of Freiburg, Germany
Dystrophic epidermolysis bullosa (DEB), a skin blistering disorder, is caused by mutations 
of collagen VII, the major component of anchoring fibrils. Glycine substitutions within the 
collagenous domain may exert dominant negative effects on fibril function, but very little is 
known about genotype-phenotype correlations underlying different degrees of skin fragility. 
We used recombinant expression and site directed mutagenesis to generate wild type and 
mutant collagen VII and measured their helix-to-coil transition (or melting temperature, Tm) 
by determining the resistance to limited proteolysis. Coexpression of wild type (wt) and 
mutant collagen VII was used to mimic coexpression of both Col7A1 alleles. In contrast to 
wt collagen VII with a Tm of 41 °C, recessively inherited glycine substitutions decreased 
the Tm to 38°C when expressed in combination with wt protein (G1845R/wt, G2316R/wt). 
Hybrid triple helices of mutant collagen VII with glycine substitutions found in patients with 
dominant DEB showed significantly lower Tm (e.g. G1776R/wt, 31°C; G2006R/wt, 32°C; 
G2015R/wt, 34°C; G2207R/wt, 34°C). Interestingly, mutations associated with a minimal 
clinical phenotype reduced the Tm only to 36 °C (G1815R/wt). No intracellular accumulation 
of hybrid proteins was observed by immunofluorescent staining of patients´ keratinocytes 
(G2015E, G2034R, G2043R), suggesting that the phenotype was due to structural defects 
rather than impaired secretion. Our results show a significant difference in triple helix stability 
of collagen VII mutants associated with recessive and dominant DEB and that the Tm reflects 
the severity of the clinical phenotype. We will use this experimental system to determine the 
amount of wt collagen VII necessary to overcome the dominant negative effect of a given 
glycine substitution, thereby paving the road for gene or protein therapy for dominant DEB. 
 
500
Comorbidities Associated with Psoriasis in the Newfoundland and Labrador Founder 
Population
W Gulliver, Z Tomi, R Alaghehbandan NewLab Clinical Research, St. John’s, 
Newfoundland, Canada
Psoriasis is a common inherited inflammatory disorder of the skin that affects 1 to 2 
percent of the population. The relationship between psoriasis and psoriatic arthritis has 
been well established clinically and genetically. Recently researchers have suggested 
that there may be other comorbidities such as lymphoma, obesity, type 2 diabetes, 
dyslipidemia, hypertension, cardiovascular disease and lymphoma and melanoma 
and non melanoma skin cancer linked to psoriasis. Using the Newfoundland and 
Labrador founder population through the Newfoundland & Labrador Centre for 
Health Information (NLCHI) we have undertaken the task of studying 3400 psoriasis 
patients with respect to these comorbidities.Initial investigation of 100 patients with 
mild and severe psoriasis showed increased rates of heart disease, diabetes, and 
hypertension with under representation of asthma. The present study has analyzed 
3400 patients for these and other comorbidities, as well as, 800 patients who have 
been genotyped for HLACw6 and TNF-alpha 238 will have comorbidities and the 
genetic markers linked. This study demonstrates that the use of the Newfoundland 
and Labrador founder population and its comprehensive health information data base 
linked to genetic analysis will be a powerful tool in understanding the genetics of 
comorbidities linked to psoriasis. Other significant findings include the association 
between early age of onset and HLACw6 as well as the presence of psoriatic arthritis 
and genetic markers. 
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Variable patterns of kindlin-1 skin immunolabelling resulting from KIND1 gene 
mutations in Kindler syndrome
JE Lai-Cheong, JA McGrath St John’s Institute of Dermatology, London, UK
Kindler syndrome (KS) is a rare autosomal recessive blistering and poikilodermatous 
genodermatosis characterised by loss-of-function mutations in KIND1 gene which 
encodes for kindlin-1. Clinically, KS can be difficult to diagnose, especially in infancy 
when there is considerable overlap with epidermolysis bullosa (EB). Many recessive 
forms of EB, however, can be accurately diagnosed by demonstrating reduced/absent skin 
immunostaining for specific skin adhesion proteins. Our study, therefore, aimed to assess 
whether altered patterns of skin immunolabelling using a C-terminal rabbit polyclonal anti-
kindlin-1 antibody might be useful in making a robust diagnosis of KS. Immunostaining 
was performed on skin biopsies obtained from 13 patients with loss-of-function mutations 
(nonsense/frameshift/splice site) on both alleles of KIND1 gene. In normal skin, kindlin-1 
immunoreactivity was seen especially in the basal keratinocyte layer, with labelling 
appearing intracellular but close to the cell periphery. Contrastingly, skin labelling from 
KS subjects demonstrated a reduction/complete absence of anti-kindlin-1 immunostaining 
in 7/13 patients but, somewhat surprisingly, normal/near-normal labelling in the remaining 
cases. To explore this further, semi-quantitative RT-PCR was used to analyse expression 
levels of KIND1 mRNA extracted from skin biopsies obtained from 4 patients with KS (3 
with reduced kindlin-1 labelling and 1 with normal staining). The results showed that loss 
of kindlin-1 immunoreactivity was associated with reduced KIND1 mRNA expression 
whilst bright immunostaining was paralleled by normal mRNA level. However, there was 
no correlation with the nature/site of the KIND1 mutations in genomic DNA. Nor was 
there any correlation between kindlin-1 immunolabelling patterns and the clinical findings 
in this cohort of KS patients. In conclusion, this study shows that immunofluorescence 
microscopy gives variable kindlin-1 labelling patterns in KS skin and, if performed 
using this anti-kindlin-1 antibody, cannot be used to make an accurate diagnosis of KS. 
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Multi-locus genetic analysis of monilethrix in a 3 generation Hungarian pedigree
AZ Blazsek1, M Németh2, Z Hatvani1, R Lepesi-Benko1, A Bóna1, S Kárpáti1, 
M Medvecz1 1Semmelweis University, Budapest, Hungary 2HAS-SU Molecular 
Medicin RG., Budapest, Hungary
Monilethrix (MIM #158 000) is a rare disorder characterized by periodic beading of hair 
shafts, pronounced hair fragility, resulting in hair loss or eventually scarring alopecia. 
Genetical analysis of affected families showed that the autosomal dominant inheritance is 
caused by mutations in the type II basic hair keratins 1, 3 or 6 (hHb1, hHb3, hHb6) genes 
and the most recently identified mutations were found in the desmoglein 4 (DSG4) gene. In 
this work we describe the first case of monilethrix mutation analysis of Hungarian patients of 
a 3 generation pedigree. A 28-year-old female patient came to our Department with severe 
hair loss and nail vulnaribilty. Her scalp presented with short hairs that broken at 0,5-2 
cm length and erosions. No blister formation, nail dystrophy or anonychia was seen. Her 
mother and her grandmother of the maternal side had similar symptoms. Genomic DNA of 
the index person was isolated from 200 ul peripheral blood. Routine PCR-analysis of exons 
and surrounding intronic splice sites for hHb1, hHb3 was performed as described earlier by 
van Steensel, hHb6 mutation analysis was performed via the publicly available VARSEQr 
analysis system. PCR-CSGE and high resolution melting curve analysis of amplicons for 
all genes was performed to identify allelic variants, which then were submitted automated 
cycle sequencing. The identified mutations and polymorphisms were reconfirmed with 
endonuclease restriction.Parallel analysis of basic hair keratins and application of mutation 
screening techniques led us to exclude hHb3, while hHb1 carried only polymorph variants. 
Although several genes may carry mutations associated with monilethrix, in this case 
we disclosed a classical mutation in hHb6. In the patient the E402K mutation of hHb6, 
previously identified as a monilethrix-associated, disease causing aberrant variation had 
been identified.
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Heterozygous nonsense mutation affecting all six isoforms of the p63 gene 
underlying AEC syndrome
SE Clements1, TY Tan2, L Ozoemena1, JA McGrath1 1St John’s Institute of Dermatology, 
London, UK 2Murdoch Children’s Research Institute, Royal Children’s Hospital, 
Melbourne, Australia
AEC (ankyloblepharon-ectodermal dysplasia-clefting) syndrome is an autosomal dominant 
ectodermal dysplasia disorder. Most cases result from heterozygous missense (or occasionally 
frameshift) mutations in the sterile alpha motif (SAM) domain of the p63-alpha isoforms of 
the transcription factor p63, although previously published atypical mutations comprise 
an upstream splice site mutation (intron 10) and an in-frame 3-bp insertion in exon 13. We 
report a case of an unusual p63 mutation in an individual with AEC syndrome. An Australian 
infant male of Greek descent presented with left-sided ankyloblepharon filiforme, unilateral 
clefting of the soft palate, sparse eyebrows and eyelashes and hypoplastic alae nasi. He had 
no limb abnormalities and both parents were phenotypically normal. Direct sequencing of 
p63 identified a heterozygous C>T transition, c.211C>T (nucleotide numbering for the TA-
p63 isoform), which converts glutamine (CAG) to a premature stop codon (TAG), designated 
p.Q71X in TA-p63 transcripts. This mutation occurs in exon 4, upstream of the DNA binding 
domain, but the mutated residue is common to all six isoforms of p63, i.e. the three TA-isoforms 
as well as the three delta-N isoforms (in the deltaN-p63 isoforms, the mutation numbering is 
p.Q16X). Sequence analysis of both parents’ DNA revealed wild-type p63 only, establishing 
this as a de novo mutation. Knowledge of the mutation was also used to exclude recurrence 
in a subsequent pregnancy by sequencing fetal DNA extracted from chorionic villi. Although, 
the consequences of this particular nonsense mutation (e.g. haploinsufficiency or dominant-
negative interference or utilization of a new downstream methionine initiation codon) have 
yet to be determined, the findings in genomic DNA extend the spectrum of p63 mutations 
underlying ectodermal dysplasia disorders such as AEC syndrome and provide new insight 
into the role of p63 in the development and maintenance of human ectodermal structures. 
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Analysis of the Expression and Function of LY6/PLAUR Proteins in the Differentiation 
Program of Keratinocytes
B Favre, M Obarzanek-Fojt, D Hohl Uni Hospital Center of Lausanne, Switzerland
Lymphocyte antigen 6/plasminogen activator urokinase receptor (LY6/PLAUR) proteins 
are extracellular protein-protein interaction modules. Most of them are glycosyl-
phosphatidylinositol (GPI)-anchored but some, i.e. SLURP1 and LYNX1B, are secreted. 
Only the function of CD59 and PLAUR among this family comprising at least 30 members 
is well known. In the epidermis several LY6/PLAUR proteins, in addition to PLAUR, 
are expressed, suggesting that they play an important role for skin homeostasis. As a 
first step toward the understanding of their function we have analyzed their expression 
in the skin by qualitative and quantitative PCR, in situ hybridization (ISH) and gene 
expression profiling during differentiation of cultured keratinocytes. Four LY6/PLAUR 
genes were up-regulated during differentiation, SLURP1, LYNX1B, LYPD3 and LY6G6C. 
ISH analysis revealed that both SLURP1 and LYNX1B were mainly transcribed in 
the granular layer. In contrast LY6D gene was only expressed in the basal and spinous 
layers. Immunofluorescence analysis on skin sections revealed the presence of LY6D 
all over the epidermis, indicating that the protein was stable during late differentiation. 
However, detailed immunofluorescence analysis in cultured cells revealed that LY6D was 
surprisingly negligibly expressed in proliferating keratinocytes. Therefore, LY6D should 
be considered as an early marker of differentiation. To understand more specifically the 
function of SLURP1 we cultured normal human keratinocytes and keratinocytes isolated 
from patients suffering from Mal de Meleda, a genetic palmoplantar disease caused by 
mutations in the gene encoding SLURP1, and performed gene expression profiling. Several 
genes were specifically up or down regulated in diseased versus normal keratinocytes. 
These results suggest that a knock down approach could be envisaged for the analysis of 
the function of other LY6/PLAUR proteins in the differentiation process of keratinocytes. 
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Novel transglutaminase 1 (TGM1) mutations in a girl with severe lamellar ichthyosis
R Lepesi-Benko1, M Medvecz1, K Becker1, M Németh2, A Bóna1, R Sajo1, M Nemeth3, 
S Kárpáti1 1Semmelweis Uni, Budapest, Hungary 2HAS-SU Molecular Medicin RG, 
Budapest, Hungary 3MTA-SE Molecular Med Research Group, Budapest, Hungary
Transglutaminase (TG) 1 is a member of structurally and functionally related enzymes stabilizing 
protein assemblies through the formation of gamma-glutamyl-epsilon-lysine crosslinks with a key 
role in the development of epidermal stratum corneum. Lamellar ichthyosis (LI) has been linked to 
mutations in the TGM1 (14q11.2) The genetic heterogeneity of the disease, indicated in patients with 
LI with normal TGM1 gene sequence, was confirmed by demonstrating mutations within the ABCA12 
gene (2q34), as well as by mutations in FLJ3950 (19p12), or ALOXE3(17p13.1), ALOX12B(17p13.1) 
and Ichthin(5q33). In this work we present data on compound heterozygous mutations within 
the TGM1 gene performed in a female patient. The background of the disease was clarified by 
conformation sensitive gel electrophoresis - heteroduplex analysis and by direct sequencing. The 14-
year-old female patient showed the typical clinical picture of severe LI. She was born as a collodium 
baby, and soon after the skin developed large, grayish brown scales covering the entire body, and 
had palmoplantar hyperkeratosis with hyperlinear, rigid skin on the palms. Nobody in the family 
had similar skin disease, and all of her three siblings are healthy. The acanthotic epidermis was 
covered by a hyperkeratotic stratum corneum with typical cholesterol crystals ultrastructurally. In 
her case we observed a new compound heterozygous genotype, consisting of R553P in exon12 and 
R126H in exon3. R553P is within the catalytic core-domain of the enzyme as most of the previously 
published mutations. The substitution of the hydrophobic arginine with an apolar proline could lead 
to conformation alteration of the enzyme. The R126H is positioned around the interface between the 
amino-terminal -sandwich-domain and the central catalytic core domain. Point-mutations within the 
same domains had been described before. Combination of R553P and R126H mutations possibly 
causes a biallelic loss of enzymatic function in TG1 leading to a phenotype of lamellar ichthyosis.
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Transcriptional profiling identifies IFN-associated inflammation in invasive squamous cell 
carcinoma of the skin
J Wenzel1, A Wiechert1, JM Baron2, HF Merk2, C Mauch3, T Krieg3, T Bieber1, T Tüting1, 
A Bosio4, B Peters4 1Uni of Bonn, Germany 2RWTH Aachen, Germany 3Uni of Cologne, 
Germany 4Miltenyi Biotec GmbH, MACSmolecular, Cologne, Germany
Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) present the two most 
common kinds of skin cancer. Both are of keratinocytic origin but show a distinct biological 
behavior. Therefore, we hypothesized that a specific gene expression pattern, including 
cytokeratins, matrixproteins and cell-proliferation signature should distinguish SCC from 
BCC. Multiple biopsies were taken from SSC (n=42), BCC (n=114), and unaffected skin 
(n=72). mRNA was isolated and Serial Analysis of Gene Expression (SAGE™) of pooled 
samples was performed to identify frequent differentially expressed tags. In a second step, 
gene expression of individual samples was analyzed using the Skin Patho™ Microarray. 
The results were confirmed by in situ hybridisation and immunohistochemistry. SAGE-
analyses revealed 86 genes whose expression was specifically regulated in SCC compared 
to BCC. These genes clustered mainly into the groups ‘inflammatory response’, ‘epidermis 
development’, ‘matrix’, and ‘cell cycle’. Similar results were observed in individual patients 
using the Skin Patho microarray. Interestingly, invasive SCC showed an IFN-induced gene 
expression signature. In these tumours, upreguation of MHC molecules and a CXCR3-
positive lymphocytic inflammatory infiltrate was detectable. Several specific marker genes 
distinguish SCC from BCC and may be useful for a ‘diagnostic’assignment of gene expression 
profiling. These genes reflect mainly the known differences in the pathogenesis, including 
cell differentiation, proliferation and invasion. Additionally, our analyses identified a strong 
IFN-associated gene expression profile in invasive SCC. These results point to a role for IFN-
associated inflammation as an endogeneous tumour-defence mechanism. 
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Ichthyosis vulgaris, common filaggrin mutations, atopic eczema and allergic 
rhinitis
V Oji1, N Seller1, R Gruber3, U Hüffmeier4, J Gerß5, K Aufenvenne1, D Metze1, 
I Hausser7, H Traupe1 1University of Muenster, Germany 2University of Innsbruck, 
Austria 3University of Erlangen, Germany 4Coordinating Centre for Clinical Trials, 
Münster, Germany 5University of Heidelberg, Germany
Ichthyosis vulgaris (IV) is a common genetic skin disease having a prevalence of 
1:250 to 1:1,000 in the general population. Highly frequent Filaggrin mutations cause 
the disease and at the same time predispose to atopic eczema (AE). We wondered 
whether the epidermal barrier defect in IV is associated with changes of the dendritic 
cell network possibly explaining the atopic disposition and wanted to evaluate the 
genotype/phenotype correlations. Therefore we performed clinical, histological, 
ultrastructural and immunologic studies in a cohort of 25 patients. We found that 
common loss of function mutations in IV not only predispose to AE, but independently 
also to other atopic diseases such as allergic rhinitis. The atopic subgroups exhibited 
elevated counts of CD1a positive cells in their ichthyotic skin. While there was a 
good correlation in homozygous or compound heterozygous gene carriers with the 
ultrastructure and Filaggrin staining, this correlation was less clear cut for the histologic 
evaluation. We conclude that FLG mutations in IV predispose independently to both 
AE and other atopic manifestations such as allergic rhinoconjunctivitis requiring a 
revaluation of the popular concept of the atopic march, e.g. our data indicate that the 
impaired epidermal barrier is sufficient to directly develop allergic rhinitis without 
prior development of AE.
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Transcription Profiling of an In Vitro Model for Epidermolytic Hyperkeratosis
M Obarzanek-Fojt, B Favre, D Hohl Uni Hospital Center of Lausanne, Switzerland
Epidermolytic hyperkeratosis (EHK) is an autosomal dominant transmitted skin 
disorder. The phenotype of the disease is heterogeneous and characterized by 
hyperkeratosis of the stratum corneum, frequent blistering, scaling and redness. 
Mutations responsible for EHK occur in keratin 1 or keratin 10 gene. Both genes 
encode structural intermediate filament proteins which dimerize and form a scaffold 
for the cells in the suprabasal layers of the epidermis. To understand the mechanisms 
underlying EHK phenotype we used an in vitro model and searched for important 
changes in gene expression. Keratinocytes, isolated from either healthy volunteers or 
patients with diagnosed EHK and mutations in K10 gene, were cultivated in defined 
keratinocyte serum-free low Ca2+ medium. Cells at passage number 4 were used 
for analysis. Differentiation was induced by low to high Ca2+ shift. Total RNA was 
isolated from keratinocytes at two different stages, end of proliferation (day 0) and 
late differentiation (day 7). Transcriptomes were analyzed using GeneChip® Human 
Genome U133A 2.0 Array (Affymetrix). Results showed significant down-regulation 
of some genes specific for differentiation, i.e. loricrin, in diseased versus normal 
keratinocytes, confirming disturbances in the formation of the cornified envelope. 
Desmocollin1 and desmoglein1, membrane glycoproteins connecting the keratin 
filaments between cells, were also down-regulated in differentiated EHK keratinocytes. 
In contrast S100A7 gene, known to be over-expressed in psoriatic lesions, was up-
regulated in the diseased keratinocytes. These results indicate that cultured diseased 
keratinocytes can recapitulate in vitro some of the abnormalities observed in 
vivo and could help for the understanding of the molecular mechanisms of EHK. 
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SAMD9, a gene associated with inherited calcinosis cutis, is involved in stress 
response
I Chefetz1, D Ben Amitai2, O Topaz3, M Indelman3, J Uitto4, R Bergman3, G Richard5, 
E Sprecher3 1Technion, Haifa, Israel 2Schneider Children Hosp, Petach Tikva, Israel 
3Rambam Med Center, Haifa, Israel 4Thomas Jeff Uni, Philadelphia, USA 5GeneDx, 
Gaithersburg, USA
Normophosphatemic Familial Tumoral Calcinosis (NFTC) is a severe autosomal recessive disorder exclusively 
found in Yemenite Jews, characterized by calcium deposition in skin and mucosa. A homozygous missense 
mutation (K1495E) in SAMD9 was recently shown to cause NFTC in 5 families. In the present study, we 
evaluated another NFTC kindred of Jewish Yemenite ancestry. All patients were compound heterozygous for 
SAMD9 mutations K1495E, which induced protein degradation, and a novel nonsense mutation, R344X, 
associated with decreased SAMD9 RNA levels. Screening of unaffected population-matched controls revealed 
heterozygosity for K1495E in one and for R344X in three individuals of Jewish Yemenite ancestry, who shared 
a common hemihaplotype with the patients, but not in 600 individuals of other origins, suggesting positive 
selection. Despite these advances in our understanding of the genetic basis of NFTC, little is currently known 
about the physiologic role of SAMD9. Endothelial dysfunction precedes calcification in NFTC. Accordingly, 
qRT-PCR revealed that the gene is strongly expressed in endothelial cells and to a lesser degree in fibroblasts. 
We further assessed the effect of cellular stress on SAMD9 transcription. While exogenous hydrogen peroxide 
and heat shock did not affect SAMD9 transcription, osmotic shock was found to markedly up-regulate SAMD9 
expression. In addition, TNF-alpha caused a dose-dependant increase in SAMD9 expression, peaking at 6 
hours post-exposure. Both osmotic shock and TNF-alpha typically trigger the p38 MAPK signal transduction 
pathway. Accordingly, SB203580, a p38 MAPK inhibitor, significantly attenuated TNF-alpha mediated 
up-regulation of SAMD9, while inhibition of NFkB signaling substantially increased SAMD9 expression, 
suggesting that SAMD9 is involved in TNF-alpha mediated pro-apoptotic signaling. Considering that skin 
trauma triggers calcifications in NFTC our results not only indicate that TNF-alpha is a major regulator of 
SAMD9 expression, but also suggest that this protein may be involved in physiologic responses to tissue injury. 
510
Bicistronic vectors for skin gene therapy
W Pfützner1, F Scheidemann2, J-P Therrien3 1Philipps University Marburg, Marburg, 
Germany 2Ludwig-Maximillians-Universität, Munich, Germany 3National Cancer 
Institute, NIH, Bethesda, USA
Retroviral bicistronic vectors (BCV) are distinguished by carrying two different 
genes connected to each other through an internal ribosomal entry side (IRES), 
thus allowing simultaneous expression in a genetically modified cell. To determine 
which factors might influence the effectivity of BCV in skin gene therapy applications 
both keratinocytes (KC) and fibroblasts (FB) were transduced with different BCV 
constructs containing the GFP gene linked to the multi-drug resistance (MDR) 
gene. In the first two BCV BGIM (GFP/MDR-cassette) and BMIG (MDR/GFP-
cassette) gene expression was driven by an MMLV-LTR-promoter. After transduction 
with BGIM FACS-analysis showed only 17.9+/-2.6% KC and 8.3+/-2.8% FB co-
epressing GFP and MDR. Selection with colchicine, which is pumped out by MDR-
expressing cells, increased the percentage to 29.9+/-4.8% KC and 18.6+/-5.3% FB. 
In contrast, transduction with BMIG resulted in 35.5+/-2.4% KC and 38.4+/-9.5% 
FB showing MDR/GFP-expression, which was enriched by colchicine treatment to 
85.0+/-15.9% and 98.0+/-0.4% MDR/GFP-KC and -FB, respectively. Real-time PCR 
analysis revealed a higher BCV-uptake for BMIG than for BGIM in KC, while FB 
integrated similar numbers (but to a lower extend than KC) of vector constructs. 
Employing another BCV, QGIM, with expression of the GFP/MDR-cassette driven 
by a CMV-LTR-promoter, transduction resulted in 47.9+/-2.9% and 56.7+/-25% 
GFP/MDR-KC and -FB, respectively. After colchicine selection, 97.1+/-1.8% KC 
and 97.8+/-1.7% FB showed GFP/MDR-expression. In summary, among the factors 
influencing the expression of a BCV in KC and FB both the order of the genes and 
retroviral vector elements play important roles. Utilization of a selectable gene such 
as the MDR gene can help to increase the expression of a desired gene in skin. 
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Sustained increase in COL7A1 gene expression in recessive dystrophic epidermolysis 
bullosa: evidence for a paracrine effect three months following a single intradermal 
injection of allogeneic fibroblasts
T Wong1, L Gammon2, L Liu1, H Navsaria2, JA McGrath1 1St John’s Institute of 
Dermatology, London, UK 2Institute of Cell and Molecular Science, London, UK
Intradermal injections of allogeneic fibroblasts in individuals with recessive dystrophic 
epidermolysis bullosa (RDEB) can lead to increased deposition of the anchoring fibril protein, 
collagen VII (C7), at the dermal-epidermal junction (DEJ) for at least 3 months, even though 
these fibroblasts do not appear to persist for more than 2 weeks. It is unclear whether the 
increased C7 is derived directly from allogeneic cells or whether there might be a paracrine 
response leading to increased C7 (albeit mutant) induced by the allogeneic fibroblasts. To 
assess this, we gave a single intradermal injection of passage 2 allogeneic fibroblasts (5x106 
cells in 350ml PBS) to a 40-year-old male with RDEB and took skin biopsies at 2 weeks and 
3 months. This individual’s COL7A1 mutations were p.R2069C and IVS30-1G>A, the latter 
resulting in a 1-bp deletion in the cDNA. Immunofluorescence microscopy showed increased 
C7 labelling at the DEJ at 2 weeks and 3 months. Using primers specific for the patient’s 
cDNA bearing the 1-bp deletion, as well as for transcripts without the deletion, we found that, 
compared to baseline (pre-injection), overall COL7A1 gene expression increased 3.7 fold at 2 
weeks and 3.4 fold at 3 months. Baseline expression of the transcript bearing the 1-bp deletion 
accounted for 20% of the COL7A1 mRNA, however, following intradermal allogeneic fibroblast 
injection, this increased to 40% at 2 weeks and 46% at 3 months. These findings suggest that 
the allogeneic fibroblasts induce a paracrine effect on the recipient’s own cells to increase 
COL7A1 gene expression. Moreover, even though the allogeneic fibroblasts do not persist, 
there is a sustained increase in COL7A1 gene expression at 3 months which may reflect a 
‘slow burner’paracrine response. This C7 may be mutant but partially functional and therefore 
able to contribute to increasing adhesion at the DEJ and reduce the blistering tendency. 
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A frequent functional SNP in the MMP-1 promoter is associated with a higher 
disease severity in Recessive Dystrophic Epidermolysis Bullosa
M Titeux1, V Pendaries1, L Tonasso1, A Décha1, C Bodemer2, A Hovnanian1 1INSERM, 
U563, Toulouse, France 2Hopital Necker, Paris, France
Recessive dystrophic epidermolysis bullosa (RDEB) is caused by loss-of-function mutations 
in the COL7A1 gene encoding type VII collagen. A great clinical heterogeneity ranging from 
mild localized forms to the generalized mutilating Hallopeau-Siemens type is observed 
among RDEB patients. This variability in the severity is likely to depend on the nature and 
location of COL7A1 mutations, but the observation of intrafamilial phenotypic variations 
suggests additional genetic and/or environmental factors. Candidate modifier genes include 
MMP-1 encoding matrix metalloproteinase 1, the first gene implicated in RDEB before its 
primary role in the disease could be excluded. Type VII collagen is a substrate of MMP-1 
and an imbalance between its synthesis and degradation could conceivably worsen the 
RDEB phenotype. Here we studied a multiplex family with three affected siblings sharing 
an identical COL7A1 genotype but displaying contrasted disease severities. We show that 
the differences in severity do not correlate with the type VII collagen expression, but rather 
with the amount of the protein detectable at the dermal-epidermal junction, suggesting an 
increased degradation rate of the protein by metalloproteinases. This was supported by the 
presence of increased MMP-1 transcript levels and active MMP-1 protein in the two most 
severely affected children. We show that these two offspring carry a known SNP (1G/2G) 
in the MMP-1 promoter which creates a functional Ets binding site and results in the up-
regulation of the gene. We next studied a French cohort of 31 unrelated RDEB patients 
harbouring at least an inframe COL7A1 mutation sorted by clinical subtypes and we found 
that the 2G allele, carrying the additional Ets binding site, was more frequent in the most 
severe phenotypes (Fisher’s exact test, p=4.4x10-4). This is an example of a modifier gene 
in RDEB and has implications for its prognosis and possible new therapeutic intervention. 
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A novel GJB2 missense mutation causes focal palmoplantar keratoderma with 
deafness and interferes with gap junction transport
M van Geel1, EA De Zwart1, J Stoevesandt2, PM Steijlen1, H Hamm2, MAM Van 
Steensel1 1University Hospital Maastricht, Maastricht, Netherlands 2University of 
Würzburg, Würzburg, Germany
Gap junctions are intercellular channels that mediate rapid intercellular communication 
through passage of ions and small proteins. They consist of connexins, small 
transmembrane proteins that belong to a large family found throughout the animal 
kingdom. In the skin, several connexins are expressed and involved in the regulation 
of epidermal growth and differentiation. GJB2 is one of these genes encoding 
connexin 26, which is associated with a wide variety of keratinisation disorders. 
Here, we report on a family with a novel GJB2 mutation in the first extracellular 
domain of connexion 26 (H73R), causing focal palmoplantar keratoderma with 
sensorineural deafness. The phenotype resembles Vohwinkel syndrome, however, 
without the characteristic pseudo-ainhum. Using fluorescent C-terminally labelled 
connexin fusion proteins, we show that the mutation induces a transport defect 
similar to that found for the Vohwinkel syndrome mutation D66H. We suggest 
that there may be a weak genotype-phenotype correlation for mutations in GJB2. 
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Genetic Association of IL12B and IL23R with Psoriasis
M Weichenthal1, R Nair2, A Ruether3, PE Stuart2, S Schreiber4, E Christophers3, 
J Voorhees2, JT Elder2, C Jenisch3 1Christian-Albrechts-University, Kiel, Germany 2Univ 
of Michigan, Ann Arbor, USA 3Univ Hospital of Schleswig-Holstein, Kiel, Germany
Psoriasis is a chronic inflammatory disease with a strong genetic background. Genetic 
linkage and association studies have revealed numerous linked loci, and at least nine 
have independently been replicated. Therefore psoriasis appears as a complex disease 
with genetic contributions from multiple genes. Recently, a genome-wide association 
analysis identified two new associated genes, IL12B and IL23R. IL12B had previously 
been described as associated in a small Japanese study, and was recently also replicated 
in a study of Chinese patients. We examined the major IL12B allele (A-G) of an 
associated haplotype characterized by two SNPs, rs3212227 and rs6887695. For IL23R, 
we investigated a common haplotype (C-G) of two missense mutations in the gene 
(rs7530511 and rs11209026), which had been found to be associated with psoriasis. In a 
first cohort of 360 German patients with chronic plaque type psoriasis, both IL12B SNPs 
were significantly associated with psoriasis when compared to 1.097 healthy controls 
(rs3212227: OR=1.41; rs6887695: OR=1.37) as were the IL23R markers (OR 1.34 and 
1.25). These results could be confirmed in a collaborative US-German cohort. Combining 
the data for the case-control analysis using the Mantel-Haenszel procedure (1178 cases 
vs. 2001 controls), both markers for IL12B (rs3212227 p=1.0 x 10-9; rs6887695 p=1.7 
x 10-11) and IL23R (rs7530511 p=0.014; rs11209026 p=7.4 10-4) showed statistically 
significant association with psoriasis. In a family cohort of 462 pedigrees of varying size, 
the results could be confirmed for the IL12B SNPs (rs3212227 p=7.4 x 10-3; rs6887695 
p=3.7 x 10-4) but not for the IL23R markers (rs7530511 p=0.30; rs11209026 p=0.19), 
although the trend in families was in the direction of association for the known risk alleles. 
Our results confirm previously reported association of IL12B and IL23R with psoriasis. 
515 [Oral 002]
Inhibition of chronic skin inflammation by oral or topical treatment with a VEGF 
receptor tyrosine kinase
C Halin1, H Fahrngruber2, JG Meingassner2, G Bold2, A Littlewood-Evans2, A Stuetz2, 
M Detmar1 1ETH Zurich, Switzerland 2Novartis Inst for Biomed Research, Vienna, 
Austria
It is becoming increasingly clear that vascular remodeling is not only a hallmark of 
malignancies, but also accompanies many inflammatory and autoimmune conditions. In 
particlar, vascular endothelial growth factor (VEGF) A, a well known pro-(lymph)angiogenic 
molecule, has been linked with inflammatory disorders. However, thus far, treatment of 
chronic inflammation with anti-(lymph)angiogenic therapies has received little attention. In 
this study, we have tested the effects of a newly identified VEGF receptor (VEGFR) tyrosine 
kinase inhibitor, NVP-BAW2881, on blood vascular and lymphatic vessel function and 
growth in vitro and in vivo. We found that NVP-BAW2881 potently inhibits proliferation, 
migration and tube formation of lymphatic and blood vascular endothelial cells in vitro at 
concentrations ranging from 1 nM to 1 µM, depending on the assay used. Furthermore, in 
a transgenic mouse model of psoriasis, oral administration of the compound (25mg/kg/d) 
potently inhibited psoriasis-like skin inflammation elicited on the auricles of the animals. 
Immunofluorescent analysis revealed that, within few days of treatment, NVP-BAW2881 
robustly decreased the number of blood and lymphatic vessels and of infiltrating leukocytes. 
Moreover, the epidermal architecture in the formerly inflamed ears was markedly normalized, 
as assessed by expression of keratinocyte-expressed marker genes. Interestingly, topical 
application of NVP-BAW2881 onto the inflamed auricles (0.5 %, b.i.d.) was almost as 
efficacious in reducing inflammatory symptoms as oral administration of the compound. Taken 
together, these data represent the first demonstration that VEGFR tyrosine kinase inhibitors 
may be suitable for the treatment of chronic inflammatory skin disorders such as psoriasis. 
 
516 [Oral 003]
Loss of Arnt (Hif-1b) in mouse epidermis triggers paracrine epidermal-dermal 
signaling and alterations in dermal vasculature
A Panteleyev, A Wondimu, S Kalachikov, A Mezentsev, S Geng Columbia University, 
New York, USA
As one of two subunits of hypoxia-induced factor Hif-1, the Arnt plays a key role in the control 
of hypoxic response and vascularization. Vascular homeostasis is essential for different aspects 
of skin physiology, including thermoregulation, tumor and hair growth, wound healing, and 
immune response. Yet, the role of Arnt in skin functioning remains unexplored. Targeted 
ablation of Arnt in mouse epidermis using a K14-driven Cre recombination results in dermal 
hypervascularization along with dilatation and fragility of blood vessels. These vascular defects 
are associated with petechiae-like effect (multiple minute hemorrhagic spots) in the newborn 
mouse skin. On the molecular level, Arnt deficiency in the epidermis results in downregulation 
of Egln3 - a key element of Hif-1α degradation machinery under normoxic conditions - thus 
implying hypoxia-independent stabilization of Hif-1α in Arnt-null skin. Surprisingly, our in vitro 
studies showed that under high Ca++ conditions, Hif-1α is translocated to the nucleus, suggesting 
its binding to an unconventional dimerization partner in differentiating Arnt-null keratinocytes. 
Ectopic activation of Arnt2 (which is not normally expressed in the epidermis) points to Arnt2 
as a potential alternative dimerization partner for Hif-1α in Arnt-null keratinocytes. Expressional 
studies revealed several potential candidate targets for this pathway, including Procr, Pai-1, 
Hs3st1, and Mmp3. These genes are significantly up-regulated in Arnt-null epidermis, and code 
for secreted proteins with prominent ability to modulate vascular functions. Taken together, our 
data reveal a novel epidermal-dermal paracrine signaling pathway which is induced by Arnt 
deficiency in the epidermis and targets dermal vasculature, resulting in a hemorrhagic skin 
phenotype. The secretory nature of this epidermal-dermal signaling and previous designation 
of Arnt as a universal sensor of environmental stress further suggest that this pathway may 
serve as a key element of adaptation of dermal vasculature to environmental impact, and 
may take part in communication between epithelial tumors and dermal blood vessels. 
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Targeted overexpression of angiopoietin-related growth factor in the skin promotes 
lymphangiogenesis as well as angiogenesis
S Hirakawa1, ES Sato1, Y Arima1, Y Shirakata1, K Sayama1, M Tohyama1, S Tokumaru1, H 
Nagai1, X Dai1, L Yang1, Y Oike2, K Hashimoto1 1Ehime University School of Medicine, 
Toon, Japan 2Department of Molecular Genetics, Facult, Kumamoto, Japan
Angiogenesis, known to play a key role in several cutaneous disease, is potently induced by several 
angiogenic growth factors such as vascular endothelial growth factor-A. In contrast however, it still 
remains unclear whether newly identified growth factor members may further play a crucial role 
in neovascularization of the skin. Here we demonstrate that angiopoietin-related growth factor 
(AGF), a novel member of angiopoietin-like proteins, potently induces angiogenesis in vivo. In 
order to directly investigate the biological importance of AGF in positively mediating angiogenesis, 
we created transgenic mice that express AGF under control of the keratin 14 promoter in BALB/c 
background. These mice revealed grossly red, particularly in the ears and snout, suggesting that 
hypervascularization had occurred in their skin. Histologically, AGF transgenic mice demonstrated 
significantly increased number of capillary-like blood vessels. Furthermore, of particular importance, 
we identified lymphatic hyperplasia in AGF transgenic mice. Double immunofluorescence stains 
demonstrated that the enlarged lymphatic vessels are markedly increased with BrdU incorporation. 
Moreover, haptotactic migration was strongly induced towards recombinant AGF in cultured human 
lymphatic endothelial cells, suggesting that AGF may be a positive mediator of lymphangiogenesis 
as well as angiogenesis. In addition, AGF transgenic mice revealed significantly thickened epidermis 
and a remarkable increase in proliferating epidermal keratinocytes. Wound healing process of the 
skin, in fact, demonstrated rapid wound closure as compared with wild-type mice. Taken together, 
these results suggest that AGF may potently induce neovascularization including the lymphatic 
system in addition to the biological effects on keratinocytes, suggesting pleiotropic effects of AGF 
towards several cell lineages. Therefore, our findings may potentially open up novel therapeutic 
strategies for control of angiogenesis, lymphangiogenesis, and tissue regeneration in the skin. 
518 [Oral 093]
Placental cells increase angiogenesis during skin wound healing
K Khosrotehrani, C Droitcourt, E Mathieu, M Oster, S Aractingi Pierre et Marie Curie 
University, Paris, France
During pregnancy, fetal progenitor cells such as hematopoietic or mesenchymal stem cells, 
enter maternal circulation. We and others have shown that fetal cells may adopt various 
phenotypes in maternal injured tissues suggesting multipotent capacities. More recently, 
we reported that fetal endothelial progenitor cells could home to maternal sites of skin 
inflammation and formed new blood vessels. Skin wound healing is a process involving 
different stem cell populations. In this project, we asked whether fetal cells isolated from early 
placentas could improve skin wounds. Single cell suspension of 10-12 day old placentas 
from EGFP+ fetuses were obtained and injected subcutaneously in C57Bl/6 female mice 
that had a surgical wound. For each placenta, the caudal half of the corresponding fetus was 
as well injected as a control in a separate mouse. Similarly, we injected human first trimester 
placental cells in wounds performed on nude mice. Wounds that received placental cells in 
situ were evaluated for the presence and the phenotype of the injected cells and the number 
of CD31+ blood vessels under the wound and in the surrounding area. Fetal EGFP+ cells 
could be visualized in fibrotic skin wounds after injection. There was a significant increase 
in the number of blood vessels found in wounds receiving placentas (n=9) when compared 
to wounds injected with the fetal caudal half (n=9) or the vehicle alone (n=5) (11.4 versus 
9.5 et 9.1 respectively, p= 0,02). Wounds injected with human placental cells displayed 
human cells that could proliferate (Ki67+), express vimentin or CD34 and were organized 
as blood vessels. In conclusion, we observed an increase in the number of blood vessels 
after injection of placental cells. This may reflect the activity of endothelial progenitor cells 
or be the consequence of angiogenic factors released by placental cells.
 
 
519 [Oral 094]
Non Invasive in vivo Measurement of Hypoxia-induced Angiogenesis in Contact 
Hypersensitivity Reactions (CHSR) using 18F-Fluoroazomycin Arabinosid (FAZA) 
and Positron Emission Tomography (PET)
M Kneilling1, B Pichler1, G Reischl1, R Mailhammer2, A Yazdi1, D Bukala1, F Cay1, 
C Widmer1, C Reitmeier1, M Judenhofer1, C Claussen1, HJ Machulla1, M Röcken1 
1Eberhard-Karls-University, Tübingen, Germany 2GSF, Munich, Germany
Angiogenesis plays a major role in organ-specific autoimmune diseases caused by 
Delayed-type hypersensitivity reactions (DTHR). Hypoxia can induce angiogenesis 
via hypoxia inducible factor (HIF-1α) that binds to hypoxia-responsive elements 
in the regulatory regions of proangiogenic mediators. For better understanding 
of mechanisms involved in angiogenesis we investigated the role of hypoxia in 
acute and recurrent episodes of CHSR using FAZA that selectively accumulates 
in hypoxic tissue. In our experiments mice were sensitized and challenged with 
trinitrochlorobenzene (TNCB) to induce and elicit CHSR (cutaneus DTHR). Mice were 
injected with 18F-FAZA and scanned in vivo using PET and computed tomography 
(CT). In addition we performed autoradiography, H&E-staining, HIF-1α- and HIF-
2α-immunhistochemistry and real-time PCR (RT-PCR) analysis of gene expression 
patterns. 64Cu-PTSM and PET-CT was used to exclude a perfusion effect. In-vivo PET-
CT images confirmed intense 18F-FAZA uptake already in the acute phase of CHSR 
persisting at the same level even after recurrent episodes of CHSR. H&E staining 
indicated enhanced blood vessel formation in chronic CHSR. During chronic CHSR 
2% of infiltrating lymphocytes and some endothelial cells showed nuclear expression 
of HIF-1α- und HIF-2α protein. RT-PCR analysis confirmed an enhanced expression 
of pro-angiogenic genes, such as TNF, IL-1β, VEGF, HIF-1α- and HIF-α 4-24h even 
after the first TNCB-challenge. Thus, non invasive in-vivo examination of hypoxia-
induced angiogenesis using 18F-FAZA appears to be a new powerful tool to examine 
early phases of angiogenesis in autoimmune diseases such as rheumatoid arthritis. 
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Induction of lymphatic endothelial cell differentiation in mouse embryonic stem 
cells
D Marino, LR Rüdiger, M Detmar ETH Zurich, Switzerland
The lymphatic vascular system plays a pivotal role in mediating tissue fluid 
homeostasis, afferent immune responses and cancer metastasis. Despite the 
recent identification of molecules that promote lymphangiogenesis, the molecular 
mechanisms that regulate the embryonic formation of the lymphatic vascular 
system remain poorly understood. Whereas studies in embryonic stem (ES) cells 
have provided major new insights into the mechanisms of blood vessel formation, 
development of lymphatic endothelium has not been previously observed. We 
established embryoid bodies (EBs) from murine ES cells, in the presence or absence 
of potential lymphangiogenic growth factors. We found that lymphatic endothelial 
cells develop as early as day 18 after EB formation. These cells express CD31 and the 
lymphatic lineage-specific markers Prox-1 and LYVE-1, but not the blood vascular 
marker MECA-32. Lymphatic endothelial cells were frequently found to sprout from 
preexisting blood vessels - similar to normal mouse development - but formation 
of independent islands of Prox1+/CD31+ lymphatic ECs was also observed. We 
have used this model for the characterization of potential lymphangiogenic factors, 
and have found that VEGF-C and interleukin-7 potently support lymphatic vessel 
formation, whereas other proposed lymphangiogenic factors such as interleukin-3 
or HGF did not support in vitro lymphangiogenesis or lymphatic vessel maturation. 
This in vitro model can now be used for the identification of developmental pathways 
involved in vessel formation and to study the role of distinct genes during this process. 
 
521
Mapping Modifier Genes for Inflammation-associated Lymphangiogenesis
G Jurisic1, J Sundberg2, M Detmar1 1ETH Zurich, Switzerland 2The Jackson Laboratory, 
Bar Harbor, USA
Inflammatory bowel disease (IBD) is a chronic inflammatory disease caused by the 
interplay of environmental and genetic factors; however, the precise cause is still unknown. 
Genetic mouse models have helped to provide insight into the molecular etiology of IBD. 
Interleukin 10 (IL10) deficient mice develop a chronic inflammatory disease which closely 
mimics human IBD, due to the loss of the immunosuppressive activity of IL10. However, 
the phenotype is strongly influenced by the genetic background with marked differences 
between various inbred mouse strains. The C57BL/6J (B6.Il10-/-) strain shows resistance 
whereas the C3H/HeJ.Bir (C3H.Il10-/-) strain shows susceptibility to inflammation and also 
to a lymphatic vascular phenotype which includes increased number of enlarged vessels. 
Lymphatic vessels mediate the trafficking of leukocytes from inflamed tissue to the draining 
lymph node and produce inflammatory mediators. We hypothesized that there might be a 
genetic predisposition for lymphangiogenesis and lymphatic vascular activation, promoting 
the development of chronic inflammation. To search for genetic loci involved in this process, 
we performed quantitative trait locus (QTL) analyses of F2 generation intercross mice (C3H.
Il10-/- x B6.Il10-/-). We specifically labeled blood and lymphatic vessels to investigate 
the involvement of these two distinct vascular networks by a consistent scoring system. 
A genome-wide scan yielded a major peak at the distal part of chromosome 3 with highly 
significant LOD scores for the traits examined. The size of this interval is approximately 27 
Mb and it contains many interesting candidate genes. In order to narrow the interval we are 
using reciprocal congenic mice and further genotyping the interval for SNP markers. Our 
study reveals that there are genetic modifiers of chronic inflammation and  identifies an 
important role of the lymphatic vasculature in the etiology of inflammatory bowel disease. 
 
522
Identification of Novel Tumor-Specific Markers Using Laser Capture Microdissection 
and Transcriptional Profiling
M Nikolic, M Detmar ETH Zurich, Switzerland
The involvement of the lymphatic system in the tumor progression has long been 
suspected, however the lack of lymphatic vessel markers has hampered the research 
in this field. The recent identification of several lymphatic-specific proteins has 
allowed us a new insight in to the role of lymphatics in tumor progression, implicating 
thereby the lymphatic system as a crucial plays in tumor dissemination. Nevertheless, 
a major disadvantage of the common methods used for studying of the endothelial 
cell involvement in tumor progression (cell culture studies, flow cytometry...) is the 
lack of the environmental factors to which the cell are exposed in the tissue. The 
novel technique of Laser Capture Microdissection (LCM) allows the analysis of gene 
expression profiles of cells within their natural microenvironment and represents 
a promising tool for studying the events, which lead to tumor progression. Using 
the LCM technique, pure lymphatic (LECs) and blood vascular (BECs) endothelial 
cell populations were isolated from VEGF-C expressing breast carcinoma xenografts 
(MDA-MB-435) and from healthy mammary tissue of balb-c/nude mice. Total RNA 
was isolated from the cells and their mRNA content was amplified for the subsequent 
microarray analysis.The comparison of the obtained gene expression profiles of 
LECs and BECs from tumors and healthy tissue resulted in a list of genes, which 
are differentially expressed in tumors. For example, among the LEC specific-genes 
upregulated in tumors, some are well-known for their role in lymphangiogenesis 
(e.g. Lyve-1, Sox-18), whereas others haven’t yet been functionally characteized 
in endothelial cells. Further analyses of these candidate genes will reveal their 
role in physiological and tumor-associated lymphangiogenesis, as well as their 
potential contribution to the development of novel anti-cancer treatment strategies. 
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Chemical library screening reveals novel molecular pathways involved in the control 
of (lymph)angiogenesis
N Tobler, S Eugster, M Detmar ETH Zurich, Switzerland
Angiogenesis and lymphangiogenesis play essential roles in tissue regeneration, chronic 
inflammation and tumor progression. While a large number of factors with pro- or anti-
angiogenic activity have been identified, little is known about the molecular control of 
lymphatic vessel growth and function. To identify novel pathways involved in the regulation 
of (lymph)angiogenesis, a chemical library containing 1,280 small organic molecules with 
well defined pathway specificity (LOPAC1280; Sigma) was screened in cultured human 
umbilical cord vein endothelial cells (HUVEC) and lymphatic endothelial cells (LEC). We first 
evaluated the effects of the compounds on endothelial cell growth at a 10 µM concentration. 
In addition to well known inhibitors of angiogenesis such as 2-methoxyestradiol and VEGF 
receptor tyrosine kinase inhibitors, we identified a number of compounds - of which several 
act on the same distinct pathway - with potent inhibitory effects on both HUVEC and LEC, 
or specifically on one endothelial cell type. The impact of selected small molecules - and 
therewith of selected pathways - on endothelial cell function was further explored in more 
complex in vitro tests such as tube formation assays after overlay with collagen type I gels 
and in migration assays after scratching of the confluent cell monolayer. One of the newly 
identified small molecule inhibitors was tested in a mouse (lymph)angiogenesis model using 
subcutaneous Matrigel implants containing VEGF-A and was found to potently inhibit the 
formation of lymphatic and blood vessels. Thus, chemical genetics is a powerful approach to 
identify novel pathways involved in (lymph)angiogenesis. The drug-like features of the tested 
compounds, several of which have already gone through clinical development, will facilitate 
their further evaluation in preclinical models of chronic inflammation and tumor progression. 
 
524
Podoplanin Function in Lymphangiogenesis and Tumor Progression
L Cueni, M Detmar ETH Zurich, Switzerland
Podoplanin is a heavily glycosylated transmembrane protein, specifically expressed by 
lymphatic, but not blood vascular endothelium. Although studies in podoplanin-deficient 
mice suggest that podoplanin is essential for normal lymphatic vasculature formation and 
function, its exact biological function has remained unknown. Podoplanin expression is also 
found in several cancer types, and recent studies indicate that it might possibly play a role in 
tumor progression.We have produced a recombinant, soluble fusion protein, consisting of 
the extracellular domain of podoplanin linked to the Fc-domain of human IgG1 (podoplanin-
Fc), in several glycosylation defective Chinese hamster ovary cell lines, to investigate the 
effect of this protein on lymphangiogenesis and to assess the relevance of glycosylation 
for its function. In vitro studies using cultured lymphatic endothelial cells (LECs) showed a 
glycosylation-dependent, inhibitory effect of podoplanin-Fc on LEC adhesion, migration and 
tube formation. In order to identify potential binding partners of podoplanin and signaling 
events modulated by podoplanin in lymphatic endothelium, we performed protein arrays 
with podoplanin-Fc, and expression profiling after podoplanin overexpression or knockdown 
in endothelial cells. A novel binding partner with potential importance for cell adhesion was 
identified in the protein array and was confirmed by co-immunoprecipitation experiments. 
We also generated two human cancer cell lines in which podoplanin overexpression can 
be induced in a reversible manner, and performed transcriptional profiling and functional 
in vitro studies. Preliminary results indicate a potential role of podoplanin in mediating 
cellular interactions with the extracellular matrix.Together, these studies support the 
role of podoplanin in lymphangiogenesis and tumor progression, and they also reveal 
podoplanin-Fc as a potential new therapeutic tool for anti-lymphangiogenic therapy. 
 
525
Similarities in systemic sclerosis and morphea pathogenesis based on serum levels 
of VEGF, sVEGFR2 and MMP-2 and MMP-9
B Dziankowska-Bartkowiak, A Zebrowska, JD Torzecka, E Waszczykowska Medical 
University of Lodz, Lodz, Poland
Systemic sclerosis (SSc) and morphea are connective tissue diseases in the spectrum 
of scleroderma, probably presenting similar pathogenesis. Angiogenesis and fibrosing 
processes disturbances were observed in both entities. The aim of our study was to 
examine serum levels of vascular endothelial growth factor (VEGF), its soluble 2 
receptor (sVEGFR2) and gelatinases (MMP-2 and MMP-9). The study group comprised 
34 SSc patients (30 presenting limited SSc - lSSc, 4 with diffuse type - dSSc), 10 with 
morphea and 15 healthy controls. Serum levels of the examined parameters were 
evaluated by ELISA (Quantikine R&D Systems). P< 0.05 was considered statistically 
significant. MMP-2 and MMP-9 mean serum levels were significantly higher in both 
SSc patients (240.4 ng/ml; 848.6 ng/ml, respectively) and morphea (208.1ng/ml; 
844.4 ng/ml, respectively) in comparison to the control group (211.9 ng/ml; 535.9 ng/
ml, respectively). Furthermore, MMP-2 serum levels were significantly higher in SSc 
patients vs morphea group. Mean sVEGFR2 serum levels did not differ significantly 
in the examined groups. Moreover, a statistically significant different was noted in 
mean VEGF/sVEGFR2 ratio between SSc group and the controls. Additionally, only 
in the control group a significant positive correlation between MMP-9 and sVEGFR2 
was observed. The obtained results demonstrated disturbances in the examined 
parameters production both in SSc and morphea pointing at their pathogenetic 
similarities. Furthermore, significant differences in VEGF and its receptor ratio seems 
to be at least partly responsible for blockage in angiogenesis processes
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Identification of the surface-accessible, lineage-specific vascular proteome by two-
dimensional peptide mapping
V Mumprecht, C Roesli, D Neri, M Detmar ETH Zurich, Switzerland
The formation of blood vessels (angiogenesis) and of lymphatic vessels 
(lymphangiogenesis) is not only an important feature of embryonic development 
but also of tumor progression and inflammation. Better markers are needed 
to image and target these processes and to study their mechanisms. The cell 
membrane and extracellular matrix (ECM) proteins that regulate angiogenesis and 
lymphangiogenesis have been a challenge to identify using conventional proteomic 
technologies because many of these proteins are insoluble or expressed at low 
levels. We developed a gel-free proteomic methodology termed two-dimensional 
peptide mapping (2D-PM) to identify ECM and membrane proteins associated 
with these processes using cultured blood vascular (BECs) and lymphatic (LECs) 
endothelial cells. The surface-accessible proteins were biotinylated, enriched, 
purified by high-performance liquid chromatography (HPLC) and analyzed by 
mass spectrometry. We identified 184 proteins that were specifically expressed 
by LECs, 185 proteins by BECs and 377 proteins that were equally expressed by 
both cell types. The lineage-specific expression of a representative set of these 
proteins was validated by immunoblot analyses of cultured cells and differential 
immunofluorescence analyses of human tissue samples. 2D-PM is a powerful new 
technology for large-scale screening of lineage-specific protein expression and has 
provided an insight into the surface-accessible, vascular lineage-specific proteome. 
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Sirtuins modulate the inflammation response in skin microvascular endothelial cells
CM Failla1, F Chiani2, A Orecchia3, C Albanesi1, E Cesarini2, C Scarponi1, A Mai2, 
G Zambruno1, G Camilloni2 1IDI-IRCCS, Rome, Italy 2University  La Sapienza , Rome, 
Italy 3Inserm U634, Nice, France
Histone deacetylases (HDAC) are key enzymes in the epigenetic control of gene expression. 
They are divided into three categories based on their homology to yeast proteins. While 
class I and II HDAC are generally sensitive to trichostatin-A (TSA), class III HDAC are not, 
and their deacetylase activity relies on the cofactor NAD. In mammals, seven class III 
HDAC, termed sirtuins, have been described, with SIRT1 showing the highest homology. 
SIRT1 has a broad biological role linking metabolism to transcriptional silencing and 
chromatin functions through deacetylation of histone and non-histone proteins. The other 
SIRT2-7 proteins are less characterized. In this study, we investigated on the expression of 
sirtuins in primary human dermal microvascular endothelial cells (HDMEC). In addition, 
we searched for genes potentially regulated by sirtuins at the transcriptional level. RNA and 
protein analyses on HDMEC showed that SIRT2 was the most expressed class III HDAC, 
followed by SIRT5, SIRT7, SIRT1, and SIRT6. HDMEC were then treated with either sirtinol, 
a specific inhibitor of sirtuins, or resveratrol, a sirtuin activator, or TSA, as a control. Total 
RNA was hybridized on AtlasTM cDNA expression arrays, and the expression profile of 
treated cells was then evaluated. Data obtained were clustered, taking into account genes 
up-regulated in the presence of sirtinol, down-regulated in the presence of resveratrol, 
and insensitive to TSA treatment, i.e. genes putatively specifically repressed by the sirtuin 
activity, and not generically sensitive to HDAC I-II inhibition. Using this criterion, dual 
specificity phosphatase 7, BCL6, and annexin A11 mRNA were identified as specific 
targets of sirtuins in HDMEC. Since these genes are involved in both apoptotic and survival 
processes in response to inflammatory stimuli, endothelial sirtuins could be important in 
the regulation of immune responses by endothelial cells in pathological skin conditions. 
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Alarin is a novel vasoactive peptide
R Santic1, R Lang1, M Schmidhuber1, I Rauch1, E Voglas1, N Eberhard1, JW Bauer1, 
SD Brain2, S Kofler1 1Paracelsus Private Medical University, Salzburg, Austria 2Kings 
College, London, UK
Galanin-like peptide (GALP) is a hypothalamic neuropeptide belonging to the 
galanin family of peptides characterized by extensive differential splicing in a variety 
of murine tissues. One splice variant excludes exon 3 and results in a frame shift 
leading to a novel peptide sequence and a stop codon after 49 amino acids. In 
this peptide, which we termed alarin, the signal sequence of the GALP precursor 
peptide and the first 5 amino acids of the mature GALP are followed by 20 amino 
acids without homology to any other murine protein. Alarin mRNA was detected 
in murine brain, thymus and skin. In accordance with its perivascular localisation, 
the peptide exhibited potent and dose-dependent vasoconstrictor and anti-edema 
activity in the cutaneous microvasculature. However, in contrast to galanin peptides 
in general, the physiological effects of alarin do not appear to be mediated via the 
known galanin receptors. Thus, alarin is a novel regulator of skin inflammation. 
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Contribution of VEGF-A in ultraviolet-B induced vascular hyperpermeability
R Hügel1, A Schwarz1, M Weichenthal2, B Lange-Asschenfeldt3, T Schwarz1 1University 
of Schleswig-Holstein, Kiel, Germany 2Christian-Albrechts-University, Kiel, Germany 
2Charité Berlin, Berlin, Germany
There is substantial and growing experimental evidence for an interdependence between 
angiogenesis and UVB-induced inflammation. Recently, it has been reported that a single 
exposure to UVB radiation induced an upregulation of the proangiogenic protein vascular 
endothelial growth factor (VEGF)-A in murine skin. It was found that VEGF-A is involved in 
UVB-induced edema formation mainly by influencing the structure of collecting lymphatic 
vessels. In the present study we addressed the contribution of VEGF-A in UVB-induced 
plasma protein extravasation using a modified Miles assay. Hairless SKH1 mice were 
exposed to graded doses of a single UVB irradiation, ranging from 50 mJ/cm2 to 120 mJ/cm2. 
Twenty-four hours thereafter Evans Blue dye was injected intravenously and the degree of 
vascular permeability was quantified by the amount of dye that exudated in the UV-irradiated 
back skin. Thirty minutes after the intravenous injection of the dye we observed bluish 
colouration in the back skin of UVB-irradiated mice, while non-irradiated control mice did 
not reveal any bluing. Spectrophotometric quantitation of the extravasated dye eluted from 
the harvested skin revealed a 2.6-fold increase in vascular permeability in mice irradiated 
with 120 mJ/cm2 UVB. VEGF-A protein concentrations were determined by quantitative 
ELISA. We found a more than 1.5-fold increase in the protein levels in the inflamed back 
skin of irradiated mice, when compared to non-irradiated mice. In contrast to these results, 
no difference in the concentration of VEGF-A was found in the ear skin of irradiated and 
non-irradiated mice. Moreover, no UVB-induced vascular leakage was found in the ears 
of irradiated mice compared to the back skin of the same animals when irradiated with 
equivalent doses. These data highlight the role of VEGF-A in enhancing vascular permeability 
following UVB-irradiation varying on the UVB-dose and the specific skin regions irradiated. 
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Mosaic translocation (7; 21)(q31.1; q21) in lesional skin fibroblasts of a patient with 
vascular and lymphatic malformations
FA Caux1, B Benzacken2, A Aboura3, A Lévy1, A Blom1, L Laroche1 1Avicenne Hospital, 
Bobigny, France 2Cytogenetics, Jean Verdier Hospital, Bondy, France 3Robert Debré 
Hospital, Paris, France
Mosaicism is defined by the presence of different cellular populations in the same organism. It is 
responsible of segmentary manifestations in genetic diseases. We reported a 59-year-old male with 
multiple congenital cutaneous lesions predominantly located on the right lower limb with a roughly 
linear distribution. Skin pathology showed vascular and lymphatic malformations. General work-up 
revealed a brain meningioma and excluded TSC1 or TCS2 mutation. Fibroblasts of lesional and normal 
skin, keratinocytes of lesional skin and blood lymphocytes were karyotyped. Multi FISH study was 
carried out. Cytogenetic analysis performed on 50 lesional fibroblasts demonstrated 22 cells distributed 
in three populations: one normal clone 46, XY (4/22), one clone (10/22) with a supernumerary marker 
chromosome in favor of a minute chromosome and one clone (8/22) with this minute chromosome 
and an apparently balanced translocation (7; 21)(q31.1; q21) confirmed using multi FISH. Random 
abnormalities in the chromosomes number were found in the other 26 cells. Karyotyping in 
lymphocytes revealed two clones, one normal clone (18/50) and one clone with the minute 
chromosome (32/50). Similarly, one normal clone (6%) and one clone with the minute chromosome 
(94%) were detected in keratinocytes of lesional skin and fibroblasts of unaffected skin. The minute 
chromosome corresponded to a centromere of either chromosome 14 or 22 and nucleolus organizing 
regions.Our results suggest that our patient had a constitutional minute chromosome and in addition 
a translocation (7; 21)(q31.1; q21) limited to affected skin fibroblasts. To the best of our knowledge, 
molecular mosaicism has never been reported in cutaneous lymphatic malformations. Chromosomal 
alteration found in our patient may suggest the location of a gene involved in lymphogenesis on 
the long arm of chromosome 7 or 21.In conclusion we described mosaic translocation (7; 21)
(q31.1; q21) in lesional fibroblasts of congenital cutaneous vascular and lymphatic malformations. 
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Similar lymph vessel densities in various epithelial cancers of the skin and oral 
cavity in immunocompetent and immunosuppressed patients
C Antonucci, I Hegyi, B Mühleisen, G Hofbauer, A Cozzio University Hospital of 
Zurich, Zürich, Switzerland
Various skin tumors show differing propensities for lymphatic metastasis formation. 
Squamous cell carcinoma of the oral cavity, at the time of diagnosis, frequently show 
lymph node involvement, whereas in basal cell carcinoma, lymph nodes are virtually 
never involved. The purpose of this study was to determine the peritumoral lymphatic 
vessel density (LVD) using a lymphatic vessel-specific marker D2-40 and compare it 
to general vessel density (GVD) as determined by CD31 immunostaining in a series 
of epithelial lesions in immunocompetent and -suppressed patients. The peritumoral 
GVD and LVD were examined by immunohistochemistry using D2-40 and CD31 
antibodies in a series of epithelial tumors, the histologic slides were electronically 
scanned and the vessels were counted by 3 independent investigators. We found 
significantly higher LVD around epithelial tumors as compared to normal skin (p < 
0.01), but no statistically significant differences among various intra- or extraoral skin 
tumors.Our results show that perifocal LVD is significantly increased in skin tumors. 
However, the differences in LVD cannot explain the different biologic behaviour of 
metastasis formation in epithelial skin tumors.
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PPAR delta Activators effectively induce the expression of IL-8 in endothelial cells 
in a NfkB dependant way
M Meissner, I Hrgovic, M Stein, R Kaufmann, J Gille University of Frankfurt, Frankfurt 
Am Main, Germany
Peroxisome proliferators activated receptors are ligand activated transcription 
factors, mainly implicated in the regulation of lipid and glucose homeostasis. PPAR 
agonists have been shown to control inflammatory processes in part by inhibition of 
distinct pro-inflammtory genes. IL-8 is an important member of the pro-inflammatory 
Chemokine family for example mediating the activation neutrophilic granulocytes 
or the adhesion of eosinophilic granulocytes on endothelial cells. Especially for 
PPARa and PPARg activators it could be shown that they effectively inhibit the 
expression of IL-8 in a variety of cell types. We therefore explored the influence 
of PPARd activators on the expression of IL-8 in human endothelial cells.PPARd 
agonists are found to potently induce IL-8 expression by HUVEC in a concentration 
as well as time dependant manner. This induction is demonstrated both at the level 
of protein and mRNA IL-8 expression. As the mRNA stability of IL-8 was not changed 
during the treatment with a PPARd activator we hypothesized that the effects of 
PPARd agonists are mediated by inducing the transcriptional activity of the IL-8 
promoter. Transcriptional activation studies with deletional reporter gene constructs 
reveal that PPARd agonists mediated their inducing effects via a NfkB binding side. 
In addition, an increase in p65 phosphorylation could be shown.In conclusion 
our data provide evidence that PPAR delta in contrast to PPAR gamma and alpha 
activators induce IL-8 expression via a NfkB dependant mechanism and therefore 
might function as a counterpart of the other PPARs in the regulation of inflammation. 
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Isolated murine perivascular cells display a mesenchymal stem cell-like phenotype
B Brachvogel1, F Pausch2, P Farlie3, U Gaipl2, J Etich4, Z. Zhou5, T Cameron3, K Von 
der Mark2, JF Bateman3, E Poschl5 1Center for Biochemistry, Cologne, Germany 
2University of Erlangen-Nürnberg, Germany 3Murdoch Children’s Research Institute, 
Melbourne, Australia 4University of Cologne, Germany 5University of East Anglia, 
Norwich, UK
Mutual interactions of endothelial cells and pericytes are crucial to form a stable 
microvascular network within the skin. Pericytes are critical for mediating the local blood 
flow, microvessel stability and angiogenic events, and may serve as a pool of vascular 
associated mesenchymal stem cells within the skin. Impaired pericyte coverage of the 
microvasculature is associated with the pathogenesis of scleroderma and photo aging 
of the skin. However, little is known so far about pericyte biology in skin development 
mainly due to the lack of suitable purification techniques from mouse tissues. Recently, 
we developed a method to isolate and characterize pericytes from the mouse. Here we 
show that these populations display typical characteristics of pericytes by the presentation 
of pericyte markers NG2-proteoglycan, desmin, SMA, PDGFR-beta as well as the stem cell 
marker Sca-1. Expression of endothelial (PECAM), hematopoietic (CD45) or myeloid (F4/80, 
CD11b) markers was not detectable. Purified perivascular cells (PVCs) do not contribute to 
lymphoid or myeloid lineages and cannot transdifferentiate to endothelial cells in vitro. By 
contact with endothelial cells, PVCs stimulate angiogenic differentiation as indicated by an 
increased expression of the endothelial marker PECAM and specific deposition of basement 
membrane (BM) proteins. Accordingly, in vivo grafts of PVCs on the chorioallantoic 
membrane of the quail embryo get highly vascularized and deposit BM components. 
Our data demonstrate that functional pericytes can be specifically isolated and retain 
their unique perivascular character as well as features of mesenchymal stem cells in vitro. 
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Limited potential of angiogenesis-related factors like VEGF, bFGF or endostatin as 
tumor markers in the serum of melanoma patients
P Kurschat1, S Eming1, D Nashan2, T Krieg1, C Mauch1 1University of Cologne, 
Cologne, Germany 2University of Freiburg, Freiburg, Germany
Angiogenesis-related factors like bFGF, VEGF or endostatin have been demonstrated to 
be increased during disease progression in patients sera for a variety of tumors. Therefore, 
the potential use of these factors as diagnostic or as prognostic tumor markers has been 
suggested. In our study we investigated a possible correlation of endostatin, VEGF or bFGF 
serum levels with disease progression in melanoma. Sera from 197 melanoma patients and 
35 healthy controls were measured by ELISA-technique. 72 patients had primary tumors 
(AJCC stage I and II), 55 had regional lymph node metastasis (stage III) and 70 patients 
had distant organ metastasis (stage IV). Serum levels of all three factors were significantly 
elevated in stage IV disease, as compared to the control group. In stage III, endostatin and 
bFGF, but not VEGF or S-100 B were significantly increased. However, follow-up of this 
patient group did not show a correlation with the future clinical course including time 
until progression or overall survival, arguing against a role of endostatin, VEGF or bFGF 
as prognostic markers. But our data indicate that endostatin or bFGF might be useful as 
diagnostic markers for the early detection of locoregional metastasis. An extensive review 
of the available literature revealed that no reliable reference values have been established 
for any of these factors so far. The absolute amounts detected are highly dependent on 
the assay system and the handling of the samples. Furthermore, angiogenesis-related 
factors are not specific for a certain type of malignancy, and they are frequently elevated 
in many non-malignant diseases. Basically, any condition with hypoxia like anemia or 
lung diseases can be associated with elevated serum levels. Therefore we conclude that 
regardless of the fact that angiogenesis-related factors are increased during melanoma 
progression, their use as tumor markers can not be recommended at the present time. 
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Development of a 3D tissue culture model of human skin carcinoma
S Commandeur, R Siamari, JN Bouwes Bavinck, FR De Gruijl, CP Tensen, A El 
Ghalbzouri Leiden University Medical Center, Leiden, Netherlands
Squamous cell carcinomas (SCCs) represent a large clinical problem, which is 
particularly dramatic in immune-suppressed individuals. Since medical intervention 
is crucial against successive and recurrent SCCs, refined therapies are indispensable. 
Therefore, well-targeted therapeutics should be screened in skin carcinoma models. 
Our goal is to generate a validated in vitro human skin cancer equivalent that 
mimics SCCs to reduce and refine the current exploitation of animal models. For this 
purpose, different skin equivalent models with carcinomas were engineered directly 
from biopsies or from isolated keratinocytes and fibroblasts of immune-suppressed 
individuals. Immunohistochemical analyses of these different SCC models revealed a 
hyperproliferative epidermis as judged by the keratins K6, K16 and K17 and a disturbed 
differentiation program (K10, involucrin, SKALP, filaggrin) compared to healthy skin 
models. The basal keratinocytes in the SCC model also showed a high proliferation 
rate (Ki67) and, most interestingly, an invasive behavior with the formation of keratin 
pearls in the dermal matrix. Thus, the model reproduced important histological 
hallmarks of SCC. Molecular characterization (proteomic and genomic analyses) is 
underway to further define SCC development using these skin cancer equivalents. 
This work is aimed to contribute to replace animal models for therapeutic, diagnostic 
and screening purposes, and to the development of a new generation of skin models. 
 
536 [Oral 089]
A processed laminin-332 domain selectively localizes to and potentiates carcinoma 
development
MM Tran1, P Rousselle2, NP Nokelainen1, S Talapragada1, N Nguyen1, MP Marinkovich1 
1Stanford University, Stanford, USA 2Institute for Biology and Biochem, Lyon, France
Squamous cell carcinoma (SCC) is a highly prevalent and invasive neoplasm that arises 
in many epithelial tissues and causes significant morbidity and mortality. Expression 
of the extracellular basement membrane zone (BMZ) protein laminin-332 correlates 
closely with SCC invasion and patient prognosis. To localize pro-tumorigenic activity 
on the laminin-332 molecule, we examined the proteolytic remainder of the α3 
chain known for its two EGF-like repeats, the 37 kDa G45 domain. The G45 domain 
is absent in normal mature tissues but is detectable in proliferating wound edges. 
Our study demonstrated the G45 domain is present in over 75% of human SCCs in 
an extensive survey of 75 cutaneous and 56 extracutaneous tumors. Keratinocytes 
expressing mutant laminin-332 lacking the G45 domain (ΔG45) showed adhesion, 
migration and matrix deposition abnormalities. Upon SCC tranformation, through Ras/
IkΒα overexpression, ΔG45 cells showed deficient ERK and phosphoinositol-3 kinase 
(PI3K) pathway activation as well as a complete lack of invasion or tumorigenicity 
when transferred to immunodeficient mice. Tumorigenic capacity of ΔG45 cells was 
partially restored with G45 domain expression and fully restored with a constitutively 
active PI3K subunit expression. Deficiency of transformed ΔG45 cells to invade 
in mice was characterized in in vitro studies of metalloproteinase activity (MMP1, 
MMP2, MMP9) and matrigel invasion cell assays. G45 antibody treatment in mice 
promoted SCC tumor apoptosis, decreased SCC tumor proliferation and markedly 
impaired SCC tumor formation without affecting normal tissue adhesion. These 
results suggest the G45 domain as a promising target for anti-cancer therapy.
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Tissue Microarray Based Analysis of MMP-7, CD44v3 and HB-EGF in Recessive Dystrophic 
Epidermolysis Bullosa - associated and Sporadic Squamous Cell Carcinomas
A Kivisaari1, M Kallajoki1, JA McGrath2, JW Bauer3, F Weber4, R Königová5, M Csikós-
Medvecz6, H Shimizu7, D Sawamura7, KC Sato-Matsumura7, K Sinemus8, W Beckert9, 
V-M Kähäri1 1Uni of Turku, Finland 2St John’s Inst of Dermatology, London, UK 3PPMU, 
Salzburg, Austria 4Med Uni of Innsbruck, Austria 5Charles Uni, Prague, Czech Rep 
6Semmelweis Uni, Budapest, Hungary 7Hokkaido Uni School of Med, Japan 8Helios 
Klinikum Wuppertal, Germany 9Lab for Histology & Cytology, Nürtingen, Germany
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe hereditary mechano-bullous disease 
resulting from mutations in COL7A1. Cutaneous squamous cell carcinoma (SCC) is a frequent 
complication in chronic ulcers in RDEB patients. Cutaneous SCCs in RDEB are characterized by 
rapid invasion and development of metastases resulting in poor prognosis. In this study, we have 
investigated the role of matrilysin-1 (matrix metalloproteinase-7, MMP-7), CD44v3 and HB-EGF 
in 13 RDEB-associated cutaneous SCCs, 60 sporadic cutaneous SCCs and 28 Bowen’s diseases. 
Tissue microarrays were generated from the formalin-fixed, paraffin embedded samples and 
immunohistochemistry was performed using monoclonal antibodies. MMP-7 was expressed by 
tumour cells in most of SCCs studied. Cytoplasmic staining for MMP-7 was stronger in RDEB-SCCs 
compared to sporadic SCCs. MMP-7 was also expressed in part of Bowen’s diseases but not in 
normal epidermis. Irregular CD44v3 staining on the cell surfaces of tumour cells was noted in the 
same areas where MMP-7 was expressed. Similar areal co-localisation was noted also in Bowen’s 
disease, but not in normal epidermis where CD44v3 is homogenously present but MMP-7 is not 
expressed. The SCCs and Bowen’s diseases that expressed MMP-7 and CD44v3 where also positive 
for HB-EGF. Interestingly, CD44v3 expression was elevated in part of Bowen’s diseases while it 
was typically dimished in the SCCs studied. In conclusion, our findings support the hypothesis that 
CD44v3 recruits proteolytically active MMP-7 to cleave proHB-EGF in vivo in RDEB-associated 
and sporadic SCCs and also in early stage of tumorigenesis i.e. in Bowen’s diseases. These results 
suggest that MMP-7 can be considered as a potential therapeutic target in these carcinomas. 
538 [Oral 091]
IKKα is a tumor suppressor in stratified epithelia as a component of the TGFβ anti-
proliferative pathway
A Costanzo1, F Moretti1, B Marinari1, ML Giustizieri1, A Giunta1, C Ballaro2, 
M Papoutsaki1, S Alema2, S Chimenti1 1Univerity of Rome Tor Vergata, Rome, Italy 
2Institute of Cell Biology, CNR, Rome, Italy
Transforming growth factor beta is regarded as a major tumor suppressor during 
early tumor development because of his strong anti-proliferative activity on 
epithelial cells that is mediated mainly by the downregulation of c-myc activity. 
However, dedifferentiated late stage tumors are resistant to growth inhibition by 
TGF-beta, and often overproduce TGF-beta that acts as a promoter of invasiveness 
and metastasis. In this study we have uncovered a novel function of the protein 
kinase IKKα that acts as a key mediator of TGF-beta anti-proliferative activity in the 
development of squamous cell carcinomas (SCC). IKKα was found to be progressively 
downregulated in the development of SCC arising from stratified epithelia and to 
lose its nuclear localization when an in situ SCC becomes invasive. We have 
observed that IKKα is rapidly translocated into the nuclei of TGFβ-stimulated 
epithelial cells and functions as an activator of Mad1 and Ovol1 genes that in turn 
downregulate the transcription and the activity of cMyc, allowing the cell cycle 
arrest. SCC cells are resistant to TGFβ mediated cell cycle arrest, and unable to 
shuttle IKKα into the nucleus, but regain the ability to arrest the cell growth upon 
the reintroduction of nuclear IKKα. Our results attribute an additional role to 
IKKα as a potential tumor suppressor gene acting on the control of c-myc activity. 
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Transgenic expression of Noggin promotes skin tumorigenesis via stimulation of 
Sonic Hedgehog signaling pathway
AN Mardaryev1, AA Sharov2, T Sharova2, M Grachtchouk3, HR Byers2, R Atoyan2, 
AV Sargsyan2, PA Overbeek4, AA Dlugosz3, VA Botchkarev1 1University of Bradford, 
Bradford, UK 2Boston University, Boston, USA 3University of Michigan, Ann Arbor, 
USA 4Baylor College of Medicine, Houston, USA
Bone morphogenetic protein (BMP) signaling serves as an important tumor suppressor pathway 
in skin, which activity is modulated by a number of extracellular inhibitors including Noggin. 
The role of Noggin in skin tumorigenesis was examined using K14-Noggin mice, which 
showed formation of spontaneous hair follicle-derived tumors that strikingly resemble human 
trichofolliculoma. In chemical carcinogenesis model, K14-Noggin mice showed formation 
of papilloma-like epidermal tumors, which were markedly increased in number and size, 
compared to wild-type animals. Strongly reduced pSmad1/5 expression was observed in both 
murine and human trichofolliculomas suggesting alteration in the BMP-Smad pathway. Global 
gene expression profile revealed that in contrast to hair matrix keratinocytes obtained from 
anagen hair follicles of wild-type mice, keratinocytes obtained from trichofolliculoma-like 
tumors of K14-Noggin mice showed markedly increased expression of growth regulatory 
molecules involved in the control of cell proliferation including several members of the Shh 
signaling pathway (Shh, Smo, Gli1, Ptc1). Cultured tumor cells also showed marked increase in 
Shh expression, compared to non-malignant keratinocytes, and BMP4 treatment of tumor cells 
in culture resulted in significant decrease of Shh mRNA expression. Furthermore, treatment of 
K14-Noggin mice with Shh inhibitor cyclopamine resulted in significant retardation of tumor 
formation associated with strong decrease in expression of Shh target genes, such as cyclin D2 
and Ptc1. These data suggest that tumor-suppressor activity of BMPs in the epidermis and hair 
follicle is modulated by local concentrations of the BMP antagonist Noggin, which targeted 
expression promotes skin tumorigenesis at least in part via stimulating Shh signaling pathway. 
540 [Oral 095]
Senescence driven by reactive oxygen species (ROS) via NF-kappa B suppresses 
UVB-induced skin photocarcinogenesis
AL Kim1, JH Back1, Y Zhu1, M Athar2, X Tang1, L Kopelovich3, DR Bickers1 1Columbia 
Uni, New York, USA 2The Uni of Alabama at Birmingham, USA 3NCI, Bethesda, USA
Plant-derived polyphenolic compounds such as the tri-hydroxy stilbene resveratrol are potent 
antioxidants and anticancer agents. It is also known that resveratrol may induce oxidative DNA 
damage either alone or in the presence of transition metal ions such as copper. Here, we report the 
ability of resveratrol to induce ROS-mediated premature senescence in various human and murine 
carcinoma cell lines, including cells derived from either squamous cell (A431 and SCC13) or basal 
cell (AZ001) carcinomas. Pre-treatment of A431 cells with neocuproine, a copper chelator, blocked 
ROS-mediated cellular senescence and inhibited resveratrol-induced, p53-independent up-regulation 
of p21WAF1. A cDNA microarray analysis of senescent A431 cells revealed a dose-dependent up-
regulation of Bfl-1/A1, a direct NF-kappa B target gene of the Bcl-2 gene family. Bfl-1/A1 inducion 
in senescent cells was shown to be ROS-dependent. siRNA-mediated Bfl-1/A1 knockdown in A431 
cells abolished p21WAF1 expression and suppressed resveratrol-induced senescence. Furthermore, 
resveratrol augmented nuclear translocation of the NF-kappa B proteins RelA/p65 and p52 and this 
was blocked by neocuproine treatment. Down-regulation of NF-kappa B p65 or p52 prevented 
resveratrol-induced Bfl-1/A1 expression. Next we determined the in vivo anti-tumorigenic effects 
of reveratrol. Oral administration (200 mg/kg body weight, three times a week) inhibited UVB 
(180 mJ/cm2, twice a week)-induced skin tumorigenesis in p53+/-/SKH-1 hairless mice. At week 
25, resveratrol-treated animals showed substantial reductions in total skin tumor numbers and size 
showing 43% and 79% decreases, respectively. The number of SCCs in the resveratrol-treated mice 
was 70% less than in the UVB-only group; furthermore in vivo senescence induction occurred only 
in SCCs harvested from resveratrol-treated mice. Our data indicate that resveratrol drives tumor cell 
senescence by generating ROS that drive p53-independent induction of p21WAF1 and Bfl-1/A1 up-
regulation via NF-kappa B that inhibits cell proliferation and UVB-induced photocarcinogenesis. 
 
2007 ESDR Abstracts v2.indd   90 8/13/07   11:31:49 PM
www.jidonline.org  S91
ABSTRACTS
541 [Oral 096]
Combining ER-stress inducing agents with protein disulphide inhibitors as a novel 
therapeutic strategy for metastatic melanoma
P Lovat, CPF Redfern, MA Birch-Machin Newcastle Uni, Newcastle Upon Tyne, UK
Malignant melanoma remains largely untreatable due to the notorious resistance of such 
tumours to apoptosis induced by conventional mechanisms. Currently there is considerable 
clinical interest in two agents, fenretinide (a synthetic derivative of vitamin A) and Velcade 
(a 26S proteosome inhibitor) both which induce potent apoptosis of melanoma cells whilst 
having no effect on normal melanocytes. We have demonstrated both these agents induce 
cell death by targeting mechanisms culminating in endoplasmic reticulum (ER) stress. 
Targeting ER-stress-induced apoptosis presents a powerful novel therapeutic approach but 
may be counteracted by the defensive homeostatic unfolded protein response (UPR) resulting 
in the up regulation of protein disulphide isomerase (PDI) family members, key chaperones 
which assist in the clearance of unfolded proteins and promotion of cell survival. The aim of 
the current study was to test the hypothesis that the efficacy of ER stress-induced apoptosis 
in response to fenretinide or velcade would be increased by the combination of these agents 
with inhibitors of PDI. Dose response and fixed dose ratio experiments of Bacitracin and 
novel PDI inhibitors were performed in combination with fenretinide or velcade in a panel of 
melanoma cell lines and apoptosis evaluated by flow cytometry. ER-stress-induced apoptosis 
was confirmed by Western blotting for GADD 153, the key transcription factor regulating 
the transition from pro-survival to pro-apoptotic signalling during ER stress. Transient 
transfection of either mutant or wild type PDI confirmed the target activity of novel PDI 
inhibitors. Results demonstrated there was no apparent toxicity using PDI inhibitors alone 
and confirmed a synergistic apoptotic response was induced by combination with fenretinide 
or Velcade (eg: for the combination of bacitracin and fenretinide at a fixed dose ratio of 50:1, 
ED50, CI=0.096). These data support the novel concept of combining ER stress-inducing 
agents with PDI inhibition as a more effective therapeutic strategy for metastatic melanoma. 
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Mycosis Fungoides Tissue Proteomics for Biomarker Discovery
J Liu, B Wang Peking Union Medical College Hospital, Beijing, China
Mycosis fungoides(MF) is the most common type of Cutaneous T cell lymphoma and 
accounts for almost 50% of all primary cutaneous lymphomas. New technologies 
for the early detection and therapy of MF are still needed. ProteinChip®Surface-
Enhanced Laser Desorption and Ionization Time-of-flight Mass Spectrometry, SELDI-
TOF-MStechnology was used as a tool for the discovery of protein patterns of MF 
lesions (n=12) and normal controls (n=15). Each whole protein extract from skin 
tissue was analyzed by ProteinChip technology. The resulting protein profiles were 
submitted to Biomarker Wizard software. 24 peaks had mean signal intensities 
significantly different (p < 0.01) between MF lesions and normal controls. The mass 
spectrum peaks at 2285Da, 2893Da, 3246Da, 3363Da, 3385Da, 3434Da, 3455Da, 
3498Da, 3581Da, 4632Da, 10837Da, 11371Da, 12686Da, and 13152Da were 
increased in MF skin lesions. The mass spectrum peaks at 4077Da,7671Da,7927D
a,8043Da,15331Da, 15503Da, 15884Da, 16067Da, 31023Da and 31743Da were 
decreased in MF skin lesions. We concluded that these proteins may be used for the 
diagnosis or monitoring of mycosis fungoides.
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Bcl-3 and RelB Expression in Mycosis fungoides and Sézary Syndrome
U Döbbeling, J Qin, J Kamarachev, R Dummer University Hospital Zurich, 
Switzerland
Mycosis fungoides (MF) and its leukemic variant Sézary syndrome (SS) are the 
most frequent types of cutaneous T cell lymphomas (CTCL). They progress from a 
patch/plaque stage to a tumor stage. Such stage transitions are accompanied with 
changes in transcription factor activities, which cause changes in oncogene and 
tumor suppressor gene expression. It has been reported that MF and SS cells contain 
constitutive the NFkB transcription factor molecules, p50, p52 and p65. We tested 
MF and SS cell lines and skin lesions for the presence of another NFkB protein, RelB 
and the related Bcl-3 protein to see whether these molecules are involved in the 
pathogenesis of these diseases. The presence and DNA binding of the RelB protein 
in MF and SS cell lines was tested by transcription factor (TF) ELISA. Biopsies from 
MF and SS skin lesions were tested for RelB and Bcl-3 by specific antibodies. Several 
stages of MF and SS were compared. The TF-ELISAs showed that DNA-binding RelB 
was present in the nuclear extracts of MF and SS cell lines. In the skin lesions RelB 
was present in all tumor stage patients of MF (7/7) and SS stage IV patients (8/8). In 
non-tumor skin lesions of the MF stage IB we found RelB staining in 5/9 patients and 
1/4 in stage III SS patients. All MF stage IA skin lesions (0/9) did not stain with RelB. 
Thus RelB activation may occur before the transition to the tumor stage and may be a 
good marker for disease progression. In contrast to RelB, Bcl-3 staining was found in 
all CTCL samples (50/50) but not in psoriasis samples. Bcl-3 my therefore be suited 
to discern MF from psoriasis.
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Dysregulation of Kallikrein 14 and its Possible Role via PAR-2 in Squamocellular 
Carcinoma Biology
G Bocheva1, A Rattenholl2, M Steinhoff2 1Sofia Medical University, Sofia, Bulgaria 
2University of Münster, Germany
Human tissue kallikreins (hKs) represent a large family of secreted serine proteinases. 
These enzymes are up-regulated in the local tumour area and in the circulation of 
many cancers indicating a role of kallikreins in the regulation of tumor progression. 
HKs exhibit trypsin-like activity and can trigger signal transduction pathways by 
regulating PARs. Because of well-recognized susceptibility to tryptic activation, PAR2 
could be a potential target for hK14, as well. Therefore, the aim of our study was 
to investigate the expression of hK14 and PAR2 in skin squamocellular carcinomas 
(SCCs) of different histological grades by immunohistochemistry.We examined initial, 
well-, moderate-, and poorly differentiated SCCs for both, hK14 and PAR2. In all 
tested tumour tissues hK14 was well expressed, in comparison with healthy skin 
surrounding tumours. Moreover, we found much stronger immunolabeling in tumour 
cells of moderate to poorly differentiated SCCs. In contrast, the expression of PAR2 
was higher in initial SCCs and was decreasing with the differentiation of the tumour. In 
conclusion we propose that hK14 via PAR-2 mediated signalling may play a prominent 
role in skin squamocellular carcinomas. In addition, down-regulation of PAR2 
within the differentiation of the SCCs points to its tumor-protective role in the skin. 
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Diagnostic image analysis of malignant melanoma in in-vivo confocal laser-scanning 
microscopy
M Horn1, A Gerger1, M Wiltgen2, U Langsenlehner1, R Hofmann-Wellenhof1, 
W Weger1, E Richtig1, H Samonigg1, J Smolle2 1Medical University of Graz, Austria 
2Institute of Medical Informatics, Graz, Austria
In this study we assessed the applicability of image analysis and a machine learning 
algorithm on diagnostic discrimination of benign and malignant melanocytic skin 
tumors in in-vivo confocal laser scanning microscopy (CLSM). A total of 857 CLSM 
tumor images including 408 benign nevi images and 449 melanoma images was 
evaluated. Image analysis was based on features of the wavelet transform. For 
classification purposes we used a classification tree software (CART). Moreover, 
automated image analysis results were compared with the prediction success of 
an independent human observer. CART analysis of the whole set of CLSM tumor 
images correctly classified 97.55% and 96.32% of melanoma and nevi images. In 
contrast, sensitivity and specificity of 85.52% and 80.15% could be reached by the 
human observer. When the image set was randomly divided into a learning (67% 
of the images) and a test set (33% of the images), overall 97.31% and 81.03% of 
the tumor images in the learning and test set could be classified correctly by the 
CART procedure. Diagnostic suggestions generated by computerized image analysis 
may serve as an “expert second opinion”. Our study shows that such an automated 
procedure may be helpuf in in vivo confocal laser scanning microscopy. 
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Attenuation of EGFR-ERK Signalling by GLI1 Highlights a Mechanism to Promote 
the Epithelial Phenotype and May Account for the Poor Metastatic Potential of Basal 
Cell Carcinoma
W Neill1, WJ Harrison1, MS Ikram1, TDL Williams1, JL Green1, L Ghali1, AM 
Frischauf2, EA O’Toole1, F Aberger2, M Philpott1 1Queen Mary University of London, 
UK 2University of Salzburg, Austria
The formation of basal cell carcinoma (BCC) is associated with increased expression 
of the GLI (GLI1 and GLI2) transcription factors and represents a highly compact, non-
metastatic epithelial tumour type that may arise from the aberrant propagation of epidermal 
or progenitor stem cell (SC) populations. As a model to investigate BCC biology, we employ 
retroviral transduction to express GLI1 in immortalised N/Tert-1 keratinocytes and have 
recently shown that GLI1 induces the expression of various epidermal SC markers. Here we 
reveal that GLI1 promotes other SC characteristics including compact colony formation and 
reduced expression of EGFR (epidermal growth factor receptor) and phospho-ERK (extra-
cellular signal-regulated kinase). ERK activity remains low when EGFR levels are increased 
exogenously in GLI1 cells suggesting that ERK is inhibited downstream of the receptor. 
Colony formation is associated with reduced ERK and/or c-Jun activity as exposure of control 
cells to the pharmacological inhibitors U0126 (MEK) or SP600125 (JNK) promotes colony 
formation and, as for GLI1, these cells display reduced expression of both phospho-ERK 
and phospho-c-Jun. Activation of ERK by exposure to EGF or co-expression of constitutively 
active MEK negates GLI1 colony formation but migrating cells remain ‘sticky’ displaying an 
elongated phenotype through inefficient cell-cell detachment and impaired tail retraction. 
In addition, GLI1 attenuates EGF-mediated induction of the mesenchymal marker, vimentin, 
revealing that GLI1 opposes EGFR signalling to maintain the epithelial phenotype. Finally, 
ERK activity was predominantly negative in 13/14 BCCs (superficial and nodular) revealing 
that, paradoxically, GLI1 repression of ERK is a feature of BCC that may account for why 
these tumours often manifest as highly compact epithelial masses that are rarely metastatic. 
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Functional copy number changes in Sézary syndrome
X Mao, S McElwaine Queen Mary University of London, UK
Sézary syndrome (SS) is a leukaemic variant of primary cutaneous T-cell lymphoma 
with an aggressive clinical course. Previous studies have revealed complex genetic 
aberrations affecting almost all chromosomes with copy number losses being the dominant 
chromosomal abnormalities. However, it is still unclear which of these genetic alterations 
are the primary changes in the pathogenesis of this skin cancer and which are the secondary 
ones or byproducts as a resullt of disease progression. To address these issues we put 
forward a concept of functional copy number change in cancer cells in which we assume 
some chromosome copy number changes may have a direct impact on gene expression and 
presumably these copy number changes are functional. To test this hypothesis we initially 
analysed RNA samples isolated from peripheral blood mononuclear cells from 6 SS cases 
and 2 healthy individuals for global gene expression profiling by using Affymetrix 133A 
geneChip and GeneSpring software. Next we generated gene-lists from the chromosomal 
regions showing significant copy number gains and losses throughout human genome, 
which were described by previous metaphase comparative genomic hybridisation (CGH) 
and array-CGH studies. Then we imported these gene-lists into the GeneSpring platform 
to establish if they affected gene clustering in terms of separation of SS cases from the 
normal controls. The bioinformatic analysis with GeneSpring showed that only gene-lists 
from copy number losses at 1p36p22, 6q24, 15q11.2 and gains at 22q11.2q13.3 were 
capable of separating all 6 SS cases from 2 controls while the others produced mixed gene 
clustering patterns between SS and the controls. This finding suggest that the gene copy 
number changes from these chromosomal regions be functional and therefore have a key 
role in SS pathology.
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Increased uptake of macromolecules in a xenograft tumour model is facilitated via 
enhanced colloid osmotic pressure
M Hofmann1, E McCormack2, H Wiig2, A Bernd1, J Bereiter-Hahn1, R Kaufmann1, 
S Kippenberger1 1JW Goethe-University, Frankfurt/Main, Germany 2University of 
Bergen, Norway
Elevated tumour interstitial fluid pressure (TIFP) is a characteristic of most solid 
tumours. Clinically, TIFP is described as a physical parameter that hampers the 
uptake of anti-tumour drugs into tumour tissue and thus lack of therapeutic effects. 
In the present study the impact of an increased colloid osmotic pressure (COP) on 
TIFP was investigated. Furthermore, intratumoural distribution of macromolecules 
in control and COP increased animals was shown by i.v. injection of fluorescent-
coupled dextrans. A431 vulva carcinoma cells were s.c. implanted into the back 
of immunodeficient animals. TIFP was measured directly in the central region of 
solid tumours. COP was enhanced via injection of hyperosmotic human serum 
albumin (HSA) solutions. In our experimental set-up we could demonstrate that the 
increase of COP reduces the TIFP significantly. At different time-points after the HSA 
injection fluorescent-dextrans or fluorescent labeled cetuximab were i.v. applied. 
The distribution of dextrans or cetuximab in TIFP-lowered vs untreated tumour tissue 
was investigated using fluorescence microscopy and time-domain optical imaging 
techniques. These data demonstrate that an increased COP can lower TIFP and 
can augment the delivery of therapeutics to tumour tissue. Therefore, lowering of 
TIFP could enhance the efficacy and efficiency of anti-tumour therapies utilising 
chemotherapeutics.
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The oncogenic GLI (GLI1 and GLI2) transcription factors induce characteristics of 
cellular senescence in N/Tert-1 keratinocytes
TDL Williams1, WJ Harrison2, MS Ikram2, M Philpott3, W Neill1 1Institute of Cell and 
Molecular Biology, London, UK 2Queen Mary University of London, UK
The phenomenon of oncogene-induced senescence (OIS) recently gained credence 
as a physiological mechanism to maintain tumours in a pre-malignant state with 
additional genetic hits required for malignant progression. This concept is difficult 
to reconcile with basal cell carcinoma (BCC) as these tumours do not appear to 
derive from pre-cancerous lesions and may in fact represent dysplastic hair follicle 
organogenesis. Indeed, in contrast to other oncogenic proteins such as mutant Ras or 
Raf, OIS has not previously been attributed to the GLI (GLI1 and GLI2) transcription 
factors that are associated with the formation/maintenance of several tumour types 
including BCC. Here we show that retroviral expression of GLI in N/Tert-1 keratinocytes 
induces compact colony formation and potently inhibits cell proliferation as shown 
by MTT and FACS analysis with cells arrested in the G1 phase of the cell cycle. 
GLI induces characteristics of cellular senescence/hypermitogenic arrest as revealed 
by the concomitant induction of cyclin D1 (pro-proliferative) and cyclin dependent 
kinase inhibitors p21 and p27 (anti-proliferative).Targeted knockdown of p53 by RNA 
interference was insufficient to overcome growth arrest. In contrast, co-expression of 
the adenoviral 12S E1A protein that targets various cell cycle inhibitors including p21 
and p27 was sufficient to overcome GLI-induced growth arrest, although both E1A 
and E1A/GLI cells proliferated slower than empty N/Tert-1 cells. These data provide 
the first evidence of GLI evoking an oncogene-induced stress response and suggest 
that, in the absence of PTCH mutations, other genetic or epigenetic event(s) are 
required for BCC development. Accordingly, whether loss of p21 or p27 expression 
is observed in these tumours is currently being investigated.
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TNFα-induced Akt signalling is crucially involved in DNA repair and cell survival of 
UVB-irradiated keratinocytes
A Faurschou1, R Gniadecki1, D Calay2, HC Wulf1 1Bispebjerg Hospital, Copenhagen 
NV, Denmark 2University of Namur, Belgium
Tumor necrosis factor α (TNFα) is induced by ultraviolet B radiation (UVB) and has 
been implicated in the early stages of photocarcinogenesis. We found that in normal 
keratinocytes and in the transformed keratinocyte cell lines, HaCaT and A431, TNFα 
stimulates protein kinase B/Akt via atypical protein kinase species, which results 
in activation of the survival complex mTORC1 (mammalian target of rapamycin 
complex 1) and inhibition of the proapoptotic proteins Bad and FoxO3a. In UVB 
irradiated cells, exogenous TNFα (10 ng/ml) increased the proportion of cycling 
cells and blocked apoptotic cell death. A significantly higher proportion of UVB-
treated HaCaT cells containing unrepaired cyclobutane pyrimidine dimers (CPD) 
escaped the G2/M cell cycle checkpoint in the presence of TNFα (9.5%±3.3% 
versus 4.8%±2.2%). These effects were reversed by infliximab, a TNFa neutralizing 
antibody, indicating that also endogenously produced TNFa cytokine stimulates cell 
proliferation and weakens cell cycle checkpoint control and apoptotic response. The 
PI3K inhibitor LY294002 alone or in combination with TNFa reduced significantly the 
proportion of mitotically active, CPD-containing cells. Our data suggest that TNFα 
overrides the G2/M checkpoint and allows for some cells containing unrepaired CPD 
to enter the cell cycle. The effect of TNFα seems to be dependent on the activation 
of Akt and may constitute a relevant mechanism enhancing mutagenesis and tumor 
development. 
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Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary 
cutaneous large B-cell lymphoma, leg type
NJ Senff, WH Zoutman, MH Vermeer, PA Van der Velden, R Willemze, CP Tensen 
Leiden University Medical Center, Leiden, Netherlands
Purpose was to assess the prevalence and prognostic significance of chromosomal loss 
at 9p21 (CDKN2B/CDKN2A/MTAP) in primary cutaneous large B-cell lymphoma, leg 
type (PCLBCL, LT), a primary cutaneous lymphoma with intermediate prognosis.We used 
Multiplex Ligation-dependent Probe Amplification (MLPA), a PCR based technique permitting 
detection of deletions and/or amplifications of short DNA sequences. Tumour DNA derived 
from fresh-frozen material (n = 15) and formalin-fixed paraffin-embedded sections (n = 12) 
was analysed with a commercially available MLPA kit containing 23 probes specific for the 
9p21 region. Four of these probes hybridise to the region within CDKN2A encoding p16. 
In cases with no loss in CDKN2A or with only monoallelic loss, melting curve analysis 
was performed on bisulphite-converted and PCR amplified DNA to analyse the promoter 
methylation status of the p16 gene in these patients. Most aberrations at 9p21 were found in 
the region encoding p16. In 17 of 27 patients, one or more probes showed a biallelic loss 
for the p16 gene and in 4 cases monoallelic loss was found. Six patients showed no loss of 
probes for p16. In 1 patient with monoallelic loss we found promoter hypermethylation of 
the remaining allele and in 1 patient with no loss, we found p16 promoter hypermethylation 
of both alleles. Patients with loss of p16 due to either deletion or promoter hypermethylation 
showed a significantly worse survival as compared to patients without these aberrations 
(5-year survival 27% vs. 100%; p = 0.009). We concluded that MLPA appears to be a 
simple, reliable and reproducible method for analysing DNA extracted from paraffin and 
frozen tumour material. Loss of p16 seems to have prognostic significance in the group of 
PCLBCL, LT patients. 
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Quantification of angiogenesis in a mouse model of pancreatic cancer
H Braumüller1, B Pichler1, M Kneilling1, R Haubner2, M Röcken1 1Eberhard-Karls-
University, Tübingen, Germany 2Medical University of Innsbruck, Innsbruck, Austria
Antiangiogenic therapies rely on animal models of cancer such as traditional tumor 
transplants or newer, genetically engineered mouse models. In one transgenic model, 
the RIP1-Tag2 mouse, the oncogene T antigene (Tag) is expressed in all insulin-
producing beta cells. Tag induces multistage carcinogenesis with adenomas leading 
to carcinomas. The transition from normal vasculature to abnormal tumor vessels 
is accompanied by the upregulation of the integrin avb3. To monitor tumor growth 
we measured blood glucose level twice weekly. 7 weeks old RIP1-Tag2 mice show 
decreased blood glucose compared to non-transgenic controls. As tumor growth 
progresses, blood glucose levels fall rapidly. Tumor vessels were characterized by 
immunohistochemistry with the endothelial marker CD31/PECAM, alpha-actin and 
b3-integrin. CD31 staining showed no significant vascularization in 7 weeks old 
mice. From week 7 to 12 of life islets developed rapid angiogenesis, associated with 
aberrant fragmentation of pathogenic vascular lakes. Next we studied the correlation 
of [125I]Gluco-RGD uptake and integrin avb3 expression. Autoradiography of the 
pancreata of 7 weeks old C3H wildtype mice showed no uptake of [125I]Gluco-
RGD, while 7 weeks old RIP1-Tag2 mice showed focal tracer uptake corresponding 
to small islet tumors. At 12 weeks RIP1-Tag2 mice had three large lesions with focal 
accumulation of 125I-Gluco-RGD. The uptake ratio of tumor to pancreas tissue of 10-
13 weeks old RIP1-Tag2 mice (n=4) was 6.0 times over background as compared to 1.4 
(p = 0.001) in control mice (n = 6). As the growth of new tumor vessels started before 
tumor growth is visible, tracking in vivo the switch from quiescent endothelial cells to 
activated vasculature will be of great benefit for the development of therapeutic studies. 
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Differential Expression of Stromal MMP-1, MMP-9 and TIMP-1 IN Basal Cell 
Carcinomas of Immunosuppressed Patients and Controls
S Boyd1, K Saarialho-Kere2, T Kuivanen2, MS Virolainen2, L Kyllönen2 1Helsinki 
University and Huslab, T, Finland 2Helsinki University Central Hospital, Helsinki, 
Finland
Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) have an important 
role in the initiation, growth, and invasion of malignant tumors. Basal cell carcinoma 
(BCC) is the most common human malignancy. The risk of BCC is 10-16 times higher 
among organ transplant recipients compared with the nontransplanted population. 
The aim of this study was to compare the expression of several MMPs and TIMPs in 
BCCs from kidney transplant recipients and controls. Expression of MMPs-1, -7, -8, 
-9, -10, -13, -26, and TIMPs-1 and -3 was evaluated by immunohistochemistry in 25 
samples of BCC of kidney transplant recipients and 25 matched controls representing 
superficial and nodular subtypes. No significant differences were detected in MMP 
expression of cancer cells at the invasive edge of the tumors. However, MMPs-1 and 
-9 and TIMP-1 were expressed more frequently in stromal macrophages in the BCCs of 
immunocompetent patients. No significant differences were detected in the expression 
of MMPs -7, -8, -10, -13, -26, and TIMP-3 in the two categories. When superficial and 
nodular tumors were compared irrespective of the patient group, more MMP-1 positive 
fibroblasts and MMP-9 positive neutrophils were detected in the superficial subtype 
while stromal MMP-10 expression was more abundant in nodular tumors. Our results 
suggest that abundant peritumoral expression of TIMP-1 in non-immunocompromised 
patients limits ECM degradation permissive for cancer cell migration. 
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Pharmacological regulation of epigenetic gene expression in tissue culture of 
squamous cell carcinoma of the skin
H Fujiwara, M Ito Niigata University, Niigata, Japan
Epigenetic regulation of tumor suppressor genes plays an important role in development 
of skin cancers. DNA methylation and histone acetylation are well-studied negative and 
positive regulators of gene expression. We previously reported DNA methylation profiles 
of several tumor suppressor genes, such as p16, p15, and CDH1 (E-cadherin), in basal 
cell carcinoma, malignant melanoma, and squamous cell carcinoma of the skin. While the 
detection methods of DNA methylation and histone acetylation are already established, 
their effect in the tumor is usually studied by pharmacological regulation of epigenetic state 
in cancer cell line culture, although it is known that DNA methylation in excised tumor 
and cancer cell lines was different, and that in cell line culture, DNA methylation state can 
change up to 30% in only one passage. To elucidate the true epigenetic effect in skin cancer, 
we conducted short term tissue culture with basic medium or epigenetic state regulators. 
Squamous cell carcinoma of the skin (n=4) was surgically removed, cut in small pieces, and 
incubated for 6 hours in normal saline, Dulbecco’s modified Eagle medium supplemented 
with fetal bovine serum (DMEM), DMEM with 5-aza-2’-deoxycytidine (AZA), or DMEM 
with 5-aza-2’-deoxycytidine and trichostatin A (AZA-TSA). 5-aza-2’-deoxycytidine leads 
DNA demethylation, and trichostatin A induces histone acethylation; both can up-regulate 
gene expression which was epigenetically suppressed previously. Gene expression was 
assessed by RT-PCR and in situ hybridization for CDH-1 gene and p16 gene where their 
expression was suppressed in the excised tumor. After the culture mRNA expression of 
CDH-1 and p16 was restored in the tumor with AZA or AZA-TSA, but not with normal 
saline or DMEM. Normal skin cultured in either medium did not change gene expression 
markedly. Therefore, CDH1 and p16 DNA methylation truly suppressed gene expression in 
the tumor. Our method can elucidate true epigenetic effect in cancers.
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Langerhans cells in early and late lesions of vulvar lichen sclerosus
H Rotsztejn1, E Trznadel-Budzko2, D Jesionek-Kupnicka2 1Polish Mother’s Memorial 
Hospital, Lodz, Poland 2Medical University of Lodz, Lodz, Poland
Langerhans cells, a part of dendritic cells, specialize in antigen presentation and 
play an important role in the skin immune system. We estimated skin biopsies taken 
from 22 women with vulvar lichen sclerosus: 15 patients with early stage and 7 
patients with late stage of the disease. The control group consisted of 9 women who 
underwent a plastic surgery operation of the vulvar region. Immunohistochemical 
staining was performed on formalin-fixed, paraffin-embedded tissues samples, using 
antihuman CD1a antibody (NCL-CD1a-235, NOVOCASTRA). Increased numbers of 
Langerhans cells staining were present in early lichen sclerosus, whereas decreased 
numbers of these cells were present in late lichen sclerosus compared to the control 
group. Our study has shown a decreased number of Langerhans cells in late lesions of 
vulvar lichen sclerosus, where the tendency of cacinogenesis is much higher.
 
 
556
The decreased number of CD3 lymphocytes bearing CD26 molecules in inflammatory 
infiltrates in vulvar lichen sclerosus
H Rotsztejn E Glowacka, P Lewkowicz, H Tchórzewski Polish Mother’s Memorial 
Hospital, Lodz, Poland
Lichen sclerosus is a chronic infammatory skin or mucosa disease. Inlammatory 
T lymphocytes under homogenization zone seem to play a crucial role in the 
pathogenesis of lichen sclerosus. CD26 is a lymphocyte-associated dipeptidyl 
peptidase IV which is able to inactivate chemokines and can be regarded as an anti-
inflammatory molecule. The investigation included 22 women with vulvar lichen 
sclerosus and 19 women after plastic surgery of the vulvar region.The activation 
of antigen expression on analyzed cells CD26 was evaluated by a double staining 
procedure with monoclonal antibody. The cells were analyzed using a BD FACS 
Calibur cytometer and CellQuest Software. We showed a diminished number of 
CD3 lymphocytes bearing CD26 molecules. The decreased number of lymphocytes 
bearing CD26 molecules can be connected with chronic inflammation in vulvar 
lichen sclerosus and may be a starting point for carcinogenesis process.
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High loss of heterozygosity rates on chromosome 9p in cutaneous squamous cell 
carcinoma
B Muehleisen, I Petrov, S Frigerio, R Dummer, G Burg1 LE French, G Hofbauer
University Hospital of Zurich, Switzerland
Genetic alterations on chromosome 9p are frequent during carcinogenesis in a variety of 
tumors. Genomic mutations can be detected early by loss of heterozygosity (LOH) analysis. 
Incidence of cutaneous squamous cell carcinoma is much higher in immunocompromised 
than in immunocompetent patients . Our aim was to assess LOH at 3 microsatellite markers 
on chromosome 9p in the course from intraepidermal (actinic keratosis or Bowen’s disease) 
to invasive squamous cell carcinoma in organ transplant recipients (OTR) (n = 42) and 
immunocompetent patients (n = 43). Thus, in 170 tissue samples equal numbers of tumor 
cells and internal control tissue cells were microdissected. DNA was extracted, amplified by 
PCR at three microsatellite loci (IFNA, D9S162 and D9S925) and then analyzed for LOH. 
In addition, correlation between LOH on chromosome 9p and protein p16 expression as 
measured by immunohistochemistry was assessed. We found high LOH rates at all three loci 
(61% at IFNA, 42% at D9S162 and 51% at D9S925). LOH at these loci was comparable 
between intraepidermal and invasive forms of squamous cell carcinoma (p = 0.59, 0.66, 
0.08 respectively). OTRs showed significantly more LOH than immunocompetent patients 
at D9S162 (p = 0.04) but not at IFNA or at D9S925 (p = 0.88, 0.92 respectively). P16 
protein expression was similar in intraepidermal and invasive squamous cell carcinoma and 
similar between OTRs and immunocompetent patients. Correlation between LOH and p16 
immunoreactivity was poor (Spearman’s rho ranging from 0.09 to 0.13). Our study revealed 
high genomic instability on chromosome 9p in cutaneous squamous cell carcinoma. Further 
efforts should be undertaken to identify new tumor suppressor genes in those regions. 
Increased allelic imbalance around locus D9S162 in OTRs may be a genomic correlate 
for the clinically more aggressive behaviour of squamous cell carcinoma in these patients. 
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RAGE signaling links inflammation and cancer development by establishing effective 
tumor promotion
C Gebhardt1, A Riehl1, M Durchdewald1, J Németh1, G Fürstenberger1, K Müller-
Decker1, AH Enk2, B Arnold1, A Bierhaus2, PP Nawroth2, J Hess1, P Angel1 1German 
Cancer Research Center, Heidelberg, Germany 2University of Heidelberg, Germany
Experimental and clinical evidence have highlighted the critical role of chronic inflammation 
in promoting tumor development. However, the molecular mechanisms converting a 
transient inflammatory reaction into a tumor-promoting microenvironment remain largely 
elusive. We show that mice deficient for the receptor for advanced glycation end-products 
(RAGE) are resistant to DMBA/TPA-induced skin carcinogenesis, characterized by a severe 
defect in sustaining inflammation during the promotion phase, thereby providing direct 
genetic evidence for a novel role for RAGE in linking chronic inflammation and cancer. 
Accordingly, upon single and repeated TPA treatment Rage-/- skin exhibits reduced epithelial 
cell proliferation, stromal inflammation and impaired up-regulation of proinflammatory 
mediators COX-2 and MIPs representing novel targets of RAGE signaling in vivo. Furthermore, 
our data prove that RAGE deficiency does not inflict a primary block in tumorigenesis in the 
epithelial cells and strongly suggests that RAGE deficiency impairs tumorigenesis through 
attenuating the inflammatory response to TPA. Finally, RAGE-dependent upregulation of its 
potential ligands S100A8 and S100A9 involving several cellular compartements supports 
the existence of an S100/RAGE-driven feed-forward-loop in sustained inflammation and 
tumor promotion. We propose that RAGE signaling drives the strength and maintenance 
of an inflammatory reaction during tumor-promotion and thereby critically contributes 
to carcinogenesis. This data provides the first in vivo evidence that RAGE signaling 
represents a novel tumor-promoting axis in multistage carcinogenesis. Thus, strategies that 
specifically block RAGE activation may be useful in cancer treatment and prevention in 
order to target both the inflammatory and the malignant components of epithelial tumors. 
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Peroxisome proliferator-activated receptor (PPAR)-ligands and/or calcitriol regulate 
proliferation of melanoma cells: an outlook in future melanoma therapy?
P Sertznig, M Seifert, W Tilgen, J Reichrath The Saarland University Hospital, 
Homburg/Saar, Germany
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear receptor 
superfamily of transcriptional regulators that regulate lipid, glucose, and amino acid 
metabolism. In recent studies it also has been shown that these receptors are implicated in 
tumor progression, cellular differentiation, and apoptosis and modulation of their function 
is therefore considered as a potential target for cancer prevention and treatment. PPAR 
ligands and other agents influencing PPAR signalling pathways have been shown to reveal 
chemopreventive potential by mediating tumor suppressive activities in a variety of human 
cancers and could represent a potential novel strategy to inhibit tumor carcinogenesis and 
progression. In addition, transcription of PPARs has been shown to be directly regulated 
by calcitriol. To further evaluate the potential role of PPAR-ligands and calcitriol in 
melanoma therapy, we have asked the following questions: (i) which PPAR-isotypes are 
expressed in cultured normal melanocytes and melanoma cell lines? (ii) do PPAR-ligands 
and/or calcitriol regulate cell proliferation (iii) do PPAR-ligands and/or calcitriol modulate 
expression of corresponding nuclear receptors in melanoma cells? Using real time PCR, we 
have characterized expression of PPARalpha, delta and gamma in primary cultured normal 
melanocytes and in melanoma cell lines. We show that PPARalpha and delta are much 
stronger expressed in primary cultured normal melanocytes and in melanoma cell lines 
than PPARgamma. We demonstrate antiproliferative effects of various PPAR-ligands and/or 
calcitriol on melanoma cell lines. In conclusion, our data support the concept that PPARs 
may be of importance for pathogenesis, progression, and therapy of malignant melanoma. 
 
560
Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations 
differing from primary lung cancer
S Hahtola1, E Burghart2, M Puputti3, L Karenko3, WM Abdel-Rahman3, L Väkevä3, 
L Jeskanen3, S Virolainen3, J Karvonen3, K Salmenkivi3, V Kinnula3, H Joensuu3, 
P Peltomäki3, CA Klein2, A Ranki3 1Skin and Allergy Hospital, Helsinki, Finland 
2University of Regensburg, Regensburg, Germany 3University of Helsinki, Finland
Cutaneous T-cell lymphoma (CTCL) patients have an increased risk of certain secondary 
cancers, the most common of which are lung cancers, especially small cell lung cancer. To 
reveal the molecular pathogenesis underlying CTCL-associated lung cancer, we analysed 
genomic aberrations in CTCL-associated and reference lung cancer samples. DNA derived 
from microdissected lung cancer cells of five CTCL-associated lung cancers and five reference 
lung cancers without CTCL association was analysed by comparative genomic hybridisation 
(CGH). Fluorescent in situ hybridisation (FISH), immunohistochemistry (IHC), and loss of 
heterozygosity (LOH) analysis were performed for selected genes. In CTCL-associated lung 
cancer, CGH revealed chromosomal aberrations characterizing both lung cancer and CTCL, 
but also losses of 1p, and 19, and gains of 4q and 7, hallmarks of CTCL. LOH for the CTCL-
associated NAV3 gene deletion was detected in two of the four informative primary lung 
cancers. In the chromosomal area 4q12, FISH revealed increased copy number of the KIT 
gene in 75% of CTCL-associated lung cancers and 20% of primary lung cancers. PDGFRα 
and VEGFR2 copy numbers were also increased. IHC showed moderate KIT expression, when 
gene copy number was increased. We concluded that CTCL-associated lung cancer shows 
chromosomal aberrations different from primary lung cancer, especially amplifications of 4q, 
a chromosome arm frequently deleted in the latter. Copy numbers and expression of selected 
genes in chromosome 4 differed between the CTCL-associated and primary lung cancers. 
These preliminary observations warrant further prospective studies to identify the common 
underlying factors between CTCL and CTCL-associated lung cancer. 
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Potential Involvement of Notch1 Signaling in the Pathogenesis and Progression of 
Primary Cutaneous CD30+ Lymphoproliferations
M Kamstrup1, E Ralfkiaer2, G Skovgaard1, R Gniadecki1 1Bispebjerg Hospital, 
Copenhagen NV, Denmark 2Rigshospitalet, Copenhagen N, Denmark
Potential Involvement of Notch1 Signaling in the Pathogenesis and Progression of 
Primary Cutaneous CD30+ Lymphoproliferations. The central role of Notch signaling 
in T-cell development and oncogenesis raises the question of the importance of this 
pathway in cutaneous T-cell lymphomas. We investigated the pattern of expression 
of Notch and its ligands, Jagged and Delta, in skin samples of primary cutaneous 
CD30+ lymphoproliferative disorders by immunohistochemistry of formalin-fixed, 
paraffin-embedded skin samples from 12 patients with lymphomatoid papulosis and 
11 patients with primary cutaneous anaplastic large cell lymphoma. Furthermore, we 
performed immunofluoresence studies of fresh skin samples obtained from 3 patients 
with lymphomatoid papulosis and 2 patients with primary cutaneous anaplastic 
large cell lymphoma. We identified single Notch1-positive cells or small clusters 
of atypical cells in lymphomatoid papulosis. Similarly, strongly positive Jagged1 
cells tended to be localized in clusters. Primary cutaneous anaplastic large cell 
lymphoma had higher expression of Notch1 and Jagged1 compared to lymphomatoid 
papulosis. Cells expressing Notch1 and Jagged1 were co-localized and a subset of 
cells expressed both the receptor and ligand. The expression of the ligand Delta1 
was low to undetectable in both types of lymphoproliferations. A subpopulation of 
lymphoma cells was found to co-express Notch1 and activated Akt kinase. These 
results imply a potential role for Notch signaling pathway in the pathogenesis of 
primary cutaneous CD30+ lymphoproliferations and provide rationale for the 
exploration of the activity of Notch antagonists in the therapy of these diseases. 
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Tumor-specific T helper cells arrest multistage carcinogenesis without tumor 
infiltration
K Ghoreschi1, H Braumüller1, B Pichler1, M Kneilling1, R Haubner2, M Röcken1 
1Eberhard Karls University, Tübingen, Germany 2Medical Univ of Innsbruck, Austria
The transgenic mouse model RIP1-Tag2 is an established model for studying multistage 
carcinogenesis. In these mice the large T antigen (Tag) of the Simian Virus 40 is only 
expressed in insulin-producing beta cells of the pancreas, leading to the successive 
development of islet cell hyperplasia, adenomas, and finally invasive carcinomas. Previously 
we found that intra peritoneal (i.p.) injection of Tag-specific Interferon-γ (IFN-γ) producing 
CD4+ Th1 (Tag-Th1) cells delayed tumor development significantly. To understand the 
mechanism underlyingTh1 cell-mediated arrest of tumor growth, we visualized Th1 cell 
trafficking, homing, and accumulation in vivo with non-invasive high-resolution positron 
emission tomography (PET) and invasive methods such as autoradiography combined 
with histology, fluorescence imaging and functional assays. Tag-Th1 cells were labeled in 
vitro either with [64Cu]PTSM, a fluorescent Cy5-dye or remained unlabeld. We injected 
10x106 labeled Th1 cells i.p. into RIP1-Tag2 and naïve C3H mice. At 30 minutes, and 3, 
8, and 24 hours after [64Cu]PTSM injection PET scans showed that Tag-Th1 cells homed 
in the pancreatic lymph node and the pancreas. Surprisingly, autoradiography combined 
with micrographic analysis of the pancreas and the lymph nodes revealed accumulation 
of tumor-specific Th1 cells exclusively in the tumor draining lymph node or in the tumor 
micr-environment surrounding the islet tumors. These results were confirmed with Cy5-
labeled Tag-Th1 cells three days after i.p. injection. In sharp contrast, tumor-specific Th1 
cells did not infiltrate the islet tumors. Functional assays after 2 and 6 injections showed, 
that Tag-Th1 cells homed in the draining lymph node and in the spleen where they could be 
activated with Tag peptide. Together, the findings strongly suggest that the arrest of multistage 
carcinogenesis by Th1 cells is largely independent of Th1 cell-infiltration into the tumor. 
563
Study of Regulatory T Cells in Peripheral Blood and Cutaneous Lesions in Patients 
with Cutaneous T Cell Lymphomas: Identification of Sézary Syndrome as a Treg-
Deficient Disease
O Dereure, P Raynaud, MS Saifi, P Portales, B Guillot University of Montpellier I, 
Montpellier, France
The involvement of regulatory T cells in cutaneous T cell lymphomes (CTCL) has been recently 
questioned and a study was designed to assess the presence of these cells in peripheral blood 
and cutaneous lesions of CTCL patients. 20 patients with Mycosis Fungoides (MF) and 6 
patients with Sézary syndromes (SS) were enrolled. Cutaneous biopsy samples were subjected 
to histological and immunohistochemical analysis using anti CD4 and Foxp3 antibodies. 
The percentage of Foxp3-positive lymphocytes among CD4+ cells was determined on 400 
lymphocytes in areas with the impression of highest expression (‘hot spot’) at low magnification. 
A FACScan analysis simultaneously assessed the percentage of circulating regulatory T cells 
identified as DR-CD25+CD27+ cells among CD4+ circulating lymphocytes. Results in 
CTCL patients were compared to data from 47 patients with benign lymphocytes-dependent 
cutaneous diseases, mainly eczema and cutaneous side effects of drugs, considered as control 
patients and who benefited from the same investigations. No healthy control was used in this 
study. In skin lesons of MF patients, Foxp3+ lymphocytes represented between 11 and 40.5 
% (mean : 26 %) of CD4+ cells vs 1 to 12 % (mean : 7.9%) in SS patients and 11.5 and 34.5 
% (mean 20.8 %) in benign infiltrates. CD4+DR-CD25+CD27+/CD4+ ratio was comprised 
between 0.74 and 7.31 % % (mean 3.73 %) in patients with SS, between 5.75 and 40 % in 
MF patients (mean 17.52 %) and between 3.46% and 42.75 % (mean 14.5 %) in controls. 
To conclude, these results do not favour the hypothesis of T regulators being significantly 
involved in MF since results in MF and controls were not significantly different but instead 
confirmed a relevant decrease of this subset of T cells in SS, a data that might be related to . 
the more aggressive nature of SS compared with other CTCL.
564
T cell mediated regulation of the tumor microenvironment
K Schaak, H Braumüller, M Röcken Eberhard Karls University, Tübingen, Germany
RIP-Tag2 mice develop endogenous insulinomas and islet cell-carcinomas due 
to aberrant levels of p53 and Rb protein. As we have recently found that tumor 
associated antigen (TAA)-specific, IFNg-producing CD4+ Tcells can arrest multistage 
carcinogenesis, we have started to analyze the underlying mechanism. To this end 
RIP-Tag2 mice were either sham-treated or treated by weekly injections of TAA-
specific Th1 cells. Blood glucose levels were measured twice weekly and mice were 
sacrificed at values ≤ 20mg/dl. Pancreata were excised and RNA was extracted from 
either the entire pancreas or from collagenase isolated islet tumors. Gene expression 
levels were determined by quantitative real time PCR (RT PCR) for cytokines, 
chemokines and cell cycle regulators. Following T cell transfer we found a strong 
and selective signal of the potent angiogenesis inhibitors CXCL9 and CXCL10 which 
was strictly IFNgamma- dependent. In the presence of anti-IFNgamma CXCL9 and 
CXCL10 induction was completely abolished. Moreover, TAA-specific Th1 lost their 
protective efficacy and turned into tumor promoting cells. As we were able to detect 
a selective signal of the TAA-specific Th1 TCR and high levels of IFNg, IL-10 and IL-
12/IL23p40 in pancreatic tissue of treated mice but not in tumors we conclude that 
infiltratory lymphocytes just reach peritumoral areas. Thus TAA- specific Th1 cells 
arrest multistage carcinogenesis without infiltrating the tumor.
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Aspartic Acid 681 in CYLD is Required for the Cleavage of K63-linked Polyubiquitin 
Chains
S Almeida, C Maillard, D Hohl, M Huber Uni Hospital Center of Lausanne, 
Switzerland
The ubiquitin-specific protease (UBP) CYLD is a tumor suppressor which specifically 
removes K63-linked polyubiquitin chains from Bcl-3, TRAF2, TRAF6, NEMO and Lck. 
CYLD regulates negatively NF-kB and JNK signaling and positively T-cell receptor 
signaling. We investigated the novel missense mutation D681G found in the germline 
of a family in which 11 out of 12 tumors isolated from different body sites of 3 
members were trichoepitheliomas, benign tumors of skin appendages. Aspartic acid 
681 is highly conserved in CYLD homologues and other members of the UBP family 
but does not belong to the Cys and His boxes providing the CYLD catalytic triad 
(Cys601, His871, Asp889). CYLD-D681G and CYLD-C601A (active-site mutant) had 
a strongly reduced ability to inhibit TRAF2- and TRAF6-mediated NF-kB activation 
and TNFalpha-induced JNK signaling in 293T cells. Unlike wild- type protein, CYLD 
mutants were unable to deubiquitinate polyubiquitinated TRAF2 in 293T cells. 
CYLD-D681G was coimmunoprecipitated by TRAF2 to the same extent as the wild 
type enzyme showing that the D681G mutation did not affect TRAF2 binding. In 
contrast, immunopurified CYLD-D681G could not cleave K63-linked polyubiquitin 
chains in vitro. These findings support the notion that aspartic acid 681 is required for 
binding and/or enzymatic reaction of CYLD with K63-linked polyubiquitin chains. 
 
566
Non-melanoma skin cancer and skin innervation: a correlation?
G Sepic, P Wolf, FJ Legat, B Leinweber, H Kerl Medical University of Graz, Austria
Chronic UVR exposure induces photoaging and increases the risk for photocarcinogenesis. 
After tumor initiation, UVR-induced immunosuppression is capable of promoting tumor 
growth. Neuropeptides from cutaneous nerves contribute to local and systemic UVR-induced 
immunosuppression, and the number of skin nerves is increased in chronic UVR-exposed 
skin. Thus, we investigated the innervation of the skin within and around non-melanoma 
skin cancers (NMSC) to learn more about possible correlations between skin innervation and 
skin tumor development. Histological sections from excision or shaving biopsies of NMSC, 
such as actinic keratosis (AK), carcinoma in situ (Cis), or squamous cell carcinoma (SCC), or 
basal cell carcinoma (BCC), from 45 patients were stained using a polyclonal antibody to the 
panneuronal marker protein gene product (PGP) 9.5. Stained sections were analysed for the 
PGP 9.5-immunoreactive area as a percentage of the whole skin section comprising tumor 
as well as surrounding non-tumor tissue using ‘analySIS’software (Olympus).Skin sections 
from BCC (n=28) had a significant higher innervation density than the group of NMSC 
comprising AK, Cis, and SCC (n=36). This was the case for the innervation density of the 
whole tissue sections as well as for tumor adjacent skin at the edges of the respective tissue 
sections. While innervation density of the whole BCC sections was significantly higher than 
non-tumor tissue in BCC sections, there was no significant difference between innervation 
densities of whole NMSC sections compared to non-tumor tissue in NMSC sections. In 
summary, BCC and its surrounding skin shows a higher innervation density compared to the 
group of NMSC comprising AK, Cis, and SCC. Whether this is relevant for the pathogenesis of 
the respective NMSC and possibly may contribute to the promotion of the different types of 
NMSC in photo-damaged skin, or represents an epiphenomenon, remains to be determined. 
 
567
RANKL, a regulator of keratinocyte proliferation and survival is overexpressed in 
cutaneous malignancies
J-B Barbaroux1, CG Mueller2, RW Groves3 1King’s College London, UK 2IBMC, 
Strasbourg, France 3St. Johns Institute of Dermatology, London, UK
The TNF superfamily signalling pathway consisting of RANK, its ligand (RANKL) and a decoy 
receptor osteoprotegerin (OPG), has been associated with numerous activities including 
regulation of dendritic cell function, differentiation and activation of osteoclasts as well as major 
functions in epithelial systems. We have previously demonstrated expression of RANK and its 
ligand in epidermis and were therefore interested to explore its role in the regulation of epidermal 
homeostasis. Normal human skin samples (N=3) were analysed by immunofluorescence 
and flow cytometry for RANK, RANKL and OPG expression. Immunofluorescent labelling 
demonstrated that RANK and RANKL were expressed by KC and were significantly regulated 
with differentiation in situ. OPG could not be detected. Flow cytometric analysis of fresh 
epidermal cell suspensions demonstrated intracellular RANKL in all keratinocytes, with 
additional cell surface bound RANKL in the suprabasal population. RANK was expressed 
by all KC. In vitro, RANKL had a marked protective effect against TRAIL induced apoptosis 
in HaCaT cells (mean Δ=12.19%; N=3; P=0.0103) and significantly increased their growth 3 
fold (N=3; P<0.001). In vivo, RANKL deficient mice displayed 2.5 fold decreased keratinocyte 
proliferation when compared to littermate controls (N=7; P<0.0001). RANK and RANKL 
expression was next analysed in BCC (n=5) and in actinic keratoses (N=3). Keratinocytes in both 
tumours expressed RANKL and demonstrated increased expression of RANK and dysregulated 
differentiation associated expression of both molecules, with increased labelling of the basal 
compartment. These data indicate that RANK and RANKL are regulated upon KC differentiation 
and transformation. Signalling through RANK sustained HaCaT growth and survival. In other cell 
types RANK mediates activation of NFkB, AKT and JNK pathways, all known to play key roles 
skin cancers. We hypothesise that RANKL signalling may protect transformed KC in BCC and 
actinic keratoses from apoptosis and promote their proliferation.
568
Recent Advances in the Molecular Biology of Cutaneous Lymphomas
MH Vermeer, CP Tensen, R Van Doorn, R Willemze Leiden University Medical Center, 
Leiden, Netherlands
Primary cutaneous T-cell lymphomas (CTCL) encompass a clinically and biologically heterogeneous 
group of extranodal non-Hodgkin lymphomas that clinically present in the skin. Recent studies 
have used unbiased, genome wide platforms to identify (epi)genetic alterations and gene expression 
profiles in CTCL with the goal of identifying the characteristic disease specific genetic lesions in 
CTCL. In Sézary syndrome (Sz) a CTCL characterized by the presence of neoplastic T-cells in the 
skin, lymph nodes and peripheral blood a detailed catalog of numerical and structural chromosomal 
abnormalities was obtained using high-resolution array-based CGH, in combination with COBRA-
FISH. Quantitative polymerase chain reaction (PCR) confirmatory studies validated expression 
levels of selected oncogenes and tumor suppressor genes residing within loci with frequent 
copy number alterations. Results indicate that increased IL-2 cytokine signalling and oncogenic 
activation of Myc in conjunction with abrogation of the Myc-induced apoptotic response are central 
in the pathogenesis of Sz. In CD4+CD56+ hematodermic neoplasm an aggressive hematopoietic 
malignancy that commonly involves the skin, bone marrow, and blood array CGH and gene 
expression profiling identified recurrent deletion of regions on chromosome 4 (4q34), chromosome 
9 (9p13-p11 and 9q12-q34), and chromosome 13 (13q12-q31) that contain several tumor 
suppressor genes with diminished expression (Rb1, LATS2). Elevated expression of the oncogenes 
HES6, RUNX2, and FLT3 was found but was not associated with genomic amplification. In addition, 
epigenetic silencing of several tumor suppressor genes by promoter methylation was identified in 
mycosis fungoides and CD30- CTCL including BCL7a (48% of CTCL samples), PTPRG (27%), and 
THBS4 (52%) using CpG island microarrays. In conclusion, these studies demonstrate recurrent 
genetic and epigenetic alterations in CTCL resulting in activation of oncogenes and inactivation of 
tumor suppressor genes. These results may provide a framework to advance the dissection of disease 
pathogenesis, early detection of disease and development of targeted drug discovery. 
569
TRAIL-mediated activation of mitogen-activated protein kinases in human 
keratinocytes: p38 activation is necessary for TRAIL-induced IL-8 secretion
T Wachter1, M Felcht1, M Feoktistova2, S Kavuri2, P Geserick2, D Siegmund2, 
EB Bröcker2, M Leverkus3 1UniHautklinik Würzburg 2Uni of Magdeburg, Germany
The death ligand TRAIL represents an interesting target for tumour therapy because of its ability to 
specifically induce apoptosis in transformed, but not primary cells. While transformed keratinocytes 
(HaCaT) activate an apoptotic program following ligation of TRAIL death receptors 1 (TRAIL-R1) and TRAIL-
R2, primary keratinocytes are relatively resistant towards TRAIL-mediated apoptosis. However, under 
apoptosis-resistant conditions, alternative non-apoptotic signalling pathways as the transcription factor NF-
kB are activated by TRAIL. In contrast the induction of TRAIL-mediated mitogen-activated protein kinases 
(MAPK) and its potential function is currently unclear. To investigate if TRAIL activates MAPK in primary 
and transformed human keratinocytes, we characterized posttranslational MAPK modifications following 
TRAIL stimulation. The phosphorylated active forms of the MAPK ERK1/2 and p38 were rapidly induced 
within minutes by TRAIL in a caspase-independent manner. In contrast, JNK activation as determined by 
c-Jun kinase assays occurred only at late time points and could be inhibited by the pancaspase-inhibitor 
zVAD-fmk. To block caspases more physiologically, HaCaT keratinocytes were stably transfected with the 
intracellular caspase-8 inhibitor cFLIPL. Interestingly, cFLIPL was unable to interfere with TRAIL-mediated 
ERK activation, while delayed JNK activation was fully blocked. To assess the physiological relevance of 
these TRAIL-activated signalling pathways, we investigated TRAIL-mediated induction of the known target 
gene interleukin (IL)-8 in the presence of different MAPK inhibitors. While MEK inhibitor U0126 efficiently 
blocked TRAIL-induced ERK activation, it did not interfere with TRAIL-mediated IL-8 secretion. In contrast, 
p38 inhibitor SB 203580 partially repressed TRAIL-mediated IL-8 secretion, indicating a crucial role of 
p38 activation for target gene induction by TRAIL. Our data indicate that TRAIL-induced MAPK activation 
might initiate apoptosis-independent signals including differentiation, proliferation and inflammation in 
the skin. We speculate that TRAIL, under apoptosis-resistant conditions, could exert protumoral activity via 
activation of different MAPK in a tissue-specific manner. 
570
Contribution of Rac1 to the formation of malignant sweat gland tumours in mice
I Haase, K Behrendt, M Tscharntke, R Pofahl, R Knaup, T Krieg, C Niemann University 
of Cologne, Germany
The small GTP binding protein Rac1 can regulate the proliferative potential as 
well as adhesion and migration of epidermal keratinocytes. It plays an important 
role in epidermal wound healing and the morphogenesis of hair follicles. Over- 
expression and constitutive activation of Rac1 have been described in squamous 
cell carcinomas of the skin and mucosa. We have asked whether activation of 
Rac1 was sufficient to cause progression of benign skin lesions to invasive tumours. 
Mice with epidermis specific expression of delta n LEF, a truncated version of the 
transcription factor LEF (K14 delta nLEF transgenic mice), develop sebaceous 
adenomas of the skin. We have activated Rac1 signalling in these benign skin 
lesions by crossing mice expressing a mutated version of Rac1, L61Rac1, as a 
transgene under the control of the keratin 14 promoter (K14Rac1L61 mice) to 
K14 delta nLEF transgenic mice. Resulting K14 delta nLEF/ K14Rac1L61 double 
transgenic mice developed, in addition to sebaceous adenomas, fast growing, 
poorly differentiated, invasive skin tumours at low frequency. These tumours stained 
positive for keratin 14 but only focally expressed markers of squamous epithelial 
differentiation. Instead, expression of markers of sebaceous differentiation could be 
demonstrated. These tumours did not develop in K14 delta nLEF transgenic mice or 
in K14Rac1L61 mice. We conclude that constitutive activation of Rac1 contributes 
to the progression of sebaceous adenomas to invasive sebaceous tumours of the skin. 
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A Role for the Receptor Tyrosine Kinase, Axl, in Cutaneous Squamous Cell 
Carcinoma Survival
E Papadakis, JJ Vyas, EA O’Toole, A Storey Queen Mary University of London, UK
Axl is a transmembrane receptor tyrosine kinase with oncogenic potential and transforming 
activity. Axl overexpression has been reported in several human cancers including uveal 
melanoma, colon and prostate carcinoma and cutaneous squamous cell carcinoma (SCC). 
Axl is overexpressed in MET1 (a SCC cell line derived from a primary tumour), but is not 
expressed in PM1 (a spontaneously immortalised cell line derived from dysplastic skin from 
the same patient). We hypothesised that Axl may have an anti-apoptotic effect in SCC, thereby 
promoting sustained tumour cell proliferation and survival. To investigate this hypothesis, 
PM1 cells were transduced with wt Axl (PM1-Axlwt), mutant Axl (PM1-Axlmut) or a pLXSN 
vector control. Axl expression was also abrogated in MET1 cells using the pSuperior shRNA 
retroviral vector (MET1-pSupshRNA). PM1-Axlwt exhibited increased proliferation compared 
to PM1-Axlmut or pLXSN control cells. MET1-pSupshRNA exhibited increased sensitivity 
to UV-induced apoptosis and increased caspase-3 and -8 activity shown by Annexin V-FITC 
FACS staining and fluorogenic caspase assays respectively. Western blotting data showed 
that basal expression levels of the pro-apoptotic protein Bid were elevated in PM1-Axlwt 
and in MET1. Moreover, Bax expression levels were increased in response to UV in MET1 
and PM1-Axlwt but not in PM1-Axlmut. Phosphorylation of the survival signalling protein 
Akt on Ser473 and its downstream pro-apoptotic substrate Bad on Ser136, resulting in Bad 
deactivation, was sustained during UV treatment in MET1 containing pSuperior alone but not 
in MET1-pSupshRNA. These data show that Axl confers resistance of SCC cells to apoptosis 
by modulating apoptotic and survival signalling pathways. This study further contributes 
to establishing Axl as a possible target for therapeutic intervention in cutaneous SCC. 
 
572
Epidermal growth factor receptor expression increases with malignant potential in 
peripheral nerve sheath tumors of patients with NF1
N Ortonne, L Allanore, L Zelek, L Lantieri, P Wolkenstein Hôpital Henri Mondor, 
Créteil, France
Malignant peripheral nerve sheath tumors (MPNSTs) cell lines and tumors have been 
shown to express EGFR, but the spectrum of EGFR expression in benign and malignant 
tumors from patients with neurofibromatosis type 1 (NF1) has not been investigated.EGFR 
expression was evaluated (staining intensity and pattern, and proportion of positive cells) by 
immunohistochemistry in 24 tumor samples (7 diffuse neurofibroma (NF), 9 plexiform NF, 
and 8 MPNSTs) from 17 patients with NF1. Diffuse NF areas around plexiform variants (n=4) 
were also analyzed. We found that EGFR expression correlated to the histopathological 
subtypes of tumors. Staining was negative (27%) or involved less than 5% cells (73%) in 
diffuse areas. EGFR expression was more diffusely and intensely expressed in all plexiform 
variants, with a strong staining intensity in 5 cases (56%), and a higher proportion (5-50%) 
of positive cells in 7 (78%). Interestingly, EGFR expression appeared in all cases to be 
more prominent at the periphery of the plexiform structures, reminiscent of perineurial 
cells. Interestingly, in a subset of diffuse neurofibromas, focal plexiform structures were 
present, in which the staining was significantly higher than in the remaining diffuse areas. 
All MPNSTs (100%) expressed EGFR, with more than 50% of positive cells in 3 cases. EGFR 
expression in NF1 correlates with tumor growth pattern and malignant potential, as it is 
mostly expressed in MPNSTs and plexiform NFs. Our results further suggest that plexiform 
and diffuse NFs are biologically distinct and support that mixed variant, ie diffuse NF with 
plexiform structures exist. These results also suggest that the downstream signaling cascade 
mediated by EGFR plays a role in tumor development. In such hypothesis, the therapeutic 
blockade of EGFR may be of benefit in these patients, both to treat malignant tumors and/or 
prevent their development by targeting deep-seated plexiform NF.
573
Genetic background and p53 gene-dose are major susceptibility factors for basal 
cell carcinomas (BCCs) in murine skin
X Tang1, AL Kim1, L Kopelovich2, DR Bickers1, M Athar3 1Columbia University, New 
York, USA 2NCI, Bethesda, USA 3The University of Alabama at Birmingham, USA
Mutations in sonic hedgehog (shh) signaling genes including patched (ptch) drive 
the growth of BCCs. p53 gene mutations are also found in human BCCs. However, 
genetic susceptibility factors for the pathogenesis of shh signaling-dependent 
epithelial tumors are poorly understood. We developed transgenic ptch1+/- on 
SKH-1 hairless background that manifested accelerated growth of both spontaneous 
and radiation-induced BCCs, compared to ptch+/- on C57BL/6 background. This 
enhanced tumor susceptibility was due to a single nucleotide polymorphism (SNP) at 
T1267N in ptch1 gene in SKH-1 mice. The same mutation was present in UVB- or IR-
induced BCCs in ptch1+/-/C57BL/6 strain. The T1267N SNP is known to regulate the 
expression of a tumor suppressor, Tid1, which if dysregulated, augments NFkappaB-
mediated cell proliferation. We found that Tid1 preferentially accumulated in murine 
BCCs as compared to overlying epidermis. Cyclin D1, a NFkappaB target gene, was 
also increased in BCCs. We further assessed the role of p53 inactivation in BCC 
growth in ptch1+/-/C57BL/6 mice. These animals were treated with CP-31398 a 
styrylquinazoline known to restore tumor suppressor functions of mutant p53 protein. 
Topical administration of CP-31398 (50 mg/kg) inhibited the growth of IR-induced 
BCCs. CP-31398 restored wild-type p53 activity and augmented expression of p53-
responsive genes such as p21 and mdm2, but reduced UVB-induced overexpression 
of Bcl-2, PCNA and cyclin D1. ptch1+/-/p53+/-/SKH-1 strain developed multiple 
spontaneous BCC on both dorsal and ventral skin, whereas p53+/- or ptch1+/- 
littermates had no such lesions. Chemical inactivation of p53 with pifithrin-alpha 
accelerated the onset of spontaneous tumors. Our data confirm that p53 status and 
genetic background influence susceptibility to spontaneous and UVB-induced BCCs. 
574
Cell cycle dependent H2AX phosphorylation in MSH2 deficient mouse fibroblasts 
after irradiation with UVB
M Seifert, A Weinhold, W Tilgen, J Reichrath
University of Saarland, Homburg, Germany
UV-induced DNA damage is the major risk factor for the carcinogenesis of epithelial 
skin tumors. Recent observations show increasing evidence that defective DNA 
mismatch repair (MMR) is also attributable to be a risk factor for the multistep 
tumourigenesis of UV-associated skin cancer. Increase in phosphorylated histone 
H2AX foci has been shown to signal the presence of DNA damage, in particular 
double strand breaks. UV-light does not directly produce DNA double-strand breaks 
but rather produces pyrimidine dimers and other photoproducts, that must be removed 
or bypassed to prevent arrest of the replication fork. We have analyzed effects of 
UV irradiation on expression of phosphorylated H2AX in MSH2-defective (MSH2-/-) 
and MSH2 wild type cells in different cell cycle phases by FACS analysis. While 
IR characteristically induced visual H2AX foci, we observed in contrast in response 
to UV-radiation the induction of a more homogeneous lawn of fluorescence rather 
than countable individual foci. Interestingly, induction of H2AX-immunoreactivity in 
response to greater doses of UV-B was increased in MSH2-deficient as compared to 
wt cells in early S-Phase cells. 
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Proteinase-activated receptors 1 and 2 in non-melanoma skin cancer
A Rattenholl1, G Bocheva2, S Seeliger1, J Ehrchen1, M Schön3, MP Schön3, C Kempkes1, 
J Buddenkotte1, M D’Andrea4, S Ständer1, M Steinhoff1 1University of Münster, 
Germany 2Sofia Medical University, Bulgaria 3University of Würzburg, Germany 
4Johnson & Johnson, Spring House, USA
Proteinase-activated receptors 1 and 2 (PAR-1 and PAR-2) are G-protein coupled receptors which 
are stimulated by specific proteolytic cleavage of the extracellular N-terminus. Both receptors 
were reported to be involved in tumor progression and metastasis. However, PAR-2 was also 
previously found to be downregulated in some gastric carcinomas, suggesting a tumor protective 
role for this receptor in certain epithelial tissues. To further address this issue, the presence of 
PAR-1 and PAR-2 in basal (BCCs) and squamous cell carcinomas (SCCs) was investigated 
by immunohistochemistry. A total of 18 basal cell carcinomas (BCCs) and 35 squamous cell 
carcinomas (SCCs) of different stages was analyzed. Whereas PAR-1 immunoreactivity was 
significantly upregulated in all types of BCCs and in well to poorly differentiated SCCs, PAR-2 
immunolabeling was significantly downregulated in BCCs and in moderate to poorly differentiated 
SCCs. This hints to a diverse regulation of PAR-1 and PAR-2 expression during carcinogenesis of 
non-melanoma skin cancer indicating that PAR-1 may be involved in cancer progression whereas 
PAR-2 has an opposed function and prevents tumorigenesis. To further investigate a probable tumor 
suppressive role of PAR-2 in skin, we established a mouse skin tumor model using chemically 
induced carcinogenesis. After 13 weeks, PAR-2-deficient mice showed a significantly increased 
number of skin tumors (14 per animal on the average) in contrast to the wild-type (eight tumors per 
mouse). Keratinocyte proliferation and apoptosis was comparable in papillomas of both groups. 
Moreover, angiogenesis was slightly enhanced in PAR-2-deficient tumors. Antibody array analysis 
revealed that the chemokine LIX/CXCL5 was upregulated in PAR-2-deficient mouse papillomas. 
CXCL5 is known to contribute to squamous cell carcinoma proliferation and invasion. Together, 
PAR-2 might play an important role in the regulation of chemokine expression in the skin. 
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